0001306830-24-000098 10-Q 111 20240331 20240510 20240510 Celanese Corp 0001306830 2820 08 Industrial Applications and Services 980420726 DE 1231 10-Q 34 001-32410 24935059 222 W. LAS COLINAS BLVD., SUITE 900N IRVING TX 75039-5421 972-443-4000 222 W. LAS COLINAS BLVD., SUITE 900N IRVING TX 75039-5421 Celanese CORP 20041102 Blackstone Crystal Holdings Capital Partners (Cayman) IV Ltd. 20041022 10-Q 1 ce-20240331.htm 10-Q ce-20240331
000130683012/312024Q1falsehttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#InterestExpensehttp://fasb.org/us-gaap/2023#InterestExpensehttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#CostOfGoodsAndServicesSoldhttp://fasb.org/us-gaap/2023#ForeignCurrencyTransactionGainLossBeforeTaxhttp://fasb.org/us-gaap/2023#ForeignCurrencyTransactionGainLossBeforeTaxhttp://fasb.org/us-gaap/2023#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2023#ForeignCurrencyTransactionGainLossBeforeTax http://fasb.org/us-gaap/2023#OtherNonoperatingIncomeExpensehttp://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsCurrent http://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2023#OtherAssetsCurrenthttp://fasb.org/us-gaap/2023#OtherAssetsCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent911xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureiso4217:CNYiso4217:EUR00013068302024-01-012024-03-310001306830us-gaap:CommonStockMember2024-01-012024-03-310001306830ce:EURSeniorUnsecuredNotesDue2025Member2024-01-012024-03-310001306830ce:EURSeniorUnsecuredNotesDue2026Member2024-01-012024-03-310001306830ce:EURSeniorUnsecuredNotesDue2027Member2024-01-012024-03-310001306830ce:EURSeniorUnsecuredNotesDue2028Member2024-01-012024-03-310001306830ce:EURSeniorUnsecuredNotesDue2029Member2024-01-012024-03-3100013068302024-05-0300013068302023-01-012023-03-3100013068302024-03-3100013068302023-12-310001306830us-gaap:CommonStockMember2023-12-310001306830us-gaap:CommonStockMember2022-12-310001306830us-gaap:CommonStockMember2024-01-012024-03-310001306830us-gaap:CommonStockMember2023-01-012023-03-310001306830us-gaap:CommonStockMember2024-03-310001306830us-gaap:CommonStockMember2023-03-310001306830us-gaap:TreasuryStockCommonMember2023-12-310001306830us-gaap:TreasuryStockCommonMember2022-12-310001306830us-gaap:TreasuryStockCommonMember2024-01-012024-03-310001306830us-gaap:TreasuryStockCommonMember2023-01-012023-03-310001306830us-gaap:TreasuryStockCommonMember2024-03-310001306830us-gaap:TreasuryStockCommonMember2023-03-310001306830us-gaap:AdditionalPaidInCapitalMember2023-12-310001306830us-gaap:AdditionalPaidInCapitalMember2022-12-310001306830us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001306830us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001306830us-gaap:AdditionalPaidInCapitalMember2024-03-310001306830us-gaap:AdditionalPaidInCapitalMember2023-03-310001306830us-gaap:RetainedEarningsMember2023-12-310001306830us-gaap:RetainedEarningsMember2022-12-310001306830us-gaap:RetainedEarningsMember2024-01-012024-03-310001306830us-gaap:RetainedEarningsMember2023-01-012023-03-310001306830us-gaap:RetainedEarningsMember2024-03-310001306830us-gaap:RetainedEarningsMember2023-03-310001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001306830us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-3100013068302023-03-310001306830us-gaap:NoncontrollingInterestMember2023-12-310001306830us-gaap:NoncontrollingInterestMember2022-12-310001306830us-gaap:NoncontrollingInterestMember2024-01-012024-03-310001306830us-gaap:NoncontrollingInterestMember2023-01-012023-03-310001306830us-gaap:NoncontrollingInterestMember2024-03-310001306830us-gaap:NoncontrollingInterestMember2023-03-3100013068302022-12-310001306830ce:ConsolidatedVenturesMember2024-03-310001306830ce:NutrinovaJointVentureMemberce:CelaneseCorporationMember2023-09-300001306830ce:NutrinovaJointVentureMemberce:MitsuiCoLtdMember2023-09-300001306830ce:NutrinovaJointVentureMemberce:MitsuiCoLtdMember2023-09-012023-09-300001306830ce:NutrinovaJointVentureMember2023-09-012023-09-300001306830ce:UentropGermanyMemberce:EngineeredMaterialsMember2024-01-012024-03-310001306830ce:UentropGermanyMemberce:EngineeredMaterialsMember2024-03-310001306830ce:MechelenBelgiumMemberce:EngineeredMaterialsMember2024-01-012024-03-310001306830ce:MechelenBelgiumMemberce:EngineeredMaterialsMember2024-03-310001306830ce:EngineeredMaterialsMember2023-12-310001306830ce:AcetylChainMember2023-12-310001306830ce:EngineeredMaterialsMember2024-01-012024-03-310001306830ce:AcetylChainMember2024-01-012024-03-310001306830ce:EngineeredMaterialsMember2024-03-310001306830ce:AcetylChainMember2024-03-310001306830us-gaap:LicensingAgreementsMember2023-12-310001306830us-gaap:CustomerRelationshipsMember2023-12-310001306830us-gaap:DevelopedTechnologyRightsMember2023-12-310001306830us-gaap:OtherIntangibleAssetsMember2023-12-310001306830us-gaap:LicensingAgreementsMember2024-01-012024-03-310001306830us-gaap:CustomerRelationshipsMember2024-01-012024-03-310001306830us-gaap:DevelopedTechnologyRightsMember2024-01-012024-03-310001306830us-gaap:OtherIntangibleAssetsMember2024-01-012024-03-310001306830us-gaap:LicensingAgreementsMember2024-03-310001306830us-gaap:CustomerRelationshipsMember2024-03-310001306830us-gaap:DevelopedTechnologyRightsMember2024-03-310001306830us-gaap:OtherIntangibleAssetsMember2024-03-310001306830us-gaap:TrademarksAndTradeNamesMember2023-12-310001306830us-gaap:TrademarksAndTradeNamesMember2024-01-012024-03-310001306830us-gaap:TrademarksAndTradeNamesMember2024-03-310001306830us-gaap:RevolvingCreditFacilityMember2024-03-310001306830us-gaap:RevolvingCreditFacilityMember2023-12-310001306830us-gaap:ShortTermDebtMember2024-03-310001306830us-gaap:ShortTermDebtMember2023-12-310001306830us-gaap:RevolvingCreditFacilityMember2024-03-310001306830us-gaap:RevolvingCreditFacilityMember2023-12-310001306830ce:SeniorUnsecuredNotesDue2024Member2024-03-310001306830ce:SeniorUnsecuredNotesDue2024Member2023-12-310001306830ce:USDSeniorUnsecuredNotesDue2024Member2024-03-310001306830ce:USDSeniorUnsecuredNotesDue2024Member2023-12-310001306830ce:EURSeniorUnsecuredNotesDue2025Member2024-03-310001306830ce:EURSeniorUnsecuredNotesDue2025Member2023-12-310001306830ce:USDSeniorUnsecuredNotesDue2025Member2024-03-310001306830ce:USDSeniorUnsecuredNotesDue2025Member2023-12-310001306830ce:USDSeniorUnsecuredNotesDue2026Member2024-03-310001306830ce:USDSeniorUnsecuredNotesDue2026Member2023-12-310001306830ce:EURSeniorUnsecuredNotesDue2026Member2024-03-310001306830ce:EURSeniorUnsecuredNotesDue2026Member2023-12-310001306830ce:EURSeniorUnsecuredNotesDue2027Member2024-03-310001306830ce:EURSeniorUnsecuredNotesDue2027Member2023-12-310001306830ce:USDSeniorUnsecuredNotesDue2027Member2024-03-310001306830ce:USDSeniorUnsecuredNotesDue2027Member2023-12-310001306830ce:SeniorUnsecuredTermLoanDue2027Member2024-03-310001306830ce:SeniorUnsecuredTermLoanDue2027Member2023-12-310001306830ce:EURSeniorUnsecuredNotesDue2028Member2024-03-310001306830ce:EURSeniorUnsecuredNotesDue2028Member2023-12-310001306830ce:USDSeniorUnsecuredNotesDue2028Member2024-03-310001306830ce:USDSeniorUnsecuredNotesDue2028Member2023-12-310001306830ce:EURSeniorUnsecuredNotesDue2029Member2024-03-310001306830ce:EURSeniorUnsecuredNotesDue2029Member2023-12-310001306830ce:USDSeniorUnsecuredNotesDue2029Member2024-03-310001306830ce:USDSeniorUnsecuredNotesDue2029Member2023-12-310001306830ce:USDSeniorUnsecuredNotesDue2030Member2024-03-310001306830ce:USDSeniorUnsecuredNotesDue2030Member2023-12-310001306830ce:USDSeniorUnsecuredNotesDue2032Member2024-03-310001306830ce:USDSeniorUnsecuredNotesDue2032Member2023-12-310001306830ce:USDSeniorUnsecuredNotesDue2033Member2024-03-310001306830ce:USDSeniorUnsecuredNotesDue2033Member2023-12-310001306830ce:PollutionControlAndIndustrialRevenueBondsMember2024-03-310001306830ce:PollutionControlAndIndustrialRevenueBondsMember2023-12-310001306830ce:BankLoanDue2026Member2024-03-310001306830ce:BankLoanDue2026Member2023-12-310001306830us-gaap:LoansPayableMember2024-03-310001306830us-gaap:LoansPayableMember2023-12-310001306830srt:MinimumMemberce:PollutionControlAndIndustrialRevenueBondsMember2024-03-310001306830srt:MaximumMemberce:PollutionControlAndIndustrialRevenueBondsMember2024-03-310001306830ce:TermLoanFacilityMemberce:A364DayDelayedDrawTermLoanMember2022-03-012022-03-310001306830ce:TermLoanFacilityMemberce:A364DayDelayedDrawTermLoanMember2022-03-310001306830ce:A5YearDelayedDrawTermLoanMemberce:TermLoanFacilityMember2022-03-012022-03-310001306830ce:A5YearDelayedDrawTermLoanMemberce:TermLoanFacilityMember2022-03-310001306830us-gaap:RevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2022-03-310001306830ce:VariableInterbankInterestRateMemberus-gaap:RevolvingCreditFacilityMembersrt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2024-01-012024-03-310001306830ce:VariableInterbankInterestRateMembersrt:MaximumMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2024-01-012024-03-310001306830ce:ChinaRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2023-01-310001306830ce:ChinaWorkingCapitalTermLoanMemberce:ChinaWorkingCapitalTermLoanMember2024-01-012024-03-310001306830ce:ChinaWorkingCapitalTermLoanMemberce:ChinaWorkingCapitalTermLoanMember2023-01-310001306830ce:ChinaWorkingCapitalTermLoanMemberce:ChinaWorkingCapitalTermLoanMember2023-01-012023-01-310001306830ce:VariableInterbankInterestRateMemberce:ChinaWorkingCapitalTermLoanMemberce:ChinaWorkingCapitalTermLoanMember2023-01-012023-01-310001306830ce:BankLoanDue2026Memberce:CNCWorkingCapitalLoanMember2023-12-310001306830us-gaap:RevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2024-03-310001306830ce:ChinaRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2024-03-310001306830us-gaap:RevolvingCreditFacilityMemberus-gaap:SubsequentEventMember2024-05-082024-05-080001306830ce:SeniorUnsecuredNotesDue2024Memberus-gaap:SubsequentEventMember2024-05-082024-05-080001306830ce:SeniorUnsecuredNotesDue2024Memberus-gaap:SubsequentEventMember2024-05-080001306830ce:USDSeniorUnsecuredNotesDue2028Member2023-08-310001306830ce:USDSeniorUnsecuredNotesDue2030Member2023-08-310001306830ce:USDSeniorUnsecuredNotesDue2033Member2023-08-3100013068302023-08-310001306830ce:USDSeniorUnsecuredNotesDue2024Member2023-08-310001306830ce:USDSeniorUnsecuredNotesDue2024Member2023-08-012023-08-310001306830ce:USDSeniorUnsecuredNotesDue2025Member2023-08-310001306830ce:USDSeniorUnsecuredNotesDue2025Member2023-08-012023-08-310001306830ce:SeniorUnsecuredNotesDue2024Member2023-08-310001306830ce:SeniorUnsecuredNotesDue2024Member2023-08-012023-08-310001306830us-gaap:SecuredDebtMemberce:AmendedRestatedReceivablePurchasingFacilityMember2024-01-012024-03-310001306830us-gaap:SecuredDebtMemberce:AmendedRestatedReceivablePurchasingFacilityMember2024-03-310001306830us-gaap:SecuredDebtMemberce:AmendedRestatedReceivablePurchasingFacilityMember2023-12-310001306830us-gaap:SecuredDebtMemberce:AmendedRestatedReceivablePurchasingFacilityMember2023-01-012023-12-310001306830ce:EuropeFactoringAgreementsMember2024-03-310001306830ce:SingaporeFactoringAgreementsMember2024-03-310001306830ce:ChinaFactoringAgreementsMember2024-03-310001306830ce:ChinaEuropeAndSingaporeFactoringAgreementsMember2024-03-310001306830ce:ChinaEuropeAndSingaporeFactoringAgreementsMember2023-12-310001306830ce:ChinaEuropeAndSingaporeFactoringAgreementsMember2024-01-012024-03-310001306830ce:ChinaEuropeAndSingaporeFactoringAgreementsMember2023-01-012023-12-310001306830ce:MasterDiscountingAgreementMember2024-03-310001306830ce:MasterDiscountingAgreementMember2023-12-310001306830us-gaap:PensionPlansDefinedBenefitMember2024-01-012024-03-310001306830us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-01-012024-03-310001306830us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-03-310001306830us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-01-012023-03-310001306830us-gaap:PensionPlansDefinedBenefitMember2024-03-310001306830us-gaap:OtherPensionPlansDefinedBenefitMember2024-01-012024-03-310001306830us-gaap:OtherPensionPlansDefinedBenefitMember2024-03-310001306830us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-03-310001306830us-gaap:PensionPlansDefinedBenefitMember2023-12-310001306830us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-12-310001306830ce:PassaicRiverNewJerseyMember2024-01-012024-03-310001306830ce:PassaicRiverNewJerseyMember2016-03-012016-03-310001306830ce:PassaicRiverNewJerseyMember2021-09-012021-09-300001306830ce:PassaicRiverNewJerseyMember2022-12-012022-12-310001306830ce:PassaicRiverNewJerseyMember2023-03-012023-03-310001306830ce:PassaicRiverNewJerseyMember2024-03-310001306830us-gaap:SubsequentEventMember2024-04-172024-04-1700013068302008-02-012024-03-310001306830us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001306830us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember2023-12-310001306830us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310001306830us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-03-310001306830us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember2024-01-012024-03-310001306830us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-03-310001306830us-gaap:AccumulatedTranslationAdjustmentMember2024-03-310001306830us-gaap:AociDerivativeQualifyingAsHedgeExcludedComponentParentMember2024-03-310001306830us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-03-310001306830us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMember2024-01-012024-03-310001306830us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMember2023-01-012023-03-310001306830us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2024-01-012024-03-310001306830us-gaap:InterestRateSwapMemberus-gaap:CashFlowHedgingMember2023-01-012023-03-310001306830us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2024-01-012024-03-310001306830us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMember2023-01-012023-03-310001306830us-gaap:CashFlowHedgingMember2024-01-012024-03-310001306830us-gaap:CashFlowHedgingMember2023-01-012023-03-310001306830us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMember2024-01-012024-03-310001306830us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMember2023-01-012023-03-310001306830us-gaap:NetInvestmentHedgingMemberce:ForeignCurrencyDenominatedDebtMember2024-01-012024-03-310001306830us-gaap:NetInvestmentHedgingMemberce:ForeignCurrencyDenominatedDebtMember2023-01-012023-03-310001306830us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMember2024-01-012024-03-310001306830us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMember2023-01-012023-03-310001306830us-gaap:NetInvestmentHedgingMember2024-01-012024-03-310001306830us-gaap:NetInvestmentHedgingMember2023-01-012023-03-310001306830us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-01-012024-03-310001306830us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-01-012023-03-310001306830us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMemberce:JapaneseYenDenominatedBorrowingMember2024-03-310001306830us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMemberce:JapaneseYenDenominatedBorrowingMember2023-08-310001306830us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMemberce:EuroDenominatedBorrowingsMember2023-08-310001306830us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMemberce:EuroDenominatedBorrowingsMember2024-03-310001306830ce:EuroDenominatedBorrowingDue2028Member2023-08-012023-08-310001306830ce:EuroDenominatedBorrowingDue2030Member2023-08-012023-08-310001306830us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2024-03-310001306830us-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:FairValueHedgingMemberce:ForeignCurrencyDenominatedDebtMember2024-03-312024-03-310001306830us-gaap:CurrencySwapMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueHedgingMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:CurrencySwapMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueHedgingMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:NetInvestmentHedgingMemberce:ForeignCurrencyDenominatedDebtMember2024-03-312024-03-310001306830us-gaap:CurrencySwapMemberus-gaap:OtherCurrentAssetsMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:CurrencySwapMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-03-310001306830us-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NondesignatedMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:FairValueMeasurementsRecurringMemberus-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NondesignatedMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NondesignatedMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMember2023-12-310001306830us-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:FairValueHedgingMemberce:ForeignCurrencyDenominatedDebtMember2023-12-312023-12-310001306830us-gaap:CurrencySwapMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueHedgingMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:CurrencySwapMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueHedgingMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:CurrencySwapMemberus-gaap:FairValueHedgingMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:NetInvestmentHedgingMemberce:ForeignCurrencyDenominatedDebtMember2023-12-312023-12-310001306830us-gaap:CurrencySwapMemberus-gaap:OtherCurrentAssetsMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:CurrencySwapMemberus-gaap:OtherCurrentLiabilitiesMemberus-gaap:NetInvestmentHedgingMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:CurrencySwapMemberus-gaap:NetInvestmentHedgingMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-12-310001306830us-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NondesignatedMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:FairValueMeasurementsRecurringMemberus-gaap:NondesignatedMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NondesignatedMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:NondesignatedMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:FairValueMeasurementsRecurringMemberus-gaap:OtherNoncurrentAssetsMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:OtherCurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:FairValueInputsLevel2Member2024-03-310001306830us-gaap:FairValueInputsLevel3Member2024-03-310001306830us-gaap:FairValueInputsLevel2Member2023-12-310001306830us-gaap:FairValueInputsLevel3Member2023-12-310001306830ce:IndemnificationAgreementsHoechstMember2024-03-310001306830ce:IndemnificationAgreementsHoechstMember1999-11-012024-03-310001306830ce:DivestitureAgreementsMember2024-03-310001306830us-gaap:OperatingSegmentsMemberce:EngineeredMaterialsMember2024-01-012024-03-310001306830ce:AcetylChainMemberus-gaap:OperatingSegmentsMember2024-01-012024-03-310001306830us-gaap:CorporateAndOtherMemberus-gaap:CorporateNonSegmentMember2024-01-012024-03-310001306830us-gaap:IntersegmentEliminationMember2024-01-012024-03-310001306830us-gaap:OperatingSegmentsMemberce:EngineeredMaterialsMember2024-03-310001306830ce:AcetylChainMemberus-gaap:OperatingSegmentsMember2024-03-310001306830us-gaap:CorporateAndOtherMemberus-gaap:CorporateNonSegmentMember2024-03-310001306830us-gaap:IntersegmentEliminationMember2024-03-310001306830us-gaap:OperatingSegmentsMemberce:EngineeredMaterialsMember2023-01-012023-03-310001306830ce:AcetylChainMemberus-gaap:OperatingSegmentsMember2023-01-012023-03-310001306830us-gaap:CorporateAndOtherMemberus-gaap:CorporateNonSegmentMember2023-01-012023-03-310001306830us-gaap:IntersegmentEliminationMember2023-01-012023-03-310001306830us-gaap:OperatingSegmentsMemberce:EngineeredMaterialsMember2023-12-310001306830ce:AcetylChainMemberus-gaap:OperatingSegmentsMember2023-12-310001306830us-gaap:CorporateAndOtherMemberus-gaap:CorporateNonSegmentMember2023-12-310001306830us-gaap:IntersegmentEliminationMember2023-12-3100013068302024-04-012024-03-3100013068302025-01-012024-03-3100013068302026-01-012024-03-310001306830srt:NorthAmericaMemberce:EngineeredMaterialsMember2024-01-012024-03-310001306830srt:NorthAmericaMemberce:EngineeredMaterialsMember2023-01-012023-03-310001306830us-gaap:EMEAMemberce:EngineeredMaterialsMember2024-01-012024-03-310001306830us-gaap:EMEAMemberce:EngineeredMaterialsMember2023-01-012023-03-310001306830srt:AsiaPacificMemberce:EngineeredMaterialsMember2024-01-012024-03-310001306830srt:AsiaPacificMemberce:EngineeredMaterialsMember2023-01-012023-03-310001306830srt:SouthAmericaMemberce:EngineeredMaterialsMember2024-01-012024-03-310001306830srt:SouthAmericaMemberce:EngineeredMaterialsMember2023-01-012023-03-310001306830ce:EngineeredMaterialsMember2023-01-012023-03-310001306830srt:NorthAmericaMemberce:AcetylChainMember2024-01-012024-03-310001306830srt:NorthAmericaMemberce:AcetylChainMember2023-01-012023-03-310001306830ce:AcetylChainMemberus-gaap:EMEAMember2024-01-012024-03-310001306830ce:AcetylChainMemberus-gaap:EMEAMember2023-01-012023-03-310001306830srt:AsiaPacificMemberce:AcetylChainMember2024-01-012024-03-310001306830srt:AsiaPacificMemberce:AcetylChainMember2023-01-012023-03-310001306830srt:SouthAmericaMemberce:AcetylChainMember2024-01-012024-03-310001306830srt:SouthAmericaMemberce:AcetylChainMember2023-01-012023-03-310001306830ce:AcetylChainMember2023-01-012023-03-310001306830us-gaap:IntersegmentEliminationMemberce:AcetylChainMember2024-01-012024-03-310001306830us-gaap:IntersegmentEliminationMemberce:AcetylChainMember2023-01-012023-03-310001306830us-gaap:EmployeeStockOptionMember2024-01-012024-03-310001306830us-gaap:EmployeeStockOptionMember2023-01-012023-03-310001306830us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-03-310001306830us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001306830us-gaap:EmployeeSeveranceMemberce:EngineeredMaterialsMember2023-12-310001306830us-gaap:EmployeeSeveranceMemberce:AcetylChainMember2023-12-310001306830us-gaap:EmployeeSeveranceMemberus-gaap:CorporateAndOtherMember2023-12-310001306830us-gaap:EmployeeSeveranceMember2023-12-310001306830us-gaap:EmployeeSeveranceMemberce:EngineeredMaterialsMember2024-01-012024-03-310001306830us-gaap:EmployeeSeveranceMemberce:AcetylChainMember2024-01-012024-03-310001306830us-gaap:EmployeeSeveranceMemberus-gaap:CorporateAndOtherMember2024-01-012024-03-310001306830us-gaap:EmployeeSeveranceMember2024-01-012024-03-310001306830us-gaap:EmployeeSeveranceMemberce:EngineeredMaterialsMember2024-03-310001306830us-gaap:EmployeeSeveranceMemberce:AcetylChainMember2024-03-310001306830us-gaap:EmployeeSeveranceMemberus-gaap:CorporateAndOtherMember2024-03-310001306830us-gaap:EmployeeSeveranceMember2024-03-31
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_______________________________________________________
Form 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
March 31, 2024
Or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Commission File Number: 001-32410
CElogo.jpg
CELANESE CORPORATION
(Exact Name of Registrant as Specified in its Charter)
Delaware98-0420726
(State or Other Jurisdiction of Incorporation or Organization)(I.R.S. Employer Identification No.)

222 W. Las Colinas Blvd., Suite 900N
Irving, TX 75039-5421
(Address of Principal Executive Offices and zip code)

(972443-4000
(Registrant's telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of Each ClassTrading Symbol(s) Name of Each Exchange on Which Registered
Common Stock, par value $0.0001 per shareCEThe New York Stock Exchange
1.250% Senior Notes due 2025CE /25The New York Stock Exchange
4.777% Senior Notes due 2026CE /26AThe New York Stock Exchange
2.125% Senior Notes due 2027CE /27The New York Stock Exchange
0.625% Senior Notes due 2028CE /28The New York Stock Exchange
5.337% Senior Notes due 2029CE /29AThe New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes   No 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes   No 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer  þ Accelerated filer   Non-accelerated filer   Smaller reporting company   Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes   No 
The number of outstanding shares of the registrant's Common Stock, $0.0001 par value, as of May 3, 2024 was 109,219,856.


CELANESE CORPORATION AND SUBSIDIARIES
Form 10-Q
For the Quarterly Period Ended March 31, 2024
TABLE OF CONTENTS
Page
2


Item 1. Financial Statements
CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months Ended
March 31,
20242023
(In $ millions, except share and per share data)
Net sales2,611 2,853 
Cost of sales(2,057)(2,222)
Gross profit554 631 
Selling, general and administrative expenses(265)(285)
Amortization of intangible assets(41)(41)
Research and development expenses(34)(42)
Other (charges) gains, net(14)(23)
Foreign exchange gain (loss), net11 6 
Gain (loss) on disposition of businesses and assets, net(1)5 
Operating profit (loss)210 251 
Equity in net earnings (loss) of affiliates55 15 
Non-operating pension and other postretirement employee benefit (expense) income2 1 
Interest expense(169)(182)
Interest income13 8 
Dividend income - equity investments34 34 
Other income (expense), net12 (6)
Earnings (loss) from continuing operations before tax157 121 
Income tax (provision) benefit(33)(25)
Earnings (loss) from continuing operations124 96 
Earnings (loss) from operation of discontinued operations (3)
Income tax (provision) benefit from discontinued operations  
Earnings (loss) from discontinued operations (3)
Net earnings (loss)124 93 
Net (earnings) loss attributable to noncontrolling interests(3)(2)
Net earnings (loss) attributable to Celanese Corporation121 91 
Amounts attributable to Celanese Corporation  
Earnings (loss) from continuing operations121 94 
Earnings (loss) from discontinued operations (3)
Net earnings (loss)121 91 
Earnings (loss) per common share - basic  
Continuing operations1.11 0.87 
Discontinued operations (0.03)
Net earnings (loss) - basic1.11 0.84 
Earnings (loss) per common share - diluted  
Continuing operations1.10 0.86 
Discontinued operations (0.03)
Net earnings (loss) - diluted1.10 0.83 
Weighted average shares - basic109,069,060 108,634,068 
Weighted average shares - diluted109,513,991 109,188,266 

See the accompanying notes to the unaudited interim consolidated financial statements.
3

CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF
COMPREHENSIVE INCOME (LOSS)
Three Months Ended
March 31,
20242023
(In $ millions)
Net earnings (loss)124 93 
Other comprehensive income (loss), net of tax
Foreign currency translation gain (loss)(54)13 
Gain (loss) on derivative hedges2 4 
Pension and postretirement benefits(1)(1)
Total other comprehensive income (loss), net of tax(53)16 
Total comprehensive income (loss), net of tax71 109 
Comprehensive (income) loss attributable to noncontrolling interests
(3)(2)
Comprehensive income (loss) attributable to Celanese Corporation
68 107 

See the accompanying notes to the unaudited interim consolidated financial statements.
4

CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED CONSOLIDATED BALANCE SHEETS
As of
March 31,
2024
As of
December 31,
2023
(In $ millions, except share data)
ASSETS
Current Assets  
Cash and cash equivalents1,483 1,805 
Trade receivables - third party and affiliates1,289 1,243 
Non-trade receivables, net536 541 
Inventories2,354 2,357 
Other assets283 272 
Total current assets5,945 6,218 
Investments in affiliates1,238 1,220 
Property, plant and equipment (net of accumulated depreciation - 2024: $4,243; 2023: $4,080)
5,471 5,584 
Operating lease right-of-use assets396 422 
Deferred income taxes1,618 1,677 
Other assets537 524 
Goodwill6,926 6,977 
Intangible assets, net3,902 3,975 
Total assets26,033 26,597 
LIABILITIES AND EQUITY
Current Liabilities  
Short-term borrowings and current installments of long-term debt - third party and affiliates2,439 1,383 
Trade payables - third party and affiliates1,447 1,510 
Other liabilities1,011 1,154 
Income taxes payable28 25 
Total current liabilities4,925 4,072 
Long-term debt, net of unamortized deferred financing costs11,018 12,301 
Deferred income taxes1,016 999 
Uncertain tax positions298 300 
Benefit obligations444 457 
Operating lease liabilities296 325 
Other liabilities505 591 
Commitments and Contingencies
Shareholders' Equity  
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2024 and 2023: 0 issued and outstanding)
  
Common stock, $0.0001 par value, 400,000,000 shares authorized (2024: 170,780,600 issued and 109,210,286 outstanding; 2023: 170,476,740 issued and 108,906,426 outstanding)
  
Treasury stock, at cost (2024: 61,570,314 shares; 2023: 61,570,314 shares)
(5,488)(5,488)
Additional paid-in capital383 394 
Retained earnings12,973 12,929 
Accumulated other comprehensive income (loss), net(797)(744)
Total Celanese Corporation shareholders' equity7,071 7,091 
Noncontrolling interests460 461 
Total equity7,531 7,552 
Total liabilities and equity26,033 26,597 

See the accompanying notes to the unaudited interim consolidated financial statements.
5

CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF EQUITY
Three Months Ended March 31,
20242023
SharesAmountSharesAmount
(In $ millions, except share data)
Common Stock
Balance as of the beginning of the period108,906,426  108,473,932  
Stock option exercises7,947    
Stock awards295,913  312,806  
Balance as of the end of the period109,210,286  108,786,738  
Treasury Stock
Balance as of the beginning of the period61,570,314 (5,488)61,661,493 (5,491)
Issuance of treasury stock under stock plans    
Balance as of the end of the period61,570,314 (5,488)61,661,493 (5,491)
Additional Paid-In Capital
Balance as of the beginning of the period394 372 
Stock-based compensation, net of tax(12)(7)
Stock option exercises, net of tax1  
Balance as of the end of the period383 365 
Retained Earnings
Balance as of the beginning of the period12,929 11,274 
Net earnings (loss) attributable to Celanese Corporation121 91 
Common stock dividends(77)(76)
Balance as of the end of the period12,973 11,289 
Accumulated Other Comprehensive Income (Loss), Net
Balance as of the beginning of the period(744)(518)
Other comprehensive income (loss), net of tax(53)16 
Balance as of the end of the period(797)(502)
Total Celanese Corporation shareholders' equity7,071 5,661 
Noncontrolling Interests
Balance as of the beginning of the period461 468 
Net earnings (loss) attributable to noncontrolling interests3 2 
Distributions/dividends to noncontrolling interests(4)(1)
Balance as of the end of the period460 469 
Total equity7,531 6,130 

See the accompanying notes to the unaudited interim consolidated financial statements.
6

CELANESE CORPORATION AND SUBSIDIARIES
UNAUDITED INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS
Three Months Ended
March 31,
20242023
(In $ millions)
Operating Activities
Net earnings (loss)124 93 
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities
Depreciation, amortization and accretion227 178 
Pension and postretirement net periodic benefit cost1 3 
Pension and postretirement contributions(13)(12)
Deferred income taxes, net(6)1 
(Gain) loss on disposition of businesses and assets, net1 (6)
Stock-based compensation10 14 
Undistributed earnings in unconsolidated affiliates(28)25 
Other, net3 (1)
Operating cash provided by (used in) discontinued operations(8)1 
Changes in operating assets and liabilities
Trade receivables - third party and affiliates, net(55)(216)
Inventories(19)45 
Other assets34 99 
Trade payables - third party and affiliates(21)(22)
Other liabilities(149)(298)
Net cash provided by (used in) operating activities101 (96)
Investing Activities
Capital expenditures on property, plant and equipment(137)(164)
Proceeds from sale of businesses and assets, net 9 
Other, net(14)(23)
Net cash provided by (used in) investing activities(151)(178)
Financing Activities
Net change in short-term borrowings with maturities of 3 months or less10 (300)
Proceeds from short-term borrowings146 338 
Repayments of short-term borrowings(418) 
Proceeds from long-term debt111  
Repayments of long-term debt(6)(7)
Stock option exercises
1  
Common stock dividends(77)(76)
Distributions/dividends to noncontrolling interests
(4)(1)
Other, net(22)(23)
Net cash provided by (used in) financing activities(259)(69)
Exchange rate effects on cash and cash equivalents(13)2 
Net increase (decrease) in cash and cash equivalents(322)(341)
Cash and cash equivalents as of beginning of period1,805 1,508 
Cash and cash equivalents as of end of period1,483 1,167 

See the accompanying notes to the unaudited interim consolidated financial statements.
7

CELANESE CORPORATION AND SUBSIDIARIES
NOTES TO THE UNAUDITED INTERIM CONSOLIDATED FINANCIAL STATEMENTS
1. Description of the Company and Basis of Presentation
Description of the Company
Celanese Corporation and its subsidiaries (collectively, the "Company") is a global chemical and specialty materials company. The Company produces high performance engineered polymers that are used in a variety of high-value applications, as well as acetyl products, which are intermediate chemicals for nearly all major industries. The Company also engineers and manufactures a wide variety of products essential to everyday living. The Company's broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, medical, consumer electronics, energy storage, filtration, paints and coatings, paper and packaging, industrial applications and textiles.
Definitions
In this Quarterly Report on Form 10-Q ("Quarterly Report"), the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The term "Celanese U.S." refers to the Company's subsidiary, Celanese US Holdings LLC, a Delaware limited liability company, and not its subsidiaries.
Basis of Presentation
The unaudited interim consolidated financial statements for the three months ended March 31, 2024 and 2023 contained in this Quarterly Report were prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for all periods presented and include the accounts of the Company, its majority owned subsidiaries over which the Company exercises control and, when applicable, variable interest entities in which the Company is the primary beneficiary. The unaudited interim consolidated financial statements and other financial information included in this Quarterly Report, unless otherwise specified, have been presented to separately show the effects of discontinued operations.
In the opinion of management, the accompanying unaudited consolidated balance sheets and related unaudited interim consolidated statements of operations, comprehensive income (loss), cash flows and equity include all adjustments, consisting only of normal recurring items necessary for their fair presentation in conformity with U.S. GAAP. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with rules and regulations of the Securities and Exchange Commission ("SEC"). These unaudited interim consolidated financial statements should be read in conjunction with the Company's consolidated financial statements as of and for the year ended December 31, 2023, filed on February 23, 2024 with the SEC as part of the Company's Annual Report on Form 10-K.
Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results to be expected for the entire year.
In the ordinary course of business, the Company enters into contracts and agreements relative to a number of topics, including acquisitions, dispositions, joint ventures, supply agreements, product sales and other arrangements. The Company endeavors to describe those contracts or agreements that are material to its business, results of operations or financial position. The Company may also describe some arrangements that are not material but in which the Company believes investors may have an interest or which may have been included in a Form 8-K filing. Investors should not assume the Company has described all contracts and agreements relative to the Company's business in this Quarterly Report.
For those consolidated ventures in which the Company owns or is exposed to less than 100% of the economics, the outside shareholders' interests are shown as noncontrolling interests.
Estimates and Assumptions
The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of net sales, expenses and allocated charges during the reporting period. Significant estimates pertain to impairments of goodwill, intangible assets and other long-lived assets, purchase price allocations, restructuring costs and other (charges) gains, net, income taxes, pension and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates.
8

2. Recent Accounting Pronouncements
The following table provides a brief description of recent Accounting Standard Updates ("ASU") issued by the Financial Accounting Standards Board ("FASB"):
StandardDescriptionEffective DateEffect on the Financial Statements or Other Significant Matters
In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures.
The new guidance requires an entity to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Additionally, the guidance requires an entity to disclose annual income taxes paid (net of refunds received) disaggregated by federal (national), state and foreign taxes and disaggregate the information by jurisdiction based on a quantitative threshold. The guidance also requires an entity to disclose income (loss) from continuing operations before income tax expense (benefit) disaggregated between domestic and foreign and income tax expense (benefit) from continuing operations disaggregated by federal (national), state and foreign.Effective for annual periods beginning after December 15, 2024. Early adoption is permitted.The Company is currently evaluating the impact of the adoption on its financial statement disclosures.
In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures.
The new guidance requires an entity to disclose, on an annual and interim basis, significant segment expenses that are regularly provided to the chief operating decision maker ("CODM") and included within segment profit or loss, as well as an amount of other segment items by reportable segment and a description of its composition. Additionally, the guidance requires an entity to disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The update is required to be applied retrospectively to prior periods presented, based on the significant segment expense categories identified and disclosed in the period of adoption.Effective for annual periods beginning after December 15, 2023, and for interim periods beginning after December 15, 2024. Early adoption is permitted.The Company is currently evaluating the impact of the adoption on its financial statement disclosures.
9

3. Acquisitions, Dispositions and Plant Closures
Acquisitions
•    Nutrinova Joint Venture
In September 2023, the Company formed a food ingredients joint venture with Mitsui & Co., Ltd. ("Mitsui") under the name Nutrinova. The Company contributed receivables, inventory, property, plant and equipment, certain other assets, liabilities, technology and employees of its food ingredients business while retaining a 30% interest in the joint venture. Mitsui acquired the remaining 70% interest in the food ingredients business for a purchase price of $503 million, subject to transaction adjustments. The Company is accounting for its interest in the joint venture as an equity method investment, and its portion of the results continues to be included in the Engineered Materials segment. A gain on the transaction of $515 million was included in Gain (loss) on disposition of businesses and assets, net in the consolidated statements of operations for the year ended December 31, 2023.
Plant Closures
Uentrop, Germany
In October 2023, the Company announced the intended closure of its Polyamide 66 ("PA66") and High-Performance Nylon ("HPN") polymerization units at its facility in Uentrop, Germany to optimize production costs across its global network. These operations are included in the Company's Engineered Materials segment. The Company fully ceased operation of the PA66 polymerization unit and partially ceased operation of the HPN polymerization units during the three months ended March 31, 2024.
The exit and shutdown costs related to the closure of the PA66 and HPN polymerization units in Uentrop, Germany were as follows:
Three Months Ended
March 31,
2024
(In $ millions)
Restructuring(1)
5 
Accelerated depreciation expense(2)
37 
Total42 
______________________________
(1)Included in Other (charges) gains, net in the unaudited interim consolidated statements of operations (Note 18).
(2)Included in Cost of sales in the unaudited interim consolidated statements of operations.
The Company expects to incur additional exit and shutdown costs related to the closure of the PA66 and HPN polymerization units in Uentrop, Germany of approximately $36 million, inclusive of estimated employee termination costs, through 2025.
10

Mechelen, Belgium
On February 29, 2024, the Company announced the intended closure of its facility in Mechelen, Belgium to optimize production costs across its global network. This operation is included in the Company's Engineered Materials segment. The Company plans to cease operations in the fourth quarter of 2024.
Three Months Ended
March 31,
2024
(In $ millions)
Accelerated depreciation expense(1)
8 
Total8 
______________________________
(1)Included in Cost of sales in the unaudited interim consolidated statements of operations.
The Company expects to incur additional exit and shutdown costs related to the closure of the facility at Mechelen, Belgium of approximately $130 million, inclusive of estimated employee termination costs, through 2025.
4. Inventories
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Finished goods1,650 1,604 
Work-in-process128 160 
Raw materials and supplies576 593 
Total2,354 2,357 
5. Goodwill and Intangible Assets, Net
Goodwill
Engineered
Materials
Acetyl ChainTotal
(In $ millions)
As of December 31, 20236,602 375 6,977 
Exchange rate changes(46)(5)(51)
As of March 31, 2024(1)
6,556 370 6,926 
______________________________
(1)There were no accumulated impairment losses as of March 31, 2024.
11

Intangible Assets, Net
Finite-lived intangible assets are as follows:
LicensesCustomer-
Related
Intangible
Assets
Developed
Technology
Covenants
Not to
Compete
and Other
Total
(In $ millions)
Gross Asset Value
As of December 31, 202341 2,437 601 55 3,134 
Exchange rate changes(1)(28)  (29)
As of March 31, 202440 2,409 601 55 3,105 
Accumulated Amortization
As of December 31, 2023(38)(639)(95)(42)(814)
Amortization (30)(11) (41)
Exchange rate changes 9 2 1 12 
As of March 31, 2024(38)(660)(104)(41)(843)
Net book value2 1,749 497 14 2,262 
Indefinite-lived intangible assets are as follows:
Trademarks
and Trade Names
(In $ millions)
As of December 31, 20231,655 
Exchange rate changes(15)
As of March 31, 20241,640 
During the three months ended March 31, 2024, the Company did not renew or extend any intangible assets.
Estimated amortization expense for the succeeding five fiscal years is as follows:
(In $ millions)
2025161 
2026160 
2027160 
2028160 
2029155 
12

6. Current Other Liabilities
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Benefit obligations (Note 8)
25 25 
Customer rebates76 96 
Derivatives (Note 12)
58 90 
Interest (Note 7)
194 246 
Legal (Note 14)
12 34 
Operating leases86 89 
Restructuring (Note 18)
19 18 
Salaries and benefits133 175 
Sales and use tax/foreign withholding tax payable133 128 
Investment in affiliates96 96 
Other179 157 
Total1,011 1,154 
7. Debt
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates
Current installments of long-term debt2,348 1,025 
Short-term borrowings, including amounts due to affiliates(1)
50 146 
Revolving credit facilities(2)
41 212 
Total2,439 1,383 
______________________________
(1)The weighted average interest rate was 2.2% and 2.9% as of March 31, 2024 and December 31, 2023, respectively.
(2)The weighted average interest rate was 3.2% and 3.4% as of March 31, 2024 and December 31, 2023, respectively.
13

As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Long-Term Debt
Senior unsecured notes due 2024, interest rate of 3.500%
473 473 
Senior unsecured notes due 2024, interest rate of 5.900%
527 527 
Senior unsecured notes due 2025, interest rate of 1.250%
324 331 
Senior unsecured notes due 2025, interest rate of 6.050%
1,000 1,000 
Senior unsecured notes due 2026, interest rate of 1.400%
400 400 
Senior unsecured notes due 2026, interest rate of 4.777%
1,081 1,105 
Senior unsecured notes due 2027, interest rate of 2.125%
539 551 
Senior unsecured notes due 2027, interest rate of 6.165%
2,000 2,000 
Senior unsecured term loan due 2027(1)
880 880 
Senior unsecured notes due 2028, interest rate of 0.625%
540 552 
Senior unsecured notes due 2028, interest rate of 6.350%
1,000 1,000 
Senior unsecured notes due 2029, interest rate of 5.337%
540 552 
Senior unsecured notes due 2029, interest rate of 6.330%
750 750 
Senior unsecured notes due 2030, interest rate of 6.550%
999 999 
Senior unsecured notes due 2032, interest rate of 6.379%
1,000 1,000 
Senior unsecured notes due 2033, interest rate of 6.700%
1,000 1,000 
Pollution control and industrial revenue bonds due at various dates through 2030(2)
126 127 
Bank loan due 2026, interest rate of 2.8%
111  
Bank loans due at various dates through 2030(3)
5 5 
Obligations under finance leases due at various dates through 2054
140 148 
Subtotal13,435 13,400 
Unamortized deferred financing costs(4)
(69)(74)
Current installments of long-term debt(2,348)(1,025)
Total11,018 12,301 
______________________________
(1)The interest rate was 6.922% and 6.943% as of March 31, 2024 and December 31, 2023, respectively.
(2)Interest rates range from 4.05% to 5.00%.
(3)The weighted average interest rate was 2.7% and 2.6% as of March 31, 2024 and December 31, 2023, respectively.
(4)Related to the Company's long-term debt, excluding obligations under finance leases.
Senior Credit Facilities
In March 2022, Celanese, Celanese U.S. and certain subsidiaries entered into a term loan credit agreement (as amended to date, the "March 2022 U.S. Term Loan Credit Agreement"), pursuant to which lenders provided a tranche of delayed-draw term loans due 364 days from issuance in an amount equal to $500 million (the "364-day Term Loans") and a tranche of delayed-draw term loans due 5 years from issuance in an amount equal to $1.0 billion (the "5-year Term Loans"). The 364-day Term Loans have been fully repaid.
Also in March 2022, Celanese, Celanese U.S. and certain subsidiaries entered into a new revolving credit agreement (as amended to date, the "U.S. Revolving Credit Agreement" and, together with the March 2022 U.S. Term Loan Credit Agreement, the "U.S. Credit Agreements") consisting of a $1.75 billion senior unsecured revolving credit facility (with a letter of credit sublimit), maturing in 2027 (the "U.S. Revolving Credit Facility"). The margin for borrowings under the U.S. Revolving Credit Facility was 1.00% to 2.00% above certain interbank rates at current Company credit ratings.
In August 2023, the Company amended certain covenants in the March 2022 U.S. Term Loan Credit Agreement to permit refinancing of certain senior notes without requiring a mandatory prepayment under the March 2022 U.S. Term Loan Credit Agreement.
14

On February 16, 2024 and February 21, 2023, the Company amended certain covenants in the U.S. Credit Agreements, including financial ratio maintenance covenants.
The U.S. Credit Agreements are guaranteed by Celanese, Celanese U.S. and domestic subsidiaries together representing substantially all of the Company's U.S. assets and business operations (the "Subsidiary Guarantors"). The Subsidiary Guarantors are listed in Exhibit 22.1 to this Quarterly Report.
In January 2023, Celanese (Shanghai) International Trading Co., Ltd ("CSIT"), a fully consolidated subsidiary, entered into a restatement of an existing credit facility agreement (the "China Revolving Credit Agreement") to upsize and modify the facility thereunder to consist of an aggregate CNY1.75 billion uncommitted senior unsecured revolving credit facility available under two tranches (with overdraft, bank guarantee and documentary credit sublimits) (the "China Revolving Credit Facility"). Obligations bear interest at certain fixed and floating rates. The China Revolving Credit Agreement is guaranteed by Celanese U.S.
Also in January 2023, CSIT entered into a senior unsecured working capital loan contract for CNY800 million (the "China Working Capital Term Loan Agreement"), payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates. The loan under the China Working Capital Term Loan Agreement was fully drawn in January 2023 and was supported by a letter of comfort from the Company. The China Working Capital Term Loan Agreement was fully repaid in the three months ended March 31, 2024.
In December 2023, Celanese (Nanjing) Chemical Co., Ltd. ("CNC") entered into a senior unsecured working capital loan agreement for CNY800 million, payable on December 25, 2026 and bearing interest at 2.8% (the "CNC Working Capital Loan Agreement," together with the China Revolving Credit Agreement and the China Working Capital Term Loan Agreement, the "China Credit Agreements," and the China Credit Agreements together with the U.S. Credit Agreements, the "Global Credit Agreements"). The loan under the CNC Working Capital Loan Agreement was fully drawn during the three months ended March 31, 2024. The Company expects that the China Credit Agreements will continue to facilitate its efficient repatriation of cash to the U.S. to repay debt and effectively redomicile a portion of its U.S. debt to China at a lower average interest rate.
The Company's debt balances and amounts available for borrowing under its senior unsecured revolving credit facilities are as follows:
As of
March 31,
2024
(In $ millions)
U.S. Revolving Credit Facility
Borrowings outstanding 
Available for borrowing1,750 
China Revolving Credit Facility
Borrowings outstanding41 
Available for borrowing201 
On May 8, 2024, the Company drew $300 million from its U.S. Revolving Credit Facility. This borrowing and cash on hand were used to repay in full the Company's senior unsecured notes due 2024, with an interest rate of 3.500%, due on May 8, 2024.
Senior Notes
The Company has outstanding senior unsecured notes, issued in public offerings registered under the Securities Act of 1933, as amended (the "Securities Act") (collectively, the "Senior Notes"). The Senior Notes were issued by Celanese U.S. and are guaranteed on a senior unsecured basis by Celanese and the Subsidiary Guarantors. Celanese U.S. may redeem some or all of each of the Senior Notes, prior to their respective maturity dates, at a redemption price of 100% of the principal amount, plus a "make-whole" premium as specified in the applicable indenture, plus accrued and unpaid interest, if any, to the redemption date.
15

In August 2023, Celanese U.S. completed a public offering registered under the Securities Act of senior unsecured notes as follows (collectively, the "2023 Offering"):
Maturity DateAggregate Principal
Amount Issued
Discount to ParInterest Rate
(In $ millions)
November 15, 20281,000 99.986%6.350%
November 15, 2030999 99.950%6.550%
November 15, 20331,000 99.992%6.700%
In August 2023, Celanese U.S. completed a cash tender offer for $2.25 billion in aggregate principal amount (the "Tender Offer") as follows:
Maturity DateAggregate Principal Amount TenderedPurchase price per $1,000 principal amountTotal Tender Offer ConsiderationAccrued and Unpaid Interest
(In $ millions)(In $ millions)
June 30, 20241,473 $999.92 1,473 12 
March 15, 2025750 $1,002.85 752 20 
April 30, 202427 $983.95 27  
The net proceeds from the 2023 Offering were used (i) to fund the Tender Offer and (ii) for the repayment of other outstanding indebtedness, including the payment in full of the 364-day Term Loans and certain 3-year term loans pursuant to a term loan credit agreement entered into in September 2022.
Accounts Receivable Purchasing Facility
In June 2023, the Company entered into an amendment to the amended and restated receivables purchase agreement (the "Amended Receivables Purchase Agreement") under its U.S. accounts receivable purchasing facility among certain of the Company's subsidiaries, its wholly-owned, "bankruptcy remote" special purpose subsidiary ("SPE") and certain global financial institutions ("Purchasers"). The Amended Receivables Purchase Agreement extends the term of the accounts receivable purchasing facility such that the SPE may sell certain receivables until June 18, 2025. Under the Amended Receivables Purchase Agreement, transfers of U.S. accounts receivable from the SPE are treated as sales and are accounted for as a reduction in accounts receivable because the agreement transfers effective control over and risk related to the U.S. accounts receivable to the SPE. The Company and related subsidiaries have no continuing involvement in the transferred U.S. accounts receivable, other than collection and administrative responsibilities and, once sold, the U.S. accounts receivable are no longer available to satisfy creditors of the Company or the related subsidiaries. These sales are transacted at 100% of the face value of the relevant U.S. accounts receivable, resulting in derecognition of the U.S. accounts receivables from the Company's unaudited consolidated balance sheet. The Company de-recognized $290 million and $1.4 billion of accounts receivable under this agreement for the three months ended March 31, 2024 and year ended December 31, 2023, respectively, and collected $318 million and $1.3 billion of accounts receivable sold under this agreement during the same periods. Unsold U.S. accounts receivable of $153 million were pledged by the SPE as collateral to the Purchasers as of March 31, 2024.
Factoring and Discounting Agreements
The Company has factoring agreements in Europe and Singapore with financial institutions to sell 100% and 90% of certain accounts receivable, respectively, on a non-recourse basis. The Company also has a factoring agreement in China with a financial institution to sell 100% of certain accounts receivable on a limited recourse basis. These transactions are treated as sales and are accounted for as reductions in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyer. The Company has no material continuing involvement in the transferred receivables, other than collection and administrative responsibilities and, once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. The Company de-recognized $164 million and $423 million of accounts receivable under these factoring agreements for the three months ended March 31, 2024 and year ended December 31, 2023, respectively, and collected $110 million and $407 million of accounts receivable sold under these factoring agreements during the same periods.
In December 2023, the Company entered into a Master Discounting Agreement (the "Master Discounting Agreement") with a financial institution in China to discount, on a non-recourse basis, banker's acceptance drafts ("BADs"), classified as accounts receivable. Under the Master Discounting Agreement, the transfer of BADs are treated as sales and are accounted for as a reduction in accounts receivable because the Master Discounting Agreement transfers effective control over and risk related to
16

the transferred BADs to the financial institution. The Company has no continuing involvement in the transferred BADs and the BADs are no longer available to satisfy creditors in the event of a bankruptcy. The Company received $15 million and $45 million from the accounts receivable transferred under the Master Discounting Agreement as of March 31, 2024 and December 31, 2023, respectively.
Covenants
The Company's material financing arrangements contain customary covenants, such as events of default and change of control provisions, and in the case of the U.S. Credit Agreements the maintenance of certain financial ratios (subject to adjustment following certain qualifying acquisitions and dispositions, as set forth in the U.S. Credit Agreements, as amended). Failure to comply with these covenants, or the occurrence of any other event of default, could result in acceleration of the borrowings and other financial obligations.
The Company is in compliance with the covenants in its material financing arrangements as of March 31, 2024.
8. Benefit Obligations
The components of net periodic benefit cost are as follows:
Three Months Ended March 31,
20242023
Pension
Benefits
Post-retirement
Benefits
Pension
Benefits
Post-retirement
Benefits
(In $ millions)
Service cost3  4  
Interest cost31 1 32  
Expected return on plan assets
(34) (33) 
Total 1 3  
Benefit obligation funding is as follows:
As of
March 31,
2024
Total
Expected
2024
(In $ millions)
Cash contributions to defined benefit pension plans7 29 
Benefit payments to nonqualified pension plans5 19 
Benefit payments to other postretirement benefit plans1 3 
The Company's estimates of its U.S. defined benefit pension plan contributions reflect the provisions of the Pension Protection Act of 2006.
Pension and postretirement benefit plan balances recognized in the unaudited consolidated balance sheets consist of the following:
As of March 31, 2024As of December 31, 2023
Pension
Benefits
Post-retirement
Benefits
Pension
Benefits
Post-retirement
Benefits
(In $ millions)
Noncurrent Other assets169  166  
Current Other liabilities(22)(3)(22)(3)
Benefit obligations(402)(37)(415)(37)
Net amount recognized(255)(40)(271)(40)
17

9. Environmental
The Company is subject to environmental laws and regulations worldwide that impose limitations on the discharge of pollutants into the air and water, establish standards for the treatment, storage and disposal of solid and hazardous wastes, and impose record keeping and notification requirements. Failure to timely comply with these laws and regulations may expose the Company to penalties. The Company believes that it is in substantial compliance with all applicable environmental laws and regulations and engages in an ongoing process of updating its controls to mitigate compliance risks. The Company is also subject to retained environmental obligations specified in various contractual agreements arising from the divestiture of certain businesses by the Company or one of its predecessor companies.
The components of environmental remediation liabilities are as follows:
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Demerger obligations (Note 14)
13 14 
Divestiture obligations (Note 14)
13 13 
Active sites25 25 
U.S. Superfund sites7 8 
Other environmental remediation liabilities2 2 
Total60 62 
Remediation
Due to its industrial history and through retained contractual and legal obligations, the Company has the obligation to remediate specific areas on its own sites as well as on divested, demerger, orphan or U.S. Superfund sites (defined below). In addition, as part of the demerger agreement between the Company and Hoechst AG ("Hoechst"), a specified portion of the responsibility for environmental liabilities from a number of Hoechst divestitures was transferred to the Company (Note 14). Certain of these sites, at which the Company maintains continuing involvement, were and continue to be designated as discontinued operations when closed. The Company provides for such obligations when the event of loss is probable and reasonably estimable. The Company believes that environmental remediation costs will not have a material adverse effect on the financial position of the Company, but may have a material adverse effect on the results of operations or cash flows in any given period.
U.S. Superfund Sites
In the U.S., the Company may be subject to substantial claims brought by U.S. federal or state regulatory agencies or private individuals pursuant to statutory authority or common law. In particular, the Company has a potential liability under the U.S. Federal Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, and related state laws (collectively referred to as "Superfund") for investigation and cleanup costs at certain sites. At most of these sites, numerous companies, including the Company, or one of its predecessor companies, have been notified that the U.S. Environmental Protection Agency ("EPA"), state governing bodies or private individuals consider such companies to be potentially responsible parties ("PRP") under Superfund or related laws. The proceedings relating to these sites are in various stages. The cleanup process has not been completed at most sites, and the status of the insurance coverage for some of these proceedings is uncertain. Consequently, the Company cannot accurately determine its ultimate liability for investigation or cleanup costs at these sites.
As events progress at each site for which it has been named a PRP, the Company accrues any probable and reasonably estimable liabilities. In establishing these liabilities, the Company considers the contaminants of concern, the potential impact thereof, the relationship of the contaminants of concern to its current and historic operations, its shipment of waste to a site, its percentage of total waste shipped to the site, the types of wastes involved, the conclusions of any studies, the magnitude of any remedial actions that may be necessary and the number and viability of other PRPs. Often the Company joins with other PRPs to sign joint defense agreements that settle, among PRPs, each party's percentage allocation of costs at the site. Although the ultimate liability may differ from the estimate, the Company routinely reviews the liabilities and revises the estimate, as appropriate, based on the most current information available.
One such site is the Diamond Alkali Superfund Site, which is comprised of a number of sub-sites, including the Lower Passaic River Study Area ("LPRSA"), which is the lower 17-mile stretch of the Passaic River ("Lower Passaic River Site"), and the
18

Newark Bay Study Area. The Company and 70 other companies are parties to a May 2007 Administrative Order on Consent with the EPA to perform a Remedial Investigation/Feasibility Study ("RI/FS") at the Lower Passaic River Site in order to identify the levels of contaminants and potential cleanup actions, including the potential migration of contaminants between the LPRSA and the Newark Bay Study Area.
In March 2016, the EPA issued its final Record of Decision concerning the remediation of the lower 8.3 miles of the Lower Passaic River Site ("Lower 8.3 Miles"). Pursuant to the EPA's Record of Decision, the Lower 8.3 Miles must be dredged bank to bank and an engineered cap must be installed at an EPA estimated cost of approximately $1.4 billion. In September 2021, the EPA issued a Record of Decision selecting an interim remedial plan for the upper 9 miles of the Lower Passaic River ("Upper 9 Miles"). Pursuant to the EPA's Record of Decision, targeted dredging will be conducted in the Upper 9 Miles to address surface sediments with elevated contamination followed by the installation of an engineered cap at an EPA estimated cost of $441 million.
The Company owned and/or operated facilities in the vicinity of the Lower 8.3 Miles, but has found no evidence that it contributed any of the contaminants of concern to the Passaic River. In June 2018, Occidental Chemical Corporation ("OCC"), the successor to the Diamond Alkali Company, sued a subsidiary of the Company and 119 other parties alleging claims for joint and several damages, contribution and declaratory relief under Section 107 and 113 of Superfund for costs to clean up the LPRSA portion of the Diamond Alkali Superfund Site, Occidental Chemical Corporation v. 21st Century Fox America, Inc., et al, No. 2:18-CV-11273 (MCA) (LDW) (U.S. District Court New Jersey) (the "2018 OCC Lawsuit"), alleging that each of the defendants owned or operated a facility that contributed contamination to the LPRSA. With respect to the Company, the 2018 OCC lawsuit is limited to the former Celanese facility that Essex County, New Jersey has agreed to indemnify the Company for and does not change the Company's estimated liability for LPRSA cleanup costs.
Separately, the United States lodged a Consent Decree in U.S. District Court for the District of New Jersey in December 2022 that will resolve the Company's liability (and that of more than 80 other settling defendants) to the EPA for costs to clean up both the Lower 8.3 Miles and Upper 9 Miles of the Lower Passaic River Site in exchange for a collective payment of $150 million, United States v. Alden Leeds, Inc., No. 2:22-7326 (MCA) (LDW) (U.S. District Court New Jersey) ("Consent Decree Action"). The Consent Decree also will provide the Company protection from contribution claims by others for costs incurred to clean up both the Lower 8.3 Miles and Upper 9 Miles of the Lower Passaic River Site. The Company's proposed payment toward the $150 million collective settlement payment is not material to the Company's results of operations, cash flows or financial position. The Consent Decree is still subject to public comment and court approval.
In March 2023, the U.S. District Court for the District of New Jersey entered an order staying and administratively terminating the 2018 OCC Lawsuit, pending resolution of the request for judicial approval of the Consent Decree in the Consent Decree Action. Also in March 2023, OCC filed a new lawsuit against 40 parties, including a subsidiary of the Company, seeking to recover costs for remedial design work the EPA has ordered OCC to undertake for a portion of the LPRSA at an estimated cost of $71 million, Occidental Chemical Corporation v. Givaudan Fragrances Corporation, No. 2:23-cv-1699 (U.S. District Court New Jersey) (the "2023 OCC Lawsuit"). Like the earlier lawsuit, the 2023 OCC Lawsuit concerns the facility Essex County, New Jersey purchased and for which Essex County, New Jersey has agreed to defend and indemnify the Company. This new lawsuit does not change the Company's estimated liability for LPRSA cleanup costs.
The Company will continue to vigorously defend these matters and continues to believe that its ultimate allocable share of the cleanup costs with respect to the Lower Passaic River Site, previously estimated at less than 1%, will not be material.
Other Environmental Matters
In April 2022, a methanol leak on a pipeline to the Company's Bishop, Texas facility was discovered. The release has been contained, the leak has been repaired and the pipeline has resumed operation. The Company promptly disclosed the incident to state and federal authorities, including the Texas Commission on Environmental Quality and the EPA, and remediation activities are now completed. While the Company has not received a notice of violation nor been assessed any fines or penalties to date, the Company recorded a reserve in Other current liabilities based on anticipated clean-up costs and possible penalties to state or federal authorities. The Company does not believe that resolution of this matter will have a material impact on its financial condition or results of operations.
19

10. Shareholders' Equity
Common Stock
The Company's Board of Directors follows a policy of declaring, subject to legally available funds, a quarterly cash dividend on each share of the Company's Common Stock, par value $0.0001 per share ("Common Stock"), unless the Company's Board of Directors, in its sole discretion, determines otherwise. The amount available to the Company to pay cash dividends is not currently restricted by the Global Credit Agreements and its indentures governing its senior unsecured notes. Any decision to declare and pay dividends in the future will be made at the discretion of the Company's Board of Directors and will depend on, among other things, the results of operations, cash requirements, financial condition, contractual restrictions and other factors that the Company's Board of Directors may deem relevant.
The Company declared a quarterly cash dividend of $0.70 per share on its Common Stock on April 17, 2024, amounting to $76 million. The cash dividend will be paid on May 13, 2024 to holders of record as of April 29, 2024.
Treasury Stock
The Company's Board of Directors authorizes repurchases of Common Stock from time to time. These authorizations give management discretion in determining the timing and conditions under which shares may be repurchased. This repurchase program does not have an expiration date.
Total From
February 2008
Through
March 31, 2024
Shares repurchased69,324,429 
Average purchase price per share$83.71 
Shares repurchased (in $ millions)5,803 
Aggregate Board of Directors repurchase authorizations during the period (in $ millions)
6,866 
The purchase of treasury stock reduces the number of shares outstanding. The repurchased shares may be used by the Company for compensation programs utilizing the Company's stock and other corporate purposes. The Company accounts for treasury stock using the cost method and includes treasury stock as a component of shareholders' equity.
The Company did not repurchase any Common Stock during the three months ended March 31, 2024 or 2023.
Other Comprehensive Income (Loss), Net
Three Months Ended March 31,
20242023
Gross
Amount
Income
Tax
(Provision)
Benefit
Net
Amount
Gross
Amount
Income
Tax
(Provision)
Benefit
Net
Amount
(In $ millions)
Foreign currency translation gain (loss)(27)(27)(54)(4)17 13 
Gain (loss) on derivative hedges2  2 4  4 
Pension and postretirement benefits gain (loss)(1) (1)(1) (1)
Total(26)(27)(53)(1)17 16 
20

Adjustments to Accumulated other comprehensive income (loss), net, are as follows:
Foreign
Currency
Translation Gain (Loss)
Gain (Loss)
on Derivative
Hedges
Pension and
Postretirement
Benefits Gain (Loss)
Accumulated
Other
Comprehensive
Income
(Loss), Net
(In $ millions)
As of December 31, 2023(701)(28)(15)(744)
Other comprehensive income (loss) before reclassifications(27)23 (1)(5)
Amounts reclassified from accumulated other comprehensive income (loss)
 (21) (21)
Income tax (provision) benefit(27)  (27)
As of March 31, 2024(755)(26)(16)(797)
11. Income Taxes
Three Months Ended
March 31,
20242023
(In percentages)
Effective income tax rate21 21 
The effective income tax rate for the three months ended March 31, 2024 was consistent with the same period in 2023. The effective income tax rate for the three months ended March 31, 2024 included the tax effects related to internal debt refinancing transactions. The effective income tax rate for the three months ended March 31, 2023 included the impacts of increased valuation allowance on U.S. foreign tax credit carryforwards due to changes in forecasts of foreign sourced income and deductions that did not re-occur in the three months ended March 31, 2024.
In December 2017, the Tax Cuts and Jobs Act (the "TCJA") was enacted and was effective January 1, 2018. The U.S. Treasury has issued various notices and final and proposed regulatory packages supplementing the TCJA provisions since 2018. There have been no material proposed or final regulatory packages during the three months ended March 31, 2024.
In August 2022, the Inflation Reduction Act (the "IRA") was enacted and included a 1% excise tax on share repurchases in excess of $1 million, and a corporate minimum tax of 15% on adjusted book earnings. The corporate minimum tax paid is creditable in future years to the extent regular tax liability exceeds the minimum tax in any given year. The U.S. Treasury issued two sets of proposed regulations related to Section 4501, Excise Tax on Share Repurchase, on April 12, 2024. The Company does not expect these provisions or proposed regulations will have a material impact to future income tax expense. The IRA also provides various beneficial credits for energy efficient related manufacturing, transportation and fuels, hydrogen/carbon recapture and renewable energy, which the Company is evaluating in regard to planned projects.
The Company will continue to monitor the expected impacts of any new guidance on the Company's filing positions and will record the impacts as discrete income tax expense adjustments in the period the guidance is finalized or becomes effective.
Due to the TCJA and uncertainty as to future foreign source income, the Company previously recorded a valuation allowance on a substantial portion of its foreign tax credit carryforwards. The Company is currently evaluating tax planning strategies to enable the use of the Company's foreign tax credit carryforwards that may decrease the Company's effective tax rate in future periods as the valuation allowance is reversed.
In December 2021, the Organization for Economic Co-operation and Development ("OECD") issued final Model Rules for Pillars One and Two of its Base Erosion and Profit Shifting ("BEPS") project. In general, Pillar One addresses nexus concerns and the allocation of profits among companies in which a multinational enterprise ("MNE") conducts its business. Pillar Two aims to ensure that all MNEs pay an effective tax rate of no less than 15% on their adjusted net income in each of the jurisdictions in which they have operations. Pillar Two is more impactful to the Company as it allows for assessment even if the individual countries do not enact its minimum tax provisions. In effect, Pillar Two allows any country within which an MNE operates to levy tax upon that MNE to the extent it determines that the MNE is paying less than a 15% effective tax rate on its adjusted net income. The taxes levied may then be allocated among the jurisdictions that conform to the OECD rules.
21

In December 2022, the member states of the European Union ("EU") unanimously voted to adopt the OECD's minimum tax which was agreed to by consensus of the BEPS 2.0 (Pillars One and Two) signatory jurisdictions. Under the EU's minimum tax directive, member states are to adopt domestic legislation implementing the minimum tax rules effective for periods beginning on or after December 31, 2023, with Pillar Two's "under-taxed profit rule" to take effect for periods beginning on or after December 31, 2024. The EU effective dates are January 1, 2024, and January 1, 2025, for different aspects of the directive. Legislatures in multiple countries outside of the EU have also drafted legislation to implement the OECD's minimum tax proposals.
In July 2023, the OECD published Administrative Guidance proposing certain safe harbor provisions, including an effective rate test and a routine profits test, which if satisfied effectively will delay effective dates of Pillar Two to January 1, 2027. The EU and a significant number of other countries are expected to implement the safe harbor in local legislation. Based on these safe harbor provisions, the Company currently expects that, in several material jurisdictions, including the U.S., Netherlands, Switzerland, Germany, China, Singapore and Canada, it will qualify for the safe harbor effectively extending the application of the global minimum tax until January 1, 2027.
The Company will continue to monitor the developments and implementation of the OECD BEPS projects. Currently the Company does not meet the requirements for the application of Pillar One. The Company analyzed the application of the safe harbor provisions and does not expect a material impact in 2024 from the local adoption of the OECD Pillar Two proposals, but is continuing to model the effect of these provisions on its future effective tax rate and cash taxes.
The Company's tax returns have been under audit for the years 2013 through 2015 by the United States, Netherlands and Germany (the "Authorities"). In September 2021, the Company received a draft joint audit report proposing adjustments to transfer pricing and the reallocation of income between the related jurisdictions. The Authorities also proposed to apply these adjustments to open tax years through 2019. The Company and the Authorities were unable to reach an agreement jointly and therefore the audits continued on a separate jurisdictional basis. In the fourth quarter of 2022, the Company concluded settlement discussions with the Dutch tax authority. The Company is engaged in continuing discussions with the other Authorities and is currently evaluating all additional potential remedies regarding the ongoing examinations.
In addition, the Company's income tax returns in Mexico are under audit for the year 2018, and in Canada for the years 2016 through 2022. In August 2023, the Company negotiated a partial settlement with the Mexico tax authority for its audit for the year 2018. The partial settlement did not have a material impact on income tax expense in the consolidated statements of operations for the year ended December 31, 2023. In September 2023, the Canadian tax authority opened tax audits for the years 2019 through 2022, and the audits are in the preliminary stages. The Company is in ongoing discussions regarding the audit findings with the Canadian tax authority for the years 2016 through 2018 and does not expect a material impact to income tax expense.
As of March 31, 2024, the Company believes that an adequate provision for income taxes has been made for all open tax years related to the examinations by government authorities. However, the outcome of tax audits cannot be predicted with certainty. If any issues raised in the audits described above are resolved in a manner inconsistent with the Company's expectations or the Company is unsuccessful in defending its positions, the Company could be required to adjust its provision for income taxes in the period such resolution occurs. If required, any such adjustments could be material to the statements of operations and cash flows in the period(s) recorded.
22

12. Derivative Financial Instruments
Information regarding changes in the fair value of the Company's derivative and non-derivative instruments is as follows:
Gain (Loss) Recognized in Other Comprehensive Income (Loss)Gain (Loss) Recognized in Earnings (Loss)
Three Months Ended March 31, Statement of Operations Classification
2024202320242023
(In $ millions)
Designated as Cash Flow Hedges
Commodity swaps3  (1)1 Cost of sales
Interest rate swaps  (2)(2)Interest expense
Foreign currency forwards 2  (1)Cost of sales
Total3 2 (3)(2)
Designated as Fair Value Hedges
Cross-currency swaps(1)
19  24  Foreign exchange gain (loss), net
Designated as Net Investment Hedges
Foreign currency denominated debt67 (56)  N/A
Cross-currency swaps70 (19)  N/A
Total137 (75)  
Not Designated as Hedges
Foreign currency forwards and swaps  16 2 Foreign exchange gain (loss), net; Other income (expense), net
______________________________
(1)In conjunction with the 2023 Offering (Note 7) in August 2023, the Company entered into a cross-currency swap to effectively convert $500 million of the issued notes into a Japanese yen-denominated borrowing at prevailing yen interest rates, maturing on July 15, 2029. The swap qualifies and has been designated as a fair value hedge of the Company's foreign currency exchange rate exposure on the long-term debt of its Japanese yen-denominated subsidiary.
Additionally, in conjunction with the 2023 Offering (Note 7) in August 2023, the Company entered into cross-currency swaps to effectively convert $1.0 billion of the issued notes into 5-year and 7-year euro-denominated borrowings at prevailing euro interest rates, maturing on November 15, 2028 and November 15, 2030, respectively. The swaps qualify and have been designated as fair value hedges of the Company's foreign currency exchange rate exposure on the long-term debt of its euro-denominated subsidiary.
See Note 13 for additional information regarding the fair value of the Company's derivative instruments.
Certain of the Company's commodity swaps, interest rate swaps, cross-currency swaps and foreign currency forwards and swaps permit the Company to net settle all contracts with the counterparty through a single payment in an agreed upon currency in the event of default or early termination of the contract, similar to a master netting arrangement.
23

Information regarding the gross amounts of the Company's derivative instruments and the amounts offset in the unaudited consolidated balance sheets is as follows:
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Derivative Assets
Gross amount recognized201 183 
Gross amount offset in the consolidated balance sheets  
Net amount presented in the consolidated balance sheets201 183 
Gross amount not offset in the consolidated balance sheets32 40 
Net amount169 143 
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Derivative Liabilities
Gross amount recognized316 440 
Gross amount offset in the consolidated balance sheets  
Net amount presented in the consolidated balance sheets316 440 
Gross amount not offset in the consolidated balance sheets32 40 
Net amount284 400 
24

13. Fair Value Measurements
The Company's financial assets and liabilities are measured at fair value on a recurring basis as follows:
Derivative financial instruments include interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps and are valued in the market using discounted cash flow techniques. These techniques incorporate Level 1 and Level 2 fair value measurement inputs such as interest rates and foreign currency exchange rates. These market inputs are utilized in the discounted cash flow calculation considering the instrument's term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation for interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps are observable in the active markets and are classified as Level 2 in the fair value measurement hierarchy.
Fair Value Measurement
Significant Other Observable Inputs (Level 2)
Other assetsOther liabilities
Notional AmountCurrentNoncurrentCurrentNoncurrent
(In millions)(In $ millions)
As of March 31, 2024
Derivatives Designated as Cash Flow Hedges
Commodity swaps$59 5 40 2  
Designated as Fair Value Hedges
Cross-currency swaps$1,500 54 2 22 16 
Derivatives Designated as Net Investment Hedges
Cross-currency swaps5,712 77  29 230 
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps$2,137 23  5 12 
Total159 42 58 258 
As of December 31, 2023
Derivatives Designated as Cash Flow Hedges
Commodity swaps$67 5 36 2  
Designated as Fair Value Hedges
Cross-currency swaps$1,500 40  11 61 
Derivatives Designated as Net Investment Hedges
Cross-currency swaps5,712 93  61 281 
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps$1,954 9  16 8 
Total147 36 90 350 
25

Carrying values and fair values of financial instruments that are not carried at fair value are as follows:
Fair Value Measurement
Carrying
Amount
Significant Other
Observable
Inputs
(Level 2)
Unobservable
Inputs
(Level 3)
Total
(In $ millions)
As of March 31, 2024
Equity investments without readily determinable fair values
170    
Insurance contracts in nonqualified trusts18 18  18 
Long-term debt, including current installments of long-term debt
13,435 13,472 140 13,612 
As of December 31, 2023
Equity investments without readily determinable fair values
170    
Insurance contracts in nonqualified trusts21 21  21 
Long-term debt, including current installments of long-term debt
13,400 13,514 148 13,662 
In general, the equity investments included in the table above are not publicly traded and their fair values are not readily determinable. The Company believes the carrying values approximate fair value. Insurance contracts in nonqualified trusts consist of long-term fixed income securities, which are valued using independent vendor pricing models with observable inputs in the active market and therefore represent a Level 2 fair value measurement. The fair value of long-term debt is based on valuations from third-party banks and market quotations and is classified as Level 2 in the fair value measurement hierarchy. The fair value of obligations under finance leases, which are included in long-term debt in the unaudited consolidated balance sheets, is based on lease payments and discount rates, which are not observable in the market and therefore represents a Level 3 fair value measurement.
As of March 31, 2024 and December 31, 2023, the fair values of cash and cash equivalents, receivables, trade payables, short-term borrowings and the current installments of long-term debt approximate carrying values due to the short-term nature of these instruments. These items have been excluded from the table with the exception of the current installments of long-term debt.
14. Commitments and Contingencies
Commitments
Guarantees
The Company has agreed to guarantee or indemnify third parties for environmental and other liabilities pursuant to a variety of agreements, including asset and business divestiture agreements, leases, settlement agreements and various agreements with affiliated companies. Although many of these obligations contain monetary and/or time limitations, others do not provide such limitations.
The Company has accrued for all probable and reasonably estimable losses associated with all known matters or claims. These known obligations include the following:
Demerger Obligations
In connection with the Hoechst demerger, the Company agreed to indemnify Hoechst, and its legal successors, for various liabilities under the demerger agreement, including for environmental liabilities associated with contamination arising either from environmental damage in general ("Category A") or under 19 divestiture agreements entered into by Hoechst prior to the demerger ("Category B") (Note 9).
The Company's obligation to indemnify Hoechst, and its legal successors, is capped under Category B at €250 million. If and to the extent the environmental damage should exceed €750 million in aggregate, the Company's obligation to indemnify Hoechst
26

and its legal successors applies, but is then limited to 33.33% of the remediation cost without further limitations. Cumulative payments under the divestiture agreements as of March 31, 2024 are $114 million. Though the Company is significantly under its obligation cap under Category B, most of the divestiture agreements have become time barred and/or any notified environmental damage claims have been partially settled.
The Company has also undertaken in the demerger agreement to indemnify Hoechst and its legal successors for (i) 33.33% of any and all Category A liabilities that result from Hoechst being held as the responsible party pursuant to public law or current or future environmental law or by third parties pursuant to private or public law related to contamination and (ii) liabilities that Hoechst is required to discharge, including tax liabilities, which are associated with businesses that were included in the demerger but were not demerged due to legal restrictions on the transfers of such items. These indemnities do not provide for any monetary or time limitations. The Company has not been requested by Hoechst to make any payments in connection with this indemnification. Accordingly, the Company has not made any payments to Hoechst and its legal successors.
Based on the Company's evaluation of currently available information, including the lack of requests for indemnification, the Company cannot estimate the remaining demerger obligations, if any, in excess of amounts accrued.
Divestiture Obligations
The Company and its predecessor companies agreed to indemnify third-party purchasers of former businesses and assets for various pre-closing conditions, as well as for breaches of representations, warranties and covenants. Such liabilities also include environmental liability, product liability, antitrust and other liabilities. These indemnifications and guarantees represent standard contractual terms associated with typical divestiture agreements and, other than environmental liabilities, the Company does not believe that they expose the Company to significant risk (Note 9).
The Company has divested numerous businesses, investments and facilities through agreements containing indemnifications or guarantees to the purchasers. Many of the obligations contain monetary and/or time limitations, which extend through 2037. The aggregate amount of outstanding indemnifications and guarantees provided for under these agreements is $116 million as of March 31, 2024. Other agreements do not provide for any monetary or time limitations.
Based on the Company's evaluation of currently available information, including the number of requests for indemnification or other payment received by the Company, the Company cannot estimate the remaining divestiture obligations, if any, in excess of amounts accrued.
Purchase Obligations
In the normal course of business, the Company enters into various purchase commitments for goods and services. The Company maintains a number of "take-or-pay" contracts for purchases of raw materials, utilities and other services. Certain of the contracts contain a contract termination buy-out provision that allows for the Company to exit the contracts for amounts less than the remaining take-or-pay obligations. Additionally, the Company has other outstanding commitments representing maintenance and service agreements, energy and utility agreements, consulting contracts and software agreements. As of March 31, 2024, the Company had unconditional purchase obligations of $4.2 billion, of which $530 million will be paid in 2024, $592 million in 2025, $483 million in 2026, $429 million in 2027, $289 million in 2028 and the balance thereafter through 2042.
Contingencies
The Company is involved in legal and regulatory proceedings, lawsuits, claims and investigations incidental to the normal conduct of business, relating to such matters as product liability, land disputes, insurance coverage disputes, contracts, employment, antitrust or competition, intellectual property, personal injury and other actions in tort, workers' compensation, chemical exposure, asbestos exposure, taxes, trade compliance, acquisitions and divestitures, claims of current and legacy shareholders, past waste disposal practices and release of chemicals into the environment. The Company is actively defending those matters where the Company is named as a defendant and, based on the current facts, does not believe the outcomes from these matters would be material to the Company's results of operations, cash flows or financial position.
As previously reported, in July 2020, the Company settled a European Commission competition law investigation involving certain of its subsidiaries and three other companies related to certain past ethylene purchases. Shell Chemicals Europe and another group of corporate claimants have filed claims for damages with the District Court of Amsterdam against four companies, including Celanese, arising from those activities, and the first court hearing was held in late September 2023. The Company intends to vigorously defend itself against these claims. While it is possible that additional parties could assert
27

demands or claims related to this matter, based on information available at this time, the Company does not expect ultimate resolution of this matter to have a material impact on its financial condition or results of operations.
15. Segment Information
Engineered
Materials
Acetyl
Chain
Other
Activities
EliminationsConsolidated
(In $ millions)
Three Months Ended March 31, 2024
Net sales1,378 1,261  (28)(1)2,611 
Other (charges) gains, net (Note 18)
(11) (3) (14)
Operating profit (loss)89 254 (133) 210 
Equity in net earnings (loss) of affiliates
49 2 4  55 
Depreciation and amortization147 57 17  221 
Capital expenditures37 40 28  105 (2)
As of March 31, 2024
Goodwill and intangible assets, net
10,407 421   10,828 
Total assets
17,620 5,520 2,893  26,033 
Three Months Ended March 31, 2023
Net sales
1,630 

1,250 

 (27)(1)2,853 
Other (charges) gains, net (Note 18)
(21)(1)(1) (23)
Operating profit (loss)
112 278 (139) 251 
Equity in net earnings (loss) of affiliates
11 1 3  15 
Depreciation and amortization
112 54 6  172 
Capital expenditures
45 51 12  108 (2)
As of December 31, 2023
Goodwill and intangible assets, net
10,525 427   10,952 
Total assets
17,930 5,538 3,129  26,597 
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes a decrease in accrued capital expenditures of $32 million and $56 million for the three months ended March 31, 2024 and 2023, respectively.
16. Revenue Recognition
The Company has certain contracts that represent take-or-pay revenue arrangements in which the Company's performance obligations extend over multiple years. As of March 31, 2024, the Company had $1.3 billion of remaining performance obligations related to take-or-pay contracts. The Company expects to recognize approximately $458 million of its remaining performance obligations as Net sales in 2024, $423 million in 2025, $195 million in 2026 and the balance thereafter.
Contract Balances
Contract liabilities primarily relate to advances or deposits received from the Company's customers before revenue is recognized. These amounts are recorded as deferred revenue and are included in Current and Noncurrent Other liabilities in the unaudited consolidated balance sheets.
The Company does not have any material contract assets as of March 31, 2024.
Disaggregated Revenue
In general, the Company's business segmentation is aligned according to the nature and economic characteristics of its products and customer relationships and provides meaningful disaggregation of each business segment's results of operations.
28

The Company manages its Engineered Materials business segment through its project management pipeline, which is comprised of a broad range of projects that are solutions-based and are tailored to each customer's unique needs. Projects are identified and selected based on success rate and may involve a number of different polymers per project for use in multiple end-use applications. Therefore, the Company is agnostic toward products and end-use markets for the Engineered Materials business segment.
The Company manages its Acetyl Chain business segment by leveraging its ability to sell chemicals externally to end-use markets or downstream to its acetate tow, intermediate chemistry, emulsion polymers, redispersible powders and ethylene vinyl acetate polymers businesses. Decisions to sell externally and geographically or downstream and along the Acetyl Chain are based on market demand, trade flows and maximizing the value of its chemicals. Therefore, the Company's strategic focus is on executing within this integrated chain model and less on driving product-specific revenue.
Further disaggregation of Net sales by business segment and geographic destination is as follows:
Three Months Ended
March 31,
20242023
(In $ millions)
Engineered Materials
North America372 479 
Europe and Africa456 560 
Asia-Pacific516 548 
South America34 43 
Total1,378 1,630 
Acetyl Chain
North America388 365 
Europe and Africa423 460 
Asia-Pacific394 367 
South America28 31 
Total(1)
1,233 1,223 
______________________________
(1)Excludes intersegment sales of $28 million and $27 million for the three months ended March 31, 2024 and 2023, respectively.
17. Earnings (Loss) Per Share
Three Months Ended
March 31,
20242023
(In $ millions, except share data)
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations121 94 
Earnings (loss) from discontinued operations (3)
Net earnings (loss)121 91 
Weighted average shares - basic109,069,060 108,634,068 
Incremental shares attributable to equity awards(1)
444,931 554,198 
Weighted average shares - diluted109,513,991 109,188,266 
______________________________
(1)Excludes stock options to purchase 68,415, and 86,194 shares of Common Stock for the three months ended March 31, 2024 and 2023, respectively; and 0 and 72,574 equity award shares for the three months ended March 31, 2024 and 2023, respectively, as their effect would have been antidilutive.
29

18. Other (Charges) Gains, Net
Three Months Ended
March 31,
20242023
(In $ millions)
Restructuring(1)
(14)(23)
Total(14)(23)
______________________________
(1)Includes employee termination benefits related to Company-wide business optimization projects and the previously announced closure of its polymerization units in Uentrop, Germany (Note 3).
The changes in the restructuring liabilities by business segment are as follows:
Engineered
Materials
Acetyl
Chain
OtherTotal
(In $ millions)
Employee Termination Benefits
As of December 31, 202313 2 3 18 
Additions12  3 15 
Cash payments(8)(1)(4)(13)
Other changes(1)  (1)
As of March 31, 202416 1 2 19 
30

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
In this Quarterly Report on Form 10-Q ("Quarterly Report"), the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The terms the "Company," "we," "our" and "us," refer to Celanese and its subsidiaries on a consolidated basis. The term "Celanese U.S." refers to the Company's subsidiary, Celanese US Holdings LLC, a Delaware limited liability company, and not its subsidiaries.
The following discussion should be read in conjunction with the Celanese Corporation and Subsidiaries consolidated financial statements as of and for the year ended December 31, 2023 filed on February 23, 2024 with the Securities and Exchange Commission ("SEC") as part of the Company's Annual Report on Form 10-K ("2023 Form 10-K") and the unaudited interim consolidated financial statements and notes to the unaudited interim consolidated financial statements herein, which are prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP").
Investors are cautioned that the forward-looking statements contained in this section and other parts of this Quarterly Report involve both risk and uncertainty. Several important factors could cause actual results to differ materially from those anticipated by these statements. Many of these statements are macroeconomic in nature and are, therefore, beyond the control of management. See "Forward-Looking Statements" below and at the beginning of our 2023 Form 10-K.
Forward-Looking Statements
Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") and other parts of this Quarterly Report contain certain forward-looking statements and information relating to us that are based on the beliefs of our management as well as assumptions made by, and information currently available to, us. Generally, words such as "believe," "expect," "intend," "estimate," "anticipate," "project," "plan," "may," "can," "could," "might," and "will," and similar expressions, as they relate to us are intended to identify forward-looking statements. These statements reflect our current views and beliefs with respect to future events at the time that the statements are made, are not historical facts or guarantees of future performance and involve risks and uncertainties that are difficult to predict and many of which are outside of our control. Further, certain forward-looking statements are based upon assumptions as to future events that may not prove to be accurate. All forward-looking statements made in this Quarterly Report are made as of the date hereof, and the risk that actual results will differ materially from expectations expressed in this Quarterly Report will increase with the passage of time. We undertake no obligation, and disclaim any duty, to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in our expectations or otherwise.
Risk Factors
See Part I - Item 1A. Risk Factors of our 2023 Form 10-K for a description of certain risk factors that you should consider which could significantly affect our financial results. In addition, the following factors, among others, could cause our actual results to differ materially from those results, performance or achievements that may be expressed or implied by such forward-looking statements:
changes in general economic, business, political and regulatory conditions in the countries or regions in which we operate;
the length and depth of product and industry business cycles particularly in the automotive, electrical, textiles, electronics and construction industries;
volatility or changes in the price and availability of raw materials and energy, particularly changes in the demand for, supply of, and market prices of ethylene, methanol, natural gas, wood pulp and fuel oil and the prices for electricity and other energy sources;
the ability to pass increases in raw materials prices, logistics costs and other costs on to customers or otherwise improve margins through price increases;
the possibility that we will not be able to timely or effectively continue to integrate the Mobility & Materials business (the "M&M Business") we acquired from DuPont de Nemours, Inc. (the "M&M Acquisition") in order to realize the anticipated benefits of the M&M Acquisition, including synergies and growth opportunities, whether as a result of difficulties arising from the operation of the M&M Business or other unanticipated delays, costs, inefficiencies or liabilities;
increased commercial, legal or regulatory complexity of entering into, or expanding our exposure to, certain end markets and geographies;
31

risks in the global economy and equity and credit markets and their potential impact on our ability to pay down debt in the future and/or refinance at suitable rates, in a timely manner, or at all;
risks and costs associated with increased leverage from the M&M Acquisition, including increased interest expense and potential reduction of business and strategic flexibility;
the ability to maintain plant utilization rates and to implement planned capacity additions, expansions and maintenance;
the ability to reduce or maintain current levels of production costs and to improve productivity by implementing technological improvements to existing plants;
increased price competition and the introduction of competing products by other companies;
the ability to identify desirable potential acquisition or divestiture opportunities and to complete such transactions, including obtaining regulatory approvals, consistent with our strategy;
market acceptance of our products and technology;
compliance and other costs and potential disruption or interruption of production or operations due to accidents, interruptions in sources of raw materials, transportation, logistics or supply chain disruptions, cybersecurity incidents, terrorism or political unrest, public health crises (including, but not limited to, the COVID-19 pandemic), or other unforeseen events or delays in construction or operation of facilities, including as a result of geopolitical conditions, the direct or indirect consequences of acts of war or conflict (such as the Russia-Ukraine conflict or the Israel-Hamas conflict) or terrorist incidents or as a result of weather, natural disasters, or other crises;
the ability to obtain governmental approvals and to construct facilities on terms and schedules acceptable to us;
changes in applicable tariffs, duties and trade agreements, tax rates or legislation throughout the world including, but not limited to, adjustments, changes in estimates or interpretations or the resolution of tax examinations or audits that may impact recorded or future tax impacts and potential regulatory and legislative tax developments in the United States and other jurisdictions;
changes in the degree of intellectual property and other legal protection afforded to our products or technologies, or the theft of such intellectual property;
potential liability for remedial actions and increased costs under existing or future environmental, health and safety regulations, including those relating to climate change or other sustainability matters;
potential liability resulting from pending or future claims or litigation, including investigations or enforcement actions, or from changes in the laws, regulations or policies of governments or other governmental activities, in the countries in which we operate;
changes in currency exchange rates and interest rates; and
various other factors, both referenced and not referenced in this Quarterly Report.
Many of these factors are macroeconomic in nature and are, therefore, beyond our control. Should one or more of these risks or uncertainties materialize, affect us in ways or to an extent that we currently do not expect or consider to be significant, or should underlying assumptions prove incorrect, our actual results, performance or achievements may vary materially from those described in this Quarterly Report as anticipated, believed, estimated, expected, intended, planned or projected. We neither intend nor assume any obligation to update these forward-looking statements, which speak only as of their dates.
Overview
We are a global chemical and specialty materials company. We are a leading global producer of high performance engineered polymers that are used in a variety of high-value applications, as well as one of the world's largest producers of acetyl products, which are intermediate chemicals for nearly all major industries. As a recognized innovator in the chemicals industry, we engineer and manufacture a wide variety of products essential to everyday living. Our broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, medical, consumer electronics, energy storage, filtration, paints and coatings, paper and packaging, industrial applications and textiles.
32

Our products enjoy leading global positions due to our differentiated business models, large global production capacity, operating efficiencies, proprietary technology and competitive cost structures.
Our large and diverse global customer base primarily consists of major companies across a broad array of industries. We hold geographically balanced global positions and participate in diversified end-use applications. We combine a demonstrated track record of execution, strong performance built on differentiated business models and a clear focus on growth and value creation. Known for operational excellence, reliability and execution of our business strategies, we partner with our customers around the globe to deliver best-in-class technologies and solutions.
Results of Operations
Financial Highlights
Three Months Ended March 31,
20242023Change
(unaudited)
(In $ millions, except percentages)
Statement of Operations Data
Net sales2,611 2,853 (242)
Gross profit554 631 (77)
Selling, general and administrative ("SG&A") expenses(265)(285)20 
Other (charges) gains, net(14)(23)
Gain (loss) on disposition of businesses and assets, net(1)(6)
Operating profit (loss)210 251 (41)
Equity in net earnings (loss) of affiliates55 15 40 
Non-operating pension and other postretirement employee benefit (expense) income
Interest expense(169)(182)13 
Interest income13 
Dividend income - equity investments34 34 — 
Earnings (loss) from continuing operations before tax157 121 36 
Earnings (loss) from continuing operations124 96 28 
Earnings (loss) from discontinued operations— (3)
Net earnings (loss)124 93 31 
Net earnings (loss) attributable to Celanese Corporation121 91 30 
Other Data
Depreciation and amortization221 172 49 
SG&A expenses as a percentage of Net sales10.1 %10.0 %
Operating margin(1)
8.0 %8.8 %
Other (charges) gains, net
Restructuring
(14)(23)
Total Other (charges) gains, net
(14)(23)
______________________________
(1)Defined as Operating profit (loss) divided by Net sales.
33

As of
March 31,
2024
As of
December 31,
2023
(unaudited)
(In $ millions)
Balance Sheet Data
Cash and cash equivalents1,483 1,805 
Short-term borrowings and current installments of long-term debt - third party and affiliates2,439 1,383 
Long-term debt, net of unamortized deferred financing costs11,018 12,301 
Total debt13,457 13,684 
Factors Affecting Business Segment Net Sales
The percentage increase (decrease) in Net sales attributable to each of the factors indicated for each of our business segments is as follows:
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
VolumePriceCurrencyTotal
(unaudited)
(In percentages)
Engineered Materials(12)(2)(1)(15)
Acetyl Chain11 (10)— 
Total Company(2)(5)(1)(8)
Consolidated Results
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
Net sales decreased $242 million, or 8%, for the three months ended March 31, 2024 compared to the same period in 2023, primarily due to:
lower volume in our Engineered Materials segment, primarily driven by weaker global economic conditions, the formation of the Nutrinova joint venture (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information) and customer destocking;
lower pricing, primarily driven by our Acetyl Chain segment due to a more balanced global demand and supply environment, as well as our Engineered Materials segment due to competitive markets, product mix, and decreased energy surcharges; and
an unfavorable currency impact, primarily resulting from a weaker Chinese Yuan ("CNY") relative to the U.S. dollar;
partially offset by:
higher volume in our Acetyl Chain segment due to increased demand for most of our products, primarily in Asia.
Operating profit decreased $41 million, or 16%, for the three months ended March 31, 2024 compared to the same period in 2023, primarily due to:
lower Net sales in our Engineered Materials segment;
higher spending in our Acetyl Chain segment of $43 million, primarily as a result of plant turnaround costs related to our joint venture, Fairway Methanol LLC, and inventory impacts of increased demand in downstream derivative products;
34

higher accelerated depreciation expense of $37 million in our Engineered Materials segment, related to the previously announced closure of our polymerization units in Uentrop, Germany (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information); and
higher functional spending of $24 million in our Other Activities segment, primarily due to IT integration costs;
partially offset by:
lower raw materials costs in our Engineered Materials and Acetyl Chain segments and favorable raw materials mix in our Engineered Materials segment;
lower spending in our Engineered Materials segment primarily driven by distribution and administrative costs;
lower merger and acquisition project spending of $23 million in our Other Activities segment; and
higher Net sales in our Acetyl Chain segment.
Equity in net earnings (loss) of affiliates increased $40 million for the three months ended March 31, 2024 compared to the same period in 2023, primarily due to:
an increase in earnings from our Mylar Specialty Films strategic affiliates of $18 million primarily due to increased restructuring costs incurred in the three months ended March 31, 2023; and
an increase in earnings from our Ibn Sina strategic affiliate primarily as a result of higher methyl tertiary-butyl ether volume and margin.
Our effective income tax rate of 21% for the three months ended March 31, 2024 was consistent with the same period in 2023. The effective income tax rate for the current period included the tax effects related to internal debt refinancing transactions. The effective income tax rate for the three months ended March 31, 2023 included the impacts of increased valuation allowance on U.S. foreign tax credit carryforwards due to changes in forecasts of foreign sourced income and deductions that did not re-occur in the current year. See Note 11 - Income Taxes in the accompanying unaudited interim consolidated financial statements for further information.
Business Segments
Engineered Materials
Three Months Ended March 31, Change%
Change
20242023
(unaudited)
(In $ millions, except percentages)
Net sales1,378 1,630 (252)(15.5)%
Net Sales Variance
Volume(12)%
Price(2)%
Currency(1)%
Other (charges) gains, net(11)(21)10 47.6 %
Operating profit (loss)89 112 (23)(20.5)%
Operating margin6.5 %6.9 %
Equity in net earnings (loss) of affiliates
49 11 38 345.5 %
Depreciation and amortization
147 112 35 31.3 %
Our Engineered Materials segment includes our engineered materials business and certain strategic affiliates. Our engineered materials business develops, produces and supplies a broad portfolio of high performance specialty polymers for automotive and medical applications, as well as industrial products and consumer electronics. Together with our strategic affiliates, our engineered materials business is a leading participant in the global specialty polymers industry.
35

The pricing of products within the Engineered Materials segment is primarily based on the value of the material we produce and is generally independent of changes in the cost of raw materials, but may be impacted during periods of inflation and increased costs. Therefore, in general, margins may expand or contract in response to changes in raw materials costs. We attempt to address increases in raw materials costs through appropriate pricing actions.
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
Net sales decreased for the three months ended March 31, 2024 compared to the same period in 2023, primarily due to:
lower volume, primarily driven by weaker global economic conditions, the formation of the Nutrinova joint venture (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information) and customer destocking;
lower pricing for most of our products, primarily due to competitive markets, product mix, and decreased energy surcharges; and
an unfavorable currency impact, primarily resulting from a weaker CNY relative to the U.S. dollar.
Operating profit decreased for the three months ended March 31, 2024 compared to the same period in 2023, primarily due to:
lower Net sales; and
higher accelerated depreciation expense of $37 million, related to the previously announced closure of our polymerization units in Uentrop, Germany (see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements for further information);
partially offset by:
lower raw materials costs and favorable raw materials mix; and
lower spending of $38 million, primarily driven by distribution and administrative costs.
Equity in net earnings (loss) of affiliates increased for the three months ended March 31, 2024 compared to the same period in 2023, primarily due to:
an increase in earnings from our Mylar Specialty Films strategic affiliates of $18 million primarily due to increased restructuring cost incurred in the three months ended March 31, 2023; and
an increase in earnings from our Ibn Sina strategic affiliate, primarily as a result of higher methyl tertiary-butyl ether volume and margin.
36

Acetyl Chain
Three Months Ended March 31, Change%
Change
20242023
(unaudited)
(In $ millions, except percentages)
Net sales1,261 1,250 11 0.9 %
Net Sales Variance
Volume11 %
Price(10)%
Currency— %
Operating profit (loss)254 278 (24)(8.6)%
Operating margin20.1 %22.2 % 
Dividend income - equity investments
34 33 3.0 %
Depreciation and amortization
57 54 5.6 %
Our Acetyl Chain segment, which includes the integrated chain of our intermediate chemistry, emulsion polymers, ethylene vinyl acetate polymers, redispersible powders and acetate tow businesses, is active in every major global industrial sector and serves diverse consumer end-use applications. These include conventional uses, such as paints, coatings, adhesives, and filter products, as well as other unique, high-value end uses including flexible packaging, thermal laminations, pharmaceuticals, wire and cable, and compounds. Together with our strategic affiliates, our Acetyl Chain businesses are leading producers and suppliers in multiple global industrial sectors.
The pricing of products within the Acetyl Chain is influenced by industry utilization rates and changes in the cost of raw materials. Therefore, in general, there is a directional correlation between these factors and our Net sales for most Acetyl Chain products. This impact to pricing typically lags changes in raw materials costs over months or quarters.
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
Net sales increased for the three months ended March 31, 2024 compared to the same period in 2023, primarily due to:
higher volume due to increased demand for most of our products, primarily in Asia;
partially offset by:
lower pricing for our products, due to a more balanced global demand and supply environment.
Operating profit decreased for the three months ended March 31, 2024 compared to the same period in 2023, primarily due to:
higher spending of $43 million, primarily as a result of plant turnaround costs related to our joint venture, Fairway Methanol LLC, and inventory impacts of increased demand in downstream derivative products;
partially offset by:
lower raw materials and sourcing costs, primarily for carbon monoxide and ethylene; and
higher Net sales.
37

Other Activities
Three Months Ended March 31, Change%
Change
20242023
(unaudited)
(In $ millions, except percentages)
Operating profit (loss)(133)(139)4.3 %
Non-operating pension and other postretirement employee benefit (expense) income
100.0 %
Our Other Activities segment primarily consists of corporate center costs, including administrative activities such as finance, information technology and human resource functions, interest income and expense associated with financing activities and results of our captive insurance companies. The Other Activities segment also includes the components of net periodic benefit cost (interest cost, expected return on assets and net actuarial gains and losses) for our defined benefit pension plans and other postretirement plans not allocated to our business segments.
Three Months Ended March 31, 2024 Compared to Three Months Ended March 31, 2023
Operating loss decreased for the three months ended March 31, 2024 compared to the same period in 2023, primarily due to:
lower merger and acquisition project spending of $23 million; and
lower incentive compensation costs;
partially offset by:
higher functional spending of $24 million, primarily due to IT integration costs.
Liquidity and Capital Resources
Our primary sources of liquidity are cash generated from operations, available cash and cash equivalents, dividends from our portfolio of strategic investments and available borrowings under our senior unsecured revolving credit facilities. As of March 31, 2024, we have $1.75 billion available for borrowing under our senior U.S. unsecured revolving credit facility and $201 million available for borrowing under our separate China Revolving Credit Facility (defined below), if required, to meet our working capital needs and other contractual obligations. In addition, we held cash and cash equivalents of $1.5 billion as of March 31, 2024. We are actively managing our business to maintain and improve cash flow and reduce our debt, and we believe that liquidity from the above-referenced sources will be sufficient to meet our operational and capital investment needs and financial obligations for the foreseeable future.
On February 29, 2024, we announced the intended closure of our facility in Mechelen, Belgium to optimize production costs across our global network. These operations are included in the Engineered Materials segment. We expect to incur additional exit and shutdown costs related to the closure of the facility of approximately $130 million, inclusive of estimated employee termination costs, through 2025. See Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements.
In October 2023, we announced the intended closure of our Polyamide 66 ("PA66") and High-Performance Nylon ("HPN") polymerization units at our facility in Uentrop, Germany to optimize production costs across our global network. These operations are included in the Engineered Materials segment. We expect to incur additional exit and shutdown costs related to the closure of the PA66 and HPN polymerization units in Uentrop, Germany of approximately $36 million, inclusive of estimated employee termination costs, through 2025. See Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements.
In September 2023, we formed a food ingredients joint venture with Mitsui & Co., Ltd. ("Mitsui") under the name Nutrinova. We contributed receivables, inventory, property, plant and equipment, certain other assets, liabilities, technology and employees of our food ingredients business while retaining a 30% interest in the joint venture. Mitsui acquired the remaining 70% interest in the food ingredients business for a purchase price of $503 million, subject to transaction adjustments. We are accounting for our interest in the joint venture as an equity method investment, and our portion of the results continues to be included in the
38

Engineered Materials segment. For further information regarding the food ingredients joint venture, see Note 3 - Acquisitions, Dispositions and Plant Closures in the accompanying unaudited interim consolidated financial statements.
Our incurrence of debt to finance the purchase price for a majority of the Mobility & Materials business (the "M&M Business") acquired from DuPont de Nemours, Inc. in November 2022 (the "M&M Acquisition") has increased our leverage and our ratio of indebtedness to consolidated EBITDA as set forth in our senior unsecured credit facilities. We believe that cash flows from our operations, together with cash generation, synergy opportunities from the M&M Acquisition and cost reduction initiatives, will support our deleveraging efforts over the next few years. In furtherance of these deleveraging efforts, we have paused our share repurchase program and are in the process of evaluating additional cash generation opportunities which may also include, in addition to the food ingredients joint venture described above, additional opportunistic dispositions or monetization of other product or business lines or other assets. We are committed to rapid deleveraging and to maintaining our investment grade debt rating.
While our contractual obligations, commitments and debt service requirements over the next several years are significant, we continue to believe we will have available resources to meet our liquidity requirements, including debt service, for the next 12 months. If our cash flow from operations is insufficient to fund our debt service and other obligations, we may be required to use other means available to us such as increasing our borrowings, reducing or delaying capital expenditures, seeking additional capital or seeking to restructure or refinance our indebtedness. There can be no assurance, however, that we will continue to generate cash flows at or above current levels.
We continue to prioritize projects that drive growth and productivity in the near term and expect total capital expenditures to be approximately $425 million in 2024, primarily associated with certain investments in growth opportunities and productivity improvements. In Engineered Materials, at our Nanjing, China facility, our expansions of (1) the compounding plant and (2) the new liquid crystal polymer ("LCP") plant are on schedule and in construction. At our Bishop, Texas facility, our debottleneck of the ultra-high molecular weight polyethylene ("UHMW-PE") unit is on schedule and in detailed engineering design while construction is delayed nine to 12 months. Our energy optimization productivity project at our polyoxymethylene ("POM") unit in Frankfurt, Germany is on schedule in detailed engineering design. In the Acetyl Chain, the planned expansion of our acetic acid unit at Clear Lake, Texas was successfully commissioned and started in the first quarter of 2024 and is operating as designed, and our vinyl acetate ethylene ("VAE") emulsions unit in Nanjing, China was successfully commissioned in the first quarter of 2024, started in the second quarter of 2024 on schedule and is operating as designed. Our planned expansions of our VAE emulsion plant in Frankfurt, Germany are in construction and on schedule. We continue to see the incremental capacity from investments made in recent years strengthen the growth and reliability of our manufacturing network to best serve our customers.
On a stand-alone basis, Celanese and its immediate 100% owned subsidiary, Celanese U.S., have no independent external operations of their own. Accordingly, they generally depend on the cash flow of their subsidiaries and their ability to pay dividends and make other distributions to Celanese and Celanese U.S. in order to meet their obligations, including their obligations under senior credit facilities and senior notes, and to pay dividends on our Common Stock.
We are subject to capital controls and exchange restrictions imposed by the local governments in certain jurisdictions where we operate, such as China, South Korea, India and Indonesia. Capital controls impose limitations on our ability to exchange currencies, repatriate earnings or capital, lend via intercompany loans or create cross-border cash pooling arrangements. Our largest exposure to a country with capital controls is in China. Pursuant to applicable regulations, foreign-invested enterprises in China may pay dividends only out of their accumulated profits, if any, determined in accordance with Chinese accounting standards and regulations. In addition, the Chinese government imposes certain currency exchange controls on cash transfers out of China, puts certain limitations on duration, purpose and amount of intercompany loans, and restricts cross-border cash pooling. While it is possible that future tightening of these restrictions or application of new similar restrictions could impact us, these limitations do not currently restrict our operations.
We remain in compliance with the covenants in the Global Credit Agreements (defined below) and expect to remain in compliance based on our current expectation of future results of operations and planned cash generation activities. If the actual future results of our operations and cash generation activities differ materially from these expectations, we may be required to seek an amendment to or waiver of any impacted covenants, which may increase our borrowing costs under the Global Credit Agreements.
39

Cash Flows
Cash and cash equivalents decreased $322 million to $1.5 billion as of March 31, 2024 compared to December 31, 2023. As of March 31, 2024, $1.3 billion of the $1.5 billion of cash and cash equivalents was held by our foreign subsidiaries. Under the Tax Cuts and Jobs Act, we incurred a charge in a prior year associated with the deemed repatriation of foreign earnings. These funds are largely accessible without additional material tax consequences, if needed in the U.S., to fund operations.
Net Cash Provided by (Used in) Operating Activities
Net cash provided by operating activities increased $197 million to $101 million for the three months ended March 31, 2024 compared to net cash used in operating activities of $96 million for the same period in 2023, primarily due to:
favorable trade working capital of $98 million, primarily due to the timing of collections of trade receivables, inventory reduction due to lower volume and lower raw materials costs, and settlement of trade payables during the three months ended March 31, 2024;
a decrease in net cash interest paid of $75 million; and
an increase in Net earnings.
Net Cash Provided by (Used in) Investing Activities
Net cash used in investing activities decreased $27 million to $151 million for the three months ended March 31, 2024 compared to net cash used in investing activities of $178 million for the same period in 2023; primarily due to:
a decrease of $27 million in capital expenditures during the three months ended March 31, 2024.
Net Cash Provided by (Used in) Financing Activities
Net cash used in financing activities increased $190 million to $259 million for the three months ended March 31, 2024 compared to net cash used in financing activities of $69 million for the same period in 2023, primarily due to:
an increase in net payments on short-term debt of $300 million, primarily as a result of higher payments and lower borrowings under our revolving credit facilities and China Working Capital Term Loan Agreement (defined below);
partially offset by:
an increase in net proceeds on long-term debt of $112 million, primarily due to borrowing under the CNC Working Capital Loan Agreement (defined below).
Debt and Other Obligations
Senior Credit Facilities
In March 2022, we entered into a term loan credit agreement (as amended to date, the "March 2022 U.S. Term Loan Credit Agreement"), pursuant to which lenders provided a tranche of delayed-draw term loans due 364 days from issuance in an amount equal to $500 million (the "364-day Term Loans") and a tranche of delayed-draw term loans due 5 years from issuance in an amount equal to $1.0 billion (the "5-year Term Loans"). The 364-day Term Loans have been fully repaid.
Also in March 2022, we entered into a new revolving credit agreement (as amended to date, the "U.S. Revolving Credit Agreement" and, together with the March 2022 U.S. Term Loan Credit Agreement the "U.S. Credit Agreements") consisting of a $1.75 billion senior unsecured revolving credit facility (with a letter of credit sublimit), maturing in 2027.
In August 2023, we amended certain covenants in the March 2022 U.S. Term Loan Credit Agreement to permit refinancing of certain senior notes without requiring a mandatory prepayment under the March 2022 U.S. Term Loan Credit Agreement.
On February 16, 2024 and February 21, 2023, we amended certain covenants in the U.S. Credit Agreements, including financial ratio maintenance covenants.
40

The U.S. Credit Agreements are guaranteed by Celanese, Celanese U.S. and domestic subsidiaries together representing substantially all of the Company's U.S. assets and business operations (the "Subsidiary Guarantors").
In January 2023, Celanese (Shanghai) International Trading Co., Ltd ("CSIT"), a fully consolidated subsidiary, entered into a restatement of an existing credit facility agreement (the "China Revolving Credit Agreement") to upsize and modify the facility thereunder to consist of an aggregate CNY1.75 billion uncommitted senior unsecured revolving credit facility available under two tranches (with overdraft, bank guarantee and documentary credit sublimits) (the "China Revolving Credit Facility"). Obligations bear interest at certain fixed and floating rates. The China Revolving Credit Agreement is guaranteed by Celanese U.S.
Also in January 2023, CSIT entered into a senior unsecured working capital loan contract for CNY800 million (the "China Working Capital Term Loan Agreement"), payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates. The loan under the China Working Capital Term Loan Agreement was fully drawn in January 2023 and was supported by a letter of comfort from us. The China Working Capital Term Loan Agreement was fully repaid in the three months ended March 31, 2024.
In December 2023, Celanese (Nanjing) Chemical Co., Ltd. ("CNC") entered into a senior unsecured working capital loan agreement for CNY800 million, payable on December 25, 2026 and bearing interest at 2.8% (the "CNC Working Capital Loan Agreement," together with the China Revolving Credit Agreement and the China Working Capital Term Loan Agreement, the "China Credit Agreements," and the China Credit Agreements together with the U.S. Credit Agreements, the "Global Credit Agreements"). The loan under the CNC Working Capital Loan Agreement was fully drawn during the three months ended March 31, 2024. We expect the China Credit Agreements will continue to facilitate our efficient repatriation of cash to the U.S. to repay debt and effectively redomicile a portion of our U.S. debt to China at a lower average interest rate.
On May 8, 2024, we drew $300 million from our U.S. Revolving Credit Facility. This borrowing and cash on hand were used to repay in full our senior unsecured notes due 2024, with an interest rate of 3.500%, due on May 8, 2024.
Senior Notes
In August 2023, we completed a public offering registered under the Securities Act of senior unsecured notes as follows (collectively, the "2023 Offering"):
Maturity DateAggregate Principal
Amount Issued
Discount to ParInterest Rate
(In $ millions)
November 15, 20281,000 99.986%6.350%
November 15, 2030999 99.950%6.550%
November 15, 20331,000 99.992%6.700%
In August 2023, we completed a cash tender offer for $2.25 billion in aggregate principal amount (the "Tender Offer") as follows:
Maturity DateAggregate Principal Amount TenderedPurchase price per $1,000 principal amountTotal Tender Offer ConsiderationAccrued and Unpaid Interest
(In $ millions)(In $)(In $ millions)
June 30, 20241,473 999.92 1,473 12 
March 15, 2025750 1,002.85 752 20 
April 30, 202427 983.95 27 — 
The net proceeds from the 2023 Offering were used (i) to fund the Tender Offer and (ii) for the repayment of other outstanding indebtedness, including the payment in full of the 364-day Term Loans and certain 3-year term loans pursuant to a term loan credit agreement entered into in September 2022.
There have been no material changes to our debt or other obligations described in our 2023 Form 10-K other than those disclosed above and in Note 7 - Debt in the accompanying unaudited interim consolidated financial statements.
41

Accounts Receivable Purchasing Facility
In June 2023, we entered into an amendment to the amended and restated receivables purchase agreement under our U.S. accounts receivable purchasing facility among certain of our subsidiaries, our wholly-owned, "bankruptcy remote" special purpose subsidiary ("SPE") and certain global financial institutions ("Purchasers"). We de-recognized $290 million and $1.4 billion of accounts receivable under this agreement for the three months ended March 31, 2024 and year ended December 31, 2023, respectively, and collected $318 million and $1.3 billion of accounts receivable sold under this agreement during the same periods. Unsold U.S. accounts receivable of $153 million were pledged by the SPE as collateral to the Purchasers as of March 31, 2024.
Factoring and Discounting Agreements
We have factoring agreements in Europe, Singapore and China with financial institutions. We de-recognized $164 million and $423 million of accounts receivable under these factoring agreements for the three months ended March 31, 2024 and year ended December 31, 2023, respectively, and collected $110 million and $407 million of accounts receivable sold under these factoring agreements during the same periods.
In December 2023, we entered into a Master Discounting Agreement (the "Master Discounting Agreement") with a financial institution in China to discount, on a non-recourse basis, banker's acceptance drafts ("BADs"), classified as accounts receivable. We received $15 million and $45 million from the accounts receivable transferred under the Master Discounting Agreement as of March 31, 2024 and December 31, 2023, respectively.
Covenants
The Company's material financing arrangements contain customary covenants, such as events of default and change of control provisions, and in the case of the U.S. Credit Agreements the maintenance of certain financial ratios (subject to adjustment following certain qualifying acquisitions and dispositions, as set forth in the U.S. Credit Agreements, as amended). Failure to comply with these covenants, or the occurrence of any other event of default, could result in acceleration of the borrowings and other financial obligations.
We are in compliance with the covenants in our material financing arrangements as of March 31, 2024.
See Note 7 - Debt in the accompanying unaudited interim consolidated financial statements for further information.
Guarantor Financial Information
We have outstanding senior unsecured notes, issued in public offerings registered under the Securities Act of 1933, as amended (collectively, the "Senior Notes"). The Senior Notes were issued by Celanese U.S. ("Issuer") and are guaranteed by Celanese Corporation ("Parent Guarantor") and the Subsidiary Guarantors (collectively the "Obligor Group"). See Note 7 - Debt in the accompanying unaudited interim consolidated financial statements for further information. The Issuer and Subsidiary Guarantors are 100% owned subsidiaries of the Parent Guarantor. The Subsidiary Guarantors are listed in Exhibit 22.1 to this Quarterly Report.
The Parent Guarantor and the Subsidiary Guarantors have guaranteed the Senior Notes on a full and unconditional, joint and several, senior unsecured basis. The guarantees are subject to certain customary release provisions, including that a Subsidiary Guarantor will be released from its respective guarantee in specified circumstances, including (i) the sale or transfer of all of its assets or capital stock; (ii) its merger or consolidation with, or transfer of all or substantially all of its assets to, another person; or (iii) its ceasing to be a majority-owned subsidiary of the Issuer in connection with any sale of its capital stock or other transaction. Additionally, a Subsidiary Guarantor will be released from its guarantee of the Senior Notes at such time that it ceases to guarantee the Issuer's obligations under the U.S. Credit Agreements (subject to the satisfaction of customary document delivery requirements). The obligations of the Subsidiary Guarantors under their guarantees are limited as necessary to prevent such guarantees from constituting a fraudulent conveyance or fraudulent transfer under applicable law.
The Parent Guarantor and the Issuer are holding companies that conduct substantially all of their operations through their subsidiaries, which own substantially all of our consolidated assets. The Parent Guarantor holds the stock of its immediate 100% owned subsidiary, the Issuer, but has no material consolidated assets. The principal source of cash to pay the Parent Guarantor's and the Issuer's obligations, including obligations under the Senior Notes and the guarantee of the Issuer's obligations under the U.S. Credit Agreements, is the cash that our subsidiaries generate from their operations. Each of the Subsidiary Guarantors and our non-guarantor subsidiaries is a distinct legal entity and, under certain circumstances, applicable
42

country or state laws, regulatory limitations and terms of other debt instruments may limit our subsidiaries' ability to distribute cash to the Issuer and the Parent Guarantor.
For cash management purposes, we transfer cash among the Parent Guarantor, Issuer, Subsidiary Guarantors and non-guarantors through intercompany financing arrangements, contributions or declaration of dividends between the respective parent and its subsidiaries. While the non-guarantor subsidiaries do not guarantee the Issuer's obligations under our outstanding debt, the transfer of cash under these activities facilitates the ability of the recipient to make specified third-party payments for principal and interest on the Senior Notes, the U.S. Credit Agreements, other outstanding debt, Common Stock dividends and Common Stock repurchases.
The summarized financial information of the Obligor Group is presented below on a combined basis after the elimination of: (i) intercompany transactions among such entities and (ii) equity in earnings from and investments in the non-guarantor subsidiaries. Transactions with, and amounts due to or from, non-guarantor subsidiaries and affiliates are separately disclosed.
Three Months Ended
March 31, 2024
(In $ millions)
(unaudited)
Net sales to third parties439 
Net sales to non-guarantor subsidiaries285 
Total net sales724 
Gross profit117 
Earnings (loss) from continuing operations(103)
Net earnings (loss)(104)
Net earnings (loss) attributable to the Obligor Group(104)
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
(unaudited)
Receivables from non-guarantor subsidiaries900 787 
Other current assets2,131 2,245 
Total current assets3,031 3,032 
Goodwill536 536 
Other noncurrent assets3,258 3,289 
Total noncurrent assets3,794 3,825 
Current liabilities due to non-guarantor subsidiaries3,386 2,993 
Current liabilities due to affiliates
Other current liabilities3,107 1,940 
Total current liabilities6,499 4,939 
Noncurrent liabilities due to non-guarantor subsidiaries3,356 3,365 
Other noncurrent liabilities11,504 13,007 
Total noncurrent liabilities14,860 16,372 
Share Capital
On April 17, 2024, we declared a quarterly cash dividend of $0.70 per share on our Common Stock amounting to $76 million. The cash dividend will be paid on May 13, 2024 to holders of record as of April 29, 2024.
There have been no material changes to our share capital described in our 2023 Form 10-K other than those disclosed above and in Note 10 - Shareholders' Equity in the accompanying unaudited interim consolidated financial statements.
43

Contractual Obligations
We have not entered into any material off-balance sheet arrangements.
Except as otherwise described in this report, there have been no material revisions outside the ordinary course of business to our contractual obligations as described in our 2023 Form 10-K.
Tax Return Audits
Our tax returns have been under joint audit for the years 2013 through 2015 by the United States, Netherlands and Germany (the "Authorities"). The Company and the Authorities were unable to reach an agreement jointly and therefore the audits continued on a separate jurisdictional basis. In the fourth quarter of 2022, the Company concluded settlement discussions with the Dutch tax authority. In addition, our income tax returns in Mexico are under audit for the year 2018 and in Canada for the years 2016 through 2022. In August 2023, we negotiated a partial settlement with the Mexico tax authority for its audit for the year 2018. The partial settlement did not have a material impact on income tax expense in the consolidated statements of operations for the year ended December 31, 2023. In September 2023, the Canadian tax authority opened tax audits for the years 2019 through 2022, and the audits are in the preliminary stages. As of March 31, 2024, we believe that an adequate provision for income taxes has been made for all open tax years related to the examinations by government authorities. However, the outcome of tax audits cannot be predicted with certainty. If any issues raised by the government authorities are resolved in a manner inconsistent with our expectations or we are unsuccessful in defending our positions, we could be required to adjust our provision for income taxes in the period such resolution occurs. If required, any such adjustments could be material to the statements of operations and cash flows in the period(s) recorded. See Note 11 - Income Taxes in the accompanying unaudited interim consolidated financial statements for further information.
Business Environment
We experienced below-normal underlying demand conditions across several end-markets. We continue to closely monitor the impact of, and responses to, geopolitical effects on demand conditions and the supply chain. Demand conditions and moderating raw materials costs resulted in elevated industry competitive dynamics and continuing pricing pressure across end-markets. We expect demand challenges to persist and to pressure pricing, which effects we anticipate to be partially offset by improvement in input costs across the year.
Critical Accounting Policies and Estimates
Our unaudited interim consolidated financial statements are based on the selection and application of significant accounting policies. The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of Net sales, expenses and allocated charges during the reporting period. Actual results could differ from those estimates. However, we are not currently aware of any reasonably likely events or circumstances that would result in materially different results.
We describe our significant accounting policies in Note 2 - Summary of Accounting Policies, of the Notes to the Consolidated Financial Statements included in our 2023 Form 10-K. We discuss our critical accounting policies and estimates in MD&A in our 2023 Form 10-K.
Recent Accounting Pronouncements
See Note 2 - Recent Accounting Pronouncements in the accompanying unaudited interim consolidated financial statements included in this Quarterly Report for information regarding recent accounting pronouncements.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Market risk for the Company has not changed materially from the foreign exchange, interest rate and commodity risks disclosed in Item 7A. Quantitative and Qualitative Disclosures about Market Risk in our 2023 Form 10-K. See also Note 12 - Derivative Financial Instruments in the accompanying unaudited interim consolidated financial statements for further discussion of our market risk management and the related impact on the Company's financial position and results of operations.
44

Item 4. Controls and Procedures
Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this report. Based on that evaluation, as of March 31, 2024, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective.
Changes in Internal Control Over Financial Reporting
During the period covered by this report, there were no changes in our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
45

PART II — OTHER INFORMATION
Item 1. Legal Proceedings
The Company is involved in legal and regulatory proceedings, lawsuits, claims and investigations incidental to the normal conduct of its business, relating to such matters as product liability, land disputes, insurance coverage disputes, contracts, employment, antitrust and competition, intellectual property, personal injury and other actions in tort, workers' compensation, chemical exposure, asbestos exposure, taxes, trade compliance, acquisitions and divestitures, claims of current and legacy shareholders, past waste disposal practices and release of chemicals into the environment. The Company is actively defending those matters where it is named as a defendant. Due to the inherent subjectivity of assessments and unpredictability of outcomes of legal proceedings, the Company's litigation accruals and estimates of possible loss or range of possible loss may not represent the ultimate loss to the Company from legal proceedings. See Note 9 - Environmental and Note 14 - Commitments and Contingencies in the accompanying unaudited interim consolidated financial statements for a discussion of material environmental matters and material commitments and contingencies related to legal and regulatory proceedings. There have been no significant developments in the "Legal Proceedings" described in our 2023 Form 10-K other than those disclosed in Note 9 - Environmental and Note 14 - Commitments and Contingencies in the accompanying unaudited interim consolidated financial statements. See Part I - Item 1A. Risk Factors of our 2023 Form 10-K for certain risk factors relating to these legal proceedings.
Item 1A. Risk Factors
In addition to the information in this Quarterly Report, readers should carefully consider the information in Part I, Item 1A. Risk Factors of our 2023 Form 10-K.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
We did not repurchase any Common Stock during the three months ended March 31, 2024. As of March 31, 2024, our Board of Directors had authorized the repurchase of $6.9 billion of our Common Stock since February 2008, with approximately $1.1 billion value of shares remaining that may be purchased under the program. See Note 10 - Shareholders' Equity in the accompanying unaudited interim consolidated financial statements for further information.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
None.
Item 5. Other Information
(c) Trading Plans
During the quarter ended March 31, 2024, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading plans or "non-Rule 10b5-1 trading arrangements" as defined in Item 408 of Regulation S-K.
46

Item 6. Exhibits(1)
Exhibit
Number
Description
3.1
3.1(a)
3.1(b)
3.1(c)
3.2
10.1
10.2
10.3*‡
10.4*‡
10.5*‡
10.6*‡
22.1
31.1*
31.2*
32.1*
32.2*
101.INS*Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH*Inline XBRL Taxonomy Extension Schema Document.
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104The cover page from the Company's Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 has been formatted in Inline XBRL.
47

*    Filed herewith.
‡    Indicates a management contract or compensatory plan or arrangement.

(1)The Company and its subsidiaries have in the past issued, and may in the future issue from time to time, long-term debt. The Company may not file with the applicable report copies of the instruments defining the rights of holders of long-term debt to the extent that the aggregate principal amount of the debt instruments of any one series of such debt instruments for which the instruments have not been filed has not exceeded or will not exceed 10% of the assets of the Company at any pertinent time. The Company hereby agrees to furnish a copy of any such instrument(s) to the SEC upon request.
48

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
CELANESE CORPORATION
By: /s/ LORI J. RYERKERK
Lori J. Ryerkerk
Chair of the Board of Directors,
Chief Executive Officer and President
Date:May 10, 2024

By: /s/ CHUCK B. KYRISH
Chuck B. Kyrish
Senior Vice President and
Chief Financial Officer
Date:May 10, 2024
49
EX-10.3 2 ex1033312410q.htm EX-10.3 Document

Exhibit 10.3
[Form of 2024 Performance-Based RSU Agreement]





celogob.jpg








CELANESE CORPORATION
AMENDED AND RESTATED 2018 GLOBAL INCENTIVE PLAN

PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT
DATED [Grant Date]



Pursuant to the terms and conditions of the Celanese Corporation Amended and Restated 2018 Global Incentive Plan, you have been awarded Performance-Based Restricted Stock Units, subject to the restrictions described in this Agreement. In addition to the information included in this Award Agreement, the Participant's name and the number of Restricted Stock Units awarded can be found in the Grant Summary located in the electronic stock plan award administration system maintained by the Company or its designee that contains a link to this Agreement (which summary information is set forth in the appropriate records of the Company authorizing such award).


2024 Performance RSU Award

Target Award: [Number of Shares Granted] Units


This grant is made pursuant to the Performance-Based Restricted Stock Unit Award Agreement dated as of [Grant Date], between Celanese and [Participant Name], covering a performance period from January 1, 2024 through December 31, 2026, which Agreement is attached hereto and made a part hereof.


Page 1 of 15
© 2024 Celanese Corporation


CELANESE CORPORATION
AMENDED AND RESTATED 2018 GLOBAL INCENTIVE PLAN

PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT
This Performance-Based Restricted Stock Unit Award Agreement (the "Agreement") is made and entered into as of [Grant Date] (the "Grant Date"), by and between Celanese Corporation, a Delaware corporation ("Celanese" and together with the participating subsidiaries that are employers of the Participants, the "Company"), and [Participant Name] (the "Participant"). Capitalized terms used, but not otherwise defined, herein shall have the meanings ascribed to such terms in the Celanese Corporation Amended and Restated 2018 Global Incentive Plan (as amended from time to time, the "2018 Plan").
1.Performance RSU Award: In order to encourage the Participant's contribution to the successful performance of the Company, Celanese hereby grants to the Participant as of the Grant Date, pursuant to the terms of the 2018 Plan and this Agreement, an award (the "Award") of [Number of Shares Granted] performance-based Restricted Stock Units ("Performance RSUs") representing the right to receive, subject to the attainment of the performance goals set forth in Appendix A, the number of Common Shares to be determined in accordance with the formula set forth in Appendix A. The Participant hereby acknowledges and accepts such Award upon the terms and subject to the performance requirements and other conditions, restrictions and limitations contained in this Agreement and the 2018 Plan.
2.Performance-Based Adjustment and Vesting:
(a)    Subject to Section 3 and Section 6 of this Agreement, the Performance RSUs are subject to adjustment for performance during the Performance Period in accordance with the performance measures, targets and methodology set forth in Appendix A. The number of Performance RSUs determined after the Performance Period based on such performance is referred to as the "Performance-Adjusted RSUs."
(b)    Subject to Section 3 and Section 6 of this Agreement, the Performance-Adjusted RSUs shall vest on February 15, 2027 (the "Vesting Date"). The period between the Grant Date and the Vesting Date shall be referred to as the "Vesting Period."
3.Effects of Certain Events:
(a)If the Participant's employment with the Company is terminated by the Company without Cause or due to the Participant's Retirement prior to the Vesting Date (other than as provided in Section 3(b)), then:
(i) in all such cases the Performance RSUs shall remain subject to adjustment for performance as provided in Section 2(a) above, including if such termination of employment occurs during the Performance Period; and
(ii) a prorated number of the Performance-Adjusted RSUs will vest on the Vesting Date in an amount equal to (x) the unvested Performance-Adjusted RSUs in the Vesting Period multiplied by (y) a fraction, the numerator of which is the number of complete and partial calendar months from the Grant Date to the date of termination, and the denominator of which is the number of complete and partial calendar months in the Vesting Period, such product to be rounded up to the nearest whole number.
Page 2 of 15
© 2024 Celanese Corporation


Such prorated Performance-Adjusted RSUs will be settled following the Vesting Date in accordance with the provisions of Section 4, subject to any applicable taxes under Section 7 upon such vesting and settlement. The remaining portion of the Award shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of employment. To the extent permitted by applicable country, state or province law, as consideration for the vesting provisions upon Retirement contained in this Section 3(a), upon Retirement, the Participant shall enter into a departure and general release of claims agreement with the Company that includes two-year noncompetition and non-solicitation covenants in a form acceptable to the Company.
(b)Notwithstanding any provision herein to the contrary, if the Participant's employment with the Company is terminated by the Company in connection with a Qualifying Disposition, as determined by the Company in its sole discretion, other than for Cause, and regardless of whether the Participant is then eligible for Retirement or is offered employment with the acquiror or successor, then:
(i) a prorated number of the unvested Performance RSUs determined in accordance with the provisions of Section 3(a) had those provisions applied shall remain subject to adjustment for performance as provided in Section 2(a) above, including if such termination of employment occurs during the Performance Period, and shall be settled in accordance with the provisions of Section 3(a); and
(ii) the remaining number of the unvested Performance RSUs that would have otherwise been forfeited had the provisions of Section 3(a) applied shall remain subject to adjustment for performance as provided in Section 2(a) above, including if such termination of employment occurs during the Performance Period, and any such Performance-Adjusted RSUs will vest and be settled in accordance with the provisions of Section 4, subject to any applicable taxes under Section 7 upon such vesting and settlement.
Notwithstanding the foregoing, in case of a termination of employment covered by this Section 3(b), if the Company determines that the Participant has been offered employment with the acquiror or successor and in connection with that employment will receive a substitute award from the acquiror or successor with an equivalent (or greater) economic value and no less favorable vesting conditions as this Award, the Company, in its sole discretion, may determine not to provide for the additional vesting under clause (ii) of this Section 3(b).
(c)If the Participant's employment with the Company is terminated due to the Participant's death or Disability prior to the Vesting Date, then a prorated number of Performance RSUs will vest in an amount equal to:
(i) the Target number of Performance RSUs granted hereby multiplied by
(ii) a fraction, the numerator of which is the number of complete and partial calendar months from the Grant Date to the date of termination, and the denominator of which is the number of complete and partial calendar months in the Vesting Period, such product to be rounded up to the nearest whole number.
The prorated number of Performance RSUs shall immediately vest and a number of Common Shares equal to such prorated number of Performance RSUs described above shall be delivered to the Participant or beneficiary within thirty (30) days following the date of termination, subject to the provisions of Section 7. The remaining portion of the Award shall be immediately forfeited
Page 3 of 15
© 2024 Celanese Corporation


and cancelled without consideration as of the date of the Participant's termination of employment for death or Disability.
(d)Upon the termination of a Participant's employment with the Company for any other reason prior to the Vesting Date, the Award shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of employment.
A Participant's employment will be considered to have been terminated for Cause, and the Award forfeited and cancelled without consideration, if the Company determines, in its sole discretion, that the Participant engaged in an act constituting Cause at any time prior to the Vesting Date, regardless of whether the Participant's termination initially was considered to have been without Cause. In such case, the provisions of Section 3(a), 3(b) or 3(c) are inapplicable.
4.Settlement of Performance RSUs: The Committee shall determine the Performance-Adjusted RSUs as soon as administratively practicable following the computation of Celanese's performance for the Performance Period (but not later than 2 ½ months after the end of the Performance Period (i.e., March 15, 2027)). The date of such determination is referred to as the "Performance Certification Date." Subject to Sections 2, 3, 5, 6 and 7 of this Agreement, Celanese shall deliver to the Participant (or to a Company-designated brokerage firm or plan administrator) as soon as administratively practicable after the Performance Certification Date (but not later than 2 ½ months after the end of the Performance Period (i.e., March 15, 2027)), in complete settlement of the Performance-Adjusted RSUs vesting on such Vesting Date, a number of Common Shares equal to the Performance-Adjusted RSUs determined in accordance with this Agreement.
5.Rights as a Stockholder: The Participant shall have no voting, dividend or other rights as a stockholder with respect to the Award until the Performance RSUs have vested and Common Shares have been delivered pursuant to this Agreement.
6.Change in Control; Dissolution:
(a)Notwithstanding any other provision of this Agreement to the contrary, in connection with the occurrence of a Change in Control, with respect to any unvested Performance RSUs granted pursuant to this Agreement that have not previously been forfeited:
(i)If (A) a Participant's rights to the unvested portion of the Award are not adversely affected in connection with the Change in Control, or, if adversely affected, a substitute award with an equivalent (or greater) economic value and no less favorable vesting conditions is granted to the Participant in connection with the occurrence of a Change in Control, and (B) the Participant's employment is terminated by the Company (or its successor) without Cause within two years following the Change in Control, then Performance RSUs in an amount equal to the higher of (x) the Target number of Performance RSUs granted hereby (or, as applicable, the substitute award) or (y) the number of Performance RSUs payable based on estimated Celanese performance during the Performance Period through the Change in Control as determined by the Committee in accordance with this Agreement, shall immediately vest and a number of Common Shares equal to the number of Performance RSUs so determined shall be delivered to the Participant within 30 days following the date of termination, subject to the provisions of Section 7.
(ii)If a Participant's right to the unvested portion of the Award is adversely affected in connection with the Change in Control and a substitute award is not made pursuant to Section 6(a)(i) above, then upon the occurrence of a Change in Control, a
Page 4 of 15
© 2024 Celanese Corporation


number of Performance RSUs equal to the higher of (A) the Target number of Performance RSUs granted hereby or (B) the number of Performance RSUs payable based on estimated Celanese performance during the Performance Period through the Change in Control as determined by the Committee in accordance with this Agreement, shall immediately vest and a number of Common Shares equal to the number of Performance RSUs so determined shall be delivered to the Participant within 30 days following the occurrence of the Change in Control, subject to the provisions of Section 7.
(b)Notwithstanding any other provision of this Agreement to the contrary, in the event of a corporate dissolution of Celanese that is taxed under Section 331 of the Code, then in accordance with Treasury Regulation Section 1.409A-3(j)(4)(ix)(A), this Agreement shall terminate and any Performance RSUs granted pursuant to this Agreement that have not previously been forfeited shall immediately become Common Shares and shall be delivered to the Participant within 30 days following such dissolution.
7.Income and Other Taxes: The Company shall not deliver Common Shares in respect of any vested Performance RSUs unless and until the Participant has made arrangements satisfactory to the Company to satisfy applicable withholding tax obligations for U.S. federal, state, and local income taxes (or the foreign counterpart thereof) and applicable employment taxes. Unless otherwise permitted by the Committee, withholding shall be effectuated by withholding Common Shares in connection with the vesting and/or settlement of Performance-Adjusted RSUs. Withholding shall be effected using a rate or method chosen by the Company consistent with ASC Topic 718 (or any successor applicable equity accounting standard applicable to this Award) and the U.S. Internal Revenue Service withholding regulations or other applicable tax requirements, not to exceed maximum statutory rates. The Participant acknowledges that the Company shall have the right to deduct any taxes required to be withheld by law in connection with the vesting or settlement of Performance-Adjusted RSUs from any amounts payable by it to the Participant (including, without limitation, future cash wages). The Participant acknowledges and agrees that amounts withheld by the Company for taxes may be less than amounts actually owed for taxes by the Participant in respect of the Award. Any vested Performance-Adjusted RSUs shall be reflected in the Company's records as issued on the respective dates of issuance set forth in this Agreement, irrespective of whether delivery of such Common Shares is pending the Participant's satisfaction of his or her withholding tax obligations.
8.Securities Laws: The Company may impose such restrictions, conditions or limitations as it determines appropriate as to the timing and manner of any resales by the Participant or other subsequent transfers by the Participant of any Common Shares issued as a result of the vesting or settlement of the Performance RSUs, including without limitation (a) restrictions under an insider trading policy, and (b) restrictions as to the use of a specified brokerage firm for such resales or other transfers. Upon the acquisition of any Common Shares pursuant to the vesting or settlement of the Performance-Adjusted RSUs, the Participant will make or enter into such written representations, warranties and agreements as the Company may reasonably request in order to comply with applicable securities laws or with this Agreement and the 2018 Plan. All accounts in which such Common Shares are held or any certificates for Common Shares shall be subject to such stop transfer orders and other restrictions as the Company may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, any stock exchange or quotation system upon which the Common Shares are then listed or quoted, and any applicable federal or state securities law, and the Company may cause a legend or legends to be put on any such certificates (or other appropriate restrictions and/or notations to be associated with any accounts in which such Common Shares are held) to make appropriate reference to such restrictions.
9.Non-Transferability of Award: The Performance RSUs may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Participant other than by will or by
Page 5 of 15
© 2024 Celanese Corporation


the laws of descent and distribution, and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company; provided, that the Participant may designate a beneficiary, on a form provided by the Company, to receive any portion of the Award payable hereunder following the Participant's death.
10.Other Agreements; Release of Claims: Subject to Sections 10(a), 10(b) and 10(c) of this Agreement, this Agreement and the 2018 Plan constitute the entire understanding between the Participant and the Company regarding the Award, and any prior and/or contemporaneous agreements, understandings, representations, discussions, commitments or negotiations concerning the Award, whether written or oral, are superseded. No oral statements or other prior written material not specifically incorporated into this Agreement, other than the 2018 Plan, shall be of any force or effect.
(a)The Participant acknowledges that as a condition to the receipt of the Award, the Participant:
(1)    shall have delivered to the Company an executed copy of this Agreement;
(2)    shall be subject to the Company's stock ownership guidelines, to the extent applicable to the Participant;
(3)    shall be subject to policies and agreements adopted by the Company from time to time, and applicable laws and regulations, requiring the repayment by the Participant of incentive compensation under certain circumstances, including (i) that certain Celanese Corporation Incentive-Based Compensation Recoupment (Clawback) Policy (Financial Restatements) (as applicable) adopted by the Committee on October 18, 2023 and (ii) that certain Celanese Corporation Amended and Restated Incentive Compensation Recoupment Policy (Detrimental Conduct; Violations of Restrictive Covenants) adopted by the Committee on October 18, 2023 (collectively, "Clawback Policies"), without any further act or deed or consent of the Participant; and
(4)    shall have delivered to the Company an executed copy of the current form of Long-Term Incentive Claw-Back Agreement, as determined by the Company in its sole discretion. For purposes hereof, "Long-Term Incentive Claw-Back Agreement" means an agreement between the Company and the Participant associated with the grant of long-term incentives of the Company, which contains terms, conditions, restrictions and provisions regarding one or more of (i) noncompetition by the Participant with the Company, and its customers and clients; (ii) non-solicitation and non-hiring by the Participant of the Company's employees, former employees or consultants; (iii) maintenance of confidentiality of the Company's and/or clients' information, including intellectual property; (iv) nondisparagement of the Company; and (v) such other matters deemed necessary, desirable or appropriate by the Company for such an agreement in view of the rights and benefits conveyed in connection with an award.
(b)The Participant acknowledges that if the Participant violates any of the terms or provisions of the Clawback Policies or the Long-Term Incentive Claw-Back Agreement, whether before or after termination of employment, then the Company will, to the fullest extent permitted by applicable law, (i) terminate the Participant's rights in any unvested Performance RSUs under this Award, and (ii) claw back (i.e., recover) all Common Shares previously issued under this Award.
Page 6 of 15
© 2024 Celanese Corporation


(c)If the Participant is a non-resident of the U.S., there may be an addendum containing special terms and conditions applicable to awards in the Participant's country ("International Supplement"). The issuance of the Award to any such Participant is contingent upon the Participant executing and returning any such addendum in the manner directed by the Company.
11.Not a Contract for Employment; No Acquired Rights; Agreement Changes: This Agreement and the Award evidenced hereby are not an employment agreement, and nothing in this Agreement, the International Supplement, if applicable, or the 2018 Plan shall alter the Participant's status as an "at-will" employee of the Company or your employment status at the Company. None of this Agreement, the International Supplement, if applicable, or the 2018 Plan shall be construed as guaranteeing your employment by the Company, or as giving you any right to continue in the employ of the Company, during any period (including without limitation the period between the Date of the Agreement and the Vesting Date, or any portion of such period), nor shall they be construed as giving you any right to be reemployed by the Company following any termination of employment. This Agreement and the Award evidenced hereby, and all other long-term incentive awards and other equity-based awards, are discretionary. This Award does not confer on the Participant any right or entitlement to receive another Award or any other equity-based award at any time in the future or in respect of any future period. The Company has made this Award to you in its sole discretion. This Award does not confer on you any right or entitlement to receive compensation in any specific amount for any future year, and does not diminish in any way the Company's discretion to determine the amount, if any, of your compensation. This Award is not part of your base salary or wages and will not be taken into account in determining any other employment-related rights you may have, such as rights to pension or severance pay. The Company has the right, at any time and for any reason, to amend, suspend or terminate the 2018 Plan; provided, however, that no such amendment, suspension, or termination shall adversely affect the Participant's rights hereunder.
12.Severability: Should any provision of this Agreement be declared or held to be illegal, invalid or otherwise unenforceable, (a) such provision shall either be reformed, if possible, to the extent necessary to render it legal, valid and enforceable, or otherwise severed, (b) the remainder of this Agreement shall not be affected except to the extent necessary to reform or sever such illegal, invalid or unenforceable provision, and (c) in no event should such partial invalidity affect the remainder of this Agreement, which shall still be enforced.
13.Further Assurances: Each party shall cooperate and take such action as may be reasonably requested by either party hereto in order to carry out the provisions and purposes of this Agreement.
14.Binding Effect: The Award and this Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective permitted heirs, beneficiaries, successors and assigns.
15.Electronic Delivery: By executing this Agreement, the Participant hereby consents to the delivery of any and all information (including, without limitation, information required to be delivered to the Participant pursuant to applicable securities laws), in whole or in part, regarding Celanese and its subsidiaries, the 2018 Plan, and the Award via electronic mail, the Company's or a plan administrator's web site, or other means of electronic delivery.
16.Personal Data: By accepting the Award under this Agreement, the Participant hereby consents to the Company's use, dissemination and disclosure of any information pertaining to the Participant that the Company determines to be necessary or desirable for the implementation, administration and management of the 2018 Plan.
Page 7 of 15
© 2024 Celanese Corporation


17.Miscellaneous:
(a)Governing Law. Notwithstanding the place where this Agreement may be executed by any of the parties hereto, the parties expressly agree that all the terms and provisions hereof shall be governed by, construed under and interpreted in accordance with the laws of the State of Delaware, without regard to its conflicts of laws rules.
(b)Notice. The Participant is reminded to read the following carefully and after consulting with counsel of their choice:
The Participant agrees that the following provisions requiring arbitration, prohibiting recovery of attorneys' fees, waiving class actions and mass actions, waiving the right to a jury trial, waiving any right to seek punitive damages, limiting actual damages, and limiting remedies by waiving any right to injunctive or other equitable or legal relief are and were an important part of the Company's decision to adopt the Operative Documents and for Participant to be offered this Agreement. The Participant understands and agrees that absent the foregoing provisions, the Operative Documents would not have been offered or entered into or would have materially changed. The Participant acknowledges the benefits of receiving potential incentive awards. In reliance on the Participant's intent to abide by and enter into the following provisions, the parties have entered into the Operative Documents.
(c)MANDATORY ARBITRATION. All disputes arising out of or related in any manner to the Operative Documents shall be resolved exclusively by arbitration to be conducted only in the county and state of Dallas, Texas in accordance with the rules of the International Institute for Conflict Prevention and Resolution Rules for Non-Administered Arbitration ("CPR") applying the laws of Delaware and by a sole arbitrator. Within 45 days of the service of any demand for arbitration, the parties shall attempt to mutually agree on the appointment of an arbitrator and may seek names of potential arbitrators from CPR for their consideration. Failing agreement on selection of an agreed arbitrator, upon written request of either party, CPR shall appoint a single arbitrator in accordance with its rules, with the parties expressing a contractual preference for the selection of a retired judge with at least 10 years of judicial experience. Discovery shall be as provided by the CPR rules. The arbitration award shall be in writing and shall include a reasoned opinion by the Arbitrator. Consistent with the waiver of all claims to punitive or exemplary damages, the Arbitrator shall have no authority to award such damages. The parties understand that their right to appeal or to seek modification of any ruling or award of the arbitrator is severely limited, if any. Awards issued by the arbitrator shall be final and binding, and judgment may be entered on it in any court of competent jurisdiction. All parties shall keep confidential the fact of the arbitration, the dispute being arbitrated, and the decision of the arbitrator. Any and all disputes regarding this arbitration provision and its enforceability shall be exclusively submitted to the United States District Court for the District of Delaware, if it has jurisdiction, and failing that, to the Delaware state court in Wilmington, Delaware.
(d)NO RECOVERY OF ATTORNEYS' FEES AND COSTS. Each party agrees that in any litigation or proceeding between the parties arising out of, connected with, related to, or incidental to the relationship between them in connection with the Operative Documents, each party shall bear all of its own attorneys' fees and costs regardless of which party prevails, except when prohibited by applicable law.
(e)CLASS ACTION AND MASS ACTION WAIVER. As part of this provision of arbitration as the contracted method of all dispute resolution under this Agreement, any claim, whether brought in a court of law or in arbitration, must be brought in the Participant's individual
Page 8 of 15
© 2024 Celanese Corporation


capacity, and not as a representative of any purported class or as a "mass action" (involving multiple plaintiffs) ("Class/Mass Action"). The parties expressly waive any ability to maintain any Class/Mass Action in any forum. The arbitrator shall not have authority to combine or aggregate similar claims or conduct any Class/Mass Action nor make an award to any person or entity not a party to the arbitration. Any claim that all or part of this Class/Mass Action waiver is unenforceable, unconscionable, void, or voidable may be determined only by a court of competent jurisdiction and not by an arbitrator. The Participant understands that but for this Agreement, he or she would have had a right to litigate through a court, to have a judge or jury decide the case and to be party to a Class/Mass Action. However, in exchange for the potential incentive awards provided herein and the receipt of the benefit of arbitration, the Participant understands and chooses to have only his or her individual claims decided, each in a separate case, by an arbitrator.
(f)WAIVER OF JURY TRIAL. TO THE EXTENT PERMITTED BY APPLICABLE LAW AND EXPRESSLY BECAUSE OF THE COMPLEXITY OF THE MATTERS IN THE OPERATIVE DOCUMENTS, EACH PARTY WAIVES ANY RIGHT TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE ARISING OUT OF OR RELATING TO THE OPERATIVE DOCUMENTS.
(g)WAIVER OF PUNITIVE AND EXEMPLARY DAMAGE CLAIMS. The Participant waives, to the fullest extent allowed by law, any claims or rights to recover punitive, exemplary or similar damages.
(h)LIMIT ON ACTUAL DAMAGES. In no event may the actual damages awarded to the Participant in a dispute arising out of or relating to the Operative Documents exceed the Fair Market Value of the Performance RSU Target Award set forth on the first page of this Agreement as of the vesting date, reduced by the value of any shares or payments previously received under this Agreement (the "Damages Limit"). The Participant knowingly, voluntarily and irrevocably waives and releases any claim to damages in excess of this Damages Limit.
(i)LIMITATION OF REMEDIES. Except when prohibited by applicable law, the procedures and remedies set forth in this Agreement shall constitute the sole remedies available to the Participant. In no event shall the Participant seek equitable relief, injunctive relief, or otherwise bring claims directly or derivatively for ultra vires, corporate waste, breach of fiduciary duty, or any other claim or cause of action, whether legal or equitable, sounding in contract or tort. Nothing in this clause is intended to waive or limit any claim brought pursuant to any federal or state statute related to the protection of civil rights. Should any provision in this Agreement be found by a court of competent jurisdiction, after all appellate rights are exhausted, to be unenforceable or void, the Parties expressly agree to sever such provision and to otherwise proceed to dispute resolution with the remaining provisions in the Mandatory Arbitration provisions.
18.Performance RSUs Subject to Plan: By entering into this Agreement the Participant agrees and acknowledges that the Participant has received and read a copy of the 2018 Plan and the 2018 Plan's prospectus. The Performance RSUs and the Common Shares issued upon settlement of such Performance RSUs are subject to the 2018 Plan, which is hereby incorporated by reference. In the event of any conflict between any term or provision of this Agreement and a term or provision of the 2018 Plan, the applicable terms and provisions of the 2018 Plan shall govern and prevail.
19.Validity of Agreement: This Agreement shall be valid, binding and effective upon the Company on the Grant Date. The Participant must accept this Agreement electronically pursuant to the
Page 9 of 15
© 2024 Celanese Corporation


online acceptance procedure established by the Company within 90 days; otherwise the Company may, in its sole discretion, rescind the Award in its entirety.
20.Headings: The headings preceding the text of the sections hereof are inserted solely for convenience of reference, and shall not constitute a part of this Agreement, nor shall they affect its meaning, construction or effect.
21.Compliance with Section 409A of the Internal Revenue Code: Notwithstanding any provision in this Agreement to the contrary, this Agreement will be interpreted and applied so that the Agreement does not fail to meet, and is operated in accordance with, the requirements of Section 409A of the Code. The Company reserves the right to change the terms of this Agreement and the 2018 Plan without the Participant's consent to the extent necessary or desirable to comply with the requirements of Code Section 409A. Further, in accordance with the restrictions provided by Treasury Regulation Section 1.409A-3(j)(2), any subsequent amendments to this Agreement or any other agreement, or the entering into or termination of any other agreement, affecting the Performance RSUs provided by this Agreement shall not modify the time or form of issuance of the Performance RSUs set forth in this Agreement. In addition, if the Participant is a "specified employee" within the meaning of Code Section 409A, as determined by the Company, any payment made in connection with the Participant's separation from service shall not be made earlier than six months and one day after the date of such separation from service to the extent required by Code Section 409A.
22.Definitions: The following terms shall have the following meanings for purposes of this Agreement, notwithstanding any contrary definition in the 2018 Plan:
(a)"Adjusted Earnings Per Share" or "Adjusted EPS" means a measure used by Celanese's management to measure performance, defined as earnings (loss) from continuing operations attributable to Celanese Corporation, adjusted for income tax (provision) benefit, certain items, refinancing and related expenses, divided by the number of basic common shares and dilutive restricted stock units and stock options calculated using the treasury method and further adjusted for certain items as determined by the Company (consistent with the provisions of Section 13(b) of the 2018 Plan) and as approved by the Committee.
Note: The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete items and other material items adjusted out of our GAAP earnings for adjusted earnings per share purposes, and changes in management's assessments regarding the ability to realize deferred tax assets. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. It is not practical to reconcile our prospective adjusted tax rate to the actual GAAP tax rate in any given future period.
(b)"Adjusted EBIT" means net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, refinancing expense and taxes, and further adjusted for certain items attributable to Celanese Corporation as determined by the Company (consistent with the provisions of Section 13(b) of the 2018 Plan) and as approved by the Committee.
Page 10 of 15
© 2024 Celanese Corporation


(c)"Cause" means, as determined by the Company in its sole discretion, (i) the Participant's willful failure to perform the Participant's duties to the Company (other than as a result of total or partial incapacity due to physical or mental illness) for a period of 30 days following written notice by the Company to the Participant of such failure, (ii) the Participant's conviction of, or a plea of nolo contendere to, (x) a felony under the laws of the United States or any state thereof or any similar criminal act in a jurisdiction outside the United States or (y) a crime involving moral turpitude, (iii) the Participant's willful malfeasance or willful misconduct which is demonstrably injurious to the Company or its affiliates, (iv) any act of fraud by the Participant, (v) any violation of the Company's business conduct policy, (vi) any violation of the Company's policies concerning harassment or discrimination by the Participant, (vii) the Participant's conduct that causes harm to the business reputation of the Company or its affiliates, or (viii) the Participant's breach of any confidentiality, intellectual property, noncompetition or non-solicitation provisions applicable to the Participant under the Long-Term Incentive Claw-Back Agreement or any other agreement between the Participant and the Company. "Cause" shall be determined by the Company in its sole discretion, and such determination shall be final, binding, and conclusive on the Participant.
(d)"Change in Control" means:
(i)    any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) (a "Person") becomes the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 30% or more of either (A) the then-outstanding shares of common stock of Celanese (the "Outstanding Celanese Common Stock") or (B) the combined voting power of the then-outstanding voting securities of Celanese entitled to vote generally in the election of directors (the "Outstanding Celanese Voting Securities"); provided, however, that, for purposes of this subparagraph, the following acquisitions shall not constitute a Change in Control: (i) any acquisition directly from the Company, (ii) any acquisition by the Company, (iii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any Affiliate, or (iv) any acquisition pursuant to a transaction that complies with clauses (A), (B) or (C) in paragraph (iii) of this definition; or
(ii)    individuals who, as of the effective date of this Agreement, constitute the Board (the "Incumbent Board") cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the effective date of this Agreement whose election, or nomination for election by Celanese's stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual was a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or
(iii)    consummation of a reorganization, merger, statutory share exchange or consolidation or similar transaction involving Celanese or any of its subsidiaries, a sale or other disposition of all or substantially all of the assets of Celanese, or the acquisition of assets or stock of another entity by Celanese or any of its subsidiaries (each, a "Business Combination"), in each case unless, following such Business Combination, (A) all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding Celanese Common Stock and the Outstanding Celanese Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly,
Page 11 of 15
© 2024 Celanese Corporation


more than 50% of the then-outstanding shares of common stock (or, for a non-corporate entity, equivalent securities) and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors (or, for a non-corporate entity, equivalent governing body), as the case may be, of the entity resulting from such Business Combination (including, without limitation, an entity that, as a result of such transaction, owns Celanese or all or substantially all of Celanese's assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership immediately prior to such Business Combination of the Outstanding Celanese Common Stock and the Outstanding Celanese Voting Securities, as the case may be, (B) no Person (excluding any corporation resulting from such Business Combination or any employee benefit plan (or related trust) of the Company or such corporation resulting from such Business Combination) beneficially owns, directly or indirectly, 30% or more of, respectively, the then-outstanding shares of common stock of the corporation resulting from such Business Combination or the combined voting power of the then-outstanding voting securities of such corporation, except to the extent that such ownership existed prior to the Business Combination, and (C) at least a majority of the members of the board of directors (or, for a non-corporate entity, equivalent governing body) of the entity resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement or of the action of the Board providing for such Business Combination; or
(iv)    approval by the stockholders of Celanese of a complete liquidation or dissolution of Celanese.
Notwithstanding the foregoing, if it is determined that an Award hereunder is subject to the requirements of Section 409A and the Change in Control is a "payment event" under Section 409A for such Award, Celanese will not be deemed to have undergone a Change in Control unless Celanese is deemed to have undergone a "change in control event" pursuant to the definition of such term in Section 409A.
(e)"Disability" has the same meaning as "Disability" in the Celanese Corporation 2008 Deferred Compensation Plan or such other meaning as determined by the Committee in its sole discretion, provided that in all events a "Disability" under this Agreement shall constitute a "disability" within the meaning of Treasury Regulation Section 1.409A-3(i)(4).
(f)"Operative Documents" means the 2018 Plan and this Agreement.
(g)"Peer Group" means, subject to the provisions below, entities included in the Dow Jones US Chemical Index as of December 31, 2023. This is a "closed group"; therefore, changes in the Peer Group during the period specified in the definition of Total Stockholder Return, shall be handled as follows:
(1)Closed Group: The composition of the Peer Group will be determined on the date specified above, and "frozen" as of that date; subsequent changes to the composition of the index will not change the Peer Group. Companies will not be market capitalization weighted.
(2)Multiple Class Companies: If a company in the Dow Jones US Chemical Index has more than one class of shares trading, only the "Class A" shares will be included in the Peer Group.
Page 12 of 15
© 2024 Celanese Corporation


(3)    Acquisitions: If a company in the Peer Group is acquired during the Performance Period, such company is excluded from the Peer Group for purposes of the TSR calculation.
(4)    Spinoffs: The surviving parent entity will be retained in the Peer Group, by treating the value of the spinco as a reinvested dividend in parent stock.
(5)    Bankruptcy: If a company in the Peer Group files for bankruptcy protection or is otherwise insolvent during the Performance Period, such company shall remain in the Peer Group but shall be assigned the lowest possible ranking for TSR.
(6)    No Trading: If a company is in the Dow Jones US Chemical Index but is not trading as of December 31, 2023, then it will be excluded from the Peer Group. If a company in the Peer Group is otherwise no longer publicly traded on the last day of the Performance Period (other than as a result of an acquisition as described in clause (3) above), such company shall remain in the Peer Group but shall be assigned the lowest possible ranking for TSR.
(h)"Performance Period" means the three-year period from January 1, 2024 through December 31, 2026.
(i)"Qualifying Disposition" means a sale or other disposition by the Company or one or more subsidiaries of all or part of a business, business unit, segment or subsidiary in a stock, asset, merger or other similar transaction or combination thereof, and determined by the Committee to be a Qualifying Disposition.
(j)"Relative Total Stockholder Return" or "Relative TSR" is assessed in comparison of the percentile rank in TSR to the Peer Group. The lowest ranked company will be the 0% rank, the middle ranked company will be the 50th percentile rank and the top ranked company will be the 100th percentile rank.
(k)"Retirement" of the Participant shall mean a voluntary separation from service on or after the date when the Participant is both 55 years of age and has 10 years of service with the Company, as determined by the Company in its discretion based on payroll records. Retirement shall not include voluntary separation from service in which the Company could have terminated the Participant's employment for Cause.
(l)"Return on Capital Employed" or "ROCE" means a measure used by Celanese's management to measure performance and is defined as Adjusted EBIT divided by capital employed, which is the beginning and end-of-year average of the sum of property, plant and equipment, net; trade working capital (calculated as trade receivables, net plus inventories less trade payables – third party and affiliates); goodwill; intangible assets, and investments in affiliates, adjusted to eliminate noncontrolling interests, and certain items as determined by the Company (consistent with the provisions of Section 13(b) of the 2018 Plan) and as approved by the Committee.
(m)"Settlement Date" means the date that Common Shares are delivered to the Participant following the Vesting Date.
(n)"Total Stockholder Return" or "TSR" measures the percent change in share price from the beginning of the Performance Period to the end of the Performance Period and assumes immediate reinvestment of dividends when declared at the closing share price on the date declared. The beginning share price will be calculated as an average of 60 data points: the closing
Page 13 of 15
© 2024 Celanese Corporation


share price on December 31, 2023 and the closing share price for each of the 59 trading days preceding December 31, 2023. The ending share price will be calculated as an average of 60 data points: the closing share price on December 31, 2026 and the closing share price for each of the 59 trading days preceding December 31, 2026.
[signatures appear on following page]

Page 14 of 15
© 2024 Celanese Corporation


IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by its duly authorized officer.

CELANESE CORPORATION
By:
Lori J. Ryerkerk
Chair, Chief Executive Officer and President
Page 15 of 15
© 2024 Celanese Corporation


APPENDIX A
CALCULATION OF THE PERFORMANCE-BASED VESTING
Performance-Based Vesting Calculation
The Performance RSUs are subject to adjustment based on the achievement of specified levels of:
(i) the Company's Adjusted EPS during the Performance Period, weighted 70%; and
(ii) the Company's ROCE during the Performance Period, weighted 30%.
In addition, the Performance RSUs will be subject to further adjustment based on Celanese's Relative TSR during the Performance Period.
Each metric will be calculated separately based on the targets set forth below. The results of each metric will determine the number of Performance RSUs earned for that metric. The total award will be the addition of the total number of Performance RSUs earned for each of the two performance metrics, with such result then subject to adjustment based on Celanese's Relative TSR during the Performance Period. The number of Performance RSUs determined after such adjustments (and subject further to the additional vesting requirements of Section 2(b) of the Agreement) are referred to as the "Performance-Adjusted RSUs." Fractional shares remaining after such adjustments will be rounded up to the nearest whole share. No fractional shares will be issued.

Page A-1
© 2024 Celanese Corporation


A. Calculation of Performance Adjustment based on the Adjusted EPS Results
The following table outlines the percentage of the Performance RSUs that may become earned based on Adjusted EPS performance during the Performance Period.
Adjusted EPS
(70% weighting)
Result
Goal Achievement for Performance Period1
Performance Adjustment Percentage
Below ThresholdLess than $[●]0%
Threshold$[●]50%
Target$[●]100%
Superior$[●]or more200%
The Performance Adjustment Percentage for Adjusted EPS for the Performance Period shall be calculated by straight-line interpolation for results achieved between Threshold and Target, or for results achieved between Target and Superior. No Performance RSUs will be earned for the Adjusted EPS component for the Performance Period if Goal Achievement is Below Threshold.

1 To the extent not otherwise included as an adjustment to Adjusted EPS (as defined) or ROCE (as defined), if
(a) the historic financial statements of the Company for period(s) ending prior to the Performance Period are retrospectively recast in connection with a change in accounting principle or method adopted during the Performance Period,
(b) the Company effects a material acquisition, disposition, merger, spin-off or other similar transaction, or enters/exits a joint venture, affecting the Company or any subsidiary or any portion thereof, during the Performance Period,
(c) the Company suffers or incurs items of gain, loss or expense determined to be unusual in nature, or charges for restructurings, discontinued operations, or any other unusual or infrequent items, or any other event materially outside the scope of those anticipated in the Company's operating plans,
(d) there are changes in tax law or other such laws or provisions affecting reported results,
(e) the Company establishes accruals or reserves, or impairs assets, for reorganization or restructuring programs, and/or
(f) the Company incurs or is adversely affected by any other eventuality contemplated by the last sentence of Section 13(b) of the 2018 Plan,
then in each such case where the amount is significant to the Company, the Committee shall, as determined appropriate in its sole discretion, adjust the performance goals or level of assessed performance, as described in this Appendix A to ensure that the Participant is not unfairly advantaged or disadvantaged by any of the events described in items (a)-(f).
Page A-2
© 2024 Celanese Corporation


B. Calculation of Performance Adjustment based on the ROCE Results
The following table outlines the percentage of the Performance RSUs that may become earned based on ROCE performance during the Performance Period.
ROCE
(30% weighting)
Result
Goal Achievement for Performance Period1
Performance Adjustment Percentage
Below ThresholdLess than [●]%0%
Threshold[●]%50%
Target[●]% - [●]%100%
Superior[●]% or more200%
The Performance Adjustment Percentage for ROCE for the Performance Period shall be calculated by straight-line interpolation for results achieved between Threshold and the low end of the Target range, or for results achieved between the high end of the Target range and Superior. No Performance RSUs will be earned for the ROCE component for the Performance Period if Goal Achievement is Below Threshold.
C. Calculation of Relative TSR Modifier
The sum of the Performance RSUs earned for the Adjusted EPS component and the Performance RSUs earned for the ROCE component will be subject to further adjustment by multiplying such aggregate Performance RSUs earned by the "Modifier Percentage" determined based on Celanese's Relative TSR percentile ranking during the Performance Period in accordance with the following table.
Relative TSR Modifier
Relative TSR Percentile AchievedModifier Percentage
< 25%
80%
25% to 75%100%
> 75%
120%

D. Adjustments In Case of Certain Dispositions and Acquisitions
In the event of a sale or other disposition by the Company or one or more subsidiaries of all or part of a business, business unit, segment or subsidiary in a stock, asset, merger or other similar transaction or combination thereof, if such transaction is determined by the Committee to constitute a "change in ownership or control" within the meaning of Section 280G of the Code (and regardless of whether such transaction also constitutes a "Change in Control" as defined in this Agreement) (e.g., a sale or other disposition of assets of the Company that have a gross fair market value equal to or more than one-third of the total gross fair market value of all assets of the Company immediately before such transaction), the Committee may, in addition to or in lieu of any permitted adjustments to the performance goals or performance provided above, in its discretion take any action as determined to be equitable to reflect the closing of the transaction, including, but not limited to: (i) adjust the performance vesting conditions in any manner, including substituting new or additional performance goals, over the remaining Performance Period, (ii) cease the measurement of performance as of the closing of the transaction and adjust the Award to a time-vesting Award over the remainder of the Performance Period (at target, based on actual
Page A-3
© 2024 Celanese Corporation


or projected performance at the time of the transaction, or on any other basis as the Committee may determine), or (iii) accelerate the vesting of all or any portion of the Award.
In the event of an acquisition by the Company of one or more subsidiaries in a stock, asset, merger or other similar transaction or combination thereof (regardless of whether such transaction also constitutes a "Change in Control" as defined in this Agreement), the Committee may, in addition to or in lieu of any permitted or required adjustments to the performance goals or performance provided above, in its discretion take any action as determined to be equitable to reflect the closing of the transaction, including, but not limited to: (i) adjust the performance vesting conditions in any manner, including substituting new or additional performance goals, over the remaining Performance Period or (ii) cease the measurement of performance as of the closing of the transaction and adjust the Award to a time-vesting Award over the remainder of the Performance Period (at target, based on actual or projected performance at the time of the transaction, or on any other basis as the Committee may determine).
Page A-4
© 2024 Celanese Corporation
EX-10.4 3 ex1043312410q.htm EX-10.4 Document

Exhibit 10.4
[Form of 2024 CEO Performance-Based RSU Agreement]





celogoa.jpg








CELANESE CORPORATION
AMENDED AND RESTATED 2018 GLOBAL INCENTIVE PLAN

PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT
DATED [Grant Date]



Pursuant to the terms and conditions of the Celanese Corporation Amended and Restated 2018 Global Incentive Plan, you have been awarded Performance-Based Restricted Stock Units, subject to the restrictions described in this Agreement. In addition to the information included in this Award Agreement, the Participant's name and the number of Restricted Stock Units awarded can be found in the Grant Summary located in the electronic stock plan award administration system maintained by the Company or its designee that contains a link to this Agreement (which summary information is set forth in the appropriate records of the Company authorizing such award).


2024 Performance RSU Award

Target Award: [Number of Shares Granted] Units


This grant is made pursuant to the Performance-Based Restricted Stock Unit Award Agreement dated as of [Grant Date], between Celanese and [Participant Name], covering a performance period from January 1, 2024 through December 31, 2026, which Agreement is attached hereto and made a part hereof.


Page 1 of 15
© 2024 Celanese Corporation


CELANESE CORPORATION
AMENDED AND RESTATED 2018 GLOBAL INCENTIVE PLAN

PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT
This Performance-Based Restricted Stock Unit Award Agreement (the "Agreement") is made and entered into as of [Grant Date] (the "Grant Date"), by and between Celanese Corporation, a Delaware corporation ("Celanese" and together with the participating subsidiaries that are employers of the Participants, the "Company"), and [Participant Name] (the "Participant"). Capitalized terms used, but not otherwise defined, herein shall have the meanings ascribed to such terms in the Celanese Corporation Amended and Restated 2018 Global Incentive Plan (as amended from time to time, the "2018 Plan").
1.Performance RSU Award: In order to encourage the Participant's contribution to the successful performance of the Company, Celanese hereby grants to the Participant as of the Grant Date, pursuant to the terms of the 2018 Plan and this Agreement, an award (the "Award") of [Number of Shares Granted] performance-based Restricted Stock Units ("Performance RSUs") representing the right to receive, subject to the attainment of the performance goals set forth in Appendix A, the number of Common Shares to be determined in accordance with the formula set forth in Appendix A. The Participant hereby acknowledges and accepts such Award upon the terms and subject to the performance requirements and other conditions, restrictions and limitations contained in this Agreement and the 2018 Plan.
2.Performance-Based Adjustment and Vesting:
(a)    Subject to Section 3 and Section 6 of this Agreement, the Performance RSUs are subject to adjustment for performance during the Performance Period in accordance with the performance measures, targets and methodology set forth in Appendix A. The number of Performance RSUs determined after the Performance Period based on such performance is referred to as the "Performance-Adjusted RSUs."
(b)    Subject to Section 3 and Section 6 of this Agreement, the Performance-Adjusted RSUs shall vest on February 15, 2027 (the "Vesting Date"). The period between the Grant Date and the Vesting Date shall be referred to as the "Vesting Period."
3.Effects of Certain Events:
(a)If the Participant's service with the Company is terminated by the Company without Cause or due to the Participant's Retirement prior to the Vesting Date (other than as provided in Section 3(b)), then:
(i) in all such cases the Performance RSUs shall remain subject to adjustment for performance as provided in Section 2(a) above, including if such termination of service occurs during the Performance Period; and
(ii) a prorated number of the Performance-Adjusted RSUs will vest on the Vesting Date in an amount equal to (x) the unvested Performance-Adjusted RSUs in the Vesting Period multiplied by (y) a fraction, the numerator of which is the number of complete and partial calendar months from the Grant Date to the date of termination, and the denominator of which is the number of complete and partial calendar months in the Vesting Period, such product to be rounded up to the nearest whole number.
Page 2 of 15
© 2024 Celanese Corporation


Such prorated Performance-Adjusted RSUs will be settled following the Vesting Date in accordance with the provisions of Section 4, subject to any applicable taxes under Section 7 upon such vesting and settlement. The remaining portion of the Award shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of service. To the extent permitted by applicable country, state or province law, as consideration for the vesting provisions upon Retirement contained in this Section 3(a), upon Retirement, the Participant shall enter into a departure and general release of claims agreement with the Company that includes a general release of claims, covenants relating to the provision of transition assistance and cooperation (including reasonable transition support to any successor CEO and cooperation in litigation related to the time period of Participant's service) and two-year noncompetition and non-solicitation covenants in a form acceptable to the Company.
(b)Notwithstanding any provision herein to the contrary, if the Participant's employment with the Company is terminated by the Company in connection with a Qualifying Disposition, as determined by the Company in its sole discretion, other than for Cause, and regardless of whether the Participant is then eligible for Retirement or is offered employment with the acquiror or successor, then:
(i) a prorated number of the unvested Performance RSUs determined in accordance with the provisions of Section 3(a) had those provisions applied shall remain subject to adjustment for performance as provided in Section 2(a) above, including if such termination of employment occurs during the Performance Period, and shall be settled in accordance with the provisions of Section 3(a); and
(ii) the remaining number of the unvested Performance RSUs that would have otherwise been forfeited had the provisions of Section 3(a) applied shall remain subject to adjustment for performance as provided in Section 2(a) above, including if such termination of employment occurs during the Performance Period, and any such Performance-Adjusted RSUs will vest and be settled in accordance with the provisions of Section 4, subject to any applicable taxes under Section 7 upon such vesting and settlement.
Notwithstanding the foregoing, in case of a termination of employment covered by this Section 3(b), if the Company determines that the Participant has been offered employment with the acquiror or successor and in connection with that employment will receive a substitute award from the acquiror or successor with an equivalent (or greater) economic value and no less favorable vesting conditions as this Award, the Company, in its sole discretion, may determine not to provide for the additional vesting under clause (ii) of this Section 3(b).
(c)If the Participant's service with the Company is terminated due to the Participant's death or Disability prior to the Vesting Date, then a prorated number of Performance RSUs will vest in an amount equal to:
(i) the Target number of Performance RSUs granted hereby multiplied by
(ii) a fraction, the numerator of which is the number of complete and partial calendar months from the Grant Date to the date of termination, and the denominator of which is the number of complete and partial calendar months in the Vesting Period, such product to be rounded up to the nearest whole number.
The prorated number of Performance RSUs shall immediately vest and a number of Common Shares equal to such prorated number of Performance RSUs described above shall be delivered to
Page 3 of 15
© 2024 Celanese Corporation


the Participant or beneficiary within thirty (30) days following the date of termination, subject to the provisions of Section 7. The remaining portion of the Award shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of service for death or Disability.
(d)Upon the termination of a Participant's service with the Company for any other reason prior to the Vesting Date, the Award shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of service.
A Participant's service will be considered to have been terminated for Cause, and the Award forfeited and cancelled without consideration, if the Company determines, in its sole discretion, that the Participant engaged in an act constituting Cause at any time prior to the Vesting Date, regardless of whether the Participant's termination initially was considered to have been without Cause. In such case, the provisions of Section 3(a), 3(b) or 3(c) are inapplicable.
4.Settlement of Performance RSUs: The Committee shall determine the Performance-Adjusted RSUs as soon as administratively practicable following the computation of Celanese's performance for the Performance Period (but not later than 2 ½ months after the end of the Performance Period (i.e., March 15, 2027)). The date of such determination is referred to as the "Performance Certification Date." Subject to Sections 2, 3, 5, 6 and 7 of this Agreement, Celanese shall deliver to the Participant (or to a Company-designated brokerage firm or plan administrator) as soon as administratively practicable after the Performance Certification Date (but not later than 2 ½ months after the end of the Performance Period (i.e., March 15, 2027)), in complete settlement of the Performance-Adjusted RSUs vesting on such Vesting Date, a number of Common Shares equal to the Performance-Adjusted RSUs determined in accordance with this Agreement.
5.Rights as a Stockholder: The Participant shall have no voting, dividend or other rights as a stockholder with respect to the Award until the Performance RSUs have vested and Common Shares have been delivered pursuant to this Agreement.
6.Change in Control; Dissolution:
(a)Notwithstanding any other provision of this Agreement to the contrary, in connection with the occurrence of a Change in Control, with respect to any unvested Performance RSUs granted pursuant to this Agreement that have not previously been forfeited:
(i)If (A) a Participant's rights to the unvested portion of the Award are not adversely affected in connection with the Change in Control, or, if adversely affected, a substitute award with an equivalent (or greater) economic value and no less favorable vesting conditions is granted to the Participant in connection with the occurrence of a Change in Control, and (B) the Participant's service is terminated by the Company (or its successor) without Cause within two years following the Change in Control, then Performance RSUs in an amount equal to the higher of (x) the Target number of Performance RSUs granted hereby (or, as applicable, the substitute award) or (y) the number of Performance RSUs payable based on estimated Celanese performance during the Performance Period through the Change in Control as determined by the Committee in accordance with this Agreement, shall immediately vest and a number of Common Shares equal to the number of Performance RSUs so determined shall be delivered to the Participant within 30 days following the date of termination, subject to the provisions of Section 7.
Page 4 of 15
© 2024 Celanese Corporation


(ii)If a Participant's right to the unvested portion of the Award is adversely affected in connection with the Change in Control and a substitute award is not made pursuant to Section 6(a)(i) above, then upon the occurrence of a Change in Control, a number of Performance RSUs equal to the higher of (A) the Target number of Performance RSUs granted hereby or (B) the number of Performance RSUs payable based on estimated Celanese performance during the Performance Period through the Change in Control as determined by the Committee in accordance with this Agreement, shall immediately vest and a number of Common Shares equal to the number of Performance RSUs so determined shall be delivered to the Participant within 30 days following the occurrence of the Change in Control, subject to the provisions of Section 7.
(b)Notwithstanding any other provision of this Agreement to the contrary, in the event of a corporate dissolution of Celanese that is taxed under Section 331 of the Code, then in accordance with Treasury Regulation Section 1.409A-3(j)(4)(ix)(A), this Agreement shall terminate and any Performance RSUs granted pursuant to this Agreement that have not previously been forfeited shall immediately become Common Shares and shall be delivered to the Participant within 30 days following such dissolution.
7.Income and Other Taxes: The Company shall not deliver Common Shares in respect of any vested Performance RSUs unless and until the Participant has made arrangements satisfactory to the Company to satisfy applicable withholding tax obligations for U.S. federal, state, and local income taxes (or the foreign counterpart thereof) and applicable employment taxes. Unless otherwise permitted by the Committee, withholding shall be effectuated by withholding Common Shares in connection with the vesting and/or settlement of Performance-Adjusted RSUs. Withholding shall be effected using a rate or method chosen by the Company consistent with ASC Topic 718 (or any successor applicable equity accounting standard applicable to this Award) and the U.S. Internal Revenue Service withholding regulations or other applicable tax requirements, not to exceed maximum statutory rates. The Participant acknowledges that the Company shall have the right to deduct any taxes required to be withheld by law in connection with the vesting or settlement of Performance-Adjusted RSUs from any amounts payable by it to the Participant (including, without limitation, future cash wages). The Participant acknowledges and agrees that amounts withheld by the Company for taxes may be less than amounts actually owed for taxes by the Participant in respect of the Award. Any vested Performance-Adjusted RSUs shall be reflected in the Company's records as issued on the respective dates of issuance set forth in this Agreement, irrespective of whether delivery of such Common Shares is pending the Participant's satisfaction of his or her withholding tax obligations.
8.Securities Laws: The Company may impose such restrictions, conditions or limitations as it determines appropriate as to the timing and manner of any resales by the Participant or other subsequent transfers by the Participant of any Common Shares issued as a result of the vesting or settlement of the Performance RSUs, including without limitation (a) restrictions under an insider trading policy, and (b) restrictions as to the use of a specified brokerage firm for such resales or other transfers. Upon the acquisition of any Common Shares pursuant to the vesting or settlement of the Performance-Adjusted RSUs, the Participant will make or enter into such written representations, warranties and agreements as the Company may reasonably request in order to comply with applicable securities laws or with this Agreement and the 2018 Plan. All accounts in which such Common Shares are held or any certificates for Common Shares shall be subject to such stop transfer orders and other restrictions as the Company may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, any stock exchange or quotation system upon which the Common Shares are then listed or quoted, and any applicable federal or state securities law, and the Company may cause a legend or legends to be put on any such certificates (or other appropriate restrictions and/or notations to be associated with any accounts in which such Common Shares are held) to make appropriate reference to such restrictions.
Page 5 of 15
© 2024 Celanese Corporation


9.Non-Transferability of Award: The Performance RSUs may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Participant other than by will or by the laws of descent and distribution, and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company; provided, that the Participant may designate a beneficiary, on a form provided by the Company, to receive any portion of the Award payable hereunder following the Participant's death.
10.Other Agreements; Release of Claims: Subject to Sections 10(a), 10(b) and 10(c) of this Agreement, this Agreement and the 2018 Plan constitute the entire understanding between the Participant and the Company regarding the Award, and any prior and/or contemporaneous agreements, understandings, representations, discussions, commitments or negotiations concerning the Award, whether written or oral, are superseded. No oral statements or other prior written material not specifically incorporated into this Agreement, other than the 2018 Plan, shall be of any force or effect.
(a)The Participant acknowledges that as a condition to the receipt of the Award, the Participant:
(1)    shall have delivered to the Company an executed copy of this Agreement;
(2)    shall be subject to the Company's stock ownership guidelines, to the extent applicable to the Participant;
(3)    shall be subject to policies and agreements adopted by the Company from time to time, and applicable laws and regulations, requiring the repayment by the Participant of incentive compensation under certain circumstances, including (i) that certain Celanese Corporation Incentive-Based Compensation Recoupment (Clawback) Policy (Financial Restatements) (as applicable) adopted by the Committee on October 18, 2023 and (ii) that certain Celanese Corporation Amended and Restated Incentive Compensation Recoupment Policy (Detrimental Conduct; Violations of Restrictive Covenants) adopted by the Committee on October 18, 2023 (collectively, "Clawback Policies"), without any further act or deed or consent of the Participant; and
(4)    shall have delivered to the Company an executed copy of the current form of Long-Term Incentive Claw-Back Agreement, as determined by the Company in its sole discretion. For purposes hereof, "Long-Term Incentive Claw-Back Agreement" means an agreement between the Company and the Participant associated with the grant of long-term incentives of the Company, which contains terms, conditions, restrictions and provisions regarding one or more of (i) noncompetition by the Participant with the Company, and its customers and clients; (ii) non-solicitation and non-hiring by the Participant of the Company's employees, former employees or consultants; (iii) maintenance of confidentiality of the Company's and/or clients' information, including intellectual property; (iv) nondisparagement of the Company; and (v) such other matters deemed necessary, desirable or appropriate by the Company for such an agreement in view of the rights and benefits conveyed in connection with an award.
(b)The Participant acknowledges that if the Participant violates any of the terms or provisions of the Clawback Policies or the Long-Term Incentive Claw-Back Agreement, whether before or after termination of service, then the Company will, to the fullest extent permitted by applicable law, (i) terminate the Participant's rights in any unvested Performance RSUs under this Award, and (ii) claw back (i.e., recover) all Common Shares previously issued under this Award.
Page 6 of 15
© 2024 Celanese Corporation


(c)If the Participant is a non-resident of the U.S., there may be an addendum containing special terms and conditions applicable to awards in the Participant's country ("International Supplement"). The issuance of the Award to any such Participant is contingent upon the Participant executing and returning any such addendum in the manner directed by the Company.
11.Not a Contract for Employment; No Acquired Rights; Agreement Changes: This Agreement and the Award evidenced hereby are not an employment agreement, and nothing in this Agreement, the International Supplement, if applicable, or the 2018 Plan shall alter the Participant's status as an "at-will" employee or service provider of the Company or your employment or service status at the Company. None of this Agreement, the International Supplement, if applicable, or the 2018 Plan shall be construed as guaranteeing your employment by or service with the Company, or as giving you any right to continue in the employ or engagement of the Company, during any period (including without limitation the period between the Date of the Agreement and the Vesting Date, or any portion of such period), nor shall they be construed as giving you any right to be reemployed or reengaged by the Company following any termination of employment or service. This Agreement and the Award evidenced hereby, and all other long-term incentive awards and other equity-based awards, are discretionary. This Award does not confer on the Participant any right or entitlement to receive another Award or any other equity-based award at any time in the future or in respect of any future period. The Company has made this Award to you in its sole discretion. This Award does not confer on you any right or entitlement to receive compensation in any specific amount for any future year, and does not diminish in any way the Company's discretion to determine the amount, if any, of your compensation. This Award is not part of your base salary or wages and will not be taken into account in determining any other employment- or service-related rights you may have, such as rights to pension or severance pay. The Company has the right, at any time and for any reason, to amend, suspend or terminate the 2018 Plan; provided, however, that no such amendment, suspension, or termination shall adversely affect the Participant's rights hereunder.
12.Severability: Should any provision of this Agreement be declared or held to be illegal, invalid or otherwise unenforceable, (a) such provision shall either be reformed, if possible, to the extent necessary to render it legal, valid and enforceable, or otherwise severed, (b) the remainder of this Agreement shall not be affected except to the extent necessary to reform or sever such illegal, invalid or unenforceable provision, and (c) in no event should such partial invalidity affect the remainder of this Agreement, which shall still be enforced.
13.Further Assurances: Each party shall cooperate and take such action as may be reasonably requested by either party hereto in order to carry out the provisions and purposes of this Agreement.
14.Binding Effect: The Award and this Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective permitted heirs, beneficiaries, successors and assigns.
15.Electronic Delivery: By executing this Agreement, the Participant hereby consents to the delivery of any and all information (including, without limitation, information required to be delivered to the Participant pursuant to applicable securities laws), in whole or in part, regarding Celanese and its subsidiaries, the 2018 Plan, and the Award via electronic mail, the Company's or a plan administrator's web site, or other means of electronic delivery.
16.Personal Data: By accepting the Award under this Agreement, the Participant hereby consents to the Company's use, dissemination and disclosure of any information pertaining to the Participant that the Company determines to be necessary or desirable for the implementation, administration and management of the 2018 Plan.
Page 7 of 15
© 2024 Celanese Corporation


17.Miscellaneous:
(a)Governing Law. Notwithstanding the place where this Agreement may be executed by any of the parties hereto, the parties expressly agree that all the terms and provisions hereof shall be governed by, construed under and interpreted in accordance with the laws of the State of Delaware, without regard to its conflicts of laws rules.
(b)Notice. The Participant is reminded to read the following carefully and after consulting with counsel of their choice:
The Participant agrees that the following provisions requiring arbitration, prohibiting recovery of attorneys' fees, waiving class actions and mass actions, waiving the right to a jury trial, waiving any right to seek punitive damages, limiting actual damages, and limiting remedies by waiving any right to injunctive or other equitable or legal relief are and were an important part of the Company's decision to adopt the Operative Documents and for Participant to be offered this Agreement. The Participant understands and agrees that absent the foregoing provisions, the Operative Documents would not have been offered or entered into or would have materially changed. The Participant acknowledges the benefits of receiving potential incentive awards. In reliance on the Participant's intent to abide by and enter into the following provisions, the parties have entered into the Operative Documents.
(c)MANDATORY ARBITRATION. All disputes arising out of or related in any manner to the Operative Documents shall be resolved exclusively by arbitration to be conducted only in the county and state of Dallas, Texas in accordance with the rules of the International Institute for Conflict Prevention and Resolution Rules for Non-Administered Arbitration ("CPR") applying the laws of Delaware and by a sole arbitrator. Within 45 days of the service of any demand for arbitration, the parties shall attempt to mutually agree on the appointment of an arbitrator and may seek names of potential arbitrators from CPR for their consideration. Failing agreement on selection of an agreed arbitrator, upon written request of either party, CPR shall appoint a single arbitrator in accordance with its rules, with the parties expressing a contractual preference for the selection of a retired judge with at least 10 years of judicial experience. Discovery shall be as provided by the CPR rules. The arbitration award shall be in writing and shall include a reasoned opinion by the Arbitrator. Consistent with the waiver of all claims to punitive or exemplary damages, the Arbitrator shall have no authority to award such damages. The parties understand that their right to appeal or to seek modification of any ruling or award of the arbitrator is severely limited, if any. Awards issued by the arbitrator shall be final and binding, and judgment may be entered on it in any court of competent jurisdiction. All parties shall keep confidential the fact of the arbitration, the dispute being arbitrated, and the decision of the arbitrator. Any and all disputes regarding this arbitration provision and its enforceability shall be exclusively submitted to the United States District Court for the District of Delaware, if it has jurisdiction, and failing that, to the Delaware state court in Wilmington, Delaware.
(d)NO RECOVERY OF ATTORNEYS' FEES AND COSTS. Each party agrees that in any litigation or proceeding between the parties arising out of, connected with, related to, or incidental to the relationship between them in connection with the Operative Documents, each party shall bear all of its own attorneys' fees and costs regardless of which party prevails, except when prohibited by applicable law.
(e)CLASS ACTION AND MASS ACTION WAIVER. As part of this provision of arbitration as the contracted method of all dispute resolution under this Agreement, any claim, whether brought in a court of law or in arbitration, must be brought in the Participant's individual
Page 8 of 15
© 2024 Celanese Corporation


capacity, and not as a representative of any purported class or as a "mass action" (involving multiple plaintiffs) ("Class/Mass Action"). The parties expressly waive any ability to maintain any Class/Mass Action in any forum. The arbitrator shall not have authority to combine or aggregate similar claims or conduct any Class/Mass Action nor make an award to any person or entity not a party to the arbitration. Any claim that all or part of this Class/Mass Action waiver is unenforceable, unconscionable, void, or voidable may be determined only by a court of competent jurisdiction and not by an arbitrator. The Participant understands that but for this Agreement, he or she would have had a right to litigate through a court, to have a judge or jury decide the case and to be party to a Class/Mass Action. However, in exchange for the potential incentive awards provided herein and the receipt of the benefit of arbitration, the Participant understands and chooses to have only his or her individual claims decided, each in a separate case, by an arbitrator.
(f)WAIVER OF JURY TRIAL. TO THE EXTENT PERMITTED BY APPLICABLE LAW AND EXPRESSLY BECAUSE OF THE COMPLEXITY OF THE MATTERS IN THE OPERATIVE DOCUMENTS, EACH PARTY WAIVES ANY RIGHT TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE ARISING OUT OF OR RELATING TO THE OPERATIVE DOCUMENTS.
(g)WAIVER OF PUNITIVE AND EXEMPLARY DAMAGE CLAIMS. The Participant waives, to the fullest extent allowed by law, any claims or rights to recover punitive, exemplary or similar damages.
(h)LIMIT ON ACTUAL DAMAGES. In no event may the actual damages awarded to the Participant in a dispute arising out of or relating to the Operative Documents exceed the Fair Market Value of the Performance RSU Target Award set forth on the first page of this Agreement as of the vesting date, reduced by the value of any shares or payments previously received under this Agreement (the "Damages Limit"). The Participant knowingly, voluntarily and irrevocably waives and releases any claim to damages in excess of this Damages Limit.
(i)LIMITATION OF REMEDIES. Except when prohibited by applicable law, the procedures and remedies set forth in this Agreement shall constitute the sole remedies available to the Participant. In no event shall the Participant seek equitable relief, injunctive relief, or otherwise bring claims directly or derivatively for ultra vires, corporate waste, breach of fiduciary duty, or any other claim or cause of action, whether legal or equitable, sounding in contract or tort. Nothing in this clause is intended to waive or limit any claim brought pursuant to any federal or state statute related to the protection of civil rights. Should any provision in this Agreement be found by a court of competent jurisdiction, after all appellate rights are exhausted, to be unenforceable or void, the Parties expressly agree to sever such provision and to otherwise proceed to dispute resolution with the remaining provisions in the Mandatory Arbitration provisions.
18.Performance RSUs Subject to Plan: By entering into this Agreement the Participant agrees and acknowledges that the Participant has received and read a copy of the 2018 Plan and the 2018 Plan's prospectus. The Performance RSUs and the Common Shares issued upon settlement of such Performance RSUs are subject to the 2018 Plan, which is hereby incorporated by reference. In the event of any conflict between any term or provision of this Agreement and a term or provision of the 2018 Plan, the applicable terms and provisions of the 2018 Plan shall govern and prevail.
19.Validity of Agreement: This Agreement shall be valid, binding and effective upon the Company on the Grant Date. The Participant must accept this Agreement electronically pursuant to the
Page 9 of 15
© 2024 Celanese Corporation


online acceptance procedure established by the Company within 90 days; otherwise the Company may, in its sole discretion, rescind the Award in its entirety.
20.Headings: The headings preceding the text of the sections hereof are inserted solely for convenience of reference, and shall not constitute a part of this Agreement, nor shall they affect its meaning, construction or effect.
21.Compliance with Section 409A of the Internal Revenue Code: Notwithstanding any provision in this Agreement to the contrary, this Agreement will be interpreted and applied so that the Agreement does not fail to meet, and is operated in accordance with, the requirements of Section 409A of the Code. The Company reserves the right to change the terms of this Agreement and the 2018 Plan without the Participant's consent to the extent necessary or desirable to comply with the requirements of Code Section 409A. Further, in accordance with the restrictions provided by Treasury Regulation Section 1.409A-3(j)(2), any subsequent amendments to this Agreement or any other agreement, or the entering into or termination of any other agreement, affecting the Performance RSUs provided by this Agreement shall not modify the time or form of issuance of the Performance RSUs set forth in this Agreement. In addition, if the Participant is a "specified employee" within the meaning of Code Section 409A, as determined by the Company, any payment made in connection with the Participant's separation from service shall not be made earlier than six months and one day after the date of such separation from service to the extent required by Code Section 409A.
22.Definitions: The following terms shall have the following meanings for purposes of this Agreement, notwithstanding any contrary definition in the 2018 Plan:
(a)"Adjusted Earnings Per Share" or "Adjusted EPS" means a measure used by Celanese's management to measure performance, defined as earnings (loss) from continuing operations attributable to Celanese Corporation, adjusted for income tax (provision) benefit, certain items, refinancing and related expenses, divided by the number of basic common shares and dilutive restricted stock units and stock options calculated using the treasury method and further adjusted for certain items as determined by the Company (consistent with the provisions of Section 13(b) of the 2018 Plan) and as approved by the Committee.
Note: The income tax rate used for adjusted earnings per share approximates the midpoint in a range of forecasted tax rates for the year. This range may include certain partial or full-year forecasted tax opportunities and related costs, where applicable, and specifically excludes changes in uncertain tax positions, discrete items and other material items adjusted out of our GAAP earnings for adjusted earnings per share purposes, and changes in management's assessments regarding the ability to realize deferred tax assets. In determining the adjusted earnings per share tax rate, we reflect the impact of foreign tax credits when utilized, or expected to be utilized, absent discrete events impacting the timing of foreign tax credit utilization. We analyze this rate quarterly and adjust if there is a material change in the range of forecasted tax rates; an updated forecast would not necessarily result in a change to our tax rate used for adjusted earnings per share. The adjusted tax rate is an estimate and may differ from the actual tax rate used for GAAP reporting in any given reporting period. It is not practical to reconcile our prospective adjusted tax rate to the actual GAAP tax rate in any given future period.
(b)"Adjusted EBIT" means net earnings (loss) attributable to Celanese Corporation, plus (earnings) loss from discontinued operations, less interest income, plus interest expense, refinancing expense and taxes, and further adjusted for certain items attributable to Celanese Corporation as determined by the Company (consistent with the provisions of Section 13(b) of the 2018 Plan) and as approved by the Committee.
Page 10 of 15
© 2024 Celanese Corporation


(c)"Cause" means, as determined by the Company in its sole discretion, (i) the Participant's willful failure to perform the Participant's duties to the Company (other than as a result of total or partial incapacity due to physical or mental illness) for a period of 30 days following written notice by the Company to the Participant of such failure, (ii) the Participant's conviction of, or a plea of nolo contendere to, (x) a felony under the laws of the United States or any state thereof or any similar criminal act in a jurisdiction outside the United States or (y) a crime involving moral turpitude, (iii) the Participant's willful malfeasance or willful misconduct which is demonstrably injurious to the Company or its affiliates, (iv) any act of fraud by the Participant, (v) any violation of the Company's business conduct policy, (vi) any violation of the Company's policies concerning harassment or discrimination by the Participant, (vii) the Participant's conduct that causes harm to the business reputation of the Company or its affiliates, or (viii) the Participant's breach of any confidentiality, intellectual property, noncompetition or non-solicitation provisions applicable to the Participant under the Long-Term Incentive Claw-Back Agreement or any other agreement between the Participant and the Company. "Cause" shall be determined by the Company in its sole discretion, and such determination shall be final, binding, and conclusive on the Participant.
(d)"Change in Control" means:
(i)    any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) (a "Person") becomes the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 30% or more of either (A) the then-outstanding shares of common stock of Celanese (the "Outstanding Celanese Common Stock") or (B) the combined voting power of the then-outstanding voting securities of Celanese entitled to vote generally in the election of directors (the "Outstanding Celanese Voting Securities"); provided, however, that, for purposes of this subparagraph, the following acquisitions shall not constitute a Change in Control: (i) any acquisition directly from the Company, (ii) any acquisition by the Company, (iii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any Affiliate, or (iv) any acquisition pursuant to a transaction that complies with clauses (A), (B) or (C) in paragraph (iii) of this definition; or
(ii)    individuals who, as of the effective date of this Agreement, constitute the Board (the "Incumbent Board") cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the effective date of this Agreement whose election, or nomination for election by Celanese's stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual was a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or
(iii)    consummation of a reorganization, merger, statutory share exchange or consolidation or similar transaction involving Celanese or any of its subsidiaries, a sale or other disposition of all or substantially all of the assets of Celanese, or the acquisition of assets or stock of another entity by Celanese or any of its subsidiaries (each, a "Business Combination"), in each case unless, following such Business Combination, (A) all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding Celanese Common Stock and the Outstanding Celanese Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly,
Page 11 of 15
© 2024 Celanese Corporation


more than 50% of the then-outstanding shares of common stock (or, for a non-corporate entity, equivalent securities) and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors (or, for a non-corporate entity, equivalent governing body), as the case may be, of the entity resulting from such Business Combination (including, without limitation, an entity that, as a result of such transaction, owns Celanese or all or substantially all of Celanese's assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership immediately prior to such Business Combination of the Outstanding Celanese Common Stock and the Outstanding Celanese Voting Securities, as the case may be, (B) no Person (excluding any corporation resulting from such Business Combination or any employee benefit plan (or related trust) of the Company or such corporation resulting from such Business Combination) beneficially owns, directly or indirectly, 30% or more of, respectively, the then-outstanding shares of common stock of the corporation resulting from such Business Combination or the combined voting power of the then-outstanding voting securities of such corporation, except to the extent that such ownership existed prior to the Business Combination, and (C) at least a majority of the members of the board of directors (or, for a non-corporate entity, equivalent governing body) of the entity resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement or of the action of the Board providing for such Business Combination; or
(iv)    approval by the stockholders of Celanese of a complete liquidation or dissolution of Celanese.
Notwithstanding the foregoing, if it is determined that an Award hereunder is subject to the requirements of Section 409A and the Change in Control is a "payment event" under Section 409A for such Award, Celanese will not be deemed to have undergone a Change in Control unless Celanese is deemed to have undergone a "change in control event" pursuant to the definition of such term in Section 409A.
(e)"Disability" has the same meaning as "Disability" in the Celanese Corporation 2008 Deferred Compensation Plan or such other meaning as determined by the Committee in its sole discretion, provided that in all events a "Disability" under this Agreement shall constitute a "disability" within the meaning of Treasury Regulation Section 1.409A-3(i)(4).
(f)"Operative Documents" means the 2018 Plan and this Agreement.
(g)"Peer Group" means, subject to the provisions below, entities included in the Dow Jones US Chemical Index as of December 31, 2023. This is a "closed group"; therefore, changes in the Peer Group during the period specified in the definition of Total Stockholder Return, shall be handled as follows:
(1)Closed Group: The composition of the Peer Group will be determined on the date specified above, and "frozen" as of that date; subsequent changes to the composition of the index will not change the Peer Group. Companies will not be market capitalization weighted.
(2)Multiple Class Companies: If a company in the Dow Jones US Chemical Index has more than one class of shares trading, only the "Class A" shares will be included in the Peer Group.
Page 12 of 15
© 2024 Celanese Corporation


(3)    Acquisitions: If a company in the Peer Group is acquired during the Performance Period, such company is excluded from the Peer Group for purposes of the TSR calculation.
(4)    Spinoffs: The surviving parent entity will be retained in the Peer Group, by treating the value of the spinco as a reinvested dividend in parent stock.
(5)    Bankruptcy: If a company in the Peer Group files for bankruptcy protection or is otherwise insolvent during the Performance Period, such company shall remain in the Peer Group but shall be assigned the lowest possible ranking for TSR.
(6)    No Trading: If a company is in the Dow Jones US Chemical Index but is not trading as of December 31, 2023, then it will be excluded from the Peer Group. If a company in the Peer Group is otherwise no longer publicly traded on the last day of the Performance Period (other than as a result of an acquisition as described in clause (3) above), such company shall remain in the Peer Group but shall be assigned the lowest possible ranking for TSR.
(h)"Performance Period" means the three-year period from January 1, 2024 through December 31, 2026.
(i)"Qualifying Disposition" means a sale or other disposition by the Company or one or more subsidiaries of all or part of a business, business unit, segment or subsidiary in a stock, asset, merger or other similar transaction or combination thereof, and determined by the Committee to be a Qualifying Disposition.
(j)"Relative Total Stockholder Return" or "Relative TSR" is assessed in comparison of the percentile rank in TSR to the Peer Group. The lowest ranked company will be the 0% rank, the middle ranked company will be the 50th percentile rank and the top ranked company will be the 100th percentile rank.
(k)"Retirement" of the Participant shall mean a voluntary separation from service on or after the earlier of (i) the date when the Participant is both 55 years of age and has 10 years of service with the Company, as determined by the Company in its discretion based on payroll records or (ii) the date when the Participant is age 62 or greater; provided, however, that in the case of clause (ii), unless waived by the Board, (1) the Participant shall have provided at least 12 months' advance notice to the Board of such planned retirement from the Chief Executive Officer position, and (2) the Board shall have designated a successor Chief Executive Officer. Retirement shall not include voluntary separation from service in which the Company could have terminated the Participant's service for Cause.
(l)"Return on Capital Employed" or "ROCE" means a measure used by Celanese's management to measure performance and is defined as Adjusted EBIT divided by capital employed, which is the beginning and end-of-year average of the sum of property, plant and equipment, net; trade working capital (calculated as trade receivables, net plus inventories less trade payables – third party and affiliates); goodwill; intangible assets, and investments in affiliates, adjusted to eliminate noncontrolling interests, and certain items as determined by the Company (consistent with the provisions of Section 13(b) of the 2018 Plan) and as approved by the Committee.
(m)"Settlement Date" means the date that Common Shares are delivered to the Participant following the Vesting Date.
Page 13 of 15
© 2024 Celanese Corporation


(n)"service" shall mean continued service as the Executive Chairman of the Board of Directors (but not service as another non-employee director that is not Executive Chairman), employee, contractor or consultant.
(o)"Total Stockholder Return" or "TSR" measures the percent change in share price from the beginning of the Performance Period to the end of the Performance Period and assumes immediate reinvestment of dividends when declared at the closing share price on the date declared. The beginning share price will be calculated as an average of 60 data points: the closing share price on December 31, 2023 and the closing share price for each of the 59 trading days preceding December 31, 2023. The ending share price will be calculated as an average of 60 data points: the closing share price on December 31, 2026 and the closing share price for each of the 59 trading days preceding December 31, 2026.
[signatures appear on following page]

Page 14 of 15
© 2024 Celanese Corporation


IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by its duly authorized officer.

CELANESE CORPORATION
By:
Vanessa Dupuis
Senior Vice President and Chief Human Resources Officer
Page 15 of 15
© 2024 Celanese Corporation


APPENDIX A
CALCULATION OF THE PERFORMANCE-BASED VESTING
Performance-Based Vesting Calculation
The Performance RSUs are subject to adjustment based on the achievement of specified levels of:
(i) the Company's Adjusted EPS during the Performance Period, weighted 70%; and
(ii) the Company's ROCE during the Performance Period, weighted 30%.
In addition, the Performance RSUs will be subject to further adjustment based on Celanese's Relative TSR during the Performance Period.
Each metric will be calculated separately based on the targets set forth below. The results of each metric will determine the number of Performance RSUs earned for that metric. The total award will be the addition of the total number of Performance RSUs earned for each of the two performance metrics, with such result then subject to adjustment based on Celanese's Relative TSR during the Performance Period. The number of Performance RSUs determined after such adjustments (and subject further to the additional vesting requirements of Section 2(b) of the Agreement) are referred to as the "Performance-Adjusted RSUs." Fractional shares remaining after such adjustments will be rounded up to the nearest whole share. No fractional shares will be issued.

Page A-1
© 2024 Celanese Corporation


A. Calculation of Performance Adjustment based on the Adjusted EPS Results
The following table outlines the percentage of the Performance RSUs that may become earned based on Adjusted EPS performance during the Performance Period.
Adjusted EPS
(70% weighting)
Result
Goal Achievement for Performance Period1
Performance Adjustment Percentage
Below ThresholdLess than $[●]0%
Threshold$[●]50%
Target$[●]100%
Superior$[●]or more200%
The Performance Adjustment Percentage for Adjusted EPS for the Performance Period shall be calculated by straight-line interpolation for results achieved between Threshold and Target, or for results achieved between Target and Superior. No Performance RSUs will be earned for the Adjusted EPS component for the Performance Period if Goal Achievement is Below Threshold.

1 To the extent not otherwise included as an adjustment to Adjusted EPS (as defined) or ROCE (as defined), if
(a) the historic financial statements of the Company for period(s) ending prior to the Performance Period are retrospectively recast in connection with a change in accounting principle or method adopted during the Performance Period,
(b) the Company effects a material acquisition, disposition, merger, spin-off or other similar transaction, or enters/exits a joint venture, affecting the Company or any subsidiary or any portion thereof, during the Performance Period,
(c) the Company suffers or incurs items of gain, loss or expense determined to be unusual in nature, or charges for restructurings, discontinued operations, or any other unusual or infrequent items, or any other event materially outside the scope of those anticipated in the Company's operating plans,
(d) there are changes in tax law or other such laws or provisions affecting reported results,
(e) the Company establishes accruals or reserves, or impairs assets, for reorganization or restructuring programs, and/or
(f) the Company incurs or is adversely affected by any other eventuality contemplated by the last sentence of Section 13(b) of the 2018 Plan,
then in each such case where the amount is significant to the Company, the Committee shall, as determined appropriate in its sole discretion, adjust the performance goals or level of assessed performance, as described in this Appendix A to ensure that the Participant is not unfairly advantaged or disadvantaged by any of the events described in items (a)-(f).
Page A-2
© 2024 Celanese Corporation


B. Calculation of Performance Adjustment based on the ROCE Results
The following table outlines the percentage of the Performance RSUs that may become earned based on ROCE performance during the Performance Period.
ROCE
(30% weighting)
Result
Goal Achievement for Performance Period1
Performance Adjustment Percentage
Below ThresholdLess than [●]%0%
Threshold[●]%50%
Target[●]% - [●]%100%
Superior[●]% or more200%
The Performance Adjustment Percentage for ROCE for the Performance Period shall be calculated by straight-line interpolation for results achieved between Threshold and the low end of the Target range, or for results achieved between the high end of the Target range and Superior. No Performance RSUs will be earned for the ROCE component for the Performance Period if Goal Achievement is Below Threshold.
C. Calculation of Relative TSR Modifier
The sum of the Performance RSUs earned for the Adjusted EPS component and the Performance RSUs earned for the ROCE component will be subject to further adjustment by multiplying such aggregate Performance RSUs earned by the "Modifier Percentage" determined based on Celanese's Relative TSR percentile ranking during the Performance Period in accordance with the following table.
Relative TSR Modifier
Relative TSR Percentile AchievedModifier Percentage
< 25%
80%
25% to 75%100%
> 75%
120%

D. Adjustments In Case of Certain Dispositions and Acquisitions
In the event of a sale or other disposition by the Company or one or more subsidiaries of all or part of a business, business unit, segment or subsidiary in a stock, asset, merger or other similar transaction or combination thereof, if such transaction is determined by the Committee to constitute a "change in ownership or control" within the meaning of Section 280G of the Code (and regardless of whether such transaction also constitutes a "Change in Control" as defined in this Agreement) (e.g., a sale or other disposition of assets of the Company that have a gross fair market value equal to or more than one-third of the total gross fair market value of all assets of the Company immediately before such transaction), the Committee may, in addition to or in lieu of any permitted adjustments to the performance goals or performance provided above, in its discretion take any action as determined to be equitable to reflect the closing of the transaction, including, but not limited to: (i) adjust the performance vesting conditions in any manner, including substituting new or additional performance goals, over the remaining Performance Period, (ii) cease the measurement of performance as of the closing of the transaction and adjust the Award to a time-vesting Award over the remainder of the Performance Period (at target, based on actual
Page A-3
© 2024 Celanese Corporation


or projected performance at the time of the transaction, or on any other basis as the Committee may determine), or (iii) accelerate the vesting of all or any portion of the Award.
In the event of an acquisition by the Company of one or more subsidiaries in a stock, asset, merger or other similar transaction or combination thereof (regardless of whether such transaction also constitutes a "Change in Control" as defined in this Agreement), the Committee may, in addition to or in lieu of any permitted or required adjustments to the performance goals or performance provided above, in its discretion take any action as determined to be equitable to reflect the closing of the transaction, including, but not limited to: (i) adjust the performance vesting conditions in any manner, including substituting new or additional performance goals, over the remaining Performance Period or (ii) cease the measurement of performance as of the closing of the transaction and adjust the Award to a time-vesting Award over the remainder of the Performance Period (at target, based on actual or projected performance at the time of the transaction, or on any other basis as the Committee may determine).
Page A-4
© 2024 Celanese Corporation
EX-10.5 4 ex1053312410q.htm EX-10.5 Document

Exhibit 10.5
[Form of 2024 Time-Based Stock Option Award]





celogo.jpg








CELANESE CORPORATION
AMENDED AND RESTATED 2018 GLOBAL INCENTIVE PLAN

NONQUALIFIED STOCK OPTION AWARD AGREEMENT
DATED [Grant Date]



Pursuant to the terms and conditions of the Celanese Corporation Amended and Restated 2018 Global Incentive Plan, you have been awarded Nonqualified Stock Options, subject to the restrictions described in this Agreement. In addition to the information included in this Agreement, the Participant's name and the number of Options can be found in the Grant Summary located in the electronic stock plan award administration system maintained by the Company or its designee that contains a link to this Agreement (which summary information is set forth in the appropriate records of the Company authorizing such award).


Stock Option Award

[Number of Common Shares Subject to Options] Shares



This grant is made pursuant to the Nonqualified Stock Option Award Agreement dated as of [Grant Date], between Celanese and [Participant Name], which Agreement is attached hereto and made a part hereof.



CELANESE CORPORATION

AMENDED AND RESTATED 2018 GLOBAL INCENTIVE PLAN

NONQUALIFIED STOCK OPTION AWARD AGREEMENT
This Nonqualified Stock Option Award Agreement (the "Agreement") is made and entered into as of [Grant Date] (the "Grant Date") by and between Celanese Corporation, a Delaware corporation ("Celanese" and together with the participating subsidiaries that are employers of the Participants, the "Company"), and [Participant Name] (the "Participant"). Capitalized terms used, but not otherwise defined herein shall have the meanings ascribed to such terms in the Celanese Corporation Amended and Restated 2018 Global Incentive Plan (as amended from time to time, the "2018 Plan").
1.Grant of Options: In order to encourage the Participant's contribution to the successful performance of the Company, the Company hereby grants to the Participant as of the Grant Date, pursuant to the terms of the 2018 Plan and this Agreement, an award (the "Award") of Nonqualified Stock Options (the "Options") to purchase all or any part of the number of Common Shares that are covered by such Options at the Exercise Price per share, in each case as specified below. The Participant hereby acknowledges and accepts such Award upon the terms and subject to the conditions, restrictions and limitations contained in this Agreement and the 2018 Plan.

Number of Common Shares Subject to Options:


[Number of Shares]



Exercise Price Per Share (the "Exercise Price"):


[Exercise Price]



Expiration Date:


[Expiration Date (Put 1 day before 10-year anniversary from Grant Date)]


Vesting Schedule:


Subject to Sections 4 and 6 of this Agreement, [33% of the Number of Shares] Options shall vest on [Vest Date 1], [33% of the Number of Shares] Options shall vest on [Vest Date 2] and [34% of the Number of Shares] Options shall vest on [Vest Date 3] (each date on which a portion of the Options vest and become exercisable, a "Vesting Date", and each period between the Grant Date and a Vesting Date, a "Vesting Period").

2.Non-Qualified Stock Option: The Options are not intended to qualify Incentive Stock Options and this Agreement will be interpreted accordingly.
3.Exercise of Options:
(a)The Options shall not be exercisable as of the Grant Date. After the Grant Date, to the extent not previously exercised, and subject to termination or acceleration as provided in this Agreement or in the 2018 Plan, the Options shall be exercisable to the extent the Options become vested, as described in this Agreement, to purchase up to that number of Common Shares as set forth in Section 1 above, subject to the Participant's continued employment with the Company (except as set forth in Section 4 or 6 below). The Vesting Period and/or exercisability of the Options may be adjusted by the Committee to reflect the decreased level of employment
Page 2
© 2024 Celanese Corporation


during any period in which the Participant is on an approved leave of absence or is employed on a less than full-time basis.
(b)To exercise the Options (or any part thereof), the Participant shall notify the Company and its designated stock plan administrator or agent, as specified by the Company, and indicate the number of whole Common Shares the Participant wishes to purchase pursuant to such Options.
(c)The Exercise Price of the Options is set forth in Section 1. The Company shall not be obligated to issue any Common Shares until the Participant shall have paid the total Exercise Price for that number of Common Shares. The Exercise Price may be paid in any of the following forms or in a combination thereof: (i) cash or its equivalent, (ii) withholding of Common Shares to be issued as a result of such exercise, or (iii) any other method approved by the Committee.
(d)Common Shares will be issued as soon as practical following exercise of the Options. Notwithstanding the above, the Company shall not be obligated to deliver any Common Shares during any period in which the Company determines that the exercisability of the Options or the delivery of Common Shares pursuant to this Agreement would violate any federal, state or other applicable laws.
4.Effects of Certain Events:
(a)Upon the termination of the Participant's employment by the Company without Cause (other than as provided in Section 4(c)), a prorated portion of the unvested Options will vest, with such prorated amount equal to (i) the unvested Options in each Vesting Period, multiplied by (ii) a fraction, the numerator of which is the number of complete and partial calendar months from the Grant Date to the date of termination without Cause, and the denominator of which is the number of complete and partial calendar months in the applicable Vesting Period, such product to be rounded up to the nearest whole number (the "Section 4(a) Pro-Rated Options"). The remaining unvested Options shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of employment without Cause. In the event of the Participant's termination without Cause, the Participant may exercise the vested portion of the Options until the earlier of (A) the 12-month anniversary of the date of such termination of employment or (B) the Expiration Date.
(b)Upon the termination of the Participant's employment by the Company due to the Participant's death or Disability (other than as provided in Section 4(c)), a prorated portion of the unvested Options will vest, with such prorated amount equal to (i) the unvested Options in each Vesting Period, multiplied by (ii) a fraction, the numerator of which is the number of complete and partial calendar months from the Grant Date to the date of termination due to the Participant's death or Disability, and the denominator of which is the number of complete and partial calendar months in the applicable Vesting Period, such product to be rounded up to the nearest whole number (the "Section 4(b) Pro-Rated Options"). The remaining unvested Options shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of employment due to the Participant's death or Disability. In the event of the Participant's death or Disability, the Participant (or the Participant's estate, beneficiary or legal representative) may exercise the vested portion of the Options until the earlier of (A) the 5-year anniversary of the date of such termination of employment or (B) the Expiration Date.
(c)Except as otherwise provided in this Section 4(c), upon the termination of the Participant's employment (i) due to the Participant's Retirement but under circumstances not
Page 3
© 2024 Celanese Corporation


amounting to Cause or (ii) by the Company in connection with a Qualifying Disposition, as determined by the Company in its sole discretion, other than for Cause (and regardless of whether the Participant is offered employment with the acquiror or successor), any unvested Options will remain outstanding and vest and become exercisable on the same Vesting Dates that would have otherwise applied had the Participant remained in continuous employment with the Company through the last Vesting Date applicable to this Award. The Participant (or the Participant's estate, beneficiary or legal representative) may exercise any vested Options held by the Participant as of the date of termination or that otherwise vest pursuant to this Section 4(c) until (i) in the case of the Participant's Retirement under circumstances not amounting to Cause, the earlier of (A) the 7-year anniversary of the date of such termination of employment or (B) the Expiration Date, or (ii) in the case of a termination by the Company in connection with a Qualifying Disposition, the Expiration Date. To the extent permitted by applicable country, state or province law, as consideration for the continued vesting provisions upon Retirement contained in this paragraph, upon Retirement, the Participant shall enter into a departure and general release of claims agreement with the Company that includes two-year noncompetition and non-solicitation covenants in a form acceptable to the Company. In the event of a termination of the Participant's employment by the Company in connection with a Qualifying Disposition as described in this Section, if the Company determines that the Participant has been offered employment with the acquiror or successor and in connection with that employment will receive a substitute award from the acquiror or successor with an equivalent (or greater) economic value and no less favorable vesting conditions as this Award, the Company, in its sole discretion, may determine not to provide for the continued vesting under this Section 4(c).
(d)Upon the termination of a Participant's employment with the Company for any reason other than as set forth in Section 4(a), 4(b), 4(c) or 4(e), (i) the unvested Options shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of employment, and (ii) the Participant may exercise the vested Options until the earlier of (A) 30 days following the date of such termination of employment and (B) the Expiration Date.
(e)Notwithstanding anything in this Section 4 to the contrary, upon the termination of a Participant's employment with the Company for Cause, the Options (whether vested and unvested) shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of employment. If at any time on or before a Vesting Date the Company determines, in its sole discretion, that the Participant engaged in an act constituting Cause, the Participant's employment shall be considered to have been terminated for Cause, and his or her Award shall be forfeited and cancelled without consideration pursuant to this Section 4(e), regardless of whether the Participant's termination initially was considered to have been without Cause. In each such case, the provisions of Sections 4(a), 4(b), 4(c) and 4(d) are inapplicable.
5.Rights as a Stockholder: The Participant shall have no voting, dividend or other rights as a stockholder with respect to the Award until the Options have been exercised and Common Shares have been delivered pursuant to this Agreement.
6.Change in Control; Dissolution:
(a)Notwithstanding any other provision of this Agreement to the contrary, upon the occurrence of a Change in Control, with respect to any unvested Options granted pursuant to this Agreement that have not previously been forfeited:
(i)If (A) the Participant's rights to the unvested Options are not adversely affected in connection with the Change in Control, or, if adversely affected, a substitute award
Page 4
© 2024 Celanese Corporation


with an equivalent (or greater) economic value and no less favorable vesting conditions is granted to the Participant in connection with the occurrence of a Change in Control, and (B) the Participant's employment is terminated by the Company (or its successor) without Cause within two years following the Change in Control, then the unvested Options (or, as applicable, the substitute award) shall immediately vest and become exercisable, and shall remain exercisable for such period (not less than 12 months, or through the Expiration Date if earlier) as specified by the Committee and communicated to the Participant.
(ii)If the Participant's rights to the unvested Options are adversely affected in connection with the Change in Control and a substitute award is not made pursuant to Section 6(a)(i) above, then immediately prior to the occurrence of such Change in Control, the unvested Options shall immediately vest and become exercisable, and shall remain exercisable for such period as specified by the Committee and communicated to the Participant.
(b)Notwithstanding any other provision of this Agreement to the contrary, in the event of a corporate dissolution of the Company that is taxed under Section 331 of the Internal Revenue Code of 1986, as amended, then in accordance with Treasury Regulation Section 1.409A-3(j)(4)(ix)(A), this Agreement shall terminate and any unvested Options granted pursuant to this Agreement shall immediately vest and be automatically exercised, as specified by the Committee and communicated to the Participant.
7.Income and Other Taxes: The Company shall not deliver Common Shares in respect of the exercise of Options unless and until the Participant has made arrangements satisfactory to the Company to satisfy applicable withholding tax obligations for US federal, state, and local income taxes (or the foreign counterpart thereof) and applicable employment taxes. Such obligations may be paid in any of the following forms or in a combination thereof: (i) cash or its equivalent, (ii) withholding of Common Shares to be issued as a result of the exercise of the Option, or (iii) any other method approved by the Committee. Withholding shall be effected using a rate or method chosen by the Company consistent with ASC Topic 718 (or any successor applicable equity accounting standard applicable to this Award) and the U.S. Internal Revenue Service withholding regulations or other applicable tax requirements, not to exceed maximum statutory rates. The Participant acknowledges that the Company shall have the right to deduct any taxes required to be withheld by law in connection with the delivery of Common Shares issued in respect of any exercised Options from any amounts payable by it to the Participant (including, without limitation, future cash wages). The Participant acknowledges and agrees that amounts withheld by the Company for taxes may be less than amounts actually owed for taxes by the Participant in respect of the Award.
8.Securities Laws: The Company may impose such restrictions, conditions or limitations as it determines appropriate as to the timing and manner of any resales by the Participant or other subsequent transfers by the Participant of any Common Shares issued as a result of the exercise of the Options, including without limitation (a) restrictions under an insider trading policy, and (b) restrictions as to the use of a specified brokerage firm for such resales or other transfers. Upon the acquisition of any Common Shares pursuant to the exercise of the Options, the Participant will make or enter into such written representations, warranties and agreements as the Company may reasonably request in order to comply with applicable securities laws or with this Agreement and the 2018 Plan. All accounts in which such Common Shares are held or any certificates for Common Shares shall be subject to such stop transfer orders and other restrictions as the Company may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, any stock exchange or quotation system upon which the Common Shares are then listed or quoted, and any applicable federal or state securities law, and the Company may cause a legend or legends to be put on any such certificates (or other appropriate restrictions and/or notations to be associated with any accounts in which such Common Shares are held) to make appropriate reference to such restrictions.
Page 5
© 2024 Celanese Corporation


9.Non-Transferability of Award: The Options may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Participant other than by will or by the laws of descent and distribution, and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company; provided, that the Participant may designate a beneficiary, on a form provided by the Company, to receive any portion of the Award payable hereunder following the Participant's death.
10.Other Agreements: Subject to Sections 10(a) and 10(b) of this Agreement, this Agreement and the 2018 Plan constitute the entire understanding between the Participant and the Company regarding the Award, and any prior and/or contemporaneous agreements, understandings, representations, discussions, commitments or negotiations concerning the Award, whether written or oral, are superseded. No oral statements or other prior written material not specifically incorporated into this Agreement, other than the 2018 Plan, shall be of any force or effect.
(a)The Participant acknowledges that as a condition to the receipt of the Award, the Participant:
(i)shall have delivered to the Company an executed copy of this Agreement;
(ii)shall be subject to the Company's stock ownership guidelines, to the extent applicable to the Participant;
(iii)shall be subject to policies and agreements adopted by the Company from time to time, and applicable laws and regulations, requiring the repayment by the Participant of incentive compensation under certain circumstances, including (i) that certain Celanese Corporation Incentive-Based Compensation Recoupment (Clawback) Policy (Financial Restatements) (as applicable) adopted by the Committee on October 18, 2023 and (ii) that certain Celanese Corporation Amended and Restated Incentive Compensation Recoupment Policy (Detrimental Conduct; Violations of Restrictive Covenants) adopted by the Committee on October 18, 2023, as the same may be amended (collectively, "Clawback Policies"), without any further act or deed or consent of the Participant; and
(iv)shall have delivered to the Company an executed copy of the current form of Long-Term Incentive Claw-Back Agreement. For purposes hereof, "Long-Term Incentive Claw-Back Agreement" means an agreement between the Company and the Participant associated with the grant of long-term incentives of the Company, which contains terms, conditions, restrictions and provisions regarding one or more of (i) noncompetition by the Participant with the Company, and its customers and clients; (ii) non-solicitation and non-hiring by the Participant of the Company's employees, former employees or consultants; (iii) maintenance of confidentiality of the Company's and/or clients' information, including intellectual property; (iv) nondisparagement of the Company; and (v) such other matters deemed necessary, desirable or appropriate by the Company for such an agreement in view of the rights and benefits conveyed in connection with an award.
(b)The Participant acknowledges that if the Participant violates any of the terms or provisions of the Clawback Policies or the Long-Term Incentive Claw-Back Agreement, whether before or after termination of employment, then the Company will, to the fullest extent permitted by applicable law, (i) terminate the Participant's rights in any unvested Options under this Award, and (ii) claw back (i.e., recover) all Common Shares previously issued upon exercise of the Option granted under this Award.
Page 6
© 2024 Celanese Corporation


(c)If the Participant is a non-resident of the U.S., there may be an addendum containing special terms and conditions applicable to awards in the Participant's country. The issuance of the Award to any such Participant is contingent upon the Participant executing and returning any such addendum in the manner directed by the Company.
11.Not a Contract for Employment; No Acquired Rights; Agreement Changes: Nothing in the 2018 Plan, this Agreement or any other instrument executed in connection with the Award shall confer upon the Participant any right to continue in the Company's employ or service nor limit in any way the Company's right to terminate the Participant's employment at any time for any reason. The grant of Options hereunder, and any future grant of awards to the Participant under the 2018 Plan, is entirely voluntary and at the complete and sole discretion of the Company. Neither the grant of these Options nor any future grant of awards by the Company shall be deemed to create any obligation to grant any further awards, whether or not such a reservation is expressly stated at the time of such grants. The Company has the right, at any time and for any reason, to amend, suspend or terminate the 2018 Plan; provided, however, that no such amendment, suspension, or termination shall adversely affect the Participant's rights hereunder.
12.Severability: In the event that any provision of this Agreement is declared to be illegal, invalid or otherwise unenforceable by a court of competent jurisdiction, such provision shall be reformed, if possible, to the extent necessary to render it legal, valid and enforceable, or otherwise deleted, and the remainder of this Agreement shall not be affected except to the extent necessary to reform or delete such illegal, invalid or unenforceable provision.
13.Further Assurances: Each party shall cooperate and take such action as may be reasonably requested by either party hereto in order to carry out the provisions and purposes of this Agreement.
14.Binding Effect: The Award and this Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective permitted heirs, beneficiaries, successors and assigns.
15.Electronic Delivery: By executing this Agreement, the Participant hereby consents to the delivery of any and all information (including, without limitation, information required to be delivered to the Participant pursuant to applicable securities laws), in whole or in part, regarding Celanese and its subsidiaries, the 2018 Plan, and the Award via electronic mail, the Company's or a plan administrator's web site, or other means of electronic delivery.
16.Personal Data: By accepting the Award under this Agreement, the Participant hereby consents to the Company's use, dissemination and disclosure of any information pertaining to the Participant that the Company determines to be necessary or desirable for the implementation, administration and management of the 2018 Plan.
17.Miscellaneous:
(a)Governing Law. Notwithstanding the place where this Agreement may be executed by any of the parties hereto, the parties expressly agree that all the terms and provisions hereof shall be governed by, construed under and interpreted in accordance with the laws of the State of Delaware, without regard to its conflicts of laws rules.
(b)Notice. The Participant is reminded to read the following carefully and after consulting with counsel of their choice:
The Participant agrees that the following provisions requiring arbitration, prohibiting recovery of attorneys' fees, waiving class actions and mass actions, waiving the right to a jury trial, waiving
Page 7
© 2024 Celanese Corporation


any right to seek punitive damages, limiting actual damages, and limiting remedies by waiving any right to injunctive or other equitable or legal relief are and were an important part of the Company's decision to adopt the Operative Documents and for Participant to be offered this Agreement. The Participant understands and agrees that absent the foregoing provisions, the Operative Documents would not have been offered or entered into or would have materially changed. The Participant acknowledges the benefits of receiving potential incentive awards. In reliance on the Participant's intent to abide by and enter into the following provisions, the parties have entered into the Operative Documents.
(c)MANDATORY ARBITRATION. All disputes arising out of or related in any manner to the Operative Documents shall be resolved exclusively by arbitration to be conducted only in the county and state of Dallas, Texas in accordance with the rules of the International Institute for Conflict Prevention and Resolution Rules for Non-Administered Arbitration ("CPR") applying the laws of Delaware and by a sole arbitrator. Within 45 days of the service of any demand for arbitration, the parties shall attempt to mutually agree on the appointment of an arbitrator and may seek names of potential arbitrators from CPR for their consideration. Failing agreement on selection of an agreed arbitrator, upon written request of either party, CPR shall appoint a single arbitrator in accordance with its rules, with the parties expressing a contractual preference for the selection of a retired judge with at least 10 years of judicial experience. Discovery shall be as provided by the CPR rules. The arbitration award shall be in writing and shall include a reasoned opinion by the arbitrator. Consistent with the waiver of all claims to punitive or exemplary damages, the arbitrator shall have no authority to award such damages. The parties understand that their right to appeal or to seek modification of any ruling or award of the arbitrator is severely limited, if any. Awards issued by the arbitrator shall be final and binding, and judgment may be entered on it in any court of competent jurisdiction. All parties shall keep confidential the fact of the arbitration, the dispute being arbitrated, and the decision of the arbitrator. Any and all disputes regarding this arbitration provision and its enforceability shall be exclusively submitted to the United States District Court for the District of Delaware, if it has jurisdiction, and failing that, to the Delaware state court in Wilmington, Delaware.
(d)NO RECOVERY OF ATTORNEYS' FEES AND COSTS. Each party agrees that in any litigation or proceeding between the parties arising out of, connected with, related to, or incidental to the relationship between them in connection with the Operative Documents, each party shall bear all of its own attorneys' fees and costs regardless of which party prevails, except when prohibited by applicable law.
(e)CLASS ACTION AND MASS ACTION WAIVER. As part of this provision of arbitration as the contracted method of all dispute resolution under this Agreement, any claim, whether brought in a court of law or in arbitration, must be brought in the Participant's individual capacity, and not as a representative of any purported class or as a "mass action" (involving multiple plaintiffs) ("Class/Mass Action"). The parties expressly waive any ability to maintain any Class/Mass Action in any forum. The arbitrator shall not have authority to combine or aggregate similar claims or conduct any Class/Mass Action nor make an award to any person or entity not a party to the arbitration. Any claim that all or part of this Class/Mass Action waiver is unenforceable, unconscionable, void, or voidable may be determined only by a court of competent jurisdiction and not by an arbitrator. The Participant understands that but for this Agreement, he or she would have had a right to litigate through a court, to have a judge or jury decide the case and to be party to a Class/Mass Action. However, in exchange for the potential incentive awards provided herein and the receipt of the benefit of arbitration, the Participant understands and chooses to have only his or her individual claims decided, each in a separate case, by an arbitrator.
Page 8
© 2024 Celanese Corporation


(f)WAIVER OF JURY TRIAL. TO THE EXTENT PERMITTED BY APPLICABLE LAW AND EXPRESSLY BECAUSE OF THE COMPLEXITY OF THE MATTERS IN THE OPERATIVE DOCUMENTS, EACH PARTY WAIVES THE RIGHT TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE ARISING OUT OF OR RELATING TO THE OPERATIVE DOCUMENTS.
(g)WAIVER OF PUNITIVE AND EXEMPLARY DAMAGE CLAIMS. The Participant waives, to the fullest extent allowed by law, any claims or rights to recover punitive, exemplary or similar damages.
(h)LIMIT ON ACTUAL DAMAGES. In no event may the actual damages awarded to the Participant in a dispute arising out of or relating to the Operative Documents exceed the Fair Market Value, less the applicable Exercise Price, of the Common Shares subject to the Award, as set forth in Section 1, as of the applicable Vesting Date, reduced by the value of any Common Shares previously received under this Agreement (the "Damages Limit"). The Participant knowingly, voluntarily and irrevocably waives and releases any claim to damages in excess of this Damages Limit.
(i)LIMITATION OF REMEDIES. Except when prohibited by applicable law, the procedures and remedies set forth in this Agreement shall constitute the sole remedies available to the Participant. In no event shall the Participant seek equitable relief, injunctive relief, or otherwise bring claims directly or derivatively for ultra vires, corporate waste, breach of fiduciary duty, or any other claim or cause of action, whether legal or equitable, sounding in contract or tort. Nothing in this clause is intended to waive or limit any claim brought pursuant to any federal or state statute related to the protection of civil rights. Should any provision in this Agreement be found by a court of competent jurisdiction, after all appellate rights are exhausted, to be unenforceable or void, the parties expressly agree to sever such provision and to otherwise proceed to dispute resolution with the remaining provisions in the Mandatory Arbitration provisions.
18.Options Subject to Plan: By entering into this Agreement the Participant agrees and acknowledges that the Participant has received and read a copy of the 2018 Plan and the 2018 Plan's prospectus. The Options and the Common Shares issued upon exercise of such Options are subject to the 2018 Plan, which is hereby incorporated by reference. In the event of any conflict between any term or provision of this Agreement and a term or provision of the 2018 Plan, the applicable terms and provisions of the 2018 Plan shall govern and prevail.
19.Validity of Agreement: This Agreement shall be valid, binding and effective upon the Company on the Grant Date. However, the Participant must accept this Agreement electronically pursuant to the online acceptance procedure established by the Company within 90 days; otherwise the Company may, in its sole discretion, rescind the Award in its entirety.
20.Headings: The headings preceding the text of the sections hereof are inserted solely for convenience of reference, and shall not constitute a part of this Agreement, nor shall they affect its meaning, construction or effect.
21.Definitions: The following terms shall have the following meanings for purposes of this Agreement, notwithstanding any contrary definition in the 2018 Plan:
(a)"Cause" means, as determined by the Company in its sole discretion, (i) the Participant's willful failure to perform the Participant's duties to the Company (other than as a result of total or partial incapacity due to physical or mental illness) for a period of 30 days
Page 9
© 2024 Celanese Corporation


following written notice by the Company to the Participant of such failure, (ii) the Participant's conviction of, or a plea of nolo contendere to, (x) a felony under the laws of the United States or any state thereof or any similar criminal act in a jurisdiction outside the United States or (y) a crime involving moral turpitude, (iii) the Participant's willful malfeasance or willful misconduct which is demonstrably injurious to the Company or its affiliates, (iv) any act of fraud by the Participant, (v) any violation of the Company's business conduct policy, (vi) any violation of the Company's policies concerning harassment or discrimination by the Participant, (vii) the Participant's conduct that causes harm to the business reputation of the Company or its affiliates, or (viii) the Participant's breach of any confidentiality, intellectual property, noncompetition or non-solicitation provisions applicable to the Participant under the Long-Term Incentive Claw-Back Agreement or any other agreement between the Participant and the Company. "Cause" shall be determined by the Company in its sole discretion, and such determination shall be final, binding, and conclusive on the Participant.
(b)"Change in Control" means:
(i)Any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) (a "Person") becomes the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 30% or more of either (A) the then-outstanding shares of common stock of Celanese (the "Outstanding Celanese Common Stock") or (B) the combined voting power of the then-outstanding voting securities of Celanese entitled to vote generally in the election of directors (the "Outstanding Celanese Voting Securities"); provided, however, that, for purposes of this subparagraph, the following acquisitions shall not constitute a Change in Control: (i) any acquisition directly from the Company, (ii) any acquisition by the Company, (iii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any affiliate, or (iv) any acquisition pursuant to a transaction that complies with clauses (A), (B) or (C) in paragraph (iii) of this definition; or
(ii)Individuals who, as of the effective date of this Agreement, constitute the Board (the "Incumbent Board") cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the effective date of this Agreement whose election, or nomination for election by Celanese's stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual was a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or
(iii)Consummation of a reorganization, merger, statutory share exchange or consolidation or similar transaction involving Celanese or any of its subsidiaries, a sale or other disposition of all or substantially all of the assets of Celanese, or the acquisition of assets or stock of another entity by Celanese or any of its subsidiaries (each, a "Business Combination"), in each case unless, following such Business Combination, (A) all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding Celanese Common Stock and the Outstanding Celanese Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock (or, for a non-corporate entity, equivalent securities) and the combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors (or, for a non-corporate entity, equivalent governing body), as the case may be, of the entity resulting from such Business Combination (including, without limitation, an entity that, as a result of such
Page 10
© 2024 Celanese Corporation


transaction, owns Celanese or all or substantially all of Celanese's assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership immediately prior to such Business Combination of the Outstanding Celanese Common Stock and the Outstanding Celanese Voting Securities, as the case may be, (B) no Person (excluding any corporation resulting from such Business Combination or any employee benefit plan (or related trust) of the Company or such corporation resulting from such Business Combination) beneficially owns, directly or indirectly, 30% or more of, respectively, the then-outstanding shares of common stock of the corporation resulting from such Business Combination or the combined voting power of the then-outstanding voting securities of such corporation, except to the extent that such ownership existed prior to the Business Combination, and (C) at least a majority of the members of the board of directors (or, for a non-corporate entity, equivalent governing body) of the entity resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement or of the action of the Board providing for such Business Combination; or
(iv)Approval by the stockholders of Celanese of a complete liquidation or dissolution of Celanese.
(c)"Disability" has the same meaning as "Disability" in the Celanese Corporation 2008 Deferred Compensation Plan or such other meaning as determined by the Committee in its sole discretion.
(d)"Operative Documents" means the 2018 Plan and this Agreement.
(e)"Qualifying Disposition" means a sale or other disposition by the Company or one or more subsidiaries of all or part of a business, business unit, segment or subsidiary in a stock, asset, merger or other similar transaction or combination thereof, and determined by the Committee to be a Qualifying Disposition.
(f)"Retirement" of the Participant shall mean a voluntary separation from service on or after the date when the Participant is both 55 years of age and has ten years of service with the Company, as determined by the Company in its discretion based on payroll records. Retirement shall not include voluntary separation from service in which the Company could have terminated the Participant's employment for Cause.
Page 11
© 2024 Celanese Corporation


IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by its duly authorized officer.

CELANESE CORPORATION
By:
Lori J. Ryerkerk
Chair, Chief Executive Officer and President
Page 12
© 2024 Celanese Corporation
EX-10.6 5 ex1063312410q.htm EX-10.6 Document

Exhibit 10.6
[Form of 2024 Time-Based CEO Stock Option Award]





celogo.jpg








CELANESE CORPORATION
AMENDED AND RESTATED 2018 GLOBAL INCENTIVE PLAN

NONQUALIFIED STOCK OPTION AWARD AGREEMENT
DATED [Grant Date]



Pursuant to the terms and conditions of the Celanese Corporation Amended and Restated 2018 Global Incentive Plan, you have been awarded Nonqualified Stock Options, subject to the restrictions described in this Agreement. In addition to the information included in this Agreement, the Participant's name and the number of Options can be found in the Grant Summary located in the electronic stock plan award administration system maintained by the Company or its designee that contains a link to this Agreement (which summary information is set forth in the appropriate records of the Company authorizing such award).


Stock Option Award

[Number of Common Shares Subject to Options] Shares



This grant is made pursuant to the Nonqualified Stock Option Award Agreement dated as of [Grant Date], between Celanese and [Participant Name], which Agreement is attached hereto and made a part hereof.



CELANESE CORPORATION

AMENDED AND RESTATED 2018 GLOBAL INCENTIVE PLAN

NONQUALIFIED STOCK OPTION AWARD AGREEMENT
This Nonqualified Stock Option Award Agreement (the "Agreement") is made and entered into as of [Grant Date] (the "Grant Date") by and between Celanese Corporation, a Delaware corporation ("Celanese" and together with the participating subsidiaries that are employers of the Participants, the "Company"), and [Participant Name] (the "Participant"). Capitalized terms used, but not otherwise defined herein shall have the meanings ascribed to such terms in the Celanese Corporation Amended and Restated 2018 Global Incentive Plan (as amended from time to time, the "2018 Plan").
1.Grant of Options: In order to encourage the Participant's contribution to the successful performance of the Company, the Company hereby grants to the Participant as of the Grant Date, pursuant to the terms of the 2018 Plan and this Agreement, an award (the "Award") of Nonqualified Stock Options (the "Options") to purchase all or any part of the number of Common Shares that are covered by such Options at the Exercise Price per share, in each case as specified below. The Participant hereby acknowledges and accepts such Award upon the terms and subject to the conditions, restrictions and limitations contained in this Agreement and the 2018 Plan.

Number of Common Shares Subject to Options:


[Number of Shares]



Exercise Price Per Share (the "Exercise Price"):


[Exercise Price]



Expiration Date:


[Expiration Date (Put 1 day before 10-year anniversary from Grant Date)]


Vesting Schedule:


Subject to Sections 4 and 6 of this Agreement, [33% of the Number of Shares] Options shall vest on [Vest Date 1], [33% of the Number of Shares] Options shall vest on [Vest Date 2] and [34% of the Number of Shares] Options shall vest on [Vest Date 3] (each date on which a portion of the Options vest and become exercisable, a "Vesting Date", and each period between the Grant Date and a Vesting Date, a "Vesting Period").
2.Non-Qualified Stock Option: The Options are not intended to qualify Incentive Stock Options and this Agreement will be interpreted accordingly.
3.Exercise of Options:
(a)The Options shall not be exercisable as of the Grant Date. After the Grant Date, to the extent not previously exercised, and subject to termination or acceleration as provided in this Agreement or in the 2018 Plan, the Options shall be exercisable to the extent the Options become vested, as described in this Agreement, to purchase up to that number of Common Shares as set forth in Section 1 above, subject to the Participant's continued service with the Company (except as set forth in Section 4 or 6 below). The Vesting Period and/or exercisability of the Options may be adjusted by the Committee to reflect the decreased level of service during any
Page 2
© 2024 Celanese Corporation


period in which the Participant is on an approved leave of absence or is employed on a less than full-time basis.
(b)To exercise the Options (or any part thereof), the Participant shall notify the Company and its designated stock plan administrator or agent, as specified by the Company, and indicate the number of whole Common Shares the Participant wishes to purchase pursuant to such Options.
(c)The Exercise Price of the Options is set forth in Section 1. The Company shall not be obligated to issue any Common Shares until the Participant shall have paid the total Exercise Price for that number of Common Shares. The Exercise Price may be paid in any of the following forms or in a combination thereof: (i) cash or its equivalent, (ii) withholding of Common Shares to be issued as a result of such exercise, or (iii) any other method approved by the Committee.
(d)Common Shares will be issued as soon as practical following exercise of the Options. Notwithstanding the above, the Company shall not be obligated to deliver any Common Shares during any period in which the Company determines that the exercisability of the Options or the delivery of Common Shares pursuant to this Agreement would violate any federal, state or other applicable laws.
4.Effects of Certain Events:
(a)Upon the termination of the Participant's service by the Company without Cause (other than as provided in Section 4(c)), a prorated portion of the unvested Options will vest, with such prorated amount equal to (i) the unvested Options in each Vesting Period, multiplied by (ii) a fraction, the numerator of which is the number of complete and partial calendar months from the Grant Date to the date of termination without Cause, and the denominator of which is the number of complete and partial calendar months in the applicable Vesting Period, such product to be rounded up to the nearest whole number (the "Section 4(a) Pro-Rated Options"). The remaining unvested Options shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of service without Cause. In the event of the Participant's termination without Cause, the Participant may exercise the vested portion of the Options until the earlier of (A) the 12-month anniversary of the date of such termination of service or (B) the Expiration Date.
(b)Upon the termination of the Participant's service by the Company due to the Participant's death or Disability (other than as provided in Section 4(c)), a prorated portion of the unvested Options will vest, with such prorated amount equal to (i) the unvested Options in each Vesting Period, multiplied by (ii) a fraction, the numerator of which is the number of complete and partial calendar months from the Grant Date to the date of termination due to the Participant's death or Disability, and the denominator of which is the number of complete and partial calendar months in the applicable Vesting Period, such product to be rounded up to the nearest whole number (the "Section 4(b) Pro-Rated Options"). The remaining unvested Options shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of service due to the Participant's death or Disability. In the event of the Participant's death or Disability, the Participant (or the Participant's estate, beneficiary or legal representative) may exercise the vested portion of the Options until the earlier of (A) the 5-year anniversary of the date of such termination of service or (B) the Expiration Date.
(c)Except as otherwise provided in this Section 4(c), upon the termination of the Participant's service (i) due to the Participant's Retirement but under circumstances not amounting
Page 3
© 2024 Celanese Corporation


to Cause or (ii) by the Company in connection with a Qualifying Disposition, as determined by the Company in its sole discretion, other than for Cause (and regardless of whether the Participant is offered employment with the acquiror or successor), any unvested Options will remain outstanding and vest and become exercisable on the same Vesting Dates that would have otherwise applied had the Participant remained in continuous service with the Company through the last Vesting Date applicable to this Award. The Participant (or the Participant's estate, beneficiary or legal representative) may exercise any vested Options held by the Participant as of the date of termination or that otherwise vest pursuant to this Section 4(c) until (i) in the case of the Participant's Retirement under circumstances not amounting to Cause, the earlier of (A) the 7-year anniversary of the date of such termination of employment or (B) the Expiration Date, or (ii) in the case of a termination by the Company in connection with a Qualifying Disposition, the Expiration Date. To the extent permitted by applicable country, state or province law, as consideration for the continued vesting provisions upon Retirement contained in this paragraph, upon Retirement, the Participant shall enter into a departure and general release of claims agreement with the Company that includes a general release of claims, covenants relating to the provision of transition assistance and cooperation (including reasonable transition support to any successor CEO and cooperation in litigation related to the time period of Participant's service) and two-year noncompetition and non-solicitation covenants in a form acceptable to the Company. In the event of a termination of the Participant's service by the Company in connection with a Qualifying Disposition as described in this Section, if the Company determines that the Participant has been offered employment with the acquiror or successor and in connection with that employment will receive a substitute award from the acquiror or successor with an equivalent (or greater) economic value and no less favorable vesting conditions as this Award, the Company, in its sole discretion, may determine not to provide for the continued vesting under this Section 4(c).
(d)Upon the termination of a Participant's service with the Company for any reason other than as set forth in Section 4(a), 4(b), 4(c) or 4(e), (i) the unvested Options shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of service, and (ii) the Participant may exercise the vested Options until the earlier of (A) 30 days following the date of such termination of service and (B) the Expiration Date.
(e)Notwithstanding anything in this Section 4 to the contrary, upon the termination of a Participant's service with the Company for Cause, the Options (whether vested and unvested) shall be immediately forfeited and cancelled without consideration as of the date of the Participant's termination of service. If at any time on or before a Vesting Date the Company determines, in its sole discretion, that the Participant engaged in an act constituting Cause, the Participant's service shall be considered to have been terminated for Cause, and his or her Award shall be forfeited and cancelled without consideration pursuant to this Section 4(e), regardless of whether the Participant's termination initially was considered to have been without Cause. In each such case, the provisions of Sections 4(a), 4(b), 4(c) and 4(d) are inapplicable.
5.Rights as a Stockholder: The Participant shall have no voting, dividend or other rights as a stockholder with respect to the Award until the Options have been exercised and Common Shares have been delivered pursuant to this Agreement.
6.Change in Control; Dissolution:
(a)Notwithstanding any other provision of this Agreement to the contrary, upon the occurrence of a Change in Control, with respect to any unvested Options granted pursuant to this Agreement that have not previously been forfeited:
Page 4
© 2024 Celanese Corporation


(i)If (A) the Participant's rights to the unvested Options are not adversely affected in connection with the Change in Control, or, if adversely affected, a substitute award with an equivalent (or greater) economic value and no less favorable vesting conditions is granted to the Participant in connection with the occurrence of a Change in Control, and (B) the Participant's service is terminated by the Company (or its successor) without Cause within two years following the Change in Control, then the unvested Options (or, as applicable, the substitute award) shall immediately vest and become exercisable, and shall remain exercisable for such period (not less than 12 months, or through the Expiration Date if earlier) as specified by the Committee and communicated to the Participant.
(ii)If the Participant's rights to the unvested Options are adversely affected in connection with the Change in Control and a substitute award is not made pursuant to Section 6(a)(i) above, then immediately prior to the occurrence of such Change in Control, the unvested Options shall immediately vest and become exercisable, and shall remain exercisable for such period as specified by the Committee and communicated to the Participant.
(b)Notwithstanding any other provision of this Agreement to the contrary, in the event of a corporate dissolution of the Company that is taxed under Section 331 of the Internal Revenue Code of 1986, as amended, then in accordance with Treasury Regulation Section 1.409A-3(j)(4)(ix)(A), this Agreement shall terminate and any unvested Options granted pursuant to this Agreement shall immediately vest and be automatically exercised, as specified by the Committee and communicated to the Participant.
7.Income and Other Taxes: The Company shall not deliver Common Shares in respect of the exercise of Options unless and until the Participant has made arrangements satisfactory to the Company to satisfy applicable withholding tax obligations for US federal, state, and local income taxes (or the foreign counterpart thereof) and applicable employment taxes. Such obligations may be paid in any of the following forms or in a combination thereof: (i) cash or its equivalent, (ii) withholding of Common Shares to be issued as a result of the exercise of the Option, or (iii) any other method approved by the Committee. Withholding shall be effected using a rate or method chosen by the Company consistent with ASC Topic 718 (or any successor applicable equity accounting standard applicable to this Award) and the U.S. Internal Revenue Service withholding regulations or other applicable tax requirements, not to exceed maximum statutory rates. The Participant acknowledges that the Company shall have the right to deduct any taxes required to be withheld by law in connection with the delivery of Common Shares issued in respect of any exercised Options from any amounts payable by it to the Participant (including, without limitation, future cash wages). The Participant acknowledges and agrees that amounts withheld by the Company for taxes may be less than amounts actually owed for taxes by the Participant in respect of the Award.
8.Securities Laws: The Company may impose such restrictions, conditions or limitations as it determines appropriate as to the timing and manner of any resales by the Participant or other subsequent transfers by the Participant of any Common Shares issued as a result of the exercise of the Options, including without limitation (a) restrictions under an insider trading policy, and (b) restrictions as to the use of a specified brokerage firm for such resales or other transfers. Upon the acquisition of any Common Shares pursuant to the exercise of the Options, the Participant will make or enter into such written representations, warranties and agreements as the Company may reasonably request in order to comply with applicable securities laws or with this Agreement and the 2018 Plan. All accounts in which such Common Shares are held or any certificates for Common Shares shall be subject to such stop transfer orders and other restrictions as the Company may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission, any stock exchange or quotation system upon which the Common Shares are then listed or quoted, and any applicable federal or state securities law, and the Company may cause a legend or legends to be put on any such certificates (or other
Page 5
© 2024 Celanese Corporation


appropriate restrictions and/or notations to be associated with any accounts in which such Common Shares are held) to make appropriate reference to such restrictions.
9.Non-Transferability of Award: The Options may not be assigned, alienated, pledged, attached, sold or otherwise transferred or encumbered by the Participant other than by will or by the laws of descent and distribution, and any such purported assignment, alienation, pledge, attachment, sale, transfer or encumbrance shall be void and unenforceable against the Company; provided, that the Participant may designate a beneficiary, on a form provided by the Company, to receive any portion of the Award payable hereunder following the Participant's death.
10.Other Agreements: Subject to Sections 10(a) and 10(b) of this Agreement, this Agreement and the 2018 Plan constitute the entire understanding between the Participant and the Company regarding the Award, and any prior and/or contemporaneous agreements, understandings, representations, discussions, commitments or negotiations concerning the Award, whether written or oral, are superseded. No oral statements or other prior written material not specifically incorporated into this Agreement, other than the 2018 Plan, shall be of any force or effect.
(a)The Participant acknowledges that as a condition to the receipt of the Award, the Participant:
(i)shall have delivered to the Company an executed copy of this Agreement;
(ii)shall be subject to the Company's stock ownership guidelines, to the extent applicable to the Participant;
(iii)shall be subject to policies and agreements adopted by the Company from time to time, and applicable laws and regulations, requiring the repayment by the Participant of incentive compensation under certain circumstances, including that certain (i) Celanese Corporation Incentive-Based Compensation Recoupment (Clawback) Policy (Financial Restatements) (as applicable) adopted by the Committee on October 18, 2023 and (ii) that certain Celanese Corporation Amended and Restated Incentive Compensation Recoupment Policy (Detrimental Conduct; Violations of Restrictive Covenants) adopted by the Committee on October 18, 2023, as the same may be amended (collectively, "Clawback Policies"), without any further act or deed or consent of the Participant; and
(iv)shall have delivered to the Company an executed copy of the current form of Long-Term Incentive Claw-Back Agreement. For purposes hereof, "Long-Term Incentive Claw-Back Agreement" means an agreement between the Company and the Participant associated with the grant of long-term incentives of the Company, which contains terms, conditions, restrictions and provisions regarding one or more of (i) noncompetition by the Participant with the Company, and its customers and clients; (ii) non-solicitation and non-hiring by the Participant of the Company's employees, former employees or consultants; (iii) maintenance of confidentiality of the Company's and/or clients' information, including intellectual property; (iv) nondisparagement of the Company; and (v) such other matters deemed necessary, desirable or appropriate by the Company for such an agreement in view of the rights and benefits conveyed in connection with an award.
(b)The Participant acknowledges that if the Participant violates any of the terms or provisions of the Clawback Policies or the Long-Term Incentive Claw-Back Agreement, whether before or after termination of employment, then the Company will, to the fullest extent permitted by applicable law, (i) terminate the Participant's rights in any
Page 6
© 2024 Celanese Corporation


unvested Options under this Award, and (ii) claw back (i.e., recover) all Common Shares previously issued upon exercise of the Option granted under this Award.
(c)If the Participant is a non-resident of the U.S., there may be an addendum containing special terms and conditions applicable to awards in the Participant's country. The issuance of the Award to any such Participant is contingent upon the Participant executing and returning any such addendum in the manner directed by the Company.
11.Not a Contract for Employment; No Acquired Rights; Agreement Changes: Nothing in the 2018 Plan, this Agreement or any other instrument executed in connection with the Award shall confer upon the Participant any right to continue in the Company's employ or service nor limit in any way the Company's right to terminate the Participant's employment or service at any time for any reason. The grant of Options hereunder, and any future grant of awards to the Participant under the 2018 Plan, is entirely voluntary and at the complete and sole discretion of the Company. Neither the grant of these Options nor any future grant of awards by the Company shall be deemed to create any obligation to grant any further awards, whether or not such a reservation is expressly stated at the time of such grants. The Company has the right, at any time and for any reason, to amend, suspend or terminate the 2018 Plan; provided, however, that no such amendment, suspension, or termination shall adversely affect the Participant's rights hereunder.
12.Severability: In the event that any provision of this Agreement is declared to be illegal, invalid or otherwise unenforceable by a court of competent jurisdiction, such provision shall be reformed, if possible, to the extent necessary to render it legal, valid and enforceable, or otherwise deleted, and the remainder of this Agreement shall not be affected except to the extent necessary to reform or delete such illegal, invalid or unenforceable provision.
13.Further Assurances: Each party shall cooperate and take such action as may be reasonably requested by either party hereto in order to carry out the provisions and purposes of this Agreement.
14.Binding Effect: The Award and this Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective permitted heirs, beneficiaries, successors and assigns.
15.Electronic Delivery: By executing this Agreement, the Participant hereby consents to the delivery of any and all information (including, without limitation, information required to be delivered to the Participant pursuant to applicable securities laws), in whole or in part, regarding Celanese and its subsidiaries, the 2018 Plan, and the Award via electronic mail, the Company's or a plan administrator's web site, or other means of electronic delivery.
16.Personal Data: By accepting the Award under this Agreement, the Participant hereby consents to the Company's use, dissemination and disclosure of any information pertaining to the Participant that the Company determines to be necessary or desirable for the implementation, administration and management of the 2018 Plan.
17.Miscellaneous:
(a)Governing Law. Notwithstanding the place where this Agreement may be executed by any of the parties hereto, the parties expressly agree that all the terms and provisions hereof shall be governed by, construed under and interpreted in accordance with the laws of the State of Delaware, without regard to its conflicts of laws rules.
(b)Notice. The Participant is reminded to read the following carefully and after consulting with counsel of their choice:
Page 7
© 2024 Celanese Corporation


The Participant agrees that the following provisions requiring arbitration, prohibiting recovery of attorneys' fees, waiving class actions and mass actions, waiving the right to a jury trial, waiving any right to seek punitive damages, limiting actual damages, and limiting remedies by waiving any right to injunctive or other equitable or legal relief are and were an important part of the Company's decision to adopt the Operative Documents and for Participant to be offered this Agreement. The Participant understands and agrees that absent the foregoing provisions, the Operative Documents would not have been offered or entered into or would have materially changed. The Participant acknowledges the benefits of receiving potential incentive awards. In reliance on the Participant's intent to abide by and enter into the following provisions, the parties have entered into the Operative Documents.
(c)MANDATORY ARBITRATION. All disputes arising out of or related in any manner to the Operative Documents shall be resolved exclusively by arbitration to be conducted only in the county and state of Dallas, Texas in accordance with the rules of the International Institute for Conflict Prevention and Resolution Rules for Non-Administered Arbitration ("CPR") applying the laws of Delaware and by a sole arbitrator. Within 45 days of the service of any demand for arbitration, the parties shall attempt to mutually agree on the appointment of an arbitrator and may seek names of potential arbitrators from CPR for their consideration. Failing agreement on selection of an agreed arbitrator, upon written request of either party, CPR shall appoint a single arbitrator in accordance with its rules, with the parties expressing a contractual preference for the selection of a retired judge with at least 10 years of judicial experience. Discovery shall be as provided by the CPR rules. The arbitration award shall be in writing and shall include a reasoned opinion by the arbitrator. Consistent with the waiver of all claims to punitive or exemplary damages, the arbitrator shall have no authority to award such damages. The parties understand that their right to appeal or to seek modification of any ruling or award of the arbitrator is severely limited, if any. Awards issued by the arbitrator shall be final and binding, and judgment may be entered on it in any court of competent jurisdiction. All parties shall keep confidential the fact of the arbitration, the dispute being arbitrated, and the decision of the arbitrator. Any and all disputes regarding this arbitration provision and its enforceability shall be exclusively submitted to the United States District Court for the District of Delaware, if it has jurisdiction, and failing that, to the Delaware state court in Wilmington, Delaware.
(d)NO RECOVERY OF ATTORNEYS' FEES AND COSTS. Each party agrees that in any litigation or proceeding between the parties arising out of, connected with, related to, or incidental to the relationship between them in connection with the Operative Documents, each party shall bear all of its own attorneys' fees and costs regardless of which party prevails, except when prohibited by applicable law.
(e)CLASS ACTION AND MASS ACTION WAIVER. As part of this provision of arbitration as the contracted method of all dispute resolution under this Agreement, any claim, whether brought in a court of law or in arbitration, must be brought in the Participant's individual capacity, and not as a representative of any purported class or as a "mass action" (involving multiple plaintiffs) ("Class/Mass Action"). The parties expressly waive any ability to maintain any Class/Mass Action in any forum. The arbitrator shall not have authority to combine or aggregate similar claims or conduct any Class/Mass Action nor make an award to any person or entity not a party to the arbitration. Any claim that all or part of this Class/Mass Action waiver is unenforceable, unconscionable, void, or voidable may be determined only by a court of competent jurisdiction and not by an arbitrator. The Participant understands that but for this Agreement, he or she would have had a right to litigate through a court, to have a judge or jury decide the case and to be party to a Class/Mass Action. However, in exchange for the potential incentive awards provided herein and the receipt of the benefit of arbitration, the Participant
Page 8
© 2024 Celanese Corporation


understands and chooses to have only his or her individual claims decided, each in a separate case, by an arbitrator.
(f)WAIVER OF JURY TRIAL. TO THE EXTENT PERMITTED BY APPLICABLE LAW AND EXPRESSLY BECAUSE OF THE COMPLEXITY OF THE MATTERS IN THE OPERATIVE DOCUMENTS, EACH PARTY WAIVES THE RIGHT TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE ARISING OUT OF OR RELATING TO THE OPERATIVE DOCUMENTS.
(g)WAIVER OF PUNITIVE AND EXEMPLARY DAMAGE CLAIMS. The Participant waives, to the fullest extent allowed by law, any claims or rights to recover punitive, exemplary or similar damages.
(h)LIMIT ON ACTUAL DAMAGES. In no event may the actual damages awarded to the Participant in a dispute arising out of or relating to the Operative Documents exceed the Fair Market Value, less the applicable Exercise Price, of the Common Shares subject to the Award, as set forth in Section 1, as of the applicable Vesting Date, reduced by the value of any Common Shares previously received under this Agreement (the "Damages Limit"). The Participant knowingly, voluntarily and irrevocably waives and releases any claim to damages in excess of this Damages Limit.
(i)LIMITATION OF REMEDIES. Except when prohibited by applicable law, the procedures and remedies set forth in this Agreement shall constitute the sole remedies available to the Participant. In no event shall the Participant seek equitable relief, injunctive relief, or otherwise bring claims directly or derivatively for ultra vires, corporate waste, breach of fiduciary duty, or any other claim or cause of action, whether legal or equitable, sounding in contract or tort. Nothing in this clause is intended to waive or limit any claim brought pursuant to any federal or state statute related to the protection of civil rights. Should any provision in this Agreement be found by a court of competent jurisdiction, after all appellate rights are exhausted, to be unenforceable or void, the parties expressly agree to sever such provision and to otherwise proceed to dispute resolution with the remaining provisions in the Mandatory Arbitration provisions.
18.Options Subject to Plan: By entering into this Agreement the Participant agrees and acknowledges that the Participant has received and read a copy of the 2018 Plan and the 2018 Plan's prospectus. The Options and the Common Shares issued upon exercise of such Options are subject to the 2018 Plan, which is hereby incorporated by reference. In the event of any conflict between any term or provision of this Agreement and a term or provision of the 2018 Plan, the applicable terms and provisions of the 2018 Plan shall govern and prevail.
19.Validity of Agreement: This Agreement shall be valid, binding and effective upon the Company on the Grant Date. However, the Participant must accept this Agreement electronically pursuant to the online acceptance procedure established by the Company within 90 days; otherwise the Company may, in its sole discretion, rescind the Award in its entirety.
20.Headings: The headings preceding the text of the sections hereof are inserted solely for convenience of reference, and shall not constitute a part of this Agreement, nor shall they affect its meaning, construction or effect.
21.Definitions: The following terms shall have the following meanings for purposes of this Agreement, notwithstanding any contrary definition in the 2018 Plan:
Page 9
© 2024 Celanese Corporation


(a)"Cause" means, as determined by the Company in its sole discretion, (i) the Participant's willful failure to perform the Participant's duties to the Company (other than as a result of total or partial incapacity due to physical or mental illness) for a period of 30 days following written notice by the Company to the Participant of such failure, (ii) the Participant's conviction of, or a plea of nolo contendere to, (x) a felony under the laws of the United States or any state thereof or any similar criminal act in a jurisdiction outside the United States or (y) a crime involving moral turpitude, (iii) the Participant's willful malfeasance or willful misconduct which is demonstrably injurious to the Company or its affiliates, (iv) any act of fraud by the Participant, (v) any violation of the Company's business conduct policy, (vi) any violation of the Company's policies concerning harassment or discrimination by the Participant, (vii) the Participant's conduct that causes harm to the business reputation of the Company or its affiliates, or (viii) the Participant's breach of any confidentiality, intellectual property, noncompetition or non-solicitation provisions applicable to the Participant under the Long-Term Incentive Claw-Back Agreement or any other agreement between the Participant and the Company. "Cause" shall be determined by the Company in its sole discretion, and such determination shall be final, binding, and conclusive on the Participant.
(b)"Change in Control" means:
(i)Any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")) (a "Person") becomes the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 30% or more of either (A) the then-outstanding shares of common stock of Celanese (the "Outstanding Celanese Common Stock") or (B) the combined voting power of the then-outstanding voting securities of Celanese entitled to vote generally in the election of directors (the "Outstanding Celanese Voting Securities"); provided, however, that, for purposes of this subparagraph, the following acquisitions shall not constitute a Change in Control: (i) any acquisition directly from the Company, (ii) any acquisition by the Company, (iii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any affiliate, or (iv) any acquisition pursuant to a transaction that complies with clauses (A), (B) or (C) in paragraph (iii) of this definition; or
(ii)Individuals who, as of the effective date of this Agreement, constitute the Board (the "Incumbent Board") cease for any reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent to the effective date of this Agreement whose election, or nomination for election by Celanese's stockholders, was approved by a vote of at least a majority of the directors then comprising the Incumbent Board shall be considered as though such individual was a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board; or
(iii)Consummation of a reorganization, merger, statutory share exchange or consolidation or similar transaction involving Celanese or any of its subsidiaries, a sale or other disposition of all or substantially all of the assets of Celanese, or the acquisition of assets or stock of another entity by Celanese or any of its subsidiaries (each, a "Business Combination"), in each case unless, following such Business Combination, (A) all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding Celanese Common Stock and the Outstanding Celanese Voting Securities immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the then-outstanding shares of common stock (or, for a non-corporate entity, equivalent securities) and the combined voting power of the
Page 10
© 2024 Celanese Corporation


then-outstanding voting securities entitled to vote generally in the election of directors (or, for a non-corporate entity, equivalent governing body), as the case may be, of the entity resulting from such Business Combination (including, without limitation, an entity that, as a result of such transaction, owns Celanese or all or substantially all of Celanese's assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership immediately prior to such Business Combination of the Outstanding Company Celanese Stock and the Outstanding Celanese Voting Securities, as the case may be, (B) no Person (excluding any corporation resulting from such Business Combination or any employee benefit plan (or related trust) of the Company or such corporation resulting from such Business Combination) beneficially owns, directly or indirectly, 30% or more of, respectively, the then-outstanding shares of common stock of the corporation resulting from such Business Combination or the combined voting power of the then-outstanding voting securities of such corporation, except to the extent that such ownership existed prior to the Business Combination, and (C) at least a majority of the members of the board of directors (or, for a non-corporate entity, equivalent governing body) of the entity resulting from such Business Combination were members of the Incumbent Board at the time of the execution of the initial agreement or of the action of the Board providing for such Business Combination; or
(iv)Approval by the stockholders of Celanese of a complete liquidation or dissolution of Celanese.
(c)"Disability" has the same meaning as "Disability" in the Celanese Corporation 2008 Deferred Compensation Plan or such other meaning as determined by the Committee in its sole discretion.
(d)"Operative Documents" means the 2018 Plan and this Agreement.
(e)"Qualifying Disposition" means a sale or other disposition by the Company or one or more subsidiaries of all or part of a business, business unit, segment or subsidiary in a stock, asset, merger or other similar transaction or combination thereof, and determined by the Committee to be a Qualifying Disposition.
(f)"Retirement" of the Participant shall mean a voluntary separation from service on or after the earlier of (i) the date when the Participant is both 55 years of age and has ten years of service with the Company, as determined by the Company in its discretion based on payroll records, or (ii) the date when the Participant is age 62 or greater; provided, however, that in the case of clause (ii), unless waived by the Board, (1) the Participant shall have provided at least 12 months' advance notice to the Board of such planned retirement from the Chief Executive Officer position and (2) the Board shall have designated a successor Chief Executive Officer. Retirement shall not include voluntary separation from service in which the Company could have terminated the Participant's employment for Cause.
(g)"Service" shall mean continued service as the Executive Chairman of the Board of Directors (but not service as another non-employee director that is not Executive Chairman), employee, contractor or consultant.

Page 11
© 2024 Celanese Corporation


IN WITNESS WHEREOF, the Company has caused this Agreement to be executed on its behalf by its duly authorized officer.

CELANESE CORPORATION
By:
Vanessa Dupuis
Senior Vice President and Chief Human Resources Officer
Page 12
© 2024 Celanese Corporation
EX-31.1 6 ex31103302410-q.htm EX-31.1 Document

Exhibit 31.1
 
CERTIFICATION
PURSUANT TO 17 CFR 240.13a-14
PROMULGATED UNDER
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 

I, Lori J. Ryerkerk, certify that:
 
1. I have reviewed this quarterly report on Form 10-Q of Celanese Corporation;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
 
 
 /s/ LORI J. RYERKERK
Lori J. Ryerkerk
Chair of the Board of Directors,
Chief Executive Officer and President
May 10, 2024

EX-31.2 7 ex31203302410-q.htm EX-31.2 Document

Exhibit 31.2
 
CERTIFICATION
PURSUANT TO 17 CFR 240.13a-14
PROMULGATED UNDER
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
 

I, Chuck B. Kyrish, certify that:
 
1. I have reviewed this quarterly report on Form 10-Q of Celanese Corporation;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
(b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
(c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
(d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
 
5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
 
(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 /s/ CHUCK B. KYRISH
Chuck B. Kyrish
Senior Vice President and
Chief Financial Officer
May 10, 2024

EX-32.1 8 ex32103302410-q.htm EX-32.1 Document

Exhibit 32.1
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 
In connection with the Quarterly Report of Celanese Corporation (the "Company") on Form 10-Q for the period ending March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Lori J. Ryerkerk, Chair of the Board of Directors, Chief Executive Officer and President of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
 
1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 /s/ LORI J. RYERKERK
Lori J. Ryerkerk
Chair of the Board of Directors,
Chief Executive Officer and President
May 10, 2024









EX-32.2 9 ex32203302410-q.htm EX-32.2 Document

Exhibit 32.2
 
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 
In connection with the Quarterly Report of Celanese Corporation (the "Company") on Form 10-Q for the period ending March 31, 2024 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Chuck B. Kyrish, Senior Vice President and Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
 
1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 /s/ CHUCK B. KYRISH
Chuck B. Kyrish
Senior Vice President and
Chief Financial Officer
May 10, 2024





EX-101.SCH 10 ce-20240331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 0000002 - Statement - Unaudited Interim Consolidated Statement of Operations link:presentationLink link:calculationLink link:definitionLink 0000003 - Statement - Unaudited Interim Consolidated Statements of Comprehensive Income (Loss) link:presentationLink link:calculationLink link:definitionLink 0000004 - Statement - Unaudited Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 0000005 - Statement - Unaudited Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 0000006 - Statement - Unaudited Interim Consolidated Statement Equity link:presentationLink link:calculationLink link:definitionLink 0000007 - Statement - Unaudited Interim Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 0000008 - Disclosure - Description of the Company and Basis of Presentation link:presentationLink link:calculationLink link:definitionLink 0000009 - Disclosure - Recent Accounting Pronouncements link:presentationLink link:calculationLink link:definitionLink 0000010 - Disclosure - Acquisitions, Dispositions and Plant Closures link:presentationLink link:calculationLink link:definitionLink 0000011 - Disclosure - Inventories link:presentationLink link:calculationLink link:definitionLink 0000012 - Disclosure - Goodwill and Intangible Assets, net link:presentationLink link:calculationLink link:definitionLink 0000013 - Disclosure - Current Other Liabilities link:presentationLink link:calculationLink link:definitionLink 0000014 - Disclosure - Debt link:presentationLink link:calculationLink link:definitionLink 0000015 - Disclosure - Benefit Obligations link:presentationLink link:calculationLink link:definitionLink 0000016 - Disclosure - Environmental link:presentationLink link:calculationLink link:definitionLink 0000017 - Disclosure - Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 0000018 - Disclosure - Other (Charges) Gains, Net link:presentationLink link:calculationLink link:definitionLink 0000019 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 0000020 - Disclosure - Derivative Financial Instruments link:presentationLink link:calculationLink link:definitionLink 0000021 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 0000022 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 0000023 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 0000024 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 0000025 - Disclosure - Earnings (Loss) Per Share link:presentationLink link:calculationLink link:definitionLink 9954471 - Disclosure - Recent Accounting Pronouncements (Policies) link:presentationLink link:calculationLink link:definitionLink 9954472 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures (Tables) link:presentationLink link:calculationLink link:definitionLink 9954473 - Disclosure - Inventories (Tables) link:presentationLink link:calculationLink link:definitionLink 9954474 - Disclosure - Goodwill and Intangible Assets, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 9954475 - Disclosure - Current Other Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 9954476 - Disclosure - Debt (Tables) link:presentationLink link:calculationLink link:definitionLink 9954477 - Disclosure - Benefit Obligations (Tables) link:presentationLink link:calculationLink link:definitionLink 9954478 - Disclosure - Environmental (Tables) link:presentationLink link:calculationLink link:definitionLink 9954479 - Disclosure - Stockholders' Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 9954480 - Disclosure - Other (Charges) Gains, Net (Tables) link:presentationLink link:calculationLink link:definitionLink 9954481 - Disclosure - Income Taxes (Tables) link:presentationLink link:calculationLink link:definitionLink 9954482 - Disclosure - Derivative Financial Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 9954483 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 9954484 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink 9954485 - Disclosure - Revenue Recognition (Tables) link:presentationLink link:calculationLink link:definitionLink 9954486 - Disclosure - Earnings (Loss) Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9954487 - Disclosure - Description of the Company and Basis of Presentation (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954488 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954489 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures - Schedule of Exit and Shutdown Cost Related to Closure (Details) link:presentationLink link:calculationLink link:definitionLink 9954490 - Disclosure - Inventories - Schedule of Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 9954491 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details) link:presentationLink link:calculationLink link:definitionLink 9954492 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954493 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Indefinite-Lived Intangible Assets (Details) link:presentationLink link:calculationLink link:definitionLink 9954494 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) link:presentationLink link:calculationLink link:definitionLink 9954495 - Disclosure - Current Other Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9954496 - Disclosure - Debt - Schedule of Short-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954497 - Disclosure - Debt - Schedule of Long-term Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9954498 - Disclosure - Debt - Senior Credit Facilities Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954499 - Disclosure - Debt - Schedule of Revolving Credit Facility (Details) link:presentationLink link:calculationLink link:definitionLink 9954500 - Disclosure - Debt - Senior Notes Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954501 - Disclosure - Debt (Schedule of Senior Unsecured Notes Offering) (Details) link:presentationLink link:calculationLink link:definitionLink 9954502 - Disclosure - Debt (Schedule of Cash Tender Offer) (Details) link:presentationLink link:calculationLink link:definitionLink 9954503 - Disclosure - Debt - Accounts Receivable Purchasing Facility Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954504 - Disclosure - Debt - Factoring and Discounting Agreements Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954505 - Disclosure - Benefit Obligations - Schedule of Net Periodic Benefit Costs Recognized (Details) link:presentationLink link:calculationLink link:definitionLink 9954506 - Disclosure - Benefit Obligations - Schedule of Company Commitments to Fund Benefit Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 9954507 - Disclosure - Benefit Obligations - Schedule of Defined Benefit Plans Disclosures (Details) link:presentationLink link:calculationLink link:definitionLink 9954508 - Disclosure - Environmental (Schedule of Environmental Remediation Reserves) (Details) link:presentationLink link:calculationLink link:definitionLink 9954509 - Disclosure - Environmental - US Superfund Sites Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954510 - Disclosure - Stockholders' Equity - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954511 - Disclosure - Stockholders' Equity - Schedule of Treasury Stock (Details) link:presentationLink link:calculationLink link:definitionLink 9954512 - Disclosure - Stockholders' Equity - Schedule of Components of Other Comprehensive Income (Loss), Net (Details) link:presentationLink link:calculationLink link:definitionLink 9954513 - Disclosure - Stockholders' Equity - Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net (Details) link:presentationLink link:calculationLink link:definitionLink 9954514 - Disclosure - Other (Charges) Gains, Net - Schedule of Other (Charges) Gains, Net (Details) link:presentationLink link:calculationLink link:definitionLink 9954515 - Disclosure - Other (Charges) Gains, Net - Schedule of Restructuring Reserve by Type of Cost (Details) link:presentationLink link:calculationLink link:definitionLink 9954516 - Disclosure - Income Taxes - Schedule of Effective Tax Rate (Details) link:presentationLink link:calculationLink link:definitionLink 9954517 - Disclosure - Derivative Financial Instruments (Schedule of Changes in Fair Value of Derivatives) (Details) link:presentationLink link:calculationLink link:definitionLink 9954518 - Disclosure - Derivative Financial Instruments (Schedule of Offsetting Assets) (Details) link:presentationLink link:calculationLink link:definitionLink 9954519 - Disclosure - Derivative Financial Instruments (Schedule of Offsetting Liabilities) (Details) link:presentationLink link:calculationLink link:definitionLink 9954520 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:calculationLink link:definitionLink 9954521 - Disclosure - Fair Value Measurements - Schedule of Carrying Values and Fair Values of Financial Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 9954522 - Disclosure - Commitments and Contingencies - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9954523 - Disclosure - Commitments and Contingencies (Purchase Obligations Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 9954524 - Disclosure - Segment Information - Schedule of Business Segments (Details) link:presentationLink link:calculationLink link:definitionLink 9954525 - Disclosure - Revenue Recognition - Disaggregation of net sales (Details) link:presentationLink link:calculationLink link:definitionLink 9954526 - Disclosure - Revenue Recognition Remaining Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 9954526 - Disclosure - Revenue Recognition Remaining Performance Obligations (Details) link:presentationLink link:calculationLink link:definitionLink 9954527 - Disclosure - Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 9954528 - Disclosure - Earnings (Loss) Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 11 ce-20240331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 12 ce-20240331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 13 ce-20240331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Variable Rate [Domain] Variable Rate [Domain] Net (earnings) loss attributable to noncontrolling interests Net earnings (loss) attributable to noncontrolling interests Net Income (Loss) Attributable to Noncontrolling Interest Pay vs Performance Disclosure [Line Items] Other Noncurrent Liabilities Other Noncurrent Liabilities [Member] Discontinued operations - diluted (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share Statistical Measurement [Domain] Statistical Measurement [Domain] Line of Credit Facility, Maximum Borrowing Capacity Line of Credit Facility, Maximum Borrowing Capacity Research and development expenses Research and Development Expense Changes in operating assets and liabilities Increase (Decrease) in Operating Capital [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Raw materials and supplies Inventory, Raw Materials and Supplies, Net of Reserves Indemnification ceiling amount Indemnification ceiling amount Ceiling amount above which the Company will indemnify Hoechst for. All Award Types Award Type [Domain] Fair Value as of Grant Date Award Grant Date Fair Value Revenue, remaining performance obligation, expected timing of satisfaction, period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period Investment, Name [Domain] Investment, Name [Domain] Repayments of short-term borrowings Repayments of Short-Term Debt Debt Debt Disclosure [Text Block] Other Current Liabilities Other Current Liabilities [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Revolving Credit Facility Revolving Credit Facility [Member] Transfer of financial assets accounted for as sales, amount derecognized Transfer of Financial Assets Accounted for as Sales, Amount Derecognized Exchange rate effects on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Pollution control and industrial revenue bonds due at various dates through 2030(2) Pollution Control and Industrial Revenue Bonds [Member] Pollution Control and Industrial Revenue Bonds [Member]. Deferred income taxes Deferred Income Tax Liabilities, Net MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Segment Reporting [Abstract] Segment Reporting [Abstract] Trade payables - third party and affiliates Accounts Payable, Current Restatement Determination Date: Restatement Determination Date [Axis] Foreign currency translation gain (loss), income tax (provision) benefit Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax Investment, Name [Axis] Investment, Name [Axis] Commitments and Contingencies Commitments and Contingencies Insider Trading Policies and Procedures [Line Items] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Capital expenditures Segment, Expenditure, Addition to Long-Lived Assets Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Stockholders' Equity Equity [Text Block] Schedule of Goodwill [Table] Schedule of Goodwill [Table] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Geographical [Axis] Geographical [Axis] Senior unsecured notes due 2024, interest rate of 3.500% Senior Unsecured Notes Due 2024 [Member] USD Senior Unsecured Notes Due May 8, 2024 Income Taxes Income Tax Disclosure [Text Block] Environmental Environmental Loss Contingency Disclosure [Text Block] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Variable Interest Entity [Line Items] Variable Interest Entity [Line Items] Ownership [Axis] Ownership [Axis] Stock awards (in shares) Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures Current Liabilities Liabilities, Current [Abstract] Acquisitions, Dispositions and Plant Closures [Abstract] Acquisitions, Dispositions and Plant Closures [Abstract] Acquisitions, Dispositions and Plant Closures [Abstract]. Japanese Notes Due 2029 Japanese yen-denominated borrowing [Member] The amount of the 2023 Offering converted into a Japanese yen-denominated borrowing in August 2023. Matures July 15, 2029. Goodwill, impaired, accumulated impairment loss Goodwill, Impaired, Accumulated Impairment Loss Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Preferred stock, $0.01 par value, 100,000,000 shares authorized (2024 and 2023: 0 issued and outstanding) Preferred Stock, Value, Issued Eliminations Intersegment Eliminations Intersegment Eliminations [Member] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Common stock dividends Payments of Ordinary Dividends, Common Stock Net earnings (loss) - diluted (in dollars per share) Earnings Per Share, Diluted Gross amount recognized Derivative Liability, Subject to Master Netting Arrangement, before Offset PEO Total Compensation Amount PEO Total Compensation Amount Hedging Relationship [Axis] Hedging Relationship [Axis] Treasury stock, at cost (2024: 61,570,314 shares; 2023: 61,570,314 shares) Treasury Stock, Value Trade receivables - third party and affiliates Accounts Receivable, after Allowance for Credit Loss, Current Foreign Currency Contracts, Liability, Fair Value Disclosure Foreign Currency Contracts, Liability, Fair Value Disclosure Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Treasury Stock, Common, Shares Treasury Stock, Common, Shares Variable Interbank Interest Rate Variable Interbank Interest Rate [Member] Certain interbank rates at current Company credit ratings Schedule of Net Periodic Benefit Costs Recognized Schedule of Net Benefit Costs [Table Text Block] Other comprehensive income (loss) before reclassifications Other Comprehensive Income (Loss), before Reclassifications, before Tax Amended restated receivable purchasing facility Amended Restated Receivable Purchasing Facility [Member] An accounts receivable purchasing facility which allows a wholly owned, bankruptcy-remote subsidiary to sell an undivided interest in a pool of trade receivables (received through contribution from certain subsidiaries that retain the responsibility of servicing the receivables) to financial institutions participating in the facility. Loans Payable Short-Term Debt [Member] Derivative Asset, Statement of Financial Position [Extensible Enumeration] Derivative Asset, Statement of Financial Position [Extensible Enumeration] Stock option exercises Stock Issued During Period, Value, Stock Options Exercised Trading Symbol Trading Symbol Senior unsecured notes due 2033, interest rate of 6.700% USD Senior Unsecured Notes Due 2033 [Member] USD 1 Billion 6.700% Senior Unsecured Notes Due 2033 Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Long-term debt, including current installments of long-term debt, fair value Long-Term Debt, Fair Value Trade Receivables Pledged As Collateral Trade Receivables Pledged As Collateral The amount of trade receivables pledged as collateral. Total other comprehensive income (loss), tax Income tax (provision) benefit Other Comprehensive Income (Loss), Tax Net earnings (loss) attributable to Celanese Corporation Net earnings (loss) Net earnings (loss) attributable to Celanese Corporation Net Income (Loss) Unrecorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year Unrecorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year Total current liabilities Liabilities, Current Derivative Contract [Domain] Derivative Contract [Domain] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Company Selected Measure Name Company Selected Measure Name China Revolving Credit Facility China Revolving Credit Facility [Member] Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount. Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Interest (Note 7) Interest Payable, Current Balance as of the beginning of the period (in shares) Balance as of the end of the period (in shares) Shares, Issued LIABILITIES AND EQUITY Liabilities and Equity [Abstract] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Stock option exercises, shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Gain (Loss) Recognized in Other Comprehensive Income (Loss) Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Trade receivables - third party and affiliates, net Increase (Decrease) in Receivables Covenants Not to Compete and Other Other Intangible Assets [Member] Schedule of Earnings (Loss) Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Cost of sales Cost of Goods and Services Sold Foreign Currency Denominated Debt Foreign Currency Denominated Debt [Member] Foreign Currency Denominated Debt [Member] Service cost Defined Benefit Plan, Service Cost Derivative liability, statement of financial position [Extensible Enumeration] Derivative Liability, Statement of Financial Position [Extensible Enumeration] Proceeds from sale of businesses and assets, net Proceeds from Sale of Productive Assets Executive Category: Executive Category [Axis] Schedule of Indefinite-Lived Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Foreign Exchange Contract [Member] Foreign Exchange Contract [Member] Name Measure Name Name Forgone Recovery, Individual Name Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three Guarantor obligations, maximum exposure Guarantor Obligations, Maximum Exposure, Undiscounted Senior Notes [Abstract] Senior Notes [Abstract] Goodwill As of December 31, 2023 As of March 31, 2024(1) Goodwill Equity Components [Axis] Equity Components [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Hedging Relationship [Domain] Hedging Relationship [Domain] Proceeds collected on accounts receivable sold under factoring facilities Proceeds Collected on Accounts Receivable Sold under Factoring Facilities Proceeds Collected on Accounts Receivable Sold under Factoring Facilities Underlying Securities Award Underlying Securities Amount Small Reporting Company Entity Small Business 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Four Local Phone Number Local Phone Number Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Debt Instrument Tender Purchase Price Per 1000 Principal Amount Debt Instrument Tender Purchase Price Per 1000 Principal Amount Debt Instrument Tender Purchase Price Per 1000 Principal Amount Net change in short-term borrowings with maturities of 3 months or less Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less Derivative, notional amount Derivative, Notional Amount Common stock, dividends, declared (in dollar per share) Common Stock, Dividends, Per Share, Declared Schedule of Cash Tender Offer Schedule of Cash Tender Offer [Table Text Block] Schedule of Cash Tender Offer Measurement Frequency [Axis] Measurement Frequency [Axis] Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates Debt, Current [Abstract] Engineered Materials Engineered Materials [Member] Engineered Materials Operating lease liabilities Operating Lease, Liability, Noncurrent Euro Notes Due 2030 Euro denominated borrowing Due 2030 [Member] Euro denominated borrowing Due 2030 Retirement Plan Type [Domain] Retirement Plan Type [Domain] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Debt instrument, term Debt Instrument, Term Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Plant Shutdown Costs Plant Shutdown Costs Amount of plant shutdown and exist costs. Retirement Benefits [Abstract] Retirement Benefits [Abstract] Amounts reclassified from accumulated other comprehensive income (loss) Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax Line of Credit Facility [Table] Line of Credit Facility [Table] Schedule of Long-term Debt Schedule of Long-Term Debt Instruments [Table Text Block] Gross amount not offset in the consolidated balance sheets Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Offset China Working Capital Term Loan China Working Capital Term Loan [Member] CSIT senior unsecured working capital loan contract for CNY 800 million payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates. Site Contingency [Table] Site Contingency [Table] Goodwill and intangible assets, net Intangible Assets, Net (Including Goodwill) Exchange rate changes Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments Income taxes payable Accrued Income Taxes, Current Schedule of Carrying Values and Fair Values of Financial Instruments Fair Value, by Balance Sheet Grouping [Table Text Block] Finite-Lived Intangible Assets, Cost Incurred to Renew or Extend Finite-Lived Intangible Assets, Cost Incurred to Renew or Extend Other Performance Measure, Amount Other Performance Measure, Amount Interest Expense, Debt Interest Expense, Debt Short-term Debt [Line Items] Short-Term Debt [Line Items] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Inventories Increase (Decrease) in Inventories Number of parties included in USEPA order Number of Parties included in USEPA order Number of Parties included in USEPA order. Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Reserve as of the beginning of the period Reserve as of the end of the period Restructuring Reserve Bank loan due 2026, interest rate of 2.8% Bank Loan due 2026 [Member] Senior unsecured working capital loan for CNY800 million, payable 36 months and bearing interest at 2.8%. Award Type Award Type [Axis] Antidilutive securities excluded from computation of earnings per share, amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Senior unsecured notes due 2025, interest rate of 6.050% USD Senior Unsecured Notes Due 2025 [Member] USD 1.75 Billion 6.050% Senior Unsecured Notes Due 2025 Schedule of Other (Charges) Gains, Net Schedule of Other (Charges) Gains, Net [Table Text Block] Schedule of Other (Charges) Gains, Net [Table Text Block]. Document Quarterly Report Document Quarterly Report Gross amount not offset in the consolidated balance sheets Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash, Offset Against Derivative Asset Number of divestiture agreements Number of divestiture agreements Number of divestiture agreements. Interest expense Interest Expense Common stock dividends Dividends, Common Stock Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Hedging Designation [Axis] Hedging Designation [Axis] Goodwill [Line Items] Goodwill [Line Items] Gain (Loss) Recognized in Other Comprehensive Income (Loss) Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Trading Arrangement: Trading Arrangement [Axis] Total contributions year-to-date Defined Benefit Plan, Plan Assets, Contributions by Employer Estimates and Assumptions Use of Estimates, Policy [Policy Text Block] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity File Number Entity File Number Loss Contingencies [Table] Loss Contingencies [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Operating leases Operating Lease, Liability, Current Environmental Remediation Obligations [Abstract] Environmental Remediation Obligations [Abstract] Demerger obligations (Note 14) Demerger obligations Demerger obligations. Amortization of intangible assets Amortization Amortization of Intangible Assets Entity Shell Company Entity Shell Company Net book value Finite-Lived Intangible Assets, Net New Accounting Pronouncements, Policy New Accounting Pronouncements, Policy [Policy Text Block] Restatement Determination Date Restatement Determination Date Offsetting Liabilities Offsetting Liabilities [Table Text Block] Average purchase price (in dollar per share) Shares Acquired, Average Cost Per Share Other liabilities Increase (Decrease) in Other Operating Liabilities Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Cash and cash equivalents Cash and cash equivalents as of beginning of period Cash and cash equivalents as of end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents As of December 31, 2023 As of March 31, 2024 Finite-Lived Intangible Assets, Accumulated Amortization Master Discounting Agreement Master Discounting Agreement [Member] Master Discounting Agreement Interest income Investment Income, Interest Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Gain (Loss) Recognized in Other Comprehensive Income (Loss) Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax Bank loans due at various dates through 2030(3) Loans Payable [Member] Common stock, shares issued (in shares) Common Stock, Shares, Issued Gain (loss) on derivative hedges, income tax (provision) benefit Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, Tax Gross profit Gross Profit Current installments of long-term debt Long-Term Debt and Lease Obligation, Current Long-Term Debt and Lease Obligation, Current Security Exchange Name Security Exchange Name Long-term debt, including current installments of long-term debt, carrying amount Long-Term Debt Assets, Fair Value Disclosure Assets, Fair Value Disclosure Selling, general and administrative expenses Selling, General and Administrative Expense Accumulated other comprehensive income (loss), net As of December 31, 2023 As of March 31, 2024 Accumulated Other Comprehensive Income (Loss), Net of Tax Share-Based Payment Arrangement, Option Employee Stock Option [Member] Foreign Currency Translation Gain (Loss) Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Derivative Financial Instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Foreign Currency Contract, Asset, Fair Value Disclosure Foreign Currency Contract, Asset, Fair Value Disclosure Benefit obligations Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent Other, net Proceeds from (Payments for) Other Financing Activities Debt Instrument, Repurchased Face Amount Debt Instrument, Repurchased Face Amount Maximum Maximum [Member] Comprehensive income (loss) attributable to Celanese Corporation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Schedule of Exit and Shutdown Cost Related to Closure Restructuring and Related Costs [Table Text Block] Depreciation, amortization and accretion Depreciation, Amortization and Accretion, Net Document Type Document Type Unrecorded Unconditional Purchase Obligation, to be Paid, Year Four Unrecorded Unconditional Purchase Obligation, to be Paid, Year Four Net amount recognized Defined Benefit Plan, Funded (Unfunded) Status of Plan Accelerated depreciation expense Restructuring and Related Cost, Accelerated Depreciation Tabular List, Table Tabular List [Table Text Block] Currency Swap Currency Swap [Member] Discontinued operations - basic (in dollars per share) Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share Europe and Africa EMEA [Member] Entity Address, Address Line One Entity Address, Address Line One Shares repurchased (in $ millions) Treasury Stock, Value, Acquired, Cost Method 364 Day Delayed-Draw Term Loan 364 Day Delayed-Draw Term Loan [Member] 364 Day Delayed-Draw Term Loan Exchange rate changes Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss) Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Derivatives (Note 12) Derivative Liability, Current Noncontrolling interest, ownership percentage by parent Subsidiary, Ownership Percentage, Parent Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration] Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration] Active sites Active sites Active sites. Nutrinova Joint Venture Nutrinova Joint Venture [Member] Food Ingredients joint venture under the name Nutrinova Insurance contracts in nonqualified trusts, carrying amount Cash Surrender Value of Life Insurance Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Trademarks and Trade Names Trademarks and Trade Names [Member] Subsequent Event Subsequent Event [Member] Schedule of Balances Available for Borrowing Schedule of Line of Credit Facilities [Table Text Block] Derivative [Table] Derivative [Table] Schedule of Finite-Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Other liabilities Total Other Liabilities, Current Variable Rate [Axis] Variable Rate [Axis] Other (charges) gains, net Total Other (charges) gains, net (Note 14) Other Nonrecurring (Income) Expense Income Statement [Abstract] Income Statement [Abstract] Title of 12(b) Security Title of 12(b) Security Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Schedule of Restructuring Reserve by Type of Cost Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Net amount Derivative Liability Derivative Liability As of December 31, 2023 As of March 31, 2024 Indefinite-Lived Intangible Assets (Excluding Goodwill) Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Operating Segments Operating Segments [Member] Issuance of treasury stock under stock plans Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Other assets Other Assets, Current Class of Stock [Line Items] Class of Stock [Line Items] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Mechelen, Belgium Mechelen, Belgium [Member] Mechelen, Belgium Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Noncurrent Other assets Assets for Plan Benefits, Defined Benefit Plan Earnings (loss) per common share - diluted Earnings Per Share, Diluted [Abstract] Entity Tax Identification Number Entity Tax Identification Number Inventories Total Inventory, Net Statistical Measurement [Axis] Statistical Measurement [Axis] Distributions/dividends to noncontrolling interests Proceeds from (Payments to) Noncontrolling Interests Balance Sheet Location [Domain] Balance Sheet Location [Domain] Entity Interactive Data Current Entity Interactive Data Current Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Divestiture obligations (Note 14) Divestiture obligations Divestiture obligations. Total Shareholder Return Amount Total Shareholder Return Amount Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Pension and postretirement benefits gain (loss), income tax (provision) benefit Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax Segments [Domain] Segments [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Revenue Recognition and Deferred Revenue [Abstract] Revenue Recognition and Deferred Revenue [Abstract] Retained earnings Retained Earnings (Accumulated Deficit) Measure: Measure [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Name Outstanding Recovery, Individual Name Earnings (loss) from operation of discontinued operations Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax Debt instrument, face amount Debt Instrument, Face Amount Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Current Assets Assets, Current [Abstract] Other long-term debt Other Long-Term Debt Entity Address, State or Province Entity Address, State or Province Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Continuing operations - basic (in dollars per share) Income (Loss) from Continuing Operations, Per Basic Share 2025 Finite-Lived Intangible Asset, Expected Amortization, Year One Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Acetyl Chain Acetyl Chain [Member] Acetyl Chain [Member] Acetyl Chain [Member] Earnings (loss) per common share - basic Earnings Per Share, Basic [Abstract] Interest cost Defined Benefit Plan, Interest Cost PEO PEO [Member] Environmental Remediation Site [Domain] Environmental Remediation Site [Domain] Schedule of Components of Other Comprehensive Income (Loss), Net Comprehensive Income (Loss) [Table Text Block] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Benefit Obligations Retirement Benefits [Text Block] Proceeds from short-term borrowings Proceeds from Short-Term Debt Other, net Other Operating Activities, Cash Flow Statement Earnings (loss) from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Accumulated Other Comprehensive Income (Loss), net [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Schedule of Variable Interest Entities [Table] Schedule of Variable Interest Entities [Table] Gross amount recognized Derivative Asset, Subject to Master Netting Arrangement, before Offset Short-term borrowings, including amounts due to affiliates(1) Other Short-Term Borrowings Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share South America South America [Member] Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Class of Stock [Domain] Class of Stock [Domain] Schedule of Inventories Schedule of Inventory, Current [Table Text Block] Interest Rate Swap [Member] Interest Rate Swap [Member] Debt Instrument [Axis] Debt Instrument [Axis] Earnings (loss) from continuing operations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent Gain (loss) on derivative hedges Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments and Tax Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Repayments of Debt Repayments of Debt Indemnification Agreements Hoechst Indemnification Agreements Hoechst [Member] Indemnification Agreements Hoechst [Member]. Pension and postretirement benefits gain (loss), gross amount Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Credit Facility [Axis] Credit Facility [Axis] Uncertain tax positions Liability for Uncertainty in Income Taxes, Noncurrent Description of the Company and Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Environmental Remediation Site [Axis] Environmental Remediation Site [Axis] Aggregate Board of Directors repurchase authorizations during the period (in $ millions) StockRepurchaseProgramAuthorizedAmountInPeriod Amount of stock repurchase plan authorized in the period. Accumulated Other Comprehensive Income (Loss), Net AOCI Attributable to Parent [Member] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Divestiture Agreements Divestiture Agreements [Member] Divestiture Agreements [Member]. Measurement Frequency [Domain] Measurement Frequency [Domain] All Executive Categories All Executive Categories [Member] Unrecorded Unconditional Purchase Obligation, to be Paid, Year One Unrecorded Unconditional Purchase Obligation, to be Paid, Year One Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Non-trade receivables, net Nontrade Receivables, Current Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Pension and Postretirement Benefits Gain (Loss) (Note 8) Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Debt Disclosure [Abstract] Debt Disclosure [Abstract] North America North America [Member] Site Contingency [Line Items] Site Contingency [Line Items] Earnings Per Share [Abstract] Earnings Per Share [Abstract] Foreign currency translation gain (loss), gross amount Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Common stock, $0.0001 par value, 400,000,000 shares authorized (2024: 170,780,600 issued and 109,210,286 outstanding; 2023: 170,476,740 issued and 108,906,426 outstanding) Common Stock, Value, Issued Total other comprehensive income (loss), before tax Other Comprehensive Income (Loss), before Tax Debt instrument, redemption price, percentage Debt Instrument, Redemption Price, Percentage Unrecorded unconditional purchase obligations Unrecorded Unconditional Purchase Obligation Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] One Time Termination Benefits Restructuring(1) One Time Termination Benefits The charge against earnings in the period for known and estimated costs of one time termination benefits provided to current employees that are involuntarily terminated under a benefit arrangement associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan. Legal (Note 14) Loss Contingency, Accrual, Current Weighted average interest rate, short-term borrowings Short-Term Debt, Weighted Average Interest Rate, at Point in Time Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Total current assets Assets, Current Schedule of Short-term Debt Schedule of Short-Term Debt [Table Text Block] China, Europe and Singapore Factoring Agreements China, Europe and Singapore Factoring Agreements [Member] China, Europe and Singapore Factoring Agreements Investments in affiliates Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures Schedule of Defined Benefit Plans Disclosures [Table] Schedule of Defined Benefit Plans Disclosures [Table] Total Defined Benefit Plan, Net Periodic Benefit Cost (Credit) All Individuals All Individuals [Member] Non-operating pension and other postretirement employee benefit (expense) income Non-operating pension and other postretirement employee benefit (expense) income Non-operating pension and other postretirement employee benefit (expense) income Other income (expense), net Other Nonoperating Income (Expense) Entity Filer Category Entity Filer Category Derivative liability, statement of financial position [Extensible Enumeration] Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration] Restructuring Type [Axis] Restructuring Type [Axis] Schedule of Treasury Stock Class of Treasury Stock [Table Text Block] Dividend income - equity investments Investment Income, Dividend Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Short-term Debt, Type [Domain] Short-Term Debt, Type [Domain] Statement [Table] Statement [Table] Current Fiscal Year End Date Current Fiscal Year End Date Long-Term Debt and Lease Obligation, Including Current Maturities Long-Term Debt and Lease Obligation, Including Current Maturities Goodwill and Intangible Assets, Net Goodwill and Intangible Assets Disclosure [Text Block] Sales and use tax/foreign withholding tax payable Sales and Excise Tax Payable, Current Recent Accounting Pronouncements Accounting Standards Update and Change in Accounting Principle [Text Block] Schedule of Effective Tax Rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Other (Charges) Gains, Net Other (Charges) Gains, Net [Text Block] Other (Charges) Gains, Net [Text Block]. Pension and postretirement net periodic benefit cost Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash Gain (loss) on derivative hedges, gross amount Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, before Tax PEO Name PEO Name Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Term Loan Facility Term Loan Facility [Member] Term Loan Facility Other Sundry Liabilities, Current Other Sundry Liabilities, Current Asia-Pacific Asia Pacific [Member] Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Insurance contracts in nonqualified trusts, fair value Cash Surrender Value, Fair Value Disclosure 1.250% Senior Notes due 2025 Senior unsecured notes due 2025, interest rate of 1.250% EUR Senior Unsecured Notes Due 2025 [Member] Senior Unsecured Notes Due 2025 [Member] 2029 Finite-Lived Intangible Asset, Expected Amortization, Year Five Indemnification percentage, other Indemnification percentage, other Percentage of other liabilities the Company has agreed to indemnify Hoechst for as part of the Demerger Agreement. Schedule of Goodwill Schedule of Goodwill [Table Text Block] Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Post-retirement Benefits Benefit payments to other postretirement benefit plans Other Postretirement Benefits Plan [Member] Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two Exchange rate changes Goodwill, Translation and Purchase Accounting Adjustments Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Class of Stock [Axis] Class of Stock [Axis] Entities [Table] Entities [Table] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Corporate, Non-Segment Corporate, Non-Segment [Member] Senior unsecured debt Unsecured Debt Senior unsecured notes due 2032, interest rate of 6.379% USD Senior Unsecured Notes Due 2032 [Member] USD 1 Billion 6.379% Senior Unsecured Notes Due 2032 Revolving credit facilities(2) Line of Credit, Current Depreciation and amortization Depreciation, Depletion and Amortization Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Interest Rate, Stated Percentage Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Net amount presented in the consolidated balance sheets Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Information [Line Items] Entity Information [Line Items] Income tax (provision) benefit from discontinued operations Discontinued Operation, Tax Effect of Discontinued Operation Postemployment Benefits [Abstract] Benefit payments to nonqualified pension plans Other Pension Plan [Member] Business Combination and Asset Acquisition [Abstract] Total Celanese Corporation shareholders' equity Balance as of the beginning of the period Balance as of the end of the period Equity, Attributable to Parent Passaic River, New Jersey Passaic River, New Jersey [Member] Passaic River, New Jersey [Member]. Consolidation Items [Axis] Consolidation Items [Axis] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Schedule of Senior Unsecured Notes Offering Schedule of Senior Unsecured Notes Offering [Table Text Block] Schedule of new senior unsecured notes offering in the period by the Company. Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Foreign currency translation gain (loss) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Schedule of Defined Benefit Plans Disclosures Schedule of Defined Benefit Plans Disclosures [Table Text Block] Long-term debt, net of unamortized deferred financing costs Long-Term Debt and Lease Obligation Earnings (loss) from continuing operations before tax Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Indemnification amount Indemnification floor amount The amount that the Company will indemnify Hoechst for in full. Gain (Loss) on Derivative Hedges (Note 12) AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent [Member] Equity investments without readily determinable fair values, carrying amount Equity Securities without Readily Determinable Fair Value, Amount Amounts attributable to Celanese Corporation Income Amounts Attributable to Parent, Disclosures [Abstract] Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Hedging Designation [Domain] Hedging Designation [Domain] Current Other liabilities Liability, Defined Benefit Plan, Current Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Net Investment Hedging Net Investment Hedging [Member] Emerging Growth Company Entity Emerging Growth Company 36 month Working Capital Term Loan CNC Working Capital Loan [Member] CNC Working Capital Term Loan for CNY800 million; payable 36 months and bearing interest of 2.8%. Unamortized debt issuance costs Debt Issuance Costs, Net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Other Noncurrent Assets Other Noncurrent Assets [Member] Schedule of Changes in Fair Value of Derivatives Derivative Instruments, Gain (Loss) [Table Text Block] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Available for borrowing Line of Credit Facility, Remaining Borrowing Capacity Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Title Trading Arrangement, Individual Title Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Euro Notes Due 2028 Euro Denominated Borrowing Due 2028 [Member] Euro Denominated Borrowing Due 2028 Debt Instrument, Repurchase Amount Debt Instrument, Repurchase Amount Common Stock Common Stock [Member] Pension and postretirement benefits Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Individual: Individual [Axis] City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Earnings (Loss) Per Share Earnings Per Share [Text Block] Equity method investment, ownership percentage Equity Method Investment, Ownership Percentage Senior unsecured notes due 2026, interest rate of 1.400% USD Senior Unsecured Notes Due 2026 [Member] USD Senior Unsecured Notes Due 2026 [Member] Document Fiscal Year Focus Document Fiscal Year Focus Geographical [Domain] Geographical [Domain] Total equity Balance as of the end of the period Equity, Including Portion Attributable to Noncontrolling Interest Customer rebates Accrued Marketing Costs, Current Distributions/dividends to noncontrolling interests Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders Consolidated Ventures Consolidated Ventures [Member] Consolidated Ventures Minimum Minimum [Member] Property, plant and equipment (net of accumulated depreciation - 2024: $4,243; 2023: $4,080) Property, Plant and Equipment, Net Gain (Loss) Recognized in Other Comprehensive Income (Loss) Gain (Loss) On Non-Derivatives and Derivatives Used In Net Investment Hedge Adjustment in other comprehensive income reflecting gains (losses) on foreign currency transactions that are designated as, and are effective as, hedges of net investment in foreign entity, gross of tax effect. Exercise Price Award Exercise Price Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Total other comprehensive income (loss), net of tax Other comprehensive income (loss), net of tax Total other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Dividends, common stock, cash Dividends, Common Stock, Cash ASSETS Assets [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Commodity Contract Commodity Contract [Member] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Proceeds from long-term debt Proceeds from Issuance of Long-Term Debt Liabilities, Fair Value Disclosure Liabilities, Fair Value Disclosure Foreign exchange gain (loss), net Gain (Loss), Foreign Currency Transaction, before Tax Derivative Liabilities [Abstract] Derivative Liability [Abstract] Other Current Assets Other Current Assets [Member] Net earnings (loss) Net earnings (loss) Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Schedule of Environmental Remediation Reserves Environmental Exit Costs by Cost [Table Text Block] Earnings (loss) from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Deferred income taxes Deferred Income Tax Assets, Net Retirement Plan Type [Axis] Retirement Plan Type [Axis] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Continuing operations - diluted (in dollars per share) Income (Loss) from Continuing Operations, Per Diluted Share Other, net Payments for (Proceeds from) Other Investing Activities Developed Technology Developed Technology Rights [Member] Retained Earnings Retained Earnings [Member] Senior unsecured notes due 2024, interest rate of 5.900% USD Senior Unsecured Notes Due 2024 [Member] USD 2 Billion 5.900% Senior Unsecured Notes Due 2024 Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Total liabilities and equity Liabilities and Equity Other assets Other Assets, Noncurrent Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Ownership [Domain] Ownership [Domain] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Net earnings (loss) - basic (in dollars per share) Earnings Per Share, Basic Equity investments without readily determinable fair values, fair value Equity Securities, FV-NI and without Readily Determinable Fair Value Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Mitsui & Co. Ltd. Mitsui & Co. Ltd. [Member] Mitsui & Co. Ltd. Derivative Asset, Statement of Financial Position [Extensible Enumeration] Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration] Other changes Restructuring Reserve, Accrual Adjustment Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Gain (loss) on disposition of businesses and assets, net Gain (Loss) on Disposition of Assets Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Indefinite-lived Intangible Assets [Line Items] Indefinite-Lived Intangible Assets [Line Items] U.S. Superfund sites US Superfund sites US Superfund sites. Restructuring and related cost, expected cost Restructuring and Related Cost, Expected Cost Arrangement Duration Trading Arrangement Duration Entity Address, City or Town Entity Address, City or Town Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Schedule of Business Segments Schedule of Segment Reporting Information, by Segment [Table Text Block] Senior unsecured term loan due 2027(1) Senior Unsecured Term Loan Due 2027 [Member] Senior Unsecured Term Loan Due 2027 Additions Restructuring Charges Document Transition Report Document Transition Report Award Timing Predetermined Award Timing Predetermined [Flag] Senior unsecured notes due 2030, interest rate of 6.550% USD Senior Unsecured Notes Due 2030 [Member] USD 1 Billion 6.550% Senior Unsecured Notes Due 2030 Undistributed earnings in unconsolidated affiliates Income (Loss) from Equity Method Investments, Net of Dividends or Distributions Termination Date Trading Arrangement Termination Date Trade payables - third party and affiliates Increase (Decrease) in Accounts Payable Common stock, shares authorized (in shares) Common Stock, Shares Authorized Environmental liability percentage Environmental Liability Percentage Estimated ultimate allocable share of cleanup costs. Current Other Liabilities Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Benefit obligations (Note 8) Liability, Pension and Other Postretirement and Postemployment Benefits, Current Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Indefinite-lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Other environmental remediation liabilities Other environmental remediation reserves Other environmental remediation reserves. 5 Year Delayed-Draw Term Loan 5 Year Delayed-Draw Term Loan [Member] 5 Year Delayed-Draw Term Loan Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Instrument [Axis] Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] All Trading Arrangements All Trading Arrangements [Member] Uentrop, Germany Uentrop, Germany [Member] Polyamide 66 and High-Performance Nylon polymerization units at the Company's facility in Uentrop, Germany. All Adjustments to Compensation All Adjustments to Compensation [Member] Derivative [Line Items] Derivative [Line Items] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Award Timing Disclosures [Line Items] Schedule of Company Commitments to Fund Benefit Obligations Schedule of Company Commitments to Fund Benefit Obligations [Table Text Block] Schedule of Company Commitments to Fund Benefit Obligations [Table Text Block]. Compensation Amount Outstanding Recovery Compensation Amount Indemnification percentage exceeding ceiling amount Indemnification percentage exceeding ceiling amount The percentage of the amount above the ceiling that the Company will indemnify Hoechst for. 0.625% Senior Notes due 2028 Senior unsecured notes due 2028, interest rate of 0.625% EUR Senior Unsecured Notes Due 2028 [Member] EUR Senior Unsecured Notes Due 2028 Comprehensive (income) loss attributable to noncontrolling interests Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Additional paid-in capital Additional Paid in Capital Net amount Derivative Asset Derivative Asset Deferred income taxes, net Deferred Income Tax Expense (Benefit) Subsequent Event Type [Axis] Subsequent Event Type [Axis] Stock option exercises Proceeds from Stock Options Exercised Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Investment in affiliates Equity Method Investment Liability, Current Equity Method Investment Liability, Current Exchange rate changes Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss) Short-term Debt, Type [Axis] Short-Term Debt, Type [Axis] Obligations under finance leases due at various dates through 2054 Finance Lease, Liability Net amount presented in the consolidated balance sheets Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral Short-term borrowings and current installments of long-term debt - third party and affiliates Total Debt, Current 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Three Increase (decrease) in accrued capital expenditures Increase (Decrease) of Accrued Capital Expenditures Increase (Decrease) of Accrued Capital Expenditures. Insider Trading Arrangements [Line Items] Senior unsecured notes due 2027, interest rate of 6.165% USD Senior Unsecured Notes Due 2027 [Member] USD 2 Billion 6.165% Senior Unsecured Notes Due 2027 Total expected contributions in current fiscal year Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year Restructuring (Note 18) Restructuring Reserve, Current Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Issuance of treasury stock under stock plans (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Revenue, Major Customer [Line Items] Revenue, Major Customer [Line Items] Other Liabilities, Current [Abstract] Other Liabilities, Current [Abstract] Entity Registrant Name Entity Registrant Name Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Award Timing Method Award Timing Method [Text Block] Incremental shares attributable to equity awards(1) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Long-term debt, weighted average interest rate, at point in time Long-Term Debt, Weighted Average Interest Rate, at Point in Time Other assets Increase (Decrease) in Other Operating Assets 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Two Total Accrual for Environmental Loss Contingencies Adjustment to Compensation, Amount Adjustment to Compensation Amount Employee Severance Employee Severance [Member] Noncontrolling interests Balance as of the beginning of the period, noncontrolling interest Balance as of the end of the period, noncontrolling interest Equity, Attributable to Noncontrolling Interest Cash payments Payments for Restructuring Document Period End Date Document Period End Date Proceeds from lines of credit Proceeds from Lines of Credit Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Adoption Date Trading Arrangement Adoption Date Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Stock awards Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures Accumulated depreciation, depletion and amortization, property, plant, and equipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] 5.337% Senior Notes due 2029 Senior unsecured notes due 2029, interest rate of 5.337% EUR Senior Unsecured Notes Due 2029 [Member] EUR 500 Million 5.337% Senior Unsecured Notes Due 2029 [Member] Other Activities Corporate and Other [Member] Europe Factoring Agreements Europe Factoring Agreements [Member] Europe Factoring Agreements Repayments of long-term debt Repayments of long-term debt Repayments of Long-Term Debt Senior unsecured notes due 2028, interest rate of 6.350% USD Senior Unsecured Notes Due 2028 [Member] USD 1 Billion 6.350% Senior Unsecured Notes Due 2028 Treasury Stock, Common Treasury Stock, Common [Member] Entity Central Index Key Entity Central Index Key Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Gain (Loss) Recognized in Earnings (Loss) Derivative, Gain (Loss) on Derivative, Net Gain (Loss) on Disposition of Property Plant Equipment Gain (Loss) on Disposition of Property Plant Equipment Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Loss Contingencies by Nature of Contingency [Axis] Loss Contingency Nature [Axis] As of December 31, 2023 As of March 31, 2024 Finite-Lived Intangible Assets, Gross Income tax (provision) benefit Income Tax Expense (Benefit) Finished goods Inventory, Finished Goods, Net of Reserves Designated as Hedging Instrument Designated as Hedging Instrument [Member] Singapore Factoring Agreements Singapore Factoring Agreements [Member] Singapore Factoring Agreements Salaries and benefits Employee-related Liabilities, Current Fair Value Measurements Fair Value Disclosures [Text Block] Name Trading Arrangement, Individual Name Notional Amount of Nonderivative Instruments Notional Amount of Nonderivative Instruments Operating cash provided by (used in) discontinued operations Cash Provided by (Used in) Operating Activities, Discontinued Operations Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Inventories Inventory Disclosure [Text Block] Celanese Corporation Celanese Corporation [Member] Celanese Corporation Net sales Revenue from Contract with Customer, Excluding Assessed Tax Benefit obligations Liability, Defined Benefit Plan Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Amendment Flag Amendment Flag Gross amount offset in the consolidated balance sheets Derivative Liability, Subject to Master Netting Arrangement, Asset Offset Fair Value Hedging Fair Value Hedging [Member] Cost of EPA's plan estimate environmental Loss exposure for environmental contingencies at an individual site for which no accrual has been recorded based upon EPA determination. Licenses Licensing Agreements [Member] Total comprehensive income (loss), net of tax Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Credit Facility [Domain] Credit Facility [Domain] Shares repurchased (in shares) Treasury Stock, Shares, Acquired Senior unsecured notes due 2029, interest rate of 6.330% USD Senior Unsecured Notes Due 2029 [Member] USD 750 Million 6.330% Senior Unsecured Notes Due 2029 Euro Notes Due 2028 and 2030 Euro Denominated Borrowings [Member] The amount of 2023 Offerings converted to euro denominated borrowings. Maturing on November 15, 2028 and November 15, 2030. Debt instrument, basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Gain (Loss) Recognized in Other Comprehensive Income (Loss) Gain (Loss) On Non-Derivative Used In Net Investment Hedge Adjustment in other comprehensive income reflecting gains or losses on foreign currency transactions that are designated as, and are effective as, hedges of net investment in foreign entity, gross of tax effect. Weighted average shares - diluted (in shares) Weighted average shares - diluted Weighted Average Number of Shares Outstanding, Diluted Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Transfer of financial assets accounted for as sales, non-recourse basis, account receivable percentage Transfer Of Financial Assets Treated As Sales, Non-recourse or Limited recourse Basis, Accounts Receivable Percentage The percentage of accounts receivable, treated as Sales, transferred on a non-recourse or limited recourse basis, as part of a factoring or discounting agreement. Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Derivative Assets [Abstract] Derivative Asset [Abstract] Revenue Recognition Revenue from Contract with Customer [Text Block] Capital expenditures on property, plant and equipment Payments to Acquire Property, Plant, and Equipment Company Selected Measure Amount Company Selected Measure Amount Acquisitions, Dispositions and Plant Closures Acquisitions, Dispositions and Plant Closures [Text Block] Acquisitions, Dispositions and Plant Closures [Text Block]. Additional Paid-In Capital Additional Paid-in Capital [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Total assets Total assets Assets Name Awards Close in Time to MNPI Disclosures, Individual Name Equity in net earnings (loss) of affiliates Income (Loss) from Equity Method Investments Loss Contingencies [Line Items] Loss Contingencies [Line Items] Cover [Abstract] Cover [Abstract] Gain (Loss) Recognized in Earnings (Loss) Amount of Ineffectiveness on Net Investment Hedges Recent Accounting Pronouncements [Abstract] Recent Accounting Pronouncements [Abstract] Recent Accounting Pronouncements [Abstract] Percentage of fair value of sales receivables Percentage of Fair Value of Sales Receivables Percentage of fair value of sales receivables. Stock-based compensation, net of tax APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Fair Value, Recurring Fair Value, Recurring [Member] Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Schedule of Current Other Liabilities Other Current Liabilities [Table Text Block] Other liabilities Other Liabilities, Noncurrent Non-NEOs Non-NEOs [Member] Revenue, remaining performance obligation, amount Revenue, Remaining Performance Obligation, Amount 4.777% Senior Notes due 2026 Senior unsecured notes due 2026, interest rate of 4.777% EUR Senior Unsecured Notes Due 2026 [Member] EUR 1 Billion 4.777% Senior Unsecured Notes Due 2026 Cash Flow Hedging Cash Flow Hedging [Member] Pension Benefits Cash contributions to defined benefit pension plans Pension Plan [Member] Loss contingency accrual, carrying value, payments Loss Contingency Accrual, Payments Segment Information Segment Reporting Disclosure [Text Block] Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Secured Debt Secured Debt [Member] Non-PEO NEO Non-PEO NEO [Member] Equity Component [Domain] Equity Component [Domain] Adjustment to Compensation: Adjustment to Compensation [Axis] Offsetting Assets Offsetting Assets [Table Text Block] Work-in-process Inventory, Work in Process, Net of Reserves Pension and postretirement contributions Payment for Pension and Other Postretirement Benefits Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Gross amount offset in the consolidated balance sheets Derivative Asset, Subject to Master Netting Arrangement, Liability Offset Contract with Customer, Asset, after Allowance for Credit Loss Contract with Customer, Asset, after Allowance for Credit Loss Debt Instrument [Line Items] Debt Instrument [Line Items] Weighted average shares - basic (in shares) Weighted Average Number of Shares Outstanding, Basic Entity Current Reporting Status Entity Current Reporting Status Operating profit (loss) Operating profit (loss) Operating Income (Loss) Schedule of Short-term Debt [Table] Schedule of Short-Term Debt [Table] Plant Closures [Abstract] Plant Closures [Abstract] Plant Closures [Abstract] China Factoring Agreements China Factoring Agreements [Member] China Factoring Agreements Accounts Receivable Securitization Facility [Abstract] Accounts Receivable Purchasing Facility [Abstract] Accounts Receivable Purchasing Facility [Abstract] Schedule of Indefinite-Lived Intangible Assets [Table] Schedule of Indefinite-Lived Intangible Assets [Table] Debt Instrument, Discount Price, Percentage Debt Instrument, Discount Price, Percentage Debt Instrument, Discount Price, Percentage Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Segments [Axis] Segments [Axis] Statement [Line Items] Statement [Line Items] Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax [Abstract] Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Customer- Related Intangible Assets Customer Relationships [Member] 2.125% Senior Notes due 2027 Senior unsecured notes due 2027, interest rate of 2.125% EUR Senior Unsecured Notes Due 2027 [Member] EUR Senior Unsecured Notes Due 2027 [Member] Type of Restructuring [Domain] Type of Restructuring [Domain] Shareholders' Equity Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Noncontrolling Interests Noncontrolling Interest [Member] Earnings (loss) from discontinued operations Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent EX-101.PRE 14 ce-20240331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 15 ce-20240331_g1.jpg GRAPHIC begin 644 ce-20240331_g1.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X1$817AI9@ 34T *@ @ ! $[ ( M : (2H=I 0 ! (9)R= $ T 0W.H< < @, /@ M FMC.60G/SX-"CQX.GAM<&UE=&$@>&UL M;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR9&8Z4D1&('AM;&YS.G)D9CTB:'1T M<#HO+W=W=RYW,RYO&UL;G,Z#IX;7!M971A/@T*(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" \/WAP M86-K970@96YD/2=W)S\^_]L 0P '!04&!00'!@4&" <'" H1"PH)"0H5#Q , M$1@5&AD8%1@7&QXG(1L=)1T7&"(N(B4H*2LL*QH@+S,O*C(G*BLJ_]L 0P$' M" @*"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\ $0@! 3O P$B (1 0,1 ?_$ !\ $% M 0$! 0$! ! @,$!08'" D*"__$ +40 (! P,"! ,%!00$ ! M?0$" P $$042(3%!!A-180'EZ M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V]_CY^O_$ !\! ,! 0$! 0$! 0$ M ! @,$!08'" D*"__$ +41 (! @0$ P0'!00$ $"=P ! @,1! 4A M,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB) MBI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9 MVN+CY.7FY^CIZO+S]/7V]_CY^O_: P# 0 "$0,1 #\ ^D:*** "BBB@ HHH MH **** "BBB@ HHJ&ZO+:Q@,U[<1V\8ZO(X4?K2;25V-)MV1-17&:E\4-#LF M*6@FOG'>-=J_F?Z UR]_\6-5GR-/M+>U4]"V9&'X\#]*\ZKFF$I:.5WY:_\ M /6HY/C:VJA9>>G_ ?P/6Z*\'N?'7B2Z_UFJS(/2(+'_P"@@5ERZMJ,[$S: MA=2$]2TS'^M>?+/J2^&#?X?YGI0X;K/XYI>EW_D?1E%?-3RR2??D9OJQ-"32 MQ_/?$EHPVZF\J]UF57S^)&?UK:&?47\4&OQ_R,)\-UU\$T_6Z_P S MW6BO*+'XMW\; :CI]O.O']094EFDLI&XQ<+A<_[PR/S MQ7H4)9()$EC;E71@0?Q%/KT=SRM MM&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1102%4EC@#DD]J "J&K:WI^B6WGZGT\/A)Y1PURW*+_NC^+Z]/K7F-[?W6I73W-].\\SGEW.?_U#VKPL M9G%.C>%'WG^'_!/I,!D-6O:=?W8_B_\ +^M#NM>^*EU<;H=!@^RQ]//E 9S] M!T'Z_A7"WE_=ZC.9KZYEN)#_ !2.6-5Z*^7KXNMB'>I*_P"7W'V&&P6'PJM2 MC;SZ_>%%%%2V[9R0C<-]1T M/XUZ!H?Q7R4AU^V YP;F =/945V8?&U\,_P!W+3MT.'%9?AL6OWL= M>_7[SZ0LK^UU*U6YL+B.XA;H\;9'T]C[58KYXT34-5TV^$VBO,)N 5B4L''H M1W%>T^&-=OM8M<:II-S87"C)9XRL;_[N>1]#^=?6X',HXKW9*TOP/B,QRF6# M]Z,KQ_'[O\C>HHHKUCQ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH ***KWU];:;8RW=[*(H(EW,Q_P ]?:DVDKL<8N3LMQ;V M]MM/LY+J]F6&&,99V. *\<\7>.[O7Y'M;,M;:<#@(#AI?=O;VJEXK\6W?B:] M.XM%91M^Y@ST]SZG^5<]7QV8YI*NW3I:1_/_ (!]YE63QPZ56NKS_+_@A111 M7A'T84444 %%%% !1110 445MZ7X/UW6-K6EA(L3?\M91L7'KD]?PS6E.G.H M^6"N_(SJ5:=*/-4DDO,Q**].TSX2(-KZQJ)8_P 45LN!_P!]'_"NOTWP=H.E M8-KIT32#GS)AYC9]'7S_"4](7D_+;\3Q*PT#5=4 MQ_9^GW$ZG^-4.W_OH\5T]A\*];N<->2V]FIZAFWL/P''ZU[" , =!17KT MLCH1_B-O\/Z^\\2MQ%B9Z4XJ/XO^OD<#9?";2XL&^OKFY(ZA (U/\S^M=#9^ M"_#MC@PZ5 Q'>4&3_P!"S6[17I4\#AJ7PP7Y_F>15S'%UOCJ/\OR&10Q6\8C M@C2)!T5% _ 4^BBNS8XFV]6%%%% @HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBFR2)%&TDKJB("S,QP% ZDF@!U M%9/_ E7A[_H/:9_X&1_XT?\)5X>_P"@]IG_ (&1_P"- &M163_PE7A[_H/: M9_X&1_XU;L=5T[4]_P#9M_:WGEXW_9YEDVYSC.#QG!_*@"W1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 -D=8HVDD8(B@LS,< =Z\3\;^+I?$6HM!;N M5TZ!OW2CCS#_ 'S_ $]!71_$WQ45)T&P?' -TZG\D_J?P]Z\RKY/.,>YR^KT MWHM_\C[;(LM4(K$U5J]O)=_G^04445\X?5!1110 4444 %%7]*T34=;N/)TR MUDG8?>8#"K]6/ KT;0_A3:PA9==N#2U[+?\ KU/-+#3;W5+@0:?;27$A_AC7./<^@]S7<:/\*+R?;)K5 MTMJG4PQ?._T)Z#]:]/L[&UT^W$%C;QV\2]$C4 5/7T>'R2C#6J^9__YGI^&*VJ**]RG3A37+!61\]4JU M*LN:HVWYA1115F84444 %%%9FI>)-'T@'^T-0@B8?P;MS?\ ?(R:F4XP5Y.R M+A3G4?+!7?D:=%1A&I_F?Y5S%_P#$_7[O(MF@LU_Z M91[F_-LUYE7-\)3VE?T_JQZ]'(\;5U<>5>?]7/9JSKOQ!I%@2+S4K6)A_"TH MW?EUKP:]UO5-1S]NU"YG!_A>4D?ETJC7F5,^_P"?G)&*Z*OF>O9?AYXK.MZ<;"]?-[:*/F8\RI MT!^HX!_ ]ZZ*/VE;J5G@\(Z6L"9P+J^^9S[A <#\2:\GUWQWXH\2 MY&M:Y>7,9ZP^9LC_ .^%POZ4#L?86J>./"^BEAJFOZ?;NIP8VN%+C_@(.?TK MF+OX[?#^U.%UB2X/I#:RG]2H%?(E% 6/JF3]HOP2C$*FJ2>ZVR_U84)^T7X) M;[R:HG^];+_1J^5J*!V/KBU^/7@"X($FJS6V?^>MI+_[*IKHM-^(W@[5F"6/ MB33G=CA4><1LWT5L$U\2T4"L??R.LB!XV#*PR&4Y!%+7PIH_B76_#TOF:)JM MY8GN()F56^HZ'\:]^^"WQ4\3^,=>DT;7(K>[BAMFF:]5/+D7! ('RG)/8#O MUH"Q[;1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q=_R).N?] M@ZX_]%M6Q6/XN_Y$G7/^P=_U?B?ZVO_ +5KY]KZ M"_9>_P!7XG^MK_[5H!GOM%%%!(4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^*-> MC\.Z#->MAI?N0H?XG/3\NOT%;%>-_$O7O[3U_P"P0/FWLGE>#^MXE0?PK5^G_!./N)Y;JXDGN',DLC%W8]23U-1T45\ M"VV[L_3$DE9!1112&%%%=5X6\!W_ (A*W$^;2P_YZLOS/_NCO]>GUK:C1J5Y M\E-79A7Q%+#P=2J[(YRTL[F_NDMK*%YYG.%1!DFO2/#OPLC54N/$4A9^OV6) ML ?[S=_H/SKM]&T#3M M?)TVW6/(P\AY=_J>]:5?58/)J=+WJWO/MT_X)\7C ML^JU;PP_NKOU_P" 0VEG;6%LMO901P0KT2-< 5-117O))*R/FVVW=A1113$% M%%% !16%KOC'1] #)=W(DN!TMX?F?\?3\:\ZUOXGZM?EH],5=/@/ *_-(1_O M=OP'XUY^)S'#X?23N^R/4PF58K%:QC9=WHO^">J:GK6FZ/%OU*\BMP>BLWS- M]!U-<1J_Q8MXBT>BV;3GM-/\J_@HY/Z5YA-/+II37*OO9]3AN'\/3UJOF?W+^OF;VJ>-=>U?(N+]XXS_RR@_=K^G)_$FL M&BBO&J59U7S3;;\SWJ=&G2CRTXI+R"BBBLS4**** "KNCZI/HNK6]_:']Y"V M=N>''=3[$<52HJHR<9*4=T3*,9Q<9*Z9]'Z;J$&JZ;!?6C;H9T#KGJ/8^X/% M6:\R^%.O8>?1+AN#F:WSZ_Q+_7\Z]-K]"P>(6)H1J=>OJ?E^/PKPF(E2>W3T M"BBBNLX0HHHH **** "BBB@ HHHH **** "FNZ11M)(RHB@LS,< =232331 M6\#S7$BQ11J6=W.%4#J2>PKY>^+OQBG\5W$VB>'I7@T1&VR2J<->$=SZ)Z#O MU/H #K_B-^T#'8R3:7X&,=Q,N5DU)QN1#_TS4\-_O'CT!KY_U'4KW5[^6]U. MZEN[J8[GEFLWW[.7C.VR;6;3+P8R!%<,K'_ +Z4#]:Y M#6?AEXST%&?4O#MZL:\M)"@F11ZED) _&@#E:^D?V:-$%OXI?%K4S%I]EIL;?ZYS+(!Z+P/U)_*O M*Z^-SNOSUU36T?S?](^]X?P_L\,ZKWD_P7],****\(^C"GQ123S+%"C22.=J MHHR6/H!4VGZ?=:I>QVEA"TTTAP%4?J?0>]>S>$/!-KXX"SZBP^:7J(_9 M?\>]>A@L#4Q9F&94L%#WM9/9?UT,3PG\-8K=8[WQ"JRS<,EKU5/\ M>]3[=/K7H8 50J@ 8 ':EHK[;#X6EAH*\M\0_$ M?5-7W0Z>3I]L>,1M^\;ZMV^@_6N3N;J>\N7N+N9YIG.6=VR3^-15\CB\VK5_ M=A[L?Q^\^XP.28?#6E/WI>>WR0I))))R3U-)117CGNA1110 4444 %%%% !1 M110 4444 7-(U&32-8M;^'[UO('Q_>'>.ZMHKB!MT4J!T;U!& M0:^:Z]K^&NI_;_!\4+',EF[0MD]1U7]#C\*^CR*O:I*B^NO]?UT/E>(\.I4H MUUNM'Z/_ (/YG6T445]8?$A1110 4444 %%%% !1110 445Q'Q9\;?\ "$>! M[BZMW U&Z/V>S'<.1R__ $9/UP.] 'E7QZ^)KWEY+X0T.?%M"<:A*A_UC@_ MZL'T'?U/':O#*<[O+(TDC,[L2S,QR23U)--H*"BBM?POX9U'Q=X@M]'T>+S) MYCRQ^[&HZNQ[ ?\ UNIH AT/0=3\2:M%INB6I/0 >IXKZ&\$? ML\:5ID<5YXPE_M.\X8VL9*P1GT)ZO^@]C7H'@7P#I'@+15L],C$ERX'VF\=1 MYD[>_HOHO;W.2>HH%<@LK&TTZT2UT^VAM;>,82*&,(J_0#BIZ**!!1110 44 M44 _F7]]+UQ_LCV'ZG\*ZL!@98NI;:*W9R9EF,,#2OO)[+]?0E\)^%; M;PSI^Q<2W_O[;3+&2[OI5A@C&69OY>Y]J6^OK?3;&6[O9!%!$NYV/:O#?%?BN[\37 MY9R8K2,_N8 >![GU->;C\?#"0[R>R/6RW+9XZ?:*W?Z+S+GBSQU>^(9'MK;= M;:>#Q$#\TGNQ_IT^MEAX*G25D%%%%8FX4444 % M%%% !1110 4444 %%%% !1110 5Z%\)+_P O5KZQ8\30B5?JIQ_)OTKSVNC\ M 71M?&^GG.%D9HF]]RD#]<5VX"I[/%0EY_GH>?F5+VN#J1\K_=J>ZT445^A' MY>%%%% !1110 4444 %%%% !7R9\=_%;>(OB)/8POFST@&VC Z&3_EHWUW?+ M_P !%?3_ (FUE/#WA;4M7DP19VSS '^)@.!^)P*^&)II+BXDFGTMC]KN01P43!P?8L5'XU]DT"84444""BBB@ HHHH **** "BBB M@ HHHH ***Y7Q]X_TKP!H?VW43YUS+E;6S1L/,W]%'=NWN2!0!T&HZG8Z/82 M7NJ7<-I:Q#+RS.%4?B:\8\6?M(Z?:,]OX1T]K^0$C[5=92+ZA1\S#Z[:\5\9 M>.]<\ZE>7!/4S3L_\ ,U1HH&2I<31MN2:16SG(8@UK:=XR M\2Z2P.FZ_J5N!_"ET^T_5&_'2B+3[AK74,9:QN<+)[E3T8?0Y]0*^-*?#-);S)-!(\4L;!D M=&(92.A!'0T!8^_**\5^#OQF.OR0^'/%DRC4L;;6\;@7/^PWH_H?XOK][VJ@ MD**** "L?Q=_R).N?]@ZX_\ 1;5L5C^+O^1)US_L'7'_ *+:@#X8HHHH*"OH M+]E[_5^)_K:_^U:^?:^@OV7O]7XG^MK_ .U: 9[[11102%%%-D4O&RJY0L" MR]5]^: ,[7/$FC>&K/[5KVI6]C$<[3,^"^.RKU8^P!KR;Q#^TIH]IOB\-Z7< M:@XX$UPWDQ_4#EC^.*\#\4RZN_B>_B\17DUWJ%O.\$TDTA<[D8J0">W'&.*R M*!V/3=6^/_CG4F(M;JUTQ#_#:VX)_-]Q_+%^/?%NHY^V>)=5D4]4^UN%_ M[Y!Q7/T4#+4NIW\[;I[VXD;U>5B?U-$>I7T)S#>W$9SG*RL/ZU5HH Z+3OB! MXNTDC[!XDU*-1T1KEG3_ +Y8D?I7>^'_ -HWQ1I\B)KUM:ZO!_$VWR)?P9?E M_P#':\@HH ^SO!7Q1\->.5$6F71@O]N6L;D!9!ZD=F'T/UQ78U\!PS26\R30 M2/%+&P9'1B&4CH01T-?2_P &OC"WB4Q^'/$\H_M95/V:Z. +H 9VMZ.!W[@> MO4%8]EHHHH$%%%% !7R]JGQ_\;66KWEK&=/V03O&N;8YP&(]?:OJ&OAGQA%Y M/CG78O[FHW"_E(U T=W_ ,-$>./73O\ P%/_ ,51_P -$>./73O_ %/_P 5 M7E=% S[;^'VOW/BCP#I6LWWE_:;J(F7RQA=P8J<#\*W;V^M=-LI;O4+B.VMX MEW22RL%51[DUYG\'-?LM*^!-K?ZK.MO::>UP)9&[#S6;\3\V ._2O#/B1\4- M5\?:DR,[VND1/FWLE/!]&?\ O-^@[>X(]2\8_M'VMK)):>#+$7C#C[;= K'G M_93@M]21]#7DFM?%7QMKLC&[\07<2'_EE:/Y"8],)C/XYKCZ*!EB>^N[IR]S M=33,3DM)(6)_.G6NIW]DP:ROKFW8'(,4S(0?P-5:* .]T'XT^.=!==NL/J$0 M/,6H#S@WU8_/^3"O;_ ?QVT'Q5+%8:P@T;4W(51(^89F]%?C!/HWJ "37RG1 M0!]_T5\^?!/XOS?:;?PIXJN#(DA$=A>RMRI[1.3U!Z*>H/'0C'T'02%%%% ! M1110 445YM\4OBY9>!+(>)_VEIW9H?".DK&N<"ZO_ )F/N$4X'XD_2O%M M7+_QR'A1Z*.BCV'%9U ['7:K\5/&^LL3=^)+Y%/!2V?R M%QZ83%Z^$_'.@>-;'[1H%\LSJH,MN_RRQ?[R_U&1Z&OB"KFE:M?Z'J<.H:1 M=RVEW"=%><_"CXJVWCW3C9W_EV^N6R9FB'"SK_ ,]$ M'\QV^AKT:@D**** "BBB@ KAO&_Q;\->!R]O=3F]U%1_QY6Q!9?]X]%_'GVK M@_C+\99M,N+CPSX3GV7*_)>7R'F(]T0]F]3VZ#FOG=W:21GD8L['+,QR2?6@ M=CU7Q#^T-XNU61UT?[/HUN>%$2"63'NS@C\@*X+4/&/B7579M1U[4;C=U5[I M]OY9P*Q:*!DCSRR-N>5V/J6)JQ;ZOJ5F0;34+J @Y!BF9A>'/VEM2@=(O%.D0W<6<-/9'RY /7:258 M_0K7AM% 'W#X1\::+XWTMK[0+AI4C;9+'(A1XFZX(_PR*WJ\[^!FA?V)\*K! MW7;+J#->/QV;A?\ QQ5/XUZ)02%%%% !1165XD\2:9X4T.;5=:N!!;1#ZL[= ME4=R?2@#3EEC@B>69UCC0%F=S@*!U)/:O)?%W[0OA[1))+7P_"^M72Y'F*VR M!3_O'EOP&/>O&?B'\6-;\=W3P>8]CI ;]W8QMPPSP9#_ !']!V'>N"H'8]%U MOXZ>.=99Q%J2:;"W_+*QB"8_X$^)-)M=TUP^GZUJ%JPZ&&Z=/Y&LNB@#TK0/CSXVT9U%W>1 M:M .L=Y&"?P=<-GZDU[7X)^.'AKQ:\=I>,=&U%\ 0W3CRY#Z))P#]#@GL#7R M510%C[_HKYK^$GQLN-)N(=!\8733:YCW6-H0\F>CM_"O\ 4^P]Z_.:-&5>HJ<-V?JN M(KPP]*56>R.N^'/@_P#L^W76-2C_ -*E7,",/]4A'7ZG]!]:[ZBBOT'#8>&& MI*G _,,7BJF*JNK4Z_AY!11170W3?#MF#Q)-/*1_NA /_0S7SO0 M4@HHHH ^A?V8](46>N:RXR[21VD9] !O;\]R?E7O5>9?L_6@MOA):2@8-U);'PCX;NM9 MU1L0VZ\(#\TCG[J#W)_QKXQ\5^*=2\8^(;C5]7EWS2G"(/NQ)V11V _Q/4UZ M%\?O&[:]XN_L&SES8:22K@'B2?\ B/\ P'[OUW>M>24%(***[CX6_#N?X@>) M/)E+PZ9:X>\F4*O!D M$EY!1\MM-C.!Z*P!('8@CI@5Y)0,BBB@D*Q_%W_(DZY_V#KC_T6U;%8_B[ M_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ %?B?ZVO M_M6@&>^T444$A1110!\H?M >'_['^)DE[$FV#585N >V\?*X_-0W_ J\Q1'E MD5(U9W8X55&23]*^Q_B/\-+/XBII2W=Y):&QG9F>-0S/&P^91GH257GG&#P: MT_#'@'PUX0A5=#TJ&&4#FY<;YF^KGG\!@>U [GRUHOP?\<:X ]OH4UM$?^6E MZ1 /R;#'\!7:67[,VORJ#J&MZ=;D]1$KRX_,+7TI10%SYZ;]F"YV?+XJB+>A ML2!^>^L'6?V)5_ZB MMR?SE8U]NU\4?$L;?BAXC&,?\3&8_P#CQH&CEZ***!FU)XIU&3P9!X8#A-/B MNGNF"DYD=@ WL,$CW/TK%HKJ_ /P_U3Q_KGV+3_ -S;18:ZO'7*0K_5CV7O M[#)H Y4 D@ 9)Z 5KP>$?$EU");7P]JLT9&0\=E(P(^H6OKSP?\ #;PUX*MT M&E6"/=@?/>S@/,Q^I^Z/88%=70*Y\$7FGWFG2"/4+2>U(H3^!%5Z^]K M_3K+5;-[34[2&[MI/O13QAU/X&OG'XP?!B+PS9R>(?"HD.FJP^TV9)8VP/1E M)Y*9X(/(SW'0"YXO1110,4$@@@X(Z$5]B?"'QJ?&O@2"XNY-^HV9^S7>>K,! MP_\ P)<'ZY]*^.J]<_9T\0'3?B!+I#L?)U:W*@9X\R,%U/\ WSO'XT SZCHH MHH)"BBFNZQ1M)(P5%!9F)P !WH XOXI?$&#P!X7:>/;)J=WF.RA/]['+G_97 M(/N<#O7Q]?7UUJ=_/>W\[W%S<.9)99#EG8]2:Z7XE^,I?&_C:[U'P_!+X4Q^*9O^$A\01;M*MY-L$##BZ<=<_[ _4\ M=C0!RO@WX2^*?&J+<6-HMI8-TO+LE$;_ '1@EOJ!CWKTVR_9AA$(.H^)I#)C ME8+0 #\2W/Y"O>41(HUCC5410%55& .@ IU KGS]J/[,+",MI/B8,_:.YM< M _\ E8X_*O*/%_P]\1^!YU77;$K [;8[N%M\,A]F'0^S 'VK[8JKJ6FV>L: M=-8:G;1W5K.NR2*1H(/>OAZO9_P!G+Q8VG>*KCPW;Q5I.D*W[JUM#<$?[-T$^D62Q66[:;RY;RXL^W4M_P$&J/@'P]'XJ\>Z3HTY(AN9_ MWN.I1078#ZJI%?;%K;065I%:VD20P0H$CC085% P !0!\\0_LQ:FT6;CQ):1 MR?W8[9F'YDC^55+[]F?Q%$I.G:SIMSC^&4/$3^C"OI>B@5SXO\0?"OQGX:5I M-1T.X>!>3/:XF0#U)3.T?[V*YS2--EUG6[+3+;_6WEPD"<="S ?UK[SKGKGP M'X:NO$UIX@;28(]4M9#(EQ"-A1@SMAMAMXE MBC'HJC _05/110(**** (;N[@L+*:[O)5AMX(S)+(YP$4#))_"OCOXG?$.Z\ M?^)&G!:+3+8E+.W)Z+_?/^TW7VZ=J]4_:-\:FVL[;PE82X>X N+W:>B _(A^ MI!)'LOK7SM0-!116]X-\)WWC7Q/;:/IPVM(=TLI&5AC'WG/T_4D"@95T#PWK M'BC4A8Z#837LYY81CA!ZLQX4>Y->OZ-^S-J4\2OKVO6]HQ&3%:PF8CV+$J,_ MG7N7A3PEI/@W0X],T2W$4:@&20\O,W=F/<_H.@P*VJ!7/"9OV8;%H\6_B>X1 M_5[16'Y!A_.N%\5? 7Q9X=@>ZL5BUJU098VF?-4>IC/)_P" YKZPHH"Y\ D$ M$@C!'4&DKZ%^/?PQ@-G+XPT&W$N<]B3\]4#"OI M+]G[XAOJNGMX3U>;==64>ZQ=CS)".J?5>,?[)_V:^;:T_#FN7/AKQ)8:S8DB M:SF60#.-P_B4^Q&0?8T ?=E%5M.O[?5-,M;^S??;W42S1-ZJPR/T-6:"0JCK MB>9X?U%,9W6LHQ_P U>J.XA%Q:RPMTD0H?Q&*F:YHM%TY??"W0/.U.XU: MY7Y;0F*('_GH1R?P'_H5>JUX&2X7DINO+=[>A]+Q!C74JK#Q>D=_7_@!1117 MT)\N%%%% !1110 5X3X[U0ZKXOO BMV\B/'HO!_7)KV^^N/LFG7-S_ ,\8 MFD_($U\WLQ=RSG+,+N@HHHJ2@JSIJ>;JMI'_?F1?S85 M6K4\-0&Y\4Z9$/XKJ//T# G]!6E-?.K>'D[+!.?S9/\*\)KWG]I^,C4/#DO9HKA1^!C M_P :\&H*"BBB@#[#^"8 ^#>@XQ]R8\?]=I*[RO._@1<"?X.Z2@ZPO/&?^_SM M_)A7HE!(4444 %%%% !1110 4444 %%%% !6-XNUY/#'@_5-9DP?L=NSH#_$ M_1!^+$#\:V:\?_:0UZ("Q_\ 'ME 'S)//+=7$D]P[22R MN7=V/+,3DD_C4=%%!05]F?"CPFGA'X>V%HR;;NY075T< M%X;.X\7:3%JDT<%DUY$+B25@%6/>-Q)/3C-?8G_"R/!?_0U:1_X&)_C0)G34 M5S/_ LCP7_T-6D?^!B?XT?\+(\%_P#0U:1_X&)_C0(Z:BN9_P"%D>"_^AJT MC_P,3_&C_A9'@O\ Z&K2/_ Q/\: )/'_ (?3Q1X"U?2F3?)+;LT'M*OS)_X\ M!^&:^(J^V?\ A9'@O_H:M(_\#$_QKXPU184U>\6U96A6=Q&RG(*[CC!],4#1 M5ILB_*__ (\K5T%>6?L[W[7?PK$# M'/V.^FA4>@.V3^;FO4Z"0K'\7?\ (DZY_P!@ZX_]%M6Q6/XN_P"1)US_ +!U MQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_P#M6OGVOH+]E[_5^)_K:_\ M6@&>^T4 M44$A1110 4444 %%<_XA\=^&/"H(UW6;:VE SY&[?*?^ +EOTKS/6?VE]$ML MKH>C7E\P.-]PZP*?<8W$_D* /;**^8M0_:3\57#$:?IVF6:=MR/(P_$L!^E8 M%S\=?B#<9VZVL()Z16D(Q^)4F@=CZ\KY'^/-A'9?%S4'B4*+J*&<@# R4"D_ MB5S]366_Q=\>2$EO$UV,_P!T*O\ (5SFM:[J?B+4/MVMWLM[<[ GFRG)VCH/ MUH SZ***!G8?"C4#IGQ7\/3@XWWBP?\ ?P&/_P!GK[/KX7\)R-%XTT21/O)J M$#+CU$BU]T4"84444""OBKXG?\E2\1_]?\O\Z^U:^*OB=_R5+Q'_ -?\O\Z! MHY6BBB@9);P2W5S%;VZ&2:5PD:+U9B< ?G7VK\/_ ?;^"/!UGI,*KYX4274 MH_Y:3$?,?H.@]@*^6_A!8IJ/Q,M4T5R2+.X9(V;JT9Y0G MZJ0:Q*]6_:*L5M/BD)E'-Y813,?4@LG\D%>4T%!71> -0.E?$70+P' 2_A#G M_99@K?H37.U8L)3!J5M*ND;;_*/]: /#Z* M**"B]HNE7&NZ[9:59C,]Y.D*<9P6.,GV'6ON31M)M="T6STO3TV6UI$L48]@ M.I]SU-?)GP5GTFR^)EKJ&O7UO96]G#+*DEQ($4N1M R>_P Q/X5]-?\ "R/! M?_0U:1_X&)_C0)G345S/_"R/!?\ T-6D?^!B?XT?\+(\%_\ 0U:1_P"!B?XT M".FHKF?^%D>"_P#H:M(_\#$_QH_X61X+_P"AJTC_ ,#$_P : .1_:$T"/5/A MJVI!1Y^E3I*K8YV.0C+]/F4_\!KY4KZX\?\ CCP?JOP[UZRM_$FESS2V$HBB MCND9G<*2H SR<@5\CT%(*TO#VKR:#XET[5H2=]EAIU#?M+^&Y)K72?$=O%N6#=:7+#JH)W1GZ9W MCZD>M T?/-%%% SH_A_XBB\*>/\ 2-9N03!;3XFP,D1LI1B!W(5B<>U?:]K= M07MI%=600>XKX%KM_ OQ6\1> R(+&5;O32Q9K&XY0$]2I MZH?IQZ@T ?9%%>9^%OCQX0\0A(K^X;1+L\&.]($9/M(/EQ[MM^E>DPSQ7,*3 M6\J2Q.,J\;!E8>H(ZT$CZ*** "BBB@ ILLJ0PO+*P2-%+,QZ #DFG5QOQ:U< MZ+\*],/$$OBGQAJ6LS$G[5.S(#_"@X1?P M4 5BT44%!7U'^SSX372/!+ZY<1XN]6?*D]5A4D*/Q.X^XV^E?+E?96A>-?!& MC>'=/TR+Q1HX6SMHX!B\3^%0/7VH$SM:*YG_ (61X+_Z&K2/_ Q/\:/^%D>" M_P#H:M(_\#$_QH$=-17,_P#"R/!?_0U:1_X&)_C1_P +(\%_]#5I'_@8G^- M&_>V=OJ-A<65[$LMO<1M%+&W1U88(_(U\*ZUIDFBZ]?Z9/S)9W$D#''4JQ&? MTK[+_P"%D>"_^AJTC_P,3_&OE3XJ75C>_%#6[K2KJ&[M)IED2:!PR/E%)P1[ MY% T4YDTVX>UR>I7AU_1\?\!KTVOG[]F&^(D\0Z M>S<$03HOI]]6/ZK^5?0-!(4444 4]+TR#2;+[-:CY/,>0D]268D_SQ^%7*** MF,5%**V*E)SDY2W844451(4444 %%%% %#7HFG\.:E%&,M):2JH]24(KYVKZ M8KY_\4Z%)X?\07%F580[M\#'^)#TY[XZ'W%?,Y]2DU"JMMCZ_ANM%.=%[NS7 MZF/1117RQ]B%%%% !1110 4444 %%%:FE^'-7UEA_9UA-*A/^L*[4'_ CQ5P MA*;Y8J[(G4A3CS3=EYF73D1I'"1J79C@*HR2:](TCX2L=LFMWP4=X;89/XL? M\/QKN=(\-:3H:XTZRCC?O*PW.?\ @1YKV,/DV(J:U/=7X_<>#B<_PM+2G[S_ M ^\\LT7X;:UJF)+Q1IT![S#+GZ+_CBO1]!\$Z/H&V2"#S[D?\O$_P S ^PZ M#\*Z&BOHL-EN'P^J5WW9\MB\VQ6*]V3M'LOZU/-/C!]W2/K-_P"R5YE7IOQ@ M^[I'UF_]DKS*OELV_P!]G\OR1]EDG^X4_G^;"BBBO+/8"NJ^'%M]H\;VC=H4 M>0_]\D#]2*Y6O2_A'I^7U#46'0+ A_\ 'F_]EKORZG[3%07G?[M3S'_M.61D\-Z'?8XANY(<_ M[Z9_]IU\X5]=_'726U7X3:BT:[I+)X[I1CLK88_@K,:^1*"D%%%% 'TS^S3J M8N/!.IZ<6S):7WF8]$D08_5&KV:OE3]GSQ$-'^(_]G32;8-6@:#!( \U?F0G M\F4>[5]5T"84444""BBB@ HHHH **** "BBB@ KYU_:=NV?6= L\_+%;RRX] MV91_[)7T57S/^TP3_P )SI0[?V<,?]_'H&CQBBBB@84444 %%%% !1110 44 M44 %%%% 'TI^S+(3X0UB/LM\&_.,?X5[77C'[,\17P3JTW9]1VC\(T/_ +-7 ML] F%8_B[_D2=<_[!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0(^&****"@KZ"_9>_ MU?B?ZVO_ +5KY]KZ"_9>_P!7XG^MK_[5H!GOM%%%!(445A^,?%=AX+\,W.L: MFV4B&(H@<--(?NH/K^@R>U !XK\8:-X,TAM0UVZ$*=(XEYDF;^ZJ]S^@[U\V M^-OCOXD\3-);:.[:+IQXV6[?OG'^U)U'T7'XUQ7B[Q=JGC37I=5UF;<[<11+ M]R%.RJ/3^=8=!5ATDCRR-)*[.['+,QR2?4FFT44 %%==X?\ A=XR\2HLFF:' M<"!N1/<8A0CU!?&?PS7<6'[-/B6= VH:MIMIG^%"\I'Z ?K0!XS17OT7[+[E M?W_BQ0?1-/S^IDKSKXH?#I/AUJMC9IJ;:A]JA,N\P>5MPV,8W'- '#4444 ; M'A'_ )';0_\ L(V__HQ:^YZ^&/"/_([:'_V$;?\ ]&+7W/0)A1110(*^*OB= M_P E2\1_]?\ +_.OM6OBKXG?\E2\1_\ 7_+_ #H&CE:***!GH'P-_P"2SZ%_ MV\?^D\E?7]?('P-_Y+/H7_;Q_P"D\E?7] F%%%% @HHHH ^9_P!I@?\ %<:4 M?73@/_(CUXQ7M'[3'_([:3_V#O\ VH]>+T%!4EO_ ,?,7^^/YU'4EO\ \?,7 M^^/YT ??=%%%!(5\B_'B[^U?$SE;>.&(?]^E8_JQKZZKXX^,A)^+^O[NO MG)_Z+2@:.'HHHH&%%%% !1110 4444 %%%% !1110!]B?!20R?!S06;J$E7\ MIG']*[NN(^#=NUM\(- 1A@F%W_!I'8?SKMZ"0JCK>C67B'1+O2=4B\VTNXS' M(O0X]0>Q!P0?4"KU% 'Q-X\\#ZEX#\1R:;J"EX&):UN@N%N(_4>A'<=C[$$\ MS7W3XD\,:3XMT:33-=M%N;=^5)X:-NS*W4$>OX'@XKYG\>? S7_"TDEWHJ2: MSI8)(>%,S1#_ &T'7_>7CCD"@JYY=1110 5L^'_%VO\ A6X\WP_JMS9$G+(C M91C_ +2'*M^(K&HH ^A?!?[1\4K1V?C>S$#$A?M]HI*_5X^H^JY^@KW'3]1L M]5L(KW3;F*ZM9EW1S0N&5A]17P378?#_ .(^L> -6$MDYGT^1@;FQ=ODE'J/ M[K>C#\&W^&UK;KUN=1C5O]T([?S KURO%/VFL_\ "(Z-Z?;C_P"BS0!\UT444%!1 M110 4444 %%%% !1110 4444 >S_ +,\F/'&JQ_WM.+?E(G^-?3%?-G[,MNS M>+M9N!]V.Q6,_5I 1_Z":^DZ!,****!!1110 4444 %%%% !1110 5D>(O#= MCXEL/L]ZI5TR8IE^]&?;U'J*UZ*B<(U(N$U=,TIU)TIJ<'9H\-UOP%K>C2,1 M;->6XY$UNI;CW7J/Y>]"O#D; M972+<_[P)_F:Y/[!K_S+\?\ ([?]9,/;X'^'^9X'5BVL+N];;9VLUP?2*,M_ M*OH"#0-'MCFWTJSC/JL"@_GBM *, 8 ["MH9"_MS^Y&%3B5?8I_>_\ @'AM MC\/?$=\1_H/V=#_'<.%Q^'7]*Z?3OA&.&U;4L^L=LO\ [,W^%>ET5Z%+)L+3 MUDG+U_X!Y=;/L94TBU'T7^=S!TSP5H&E;6M]/CDD'_+2?]XWUYX'X 5O M# '0445ZM.E"FK022\CQJE:I5?-4DV_,****T,@HHHH \T^,'W=(^LW_ +)7 MF5>F_&#[ND?6;_V2O,J^$S;_ 'V?R_)'Z1DG^X4_G^;"BBBO+/8"O=_ NE'2 M?"%I%(,2S#SY!Z%N1^F!7C_A;1VUSQ):6>W,9??-[(.3_A^-?0(&!@=*^FR* MAK*L_1?J?(\1XG2&'7J_T_4****^I/C0HHHH **** "BBB@ HHHH K:C80:K MI=UI]XN^WNH7AE7U5@0?T-?"NKZ7<:)K5YI=ZNVXLYGAD';*G&1[<9%?>=?- M'[1GA!M-\36_B6UC_P!&U-1%.0.%G4<9_P!Y1^:M0-'B]%%% R:SNY["]@N[ M20Q3V\BR1.O564Y!_,5]L>!O%MMXU\(6>LVNU7D79<1*?]5*/O+_ %'L0>]? M$-=[\*?B3/\ #_Q ?M.^;1[PA;N%3G9Z2*/[P].XX]" &?85%06-]:ZG80WN MGSQW%M.@>*6,Y5U/<&IZ"0HHHH **** "BBB@ HHHH *^<_VG;0IKN@7F.); M:6('UV,#_P"SU]&5XW^TGI)N_ ^GZFBY:QO-K''1)%()_P"^E3\Z!H^9**** M!FQX1L+/5/&>CZ?JFXVEW>Q02[&VG:[A>O;K7TO_ ,,]^!?^>%]_X%'_ KY M4MYY+6YBN(&V2Q.'1AV(.0:^Z/#FN6WB7PW8:S8G,-Y"L@&?NG^)3[@Y!]Q0 M)G!?\,]^!?\ GA??^!1_PH_X9[\"_P#/"^_\"C_A7J%% CR__AGOP+_SPOO_ M */^%'_ SWX%_YX7W_ (%'_"O4** /+_\ AGOP+_SPOO\ P*/^%'_#/?@7 M_GA??^!1_P *]0HH \O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*] M0HH Q/"?A+2_!>BG2]#21+8RM,1(^\EB #S^ K;HHH *Q_%W_(DZY_V#KC_T M6U;%8_B[_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ M %?B?ZVO_M6@&>^T444$A7RQ^T#XN?6_'']BV\A-EI V%1T:8@%S^'"_@?6O MJ2:58+>2:3A(U+-] ,U\&ZE?2ZIJMW?W!+2W4SS.3W+,2?YT#15HHHH&6M-T MZ[U?4[?3].A:>ZN9!'%&O5F-?5GP\^#6B>#K6&ZU*&+4M9P&>>5=R0MUQ&IZ M8_O'GZ=*\R_9KT2&]\6ZGJ\R!VTZW5(LC[KRDC=]=J,/Q-?2U F%%%% @KYN M_:;_ .1IT3_KR?\ ]#KZ1KYM_::9#XKT50WSBR8E?0%S@_H?RH&CQ*BBB@9L M>$?^1VT/_L(V_P#Z,6ON>OACPC_R.VA_]A&W_P#1BU]ST"84444""OBKXG?\ ME2\1_P#7_+_.OM6OBKXG?\E2\1_]?\O\Z!HY6BBB@9Z!\#?^2SZ%_P!O'_I/ M)7U_7R!\#?\ DL^A?]O'_I/)7U_0)A1110(**** /FC]IC_D=M)_[!W_ +4> MO%Z]H_:8_P"1VTG_ +!W_M1Z\7H*"I+?_CYB_P!\?SJ.I+?_ (^8O]\?SH ^ M^Z***"0KY$^.UJ;;XPZJY&%G2"5?^_2J?U4U]=U\V_M,:2T/BG2-65,1W5H8 M&8#^*-B>??$@_*@:/$J***!G<_"+PQI'B_QT-)U]96MY+:1T$4FP[UP>OTW5 M[M_PSWX%_P">%]_X%'_"OG/X?^(%\+>/](UB9BL-O< 3$#.(V!1SC_=8U]MJ MRN@=&#*PR"#D$4"9YA_PSWX%_P">%]_X%'_"C_AGOP+_ ,\+[_P*/^%>H44" M/+_^&>_ O_/"^_\ H_X4?\ #/?@7_GA??\ @4?\*]0HH \O_P"&>_ O_/"^ M_P# H_X4?\,]^!?^>%]_X%'_ KU"B@#R_\ X9[\"_\ /"^_\"C_ (4?\,]^ M!?\ GA??^!1_PKU"B@"II.F6NBZ/::9IZ%+:TA6&)2$_&#/+JFF+%=OG-Y:GRI2?4D<,?]X&O'O$O[->K6F^;PMJ M<.H1@9%O';XVFN:?<6,_99D*[AZ@]"/<< M5G5]V:]X=TGQ/I;Z=KMC%>6S_P ,@Y0_WE/53[CFODCXH_#Z7X?>*!:([SZ= M=*9;.=QR5!Y5O]I?&,ND^+V\.7$A-EJH)C4GB M.=1D$?[R@@^IV^E?3U?!^A:@VD^(M.U&/[UI=13CZJX;^E?>% F%>0?M)6AF M^'-E<*,FWU)"3Z*8W'\\5Z_7$_SK7PHUN%!F2"'[4GMY1#G_QT,/QH$?& MU%%%!05]4V7P#\!W=A;W*0WQ6:)9 1='D$9]*^5J^Q/@UXD7Q)\,=-%]_P"!1_PH_P"&>_ O_/"^_P# H_X5 MZA10(\O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*]0HH \O\ ^&>_ M O\ SPOO_ H_X4?\,]^!?^>%]_X%'_"O4** /+_^&>_ O_/"^_\ H_X4?\ M#/?@7_GA??\ @4?\*]0HH Y?P;\/=!\"?;/^$?BF0WFSS3-+O)V[L8]/O&NH MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **R=;\3Z5X?B+:A?BLPH856D[OLOZT/4P65XC&.\5:/=_UJ:/Q5U:ROKJPM;.X6 M:6U,GG!#D(3MP,^O!KSZBBOB<5B'B:SJM6N?H6#PT<+0C1B[V_X<***V_"7A M]_$>O16N"+=#ON''9!V^IZ5E3IRJS4([LVJU848.I-Z(]!^%NA?8M'DU6=,3 M7AVQY[1@_P!3_(5WE,BB2"%(H4"1QJ%55& .@I]?H>&H1P]&-*/0_+<7B98 MJO*K+K^70****Z#E"BBB@ HHHH **** "BBB@ K%\7^&+3QAX5O=%O\ A+A/ MDDQDQ2#E7'T/Y\CO6U10!\'ZWHU[X>UR[TG58C#=VDACD7M[$>H(P0>X(-4* M^L/C)\+5\;:7_:FD1@:Y9QX09P+F,<^6??KM/O@]-K4/HE\IN-NZ2SF^2:/ZKW^HR/>OB:I(9I;>9)K>1XI4.Y'1BK* M?4$=* L??=%?)'A[X[>-M"1(IKV+5H%XVWZ%VQ_O@AB?20_M(>#)%'F6FKQ'N&MXS_)S3I/VCO!2? M=@U:3_=MD_JXH$>LT5XE>?M-:&BG^S]!U"=NPGD2(?H6KEM5_:6\07*LND:/ M86(/1I6:9A_Z"/TH'8^EB0 23@#J317Q+XA^(?BOQ2I36]:N9X3U@0B.,_5% MP#^(K['\-:J-<\*Z7JBG/VRTCF/L64$C\#D4 :=8WB_P_'XI\'ZGHLA ^V0, MB,W17'*-^# '\*V:*!'P+S?M!> FT MCQ /%.GQ?Z#J3!;D*/\ 5SXZ_1@,_4-ZBO&:"@KV/X&_%&+PS='PYX@N/+TN MZDW6\\A^6VD/4$]D;CGH#SW)KQRB@#[^!#*&4@@C(([TM?(_@+XU>(/!<,5A M/MU32H^%MIVPT0]$?J/HD45DVGBKP]?J&LM=TVX#=#%=QM_(U:;5]-49;4+4#WG7_ !H$7**Q;GQE MX8LE)N_$6E0X_OWL8/Y9KFM4^-O@/2U;_B="\D7_ )9VD+2$_0XV_K0!W]%> M!:]^TT@#Q^&=!8G^&>_DQC_MFG_Q5>N^!-?D\4>!-)UF?9YUU;@S>6,+Y@)5 ML#M\P/% '04444 %8_B[_D2=<_[!UQ_Z+:MBL?Q=_P B3KG_ &#KC_T6U 'P MQ11104%?07[+W^K\3_6U_P#:M?/M?07[+W^K\3_6U_\ :M ,]]HHHH),[Q$& M/A?5!'P_V.;;CUV&OA&OOYT62-D=0RL,,"."*^$=?TF70O$6H:5< B2SN'A. M>^UB ?Q'- T9]%%% SW?]F&_CCU3Q#I['][-##.@_P!E&=6_]&+7T17P[X-\ M57G@SQ59ZW8#>T#$21$X$L9X9#]1W['![5]@^$?'.A>-M-6ZT.]1Y-N9;5R! M-"?1EZ]>,]#V- F=#115#5]RA MK4^L:Y^;\26;\:['XK?&Y_$] MM+H?A826^EN=L]RWRR7(_N@?PKZ]S[#(/C= T%%%% S8\(_\CMH?_81M_P#T M8M?<]?"WA5MOC+16Z8OX#_Y$6ONF@3"BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5 M\3O^2I>(_P#K_E_G0-'*T444#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^ MWC_TGDKZ_H$PHHHH$%%%% 'S1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V# MO_:CUXO04%26_P#Q\Q?[X_G4=26__'S%_OC^= 'WW11102%>=_'#PP_B3X9W M;6T>^ZTUA>1 =2%!#C_O@L<=R!7HE(0&4JP!!&"#WH ^ :*[KXM>!)/ WC.: M*",C2[TM/8N!P%SS']5)Q]-I[UPM!05])_ OXI0ZEIMOX3UV=8[^V41V,KMC M[1&.D?\ O*.!ZCW'/S92JQ1@R$JP.00<$&@#[^HKYA\$?M!ZQH<,=CXG@;6+ M1!A;@/BX4>Y/#_C@^]>Q:)\:? NMJH76DL96ZQ7ZF';]6/R?^/4$G>45G0>( M=%NE#6VKV$RD9!CN48?H:DDUK2XO];J5FG^].H_K0!=HK N_'GA*Q4FZ\2Z4 MF.H^V1D_D#FN7U7X\^ ]-5O)U&;4)%_@M+=C_P"/-M7]: /1Z*^=]<_:8O)) M@GAS1(H(@PS+>/O=AGG"K@#CW-?0EO/'=6T4\)W1RH'0^H(R* )**** "BBO M&OV@_&>H>'+70[/0[Z:SO))VN6DA;!"HNT ^H)<\=#B@#V6BOG7PM^TI>6Z) M!XOTL7BC@W=EA)#[E#\I/T*_2O5]$^+?@C7@HM=?MH)6_P"65X3 P/I\^ ?P M)H [.BF0S17$2RV\B2QL,JZ,&!_$4^@ KPS]ITP_V%H ;;Y_VF79QSMVC=^N MW]*]7\1^-/#WA.U:;7=4M[8J,B'=NE?V5!R?RKY0^)WQ!G^(7B87@B:WL+93 M%:0,XCO(U&2N/N MR >JY/'<$]\5P5% 'WQ8WUKJ5C#>V$\=Q;3H'BEC;*NI[@U/7QAX'^)OB'P' M,5TJ=9K)VW265QEHV/OG+_C0 M(N45DW/BSP[9J3=Z_ID '7S+R-?YFN>U'XQ> ],4^;XBMYF[+;*TV?Q4$?K0 M!V]%>'Z[^TOI4"E/#FC7-X_3S+MA$@]P!N)_2NT^$GCNZ\?>%;F_U)(8KN"\ M>)XX%(55P&7&23T)'X&@#O**** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBJ.H:UINDH6U&]AM\#.UW&X_1>I_"IE*,5>3LBHPE-\ ML5=EZBN U7XKZ?!N32;62[<<"23Y$^OJ?TKA]7\ MI_$UY-?.,-2TB^9^7^9[>&R+%UM9+E7G_E_PQZUK7C+1="REW=B2N?$_5-0#0Z6HT^$\;E.Z0CZ]OPY]ZXBBOG\3F^(K:1?*O+_,^G MPF1X7#^])XD'<]@/8?XUA_#_P5_94: MZMJD>+V1?W43#_4J>Y_VB/R%=W7V&4Y>Z,?;5%[SV\E_F?"YWF:KR^KTG[JW M\W_D@HHHKWSYD**** "BBB@ HHHH **** "BBB@ HHHH *\N^*?P;LO&JR:K MHQCLM<5>6(Q'=8' ?T;L&_ YXQZC10!\':QHVHZ!J,]/^R>(+!+@*#YOD.0DZ#_T%OPP?:@JYXW15F_TZ]TN\:UU.TGM+A/O13QE&'X&J MU !1110 4444 %%%% !7UM\!-8_M7X46<3',FGS26K$]\'>O_CKJ/PKY)KZ0 M_9MM=8L=+UB+4-/NK>QF>*:VFFB*+(V&5MN>O 7IZ4 SV^BBB@DI:QI-EKVC MW6EZK L]I=1F.6,]Q['L0>0>Q -?('Q'^'&H_#_6VBF5Y],F8_9+S;PX_NMZ M./3OU%?9E4]6TBPUW2YM.U>UCN[2==LD4@R#_@1V(Y% SX,HKVGQY^SWJ>ER M27O@QFU*S.6-I(0)XO8'HX_(^QZUXW10,B MHHHH **** "BBB@ KZA_9OU4WGP]NK!WRUC>L%7^ZCJ&'_CV^OE_KTKZ!_9O MTG7=,OM6FO=,NK;3+VW1DGF38KNK<8!Y/#MR..* 9[[11102%8_B[_D2=<_[ M!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0!\,4444%!7T%^R]_J_$_UM?_ &K7S[7T M%^R]_J_$_P!;7_VK0#/?:***"0KYS_:*\#RVVJQ^+["(M;W(6&^VC_5R 81S M[$ +]5'K7T95;4=.M-7TVXT_4K=+BUN$,O:@#X)HKTCXF?!_5?! M%U+?:>DE_H9.4N%&7@']V0#IC^]T/'0G%>;T%!4D,TMO,LMO(\4BG*NC%2/H M14=% &\/'7BU8?*'BC61'C&W[?+C_P!"K'NKRYOIC->W$MQ*>KRN78_B:AHH M *N1Z3?3://JD=K(UC;RK#+/CY5=@2%^O!_R17Y(!R30 M!\G4444 7M$E$/B#3Y3T2ZB8_@X-?>-? 2L4<,O!4Y%??%K.+JSAN%^[+&KC MZ$9H$R6BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5\3O^2I>(_P#K_E_G0-'*T444 M#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^WC_TGDKZ_H$PHHHH$%%%% 'S M1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V#O_:CUXO04%26_P#Q\Q?[X_G4 M=26__'S%_OC^= 'WW11102%%%% '/>-_!NG>.?#4VDZF-A/SV\ZC+02 <,/7 MK@CN"?K7QYXL\)ZKX,UZ72M:@,1NQ_0]P:!GPW17I_CCX&>(_"\DESI,;ZUIHR1);I^] MC'^U&.>G<9'TKS$@@D$8(Z@T#$HHHH **** "BBB@ K[.^$^L'6_A7H5T[9D MCM_L[\\YB)CY^H4'\:^-(HI)I5BA1I)'.%1!DL?0"OJGX Z=KFD>!;FRU[3; MBQ3[69K;[0NUF1E&1M/(P1GD#[U F>IT444""OD?X[ZU_;'Q6O8T;=%I\:6B M?4#[N;1BUI<2P,>ICJ:FHVHP^:"'J%/H6/)'T'8UZQ1102%%%% ".BR1LDBAD8896&01Z5\L?&# MX1S^$;Z76=!@:709FW,J\FS8G[I_V.>#^![$_5%,EBCGA>&>-9(I%*NCKE6! MX((/44 ? =%?0WQ!_9Y2XDDU'P&R1.QW/ILSX4G_ *9N>G^ZW'N.E>#:KH^I M:%?O9:Q8SV5RG6.>,J?J,]1[C@T%%*BBB@ HHHH **** "O<_P!F351%KFN: M2S:WF*+\]K/'G M?[J01S[&HJ3Y(\UF_0TIT_:34;I7[[&U17E/_"U]6@=HKS2[82H<.OSH0?3! M)Q4J_%^<#YM'C)]IR/\ V6O,6;X/K+\&>L\CQW2-_FCU&BO+S\7YNVCQ_P#@ M0?\ XFH9/B[?G_5:9;+_ +SL?\*'F^#7VOP8+(\>_L?BO\SU:BO'IOBMKLG^ MJALHA[1L3^K5G3_$/Q-/D?VCY8](XD'ZXS64L[PJV3?R_P"";PX>QDMVE\_^ M >Y55N]4L+ $WM[;V^/^>LH7^=> W.OZO>9%UJ=W*#U5IFQ^6<50)))).2>I MKCGGR^Q#[V=U/AI_\O*GW(]NOOB-XO M4O O@$VCQ:MKD8\X8:"W8?ZL]F;W]!V^O30\'?#^'0V6^U,I<7_\"CE(?IZG MW_+UKM:^KRW*>1JK76O1?YGQ>:YU[1.AAGIU??T"BBBOHSY0**** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH I:IHNF:Y:_9]9T^UOX>R7,*R M >XR.#[BO/M8_9_\#ZF7:UM[K2Y&YS:3DKG_ '7W#'L,5Z=10!\_ZA^S"=Q; M2O$W'9+FTZ?\"5OZ5BS_ +-'BE6/V;5M(D7L9'E0G\D-?35% [GRY_PS=XS_ M .?S1O\ P(D_^-U/#^S3XK;_ %^JZ/&/]F25C_Z+%?3E% 7/GFT_9ANV(^W^ M)X8QW$-F7S^)85TVF?LW>%+5E?4K[4;]AU3>L2'\ ,_K7L%% 7.:T/X=>$?# MA#:3H-G%(,8ED3S9!CT9\D?@:Z6BB@04444 %%%% !6/K_A/0?%,(B\0:5;7 MP4;5>1/G0?[+CYE_ UL44 >.ZO\ LV^&+QR^DZA?Z:3_ $B9!] <-_X]7)W MG[,>K(Q^P>(K*<=C/ \6?R+5]'44#N?,)_9I\7[CMU/1".V9YA_[2J2+]FCQ M22//U?2$'?8\K?S05]-44!<^>K/]F&X+ ZAXGB0=Q!:%OU+#^5=1IG[.'A*T M*MJ-WJ.H,#RK2K&A_!1G]:]=HH YW0_ 'A7PVROHVA6=O*GW9C'OD'_ VRWZ MUT5%% @HHHH *KW]E%J6FW-C<[O)NH7ADVG!VL"#C\#5BB@#RK_AG7P1_>U/ M_P "1_\ $T?\,Z^"/[VI_P#@2/\ XFO5:* /*O\ AG7P1_>U/_P)'_Q-=7X) M^'>B> 5O1H)N3]M*&7[1*'^YNQC@8^\:ZJB@ HHHH **** $90ZE7 92,$$9 M!%>:^)_@/X/\0RO<6D$NCW+'):Q($9/O&00/^ [:]+HH ^;]0_9DUJ-C_96O MV%PO;[3$\)_\=WUFK^S;XR+8-]HP'K]HE_\ C=?45% [GSOIG[,=\[ ZSXBM MXE[K:0-(3^+%?Y5Z/X8^"?@WPS*EP+)]3ND.5FOV$FT^R !?T)]Z]!HH$ M P!T JIJVFV^LZ/>:9>AC;WD#P2[3@[64@X/8X-6Z* /*O^&=?!'][4_P#P M)'_Q-'_#.O@C^]J?_@2/_B:]5HH \J_X9U\$?WM3_P# D?\ Q->FV%E'IVFV MUC 6,5M"D*%SDE5 S[\58HH **** "O.-;^!GA'7]JT4 >? M^&?@OX6\)^(K76]*-\;NUW^7YLX9?F0HJ44 %%%% !1110 M4444 %_;]28')$]QL4_@@4_K7JM% C(T3PIH/AR/ M9H>D6ECQ@M%$ Q^K=3^)K7HHH **** "HKFV@O+=[>[ACGAD&'CE0,K#W!X- M2T4 >>:Y\#/ VMLTBZ:^FRL>7T^7RQ^"'*#\%KA-2_9B4DMI'B4@9XCNK7/' M^\K?TKWZB@#YCG_9I\5H3]GU31Y1_M22J?\ T6?YU"O[-OC(MAKW1E'J;B3_ M .-U]144#N?.%E^S)K+L/[1\06, [^1$\O\ /;77Z+^S?X7L7636+V^U1E/* M;A#&WU"_-_X]7L%% 7,W1?#VD>'+/[+H6G6]C#@9$,84MCNQZL?/;(9OSKZ( MHH'<^8G_ &:?%H;]WJFBLOJTTH/_ *+-+'^S3XL+?O=5T51_LRRG_P!IBOIR MB@+GSK:?LQ:@Y_T[Q+;0C_IC:M)_-EKI--_9I\.6Y5M4U;4+PCJL>R%3^&"? MUKV:B@+G):+\+?!>@,KZ?X?M#(O22X!G;/KER,+?ZQX M U[2&9OLIO(1_P M;7+_ )KU'Y8KY;$99B:&KC==T?8X7-\)B=%*S[/3_@', MT4K*58JP(8'!!'2DKS3U@HHHH **** "BBB@ HHI\,,MQ,L5O&\LC<*B*6)_ M 4]P;MJQE%==I/PVUW42K7,:V$1/+3GYL>RCG\\5Z)H7@+1=$"N8?MER.LUP M <'V7H/Y^]>IALJQ-=W:Y5W?^1XV*SG"X=63YGV7^>QYOX;\ ZGKVV>8&RLS M_P M95YF^';8QZ=#AV'[R9SEW^I_H.*U:*^IPF74<+JE> M7=_UH?&X[-,1C':3M'LOU[A1117HGE!1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4-1T+2]67&H MV,%P?[S)\P_X$.:Y>^^%>B7&39RW-FW8*^]?R//ZUV]%57/PBO5S]CU2WE]/-C9/Y9K,F^&'B.)B$CMIAZI-C/YXKVBBN M"63826R:^?\ G<].&?XV.[3]5_E8\.?X=>*%/&FAAZK/'_\ %4Y/AQXG?KIZ MI_O3Q_T->WT5E_8>&[R^]?Y&O^L>+M\,?N?^9XS#\+O$,K8D^RPCU>;/\@:U MK;X0S'!O-6C7U$4);]21_*O4**UADV$CNF_5_P"5C&>?8Z6S2]%_G,/\ GK)A?R7']:Z:QTJPTR,II]G#; ]?+0 GZGO5NBO0I8:C1_AQ M2/,K8O$5_P"+-OY_H%%%%=!RA1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 3!1110 4444 %%%% !1110!__V0$! end GRAPHIC 16 celogo.jpg GRAPHIC begin 644 celogo.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X1$817AI9@ 34T *@ @ ! $[ ( M : (2H=I 0 ! (9)R= $ T 0W.H< < @, /@ M FMC.60G/SX-"CQX.GAM<&UE=&$@>&UL M;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR9&8Z4D1&('AM;&YS.G)D9CTB:'1T M<#HO+W=W=RYW,RYO&UL;G,Z#IX;7!M971A/@T*(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" \/WAP M86-K970@96YD/2=W)S\^_]L 0P '!04&!00'!@4&" <'" H1"PH)"0H5#Q , M$1@5&AD8%1@7&QXG(1L=)1T7&"(N(B4H*2LL*QH@+S,O*C(G*BLJ_]L 0P$' M" @*"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\ $0@! 3O P$B (1 0,1 ?_$ !\ $% M 0$! 0$! ! @,$!08'" D*"__$ +40 (! P,"! ,%!00$ ! M?0$" P $$042(3%!!A-180'EZ M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V]_CY^O_$ !\! ,! 0$! 0$! 0$ M ! @,$!08'" D*"__$ +41 (! @0$ P0'!00$ $"=P ! @,1! 4A M,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB) MBI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9 MVN+CY.7FY^CIZO+S]/7V]_CY^O_: P# 0 "$0,1 #\ ^D:*** "BBB@ HHH MH **** "BBB@ HHJ&ZO+:Q@,U[<1V\8ZO(X4?K2;25V-)MV1-17&:E\4-#LF M*6@FOG'>-=J_F?Z UR]_\6-5GR-/M+>U4]"V9&'X\#]*\ZKFF$I:.5WY:_\ M /6HY/C:VJA9>>G_ ?P/6Z*\'N?'7B2Z_UFJS(/2(+'_P"@@5ERZMJ,[$S: MA=2$]2TS'^M>?+/J2^&#?X?YGI0X;K/XYI>EW_D?1E%?-3RR2??D9OJQ-"32 MQ_/?$EHPVZF\J]UF57S^)&?UK:&?47\4&OQ_R,)\-UU\$T_6Z_P S MW6BO*+'XMW\; :CI]O.O']094EFDLI&XQ<+A<_[PR/S MQ7H4)9()$EC;E71@0?Q%/KT=SRM MM&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1102%4EC@#DD]J "J&K:WI^B6WGZGT\/A)Y1PURW*+_NC^+Z]/K7F-[?W6I73W-].\\SGEW.?_U#VKPL M9G%.C>%'WG^'_!/I,!D-6O:=?W8_B_\ +^M#NM>^*EU<;H=!@^RQ]//E 9S] M!T'Z_A7"WE_=ZC.9KZYEN)#_ !2.6-5Z*^7KXNMB'>I*_P"7W'V&&P6'PJM2 MC;SZ_>%%%%2V[9R0C<-]1T M/XUZ!H?Q7R4AU^V YP;F =/945V8?&U\,_P!W+3MT.'%9?AL6OWL= M>_7[SZ0LK^UU*U6YL+B.XA;H\;9'T]C[58KYXT34-5TV^$VBO,)N 5B4L''H M1W%>T^&-=OM8M<:II-S87"C)9XRL;_[N>1]#^=?6X',HXKW9*TOP/B,QRF6# M]Z,KQ_'[O\C>HHHKUCQ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH ***KWU];:;8RW=[*(H(EW,Q_P ]?:DVDKL<8N3LMQ;V M]MM/LY+J]F6&&,99V. *\<\7>.[O7Y'M;,M;:<#@(#AI?=O;VJEXK\6W?B:] M.XM%91M^Y@ST]SZG^5<]7QV8YI*NW3I:1_/_ (!]YE63QPZ56NKS_+_@A111 M7A'T84444 %%%% !1110 445MZ7X/UW6-K6EA(L3?\M91L7'KD]?PS6E.G.H M^6"N_(SJ5:=*/-4DDO,Q**].TSX2(-KZQJ)8_P 45LN!_P!]'_"NOTWP=H.E M8-KIT32#GS)AYC9]'7S_"4](7D_+;\3Q*PT#5=4 MQ_9^GW$ZG^-4.W_OH\5T]A\*];N<->2V]FIZAFWL/P''ZU[" , =!17KT MLCH1_B-O\/Z^\\2MQ%B9Z4XJ/XO^OD<#9?";2XL&^OKFY(ZA (U/\S^M=#9^ M"_#MC@PZ5 Q'>4&3_P!"S6[17I4\#AJ7PP7Y_F>15S'%UOCJ/\OR&10Q6\8C M@C2)!T5% _ 4^BBNS8XFV]6%%%% @HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBFR2)%&TDKJB("S,QP% ZDF@!U M%9/_ E7A[_H/:9_X&1_XT?\)5X>_P"@]IG_ (&1_P"- &M163_PE7A[_H/: M9_X&1_XU;L=5T[4]_P#9M_:WGEXW_9YEDVYSC.#QG!_*@"W1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 -D=8HVDD8(B@LS,< =Z\3\;^+I?$6HM!;N M5TZ!OW2CCS#_ 'S_ $]!71_$WQ45)T&P?' -TZG\D_J?P]Z\RKY/.,>YR^KT MWHM_\C[;(LM4(K$U5J]O)=_G^04445\X?5!1110 4444 %%7]*T34=;N/)TR MUDG8?>8#"K]6/ KT;0_A3:PA9==N#2U[+?\ KU/-+#3;W5+@0:?;27$A_AC7./<^@]S7<:/\*+R?;)K5 MTMJG4PQ?._T)Z#]:]/L[&UT^W$%C;QV\2]$C4 5/7T>'R2C#6J^9__YGI^&*VJ**]RG3A37+!61\]4JU M*LN:HVWYA1115F84444 %%%9FI>)-'T@'^T-0@B8?P;MS?\ ?(R:F4XP5Y.R M+A3G4?+!7?D:=%1A&I_F?Y5S%_P#$_7[O(MF@LU_Z M91[F_-LUYE7-\)3VE?T_JQZ]'(\;5U<>5>?]7/9JSKOQ!I%@2+S4K6)A_"TH MW?EUKP:]UO5-1S]NU"YG!_A>4D?ETJC7F5,^_P"?G)&*Z*OF>O9?AYXK.MZ<;"]?-[:*/F8\RI MT!^HX!_ ]ZZ*/VE;J5G@\(Z6L"9P+J^^9S[A <#\2:\GUWQWXH\2 MY&M:Y>7,9ZP^9LC_ .^%POZ4#L?86J>./"^BEAJFOZ?;NIP8VN%+C_@(.?TK MF+OX[?#^U.%UB2X/I#:RG]2H%?(E% 6/JF3]HOP2C$*FJ2>ZVR_U84)^T7X) M;[R:HG^];+_1J^5J*!V/KBU^/7@"X($FJS6V?^>MI+_[*IKHM-^(W@[5F"6/ MB33G=CA4><1LWT5L$U\2T4"L??R.LB!XV#*PR&4Y!%+7PIH_B76_#TOF:)JM MY8GN()F56^HZ'\:]^^"WQ4\3^,=>DT;7(K>[BAMFF:]5/+D7! ('RG)/8#O MUH"Q[;1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q=_R).N?] M@ZX_]%M6Q6/XN_Y$G7/^P=_U?B?ZVO_ +5KY]KZ M"_9>_P!7XG^MK_[5H!GOM%%%!(4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^*-> MC\.Z#->MAI?N0H?XG/3\NOT%;%>-_$O7O[3U_P"P0/FWLGE>#^MXE0?PK5^G_!./N)Y;JXDGN',DLC%W8]23U-1T45\ M"VV[L_3$DE9!1112&%%%=5X6\!W_ (A*W$^;2P_YZLOS/_NCO]>GUK:C1J5Y M\E-79A7Q%+#P=2J[(YRTL[F_NDMK*%YYG.%1!DFO2/#OPLC54N/$4A9^OV6) ML ?[S=_H/SKM]&T#3M M?)TVW6/(P\AY=_J>]:5?58/)J=+WJWO/MT_X)\7C ML^JU;PP_NKOU_P" 0VEG;6%LMO901P0KT2-< 5-117O))*R/FVVW=A1113$% M%%% !16%KOC'1] #)=W(DN!TMX?F?\?3\:\ZUOXGZM?EH],5=/@/ *_-(1_O M=OP'XUY^)S'#X?23N^R/4PF58K%:QC9=WHO^">J:GK6FZ/%OU*\BMP>BLWS- M]!U-<1J_Q8MXBT>BV;3GM-/\J_@HY/Z5YA-/+II37*OO9]3AN'\/3UJOF?W+^OF;VJ>-=>U?(N+]XXS_RR@_=K^G)_$FL M&BBO&J59U7S3;;\SWJ=&G2CRTXI+R"BBBLS4**** "KNCZI/HNK6]_:']Y"V M=N>''=3[$<52HJHR<9*4=T3*,9Q<9*Z9]'Z;J$&JZ;!?6C;H9T#KGJ/8^X/% M6:\R^%.O8>?1+AN#F:WSZ_Q+_7\Z]-K]"P>(6)H1J=>OJ?E^/PKPF(E2>W3T M"BBBNLX0HHHH **** "BBB@ HHHH **** "FNZ11M)(RHB@LS,< =232331 M6\#S7$BQ11J6=W.%4#J2>PKY>^+OQBG\5W$VB>'I7@T1&VR2J<->$=SZ)Z#O MU/H #K_B-^T#'8R3:7X&,=Q,N5DU)QN1#_TS4\-_O'CT!KY_U'4KW5[^6]U. MZEN[J8[GEFLWW[.7C.VR;6;3+P8R!%<,K'_ +Z4#]:Y M#6?AEXST%&?4O#MZL:\M)"@F11ZED) _&@#E:^D?V:-$%OXI?%K4S%I]EIL;?ZYS+(!Z+P/U)_*O M*Z^-SNOSUU36T?S?](^]X?P_L\,ZKWD_P7],****\(^C"GQ123S+%"C22.=J MHHR6/H!4VGZ?=:I>QVEA"TTTAP%4?J?0>]>S>$/!-KXX"SZBP^:7J(_9 M?\>]>A@L#4Q9F&94L%#WM9/9?UT,3PG\-8K=8[WQ"JRS<,EKU5/\ M>]3[=/K7H8 50J@ 8 ':EHK[;#X6EAH*\M\0_$ M?5-7W0Z>3I]L>,1M^\;ZMV^@_6N3N;J>\N7N+N9YIG.6=VR3^-15\CB\VK5_ M=A[L?Q^\^XP.28?#6E/WI>>WR0I))))R3U-)117CGNA1110 4444 %%%% !1 M110 4444 7-(U&32-8M;^'[UO('Q_>'>.ZMHKB!MT4J!T;U!& M0:^:Z]K^&NI_;_!\4+',EF[0MD]1U7]#C\*^CR*O:I*B^NO]?UT/E>(\.I4H MUUNM'Z/_ (/YG6T445]8?$A1110 4444 %%%% !1110 445Q'Q9\;?\ "$>! M[BZMW U&Z/V>S'<.1R__ $9/UP.] 'E7QZ^)KWEY+X0T.?%M"<:A*A_UC@_ MZL'T'?U/':O#*<[O+(TDC,[L2S,QR23U)--H*"BBM?POX9U'Q=X@M]'T>+S) MYCRQ^[&HZNQ[ ?\ UNIH AT/0=3\2:M%INB6I/0 >IXKZ&\$? ML\:5ID<5YXPE_M.\X8VL9*P1GT)ZO^@]C7H'@7P#I'@+15L],C$ERX'VF\=1 MYD[>_HOHO;W.2>HH%<@LK&TTZT2UT^VAM;>,82*&,(J_0#BIZ**!!1110 44 M44 _F7]]+UQ_LCV'ZG\*ZL!@98NI;:*W9R9EF,,#2OO)[+]?0E\)^%; M;PSI^Q<2W_O[;3+&2[OI5A@C&69OY>Y]J6^OK?3;&6[O9!%!$NYV/:O#?%?BN[\37 MY9R8K2,_N8 >![GU->;C\?#"0[R>R/6RW+9XZ?:*W?Z+S+GBSQU>^(9'MK;= M;:>#Q$#\TGNQ_IT^MEAX*G25D%%%%8FX4444 % M%%% !1110 4444 %%%% !1110 5Z%\)+_P O5KZQ8\30B5?JIQ_)OTKSVNC\ M 71M?&^GG.%D9HF]]RD#]<5VX"I[/%0EY_GH>?F5+VN#J1\K_=J>ZT445^A' MY>%%%% !1110 4444 %%%% !7R9\=_%;>(OB)/8POFST@&VC Z&3_EHWUW?+ M_P !%?3_ (FUE/#WA;4M7DP19VSS '^)@.!^)P*^&)II+BXDFGTMC]KN01P43!P?8L5'XU]DT"84444""BBB@ HHHH **** "BBB M@ HHHH ***Y7Q]X_TKP!H?VW43YUS+E;6S1L/,W]%'=NWN2!0!T&HZG8Z/82 M7NJ7<-I:Q#+RS.%4?B:\8\6?M(Z?:,]OX1T]K^0$C[5=92+ZA1\S#Z[:\5\9 M>.]<\ZE>7!/4S3L_\ ,U1HH&2I<31MN2:16SG(8@UK:=XR M\2Z2P.FZ_J5N!_"ET^T_5&_'2B+3[AK74,9:QN<+)[E3T8?0Y]0*^-*?#-);S)-!(\4L;!D M=&(92.A!'0T!8^_**\5^#OQF.OR0^'/%DRC4L;;6\;@7/^PWH_H?XOK][VJ@ MD**** "L?Q=_R).N?]@ZX_\ 1;5L5C^+O^1)US_L'7'_ *+:@#X8HHHH*"OH M+]E[_5^)_K:_^U:^?:^@OV7O]7XG^MK_ .U: 9[[11102%%%-D4O&RJY0L" MR]5]^: ,[7/$FC>&K/[5KVI6]C$<[3,^"^.RKU8^P!KR;Q#^TIH]IOB\-Z7< M:@XX$UPWDQ_4#EC^.*\#\4RZN_B>_B\17DUWJ%O.\$TDTA<[D8J0">W'&.*R M*!V/3=6^/_CG4F(M;JUTQ#_#:VX)_-]Q_+%^/?%NHY^V>)=5D4]4^UN%_ M[Y!Q7/T4#+4NIW\[;I[VXD;U>5B?U-$>I7T)S#>W$9SG*RL/ZU5HH Z+3OB! MXNTDC[!XDU*-1T1KEG3_ +Y8D?I7>^'_ -HWQ1I\B)KUM:ZO!_$VWR)?P9?E M_P#':\@HH ^SO!7Q1\->.5$6F71@O]N6L;D!9!ZD=F'T/UQ78U\!PS26\R30 M2/%+&P9'1B&4CH01T-?2_P &OC"WB4Q^'/$\H_M95/V:Z. +H 9VMZ.!W[@> MO4%8]EHHHH$%%%% !7R]JGQ_\;66KWEK&=/V03O&N;8YP&(]?:OJ&OAGQA%Y M/CG78O[FHW"_E(U T=W_ ,-$>./73O\ P%/_ ,51_P -$>./73O_ %/_P 5 M7E=% S[;^'VOW/BCP#I6LWWE_:;J(F7RQA=P8J<#\*W;V^M=-LI;O4+B.VMX MEW22RL%51[DUYG\'-?LM*^!-K?ZK.MO::>UP)9&[#S6;\3\V ._2O#/B1\4- M5\?:DR,[VND1/FWLE/!]&?\ O-^@[>X(]2\8_M'VMK)):>#+$7C#C[;= K'G M_93@M]21]#7DFM?%7QMKLC&[\07<2'_EE:/Y"8],)C/XYKCZ*!EB>^N[IR]S M=33,3DM)(6)_.G6NIW]DP:ROKFW8'(,4S(0?P-5:* .]T'XT^.=!==NL/J$0 M/,6H#S@WU8_/^3"O;_ ?QVT'Q5+%8:P@T;4W(51(^89F]%?C!/HWJ "37RG1 M0!]_T5\^?!/XOS?:;?PIXJN#(DA$=A>RMRI[1.3U!Z*>H/'0C'T'02%%%% ! M1110 445YM\4OBY9>!+(>)_VEIW9H?".DK&N<"ZO_ )F/N$4X'XD_2O%M M7+_QR'A1Z*.BCV'%9U ['7:K\5/&^LL3=^)+Y%/!2V?R M%QZ83%Z^$_'.@>-;'[1H%\LSJH,MN_RRQ?[R_U&1Z&OB"KFE:M?Z'J<.H:1 M=RVEW"=%><_"CXJVWCW3C9W_EV^N6R9FB'"SK_ ,]$ M'\QV^AKT:@D**** "BBB@ KAO&_Q;\->!R]O=3F]U%1_QY6Q!9?]X]%_'GVK M@_C+\99M,N+CPSX3GV7*_)>7R'F(]T0]F]3VZ#FOG=W:21GD8L['+,QR2?6@ M=CU7Q#^T-XNU61UT?[/HUN>%$2"63'NS@C\@*X+4/&/B7579M1U[4;C=U5[I M]OY9P*Q:*!DCSRR-N>5V/J6)JQ;ZOJ5F0;34+J @Y!BF9A>'/VEM2@=(O%.D0W<6<-/9'RY /7:258 M_0K7AM% 'W#X1\::+XWTMK[0+AI4C;9+'(A1XFZX(_PR*WJ\[^!FA?V)\*K! MW7;+J#->/QV;A?\ QQ5/XUZ)02%%%% !1165XD\2:9X4T.;5=:N!!;1#ZL[= ME4=R?2@#3EEC@B>69UCC0%F=S@*!U)/:O)?%W[0OA[1))+7P_"^M72Y'F*VR M!3_O'EOP&/>O&?B'\6-;\=W3P>8]CI ;]W8QMPPSP9#_ !']!V'>N"H'8]%U MOXZ>.=99Q%J2:;"W_+*QB"8_X$^)-)M=TUP^GZUJ%JPZ&&Z=/Y&LNB@#TK0/CSXVT9U%W>1 M:M .L=Y&"?P=<-GZDU[7X)^.'AKQ:\=I>,=&U%\ 0W3CRY#Z))P#]#@GL#7R M510%C[_HKYK^$GQLN-)N(=!\8733:YCW6-H0\F>CM_"O\ 4^P]Z_.:-&5>HJ<-V?JN M(KPP]*56>R.N^'/@_P#L^W76-2C_ -*E7,",/]4A'7ZG]!]:[ZBBOT'#8>&& MI*G _,,7BJF*JNK4Z_AY!11170W3?#MF#Q)-/*1_NA /_0S7SO0 M4@HHHH ^A?V8](46>N:RXR[21VD9] !O;\]R?E7O5>9?L_6@MOA):2@8-U);'PCX;NM9 MU1L0VZ\(#\TCG[J#W)_QKXQ\5^*=2\8^(;C5]7EWS2G"(/NQ)V11V _Q/4UZ M%\?O&[:]XN_L&SES8:22K@'B2?\ B/\ P'[OUW>M>24%(***[CX6_#N?X@>) M/)E+PZ9:X>\F4*O!D M$EY!1\MM-C.!Z*P!('8@CI@5Y)0,BBB@D*Q_%W_(DZY_V#KC_T6U;%8_B[ M_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ %?B?ZVO M_M6@&>^T444$A1110!\H?M >'_['^)DE[$FV#585N >V\?*X_-0W_ J\Q1'E MD5(U9W8X55&23]*^Q_B/\-+/XBII2W=Y):&QG9F>-0S/&P^91GH257GG&#P: MT_#'@'PUX0A5=#TJ&&4#FY<;YF^KGG\!@>U [GRUHOP?\<:X ]OH4UM$?^6E MZ1 /R;#'\!7:67[,VORJ#J&MZ=;D]1$KRX_,+7TI10%SYZ;]F"YV?+XJB+>A ML2!^>^L'6?V)5_ZB MMR?SE8U]NU\4?$L;?BAXC&,?\3&8_P#CQH&CEZ***!FU)XIU&3P9!X8#A-/B MNGNF"DYD=@ WL,$CW/TK%HKJ_ /P_U3Q_KGV+3_ -S;18:ZO'7*0K_5CV7O M[#)H Y4 D@ 9)Z 5KP>$?$EU");7P]JLT9&0\=E(P(^H6OKSP?\ #;PUX*MT M&E6"/=@?/>S@/,Q^I^Z/88%=70*Y\$7FGWFG2"/4+2>U(H3^!%5Z^]K M_3K+5;-[34[2&[MI/O13QAU/X&OG'XP?!B+PS9R>(?"HD.FJP^TV9)8VP/1E M)Y*9X(/(SW'0"YXO1110,4$@@@X(Z$5]B?"'QJ?&O@2"XNY-^HV9^S7>>K,! MP_\ P)<'ZY]*^.J]<_9T\0'3?B!+I#L?)U:W*@9X\R,%U/\ WSO'XT SZCHH MHH)"BBFNZQ1M)(P5%!9F)P !WH XOXI?$&#P!X7:>/;)J=WF.RA/]['+G_97 M(/N<#O7Q]?7UUJ=_/>W\[W%S<.9)99#EG8]2:Z7XE^,I?&_C:[U'P_!+X4Q^*9O^$A\01;M*MY-L$##BZ<=<_[ _4\ M=C0!RO@WX2^*?&J+<6-HMI8-TO+LE$;_ '1@EOJ!CWKTVR_9AA$(.H^)I#)C ME8+0 #\2W/Y"O>41(HUCC5410%55& .@ IU KGS]J/[,+",MI/B8,_:.YM< M _\ E8X_*O*/%_P]\1^!YU77;$K [;8[N%M\,A]F'0^S 'VK[8JKJ6FV>L: M=-8:G;1W5K.NR2*1H(/>OAZO9_P!G+Q8VG>*KCPW;Q5I.D*W[JUM#<$?[-T$^D62Q66[:;RY;RXL^W4M_P$&J/@'P]'XJ\>Z3HTY(AN9_ MWN.I1078#ZJI%?;%K;065I%:VD20P0H$CC085% P !0!\\0_LQ:FT6;CQ):1 MR?W8[9F'YDC^55+[]F?Q%$I.G:SIMSC^&4/$3^C"OI>B@5SXO\0?"OQGX:5I M-1T.X>!>3/:XF0#U)3.T?[V*YS2--EUG6[+3+;_6WEPD"<="S ?UK[SKGKGP M'X:NO$UIX@;28(]4M9#(EQ"-A1@SMAMAMXE MBC'HJC _05/110(**** (;N[@L+*:[O)5AMX(S)+(YP$4#))_"OCOXG?$.Z\ M?^)&G!:+3+8E+.W)Z+_?/^TW7VZ=J]4_:-\:FVL[;PE82X>X N+W:>B _(A^ MI!)'LOK7SM0-!116]X-\)WWC7Q/;:/IPVM(=TLI&5AC'WG/T_4D"@95T#PWK M'BC4A8Z#837LYY81CA!ZLQX4>Y->OZ-^S-J4\2OKVO6]HQ&3%:PF8CV+$J,_ MG7N7A3PEI/@W0X],T2W$4:@&20\O,W=F/<_H.@P*VJ!7/"9OV8;%H\6_B>X1 M_5[16'Y!A_.N%\5? 7Q9X=@>ZL5BUJU098VF?-4>IC/)_P" YKZPHH"Y\ D$ M$@C!'4&DKZ%^/?PQ@-G+XPT&W$N<]B3\]4#"OI M+]G[XAOJNGMX3U>;==64>ZQ=CS)".J?5>,?[)_V:^;:T_#FN7/AKQ)8:S8DB M:SF60#.-P_B4^Q&0?8T ?=E%5M.O[?5-,M;^S??;W42S1-ZJPR/T-6:"0JCK MB>9X?U%,9W6LHQ_P U>J.XA%Q:RPMTD0H?Q&*F:YHM%TY??"W0/.U.XU: MY7Y;0F*('_GH1R?P'_H5>JUX&2X7DINO+=[>A]+Q!C74JK#Q>D=_7_@!1117 MT)\N%%%% !1110 5X3X[U0ZKXOO BMV\B/'HO!_7)KV^^N/LFG7-S_ ,\8 MFD_($U\WLQ=RSG+,+N@HHHJ2@JSIJ>;JMI'_?F1?S85 M6K4\-0&Y\4Z9$/XKJ//T# G]!6E-?.K>'D[+!.?S9/\*\)KWG]I^,C4/#DO9HKA1^!C M_P :\&H*"BBB@#[#^"8 ^#>@XQ]R8\?]=I*[RO._@1<"?X.Z2@ZPO/&?^_SM M_)A7HE!(4444 %%%% !1110 4444 %%%% !6-XNUY/#'@_5-9DP?L=NSH#_$ M_1!^+$#\:V:\?_:0UZ("Q_\ 'ME 'S)//+=7$D]P[22R MN7=V/+,3DD_C4=%%!05]F?"CPFGA'X>V%HR;;NY075T< M%X;.X\7:3%JDT<%DUY$+B25@%6/>-Q)/3C-?8G_"R/!?_0U:1_X&)_C0)G34 M5S/_ LCP7_T-6D?^!B?XT?\+(\%_P#0U:1_X&)_C0(Z:BN9_P"%D>"_^AJT MC_P,3_&C_A9'@O\ Z&K2/_ Q/\: )/'_ (?3Q1X"U?2F3?)+;LT'M*OS)_X\ M!^&:^(J^V?\ A9'@O_H:M(_\#$_QKXPU184U>\6U96A6=Q&RG(*[CC!],4#1 M5ILB_*__ (\K5T%>6?L[W[7?PK$# M'/V.^FA4>@.V3^;FO4Z"0K'\7?\ (DZY_P!@ZX_]%M6Q6/XN_P"1)US_ +!U MQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_P#M6OGVOH+]E[_5^)_K:_\ M6@&>^T4 M44$A1110 4444 %%<_XA\=^&/"H(UW6;:VE SY&[?*?^ +EOTKS/6?VE]$ML MKH>C7E\P.-]PZP*?<8W$_D* /;**^8M0_:3\57#$:?IVF6:=MR/(P_$L!^E8 M%S\=?B#<9VZVL()Z16D(Q^)4F@=CZ\KY'^/-A'9?%S4'B4*+J*&<@# R4"D_ MB5S]366_Q=\>2$EO$UV,_P!T*O\ (5SFM:[J?B+4/MVMWLM[<[ GFRG)VCH/ MUH SZ***!G8?"C4#IGQ7\/3@XWWBP?\ ?P&/_P!GK[/KX7\)R-%XTT21/O)J M$#+CU$BU]T4"84444""OBKXG?\E2\1_]?\O\Z^U:^*OB=_R5+Q'_ -?\O\Z! MHY6BBB@9);P2W5S%;VZ&2:5PD:+U9B< ?G7VK\/_ ?;^"/!UGI,*KYX4274 MH_Y:3$?,?H.@]@*^6_A!8IJ/Q,M4T5R2+.X9(V;JT9Y0G MZJ0:Q*]6_:*L5M/BD)E'-Y813,?4@LG\D%>4T%!71> -0.E?$70+P' 2_A#G M_99@K?H37.U8L)3!J5M*ND;;_*/]: /#Z* M**"B]HNE7&NZ[9:59C,]Y.D*<9P6.,GV'6ON31M)M="T6STO3TV6UI$L48]@ M.I]SU-?)GP5GTFR^)EKJ&O7UO96]G#+*DEQ($4N1M R>_P Q/X5]-?\ "R/! M?_0U:1_X&)_C0)G345S/_"R/!?\ T-6D?^!B?XT?\+(\%_\ 0U:1_P"!B?XT M".FHKF?^%D>"_P#H:M(_\#$_QH_X61X+_P"AJTC_ ,#$_P : .1_:$T"/5/A MJVI!1Y^E3I*K8YV.0C+]/F4_\!KY4KZX\?\ CCP?JOP[UZRM_$FESS2V$HBB MCND9G<*2H SR<@5\CT%(*TO#VKR:#XET[5H2=]EAIU#?M+^&Y)K72?$=O%N6#=:7+#JH)W1GZ9W MCZD>M T?/-%%% SH_A_XBB\*>/\ 2-9N03!;3XFP,D1LI1B!W(5B<>U?:]K= M07MI%=600>XKX%KM_ OQ6\1> R(+&5;O32Q9K&XY0$]2I MZH?IQZ@T ?9%%>9^%OCQX0\0A(K^X;1+L\&.]($9/M(/EQ[MM^E>DPSQ7,*3 M6\J2Q.,J\;!E8>H(ZT$CZ*** "BBB@ ILLJ0PO+*P2-%+,QZ #DFG5QOQ:U< MZ+\*],/$$OBGQAJ6LS$G[5.S(#_"@X1?P M4 5BT44%!7U'^SSX372/!+ZY<1XN]6?*D]5A4D*/Q.X^XV^E?+E?96A>-?!& MC>'=/TR+Q1HX6SMHX!B\3^%0/7VH$SM:*YG_ (61X+_Z&K2/_ Q/\:/^%D>" M_P#H:M(_\#$_QH$=-17,_P#"R/!?_0U:1_X&)_C1_P +(\%_]#5I'_@8G^- M&_>V=OJ-A<65[$LMO<1M%+&W1U88(_(U\*ZUIDFBZ]?Z9/S)9W$D#''4JQ&? MTK[+_P"%D>"_^AJTC_P,3_&OE3XJ75C>_%#6[K2KJ&[M)IED2:!PR/E%)P1[ MY% T4YDTVX>UR>I7AU_1\?\!KTVOG[]F&^(D\0Z M>S<$03HOI]]6/ZK^5?0-!(4444 4]+TR#2;+[-:CY/,>0D]268D_SQ^%7*** MF,5%**V*E)SDY2W844451(4444 %%%% %#7HFG\.:E%&,M):2JH]24(KYVKZ M8KY_\4Z%)X?\07%F580[M\#'^)#TY[XZ'W%?,Y]2DU"JMMCZ_ANM%.=%[NS7 MZF/1117RQ]B%%%% !1110 4444 %%%:FE^'-7UEA_9UA-*A/^L*[4'_ CQ5P MA*;Y8J[(G4A3CS3=EYF73D1I'"1J79C@*HR2:](TCX2L=LFMWP4=X;89/XL? M\/QKN=(\-:3H:XTZRCC?O*PW.?\ @1YKV,/DV(J:U/=7X_<>#B<_PM+2G[S_ M ^\\LT7X;:UJF)+Q1IT![S#+GZ+_CBO1]!\$Z/H&V2"#S[D?\O$_P S ^PZ M#\*Z&BOHL-EN'P^J5WW9\MB\VQ6*]V3M'LOZU/-/C!]W2/K-_P"R5YE7IOQ@ M^[I'UF_]DKS*OELV_P!]G\OR1]EDG^X4_G^;"BBBO+/8"NJ^'%M]H\;VC=H4 M>0_]\D#]2*Y6O2_A'I^7U#46'0+ A_\ 'F_]EKORZG[3%07G?[M3S'_M.61D\-Z'?8XANY(<_ M[Z9_]IU\X5]=_'726U7X3:BT:[I+)X[I1CLK88_@K,:^1*"D%%%% 'TS^S3J M8N/!.IZ<6S):7WF8]$D08_5&KV:OE3]GSQ$-'^(_]G32;8-6@:#!( \U?F0G M\F4>[5]5T"84444""BBB@ HHHH **** "BBB@ KYU_:=NV?6= L\_+%;RRX] MV91_[)7T57S/^TP3_P )SI0[?V<,?]_'H&CQBBBB@84444 %%%% !1110 44 M44 %%%% 'TI^S+(3X0UB/LM\&_.,?X5[77C'[,\17P3JTW9]1VC\(T/_ +-7 ML] F%8_B[_D2=<_[!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0(^&****"@KZ"_9>_ MU?B?ZVO_ +5KY]KZ"_9>_P!7XG^MK_[5H!GOM%%%!(445A^,?%=AX+\,W.L: MFV4B&(H@<--(?NH/K^@R>U !XK\8:-X,TAM0UVZ$*=(XEYDF;^ZJ]S^@[U\V M^-OCOXD\3-);:.[:+IQXV6[?OG'^U)U'T7'XUQ7B[Q=JGC37I=5UF;<[<11+ M]R%.RJ/3^=8=!5ATDCRR-)*[.['+,QR2?4FFT44 %%==X?\ A=XR\2HLFF:' M<"!N1/<8A0CU!?&?PS7<6'[-/B6= VH:MIMIG^%"\I'Z ?K0!XS17OT7[+[E M?W_BQ0?1-/S^IDKSKXH?#I/AUJMC9IJ;:A]JA,N\P>5MPV,8W'- '#4444 ; M'A'_ )';0_\ L(V__HQ:^YZ^&/"/_([:'_V$;?\ ]&+7W/0)A1110(*^*OB= M_P E2\1_]?\ +_.OM6OBKXG?\E2\1_\ 7_+_ #H&CE:***!GH'P-_P"2SZ%_ MV\?^D\E?7]?('P-_Y+/H7_;Q_P"D\E?7] F%%%% @HHHH ^9_P!I@?\ %<:4 M?73@/_(CUXQ7M'[3'_([:3_V#O\ VH]>+T%!4EO_ ,?,7^^/YU'4EO\ \?,7 M^^/YT ??=%%%!(5\B_'B[^U?$SE;>.&(?]^E8_JQKZZKXX^,A)^+^O[NO MG)_Z+2@:.'HHHH&%%%% !1110 4444 %%%% !1110!]B?!20R?!S06;J$E7\ MIG']*[NN(^#=NUM\(- 1A@F%W_!I'8?SKMZ"0JCK>C67B'1+O2=4B\VTNXS' M(O0X]0>Q!P0?4"KU% 'Q-X\\#ZEX#\1R:;J"EX&):UN@N%N(_4>A'<=C[$$\ MS7W3XD\,:3XMT:33-=M%N;=^5)X:-NS*W4$>OX'@XKYG\>? S7_"TDEWHJ2: MSI8)(>%,S1#_ &T'7_>7CCD"@JYY=1110 5L^'_%VO\ A6X\WP_JMS9$G+(C M91C_ +2'*M^(K&HH ^A?!?[1\4K1V?C>S$#$A?M]HI*_5X^H^JY^@KW'3]1L M]5L(KW3;F*ZM9EW1S0N&5A]17P378?#_ .(^L> -6$MDYGT^1@;FQ=ODE'J/ M[K>C#\&W^&UK;KUN=1C5O]T([?S KURO%/VFL_\ "(Z-Z?;C_P"BS0!\UT444%!1 M110 4444 %%%% !1110 4444 >S_ +,\F/'&JQ_WM.+?E(G^-?3%?-G[,MNS M>+M9N!]V.Q6,_5I 1_Z":^DZ!,****!!1110 4444 %%%% !1110 5D>(O#= MCXEL/L]ZI5TR8IE^]&?;U'J*UZ*B<(U(N$U=,TIU)TIJ<'9H\-UOP%K>C2,1 M;->6XY$UNI;CW7J/Y>]"O#D; M972+<_[P)_F:Y/[!K_S+\?\ ([?]9,/;X'^'^9X'5BVL+N];;9VLUP?2*,M_ M*OH"#0-'MCFWTJSC/JL"@_GBM *, 8 ["MH9"_MS^Y&%3B5?8I_>_\ @'AM MC\/?$=\1_H/V=#_'<.%Q^'7]*Z?3OA&.&U;4L^L=LO\ [,W^%>ET5Z%+)L+3 MUDG+U_X!Y=;/L94TBU'T7^=S!TSP5H&E;6M]/CDD'_+2?]XWUYX'X 5O M# '0445ZM.E"FK022\CQJE:I5?-4DV_,****T,@HHHH \T^,'W=(^LW_ +)7 MF5>F_&#[ND?6;_V2O,J^$S;_ 'V?R_)'Z1DG^X4_G^;"BBBO+/8"O=_ NE'2 M?"%I%(,2S#SY!Z%N1^F!7C_A;1VUSQ):6>W,9??-[(.3_A^-?0(&!@=*^FR* MAK*L_1?J?(\1XG2&'7J_T_4****^I/C0HHHH **** "BBB@ HHHH K:C80:K MI=UI]XN^WNH7AE7U5@0?T-?"NKZ7<:)K5YI=ZNVXLYGAD';*G&1[<9%?>=?- M'[1GA!M-\36_B6UC_P!&U-1%.0.%G4<9_P!Y1^:M0-'B]%%% R:SNY["]@N[ M20Q3V\BR1.O564Y!_,5]L>!O%MMXU\(6>LVNU7D79<1*?]5*/O+_ %'L0>]? M$-=[\*?B3/\ #_Q ?M.^;1[PA;N%3G9Z2*/[P].XX]" &?85%06-]:ZG80WN MGSQW%M.@>*6,Y5U/<&IZ"0HHHH **** "BBB@ HHHH *^<_VG;0IKN@7F.); M:6('UV,#_P"SU]&5XW^TGI)N_ ^GZFBY:QO-K''1)%()_P"^E3\Z!H^9**** M!FQX1L+/5/&>CZ?JFXVEW>Q02[&VG:[A>O;K7TO_ ,,]^!?^>%]_X%'_ KY M4MYY+6YBN(&V2Q.'1AV(.0:^Z/#FN6WB7PW8:S8G,-Y"L@&?NG^)3[@Y!]Q0 M)G!?\,]^!?\ GA??^!1_PH_X9[\"_P#/"^_\"C_A7J%% CR__AGOP+_SPOO_ M */^%'_ SWX%_YX7W_ (%'_"O4** /+_\ AGOP+_SPOO\ P*/^%'_#/?@7 M_GA??^!1_P *]0HH \O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*] M0HH Q/"?A+2_!>BG2]#21+8RM,1(^\EB #S^ K;HHH *Q_%W_(DZY_V#KC_T M6U;%8_B[_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ M %?B?ZVO_M6@&>^T444$A7RQ^T#XN?6_'']BV\A-EI V%1T:8@%S^'"_@?6O MJ2:58+>2:3A(U+-] ,U\&ZE?2ZIJMW?W!+2W4SS.3W+,2?YT#15HHHH&6M-T MZ[U?4[?3].A:>ZN9!'%&O5F-?5GP\^#6B>#K6&ZU*&+4M9P&>>5=R0MUQ&IZ M8_O'GZ=*\R_9KT2&]\6ZGJ\R!VTZW5(LC[KRDC=]=J,/Q-?2U F%%%% @KYN M_:;_ .1IT3_KR?\ ]#KZ1KYM_::9#XKT50WSBR8E?0%S@_H?RH&CQ*BBB@9L M>$?^1VT/_L(V_P#Z,6ON>OACPC_R.VA_]A&W_P#1BU]ST"84444""OBKXG?\ ME2\1_P#7_+_.OM6OBKXG?\E2\1_]?\O\Z!HY6BBB@9Z!\#?^2SZ%_P!O'_I/ M)7U_7R!\#?\ DL^A?]O'_I/)7U_0)A1110(**** /FC]IC_D=M)_[!W_ +4> MO%Z]H_:8_P"1VTG_ +!W_M1Z\7H*"I+?_CYB_P!\?SJ.I+?_ (^8O]\?SH ^ M^Z***"0KY$^.UJ;;XPZJY&%G2"5?^_2J?U4U]=U\V_M,:2T/BG2-65,1W5H8 M&8#^*-B>??$@_*@:/$J***!G<_"+PQI'B_QT-)U]96MY+:1T$4FP[UP>OTW5 M[M_PSWX%_P">%]_X%'_"OG/X?^(%\+>/](UB9BL-O< 3$#.(V!1SC_=8U]MJ MRN@=&#*PR"#D$4"9YA_PSWX%_P">%]_X%'_"C_AGOP+_ ,\+[_P*/^%>H44" M/+_^&>_ O_/"^_\ H_X4?\ #/?@7_GA??\ @4?\*]0HH \O_P"&>_ O_/"^ M_P# H_X4?\,]^!?^>%]_X%'_ KU"B@#R_\ X9[\"_\ /"^_\"C_ (4?\,]^ M!?\ GA??^!1_PKU"B@"II.F6NBZ/::9IZ%+:TA6&)2$_&#/+JFF+%=OG-Y:GRI2?4D<,?]X&O'O$O[->K6F^;PMJ M<.H1@9%O';XVFN:?<6,_99D*[AZ@]"/<< M5G5]V:]X=TGQ/I;Z=KMC%>6S_P ,@Y0_WE/53[CFODCXH_#Z7X?>*!:([SZ= M=*9;.=QR5!Y5O]I?&,ND^+V\.7$A-EJH)C4GB M.=1D$?[R@@^IV^E?3U?!^A:@VD^(M.U&/[UI=13CZJX;^E?>% F%>0?M)6AF M^'-E<*,FWU)"3Z*8W'\\5Z_7$_SK7PHUN%!F2"'[4GMY1#G_QT,/QH$?& MU%%%!05]4V7P#\!W=A;W*0WQ6:)9 1='D$9]*^5J^Q/@UXD7Q)\,=-%]_P"!1_PH_P"&>_ O_/"^_P# H_X5 MZA10(\O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*]0HH \O\ ^&>_ M O\ SPOO_ H_X4?\,]^!?^>%]_X%'_"O4** /+_^&>_ O_/"^_\ H_X4?\ M#/?@7_GA??\ @4?\*]0HH Y?P;\/=!\"?;/^$?BF0WFSS3-+O)V[L8]/O&NH MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **R=;\3Z5X?B+:A?BLPH856D[OLOZT/4P65XC&.\5:/=_UJ:/Q5U:ROKJPM;.X6 M:6U,GG!#D(3MP,^O!KSZBBOB<5B'B:SJM6N?H6#PT<+0C1B[V_X<***V_"7A M]_$>O16N"+=#ON''9!V^IZ5E3IRJS4([LVJU848.I-Z(]!^%NA?8M'DU6=,3 M7AVQY[1@_P!3_(5WE,BB2"%(H4"1QJ%55& .@I]?H>&H1P]&-*/0_+<7B98 MJO*K+K^70****Z#E"BBB@ HHHH **** "BBB@ K%\7^&+3QAX5O=%O\ A+A/ MDDQDQ2#E7'T/Y\CO6U10!\'ZWHU[X>UR[TG58C#=VDACD7M[$>H(P0>X(-4* M^L/C)\+5\;:7_:FD1@:Y9QX09P+F,<^6??KM/O@]-K4/HE\IN-NZ2SF^2:/ZKW^HR/>OB:I(9I;>9)K>1XI4.Y'1BK* M?4$=* L??=%?)'A[X[>-M"1(IKV+5H%XVWZ%VQ_O@AB?20_M(>#)%'F6FKQ'N&MXS_)S3I/VCO!2? M=@U:3_=MD_JXH$>LT5XE>?M-:&BG^S]!U"=NPGD2(?H6KEM5_:6\07*LND:/ M86(/1I6:9A_Z"/TH'8^EB0 23@#J317Q+XA^(?BOQ2I36]:N9X3U@0B.,_5% MP#^(K['\-:J-<\*Z7JBG/VRTCF/L64$C\#D4 :=8WB_P_'XI\'ZGHLA ^V0, MB,W17'*-^# '\*V:*!'P+S?M!> FT MCQ /%.GQ?Z#J3!;D*/\ 5SXZ_1@,_4-ZBO&:"@KV/X&_%&+PS='PYX@N/+TN MZDW6\\A^6VD/4$]D;CGH#SW)KQRB@#[^!#*&4@@C(([TM?(_@+XU>(/!<,5A M/MU32H^%MIVPT0]$?J/HD45DVGBKP]?J&LM=TVX#=#%=QM_(U:;5]-49;4+4#WG7_ !H$7**Q;GQE MX8LE)N_$6E0X_OWL8/Y9KFM4^-O@/2U;_B="\D7_ )9VD+2$_0XV_K0!W]%> M!:]^TT@#Q^&=!8G^&>_DQC_MFG_Q5>N^!-?D\4>!-)UF?9YUU;@S>6,+Y@)5 ML#M\P/% '04444 %8_B[_D2=<_[!UQ_Z+:MBL?Q=_P B3KG_ &#KC_T6U 'P MQ11104%?07[+W^K\3_6U_P#:M?/M?07[+W^K\3_6U_\ :M ,]]HHHH),[Q$& M/A?5!'P_V.;;CUV&OA&OOYT62-D=0RL,,"."*^$=?TF70O$6H:5< B2SN'A. M>^UB ?Q'- T9]%%% SW?]F&_CCU3Q#I['][-##.@_P!E&=6_]&+7T17P[X-\ M57G@SQ59ZW8#>T#$21$X$L9X9#]1W['![5]@^$?'.A>-M-6ZT.]1Y-N9;5R! M-"?1EZ]>,]#V- F=#115#5]RA MK4^L:Y^;\26;\:['XK?&Y_$] MM+H?A826^EN=L]RWRR7(_N@?PKZ]S[#(/C= T%%%% S8\(_\CMH?_81M_P#T M8M?<]?"WA5MOC+16Z8OX#_Y$6ONF@3"BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5 M\3O^2I>(_P#K_E_G0-'*T444#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^ MWC_TGDKZ_H$PHHHH$%%%% 'S1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V# MO_:CUXO04%26_P#Q\Q?[X_G4=26__'S%_OC^= 'WW11102%>=_'#PP_B3X9W M;6T>^ZTUA>1 =2%!#C_O@L<=R!7HE(0&4JP!!&"#WH ^ :*[KXM>!)/ WC.: M*",C2[TM/8N!P%SS']5)Q]-I[UPM!05])_ OXI0ZEIMOX3UV=8[^V41V,KMC M[1&.D?\ O*.!ZCW'/S92JQ1@R$JP.00<$&@#[^HKYA\$?M!ZQH<,=CXG@;6+ M1!A;@/BX4>Y/#_C@^]>Q:)\:? NMJH76DL96ZQ7ZF';]6/R?^/4$G>45G0>( M=%NE#6VKV$RD9!CN48?H:DDUK2XO];J5FG^].H_K0!=HK N_'GA*Q4FZ\2Z4 MF.H^V1D_D#FN7U7X\^ ]-5O)U&;4)%_@M+=C_P"/-M7]: /1Z*^=]<_:8O)) M@GAS1(H(@PS+>/O=AGG"K@#CW-?0EO/'=6T4\)W1RH'0^H(R* )**** "BBO M&OV@_&>H>'+70[/0[Z:SO))VN6DA;!"HNT ^H)<\=#B@#V6BOG7PM^TI>6Z) M!XOTL7BC@W=EA)#[E#\I/T*_2O5]$^+?@C7@HM=?MH)6_P"65X3 P/I\^ ?P M)H [.BF0S17$2RV\B2QL,JZ,&!_$4^@ KPS]ITP_V%H ;;Y_VF79QSMVC=^N MW]*]7\1^-/#WA.U:;7=4M[8J,B'=NE?V5!R?RKY0^)WQ!G^(7B87@B:WL+93 M%:0,XCO(U&2N/N MR >JY/'<$]\5P5% 'WQ8WUKJ5C#>V$\=Q;3H'BEC;*NI[@U/7QAX'^)OB'P' M,5TJ=9K)VW265QEHV/OG+_C0 M(N45DW/BSP[9J3=Z_ID '7S+R-?YFN>U'XQ> ],4^;XBMYF[+;*TV?Q4$?K0 M!V]%>'Z[^TOI4"E/#FC7-X_3S+MA$@]P!N)_2NT^$GCNZ\?>%;F_U)(8KN"\ M>)XX%(55P&7&23T)'X&@#O**** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBJ.H:UINDH6U&]AM\#.UW&X_1>I_"IE*,5>3LBHPE-\ ML5=EZBN U7XKZ?!N32;62[<<"23Y$^OJ?TKA]7\ MI_$UY-?.,-2TB^9^7^9[>&R+%UM9+E7G_E_PQZUK7C+1="REW=B2N?$_5-0#0Z6HT^$\;E.Z0CZ]OPY]ZXBBOG\3F^(K:1?*O+_,^G MPF1X7#^])XD'<]@/8?XUA_#_P5_94: MZMJD>+V1?W43#_4J>Y_VB/R%=W7V&4Y>Z,?;5%[SV\E_F?"YWF:KR^KTG[JW M\W_D@HHHKWSYD**** "BBB@ HHHH **** "BBB@ HHHH *\N^*?P;LO&JR:K MHQCLM<5>6(Q'=8' ?T;L&_ YXQZC10!\':QHVHZ!J,]/^R>(+!+@*#YOD.0DZ#_T%OPP?:@JYXW15F_TZ]TN\:UU.TGM+A/O13QE&'X&J MU !1110 4444 %%%% !7UM\!-8_M7X46<3',FGS26K$]\'>O_CKJ/PKY)KZ0 M_9MM=8L=+UB+4-/NK>QF>*:VFFB*+(V&5MN>O 7IZ4 SV^BBB@DI:QI-EKVC MW6EZK L]I=1F.6,]Q['L0>0>Q -?('Q'^'&H_#_6VBF5Y],F8_9+S;PX_NMZ M./3OU%?9E4]6TBPUW2YM.U>UCN[2==LD4@R#_@1V(Y% SX,HKVGQY^SWJ>ER M27O@QFU*S.6-I(0)XO8'HX_(^QZUXW10,B MHHHH **** "BBB@ KZA_9OU4WGP]NK!WRUC>L%7^ZCJ&'_CV^OE_KTKZ!_9O MTG7=,OM6FO=,NK;3+VW1DGF38KNK<8!Y/#MR..* 9[[11102%8_B[_D2=<_[ M!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0!\,4444%!7T%^R]_J_$_UM?_ &K7S[7T M%^R]_J_$_P!;7_VK0#/?:***"0KYS_:*\#RVVJQ^+["(M;W(6&^VC_5R 81S M[$ +]5'K7T95;4=.M-7TVXT_4K=+BUN$,O:@#X)HKTCXF?!_5?! M%U+?:>DE_H9.4N%&7@']V0#IC^]T/'0G%>;T%!4D,TMO,LMO(\4BG*NC%2/H M14=% &\/'7BU8?*'BC61'C&W[?+C_P!"K'NKRYOIC->W$MQ*>KRN78_B:AHH M *N1Z3?3://JD=K(UC;RK#+/CY5=@2%^O!_R17Y(!R30 M!\G4444 7M$E$/B#3Y3T2ZB8_@X-?>-? 2L4<,O!4Y%??%K.+JSAN%^[+&KC MZ$9H$R6BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5\3O^2I>(_P#K_E_G0-'*T444 M#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^WC_TGDKZ_H$PHHHH$%%%% 'S M1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V#O_:CUXO04%26_P#Q\Q?[X_G4 M=26__'S%_OC^= 'WW11102%%%% '/>-_!NG>.?#4VDZF-A/SV\ZC+02 <,/7 MK@CN"?K7QYXL\)ZKX,UZ72M:@,1NQ_0]P:!GPW17I_CCX&>(_"\DESI,;ZUIHR1);I^] MC'^U&.>G<9'TKS$@@D$8(Z@T#$HHHH **** "BBB@ K[.^$^L'6_A7H5T[9D MCM_L[\\YB)CY^H4'\:^-(HI)I5BA1I)'.%1!DL?0"OJGX Z=KFD>!;FRU[3; MBQ3[69K;[0NUF1E&1M/(P1GD#[U F>IT444""OD?X[ZU_;'Q6O8T;=%I\:6B M?4#[N;1BUI<2P,>ICJ:FHVHP^:"'J%/H6/)'T'8UZQ1102%%%% ".BR1LDBAD8896&01Z5\L?&# MX1S^$;Z76=!@:709FW,J\FS8G[I_V.>#^![$_5%,EBCGA>&>-9(I%*NCKE6! MX((/44 ? =%?0WQ!_9Y2XDDU'P&R1.QW/ILSX4G_ *9N>G^ZW'N.E>#:KH^I M:%?O9:Q8SV5RG6.>,J?J,]1[C@T%%*BBB@ HHHH **** "O<_P!F351%KFN: M2S:WF*+\]K/'G M?[J01S[&HJ3Y(\UF_0TIT_:34;I7[[&U17E/_"U]6@=HKS2[82H<.OSH0?3! M)Q4J_%^<#YM'C)]IR/\ V6O,6;X/K+\&>L\CQW2-_FCU&BO+S\7YNVCQ_P#@ M0?\ XFH9/B[?G_5:9;+_ +SL?\*'F^#7VOP8+(\>_L?BO\SU:BO'IOBMKLG^ MJALHA[1L3^K5G3_$/Q-/D?VCY8](XD'ZXS64L[PJV3?R_P"";PX>QDMVE\_^ M >Y55N]4L+ $WM[;V^/^>LH7^=> W.OZO>9%UJ=W*#U5IFQ^6<50)))).2>I MKCGGR^Q#[V=U/AI_\O*GW(]NOOB-XO M4O O@$VCQ:MKD8\X8:"W8?ZL]F;W]!V^O30\'?#^'0V6^U,I<7_\"CE(?IZG MW_+UKM:^KRW*>1JK76O1?YGQ>:YU[1.AAGIU??T"BBBOHSY0**** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH I:IHNF:Y:_9]9T^UOX>R7,*R M >XR.#[BO/M8_9_\#ZF7:UM[K2Y&YS:3DKG_ '7W#'L,5Z=10!\_ZA^S"=Q; M2O$W'9+FTZ?\"5OZ5BS_ +-'BE6/V;5M(D7L9'E0G\D-?35% [GRY_PS=XS_ M .?S1O\ P(D_^-U/#^S3XK;_ %^JZ/&/]F25C_Z+%?3E% 7/GFT_9ANV(^W^ M)X8QW$-F7S^)85TVF?LW>%+5E?4K[4;]AU3>L2'\ ,_K7L%% 7.:T/X=>$?# MA#:3H-G%(,8ED3S9!CT9\D?@:Z6BB@04444 %%%% !6/K_A/0?%,(B\0:5;7 MP4;5>1/G0?[+CYE_ UL44 >.ZO\ LV^&+QR^DZA?Z:3_ $B9!] <-_X]7)W MG[,>K(Q^P>(K*<=C/ \6?R+5]'44#N?,)_9I\7[CMU/1".V9YA_[2J2+]FCQ M22//U?2$'?8\K?S05]-44!<^>K/]F&X+ ZAXGB0=Q!:%OU+#^5=1IG[.'A*T M*MJ-WJ.H,#RK2K&A_!1G]:]=HH YW0_ 'A7PVROHVA6=O*GW9C'OD'_ VRWZ MUT5%% @HHHH *KW]E%J6FW-C<[O)NH7ADVG!VL"#C\#5BB@#RK_AG7P1_>U/ M_P "1_\ $T?\,Z^"/[VI_P#@2/\ XFO5:* /*O\ AG7P1_>U/_P)'_Q-=7X) M^'>B> 5O1H)N3]M*&7[1*'^YNQC@8^\:ZJB@ HHHH **** $90ZE7 92,$$9 M!%>:^)_@/X/\0RO<6D$NCW+'):Q($9/O&00/^ [:]+HH ^;]0_9DUJ-C_96O MV%PO;[3$\)_\=WUFK^S;XR+8-]HP'K]HE_\ C=?45% [GSOIG[,=\[ ZSXBM MXE[K:0-(3^+%?Y5Z/X8^"?@WPS*EP+)]3ND.5FOV$FT^R !?T)]Z]!HH$ M P!T JIJVFV^LZ/>:9>AC;WD#P2[3@[64@X/8X-6Z* /*O^&=?!'][4_P#P M)'_Q-'_#.O@C^]J?_@2/_B:]5HH \J_X9U\$?WM3_P# D?\ Q->FV%E'IVFV MUC 6,5M"D*%SDE5 S[\58HH **** "O.-;^!GA'7]JT4 >? M^&?@OX6\)^(K76]*-\;NUW^7YLX9?F0HJ44 %%%% !1110 M4444 %_;]28')$]QL4_@@4_K7JM% C(T3PIH/AR/ M9H>D6ECQ@M%$ Q^K=3^)K7HHH **** "HKFV@O+=[>[ACGAD&'CE0,K#W!X- M2T4 >>:Y\#/ VMLTBZ:^FRL>7T^7RQ^"'*#\%KA-2_9B4DMI'B4@9XCNK7/' M^\K?TKWZB@#YCG_9I\5H3]GU31Y1_M22J?\ T6?YU"O[-OC(MAKW1E'J;B3_ M .-U]144#N?.%E^S)K+L/[1\06, [^1$\O\ /;77Z+^S?X7L7636+V^U1E/* M;A#&WU"_-_X]7L%% 7,W1?#VD>'+/[+H6G6]C#@9$,84MCNQZL?/;(9OSKZ( MHH'<^8G_ &:?%H;]WJFBLOJTTH/_ *+-+'^S3XL+?O=5T51_LRRG_P!IBOIR MB@+GSK:?LQ:@Y_T[Q+;0C_IC:M)_-EKI--_9I\.6Y5M4U;4+PCJL>R%3^&"? MUKV:B@+G):+\+?!>@,KZ?X?M#(O22X!G;/KER,+?ZQX M U[2&9OLIO(1_P M;7+_ )KU'Y8KY;$99B:&KC==T?8X7-\)B=%*S[/3_@', MT4K*58JP(8'!!'2DKS3U@HHHH **** "BBB@ HHI\,,MQ,L5O&\LC<*B*6)_ M 4]P;MJQE%==I/PVUW42K7,:V$1/+3GYL>RCG\\5Z)H7@+1=$"N8?MER.LUP M <'V7H/Y^]>IALJQ-=W:Y5W?^1XV*SG"X=63YGV7^>QYOX;\ ZGKVV>8&RLS M_P M95YF^';8QZ=#AV'[R9SEW^I_H.*U:*^IPF74<+JE> M7=_UH?&X[-,1C':3M'LOU[A1117HGE!1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4-1T+2]67&H MV,%P?[S)\P_X$.:Y>^^%>B7&39RW-FW8*^]?R//ZUV]%57/PBO5S]CU2WE]/-C9/Y9K,F^&'B.)B$CMIAZI-C/YXKVBBN M"63826R:^?\ G<].&?XV.[3]5_E8\.?X=>*%/&FAAZK/'_\ %4Y/AQXG?KIZ MI_O3Q_T->WT5E_8>&[R^]?Y&O^L>+M\,?N?^9XS#\+O$,K8D^RPCU>;/\@:U MK;X0S'!O-6C7U$4);]21_*O4**UADV$CNF_5_P"5C&>?8Z6S2]%_G,/\ GK)A?R7']:Z:QTJPTR,II]G#; ]?+0 GZGO5NBO0I8:C1_AQ M2/,K8O$5_P"+-OY_H%%%%=!RA1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 3!1110 4444 %%%% !1110!__V0$! end GRAPHIC 17 celogoa.jpg GRAPHIC begin 644 celogoa.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X1$817AI9@ 34T *@ @ ! $[ ( M : (2H=I 0 ! (9)R= $ T 0W.H< < @, /@ M FMC.60G/SX-"CQX.GAM<&UE=&$@>&UL M;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR9&8Z4D1&('AM;&YS.G)D9CTB:'1T M<#HO+W=W=RYW,RYO&UL;G,Z#IX;7!M971A/@T*(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" \/WAP M86-K970@96YD/2=W)S\^_]L 0P '!04&!00'!@4&" <'" H1"PH)"0H5#Q , M$1@5&AD8%1@7&QXG(1L=)1T7&"(N(B4H*2LL*QH@+S,O*C(G*BLJ_]L 0P$' M" @*"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\ $0@! 3O P$B (1 0,1 ?_$ !\ $% M 0$! 0$! ! @,$!08'" D*"__$ +40 (! P,"! ,%!00$ ! M?0$" P $$042(3%!!A-180'EZ M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V]_CY^O_$ !\! ,! 0$! 0$! 0$ M ! @,$!08'" D*"__$ +41 (! @0$ P0'!00$ $"=P ! @,1! 4A M,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB) MBI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9 MVN+CY.7FY^CIZO+S]/7V]_CY^O_: P# 0 "$0,1 #\ ^D:*** "BBB@ HHH MH **** "BBB@ HHJ&ZO+:Q@,U[<1V\8ZO(X4?K2;25V-)MV1-17&:E\4-#LF M*6@FOG'>-=J_F?Z UR]_\6-5GR-/M+>U4]"V9&'X\#]*\ZKFF$I:.5WY:_\ M /6HY/C:VJA9>>G_ ?P/6Z*\'N?'7B2Z_UFJS(/2(+'_P"@@5ERZMJ,[$S: MA=2$]2TS'^M>?+/J2^&#?X?YGI0X;K/XYI>EW_D?1E%?-3RR2??D9OJQ-"32 MQ_/?$EHPVZF\J]UF57S^)&?UK:&?47\4&OQ_R,)\-UU\$T_6Z_P S MW6BO*+'XMW\; :CI]O.O']094EFDLI&XQ<+A<_[PR/S MQ7H4)9()$EC;E71@0?Q%/KT=SRM MM&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1102%4EC@#DD]J "J&K:WI^B6WGZGT\/A)Y1PURW*+_NC^+Z]/K7F-[?W6I73W-].\\SGEW.?_U#VKPL M9G%.C>%'WG^'_!/I,!D-6O:=?W8_B_\ +^M#NM>^*EU<;H=!@^RQ]//E 9S] M!T'Z_A7"WE_=ZC.9KZYEN)#_ !2.6-5Z*^7KXNMB'>I*_P"7W'V&&P6'PJM2 MC;SZ_>%%%%2V[9R0C<-]1T M/XUZ!H?Q7R4AU^V YP;F =/945V8?&U\,_P!W+3MT.'%9?AL6OWL= M>_7[SZ0LK^UU*U6YL+B.XA;H\;9'T]C[58KYXT34-5TV^$VBO,)N 5B4L''H M1W%>T^&-=OM8M<:II-S87"C)9XRL;_[N>1]#^=?6X',HXKW9*TOP/B,QRF6# M]Z,KQ_'[O\C>HHHKUCQ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH ***KWU];:;8RW=[*(H(EW,Q_P ]?:DVDKL<8N3LMQ;V M]MM/LY+J]F6&&,99V. *\<\7>.[O7Y'M;,M;:<#@(#AI?=O;VJEXK\6W?B:] M.XM%91M^Y@ST]SZG^5<]7QV8YI*NW3I:1_/_ (!]YE63QPZ56NKS_+_@A111 M7A'T84444 %%%% !1110 445MZ7X/UW6-K6EA(L3?\M91L7'KD]?PS6E.G.H M^6"N_(SJ5:=*/-4DDO,Q**].TSX2(-KZQJ)8_P 45LN!_P!]'_"NOTWP=H.E M8-KIT32#GS)AYC9]'7S_"4](7D_+;\3Q*PT#5=4 MQ_9^GW$ZG^-4.W_OH\5T]A\*];N<->2V]FIZAFWL/P''ZU[" , =!17KT MLCH1_B-O\/Z^\\2MQ%B9Z4XJ/XO^OD<#9?";2XL&^OKFY(ZA (U/\S^M=#9^ M"_#MC@PZ5 Q'>4&3_P!"S6[17I4\#AJ7PP7Y_F>15S'%UOCJ/\OR&10Q6\8C M@C2)!T5% _ 4^BBNS8XFV]6%%%% @HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBFR2)%&TDKJB("S,QP% ZDF@!U M%9/_ E7A[_H/:9_X&1_XT?\)5X>_P"@]IG_ (&1_P"- &M163_PE7A[_H/: M9_X&1_XU;L=5T[4]_P#9M_:WGEXW_9YEDVYSC.#QG!_*@"W1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 -D=8HVDD8(B@LS,< =Z\3\;^+I?$6HM!;N M5TZ!OW2CCS#_ 'S_ $]!71_$WQ45)T&P?' -TZG\D_J?P]Z\RKY/.,>YR^KT MWHM_\C[;(LM4(K$U5J]O)=_G^04445\X?5!1110 4444 %%7]*T34=;N/)TR MUDG8?>8#"K]6/ KT;0_A3:PA9==N#2U[+?\ KU/-+#3;W5+@0:?;27$A_AC7./<^@]S7<:/\*+R?;)K5 MTMJG4PQ?._T)Z#]:]/L[&UT^W$%C;QV\2]$C4 5/7T>'R2C#6J^9__YGI^&*VJ**]RG3A37+!61\]4JU M*LN:HVWYA1115F84444 %%%9FI>)-'T@'^T-0@B8?P;MS?\ ?(R:F4XP5Y.R M+A3G4?+!7?D:=%1A&I_F?Y5S%_P#$_7[O(MF@LU_Z M91[F_-LUYE7-\)3VE?T_JQZ]'(\;5U<>5>?]7/9JSKOQ!I%@2+S4K6)A_"TH MW?EUKP:]UO5-1S]NU"YG!_A>4D?ETJC7F5,^_P"?G)&*Z*OF>O9?AYXK.MZ<;"]?-[:*/F8\RI MT!^HX!_ ]ZZ*/VE;J5G@\(Z6L"9P+J^^9S[A <#\2:\GUWQWXH\2 MY&M:Y>7,9ZP^9LC_ .^%POZ4#L?86J>./"^BEAJFOZ?;NIP8VN%+C_@(.?TK MF+OX[?#^U.%UB2X/I#:RG]2H%?(E% 6/JF3]HOP2C$*FJ2>ZVR_U84)^T7X) M;[R:HG^];+_1J^5J*!V/KBU^/7@"X($FJS6V?^>MI+_[*IKHM-^(W@[5F"6/ MB33G=CA4><1LWT5L$U\2T4"L??R.LB!XV#*PR&4Y!%+7PIH_B76_#TOF:)JM MY8GN()F56^HZ'\:]^^"WQ4\3^,=>DT;7(K>[BAMFF:]5/+D7! ('RG)/8#O MUH"Q[;1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q=_R).N?] M@ZX_]%M6Q6/XN_Y$G7/^P=_U?B?ZVO_ +5KY]KZ M"_9>_P!7XG^MK_[5H!GOM%%%!(4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^*-> MC\.Z#->MAI?N0H?XG/3\NOT%;%>-_$O7O[3U_P"P0/FWLGE>#^MXE0?PK5^G_!./N)Y;JXDGN',DLC%W8]23U-1T45\ M"VV[L_3$DE9!1112&%%%=5X6\!W_ (A*W$^;2P_YZLOS/_NCO]>GUK:C1J5Y M\E-79A7Q%+#P=2J[(YRTL[F_NDMK*%YYG.%1!DFO2/#OPLC54N/$4A9^OV6) ML ?[S=_H/SKM]&T#3M M?)TVW6/(P\AY=_J>]:5?58/)J=+WJWO/MT_X)\7C ML^JU;PP_NKOU_P" 0VEG;6%LMO901P0KT2-< 5-117O))*R/FVVW=A1113$% M%%% !16%KOC'1] #)=W(DN!TMX?F?\?3\:\ZUOXGZM?EH],5=/@/ *_-(1_O M=OP'XUY^)S'#X?23N^R/4PF58K%:QC9=WHO^">J:GK6FZ/%OU*\BMP>BLWS- M]!U-<1J_Q8MXBT>BV;3GM-/\J_@HY/Z5YA-/+II37*OO9]3AN'\/3UJOF?W+^OF;VJ>-=>U?(N+]XXS_RR@_=K^G)_$FL M&BBO&J59U7S3;;\SWJ=&G2CRTXI+R"BBBLS4**** "KNCZI/HNK6]_:']Y"V M=N>''=3[$<52HJHR<9*4=T3*,9Q<9*Z9]'Z;J$&JZ;!?6C;H9T#KGJ/8^X/% M6:\R^%.O8>?1+AN#F:WSZ_Q+_7\Z]-K]"P>(6)H1J=>OJ?E^/PKPF(E2>W3T M"BBBNLX0HHHH **** "BBB@ HHHH **** "FNZ11M)(RHB@LS,< =232331 M6\#S7$BQ11J6=W.%4#J2>PKY>^+OQBG\5W$VB>'I7@T1&VR2J<->$=SZ)Z#O MU/H #K_B-^T#'8R3:7X&,=Q,N5DU)QN1#_TS4\-_O'CT!KY_U'4KW5[^6]U. MZEN[J8[GEFLWW[.7C.VR;6;3+P8R!%<,K'_ +Z4#]:Y M#6?AEXST%&?4O#MZL:\M)"@F11ZED) _&@#E:^D?V:-$%OXI?%K4S%I]EIL;?ZYS+(!Z+P/U)_*O M*Z^-SNOSUU36T?S?](^]X?P_L\,ZKWD_P7],****\(^C"GQ123S+%"C22.=J MHHR6/H!4VGZ?=:I>QVEA"TTTAP%4?J?0>]>S>$/!-KXX"SZBP^:7J(_9 M?\>]>A@L#4Q9F&94L%#WM9/9?UT,3PG\-8K=8[WQ"JRS<,EKU5/\ M>]3[=/K7H8 50J@ 8 ':EHK[;#X6EAH*\M\0_$ M?5-7W0Z>3I]L>,1M^\;ZMV^@_6N3N;J>\N7N+N9YIG.6=VR3^-15\CB\VK5_ M=A[L?Q^\^XP.28?#6E/WI>>WR0I))))R3U-)117CGNA1110 4444 %%%% !1 M110 4444 7-(U&32-8M;^'[UO('Q_>'>.ZMHKB!MT4J!T;U!& M0:^:Z]K^&NI_;_!\4+',EF[0MD]1U7]#C\*^CR*O:I*B^NO]?UT/E>(\.I4H MUUNM'Z/_ (/YG6T445]8?$A1110 4444 %%%% !1110 445Q'Q9\;?\ "$>! M[BZMW U&Z/V>S'<.1R__ $9/UP.] 'E7QZ^)KWEY+X0T.?%M"<:A*A_UC@_ MZL'T'?U/':O#*<[O+(TDC,[L2S,QR23U)--H*"BBM?POX9U'Q=X@M]'T>+S) MYCRQ^[&HZNQ[ ?\ UNIH AT/0=3\2:M%INB6I/0 >IXKZ&\$? ML\:5ID<5YXPE_M.\X8VL9*P1GT)ZO^@]C7H'@7P#I'@+15L],C$ERX'VF\=1 MYD[>_HOHO;W.2>HH%<@LK&TTZT2UT^VAM;>,82*&,(J_0#BIZ**!!1110 44 M44 _F7]]+UQ_LCV'ZG\*ZL!@98NI;:*W9R9EF,,#2OO)[+]?0E\)^%; M;PSI^Q<2W_O[;3+&2[OI5A@C&69OY>Y]J6^OK?3;&6[O9!%!$NYV/:O#?%?BN[\37 MY9R8K2,_N8 >![GU->;C\?#"0[R>R/6RW+9XZ?:*W?Z+S+GBSQU>^(9'MK;= M;:>#Q$#\TGNQ_IT^MEAX*G25D%%%%8FX4444 % M%%% !1110 4444 %%%% !1110 5Z%\)+_P O5KZQ8\30B5?JIQ_)OTKSVNC\ M 71M?&^GG.%D9HF]]RD#]<5VX"I[/%0EY_GH>?F5+VN#J1\K_=J>ZT445^A' MY>%%%% !1110 4444 %%%% !7R9\=_%;>(OB)/8POFST@&VC Z&3_EHWUW?+ M_P !%?3_ (FUE/#WA;4M7DP19VSS '^)@.!^)P*^&)II+BXDFGTMC]KN01P43!P?8L5'XU]DT"84444""BBB@ HHHH **** "BBB M@ HHHH ***Y7Q]X_TKP!H?VW43YUS+E;6S1L/,W]%'=NWN2!0!T&HZG8Z/82 M7NJ7<-I:Q#+RS.%4?B:\8\6?M(Z?:,]OX1T]K^0$C[5=92+ZA1\S#Z[:\5\9 M>.]<\ZE>7!/4S3L_\ ,U1HH&2I<31MN2:16SG(8@UK:=XR M\2Z2P.FZ_J5N!_"ET^T_5&_'2B+3[AK74,9:QN<+)[E3T8?0Y]0*^-*?#-);S)-!(\4L;!D M=&(92.A!'0T!8^_**\5^#OQF.OR0^'/%DRC4L;;6\;@7/^PWH_H?XOK][VJ@ MD**** "L?Q=_R).N?]@ZX_\ 1;5L5C^+O^1)US_L'7'_ *+:@#X8HHHH*"OH M+]E[_5^)_K:_^U:^?:^@OV7O]7XG^MK_ .U: 9[[11102%%%-D4O&RJY0L" MR]5]^: ,[7/$FC>&K/[5KVI6]C$<[3,^"^.RKU8^P!KR;Q#^TIH]IOB\-Z7< M:@XX$UPWDQ_4#EC^.*\#\4RZN_B>_B\17DUWJ%O.\$TDTA<[D8J0">W'&.*R M*!V/3=6^/_CG4F(M;JUTQ#_#:VX)_-]Q_+%^/?%NHY^V>)=5D4]4^UN%_ M[Y!Q7/T4#+4NIW\[;I[VXD;U>5B?U-$>I7T)S#>W$9SG*RL/ZU5HH Z+3OB! MXNTDC[!XDU*-1T1KEG3_ +Y8D?I7>^'_ -HWQ1I\B)KUM:ZO!_$VWR)?P9?E M_P#':\@HH ^SO!7Q1\->.5$6F71@O]N6L;D!9!ZD=F'T/UQ78U\!PS26\R30 M2/%+&P9'1B&4CH01T-?2_P &OC"WB4Q^'/$\H_M95/V:Z. +H 9VMZ.!W[@> MO4%8]EHHHH$%%%% !7R]JGQ_\;66KWEK&=/V03O&N;8YP&(]?:OJ&OAGQA%Y M/CG78O[FHW"_E(U T=W_ ,-$>./73O\ P%/_ ,51_P -$>./73O_ %/_P 5 M7E=% S[;^'VOW/BCP#I6LWWE_:;J(F7RQA=P8J<#\*W;V^M=-LI;O4+B.VMX MEW22RL%51[DUYG\'-?LM*^!-K?ZK.MO::>UP)9&[#S6;\3\V ._2O#/B1\4- M5\?:DR,[VND1/FWLE/!]&?\ O-^@[>X(]2\8_M'VMK)):>#+$7C#C[;= K'G M_93@M]21]#7DFM?%7QMKLC&[\07<2'_EE:/Y"8],)C/XYKCZ*!EB>^N[IR]S M=33,3DM)(6)_.G6NIW]DP:ROKFW8'(,4S(0?P-5:* .]T'XT^.=!==NL/J$0 M/,6H#S@WU8_/^3"O;_ ?QVT'Q5+%8:P@T;4W(51(^89F]%?C!/HWJ "37RG1 M0!]_T5\^?!/XOS?:;?PIXJN#(DA$=A>RMRI[1.3U!Z*>H/'0C'T'02%%%% ! M1110 445YM\4OBY9>!+(>)_VEIW9H?".DK&N<"ZO_ )F/N$4X'XD_2O%M M7+_QR'A1Z*.BCV'%9U ['7:K\5/&^LL3=^)+Y%/!2V?R M%QZ83%Z^$_'.@>-;'[1H%\LSJH,MN_RRQ?[R_U&1Z&OB"KFE:M?Z'J<.H:1 M=RVEW"=%><_"CXJVWCW3C9W_EV^N6R9FB'"SK_ ,]$ M'\QV^AKT:@D**** "BBB@ KAO&_Q;\->!R]O=3F]U%1_QY6Q!9?]X]%_'GVK M@_C+\99M,N+CPSX3GV7*_)>7R'F(]T0]F]3VZ#FOG=W:21GD8L['+,QR2?6@ M=CU7Q#^T-XNU61UT?[/HUN>%$2"63'NS@C\@*X+4/&/B7579M1U[4;C=U5[I M]OY9P*Q:*!DCSRR-N>5V/J6)JQ;ZOJ5F0;34+J @Y!BF9A>'/VEM2@=(O%.D0W<6<-/9'RY /7:258 M_0K7AM% 'W#X1\::+XWTMK[0+AI4C;9+'(A1XFZX(_PR*WJ\[^!FA?V)\*K! MW7;+J#->/QV;A?\ QQ5/XUZ)02%%%% !1165XD\2:9X4T.;5=:N!!;1#ZL[= ME4=R?2@#3EEC@B>69UCC0%F=S@*!U)/:O)?%W[0OA[1))+7P_"^M72Y'F*VR M!3_O'EOP&/>O&?B'\6-;\=W3P>8]CI ;]W8QMPPSP9#_ !']!V'>N"H'8]%U MOXZ>.=99Q%J2:;"W_+*QB"8_X$^)-)M=TUP^GZUJ%JPZ&&Z=/Y&LNB@#TK0/CSXVT9U%W>1 M:M .L=Y&"?P=<-GZDU[7X)^.'AKQ:\=I>,=&U%\ 0W3CRY#Z))P#]#@GL#7R M510%C[_HKYK^$GQLN-)N(=!\8733:YCW6-H0\F>CM_"O\ 4^P]Z_.:-&5>HJ<-V?JN M(KPP]*56>R.N^'/@_P#L^W76-2C_ -*E7,",/]4A'7ZG]!]:[ZBBOT'#8>&& MI*G _,,7BJF*JNK4Z_AY!11170W3?#MF#Q)-/*1_NA /_0S7SO0 M4@HHHH ^A?V8](46>N:RXR[21VD9] !O;\]R?E7O5>9?L_6@MOA):2@8-U);'PCX;NM9 MU1L0VZ\(#\TCG[J#W)_QKXQ\5^*=2\8^(;C5]7EWS2G"(/NQ)V11V _Q/4UZ M%\?O&[:]XN_L&SES8:22K@'B2?\ B/\ P'[OUW>M>24%(***[CX6_#N?X@>) M/)E+PZ9:X>\F4*O!D M$EY!1\MM-C.!Z*P!('8@CI@5Y)0,BBB@D*Q_%W_(DZY_V#KC_T6U;%8_B[ M_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ %?B?ZVO M_M6@&>^T444$A1110!\H?M >'_['^)DE[$FV#585N >V\?*X_-0W_ J\Q1'E MD5(U9W8X55&23]*^Q_B/\-+/XBII2W=Y):&QG9F>-0S/&P^91GH257GG&#P: MT_#'@'PUX0A5=#TJ&&4#FY<;YF^KGG\!@>U [GRUHOP?\<:X ]OH4UM$?^6E MZ1 /R;#'\!7:67[,VORJ#J&MZ=;D]1$KRX_,+7TI10%SYZ;]F"YV?+XJB+>A ML2!^>^L'6?V)5_ZB MMR?SE8U]NU\4?$L;?BAXC&,?\3&8_P#CQH&CEZ***!FU)XIU&3P9!X8#A-/B MNGNF"DYD=@ WL,$CW/TK%HKJ_ /P_U3Q_KGV+3_ -S;18:ZO'7*0K_5CV7O M[#)H Y4 D@ 9)Z 5KP>$?$EU");7P]JLT9&0\=E(P(^H6OKSP?\ #;PUX*MT M&E6"/=@?/>S@/,Q^I^Z/88%=70*Y\$7FGWFG2"/4+2>U(H3^!%5Z^]K M_3K+5;-[34[2&[MI/O13QAU/X&OG'XP?!B+PS9R>(?"HD.FJP^TV9)8VP/1E M)Y*9X(/(SW'0"YXO1110,4$@@@X(Z$5]B?"'QJ?&O@2"XNY-^HV9^S7>>K,! MP_\ P)<'ZY]*^.J]<_9T\0'3?B!+I#L?)U:W*@9X\R,%U/\ WSO'XT SZCHH MHH)"BBFNZQ1M)(P5%!9F)P !WH XOXI?$&#P!X7:>/;)J=WF.RA/]['+G_97 M(/N<#O7Q]?7UUJ=_/>W\[W%S<.9)99#EG8]2:Z7XE^,I?&_C:[U'P_!+X4Q^*9O^$A\01;M*MY-L$##BZ<=<_[ _4\ M=C0!RO@WX2^*?&J+<6-HMI8-TO+LE$;_ '1@EOJ!CWKTVR_9AA$(.H^)I#)C ME8+0 #\2W/Y"O>41(HUCC5410%55& .@ IU KGS]J/[,+",MI/B8,_:.YM< M _\ E8X_*O*/%_P]\1^!YU77;$K [;8[N%M\,A]F'0^S 'VK[8JKJ6FV>L: M=-8:G;1W5K.NR2*1H(/>OAZO9_P!G+Q8VG>*KCPW;Q5I.D*W[JUM#<$?[-T$^D62Q66[:;RY;RXL^W4M_P$&J/@'P]'XJ\>Z3HTY(AN9_ MWN.I1078#ZJI%?;%K;065I%:VD20P0H$CC085% P !0!\\0_LQ:FT6;CQ):1 MR?W8[9F'YDC^55+[]F?Q%$I.G:SIMSC^&4/$3^C"OI>B@5SXO\0?"OQGX:5I M-1T.X>!>3/:XF0#U)3.T?[V*YS2--EUG6[+3+;_6WEPD"<="S ?UK[SKGKGP M'X:NO$UIX@;28(]4M9#(EQ"-A1@SMAMAMXE MBC'HJC _05/110(**** (;N[@L+*:[O)5AMX(S)+(YP$4#))_"OCOXG?$.Z\ M?^)&G!:+3+8E+.W)Z+_?/^TW7VZ=J]4_:-\:FVL[;PE82X>X N+W:>B _(A^ MI!)'LOK7SM0-!116]X-\)WWC7Q/;:/IPVM(=TLI&5AC'WG/T_4D"@95T#PWK M'BC4A8Z#837LYY81CA!ZLQX4>Y->OZ-^S-J4\2OKVO6]HQ&3%:PF8CV+$J,_ MG7N7A3PEI/@W0X],T2W$4:@&20\O,W=F/<_H.@P*VJ!7/"9OV8;%H\6_B>X1 M_5[16'Y!A_.N%\5? 7Q9X=@>ZL5BUJU098VF?-4>IC/)_P" YKZPHH"Y\ D$ M$@C!'4&DKZ%^/?PQ@-G+XPT&W$N<]B3\]4#"OI M+]G[XAOJNGMX3U>;==64>ZQ=CS)".J?5>,?[)_V:^;:T_#FN7/AKQ)8:S8DB M:SF60#.-P_B4^Q&0?8T ?=E%5M.O[?5-,M;^S??;W42S1-ZJPR/T-6:"0JCK MB>9X?U%,9W6LHQ_P U>J.XA%Q:RPMTD0H?Q&*F:YHM%TY??"W0/.U.XU: MY7Y;0F*('_GH1R?P'_H5>JUX&2X7DINO+=[>A]+Q!C74JK#Q>D=_7_@!1117 MT)\N%%%% !1110 5X3X[U0ZKXOO BMV\B/'HO!_7)KV^^N/LFG7-S_ ,\8 MFD_($U\WLQ=RSG+,+N@HHHJ2@JSIJ>;JMI'_?F1?S85 M6K4\-0&Y\4Z9$/XKJ//T# G]!6E-?.K>'D[+!.?S9/\*\)KWG]I^,C4/#DO9HKA1^!C M_P :\&H*"BBB@#[#^"8 ^#>@XQ]R8\?]=I*[RO._@1<"?X.Z2@ZPO/&?^_SM M_)A7HE!(4444 %%%% !1110 4444 %%%% !6-XNUY/#'@_5-9DP?L=NSH#_$ M_1!^+$#\:V:\?_:0UZ("Q_\ 'ME 'S)//+=7$D]P[22R MN7=V/+,3DD_C4=%%!05]F?"CPFGA'X>V%HR;;NY075T< M%X;.X\7:3%JDT<%DUY$+B25@%6/>-Q)/3C-?8G_"R/!?_0U:1_X&)_C0)G34 M5S/_ LCP7_T-6D?^!B?XT?\+(\%_P#0U:1_X&)_C0(Z:BN9_P"%D>"_^AJT MC_P,3_&C_A9'@O\ Z&K2/_ Q/\: )/'_ (?3Q1X"U?2F3?)+;LT'M*OS)_X\ M!^&:^(J^V?\ A9'@O_H:M(_\#$_QKXPU184U>\6U96A6=Q&RG(*[CC!],4#1 M5ILB_*__ (\K5T%>6?L[W[7?PK$# M'/V.^FA4>@.V3^;FO4Z"0K'\7?\ (DZY_P!@ZX_]%M6Q6/XN_P"1)US_ +!U MQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_P#M6OGVOH+]E[_5^)_K:_\ M6@&>^T4 M44$A1110 4444 %%<_XA\=^&/"H(UW6;:VE SY&[?*?^ +EOTKS/6?VE]$ML MKH>C7E\P.-]PZP*?<8W$_D* /;**^8M0_:3\57#$:?IVF6:=MR/(P_$L!^E8 M%S\=?B#<9VZVL()Z16D(Q^)4F@=CZ\KY'^/-A'9?%S4'B4*+J*&<@# R4"D_ MB5S]366_Q=\>2$EO$UV,_P!T*O\ (5SFM:[J?B+4/MVMWLM[<[ GFRG)VCH/ MUH SZ***!G8?"C4#IGQ7\/3@XWWBP?\ ?P&/_P!GK[/KX7\)R-%XTT21/O)J M$#+CU$BU]T4"84444""OBKXG?\E2\1_]?\O\Z^U:^*OB=_R5+Q'_ -?\O\Z! MHY6BBB@9);P2W5S%;VZ&2:5PD:+U9B< ?G7VK\/_ ?;^"/!UGI,*KYX4274 MH_Y:3$?,?H.@]@*^6_A!8IJ/Q,M4T5R2+.X9(V;JT9Y0G MZJ0:Q*]6_:*L5M/BD)E'-Y813,?4@LG\D%>4T%!71> -0.E?$70+P' 2_A#G M_99@K?H37.U8L)3!J5M*ND;;_*/]: /#Z* M**"B]HNE7&NZ[9:59C,]Y.D*<9P6.,GV'6ON31M)M="T6STO3TV6UI$L48]@ M.I]SU-?)GP5GTFR^)EKJ&O7UO96]G#+*DEQ($4N1M R>_P Q/X5]-?\ "R/! M?_0U:1_X&)_C0)G345S/_"R/!?\ T-6D?^!B?XT?\+(\%_\ 0U:1_P"!B?XT M".FHKF?^%D>"_P#H:M(_\#$_QH_X61X+_P"AJTC_ ,#$_P : .1_:$T"/5/A MJVI!1Y^E3I*K8YV.0C+]/F4_\!KY4KZX\?\ CCP?JOP[UZRM_$FESS2V$HBB MCND9G<*2H SR<@5\CT%(*TO#VKR:#XET[5H2=]EAIU#?M+^&Y)K72?$=O%N6#=:7+#JH)W1GZ9W MCZD>M T?/-%%% SH_A_XBB\*>/\ 2-9N03!;3XFP,D1LI1B!W(5B<>U?:]K= M07MI%=600>XKX%KM_ OQ6\1> R(+&5;O32Q9K&XY0$]2I MZH?IQZ@T ?9%%>9^%OCQX0\0A(K^X;1+L\&.]($9/M(/EQ[MM^E>DPSQ7,*3 M6\J2Q.,J\;!E8>H(ZT$CZ*** "BBB@ ILLJ0PO+*P2-%+,QZ #DFG5QOQ:U< MZ+\*],/$$OBGQAJ6LS$G[5.S(#_"@X1?P M4 5BT44%!7U'^SSX372/!+ZY<1XN]6?*D]5A4D*/Q.X^XV^E?+E?96A>-?!& MC>'=/TR+Q1HX6SMHX!B\3^%0/7VH$SM:*YG_ (61X+_Z&K2/_ Q/\:/^%D>" M_P#H:M(_\#$_QH$=-17,_P#"R/!?_0U:1_X&)_C1_P +(\%_]#5I'_@8G^- M&_>V=OJ-A<65[$LMO<1M%+&W1U88(_(U\*ZUIDFBZ]?Z9/S)9W$D#''4JQ&? MTK[+_P"%D>"_^AJTC_P,3_&OE3XJ75C>_%#6[K2KJ&[M)IED2:!PR/E%)P1[ MY% T4YDTVX>UR>I7AU_1\?\!KTVOG[]F&^(D\0Z M>S<$03HOI]]6/ZK^5?0-!(4444 4]+TR#2;+[-:CY/,>0D]268D_SQ^%7*** MF,5%**V*E)SDY2W844451(4444 %%%% %#7HFG\.:E%&,M):2JH]24(KYVKZ M8KY_\4Z%)X?\07%F580[M\#'^)#TY[XZ'W%?,Y]2DU"JMMCZ_ANM%.=%[NS7 MZF/1117RQ]B%%%% !1110 4444 %%%:FE^'-7UEA_9UA-*A/^L*[4'_ CQ5P MA*;Y8J[(G4A3CS3=EYF73D1I'"1J79C@*HR2:](TCX2L=LFMWP4=X;89/XL? M\/QKN=(\-:3H:XTZRCC?O*PW.?\ @1YKV,/DV(J:U/=7X_<>#B<_PM+2G[S_ M ^\\LT7X;:UJF)+Q1IT![S#+GZ+_CBO1]!\$Z/H&V2"#S[D?\O$_P S ^PZ M#\*Z&BOHL-EN'P^J5WW9\MB\VQ6*]V3M'LOZU/-/C!]W2/K-_P"R5YE7IOQ@ M^[I'UF_]DKS*OELV_P!]G\OR1]EDG^X4_G^;"BBBO+/8"NJ^'%M]H\;VC=H4 M>0_]\D#]2*Y6O2_A'I^7U#46'0+ A_\ 'F_]EKORZG[3%07G?[M3S'_M.61D\-Z'?8XANY(<_ M[Z9_]IU\X5]=_'726U7X3:BT:[I+)X[I1CLK88_@K,:^1*"D%%%% 'TS^S3J M8N/!.IZ<6S):7WF8]$D08_5&KV:OE3]GSQ$-'^(_]G32;8-6@:#!( \U?F0G M\F4>[5]5T"84444""BBB@ HHHH **** "BBB@ KYU_:=NV?6= L\_+%;RRX] MV91_[)7T57S/^TP3_P )SI0[?V<,?]_'H&CQBBBB@84444 %%%% !1110 44 M44 %%%% 'TI^S+(3X0UB/LM\&_.,?X5[77C'[,\17P3JTW9]1VC\(T/_ +-7 ML] F%8_B[_D2=<_[!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0(^&****"@KZ"_9>_ MU?B?ZVO_ +5KY]KZ"_9>_P!7XG^MK_[5H!GOM%%%!(445A^,?%=AX+\,W.L: MFV4B&(H@<--(?NH/K^@R>U !XK\8:-X,TAM0UVZ$*=(XEYDF;^ZJ]S^@[U\V M^-OCOXD\3-);:.[:+IQXV6[?OG'^U)U'T7'XUQ7B[Q=JGC37I=5UF;<[<11+ M]R%.RJ/3^=8=!5ATDCRR-)*[.['+,QR2?4FFT44 %%==X?\ A=XR\2HLFF:' M<"!N1/<8A0CU!?&?PS7<6'[-/B6= VH:MIMIG^%"\I'Z ?K0!XS17OT7[+[E M?W_BQ0?1-/S^IDKSKXH?#I/AUJMC9IJ;:A]JA,N\P>5MPV,8W'- '#4444 ; M'A'_ )';0_\ L(V__HQ:^YZ^&/"/_([:'_V$;?\ ]&+7W/0)A1110(*^*OB= M_P E2\1_]?\ +_.OM6OBKXG?\E2\1_\ 7_+_ #H&CE:***!GH'P-_P"2SZ%_ MV\?^D\E?7]?('P-_Y+/H7_;Q_P"D\E?7] F%%%% @HHHH ^9_P!I@?\ %<:4 M?73@/_(CUXQ7M'[3'_([:3_V#O\ VH]>+T%!4EO_ ,?,7^^/YU'4EO\ \?,7 M^^/YT ??=%%%!(5\B_'B[^U?$SE;>.&(?]^E8_JQKZZKXX^,A)^+^O[NO MG)_Z+2@:.'HHHH&%%%% !1110 4444 %%%% !1110!]B?!20R?!S06;J$E7\ MIG']*[NN(^#=NUM\(- 1A@F%W_!I'8?SKMZ"0JCK>C67B'1+O2=4B\VTNXS' M(O0X]0>Q!P0?4"KU% 'Q-X\\#ZEX#\1R:;J"EX&):UN@N%N(_4>A'<=C[$$\ MS7W3XD\,:3XMT:33-=M%N;=^5)X:-NS*W4$>OX'@XKYG\>? S7_"TDEWHJ2: MSI8)(>%,S1#_ &T'7_>7CCD"@JYY=1110 5L^'_%VO\ A6X\WP_JMS9$G+(C M91C_ +2'*M^(K&HH ^A?!?[1\4K1V?C>S$#$A?M]HI*_5X^H^JY^@KW'3]1L M]5L(KW3;F*ZM9EW1S0N&5A]17P378?#_ .(^L> -6$MDYGT^1@;FQ=ODE'J/ M[K>C#\&W^&UK;KUN=1C5O]T([?S KURO%/VFL_\ "(Z-Z?;C_P"BS0!\UT444%!1 M110 4444 %%%% !1110 4444 >S_ +,\F/'&JQ_WM.+?E(G^-?3%?-G[,MNS M>+M9N!]V.Q6,_5I 1_Z":^DZ!,****!!1110 4444 %%%% !1110 5D>(O#= MCXEL/L]ZI5TR8IE^]&?;U'J*UZ*B<(U(N$U=,TIU)TIJ<'9H\-UOP%K>C2,1 M;->6XY$UNI;CW7J/Y>]"O#D; M972+<_[P)_F:Y/[!K_S+\?\ ([?]9,/;X'^'^9X'5BVL+N];;9VLUP?2*,M_ M*OH"#0-'MCFWTJSC/JL"@_GBM *, 8 ["MH9"_MS^Y&%3B5?8I_>_\ @'AM MC\/?$=\1_H/V=#_'<.%Q^'7]*Z?3OA&.&U;4L^L=LO\ [,W^%>ET5Z%+)L+3 MUDG+U_X!Y=;/L94TBU'T7^=S!TSP5H&E;6M]/CDD'_+2?]XWUYX'X 5O M# '0445ZM.E"FK022\CQJE:I5?-4DV_,****T,@HHHH \T^,'W=(^LW_ +)7 MF5>F_&#[ND?6;_V2O,J^$S;_ 'V?R_)'Z1DG^X4_G^;"BBBO+/8"O=_ NE'2 M?"%I%(,2S#SY!Z%N1^F!7C_A;1VUSQ):6>W,9??-[(.3_A^-?0(&!@=*^FR* MAK*L_1?J?(\1XG2&'7J_T_4****^I/C0HHHH **** "BBB@ HHHH K:C80:K MI=UI]XN^WNH7AE7U5@0?T-?"NKZ7<:)K5YI=ZNVXLYGAD';*G&1[<9%?>=?- M'[1GA!M-\36_B6UC_P!&U-1%.0.%G4<9_P!Y1^:M0-'B]%%% R:SNY["]@N[ M20Q3V\BR1.O564Y!_,5]L>!O%MMXU\(6>LVNU7D79<1*?]5*/O+_ %'L0>]? M$-=[\*?B3/\ #_Q ?M.^;1[PA;N%3G9Z2*/[P].XX]" &?85%06-]:ZG80WN MGSQW%M.@>*6,Y5U/<&IZ"0HHHH **** "BBB@ HHHH *^<_VG;0IKN@7F.); M:6('UV,#_P"SU]&5XW^TGI)N_ ^GZFBY:QO-K''1)%()_P"^E3\Z!H^9**** M!FQX1L+/5/&>CZ?JFXVEW>Q02[&VG:[A>O;K7TO_ ,,]^!?^>%]_X%'_ KY M4MYY+6YBN(&V2Q.'1AV(.0:^Z/#FN6WB7PW8:S8G,-Y"L@&?NG^)3[@Y!]Q0 M)G!?\,]^!?\ GA??^!1_PH_X9[\"_P#/"^_\"C_A7J%% CR__AGOP+_SPOO_ M */^%'_ SWX%_YX7W_ (%'_"O4** /+_\ AGOP+_SPOO\ P*/^%'_#/?@7 M_GA??^!1_P *]0HH \O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*] M0HH Q/"?A+2_!>BG2]#21+8RM,1(^\EB #S^ K;HHH *Q_%W_(DZY_V#KC_T M6U;%8_B[_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ M %?B?ZVO_M6@&>^T444$A7RQ^T#XN?6_'']BV\A-EI V%1T:8@%S^'"_@?6O MJ2:58+>2:3A(U+-] ,U\&ZE?2ZIJMW?W!+2W4SS.3W+,2?YT#15HHHH&6M-T MZ[U?4[?3].A:>ZN9!'%&O5F-?5GP\^#6B>#K6&ZU*&+4M9P&>>5=R0MUQ&IZ M8_O'GZ=*\R_9KT2&]\6ZGJ\R!VTZW5(LC[KRDC=]=J,/Q-?2U F%%%% @KYN M_:;_ .1IT3_KR?\ ]#KZ1KYM_::9#XKT50WSBR8E?0%S@_H?RH&CQ*BBB@9L M>$?^1VT/_L(V_P#Z,6ON>OACPC_R.VA_]A&W_P#1BU]ST"84444""OBKXG?\ ME2\1_P#7_+_.OM6OBKXG?\E2\1_]?\O\Z!HY6BBB@9Z!\#?^2SZ%_P!O'_I/ M)7U_7R!\#?\ DL^A?]O'_I/)7U_0)A1110(**** /FC]IC_D=M)_[!W_ +4> MO%Z]H_:8_P"1VTG_ +!W_M1Z\7H*"I+?_CYB_P!\?SJ.I+?_ (^8O]\?SH ^ M^Z***"0KY$^.UJ;;XPZJY&%G2"5?^_2J?U4U]=U\V_M,:2T/BG2-65,1W5H8 M&8#^*-B>??$@_*@:/$J***!G<_"+PQI'B_QT-)U]96MY+:1T$4FP[UP>OTW5 M[M_PSWX%_P">%]_X%'_"OG/X?^(%\+>/](UB9BL-O< 3$#.(V!1SC_=8U]MJ MRN@=&#*PR"#D$4"9YA_PSWX%_P">%]_X%'_"C_AGOP+_ ,\+[_P*/^%>H44" M/+_^&>_ O_/"^_\ H_X4?\ #/?@7_GA??\ @4?\*]0HH \O_P"&>_ O_/"^ M_P# H_X4?\,]^!?^>%]_X%'_ KU"B@#R_\ X9[\"_\ /"^_\"C_ (4?\,]^ M!?\ GA??^!1_PKU"B@"II.F6NBZ/::9IZ%+:TA6&)2$_&#/+JFF+%=OG-Y:GRI2?4D<,?]X&O'O$O[->K6F^;PMJ M<.H1@9%O';XVFN:?<6,_99D*[AZ@]"/<< M5G5]V:]X=TGQ/I;Z=KMC%>6S_P ,@Y0_WE/53[CFODCXH_#Z7X?>*!:([SZ= M=*9;.=QR5!Y5O]I?&,ND^+V\.7$A-EJH)C4GB M.=1D$?[R@@^IV^E?3U?!^A:@VD^(M.U&/[UI=13CZJX;^E?>% F%>0?M)6AF M^'-E<*,FWU)"3Z*8W'\\5Z_7$_SK7PHUN%!F2"'[4GMY1#G_QT,/QH$?& MU%%%!05]4V7P#\!W=A;W*0WQ6:)9 1='D$9]*^5J^Q/@UXD7Q)\,=-%]_P"!1_PH_P"&>_ O_/"^_P# H_X5 MZA10(\O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*]0HH \O\ ^&>_ M O\ SPOO_ H_X4?\,]^!?^>%]_X%'_"O4** /+_^&>_ O_/"^_\ H_X4?\ M#/?@7_GA??\ @4?\*]0HH Y?P;\/=!\"?;/^$?BF0WFSS3-+O)V[L8]/O&NH MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **R=;\3Z5X?B+:A?BLPH856D[OLOZT/4P65XC&.\5:/=_UJ:/Q5U:ROKJPM;.X6 M:6U,GG!#D(3MP,^O!KSZBBOB<5B'B:SJM6N?H6#PT<+0C1B[V_X<***V_"7A M]_$>O16N"+=#ON''9!V^IZ5E3IRJS4([LVJU848.I-Z(]!^%NA?8M'DU6=,3 M7AVQY[1@_P!3_(5WE,BB2"%(H4"1QJ%55& .@I]?H>&H1P]&-*/0_+<7B98 MJO*K+K^70****Z#E"BBB@ HHHH **** "BBB@ K%\7^&+3QAX5O=%O\ A+A/ MDDQDQ2#E7'T/Y\CO6U10!\'ZWHU[X>UR[TG58C#=VDACD7M[$>H(P0>X(-4* M^L/C)\+5\;:7_:FD1@:Y9QX09P+F,<^6??KM/O@]-K4/HE\IN-NZ2SF^2:/ZKW^HR/>OB:I(9I;>9)K>1XI4.Y'1BK* M?4$=* L??=%?)'A[X[>-M"1(IKV+5H%XVWZ%VQ_O@AB?20_M(>#)%'F6FKQ'N&MXS_)S3I/VCO!2? M=@U:3_=MD_JXH$>LT5XE>?M-:&BG^S]!U"=NPGD2(?H6KEM5_:6\07*LND:/ M86(/1I6:9A_Z"/TH'8^EB0 23@#J317Q+XA^(?BOQ2I36]:N9X3U@0B.,_5% MP#^(K['\-:J-<\*Z7JBG/VRTCF/L64$C\#D4 :=8WB_P_'XI\'ZGHLA ^V0, MB,W17'*-^# '\*V:*!'P+S?M!> FT MCQ /%.GQ?Z#J3!;D*/\ 5SXZ_1@,_4-ZBO&:"@KV/X&_%&+PS='PYX@N/+TN MZDW6\\A^6VD/4$]D;CGH#SW)KQRB@#[^!#*&4@@C(([TM?(_@+XU>(/!<,5A M/MU32H^%MIVPT0]$?J/HD45DVGBKP]?J&LM=TVX#=#%=QM_(U:;5]-49;4+4#WG7_ !H$7**Q;GQE MX8LE)N_$6E0X_OWL8/Y9KFM4^-O@/2U;_B="\D7_ )9VD+2$_0XV_K0!W]%> M!:]^TT@#Q^&=!8G^&>_DQC_MFG_Q5>N^!-?D\4>!-)UF?9YUU;@S>6,+Y@)5 ML#M\P/% '04444 %8_B[_D2=<_[!UQ_Z+:MBL?Q=_P B3KG_ &#KC_T6U 'P MQ11104%?07[+W^K\3_6U_P#:M?/M?07[+W^K\3_6U_\ :M ,]]HHHH),[Q$& M/A?5!'P_V.;;CUV&OA&OOYT62-D=0RL,,"."*^$=?TF70O$6H:5< B2SN'A. M>^UB ?Q'- T9]%%% SW?]F&_CCU3Q#I['][-##.@_P!E&=6_]&+7T17P[X-\ M57G@SQ59ZW8#>T#$21$X$L9X9#]1W['![5]@^$?'.A>-M-6ZT.]1Y-N9;5R! M-"?1EZ]>,]#V- F=#115#5]RA MK4^L:Y^;\26;\:['XK?&Y_$] MM+H?A826^EN=L]RWRR7(_N@?PKZ]S[#(/C= T%%%% S8\(_\CMH?_81M_P#T M8M?<]?"WA5MOC+16Z8OX#_Y$6ONF@3"BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5 M\3O^2I>(_P#K_E_G0-'*T444#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^ MWC_TGDKZ_H$PHHHH$%%%% 'S1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V# MO_:CUXO04%26_P#Q\Q?[X_G4=26__'S%_OC^= 'WW11102%>=_'#PP_B3X9W M;6T>^ZTUA>1 =2%!#C_O@L<=R!7HE(0&4JP!!&"#WH ^ :*[KXM>!)/ WC.: M*",C2[TM/8N!P%SS']5)Q]-I[UPM!05])_ OXI0ZEIMOX3UV=8[^V41V,KMC M[1&.D?\ O*.!ZCW'/S92JQ1@R$JP.00<$&@#[^HKYA\$?M!ZQH<,=CXG@;6+ M1!A;@/BX4>Y/#_C@^]>Q:)\:? NMJH76DL96ZQ7ZF';]6/R?^/4$G>45G0>( M=%NE#6VKV$RD9!CN48?H:DDUK2XO];J5FG^].H_K0!=HK N_'GA*Q4FZ\2Z4 MF.H^V1D_D#FN7U7X\^ ]-5O)U&;4)%_@M+=C_P"/-M7]: /1Z*^=]<_:8O)) M@GAS1(H(@PS+>/O=AGG"K@#CW-?0EO/'=6T4\)W1RH'0^H(R* )**** "BBO M&OV@_&>H>'+70[/0[Z:SO))VN6DA;!"HNT ^H)<\=#B@#V6BOG7PM^TI>6Z) M!XOTL7BC@W=EA)#[E#\I/T*_2O5]$^+?@C7@HM=?MH)6_P"65X3 P/I\^ ?P M)H [.BF0S17$2RV\B2QL,JZ,&!_$4^@ KPS]ITP_V%H ;;Y_VF79QSMVC=^N MW]*]7\1^-/#WA.U:;7=4M[8J,B'=NE?V5!R?RKY0^)WQ!G^(7B87@B:WL+93 M%:0,XCO(U&2N/N MR >JY/'<$]\5P5% 'WQ8WUKJ5C#>V$\=Q;3H'BEC;*NI[@U/7QAX'^)OB'P' M,5TJ=9K)VW265QEHV/OG+_C0 M(N45DW/BSP[9J3=Z_ID '7S+R-?YFN>U'XQ> ],4^;XBMYF[+;*TV?Q4$?K0 M!V]%>'Z[^TOI4"E/#FC7-X_3S+MA$@]P!N)_2NT^$GCNZ\?>%;F_U)(8KN"\ M>)XX%(55P&7&23T)'X&@#O**** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBJ.H:UINDH6U&]AM\#.UW&X_1>I_"IE*,5>3LBHPE-\ ML5=EZBN U7XKZ?!N32;62[<<"23Y$^OJ?TKA]7\ MI_$UY-?.,-2TB^9^7^9[>&R+%UM9+E7G_E_PQZUK7C+1="REW=B2N?$_5-0#0Z6HT^$\;E.Z0CZ]OPY]ZXBBOG\3F^(K:1?*O+_,^G MPF1X7#^])XD'<]@/8?XUA_#_P5_94: MZMJD>+V1?W43#_4J>Y_VB/R%=W7V&4Y>Z,?;5%[SV\E_F?"YWF:KR^KTG[JW M\W_D@HHHKWSYD**** "BBB@ HHHH **** "BBB@ HHHH *\N^*?P;LO&JR:K MHQCLM<5>6(Q'=8' ?T;L&_ YXQZC10!\':QHVHZ!J,]/^R>(+!+@*#YOD.0DZ#_T%OPP?:@JYXW15F_TZ]TN\:UU.TGM+A/O13QE&'X&J MU !1110 4444 %%%% !7UM\!-8_M7X46<3',FGS26K$]\'>O_CKJ/PKY)KZ0 M_9MM=8L=+UB+4-/NK>QF>*:VFFB*+(V&5MN>O 7IZ4 SV^BBB@DI:QI-EKVC MW6EZK L]I=1F.6,]Q['L0>0>Q -?('Q'^'&H_#_6VBF5Y],F8_9+S;PX_NMZ M./3OU%?9E4]6TBPUW2YM.U>UCN[2==LD4@R#_@1V(Y% SX,HKVGQY^SWJ>ER M27O@QFU*S.6-I(0)XO8'HX_(^QZUXW10,B MHHHH **** "BBB@ KZA_9OU4WGP]NK!WRUC>L%7^ZCJ&'_CV^OE_KTKZ!_9O MTG7=,OM6FO=,NK;3+VW1DGF38KNK<8!Y/#MR..* 9[[11102%8_B[_D2=<_[ M!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0!\,4444%!7T%^R]_J_$_UM?_ &K7S[7T M%^R]_J_$_P!;7_VK0#/?:***"0KYS_:*\#RVVJQ^+["(M;W(6&^VC_5R 81S M[$ +]5'K7T95;4=.M-7TVXT_4K=+BUN$,O:@#X)HKTCXF?!_5?! M%U+?:>DE_H9.4N%&7@']V0#IC^]T/'0G%>;T%!4D,TMO,LMO(\4BG*NC%2/H M14=% &\/'7BU8?*'BC61'C&W[?+C_P!"K'NKRYOIC->W$MQ*>KRN78_B:AHH M *N1Z3?3://JD=K(UC;RK#+/CY5=@2%^O!_R17Y(!R30 M!\G4444 7M$E$/B#3Y3T2ZB8_@X-?>-? 2L4<,O!4Y%??%K.+JSAN%^[+&KC MZ$9H$R6BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5\3O^2I>(_P#K_E_G0-'*T444 M#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^WC_TGDKZ_H$PHHHH$%%%% 'S M1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V#O_:CUXO04%26_P#Q\Q?[X_G4 M=26__'S%_OC^= 'WW11102%%%% '/>-_!NG>.?#4VDZF-A/SV\ZC+02 <,/7 MK@CN"?K7QYXL\)ZKX,UZ72M:@,1NQ_0]P:!GPW17I_CCX&>(_"\DESI,;ZUIHR1);I^] MC'^U&.>G<9'TKS$@@D$8(Z@T#$HHHH **** "BBB@ K[.^$^L'6_A7H5T[9D MCM_L[\\YB)CY^H4'\:^-(HI)I5BA1I)'.%1!DL?0"OJGX Z=KFD>!;FRU[3; MBQ3[69K;[0NUF1E&1M/(P1GD#[U F>IT444""OD?X[ZU_;'Q6O8T;=%I\:6B M?4#[N;1BUI<2P,>ICJ:FHVHP^:"'J%/H6/)'T'8UZQ1102%%%% ".BR1LDBAD8896&01Z5\L?&# MX1S^$;Z76=!@:709FW,J\FS8G[I_V.>#^![$_5%,EBCGA>&>-9(I%*NCKE6! MX((/44 ? =%?0WQ!_9Y2XDDU'P&R1.QW/ILSX4G_ *9N>G^ZW'N.E>#:KH^I M:%?O9:Q8SV5RG6.>,J?J,]1[C@T%%*BBB@ HHHH **** "O<_P!F351%KFN: M2S:WF*+\]K/'G M?[J01S[&HJ3Y(\UF_0TIT_:34;I7[[&U17E/_"U]6@=HKS2[82H<.OSH0?3! M)Q4J_%^<#YM'C)]IR/\ V6O,6;X/K+\&>L\CQW2-_FCU&BO+S\7YNVCQ_P#@ M0?\ XFH9/B[?G_5:9;+_ +SL?\*'F^#7VOP8+(\>_L?BO\SU:BO'IOBMKLG^ MJALHA[1L3^K5G3_$/Q-/D?VCY8](XD'ZXS64L[PJV3?R_P"";PX>QDMVE\_^ M >Y55N]4L+ $WM[;V^/^>LH7^=> W.OZO>9%UJ=W*#U5IFQ^6<50)))).2>I MKCGGR^Q#[V=U/AI_\O*GW(]NOOB-XO M4O O@$VCQ:MKD8\X8:"W8?ZL]F;W]!V^O30\'?#^'0V6^U,I<7_\"CE(?IZG MW_+UKM:^KRW*>1JK76O1?YGQ>:YU[1.AAGIU??T"BBBOHSY0**** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH I:IHNF:Y:_9]9T^UOX>R7,*R M >XR.#[BO/M8_9_\#ZF7:UM[K2Y&YS:3DKG_ '7W#'L,5Z=10!\_ZA^S"=Q; M2O$W'9+FTZ?\"5OZ5BS_ +-'BE6/V;5M(D7L9'E0G\D-?35% [GRY_PS=XS_ M .?S1O\ P(D_^-U/#^S3XK;_ %^JZ/&/]F25C_Z+%?3E% 7/GFT_9ANV(^W^ M)X8QW$-F7S^)85TVF?LW>%+5E?4K[4;]AU3>L2'\ ,_K7L%% 7.:T/X=>$?# MA#:3H-G%(,8ED3S9!CT9\D?@:Z6BB@04444 %%%% !6/K_A/0?%,(B\0:5;7 MP4;5>1/G0?[+CYE_ UL44 >.ZO\ LV^&+QR^DZA?Z:3_ $B9!] <-_X]7)W MG[,>K(Q^P>(K*<=C/ \6?R+5]'44#N?,)_9I\7[CMU/1".V9YA_[2J2+]FCQ M22//U?2$'?8\K?S05]-44!<^>K/]F&X+ ZAXGB0=Q!:%OU+#^5=1IG[.'A*T M*MJ-WJ.H,#RK2K&A_!1G]:]=HH YW0_ 'A7PVROHVA6=O*GW9C'OD'_ VRWZ MUT5%% @HHHH *KW]E%J6FW-C<[O)NH7ADVG!VL"#C\#5BB@#RK_AG7P1_>U/ M_P "1_\ $T?\,Z^"/[VI_P#@2/\ XFO5:* /*O\ AG7P1_>U/_P)'_Q-=7X) M^'>B> 5O1H)N3]M*&7[1*'^YNQC@8^\:ZJB@ HHHH **** $90ZE7 92,$$9 M!%>:^)_@/X/\0RO<6D$NCW+'):Q($9/O&00/^ [:]+HH ^;]0_9DUJ-C_96O MV%PO;[3$\)_\=WUFK^S;XR+8-]HP'K]HE_\ C=?45% [GSOIG[,=\[ ZSXBM MXE[K:0-(3^+%?Y5Z/X8^"?@WPS*EP+)]3ND.5FOV$FT^R !?T)]Z]!HH$ M P!T JIJVFV^LZ/>:9>AC;WD#P2[3@[64@X/8X-6Z* /*O^&=?!'][4_P#P M)'_Q-'_#.O@C^]J?_@2/_B:]5HH \J_X9U\$?WM3_P# D?\ Q->FV%E'IVFV MUC 6,5M"D*%SDE5 S[\58HH **** "O.-;^!GA'7]JT4 >? M^&?@OX6\)^(K76]*-\;NUW^7YLX9?F0HJ44 %%%% !1110 M4444 %_;]28')$]QL4_@@4_K7JM% C(T3PIH/AR/ M9H>D6ECQ@M%$ Q^K=3^)K7HHH **** "HKFV@O+=[>[ACGAD&'CE0,K#W!X- M2T4 >>:Y\#/ VMLTBZ:^FRL>7T^7RQ^"'*#\%KA-2_9B4DMI'B4@9XCNK7/' M^\K?TKWZB@#YCG_9I\5H3]GU31Y1_M22J?\ T6?YU"O[-OC(MAKW1E'J;B3_ M .-U]144#N?.%E^S)K+L/[1\06, [^1$\O\ /;77Z+^S?X7L7636+V^U1E/* M;A#&WU"_-_X]7L%% 7,W1?#VD>'+/[+H6G6]C#@9$,84MCNQZL?/;(9OSKZ( MHH'<^8G_ &:?%H;]WJFBLOJTTH/_ *+-+'^S3XL+?O=5T51_LRRG_P!IBOIR MB@+GSK:?LQ:@Y_T[Q+;0C_IC:M)_-EKI--_9I\.6Y5M4U;4+PCJL>R%3^&"? MUKV:B@+G):+\+?!>@,KZ?X?M#(O22X!G;/KER,+?ZQX M U[2&9OLIO(1_P M;7+_ )KU'Y8KY;$99B:&KC==T?8X7-\)B=%*S[/3_@', MT4K*58JP(8'!!'2DKS3U@HHHH **** "BBB@ HHI\,,MQ,L5O&\LC<*B*6)_ M 4]P;MJQE%==I/PVUW42K7,:V$1/+3GYL>RCG\\5Z)H7@+1=$"N8?MER.LUP M <'V7H/Y^]>IALJQ-=W:Y5W?^1XV*SG"X=63YGV7^>QYOX;\ ZGKVV>8&RLS M_P M95YF^';8QZ=#AV'[R9SEW^I_H.*U:*^IPF74<+JE> M7=_UH?&X[-,1C':3M'LOU[A1117HGE!1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4-1T+2]67&H MV,%P?[S)\P_X$.:Y>^^%>B7&39RW-FW8*^]?R//ZUV]%57/PBO5S]CU2WE]/-C9/Y9K,F^&'B.)B$CMIAZI-C/YXKVBBN M"63826R:^?\ G<].&?XV.[3]5_E8\.?X=>*%/&FAAZK/'_\ %4Y/AQXG?KIZ MI_O3Q_T->WT5E_8>&[R^]?Y&O^L>+M\,?N?^9XS#\+O$,K8D^RPCU>;/\@:U MK;X0S'!O-6C7U$4);]21_*O4**UADV$CNF_5_P"5C&>?8Z6S2]%_G,/\ GK)A?R7']:Z:QTJPTR,II]G#; ]?+0 GZGO5NBO0I8:C1_AQ M2/,K8O$5_P"+-OY_H%%%%=!RA1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 3!1110 4444 %%%% !1110!__V0$! end GRAPHIC 18 celogob.jpg GRAPHIC begin 644 celogob.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X1$817AI9@ 34T *@ @ ! $[ ( M : (2H=I 0 ! (9)R= $ T 0W.H< < @, /@ M FMC.60G/SX-"CQX.GAM<&UE=&$@>&UL M;G,Z>#TB861O8F4Z;G,Z;65T82\B/CQR9&8Z4D1&('AM;&YS.G)D9CTB:'1T M<#HO+W=W=RYW,RYO&UL;G,Z#IX;7!M971A/@T*(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" \/WAP M86-K970@96YD/2=W)S\^_]L 0P '!04&!00'!@4&" <'" H1"PH)"0H5#Q , M$1@5&AD8%1@7&QXG(1L=)1T7&"(N(B4H*2LL*QH@+S,O*C(G*BLJ_]L 0P$' M" @*"0H4"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ_\ $0@! 3O P$B (1 0,1 ?_$ !\ $% M 0$! 0$! ! @,$!08'" D*"__$ +40 (! P,"! ,%!00$ ! M?0$" P $$042(3%!!A-180'EZ M@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V]_CY^O_$ !\! ,! 0$! 0$! 0$ M ! @,$!08'" D*"__$ +41 (! @0$ P0'!00$ $"=P ! @,1! 4A M,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB) MBI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9 MVN+CY.7FY^CIZO+S]/7V]_CY^O_: P# 0 "$0,1 #\ ^D:*** "BBB@ HHH MH **** "BBB@ HHJ&ZO+:Q@,U[<1V\8ZO(X4?K2;25V-)MV1-17&:E\4-#LF M*6@FOG'>-=J_F?Z UR]_\6-5GR-/M+>U4]"V9&'X\#]*\ZKFF$I:.5WY:_\ M /6HY/C:VJA9>>G_ ?P/6Z*\'N?'7B2Z_UFJS(/2(+'_P"@@5ERZMJ,[$S: MA=2$]2TS'^M>?+/J2^&#?X?YGI0X;K/XYI>EW_D?1E%?-3RR2??D9OJQ-"32 MQ_/?$EHPVZF\J]UF57S^)&?UK:&?47\4&OQ_R,)\-UU\$T_6Z_P S MW6BO*+'XMW\; :CI]O.O']094EFDLI&XQ<+A<_[PR/S MQ7H4)9()$EC;E71@0?Q%/KT=SRM MM&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %% M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ! M1110 4444 %%%% !1102%4EC@#DD]J "J&K:WI^B6WGZGT\/A)Y1PURW*+_NC^+Z]/K7F-[?W6I73W-].\\SGEW.?_U#VKPL M9G%.C>%'WG^'_!/I,!D-6O:=?W8_B_\ +^M#NM>^*EU<;H=!@^RQ]//E 9S] M!T'Z_A7"WE_=ZC.9KZYEN)#_ !2.6-5Z*^7KXNMB'>I*_P"7W'V&&P6'PJM2 MC;SZ_>%%%%2V[9R0C<-]1T M/XUZ!H?Q7R4AU^V YP;F =/945V8?&U\,_P!W+3MT.'%9?AL6OWL= M>_7[SZ0LK^UU*U6YL+B.XA;H\;9'T]C[58KYXT34-5TV^$VBO,)N 5B4L''H M1W%>T^&-=OM8M<:II-S87"C)9XRL;_[N>1]#^=?6X',HXKW9*TOP/B,QRF6# M]Z,KQ_'[O\C>HHHKUCQ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH M **** "BBB@ HHHH ***KWU];:;8RW=[*(H(EW,Q_P ]?:DVDKL<8N3LMQ;V M]MM/LY+J]F6&&,99V. *\<\7>.[O7Y'M;,M;:<#@(#AI?=O;VJEXK\6W?B:] M.XM%91M^Y@ST]SZG^5<]7QV8YI*NW3I:1_/_ (!]YE63QPZ56NKS_+_@A111 M7A'T84444 %%%% !1110 445MZ7X/UW6-K6EA(L3?\M91L7'KD]?PS6E.G.H M^6"N_(SJ5:=*/-4DDO,Q**].TSX2(-KZQJ)8_P 45LN!_P!]'_"NOTWP=H.E M8-KIT32#GS)AYC9]'7S_"4](7D_+;\3Q*PT#5=4 MQ_9^GW$ZG^-4.W_OH\5T]A\*];N<->2V]FIZAFWL/P''ZU[" , =!17KT MLCH1_B-O\/Z^\\2MQ%B9Z4XJ/XO^OD<#9?";2XL&^OKFY(ZA (U/\S^M=#9^ M"_#MC@PZ5 Q'>4&3_P!"S6[17I4\#AJ7PP7Y_F>15S'%UOCJ/\OR&10Q6\8C M@C2)!T5% _ 4^BBNS8XFV]6%%%% @HHHH **** "BBB@ HHHH **** "BBB M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** M"BBB@ HHHH **** "BBB@ HHHH **** "BBFR2)%&TDKJB("S,QP% ZDF@!U M%9/_ E7A[_H/:9_X&1_XT?\)5X>_P"@]IG_ (&1_P"- &M163_PE7A[_H/: M9_X&1_XU;L=5T[4]_P#9M_:WGEXW_9YEDVYSC.#QG!_*@"W1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 -D=8HVDD8(B@LS,< =Z\3\;^+I?$6HM!;N M5TZ!OW2CCS#_ 'S_ $]!71_$WQ45)T&P?' -TZG\D_J?P]Z\RKY/.,>YR^KT MWHM_\C[;(LM4(K$U5J]O)=_G^04445\X?5!1110 4444 %%7]*T34=;N/)TR MUDG8?>8#"K]6/ KT;0_A3:PA9==N#2U[+?\ KU/-+#3;W5+@0:?;27$A_AC7./<^@]S7<:/\*+R?;)K5 MTMJG4PQ?._T)Z#]:]/L[&UT^W$%C;QV\2]$C4 5/7T>'R2C#6J^9__YGI^&*VJ**]RG3A37+!61\]4JU M*LN:HVWYA1115F84444 %%%9FI>)-'T@'^T-0@B8?P;MS?\ ?(R:F4XP5Y.R M+A3G4?+!7?D:=%1A&I_F?Y5S%_P#$_7[O(MF@LU_Z M91[F_-LUYE7-\)3VE?T_JQZ]'(\;5U<>5>?]7/9JSKOQ!I%@2+S4K6)A_"TH MW?EUKP:]UO5-1S]NU"YG!_A>4D?ETJC7F5,^_P"?G)&*Z*OF>O9?AYXK.MZ<;"]?-[:*/F8\RI MT!^HX!_ ]ZZ*/VE;J5G@\(Z6L"9P+J^^9S[A <#\2:\GUWQWXH\2 MY&M:Y>7,9ZP^9LC_ .^%POZ4#L?86J>./"^BEAJFOZ?;NIP8VN%+C_@(.?TK MF+OX[?#^U.%UB2X/I#:RG]2H%?(E% 6/JF3]HOP2C$*FJ2>ZVR_U84)^T7X) M;[R:HG^];+_1J^5J*!V/KBU^/7@"X($FJS6V?^>MI+_[*IKHM-^(W@[5F"6/ MB33G=CA4><1LWT5L$U\2T4"L??R.LB!XV#*PR&4Y!%+7PIH_B76_#TOF:)JM MY8GN()F56^HZ'\:]^^"WQ4\3^,=>DT;7(K>[BAMFF:]5/+D7! ('RG)/8#O MUH"Q[;1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "L?Q=_R).N?] M@ZX_]%M6Q6/XN_Y$G7/^P=_U?B?ZVO_ +5KY]KZ M"_9>_P!7XG^MK_[5H!GOM%%%!(4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^*-> MC\.Z#->MAI?N0H?XG/3\NOT%;%>-_$O7O[3U_P"P0/FWLGE>#^MXE0?PK5^G_!./N)Y;JXDGN',DLC%W8]23U-1T45\ M"VV[L_3$DE9!1112&%%%=5X6\!W_ (A*W$^;2P_YZLOS/_NCO]>GUK:C1J5Y M\E-79A7Q%+#P=2J[(YRTL[F_NDMK*%YYG.%1!DFO2/#OPLC54N/$4A9^OV6) ML ?[S=_H/SKM]&T#3M M?)TVW6/(P\AY=_J>]:5?58/)J=+WJWO/MT_X)\7C ML^JU;PP_NKOU_P" 0VEG;6%LMO901P0KT2-< 5-117O))*R/FVVW=A1113$% M%%% !16%KOC'1] #)=W(DN!TMX?F?\?3\:\ZUOXGZM?EH],5=/@/ *_-(1_O M=OP'XUY^)S'#X?23N^R/4PF58K%:QC9=WHO^">J:GK6FZ/%OU*\BMP>BLWS- M]!U-<1J_Q8MXBT>BV;3GM-/\J_@HY/Z5YA-/+II37*OO9]3AN'\/3UJOF?W+^OF;VJ>-=>U?(N+]XXS_RR@_=K^G)_$FL M&BBO&J59U7S3;;\SWJ=&G2CRTXI+R"BBBLS4**** "KNCZI/HNK6]_:']Y"V M=N>''=3[$<52HJHR<9*4=T3*,9Q<9*Z9]'Z;J$&JZ;!?6C;H9T#KGJ/8^X/% M6:\R^%.O8>?1+AN#F:WSZ_Q+_7\Z]-K]"P>(6)H1J=>OJ?E^/PKPF(E2>W3T M"BBBNLX0HHHH **** "BBB@ HHHH **** "FNZ11M)(RHB@LS,< =232331 M6\#S7$BQ11J6=W.%4#J2>PKY>^+OQBG\5W$VB>'I7@T1&VR2J<->$=SZ)Z#O MU/H #K_B-^T#'8R3:7X&,=Q,N5DU)QN1#_TS4\-_O'CT!KY_U'4KW5[^6]U. MZEN[J8[GEFLWW[.7C.VR;6;3+P8R!%<,K'_ +Z4#]:Y M#6?AEXST%&?4O#MZL:\M)"@F11ZED) _&@#E:^D?V:-$%OXI?%K4S%I]EIL;?ZYS+(!Z+P/U)_*O M*Z^-SNOSUU36T?S?](^]X?P_L\,ZKWD_P7],****\(^C"GQ123S+%"C22.=J MHHR6/H!4VGZ?=:I>QVEA"TTTAP%4?J?0>]>S>$/!-KXX"SZBP^:7J(_9 M?\>]>A@L#4Q9F&94L%#WM9/9?UT,3PG\-8K=8[WQ"JRS<,EKU5/\ M>]3[=/K7H8 50J@ 8 ':EHK[;#X6EAH*\M\0_$ M?5-7W0Z>3I]L>,1M^\;ZMV^@_6N3N;J>\N7N+N9YIG.6=VR3^-15\CB\VK5_ M=A[L?Q^\^XP.28?#6E/WI>>WR0I))))R3U-)117CGNA1110 4444 %%%% !1 M110 4444 7-(U&32-8M;^'[UO('Q_>'>.ZMHKB!MT4J!T;U!& M0:^:Z]K^&NI_;_!\4+',EF[0MD]1U7]#C\*^CR*O:I*B^NO]?UT/E>(\.I4H MUUNM'Z/_ (/YG6T445]8?$A1110 4444 %%%% !1110 445Q'Q9\;?\ "$>! M[BZMW U&Z/V>S'<.1R__ $9/UP.] 'E7QZ^)KWEY+X0T.?%M"<:A*A_UC@_ MZL'T'?U/':O#*<[O+(TDC,[L2S,QR23U)--H*"BBM?POX9U'Q=X@M]'T>+S) MYCRQ^[&HZNQ[ ?\ UNIH AT/0=3\2:M%INB6I/0 >IXKZ&\$? ML\:5ID<5YXPE_M.\X8VL9*P1GT)ZO^@]C7H'@7P#I'@+15L],C$ERX'VF\=1 MYD[>_HOHO;W.2>HH%<@LK&TTZT2UT^VAM;>,82*&,(J_0#BIZ**!!1110 44 M44 _F7]]+UQ_LCV'ZG\*ZL!@98NI;:*W9R9EF,,#2OO)[+]?0E\)^%; M;PSI^Q<2W_O[;3+&2[OI5A@C&69OY>Y]J6^OK?3;&6[O9!%!$NYV/:O#?%?BN[\37 MY9R8K2,_N8 >![GU->;C\?#"0[R>R/6RW+9XZ?:*W?Z+S+GBSQU>^(9'MK;= M;:>#Q$#\TGNQ_IT^MEAX*G25D%%%%8FX4444 % M%%% !1110 4444 %%%% !1110 5Z%\)+_P O5KZQ8\30B5?JIQ_)OTKSVNC\ M 71M?&^GG.%D9HF]]RD#]<5VX"I[/%0EY_GH>?F5+VN#J1\K_=J>ZT445^A' MY>%%%% !1110 4444 %%%% !7R9\=_%;>(OB)/8POFST@&VC Z&3_EHWUW?+ M_P !%?3_ (FUE/#WA;4M7DP19VSS '^)@.!^)P*^&)II+BXDFGTMC]KN01P43!P?8L5'XU]DT"84444""BBB@ HHHH **** "BBB M@ HHHH ***Y7Q]X_TKP!H?VW43YUS+E;6S1L/,W]%'=NWN2!0!T&HZG8Z/82 M7NJ7<-I:Q#+RS.%4?B:\8\6?M(Z?:,]OX1T]K^0$C[5=92+ZA1\S#Z[:\5\9 M>.]<\ZE>7!/4S3L_\ ,U1HH&2I<31MN2:16SG(8@UK:=XR M\2Z2P.FZ_J5N!_"ET^T_5&_'2B+3[AK74,9:QN<+)[E3T8?0Y]0*^-*?#-);S)-!(\4L;!D M=&(92.A!'0T!8^_**\5^#OQF.OR0^'/%DRC4L;;6\;@7/^PWH_H?XOK][VJ@ MD**** "L?Q=_R).N?]@ZX_\ 1;5L5C^+O^1)US_L'7'_ *+:@#X8HHHH*"OH M+]E[_5^)_K:_^U:^?:^@OV7O]7XG^MK_ .U: 9[[11102%%%-D4O&RJY0L" MR]5]^: ,[7/$FC>&K/[5KVI6]C$<[3,^"^.RKU8^P!KR;Q#^TIH]IOB\-Z7< M:@XX$UPWDQ_4#EC^.*\#\4RZN_B>_B\17DUWJ%O.\$TDTA<[D8J0">W'&.*R M*!V/3=6^/_CG4F(M;JUTQ#_#:VX)_-]Q_+%^/?%NHY^V>)=5D4]4^UN%_ M[Y!Q7/T4#+4NIW\[;I[VXD;U>5B?U-$>I7T)S#>W$9SG*RL/ZU5HH Z+3OB! MXNTDC[!XDU*-1T1KEG3_ +Y8D?I7>^'_ -HWQ1I\B)KUM:ZO!_$VWR)?P9?E M_P#':\@HH ^SO!7Q1\->.5$6F71@O]N6L;D!9!ZD=F'T/UQ78U\!PS26\R30 M2/%+&P9'1B&4CH01T-?2_P &OC"WB4Q^'/$\H_M95/V:Z. +H 9VMZ.!W[@> MO4%8]EHHHH$%%%% !7R]JGQ_\;66KWEK&=/V03O&N;8YP&(]?:OJ&OAGQA%Y M/CG78O[FHW"_E(U T=W_ ,-$>./73O\ P%/_ ,51_P -$>./73O_ %/_P 5 M7E=% S[;^'VOW/BCP#I6LWWE_:;J(F7RQA=P8J<#\*W;V^M=-LI;O4+B.VMX MEW22RL%51[DUYG\'-?LM*^!-K?ZK.MO::>UP)9&[#S6;\3\V ._2O#/B1\4- M5\?:DR,[VND1/FWLE/!]&?\ O-^@[>X(]2\8_M'VMK)):>#+$7C#C[;= K'G M_93@M]21]#7DFM?%7QMKLC&[\07<2'_EE:/Y"8],)C/XYKCZ*!EB>^N[IR]S M=33,3DM)(6)_.G6NIW]DP:ROKFW8'(,4S(0?P-5:* .]T'XT^.=!==NL/J$0 M/,6H#S@WU8_/^3"O;_ ?QVT'Q5+%8:P@T;4W(51(^89F]%?C!/HWJ "37RG1 M0!]_T5\^?!/XOS?:;?PIXJN#(DA$=A>RMRI[1.3U!Z*>H/'0C'T'02%%%% ! M1110 445YM\4OBY9>!+(>)_VEIW9H?".DK&N<"ZO_ )F/N$4X'XD_2O%M M7+_QR'A1Z*.BCV'%9U ['7:K\5/&^LL3=^)+Y%/!2V?R M%QZ83%Z^$_'.@>-;'[1H%\LSJH,MN_RRQ?[R_U&1Z&OB"KFE:M?Z'J<.H:1 M=RVEW"=%><_"CXJVWCW3C9W_EV^N6R9FB'"SK_ ,]$ M'\QV^AKT:@D**** "BBB@ KAO&_Q;\->!R]O=3F]U%1_QY6Q!9?]X]%_'GVK M@_C+\99M,N+CPSX3GV7*_)>7R'F(]T0]F]3VZ#FOG=W:21GD8L['+,QR2?6@ M=CU7Q#^T-XNU61UT?[/HUN>%$2"63'NS@C\@*X+4/&/B7579M1U[4;C=U5[I M]OY9P*Q:*!DCSRR-N>5V/J6)JQ;ZOJ5F0;34+J @Y!BF9A>'/VEM2@=(O%.D0W<6<-/9'RY /7:258 M_0K7AM% 'W#X1\::+XWTMK[0+AI4C;9+'(A1XFZX(_PR*WJ\[^!FA?V)\*K! MW7;+J#->/QV;A?\ QQ5/XUZ)02%%%% !1165XD\2:9X4T.;5=:N!!;1#ZL[= ME4=R?2@#3EEC@B>69UCC0%F=S@*!U)/:O)?%W[0OA[1))+7P_"^M72Y'F*VR M!3_O'EOP&/>O&?B'\6-;\=W3P>8]CI ;]W8QMPPSP9#_ !']!V'>N"H'8]%U MOXZ>.=99Q%J2:;"W_+*QB"8_X$^)-)M=TUP^GZUJ%JPZ&&Z=/Y&LNB@#TK0/CSXVT9U%W>1 M:M .L=Y&"?P=<-GZDU[7X)^.'AKQ:\=I>,=&U%\ 0W3CRY#Z))P#]#@GL#7R M510%C[_HKYK^$GQLN-)N(=!\8733:YCW6-H0\F>CM_"O\ 4^P]Z_.:-&5>HJ<-V?JN M(KPP]*56>R.N^'/@_P#L^W76-2C_ -*E7,",/]4A'7ZG]!]:[ZBBOT'#8>&& MI*G _,,7BJF*JNK4Z_AY!11170W3?#MF#Q)-/*1_NA /_0S7SO0 M4@HHHH ^A?V8](46>N:RXR[21VD9] !O;\]R?E7O5>9?L_6@MOA):2@8-U);'PCX;NM9 MU1L0VZ\(#\TCG[J#W)_QKXQ\5^*=2\8^(;C5]7EWS2G"(/NQ)V11V _Q/4UZ M%\?O&[:]XN_L&SES8:22K@'B2?\ B/\ P'[OUW>M>24%(***[CX6_#N?X@>) M/)E+PZ9:X>\F4*O!D M$EY!1\MM-C.!Z*P!('8@CI@5Y)0,BBB@D*Q_%W_(DZY_V#KC_T6U;%8_B[ M_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ %?B?ZVO M_M6@&>^T444$A1110!\H?M >'_['^)DE[$FV#585N >V\?*X_-0W_ J\Q1'E MD5(U9W8X55&23]*^Q_B/\-+/XBII2W=Y):&QG9F>-0S/&P^91GH257GG&#P: MT_#'@'PUX0A5=#TJ&&4#FY<;YF^KGG\!@>U [GRUHOP?\<:X ]OH4UM$?^6E MZ1 /R;#'\!7:67[,VORJ#J&MZ=;D]1$KRX_,+7TI10%SYZ;]F"YV?+XJB+>A ML2!^>^L'6?V)5_ZB MMR?SE8U]NU\4?$L;?BAXC&,?\3&8_P#CQH&CEZ***!FU)XIU&3P9!X8#A-/B MNGNF"DYD=@ WL,$CW/TK%HKJ_ /P_U3Q_KGV+3_ -S;18:ZO'7*0K_5CV7O M[#)H Y4 D@ 9)Z 5KP>$?$EU");7P]JLT9&0\=E(P(^H6OKSP?\ #;PUX*MT M&E6"/=@?/>S@/,Q^I^Z/88%=70*Y\$7FGWFG2"/4+2>U(H3^!%5Z^]K M_3K+5;-[34[2&[MI/O13QAU/X&OG'XP?!B+PS9R>(?"HD.FJP^TV9)8VP/1E M)Y*9X(/(SW'0"YXO1110,4$@@@X(Z$5]B?"'QJ?&O@2"XNY-^HV9^S7>>K,! MP_\ P)<'ZY]*^.J]<_9T\0'3?B!+I#L?)U:W*@9X\R,%U/\ WSO'XT SZCHH MHH)"BBFNZQ1M)(P5%!9F)P !WH XOXI?$&#P!X7:>/;)J=WF.RA/]['+G_97 M(/N<#O7Q]?7UUJ=_/>W\[W%S<.9)99#EG8]2:Z7XE^,I?&_C:[U'P_!+X4Q^*9O^$A\01;M*MY-L$##BZ<=<_[ _4\ M=C0!RO@WX2^*?&J+<6-HMI8-TO+LE$;_ '1@EOJ!CWKTVR_9AA$(.H^)I#)C ME8+0 #\2W/Y"O>41(HUCC5410%55& .@ IU KGS]J/[,+",MI/B8,_:.YM< M _\ E8X_*O*/%_P]\1^!YU77;$K [;8[N%M\,A]F'0^S 'VK[8JKJ6FV>L: M=-8:G;1W5K.NR2*1H(/>OAZO9_P!G+Q8VG>*KCPW;Q5I.D*W[JUM#<$?[-T$^D62Q66[:;RY;RXL^W4M_P$&J/@'P]'XJ\>Z3HTY(AN9_ MWN.I1078#ZJI%?;%K;065I%:VD20P0H$CC085% P !0!\\0_LQ:FT6;CQ):1 MR?W8[9F'YDC^55+[]F?Q%$I.G:SIMSC^&4/$3^C"OI>B@5SXO\0?"OQGX:5I M-1T.X>!>3/:XF0#U)3.T?[V*YS2--EUG6[+3+;_6WEPD"<="S ?UK[SKGKGP M'X:NO$UIX@;28(]4M9#(EQ"-A1@SMAMAMXE MBC'HJC _05/110(**** (;N[@L+*:[O)5AMX(S)+(YP$4#))_"OCOXG?$.Z\ M?^)&G!:+3+8E+.W)Z+_?/^TW7VZ=J]4_:-\:FVL[;PE82X>X N+W:>B _(A^ MI!)'LOK7SM0-!116]X-\)WWC7Q/;:/IPVM(=TLI&5AC'WG/T_4D"@95T#PWK M'BC4A8Z#837LYY81CA!ZLQX4>Y->OZ-^S-J4\2OKVO6]HQ&3%:PF8CV+$J,_ MG7N7A3PEI/@W0X],T2W$4:@&20\O,W=F/<_H.@P*VJ!7/"9OV8;%H\6_B>X1 M_5[16'Y!A_.N%\5? 7Q9X=@>ZL5BUJU098VF?-4>IC/)_P" YKZPHH"Y\ D$ M$@C!'4&DKZ%^/?PQ@-G+XPT&W$N<]B3\]4#"OI M+]G[XAOJNGMX3U>;==64>ZQ=CS)".J?5>,?[)_V:^;:T_#FN7/AKQ)8:S8DB M:SF60#.-P_B4^Q&0?8T ?=E%5M.O[?5-,M;^S??;W42S1-ZJPR/T-6:"0JCK MB>9X?U%,9W6LHQ_P U>J.XA%Q:RPMTD0H?Q&*F:YHM%TY??"W0/.U.XU: MY7Y;0F*('_GH1R?P'_H5>JUX&2X7DINO+=[>A]+Q!C74JK#Q>D=_7_@!1117 MT)\N%%%% !1110 5X3X[U0ZKXOO BMV\B/'HO!_7)KV^^N/LFG7-S_ ,\8 MFD_($U\WLQ=RSG+,+N@HHHJ2@JSIJ>;JMI'_?F1?S85 M6K4\-0&Y\4Z9$/XKJ//T# G]!6E-?.K>'D[+!.?S9/\*\)KWG]I^,C4/#DO9HKA1^!C M_P :\&H*"BBB@#[#^"8 ^#>@XQ]R8\?]=I*[RO._@1<"?X.Z2@ZPO/&?^_SM M_)A7HE!(4444 %%%% !1110 4444 %%%% !6-XNUY/#'@_5-9DP?L=NSH#_$ M_1!^+$#\:V:\?_:0UZ("Q_\ 'ME 'S)//+=7$D]P[22R MN7=V/+,3DD_C4=%%!05]F?"CPFGA'X>V%HR;;NY075T< M%X;.X\7:3%JDT<%DUY$+B25@%6/>-Q)/3C-?8G_"R/!?_0U:1_X&)_C0)G34 M5S/_ LCP7_T-6D?^!B?XT?\+(\%_P#0U:1_X&)_C0(Z:BN9_P"%D>"_^AJT MC_P,3_&C_A9'@O\ Z&K2/_ Q/\: )/'_ (?3Q1X"U?2F3?)+;LT'M*OS)_X\ M!^&:^(J^V?\ A9'@O_H:M(_\#$_QKXPU184U>\6U96A6=Q&RG(*[CC!],4#1 M5ILB_*__ (\K5T%>6?L[W[7?PK$# M'/V.^FA4>@.V3^;FO4Z"0K'\7?\ (DZY_P!@ZX_]%M6Q6/XN_P"1)US_ +!U MQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_P#M6OGVOH+]E[_5^)_K:_\ M6@&>^T4 M44$A1110 4444 %%<_XA\=^&/"H(UW6;:VE SY&[?*?^ +EOTKS/6?VE]$ML MKH>C7E\P.-]PZP*?<8W$_D* /;**^8M0_:3\57#$:?IVF6:=MR/(P_$L!^E8 M%S\=?B#<9VZVL()Z16D(Q^)4F@=CZ\KY'^/-A'9?%S4'B4*+J*&<@# R4"D_ MB5S]366_Q=\>2$EO$UV,_P!T*O\ (5SFM:[J?B+4/MVMWLM[<[ GFRG)VCH/ MUH SZ***!G8?"C4#IGQ7\/3@XWWBP?\ ?P&/_P!GK[/KX7\)R-%XTT21/O)J M$#+CU$BU]T4"84444""OBKXG?\E2\1_]?\O\Z^U:^*OB=_R5+Q'_ -?\O\Z! MHY6BBB@9);P2W5S%;VZ&2:5PD:+U9B< ?G7VK\/_ ?;^"/!UGI,*KYX4274 MH_Y:3$?,?H.@]@*^6_A!8IJ/Q,M4T5R2+.X9(V;JT9Y0G MZJ0:Q*]6_:*L5M/BD)E'-Y813,?4@LG\D%>4T%!71> -0.E?$70+P' 2_A#G M_99@K?H37.U8L)3!J5M*ND;;_*/]: /#Z* M**"B]HNE7&NZ[9:59C,]Y.D*<9P6.,GV'6ON31M)M="T6STO3TV6UI$L48]@ M.I]SU-?)GP5GTFR^)EKJ&O7UO96]G#+*DEQ($4N1M R>_P Q/X5]-?\ "R/! M?_0U:1_X&)_C0)G345S/_"R/!?\ T-6D?^!B?XT?\+(\%_\ 0U:1_P"!B?XT M".FHKF?^%D>"_P#H:M(_\#$_QH_X61X+_P"AJTC_ ,#$_P : .1_:$T"/5/A MJVI!1Y^E3I*K8YV.0C+]/F4_\!KY4KZX\?\ CCP?JOP[UZRM_$FESS2V$HBB MCND9G<*2H SR<@5\CT%(*TO#VKR:#XET[5H2=]EAIU#?M+^&Y)K72?$=O%N6#=:7+#JH)W1GZ9W MCZD>M T?/-%%% SH_A_XBB\*>/\ 2-9N03!;3XFP,D1LI1B!W(5B<>U?:]K= M07MI%=600>XKX%KM_ OQ6\1> R(+&5;O32Q9K&XY0$]2I MZH?IQZ@T ?9%%>9^%OCQX0\0A(K^X;1+L\&.]($9/M(/EQ[MM^E>DPSQ7,*3 M6\J2Q.,J\;!E8>H(ZT$CZ*** "BBB@ ILLJ0PO+*P2-%+,QZ #DFG5QOQ:U< MZ+\*],/$$OBGQAJ6LS$G[5.S(#_"@X1?P M4 5BT44%!7U'^SSX372/!+ZY<1XN]6?*D]5A4D*/Q.X^XV^E?+E?96A>-?!& MC>'=/TR+Q1HX6SMHX!B\3^%0/7VH$SM:*YG_ (61X+_Z&K2/_ Q/\:/^%D>" M_P#H:M(_\#$_QH$=-17,_P#"R/!?_0U:1_X&)_C1_P +(\%_]#5I'_@8G^- M&_>V=OJ-A<65[$LMO<1M%+&W1U88(_(U\*ZUIDFBZ]?Z9/S)9W$D#''4JQ&? MTK[+_P"%D>"_^AJTC_P,3_&OE3XJ75C>_%#6[K2KJ&[M)IED2:!PR/E%)P1[ MY% T4YDTVX>UR>I7AU_1\?\!KTVOG[]F&^(D\0Z M>S<$03HOI]]6/ZK^5?0-!(4444 4]+TR#2;+[-:CY/,>0D]268D_SQ^%7*** MF,5%**V*E)SDY2W844451(4444 %%%% %#7HFG\.:E%&,M):2JH]24(KYVKZ M8KY_\4Z%)X?\07%F580[M\#'^)#TY[XZ'W%?,Y]2DU"JMMCZ_ANM%.=%[NS7 MZF/1117RQ]B%%%% !1110 4444 %%%:FE^'-7UEA_9UA-*A/^L*[4'_ CQ5P MA*;Y8J[(G4A3CS3=EYF73D1I'"1J79C@*HR2:](TCX2L=LFMWP4=X;89/XL? M\/QKN=(\-:3H:XTZRCC?O*PW.?\ @1YKV,/DV(J:U/=7X_<>#B<_PM+2G[S_ M ^\\LT7X;:UJF)+Q1IT![S#+GZ+_CBO1]!\$Z/H&V2"#S[D?\O$_P S ^PZ M#\*Z&BOHL-EN'P^J5WW9\MB\VQ6*]V3M'LOZU/-/C!]W2/K-_P"R5YE7IOQ@ M^[I'UF_]DKS*OELV_P!]G\OR1]EDG^X4_G^;"BBBO+/8"NJ^'%M]H\;VC=H4 M>0_]\D#]2*Y6O2_A'I^7U#46'0+ A_\ 'F_]EKORZG[3%07G?[M3S'_M.61D\-Z'?8XANY(<_ M[Z9_]IU\X5]=_'726U7X3:BT:[I+)X[I1CLK88_@K,:^1*"D%%%% 'TS^S3J M8N/!.IZ<6S):7WF8]$D08_5&KV:OE3]GSQ$-'^(_]G32;8-6@:#!( \U?F0G M\F4>[5]5T"84444""BBB@ HHHH **** "BBB@ KYU_:=NV?6= L\_+%;RRX] MV91_[)7T57S/^TP3_P )SI0[?V<,?]_'H&CQBBBB@84444 %%%% !1110 44 M44 %%%% 'TI^S+(3X0UB/LM\&_.,?X5[77C'[,\17P3JTW9]1VC\(T/_ +-7 ML] F%8_B[_D2=<_[!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0(^&****"@KZ"_9>_ MU?B?ZVO_ +5KY]KZ"_9>_P!7XG^MK_[5H!GOM%%%!(445A^,?%=AX+\,W.L: MFV4B&(H@<--(?NH/K^@R>U !XK\8:-X,TAM0UVZ$*=(XEYDF;^ZJ]S^@[U\V M^-OCOXD\3-);:.[:+IQXV6[?OG'^U)U'T7'XUQ7B[Q=JGC37I=5UF;<[<11+ M]R%.RJ/3^=8=!5ATDCRR-)*[.['+,QR2?4FFT44 %%==X?\ A=XR\2HLFF:' M<"!N1/<8A0CU!?&?PS7<6'[-/B6= VH:MIMIG^%"\I'Z ?K0!XS17OT7[+[E M?W_BQ0?1-/S^IDKSKXH?#I/AUJMC9IJ;:A]JA,N\P>5MPV,8W'- '#4444 ; M'A'_ )';0_\ L(V__HQ:^YZ^&/"/_([:'_V$;?\ ]&+7W/0)A1110(*^*OB= M_P E2\1_]?\ +_.OM6OBKXG?\E2\1_\ 7_+_ #H&CE:***!GH'P-_P"2SZ%_ MV\?^D\E?7]?('P-_Y+/H7_;Q_P"D\E?7] F%%%% @HHHH ^9_P!I@?\ %<:4 M?73@/_(CUXQ7M'[3'_([:3_V#O\ VH]>+T%!4EO_ ,?,7^^/YU'4EO\ \?,7 M^^/YT ??=%%%!(5\B_'B[^U?$SE;>.&(?]^E8_JQKZZKXX^,A)^+^O[NO MG)_Z+2@:.'HHHH&%%%% !1110 4444 %%%% !1110!]B?!20R?!S06;J$E7\ MIG']*[NN(^#=NUM\(- 1A@F%W_!I'8?SKMZ"0JCK>C67B'1+O2=4B\VTNXS' M(O0X]0>Q!P0?4"KU% 'Q-X\\#ZEX#\1R:;J"EX&):UN@N%N(_4>A'<=C[$$\ MS7W3XD\,:3XMT:33-=M%N;=^5)X:-NS*W4$>OX'@XKYG\>? S7_"TDEWHJ2: MSI8)(>%,S1#_ &T'7_>7CCD"@JYY=1110 5L^'_%VO\ A6X\WP_JMS9$G+(C M91C_ +2'*M^(K&HH ^A?!?[1\4K1V?C>S$#$A?M]HI*_5X^H^JY^@KW'3]1L M]5L(KW3;F*ZM9EW1S0N&5A]17P378?#_ .(^L> -6$MDYGT^1@;FQ=ODE'J/ M[K>C#\&W^&UK;KUN=1C5O]T([?S KURO%/VFL_\ "(Z-Z?;C_P"BS0!\UT444%!1 M110 4444 %%%% !1110 4444 >S_ +,\F/'&JQ_WM.+?E(G^-?3%?-G[,MNS M>+M9N!]V.Q6,_5I 1_Z":^DZ!,****!!1110 4444 %%%% !1110 5D>(O#= MCXEL/L]ZI5TR8IE^]&?;U'J*UZ*B<(U(N$U=,TIU)TIJ<'9H\-UOP%K>C2,1 M;->6XY$UNI;CW7J/Y>]"O#D; M972+<_[P)_F:Y/[!K_S+\?\ ([?]9,/;X'^'^9X'5BVL+N];;9VLUP?2*,M_ M*OH"#0-'MCFWTJSC/JL"@_GBM *, 8 ["MH9"_MS^Y&%3B5?8I_>_\ @'AM MC\/?$=\1_H/V=#_'<.%Q^'7]*Z?3OA&.&U;4L^L=LO\ [,W^%>ET5Z%+)L+3 MUDG+U_X!Y=;/L94TBU'T7^=S!TSP5H&E;6M]/CDD'_+2?]XWUYX'X 5O M# '0445ZM.E"FK022\CQJE:I5?-4DV_,****T,@HHHH \T^,'W=(^LW_ +)7 MF5>F_&#[ND?6;_V2O,J^$S;_ 'V?R_)'Z1DG^X4_G^;"BBBO+/8"O=_ NE'2 M?"%I%(,2S#SY!Z%N1^F!7C_A;1VUSQ):6>W,9??-[(.3_A^-?0(&!@=*^FR* MAK*L_1?J?(\1XG2&'7J_T_4****^I/C0HHHH **** "BBB@ HHHH K:C80:K MI=UI]XN^WNH7AE7U5@0?T-?"NKZ7<:)K5YI=ZNVXLYGAD';*G&1[<9%?>=?- M'[1GA!M-\36_B6UC_P!&U-1%.0.%G4<9_P!Y1^:M0-'B]%%% R:SNY["]@N[ M20Q3V\BR1.O564Y!_,5]L>!O%MMXU\(6>LVNU7D79<1*?]5*/O+_ %'L0>]? M$-=[\*?B3/\ #_Q ?M.^;1[PA;N%3G9Z2*/[P].XX]" &?85%06-]:ZG80WN MGSQW%M.@>*6,Y5U/<&IZ"0HHHH **** "BBB@ HHHH *^<_VG;0IKN@7F.); M:6('UV,#_P"SU]&5XW^TGI)N_ ^GZFBY:QO-K''1)%()_P"^E3\Z!H^9**** M!FQX1L+/5/&>CZ?JFXVEW>Q02[&VG:[A>O;K7TO_ ,,]^!?^>%]_X%'_ KY M4MYY+6YBN(&V2Q.'1AV(.0:^Z/#FN6WB7PW8:S8G,-Y"L@&?NG^)3[@Y!]Q0 M)G!?\,]^!?\ GA??^!1_PH_X9[\"_P#/"^_\"C_A7J%% CR__AGOP+_SPOO_ M */^%'_ SWX%_YX7W_ (%'_"O4** /+_\ AGOP+_SPOO\ P*/^%'_#/?@7 M_GA??^!1_P *]0HH \O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*] M0HH Q/"?A+2_!>BG2]#21+8RM,1(^\EB #S^ K;HHH *Q_%W_(DZY_V#KC_T M6U;%8_B[_D2=<_[!UQ_Z+:@#X8HHHH*"OH+]E[_5^)_K:_\ M6OGVOH+]E[_ M %?B?ZVO_M6@&>^T444$A7RQ^T#XN?6_'']BV\A-EI V%1T:8@%S^'"_@?6O MJ2:58+>2:3A(U+-] ,U\&ZE?2ZIJMW?W!+2W4SS.3W+,2?YT#15HHHH&6M-T MZ[U?4[?3].A:>ZN9!'%&O5F-?5GP\^#6B>#K6&ZU*&+4M9P&>>5=R0MUQ&IZ M8_O'GZ=*\R_9KT2&]\6ZGJ\R!VTZW5(LC[KRDC=]=J,/Q-?2U F%%%% @KYN M_:;_ .1IT3_KR?\ ]#KZ1KYM_::9#XKT50WSBR8E?0%S@_H?RH&CQ*BBB@9L M>$?^1VT/_L(V_P#Z,6ON>OACPC_R.VA_]A&W_P#1BU]ST"84444""OBKXG?\ ME2\1_P#7_+_.OM6OBKXG?\E2\1_]?\O\Z!HY6BBB@9Z!\#?^2SZ%_P!O'_I/ M)7U_7R!\#?\ DL^A?]O'_I/)7U_0)A1110(**** /FC]IC_D=M)_[!W_ +4> MO%Z]H_:8_P"1VTG_ +!W_M1Z\7H*"I+?_CYB_P!\?SJ.I+?_ (^8O]\?SH ^ M^Z***"0KY$^.UJ;;XPZJY&%G2"5?^_2J?U4U]=U\V_M,:2T/BG2-65,1W5H8 M&8#^*-B>??$@_*@:/$J***!G<_"+PQI'B_QT-)U]96MY+:1T$4FP[UP>OTW5 M[M_PSWX%_P">%]_X%'_"OG/X?^(%\+>/](UB9BL-O< 3$#.(V!1SC_=8U]MJ MRN@=&#*PR"#D$4"9YA_PSWX%_P">%]_X%'_"C_AGOP+_ ,\+[_P*/^%>H44" M/+_^&>_ O_/"^_\ H_X4?\ #/?@7_GA??\ @4?\*]0HH \O_P"&>_ O_/"^ M_P# H_X4?\,]^!?^>%]_X%'_ KU"B@#R_\ X9[\"_\ /"^_\"C_ (4?\,]^ M!?\ GA??^!1_PKU"B@"II.F6NBZ/::9IZ%+:TA6&)2$_&#/+JFF+%=OG-Y:GRI2?4D<,?]X&O'O$O[->K6F^;PMJ M<.H1@9%O';XVFN:?<6,_99D*[AZ@]"/<< M5G5]V:]X=TGQ/I;Z=KMC%>6S_P ,@Y0_WE/53[CFODCXH_#Z7X?>*!:([SZ= M=*9;.=QR5!Y5O]I?&,ND^+V\.7$A-EJH)C4GB M.=1D$?[R@@^IV^E?3U?!^A:@VD^(M.U&/[UI=13CZJX;^E?>% F%>0?M)6AF M^'-E<*,FWU)"3Z*8W'\\5Z_7$_SK7PHUN%!F2"'[4GMY1#G_QT,/QH$?& MU%%%!05]4V7P#\!W=A;W*0WQ6:)9 1='D$9]*^5J^Q/@UXD7Q)\,=-%]_P"!1_PH_P"&>_ O_/"^_P# H_X5 MZA10(\O_ .&>_ O_ #POO_ H_P"%'_#/?@7_ )X7W_@4?\*]0HH \O\ ^&>_ M O\ SPOO_ H_X4?\,]^!?^>%]_X%'_"O4** /+_^&>_ O_/"^_\ H_X4?\ M#/?@7_GA??\ @4?\*]0HH Y?P;\/=!\"?;/^$?BF0WFSS3-+O)V[L8]/O&NH MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB MB@ HHHH **R=;\3Z5X?B+:A?BLPH856D[OLOZT/4P65XC&.\5:/=_UJ:/Q5U:ROKJPM;.X6 M:6U,GG!#D(3MP,^O!KSZBBOB<5B'B:SJM6N?H6#PT<+0C1B[V_X<***V_"7A M]_$>O16N"+=#ON''9!V^IZ5E3IRJS4([LVJU848.I-Z(]!^%NA?8M'DU6=,3 M7AVQY[1@_P!3_(5WE,BB2"%(H4"1QJ%55& .@I]?H>&H1P]&-*/0_+<7B98 MJO*K+K^70****Z#E"BBB@ HHHH **** "BBB@ K%\7^&+3QAX5O=%O\ A+A/ MDDQDQ2#E7'T/Y\CO6U10!\'ZWHU[X>UR[TG58C#=VDACD7M[$>H(P0>X(-4* M^L/C)\+5\;:7_:FD1@:Y9QX09P+F,<^6??KM/O@]-K4/HE\IN-NZ2SF^2:/ZKW^HR/>OB:I(9I;>9)K>1XI4.Y'1BK* M?4$=* L??=%?)'A[X[>-M"1(IKV+5H%XVWZ%VQ_O@AB?20_M(>#)%'F6FKQ'N&MXS_)S3I/VCO!2? M=@U:3_=MD_JXH$>LT5XE>?M-:&BG^S]!U"=NPGD2(?H6KEM5_:6\07*LND:/ M86(/1I6:9A_Z"/TH'8^EB0 23@#J317Q+XA^(?BOQ2I36]:N9X3U@0B.,_5% MP#^(K['\-:J-<\*Z7JBG/VRTCF/L64$C\#D4 :=8WB_P_'XI\'ZGHLA ^V0, MB,W17'*-^# '\*V:*!'P+S?M!> FT MCQ /%.GQ?Z#J3!;D*/\ 5SXZ_1@,_4-ZBO&:"@KV/X&_%&+PS='PYX@N/+TN MZDW6\\A^6VD/4$]D;CGH#SW)KQRB@#[^!#*&4@@C(([TM?(_@+XU>(/!<,5A M/MU32H^%MIVPT0]$?J/HD45DVGBKP]?J&LM=TVX#=#%=QM_(U:;5]-49;4+4#WG7_ !H$7**Q;GQE MX8LE)N_$6E0X_OWL8/Y9KFM4^-O@/2U;_B="\D7_ )9VD+2$_0XV_K0!W]%> M!:]^TT@#Q^&=!8G^&>_DQC_MFG_Q5>N^!-?D\4>!-)UF?9YUU;@S>6,+Y@)5 ML#M\P/% '04444 %8_B[_D2=<_[!UQ_Z+:MBL?Q=_P B3KG_ &#KC_T6U 'P MQ11104%?07[+W^K\3_6U_P#:M?/M?07[+W^K\3_6U_\ :M ,]]HHHH),[Q$& M/A?5!'P_V.;;CUV&OA&OOYT62-D=0RL,,"."*^$=?TF70O$6H:5< B2SN'A. M>^UB ?Q'- T9]%%% SW?]F&_CCU3Q#I['][-##.@_P!E&=6_]&+7T17P[X-\ M57G@SQ59ZW8#>T#$21$X$L9X9#]1W['![5]@^$?'.A>-M-6ZT.]1Y-N9;5R! M-"?1EZ]>,]#V- F=#115#5]RA MK4^L:Y^;\26;\:['XK?&Y_$] MM+H?A826^EN=L]RWRR7(_N@?PKZ]S[#(/C= T%%%% S8\(_\CMH?_81M_P#T M8M?<]?"WA5MOC+16Z8OX#_Y$6ONF@3"BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5 M\3O^2I>(_P#K_E_G0-'*T444#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^ MWC_TGDKZ_H$PHHHH$%%%% 'S1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V# MO_:CUXO04%26_P#Q\Q?[X_G4=26__'S%_OC^= 'WW11102%>=_'#PP_B3X9W M;6T>^ZTUA>1 =2%!#C_O@L<=R!7HE(0&4JP!!&"#WH ^ :*[KXM>!)/ WC.: M*",C2[TM/8N!P%SS']5)Q]-I[UPM!05])_ OXI0ZEIMOX3UV=8[^V41V,KMC M[1&.D?\ O*.!ZCW'/S92JQ1@R$JP.00<$&@#[^HKYA\$?M!ZQH<,=CXG@;6+ M1!A;@/BX4>Y/#_C@^]>Q:)\:? NMJH76DL96ZQ7ZF';]6/R?^/4$G>45G0>( M=%NE#6VKV$RD9!CN48?H:DDUK2XO];J5FG^].H_K0!=HK N_'GA*Q4FZ\2Z4 MF.H^V1D_D#FN7U7X\^ ]-5O)U&;4)%_@M+=C_P"/-M7]: /1Z*^=]<_:8O)) M@GAS1(H(@PS+>/O=AGG"K@#CW-?0EO/'=6T4\)W1RH'0^H(R* )**** "BBO M&OV@_&>H>'+70[/0[Z:SO))VN6DA;!"HNT ^H)<\=#B@#V6BOG7PM^TI>6Z) M!XOTL7BC@W=EA)#[E#\I/T*_2O5]$^+?@C7@HM=?MH)6_P"65X3 P/I\^ ?P M)H [.BF0S17$2RV\B2QL,JZ,&!_$4^@ KPS]ITP_V%H ;;Y_VF79QSMVC=^N MW]*]7\1^-/#WA.U:;7=4M[8J,B'=NE?V5!R?RKY0^)WQ!G^(7B87@B:WL+93 M%:0,XCO(U&2N/N MR >JY/'<$]\5P5% 'WQ8WUKJ5C#>V$\=Q;3H'BEC;*NI[@U/7QAX'^)OB'P' M,5TJ=9K)VW265QEHV/OG+_C0 M(N45DW/BSP[9J3=Z_ID '7S+R-?YFN>U'XQ> ],4^;XBMYF[+;*TV?Q4$?K0 M!V]%>'Z[^TOI4"E/#FC7-X_3S+MA$@]P!N)_2NT^$GCNZ\?>%;F_U)(8KN"\ M>)XX%(55P&7&23T)'X&@#O**** "BBB@ HHHH **** "BBB@ HHHH **** " MBBB@ HHHH **** "BBJ.H:UINDH6U&]AM\#.UW&X_1>I_"IE*,5>3LBHPE-\ ML5=EZBN U7XKZ?!N32;62[<<"23Y$^OJ?TKA]7\ MI_$UY-?.,-2TB^9^7^9[>&R+%UM9+E7G_E_PQZUK7C+1="REW=B2N?$_5-0#0Z6HT^$\;E.Z0CZ]OPY]ZXBBOG\3F^(K:1?*O+_,^G MPF1X7#^])XD'<]@/8?XUA_#_P5_94: MZMJD>+V1?W43#_4J>Y_VB/R%=W7V&4Y>Z,?;5%[SV\E_F?"YWF:KR^KTG[JW M\W_D@HHHKWSYD**** "BBB@ HHHH **** "BBB@ HHHH *\N^*?P;LO&JR:K MHQCLM<5>6(Q'=8' ?T;L&_ YXQZC10!\':QHVHZ!J,]/^R>(+!+@*#YOD.0DZ#_T%OPP?:@JYXW15F_TZ]TN\:UU.TGM+A/O13QE&'X&J MU !1110 4444 %%%% !7UM\!-8_M7X46<3',FGS26K$]\'>O_CKJ/PKY)KZ0 M_9MM=8L=+UB+4-/NK>QF>*:VFFB*+(V&5MN>O 7IZ4 SV^BBB@DI:QI-EKVC MW6EZK L]I=1F.6,]Q['L0>0>Q -?('Q'^'&H_#_6VBF5Y],F8_9+S;PX_NMZ M./3OU%?9E4]6TBPUW2YM.U>UCN[2==LD4@R#_@1V(Y% SX,HKVGQY^SWJ>ER M27O@QFU*S.6-I(0)XO8'HX_(^QZUXW10,B MHHHH **** "BBB@ KZA_9OU4WGP]NK!WRUC>L%7^ZCJ&'_CV^OE_KTKZ!_9O MTG7=,OM6FO=,NK;3+VW1DGF38KNK<8!Y/#MR..* 9[[11102%8_B[_D2=<_[ M!UQ_Z+:MBL?Q=_R).N?]@ZX_]%M0!\,4444%!7T%^R]_J_$_UM?_ &K7S[7T M%^R]_J_$_P!;7_VK0#/?:***"0KYS_:*\#RVVJQ^+["(M;W(6&^VC_5R 81S M[$ +]5'K7T95;4=.M-7TVXT_4K=+BUN$,O:@#X)HKTCXF?!_5?! M%U+?:>DE_H9.4N%&7@']V0#IC^]T/'0G%>;T%!4D,TMO,LMO(\4BG*NC%2/H M14=% &\/'7BU8?*'BC61'C&W[?+C_P!"K'NKRYOIC->W$MQ*>KRN78_B:AHH M *N1Z3?3://JD=K(UC;RK#+/CY5=@2%^O!_R17Y(!R30 M!\G4444 7M$E$/B#3Y3T2ZB8_@X-?>-? 2L4<,O!4Y%??%K.+JSAN%^[+&KC MZ$9H$R6BBB@05\5?$[_DJ7B/_K_E_G7VK7Q5\3O^2I>(_P#K_E_G0-'*T444 M#/0/@;_R6?0O^WC_ -)Y*^OZ^0/@;_R6?0O^WC_TGDKZ_H$PHHHH$%%%% 'S M1^TQ_P CMI/_ &#O_:CUXO7M'[3'_([:3_V#O_:CUXO04%26_P#Q\Q?[X_G4 M=26__'S%_OC^= 'WW11102%%%% '/>-_!NG>.?#4VDZF-A/SV\ZC+02 <,/7 MK@CN"?K7QYXL\)ZKX,UZ72M:@,1NQ_0]P:!GPW17I_CCX&>(_"\DESI,;ZUIHR1);I^] MC'^U&.>G<9'TKS$@@D$8(Z@T#$HHHH **** "BBB@ K[.^$^L'6_A7H5T[9D MCM_L[\\YB)CY^H4'\:^-(HI)I5BA1I)'.%1!DL?0"OJGX Z=KFD>!;FRU[3; MBQ3[69K;[0NUF1E&1M/(P1GD#[U F>IT444""OD?X[ZU_;'Q6O8T;=%I\:6B M?4#[N;1BUI<2P,>ICJ:FHVHP^:"'J%/H6/)'T'8UZQ1102%%%% ".BR1LDBAD8896&01Z5\L?&# MX1S^$;Z76=!@:709FW,J\FS8G[I_V.>#^![$_5%,EBCGA>&>-9(I%*NCKE6! MX((/44 ? =%?0WQ!_9Y2XDDU'P&R1.QW/ILSX4G_ *9N>G^ZW'N.E>#:KH^I M:%?O9:Q8SV5RG6.>,J?J,]1[C@T%%*BBB@ HHHH **** "O<_P!F351%KFN: M2S:WF*+\]K/'G M?[J01S[&HJ3Y(\UF_0TIT_:34;I7[[&U17E/_"U]6@=HKS2[82H<.OSH0?3! M)Q4J_%^<#YM'C)]IR/\ V6O,6;X/K+\&>L\CQW2-_FCU&BO+S\7YNVCQ_P#@ M0?\ XFH9/B[?G_5:9;+_ +SL?\*'F^#7VOP8+(\>_L?BO\SU:BO'IOBMKLG^ MJALHA[1L3^K5G3_$/Q-/D?VCY8](XD'ZXS64L[PJV3?R_P"";PX>QDMVE\_^ M >Y55N]4L+ $WM[;V^/^>LH7^=> W.OZO>9%UJ=W*#U5IFQ^6<50)))).2>I MKCGGR^Q#[V=U/AI_\O*GW(]NOOB-XO M4O O@$VCQ:MKD8\X8:"W8?ZL]F;W]!V^O30\'?#^'0V6^U,I<7_\"CE(?IZG MW_+UKM:^KRW*>1JK76O1?YGQ>:YU[1.AAGIU??T"BBBOHSY0**** "BBB@ H MHHH **** "BBB@ HHHH **** "BBB@ HHHH I:IHNF:Y:_9]9T^UOX>R7,*R M >XR.#[BO/M8_9_\#ZF7:UM[K2Y&YS:3DKG_ '7W#'L,5Z=10!\_ZA^S"=Q; M2O$W'9+FTZ?\"5OZ5BS_ +-'BE6/V;5M(D7L9'E0G\D-?35% [GRY_PS=XS_ M .?S1O\ P(D_^-U/#^S3XK;_ %^JZ/&/]F25C_Z+%?3E% 7/GFT_9ANV(^W^ M)X8QW$-F7S^)85TVF?LW>%+5E?4K[4;]AU3>L2'\ ,_K7L%% 7.:T/X=>$?# MA#:3H-G%(,8ED3S9!CT9\D?@:Z6BB@04444 %%%% !6/K_A/0?%,(B\0:5;7 MP4;5>1/G0?[+CYE_ UL44 >.ZO\ LV^&+QR^DZA?Z:3_ $B9!] <-_X]7)W MG[,>K(Q^P>(K*<=C/ \6?R+5]'44#N?,)_9I\7[CMU/1".V9YA_[2J2+]FCQ M22//U?2$'?8\K?S05]-44!<^>K/]F&X+ ZAXGB0=Q!:%OU+#^5=1IG[.'A*T M*MJ-WJ.H,#RK2K&A_!1G]:]=HH YW0_ 'A7PVROHVA6=O*GW9C'OD'_ VRWZ MUT5%% @HHHH *KW]E%J6FW-C<[O)NH7ADVG!VL"#C\#5BB@#RK_AG7P1_>U/ M_P "1_\ $T?\,Z^"/[VI_P#@2/\ XFO5:* /*O\ AG7P1_>U/_P)'_Q-=7X) M^'>B> 5O1H)N3]M*&7[1*'^YNQC@8^\:ZJB@ HHHH **** $90ZE7 92,$$9 M!%>:^)_@/X/\0RO<6D$NCW+'):Q($9/O&00/^ [:]+HH ^;]0_9DUJ-C_96O MV%PO;[3$\)_\=WUFK^S;XR+8-]HP'K]HE_\ C=?45% [GSOIG[,=\[ ZSXBM MXE[K:0-(3^+%?Y5Z/X8^"?@WPS*EP+)]3ND.5FOV$FT^R !?T)]Z]!HH$ M P!T JIJVFV^LZ/>:9>AC;WD#P2[3@[64@X/8X-6Z* /*O^&=?!'][4_P#P M)'_Q-'_#.O@C^]J?_@2/_B:]5HH \J_X9U\$?WM3_P# D?\ Q->FV%E'IVFV MUC 6,5M"D*%SDE5 S[\58HH **** "O.-;^!GA'7]JT4 >? M^&?@OX6\)^(K76]*-\;NUW^7YLX9?F0HJ44 %%%% !1110 M4444 %_;]28')$]QL4_@@4_K7JM% C(T3PIH/AR/ M9H>D6ECQ@M%$ Q^K=3^)K7HHH **** "HKFV@O+=[>[ACGAD&'CE0,K#W!X- M2T4 >>:Y\#/ VMLTBZ:^FRL>7T^7RQ^"'*#\%KA-2_9B4DMI'B4@9XCNK7/' M^\K?TKWZB@#YCG_9I\5H3]GU31Y1_M22J?\ T6?YU"O[-OC(MAKW1E'J;B3_ M .-U]144#N?.%E^S)K+L/[1\06, [^1$\O\ /;77Z+^S?X7L7636+V^U1E/* M;A#&WU"_-_X]7L%% 7,W1?#VD>'+/[+H6G6]C#@9$,84MCNQZL?/;(9OSKZ( MHH'<^8G_ &:?%H;]WJFBLOJTTH/_ *+-+'^S3XL+?O=5T51_LRRG_P!IBOIR MB@+GSK:?LQ:@Y_T[Q+;0C_IC:M)_-EKI--_9I\.6Y5M4U;4+PCJL>R%3^&"? MUKV:B@+G):+\+?!>@,KZ?X?M#(O22X!G;/KER,+?ZQX M U[2&9OLIO(1_P M;7+_ )KU'Y8KY;$99B:&KC==T?8X7-\)B=%*S[/3_@', MT4K*58JP(8'!!'2DKS3U@HHHH **** "BBB@ HHI\,,MQ,L5O&\LC<*B*6)_ M 4]P;MJQE%==I/PVUW42K7,:V$1/+3GYL>RCG\\5Z)H7@+1=$"N8?MER.LUP M <'V7H/Y^]>IALJQ-=W:Y5W?^1XV*SG"X=63YGV7^>QYOX;\ ZGKVV>8&RLS M_P M95YF^';8QZ=#AV'[R9SEW^I_H.*U:*^IPF74<+JE> M7=_UH?&X[-,1C':3M'LOU[A1117HGE!1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4-1T+2]67&H MV,%P?[S)\P_X$.:Y>^^%>B7&39RW-FW8*^]?R//ZUV]%57/PBO5S]CU2WE]/-C9/Y9K,F^&'B.)B$CMIAZI-C/YXKVBBN M"63826R:^?\ G<].&?XV.[3]5_E8\.?X=>*%/&FAAZK/'_\ %4Y/AQXG?KIZ MI_O3Q_T->WT5E_8>&[R^]?Y&O^L>+M\,?N?^9XS#\+O$,K8D^RPCU>;/\@:U MK;X0S'!O-6C7U$4);]21_*O4**UADV$CNF_5_P"5C&>?8Z6S2]%_G,/\ GK)A?R7']:Z:QTJPTR,II]G#; ]?+0 GZGO5NBO0I8:C1_AQ M2/,K8O$5_P"+-OY_H%%%%=!RA1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44 M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111 M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 3!1110 4444 %%%% !1110!__V0$! end XML 20 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover - shares
3 Months Ended
Mar. 31, 2024
May 03, 2024
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2024  
Document Transition Report false  
Entity File Number 001-32410  
Entity Registrant Name CELANESE CORPORATION  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 98-0420726  
Entity Address, Address Line One 222 W. Las Colinas Blvd., Suite 900N  
Entity Address, City or Town Irving  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 75039-5421  
City Area Code 972  
Local Phone Number 443-4000  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Small Reporting Company false  
Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   109,219,856
Entity Central Index Key 0001306830  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Common Stock    
Entity Information [Line Items]    
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol CE  
Security Exchange Name NYSE  
1.250% Senior Notes due 2025    
Entity Information [Line Items]    
Title of 12(b) Security 1.250% Senior Notes due 2025  
Trading Symbol CE /25  
Security Exchange Name NYSE  
4.777% Senior Notes due 2026    
Entity Information [Line Items]    
Title of 12(b) Security 4.777% Senior Notes due 2026  
Trading Symbol CE /26A  
Security Exchange Name NYSE  
2.125% Senior Notes due 2027    
Entity Information [Line Items]    
Title of 12(b) Security 2.125% Senior Notes due 2027  
Trading Symbol CE /27  
Security Exchange Name NYSE  
0.625% Senior Notes due 2028    
Entity Information [Line Items]    
Title of 12(b) Security 0.625% Senior Notes due 2028  
Trading Symbol CE /28  
Security Exchange Name NYSE  
5.337% Senior Notes due 2029    
Entity Information [Line Items]    
Title of 12(b) Security 5.337% Senior Notes due 2029  
Trading Symbol CE /29A  
Security Exchange Name NYSE  
XML 21 R2.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Unaudited Interim Consolidated Statement of Operations - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Net sales $ 2,611 $ 2,853
Cost of sales (2,057) (2,222)
Gross profit 554 631
Selling, general and administrative expenses (265) (285)
Amortization of intangible assets (41) (41)
Research and development expenses (34) (42)
Other (charges) gains, net (14) (23)
Foreign exchange gain (loss), net 11 6
Gain (loss) on disposition of businesses and assets, net (1) 5
Operating profit (loss) 210 251
Equity in net earnings (loss) of affiliates 55 15
Non-operating pension and other postretirement employee benefit (expense) income 2 1
Interest expense (169) (182)
Interest income 13 8
Dividend income - equity investments 34 34
Other income (expense), net 12 (6)
Earnings (loss) from continuing operations before tax 157 121
Income tax (provision) benefit (33) (25)
Earnings (loss) from continuing operations 124 96
Earnings (loss) from operation of discontinued operations 0 (3)
Income tax (provision) benefit from discontinued operations 0 0
Earnings (loss) from discontinued operations 0 (3)
Net earnings (loss) 124 93
Net (earnings) loss attributable to noncontrolling interests (3) (2)
Net earnings (loss) attributable to Celanese Corporation 121 91
Amounts attributable to Celanese Corporation    
Earnings (loss) from continuing operations 121 94
Earnings (loss) from discontinued operations 0 (3)
Net earnings (loss) $ 121 $ 91
Earnings (loss) per common share - basic    
Continuing operations - basic (in dollars per share) $ 1.11 $ 0.87
Discontinued operations - basic (in dollars per share) 0 (0.03)
Net earnings (loss) - basic (in dollars per share) 1.11 0.84
Earnings (loss) per common share - diluted    
Continuing operations - diluted (in dollars per share) 1.10 0.86
Discontinued operations - diluted (in dollars per share) 0 (0.03)
Net earnings (loss) - diluted (in dollars per share) $ 1.10 $ 0.83
Weighted average shares - basic (in shares) 109,069,060 108,634,068
Weighted average shares - diluted (in shares) 109,513,991 109,188,266
XML 22 R3.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Unaudited Interim Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Net earnings (loss) $ 124 $ 93
Other comprehensive income (loss), net of tax    
Foreign currency translation gain (loss) (54) 13
Gain (loss) on derivative hedges 2 4
Pension and postretirement benefits (1) (1)
Total other comprehensive income (loss), net of tax (53) 16
Total comprehensive income (loss), net of tax 71 109
Comprehensive (income) loss attributable to noncontrolling interests (3) (2)
Comprehensive income (loss) attributable to Celanese Corporation $ 68 $ 107
XML 23 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Unaudited Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 1,483 $ 1,805
Trade receivables - third party and affiliates 1,289 1,243
Non-trade receivables, net 536 541
Inventories 2,354 2,357
Other assets 283 272
Total current assets 5,945 6,218
Investments in affiliates 1,238 1,220
Property, plant and equipment (net of accumulated depreciation - 2024: $4,243; 2023: $4,080) 5,471 5,584
Operating lease right-of-use assets 396 422
Deferred income taxes 1,618 1,677
Other assets 537 524
Goodwill 6,926 [1] 6,977
Intangible assets, net 3,902 3,975
Total assets 26,033 26,597
Current Liabilities    
Short-term borrowings and current installments of long-term debt - third party and affiliates 2,439 1,383
Trade payables - third party and affiliates 1,447 1,510
Other liabilities 1,011 1,154
Income taxes payable 28 25
Total current liabilities 4,925 4,072
Long-term debt, net of unamortized deferred financing costs 11,018 12,301
Deferred income taxes 1,016 999
Uncertain tax positions 298 300
Benefit obligations 444 457
Operating lease liabilities 296 325
Other liabilities 505 591
Commitments and Contingencies
Shareholders' Equity    
Preferred stock, $0.01 par value, 100,000,000 shares authorized (2024 and 2023: 0 issued and outstanding) 0 0
Common stock, $0.0001 par value, 400,000,000 shares authorized (2024: 170,780,600 issued and 109,210,286 outstanding; 2023: 170,476,740 issued and 108,906,426 outstanding) 0 0
Treasury stock, at cost (2024: 61,570,314 shares; 2023: 61,570,314 shares) (5,488) (5,488)
Additional paid-in capital 383 394
Retained earnings 12,973 12,929
Accumulated other comprehensive income (loss), net (797) (744)
Total Celanese Corporation shareholders' equity 7,071 7,091
Noncontrolling interests 460 461
Total equity 7,531 7,552
Total liabilities and equity $ 26,033 $ 26,597
[1] There were no accumulated impairment losses as of March 31, 2024.
XML 24 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Unaudited Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Accumulated depreciation, depletion and amortization, property, plant, and equipment $ 4,243 $ 4,080
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock, shares authorized (in shares) 100,000,000 100,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 400,000,000 400,000,000
Common stock, shares issued (in shares) 170,780,600 170,476,740
Common stock, shares outstanding (in shares) 109,210,286 108,906,426
Treasury Stock, Common, Shares 61,570,314 61,570,314
XML 25 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Unaudited Interim Consolidated Statement Equity - USD ($)
$ in Millions
Total
Common Stock
Treasury Stock, Common
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss), Net
Noncontrolling Interests
Balance as of the beginning of the period (in shares) at Dec. 31, 2022   108,473,932 61,661,493        
Balance as of the beginning of the period at Dec. 31, 2022   $ 0 $ (5,491) $ 372 $ 11,274 $ (518)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock option exercises, shares   0          
Stock option exercises   $ 0   0      
Stock awards (in shares)   312,806          
Stock awards   $ 0          
Issuance of treasury stock under stock plans (in shares)     0        
Issuance of treasury stock under stock plans     $ 0        
Stock-based compensation, net of tax       (7)      
Net earnings (loss) attributable to Celanese Corporation $ 91       91    
Common stock dividends         (76)    
Other comprehensive income (loss), net of tax 16         16  
Balance as of the end of the period (in shares) at Mar. 31, 2023   108,786,738 61,661,493        
Balance as of the end of the period at Mar. 31, 2023 5,661 $ 0 $ (5,491) 365 11,289 (502)  
Balance as of the beginning of the period, noncontrolling interest at Dec. 31, 2022             $ 468
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) attributable to noncontrolling interests 2           2
Distributions/dividends to noncontrolling interests             (1)
Balance as of the end of the period, noncontrolling interest at Mar. 31, 2023             469
Balance as of the end of the period at Mar. 31, 2023 6,130            
Balance as of the beginning of the period (in shares) at Dec. 31, 2023   108,906,426 61,570,314        
Balance as of the beginning of the period at Dec. 31, 2023 7,091 $ 0 $ (5,488) 394 12,929 (744)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock option exercises, shares   7,947          
Stock option exercises   $ 0   1      
Stock awards (in shares)   295,913          
Stock awards   $ 0          
Issuance of treasury stock under stock plans (in shares)     0        
Issuance of treasury stock under stock plans     $ 0        
Stock-based compensation, net of tax       (12)      
Net earnings (loss) attributable to Celanese Corporation 121       121    
Common stock dividends         (77)    
Other comprehensive income (loss), net of tax (53)         (53)  
Balance as of the end of the period (in shares) at Mar. 31, 2024   109,210,286 61,570,314        
Balance as of the end of the period at Mar. 31, 2024 7,071 $ 0 $ (5,488) $ 383 $ 12,973 $ (797)  
Balance as of the beginning of the period, noncontrolling interest at Dec. 31, 2023 461           461
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) attributable to noncontrolling interests 3           3
Distributions/dividends to noncontrolling interests             (4)
Balance as of the end of the period, noncontrolling interest at Mar. 31, 2024 460           $ 460
Balance as of the end of the period at Mar. 31, 2024 $ 7,531            
XML 26 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Unaudited Interim Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating Activities    
Net earnings (loss) $ 124 $ 93
Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities    
Depreciation, amortization and accretion 227 178
Pension and postretirement net periodic benefit cost 1 3
Pension and postretirement contributions (13) (12)
Deferred income taxes, net (6) 1
Gain (Loss) on Disposition of Property Plant Equipment (1) 6
Stock-based compensation 10 14
Undistributed earnings in unconsolidated affiliates (28) 25
Other, net 3 (1)
Operating cash provided by (used in) discontinued operations (8) 1
Changes in operating assets and liabilities    
Trade receivables - third party and affiliates, net (55) (216)
Inventories (19) 45
Other assets 34 99
Trade payables - third party and affiliates (21) (22)
Other liabilities (149) (298)
Net cash provided by (used in) operating activities 101 (96)
Investing Activities    
Capital expenditures on property, plant and equipment (137) (164)
Proceeds from sale of businesses and assets, net 0 9
Other, net (14) (23)
Net cash provided by (used in) investing activities (151) (178)
Financing Activities    
Net change in short-term borrowings with maturities of 3 months or less 10 (300)
Proceeds from short-term borrowings 146 338
Repayments of short-term borrowings (418) 0
Proceeds from long-term debt 111 0
Repayments of long-term debt 6 7
Repayments of long-term debt (6) (7)
Stock option exercises 1 0
Common stock dividends (77) (76)
Distributions/dividends to noncontrolling interests (4) (1)
Other, net (22) (23)
Net cash provided by (used in) financing activities (259) (69)
Exchange rate effects on cash and cash equivalents (13) 2
Net increase (decrease) in cash and cash equivalents (322) (341)
Cash and cash equivalents as of beginning of period 1,805 1,508
Cash and cash equivalents as of end of period $ 1,483 $ 1,167
XML 27 R8.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Description of the Company and Basis of Presentation
3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Description of the Company and Basis of Presentation Description of the Company and Basis of Presentation
Description of the Company
Celanese Corporation and its subsidiaries (collectively, the "Company") is a global chemical and specialty materials company. The Company produces high performance engineered polymers that are used in a variety of high-value applications, as well as acetyl products, which are intermediate chemicals for nearly all major industries. The Company also engineers and manufactures a wide variety of products essential to everyday living. The Company's broad product portfolio serves a diverse set of end-use applications including automotive, chemical additives, construction, consumer and industrial adhesives, medical, consumer electronics, energy storage, filtration, paints and coatings, paper and packaging, industrial applications and textiles.
Definitions
In this Quarterly Report on Form 10-Q ("Quarterly Report"), the term "Celanese" refers to Celanese Corporation, a Delaware corporation, and not its subsidiaries. The term "Celanese U.S." refers to the Company's subsidiary, Celanese US Holdings LLC, a Delaware limited liability company, and not its subsidiaries.
Basis of Presentation
The unaudited interim consolidated financial statements for the three months ended March 31, 2024 and 2023 contained in this Quarterly Report were prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for all periods presented and include the accounts of the Company, its majority owned subsidiaries over which the Company exercises control and, when applicable, variable interest entities in which the Company is the primary beneficiary. The unaudited interim consolidated financial statements and other financial information included in this Quarterly Report, unless otherwise specified, have been presented to separately show the effects of discontinued operations.
In the opinion of management, the accompanying unaudited consolidated balance sheets and related unaudited interim consolidated statements of operations, comprehensive income (loss), cash flows and equity include all adjustments, consisting only of normal recurring items necessary for their fair presentation in conformity with U.S. GAAP. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted in accordance with rules and regulations of the Securities and Exchange Commission ("SEC"). These unaudited interim consolidated financial statements should be read in conjunction with the Company's consolidated financial statements as of and for the year ended December 31, 2023, filed on February 23, 2024 with the SEC as part of the Company's Annual Report on Form 10-K.
Operating results for the three months ended March 31, 2024 are not necessarily indicative of the results to be expected for the entire year.
In the ordinary course of business, the Company enters into contracts and agreements relative to a number of topics, including acquisitions, dispositions, joint ventures, supply agreements, product sales and other arrangements. The Company endeavors to describe those contracts or agreements that are material to its business, results of operations or financial position. The Company may also describe some arrangements that are not material but in which the Company believes investors may have an interest or which may have been included in a Form 8-K filing. Investors should not assume the Company has described all contracts and agreements relative to the Company's business in this Quarterly Report.
For those consolidated ventures in which the Company owns or is exposed to less than 100% of the economics, the outside shareholders' interests are shown as noncontrolling interests.
Estimates and Assumptions
The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of net sales, expenses and allocated charges during the reporting period. Significant estimates pertain to impairments of goodwill, intangible assets and other long-lived assets, purchase price allocations, restructuring costs and other (charges) gains, net, income taxes, pension and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates.
XML 28 R9.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Recent Accounting Pronouncements
3 Months Ended
Mar. 31, 2024
Recent Accounting Pronouncements [Abstract]  
Recent Accounting Pronouncements Recent Accounting Pronouncements
The following table provides a brief description of recent Accounting Standard Updates ("ASU") issued by the Financial Accounting Standards Board ("FASB"):
StandardDescriptionEffective DateEffect on the Financial Statements or Other Significant Matters
In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures.
The new guidance requires an entity to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Additionally, the guidance requires an entity to disclose annual income taxes paid (net of refunds received) disaggregated by federal (national), state and foreign taxes and disaggregate the information by jurisdiction based on a quantitative threshold. The guidance also requires an entity to disclose income (loss) from continuing operations before income tax expense (benefit) disaggregated between domestic and foreign and income tax expense (benefit) from continuing operations disaggregated by federal (national), state and foreign.Effective for annual periods beginning after December 15, 2024. Early adoption is permitted.The Company is currently evaluating the impact of the adoption on its financial statement disclosures.
In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures.
The new guidance requires an entity to disclose, on an annual and interim basis, significant segment expenses that are regularly provided to the chief operating decision maker ("CODM") and included within segment profit or loss, as well as an amount of other segment items by reportable segment and a description of its composition. Additionally, the guidance requires an entity to disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The update is required to be applied retrospectively to prior periods presented, based on the significant segment expense categories identified and disclosed in the period of adoption.Effective for annual periods beginning after December 15, 2023, and for interim periods beginning after December 15, 2024. Early adoption is permitted.The Company is currently evaluating the impact of the adoption on its financial statement disclosures.
XML 29 R10.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Acquisitions, Dispositions and Plant Closures
3 Months Ended
Mar. 31, 2024
Acquisitions, Dispositions and Plant Closures [Abstract]  
Acquisitions, Dispositions and Plant Closures Acquisitions, Dispositions and Plant Closures
Acquisitions
•    Nutrinova Joint Venture
In September 2023, the Company formed a food ingredients joint venture with Mitsui & Co., Ltd. ("Mitsui") under the name Nutrinova. The Company contributed receivables, inventory, property, plant and equipment, certain other assets, liabilities, technology and employees of its food ingredients business while retaining a 30% interest in the joint venture. Mitsui acquired the remaining 70% interest in the food ingredients business for a purchase price of $503 million, subject to transaction adjustments. The Company is accounting for its interest in the joint venture as an equity method investment, and its portion of the results continues to be included in the Engineered Materials segment. A gain on the transaction of $515 million was included in Gain (loss) on disposition of businesses and assets, net in the consolidated statements of operations for the year ended December 31, 2023.
Plant Closures
Uentrop, Germany
In October 2023, the Company announced the intended closure of its Polyamide 66 ("PA66") and High-Performance Nylon ("HPN") polymerization units at its facility in Uentrop, Germany to optimize production costs across its global network. These operations are included in the Company's Engineered Materials segment. The Company fully ceased operation of the PA66 polymerization unit and partially ceased operation of the HPN polymerization units during the three months ended March 31, 2024.
The exit and shutdown costs related to the closure of the PA66 and HPN polymerization units in Uentrop, Germany were as follows:
Three Months Ended
March 31,
2024
(In $ millions)
Restructuring(1)
Accelerated depreciation expense(2)
37 
Total42 
______________________________
(1)Included in Other (charges) gains, net in the unaudited interim consolidated statements of operations (Note 18).
(2)Included in Cost of sales in the unaudited interim consolidated statements of operations.
The Company expects to incur additional exit and shutdown costs related to the closure of the PA66 and HPN polymerization units in Uentrop, Germany of approximately $36 million, inclusive of estimated employee termination costs, through 2025.
Mechelen, Belgium
On February 29, 2024, the Company announced the intended closure of its facility in Mechelen, Belgium to optimize production costs across its global network. This operation is included in the Company's Engineered Materials segment. The Company plans to cease operations in the fourth quarter of 2024.
Three Months Ended
March 31,
2024
(In $ millions)
Accelerated depreciation expense(1)
Total
______________________________
(1)Included in Cost of sales in the unaudited interim consolidated statements of operations.
The Company expects to incur additional exit and shutdown costs related to the closure of the facility at Mechelen, Belgium of approximately $130 million, inclusive of estimated employee termination costs, through 2025.
XML 30 R11.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Inventories
3 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
Inventories Inventories
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Finished goods1,650 1,604 
Work-in-process128 160 
Raw materials and supplies576 593 
Total2,354 2,357 
XML 31 R12.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Goodwill and Intangible Assets, net
3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, Net Goodwill and Intangible Assets, Net
Goodwill
Engineered
Materials
Acetyl ChainTotal
(In $ millions)
As of December 31, 20236,602 375 6,977 
Exchange rate changes(46)(5)(51)
As of March 31, 2024(1)
6,556 370 6,926 
______________________________
(1)There were no accumulated impairment losses as of March 31, 2024.
Intangible Assets, Net
Finite-lived intangible assets are as follows:
LicensesCustomer-
Related
Intangible
Assets
Developed
Technology
Covenants
Not to
Compete
and Other
Total
(In $ millions)
Gross Asset Value
As of December 31, 202341 2,437 601 55 3,134 
Exchange rate changes(1)(28)— — (29)
As of March 31, 202440 2,409 601 55 3,105 
Accumulated Amortization
As of December 31, 2023(38)(639)(95)(42)(814)
Amortization— (30)(11)— (41)
Exchange rate changes— 12 
As of March 31, 2024(38)(660)(104)(41)(843)
Net book value1,749 497 14 2,262 
Indefinite-lived intangible assets are as follows:
Trademarks
and Trade Names
(In $ millions)
As of December 31, 20231,655 
Exchange rate changes(15)
As of March 31, 20241,640 
During the three months ended March 31, 2024, the Company did not renew or extend any intangible assets.
Estimated amortization expense for the succeeding five fiscal years is as follows:
(In $ millions)
2025161 
2026160 
2027160 
2028160 
2029155 
XML 32 R13.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Current Other Liabilities
3 Months Ended
Mar. 31, 2024
Other Liabilities, Current [Abstract]  
Current Other Liabilities Current Other Liabilities
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Benefit obligations (Note 8)
25 25 
Customer rebates76 96 
Derivatives (Note 12)
58 90 
Interest (Note 7)
194 246 
Legal (Note 14)
12 34 
Operating leases86 89 
Restructuring (Note 18)
19 18 
Salaries and benefits133 175 
Sales and use tax/foreign withholding tax payable133 128 
Investment in affiliates96 96 
Other179 157 
Total1,011 1,154 
XML 33 R14.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Debt Debt
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates
Current installments of long-term debt2,348 1,025 
Short-term borrowings, including amounts due to affiliates(1)
50 146 
Revolving credit facilities(2)
41 212 
Total2,439 1,383 
______________________________
(1)The weighted average interest rate was 2.2% and 2.9% as of March 31, 2024 and December 31, 2023, respectively.
(2)The weighted average interest rate was 3.2% and 3.4% as of March 31, 2024 and December 31, 2023, respectively.
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Long-Term Debt
Senior unsecured notes due 2024, interest rate of 3.500%
473 473 
Senior unsecured notes due 2024, interest rate of 5.900%
527 527 
Senior unsecured notes due 2025, interest rate of 1.250%
324 331 
Senior unsecured notes due 2025, interest rate of 6.050%
1,000 1,000 
Senior unsecured notes due 2026, interest rate of 1.400%
400 400 
Senior unsecured notes due 2026, interest rate of 4.777%
1,081 1,105 
Senior unsecured notes due 2027, interest rate of 2.125%
539 551 
Senior unsecured notes due 2027, interest rate of 6.165%
2,000 2,000 
Senior unsecured term loan due 2027(1)
880 880 
Senior unsecured notes due 2028, interest rate of 0.625%
540 552 
Senior unsecured notes due 2028, interest rate of 6.350%
1,000 1,000 
Senior unsecured notes due 2029, interest rate of 5.337%
540 552 
Senior unsecured notes due 2029, interest rate of 6.330%
750 750 
Senior unsecured notes due 2030, interest rate of 6.550%
999 999 
Senior unsecured notes due 2032, interest rate of 6.379%
1,000 1,000 
Senior unsecured notes due 2033, interest rate of 6.700%
1,000 1,000 
Pollution control and industrial revenue bonds due at various dates through 2030(2)
126 127 
Bank loan due 2026, interest rate of 2.8%
111 — 
Bank loans due at various dates through 2030(3)
Obligations under finance leases due at various dates through 2054
140 148 
Subtotal13,435 13,400 
Unamortized deferred financing costs(4)
(69)(74)
Current installments of long-term debt(2,348)(1,025)
Total11,018 12,301 
______________________________
(1)The interest rate was 6.922% and 6.943% as of March 31, 2024 and December 31, 2023, respectively.
(2)Interest rates range from 4.05% to 5.00%.
(3)The weighted average interest rate was 2.7% and 2.6% as of March 31, 2024 and December 31, 2023, respectively.
(4)Related to the Company's long-term debt, excluding obligations under finance leases.
Senior Credit Facilities
In March 2022, Celanese, Celanese U.S. and certain subsidiaries entered into a term loan credit agreement (as amended to date, the "March 2022 U.S. Term Loan Credit Agreement"), pursuant to which lenders provided a tranche of delayed-draw term loans due 364 days from issuance in an amount equal to $500 million (the "364-day Term Loans") and a tranche of delayed-draw term loans due 5 years from issuance in an amount equal to $1.0 billion (the "5-year Term Loans"). The 364-day Term Loans have been fully repaid.
Also in March 2022, Celanese, Celanese U.S. and certain subsidiaries entered into a new revolving credit agreement (as amended to date, the "U.S. Revolving Credit Agreement" and, together with the March 2022 U.S. Term Loan Credit Agreement, the "U.S. Credit Agreements") consisting of a $1.75 billion senior unsecured revolving credit facility (with a letter of credit sublimit), maturing in 2027 (the "U.S. Revolving Credit Facility"). The margin for borrowings under the U.S. Revolving Credit Facility was 1.00% to 2.00% above certain interbank rates at current Company credit ratings.
In August 2023, the Company amended certain covenants in the March 2022 U.S. Term Loan Credit Agreement to permit refinancing of certain senior notes without requiring a mandatory prepayment under the March 2022 U.S. Term Loan Credit Agreement.
On February 16, 2024 and February 21, 2023, the Company amended certain covenants in the U.S. Credit Agreements, including financial ratio maintenance covenants.
The U.S. Credit Agreements are guaranteed by Celanese, Celanese U.S. and domestic subsidiaries together representing substantially all of the Company's U.S. assets and business operations (the "Subsidiary Guarantors"). The Subsidiary Guarantors are listed in Exhibit 22.1 to this Quarterly Report.
In January 2023, Celanese (Shanghai) International Trading Co., Ltd ("CSIT"), a fully consolidated subsidiary, entered into a restatement of an existing credit facility agreement (the "China Revolving Credit Agreement") to upsize and modify the facility thereunder to consist of an aggregate CNY1.75 billion uncommitted senior unsecured revolving credit facility available under two tranches (with overdraft, bank guarantee and documentary credit sublimits) (the "China Revolving Credit Facility"). Obligations bear interest at certain fixed and floating rates. The China Revolving Credit Agreement is guaranteed by Celanese U.S.
Also in January 2023, CSIT entered into a senior unsecured working capital loan contract for CNY800 million (the "China Working Capital Term Loan Agreement"), payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates. The loan under the China Working Capital Term Loan Agreement was fully drawn in January 2023 and was supported by a letter of comfort from the Company. The China Working Capital Term Loan Agreement was fully repaid in the three months ended March 31, 2024.
In December 2023, Celanese (Nanjing) Chemical Co., Ltd. ("CNC") entered into a senior unsecured working capital loan agreement for CNY800 million, payable on December 25, 2026 and bearing interest at 2.8% (the "CNC Working Capital Loan Agreement," together with the China Revolving Credit Agreement and the China Working Capital Term Loan Agreement, the "China Credit Agreements," and the China Credit Agreements together with the U.S. Credit Agreements, the "Global Credit Agreements"). The loan under the CNC Working Capital Loan Agreement was fully drawn during the three months ended March 31, 2024. The Company expects that the China Credit Agreements will continue to facilitate its efficient repatriation of cash to the U.S. to repay debt and effectively redomicile a portion of its U.S. debt to China at a lower average interest rate.
The Company's debt balances and amounts available for borrowing under its senior unsecured revolving credit facilities are as follows:
As of
March 31,
2024
(In $ millions)
U.S. Revolving Credit Facility
Borrowings outstanding— 
Available for borrowing1,750 
China Revolving Credit Facility
Borrowings outstanding41 
Available for borrowing201 
On May 8, 2024, the Company drew $300 million from its U.S. Revolving Credit Facility. This borrowing and cash on hand were used to repay in full the Company's senior unsecured notes due 2024, with an interest rate of 3.500%, due on May 8, 2024.
Senior Notes
The Company has outstanding senior unsecured notes, issued in public offerings registered under the Securities Act of 1933, as amended (the "Securities Act") (collectively, the "Senior Notes"). The Senior Notes were issued by Celanese U.S. and are guaranteed on a senior unsecured basis by Celanese and the Subsidiary Guarantors. Celanese U.S. may redeem some or all of each of the Senior Notes, prior to their respective maturity dates, at a redemption price of 100% of the principal amount, plus a "make-whole" premium as specified in the applicable indenture, plus accrued and unpaid interest, if any, to the redemption date.
In August 2023, Celanese U.S. completed a public offering registered under the Securities Act of senior unsecured notes as follows (collectively, the "2023 Offering"):
Maturity DateAggregate Principal
Amount Issued
Discount to ParInterest Rate
(In $ millions)
November 15, 20281,000 99.986%6.350%
November 15, 2030999 99.950%6.550%
November 15, 20331,000 99.992%6.700%
In August 2023, Celanese U.S. completed a cash tender offer for $2.25 billion in aggregate principal amount (the "Tender Offer") as follows:
Maturity DateAggregate Principal Amount TenderedPurchase price per $1,000 principal amountTotal Tender Offer ConsiderationAccrued and Unpaid Interest
(In $ millions)(In $ millions)
June 30, 20241,473 $999.92 1,473 12 
March 15, 2025750 $1,002.85 752 20 
April 30, 202427 $983.95 27 — 
The net proceeds from the 2023 Offering were used (i) to fund the Tender Offer and (ii) for the repayment of other outstanding indebtedness, including the payment in full of the 364-day Term Loans and certain 3-year term loans pursuant to a term loan credit agreement entered into in September 2022.
Accounts Receivable Purchasing Facility
In June 2023, the Company entered into an amendment to the amended and restated receivables purchase agreement (the "Amended Receivables Purchase Agreement") under its U.S. accounts receivable purchasing facility among certain of the Company's subsidiaries, its wholly-owned, "bankruptcy remote" special purpose subsidiary ("SPE") and certain global financial institutions ("Purchasers"). The Amended Receivables Purchase Agreement extends the term of the accounts receivable purchasing facility such that the SPE may sell certain receivables until June 18, 2025. Under the Amended Receivables Purchase Agreement, transfers of U.S. accounts receivable from the SPE are treated as sales and are accounted for as a reduction in accounts receivable because the agreement transfers effective control over and risk related to the U.S. accounts receivable to the SPE. The Company and related subsidiaries have no continuing involvement in the transferred U.S. accounts receivable, other than collection and administrative responsibilities and, once sold, the U.S. accounts receivable are no longer available to satisfy creditors of the Company or the related subsidiaries. These sales are transacted at 100% of the face value of the relevant U.S. accounts receivable, resulting in derecognition of the U.S. accounts receivables from the Company's unaudited consolidated balance sheet. The Company de-recognized $290 million and $1.4 billion of accounts receivable under this agreement for the three months ended March 31, 2024 and year ended December 31, 2023, respectively, and collected $318 million and $1.3 billion of accounts receivable sold under this agreement during the same periods. Unsold U.S. accounts receivable of $153 million were pledged by the SPE as collateral to the Purchasers as of March 31, 2024.
Factoring and Discounting Agreements
The Company has factoring agreements in Europe and Singapore with financial institutions to sell 100% and 90% of certain accounts receivable, respectively, on a non-recourse basis. The Company also has a factoring agreement in China with a financial institution to sell 100% of certain accounts receivable on a limited recourse basis. These transactions are treated as sales and are accounted for as reductions in accounts receivable because the agreements transfer effective control over and risk related to the receivables to the buyer. The Company has no material continuing involvement in the transferred receivables, other than collection and administrative responsibilities and, once sold, the accounts receivable are no longer available to satisfy creditors in the event of bankruptcy. The Company de-recognized $164 million and $423 million of accounts receivable under these factoring agreements for the three months ended March 31, 2024 and year ended December 31, 2023, respectively, and collected $110 million and $407 million of accounts receivable sold under these factoring agreements during the same periods.
In December 2023, the Company entered into a Master Discounting Agreement (the "Master Discounting Agreement") with a financial institution in China to discount, on a non-recourse basis, banker's acceptance drafts ("BADs"), classified as accounts receivable. Under the Master Discounting Agreement, the transfer of BADs are treated as sales and are accounted for as a reduction in accounts receivable because the Master Discounting Agreement transfers effective control over and risk related to
the transferred BADs to the financial institution. The Company has no continuing involvement in the transferred BADs and the BADs are no longer available to satisfy creditors in the event of a bankruptcy. The Company received $15 million and $45 million from the accounts receivable transferred under the Master Discounting Agreement as of March 31, 2024 and December 31, 2023, respectively.
Covenants
The Company's material financing arrangements contain customary covenants, such as events of default and change of control provisions, and in the case of the U.S. Credit Agreements the maintenance of certain financial ratios (subject to adjustment following certain qualifying acquisitions and dispositions, as set forth in the U.S. Credit Agreements, as amended). Failure to comply with these covenants, or the occurrence of any other event of default, could result in acceleration of the borrowings and other financial obligations.
The Company is in compliance with the covenants in its material financing arrangements as of March 31, 2024.
XML 34 R15.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Benefit Obligations
3 Months Ended
Mar. 31, 2024
Retirement Benefits [Abstract]  
Benefit Obligations Benefit Obligations
The components of net periodic benefit cost are as follows:
Three Months Ended March 31,
20242023
Pension
Benefits
Post-retirement
Benefits
Pension
Benefits
Post-retirement
Benefits
(In $ millions)
Service cost— — 
Interest cost31 32 — 
Expected return on plan assets
(34)— (33)— 
Total— — 
Benefit obligation funding is as follows:
As of
March 31,
2024
Total
Expected
2024
(In $ millions)
Cash contributions to defined benefit pension plans29 
Benefit payments to nonqualified pension plans19 
Benefit payments to other postretirement benefit plans
The Company's estimates of its U.S. defined benefit pension plan contributions reflect the provisions of the Pension Protection Act of 2006.
Pension and postretirement benefit plan balances recognized in the unaudited consolidated balance sheets consist of the following:
As of March 31, 2024As of December 31, 2023
Pension
Benefits
Post-retirement
Benefits
Pension
Benefits
Post-retirement
Benefits
(In $ millions)
Noncurrent Other assets169 — 166 — 
Current Other liabilities(22)(3)(22)(3)
Benefit obligations(402)(37)(415)(37)
Net amount recognized(255)(40)(271)(40)
XML 35 R16.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Environmental
3 Months Ended
Mar. 31, 2024
Environmental Remediation Obligations [Abstract]  
Environmental Environmental
The Company is subject to environmental laws and regulations worldwide that impose limitations on the discharge of pollutants into the air and water, establish standards for the treatment, storage and disposal of solid and hazardous wastes, and impose record keeping and notification requirements. Failure to timely comply with these laws and regulations may expose the Company to penalties. The Company believes that it is in substantial compliance with all applicable environmental laws and regulations and engages in an ongoing process of updating its controls to mitigate compliance risks. The Company is also subject to retained environmental obligations specified in various contractual agreements arising from the divestiture of certain businesses by the Company or one of its predecessor companies.
The components of environmental remediation liabilities are as follows:
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Demerger obligations (Note 14)
13 14 
Divestiture obligations (Note 14)
13 13 
Active sites25 25 
U.S. Superfund sites
Other environmental remediation liabilities
Total60 62 
Remediation
Due to its industrial history and through retained contractual and legal obligations, the Company has the obligation to remediate specific areas on its own sites as well as on divested, demerger, orphan or U.S. Superfund sites (defined below). In addition, as part of the demerger agreement between the Company and Hoechst AG ("Hoechst"), a specified portion of the responsibility for environmental liabilities from a number of Hoechst divestitures was transferred to the Company (Note 14). Certain of these sites, at which the Company maintains continuing involvement, were and continue to be designated as discontinued operations when closed. The Company provides for such obligations when the event of loss is probable and reasonably estimable. The Company believes that environmental remediation costs will not have a material adverse effect on the financial position of the Company, but may have a material adverse effect on the results of operations or cash flows in any given period.
U.S. Superfund Sites
In the U.S., the Company may be subject to substantial claims brought by U.S. federal or state regulatory agencies or private individuals pursuant to statutory authority or common law. In particular, the Company has a potential liability under the U.S. Federal Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended, and related state laws (collectively referred to as "Superfund") for investigation and cleanup costs at certain sites. At most of these sites, numerous companies, including the Company, or one of its predecessor companies, have been notified that the U.S. Environmental Protection Agency ("EPA"), state governing bodies or private individuals consider such companies to be potentially responsible parties ("PRP") under Superfund or related laws. The proceedings relating to these sites are in various stages. The cleanup process has not been completed at most sites, and the status of the insurance coverage for some of these proceedings is uncertain. Consequently, the Company cannot accurately determine its ultimate liability for investigation or cleanup costs at these sites.
As events progress at each site for which it has been named a PRP, the Company accrues any probable and reasonably estimable liabilities. In establishing these liabilities, the Company considers the contaminants of concern, the potential impact thereof, the relationship of the contaminants of concern to its current and historic operations, its shipment of waste to a site, its percentage of total waste shipped to the site, the types of wastes involved, the conclusions of any studies, the magnitude of any remedial actions that may be necessary and the number and viability of other PRPs. Often the Company joins with other PRPs to sign joint defense agreements that settle, among PRPs, each party's percentage allocation of costs at the site. Although the ultimate liability may differ from the estimate, the Company routinely reviews the liabilities and revises the estimate, as appropriate, based on the most current information available.
One such site is the Diamond Alkali Superfund Site, which is comprised of a number of sub-sites, including the Lower Passaic River Study Area ("LPRSA"), which is the lower 17-mile stretch of the Passaic River ("Lower Passaic River Site"), and the
Newark Bay Study Area. The Company and 70 other companies are parties to a May 2007 Administrative Order on Consent with the EPA to perform a Remedial Investigation/Feasibility Study ("RI/FS") at the Lower Passaic River Site in order to identify the levels of contaminants and potential cleanup actions, including the potential migration of contaminants between the LPRSA and the Newark Bay Study Area.
In March 2016, the EPA issued its final Record of Decision concerning the remediation of the lower 8.3 miles of the Lower Passaic River Site ("Lower 8.3 Miles"). Pursuant to the EPA's Record of Decision, the Lower 8.3 Miles must be dredged bank to bank and an engineered cap must be installed at an EPA estimated cost of approximately $1.4 billion. In September 2021, the EPA issued a Record of Decision selecting an interim remedial plan for the upper 9 miles of the Lower Passaic River ("Upper 9 Miles"). Pursuant to the EPA's Record of Decision, targeted dredging will be conducted in the Upper 9 Miles to address surface sediments with elevated contamination followed by the installation of an engineered cap at an EPA estimated cost of $441 million.
The Company owned and/or operated facilities in the vicinity of the Lower 8.3 Miles, but has found no evidence that it contributed any of the contaminants of concern to the Passaic River. In June 2018, Occidental Chemical Corporation ("OCC"), the successor to the Diamond Alkali Company, sued a subsidiary of the Company and 119 other parties alleging claims for joint and several damages, contribution and declaratory relief under Section 107 and 113 of Superfund for costs to clean up the LPRSA portion of the Diamond Alkali Superfund Site, Occidental Chemical Corporation v. 21st Century Fox America, Inc., et al, No. 2:18-CV-11273 (MCA) (LDW) (U.S. District Court New Jersey) (the "2018 OCC Lawsuit"), alleging that each of the defendants owned or operated a facility that contributed contamination to the LPRSA. With respect to the Company, the 2018 OCC lawsuit is limited to the former Celanese facility that Essex County, New Jersey has agreed to indemnify the Company for and does not change the Company's estimated liability for LPRSA cleanup costs.
Separately, the United States lodged a Consent Decree in U.S. District Court for the District of New Jersey in December 2022 that will resolve the Company's liability (and that of more than 80 other settling defendants) to the EPA for costs to clean up both the Lower 8.3 Miles and Upper 9 Miles of the Lower Passaic River Site in exchange for a collective payment of $150 million, United States v. Alden Leeds, Inc., No. 2:22-7326 (MCA) (LDW) (U.S. District Court New Jersey) ("Consent Decree Action"). The Consent Decree also will provide the Company protection from contribution claims by others for costs incurred to clean up both the Lower 8.3 Miles and Upper 9 Miles of the Lower Passaic River Site. The Company's proposed payment toward the $150 million collective settlement payment is not material to the Company's results of operations, cash flows or financial position. The Consent Decree is still subject to public comment and court approval.
In March 2023, the U.S. District Court for the District of New Jersey entered an order staying and administratively terminating the 2018 OCC Lawsuit, pending resolution of the request for judicial approval of the Consent Decree in the Consent Decree Action. Also in March 2023, OCC filed a new lawsuit against 40 parties, including a subsidiary of the Company, seeking to recover costs for remedial design work the EPA has ordered OCC to undertake for a portion of the LPRSA at an estimated cost of $71 million, Occidental Chemical Corporation v. Givaudan Fragrances Corporation, No. 2:23-cv-1699 (U.S. District Court New Jersey) (the "2023 OCC Lawsuit"). Like the earlier lawsuit, the 2023 OCC Lawsuit concerns the facility Essex County, New Jersey purchased and for which Essex County, New Jersey has agreed to defend and indemnify the Company. This new lawsuit does not change the Company's estimated liability for LPRSA cleanup costs.
The Company will continue to vigorously defend these matters and continues to believe that its ultimate allocable share of the cleanup costs with respect to the Lower Passaic River Site, previously estimated at less than 1%, will not be material.
Other Environmental Matters
In April 2022, a methanol leak on a pipeline to the Company's Bishop, Texas facility was discovered. The release has been contained, the leak has been repaired and the pipeline has resumed operation. The Company promptly disclosed the incident to state and federal authorities, including the Texas Commission on Environmental Quality and the EPA, and remediation activities are now completed. While the Company has not received a notice of violation nor been assessed any fines or penalties to date, the Company recorded a reserve in Other current liabilities based on anticipated clean-up costs and possible penalties to state or federal authorities. The Company does not believe that resolution of this matter will have a material impact on its financial condition or results of operations.
XML 36 R17.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders' Equity
3 Months Ended
Mar. 31, 2024
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Shareholders' Equity
Common Stock
The Company's Board of Directors follows a policy of declaring, subject to legally available funds, a quarterly cash dividend on each share of the Company's Common Stock, par value $0.0001 per share ("Common Stock"), unless the Company's Board of Directors, in its sole discretion, determines otherwise. The amount available to the Company to pay cash dividends is not currently restricted by the Global Credit Agreements and its indentures governing its senior unsecured notes. Any decision to declare and pay dividends in the future will be made at the discretion of the Company's Board of Directors and will depend on, among other things, the results of operations, cash requirements, financial condition, contractual restrictions and other factors that the Company's Board of Directors may deem relevant.
The Company declared a quarterly cash dividend of $0.70 per share on its Common Stock on April 17, 2024, amounting to $76 million. The cash dividend will be paid on May 13, 2024 to holders of record as of April 29, 2024.
Treasury Stock
The Company's Board of Directors authorizes repurchases of Common Stock from time to time. These authorizations give management discretion in determining the timing and conditions under which shares may be repurchased. This repurchase program does not have an expiration date.
Total From
February 2008
Through
March 31, 2024
Shares repurchased69,324,429 
Average purchase price per share$83.71 
Shares repurchased (in $ millions)5,803 
Aggregate Board of Directors repurchase authorizations during the period (in $ millions)
6,866 
The purchase of treasury stock reduces the number of shares outstanding. The repurchased shares may be used by the Company for compensation programs utilizing the Company's stock and other corporate purposes. The Company accounts for treasury stock using the cost method and includes treasury stock as a component of shareholders' equity.
The Company did not repurchase any Common Stock during the three months ended March 31, 2024 or 2023.
Other Comprehensive Income (Loss), Net
Three Months Ended March 31,
20242023
Gross
Amount
Income
Tax
(Provision)
Benefit
Net
Amount
Gross
Amount
Income
Tax
(Provision)
Benefit
Net
Amount
(In $ millions)
Foreign currency translation gain (loss)(27)(27)(54)(4)17 13 
Gain (loss) on derivative hedges— — 
Pension and postretirement benefits gain (loss)(1)— (1)(1)— (1)
Total(26)(27)(53)(1)17 16 
Adjustments to Accumulated other comprehensive income (loss), net, are as follows:
Foreign
Currency
Translation Gain (Loss)
Gain (Loss)
on Derivative
Hedges
Pension and
Postretirement
Benefits Gain (Loss)
Accumulated
Other
Comprehensive
Income
(Loss), Net
(In $ millions)
As of December 31, 2023(701)(28)(15)(744)
Other comprehensive income (loss) before reclassifications(27)23 (1)(5)
Amounts reclassified from accumulated other comprehensive income (loss)
— (21)— (21)
Income tax (provision) benefit(27)— — (27)
As of March 31, 2024(755)(26)(16)(797)
XML 37 R18.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Other (Charges) Gains, Net
3 Months Ended
Mar. 31, 2024
Restructuring and Related Activities [Abstract]  
Other (Charges) Gains, Net Other (Charges) Gains, Net
Three Months Ended
March 31,
20242023
(In $ millions)
Restructuring(1)
(14)(23)
Total(14)(23)
______________________________
(1)Includes employee termination benefits related to Company-wide business optimization projects and the previously announced closure of its polymerization units in Uentrop, Germany (Note 3).
The changes in the restructuring liabilities by business segment are as follows:
Engineered
Materials
Acetyl
Chain
OtherTotal
(In $ millions)
Employee Termination Benefits
As of December 31, 202313 18 
Additions12 — 15 
Cash payments(8)(1)(4)(13)
Other changes(1)— — (1)
As of March 31, 202416 19 
XML 38 R19.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Income Taxes
3 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Three Months Ended
March 31,
20242023
(In percentages)
Effective income tax rate21 21 
The effective income tax rate for the three months ended March 31, 2024 was consistent with the same period in 2023. The effective income tax rate for the three months ended March 31, 2024 included the tax effects related to internal debt refinancing transactions. The effective income tax rate for the three months ended March 31, 2023 included the impacts of increased valuation allowance on U.S. foreign tax credit carryforwards due to changes in forecasts of foreign sourced income and deductions that did not re-occur in the three months ended March 31, 2024.
In December 2017, the Tax Cuts and Jobs Act (the "TCJA") was enacted and was effective January 1, 2018. The U.S. Treasury has issued various notices and final and proposed regulatory packages supplementing the TCJA provisions since 2018. There have been no material proposed or final regulatory packages during the three months ended March 31, 2024.
In August 2022, the Inflation Reduction Act (the "IRA") was enacted and included a 1% excise tax on share repurchases in excess of $1 million, and a corporate minimum tax of 15% on adjusted book earnings. The corporate minimum tax paid is creditable in future years to the extent regular tax liability exceeds the minimum tax in any given year. The U.S. Treasury issued two sets of proposed regulations related to Section 4501, Excise Tax on Share Repurchase, on April 12, 2024. The Company does not expect these provisions or proposed regulations will have a material impact to future income tax expense. The IRA also provides various beneficial credits for energy efficient related manufacturing, transportation and fuels, hydrogen/carbon recapture and renewable energy, which the Company is evaluating in regard to planned projects.
The Company will continue to monitor the expected impacts of any new guidance on the Company's filing positions and will record the impacts as discrete income tax expense adjustments in the period the guidance is finalized or becomes effective.
Due to the TCJA and uncertainty as to future foreign source income, the Company previously recorded a valuation allowance on a substantial portion of its foreign tax credit carryforwards. The Company is currently evaluating tax planning strategies to enable the use of the Company's foreign tax credit carryforwards that may decrease the Company's effective tax rate in future periods as the valuation allowance is reversed.
In December 2021, the Organization for Economic Co-operation and Development ("OECD") issued final Model Rules for Pillars One and Two of its Base Erosion and Profit Shifting ("BEPS") project. In general, Pillar One addresses nexus concerns and the allocation of profits among companies in which a multinational enterprise ("MNE") conducts its business. Pillar Two aims to ensure that all MNEs pay an effective tax rate of no less than 15% on their adjusted net income in each of the jurisdictions in which they have operations. Pillar Two is more impactful to the Company as it allows for assessment even if the individual countries do not enact its minimum tax provisions. In effect, Pillar Two allows any country within which an MNE operates to levy tax upon that MNE to the extent it determines that the MNE is paying less than a 15% effective tax rate on its adjusted net income. The taxes levied may then be allocated among the jurisdictions that conform to the OECD rules.
In December 2022, the member states of the European Union ("EU") unanimously voted to adopt the OECD's minimum tax which was agreed to by consensus of the BEPS 2.0 (Pillars One and Two) signatory jurisdictions. Under the EU's minimum tax directive, member states are to adopt domestic legislation implementing the minimum tax rules effective for periods beginning on or after December 31, 2023, with Pillar Two's "under-taxed profit rule" to take effect for periods beginning on or after December 31, 2024. The EU effective dates are January 1, 2024, and January 1, 2025, for different aspects of the directive. Legislatures in multiple countries outside of the EU have also drafted legislation to implement the OECD's minimum tax proposals.
In July 2023, the OECD published Administrative Guidance proposing certain safe harbor provisions, including an effective rate test and a routine profits test, which if satisfied effectively will delay effective dates of Pillar Two to January 1, 2027. The EU and a significant number of other countries are expected to implement the safe harbor in local legislation. Based on these safe harbor provisions, the Company currently expects that, in several material jurisdictions, including the U.S., Netherlands, Switzerland, Germany, China, Singapore and Canada, it will qualify for the safe harbor effectively extending the application of the global minimum tax until January 1, 2027.
The Company will continue to monitor the developments and implementation of the OECD BEPS projects. Currently the Company does not meet the requirements for the application of Pillar One. The Company analyzed the application of the safe harbor provisions and does not expect a material impact in 2024 from the local adoption of the OECD Pillar Two proposals, but is continuing to model the effect of these provisions on its future effective tax rate and cash taxes.
The Company's tax returns have been under audit for the years 2013 through 2015 by the United States, Netherlands and Germany (the "Authorities"). In September 2021, the Company received a draft joint audit report proposing adjustments to transfer pricing and the reallocation of income between the related jurisdictions. The Authorities also proposed to apply these adjustments to open tax years through 2019. The Company and the Authorities were unable to reach an agreement jointly and therefore the audits continued on a separate jurisdictional basis. In the fourth quarter of 2022, the Company concluded settlement discussions with the Dutch tax authority. The Company is engaged in continuing discussions with the other Authorities and is currently evaluating all additional potential remedies regarding the ongoing examinations.
In addition, the Company's income tax returns in Mexico are under audit for the year 2018, and in Canada for the years 2016 through 2022. In August 2023, the Company negotiated a partial settlement with the Mexico tax authority for its audit for the year 2018. The partial settlement did not have a material impact on income tax expense in the consolidated statements of operations for the year ended December 31, 2023. In September 2023, the Canadian tax authority opened tax audits for the years 2019 through 2022, and the audits are in the preliminary stages. The Company is in ongoing discussions regarding the audit findings with the Canadian tax authority for the years 2016 through 2018 and does not expect a material impact to income tax expense.
As of March 31, 2024, the Company believes that an adequate provision for income taxes has been made for all open tax years related to the examinations by government authorities. However, the outcome of tax audits cannot be predicted with certainty. If any issues raised in the audits described above are resolved in a manner inconsistent with the Company's expectations or the Company is unsuccessful in defending its positions, the Company could be required to adjust its provision for income taxes in the period such resolution occurs. If required, any such adjustments could be material to the statements of operations and cash flows in the period(s) recorded.
XML 39 R20.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Derivative Financial Instruments
3 Months Ended
Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
Information regarding changes in the fair value of the Company's derivative and non-derivative instruments is as follows:
Gain (Loss) Recognized in Other Comprehensive Income (Loss)Gain (Loss) Recognized in Earnings (Loss)
Three Months Ended March 31, Statement of Operations Classification
2024202320242023
(In $ millions)
Designated as Cash Flow Hedges
Commodity swaps— (1)Cost of sales
Interest rate swaps— — (2)(2)Interest expense
Foreign currency forwards— — (1)Cost of sales
Total(3)(2)
Designated as Fair Value Hedges
Cross-currency swaps(1)
19 — 24 — Foreign exchange gain (loss), net
Designated as Net Investment Hedges
Foreign currency denominated debt67 (56)— — N/A
Cross-currency swaps70 (19)— — N/A
Total137 (75)— — 
Not Designated as Hedges
Foreign currency forwards and swaps— — 16 Foreign exchange gain (loss), net; Other income (expense), net
______________________________
(1)In conjunction with the 2023 Offering (Note 7) in August 2023, the Company entered into a cross-currency swap to effectively convert $500 million of the issued notes into a Japanese yen-denominated borrowing at prevailing yen interest rates, maturing on July 15, 2029. The swap qualifies and has been designated as a fair value hedge of the Company's foreign currency exchange rate exposure on the long-term debt of its Japanese yen-denominated subsidiary.
Additionally, in conjunction with the 2023 Offering (Note 7) in August 2023, the Company entered into cross-currency swaps to effectively convert $1.0 billion of the issued notes into 5-year and 7-year euro-denominated borrowings at prevailing euro interest rates, maturing on November 15, 2028 and November 15, 2030, respectively. The swaps qualify and have been designated as fair value hedges of the Company's foreign currency exchange rate exposure on the long-term debt of its euro-denominated subsidiary.
See Note 13 for additional information regarding the fair value of the Company's derivative instruments.
Certain of the Company's commodity swaps, interest rate swaps, cross-currency swaps and foreign currency forwards and swaps permit the Company to net settle all contracts with the counterparty through a single payment in an agreed upon currency in the event of default or early termination of the contract, similar to a master netting arrangement.
Information regarding the gross amounts of the Company's derivative instruments and the amounts offset in the unaudited consolidated balance sheets is as follows:
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Derivative Assets
Gross amount recognized201 183 
Gross amount offset in the consolidated balance sheets— — 
Net amount presented in the consolidated balance sheets201 183 
Gross amount not offset in the consolidated balance sheets32 40 
Net amount169 143 
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Derivative Liabilities
Gross amount recognized316 440 
Gross amount offset in the consolidated balance sheets— — 
Net amount presented in the consolidated balance sheets316 440 
Gross amount not offset in the consolidated balance sheets32 40 
Net amount284 400 
XML 40 R21.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Fair Value Measurements
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
The Company's financial assets and liabilities are measured at fair value on a recurring basis as follows:
Derivative financial instruments include interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps and are valued in the market using discounted cash flow techniques. These techniques incorporate Level 1 and Level 2 fair value measurement inputs such as interest rates and foreign currency exchange rates. These market inputs are utilized in the discounted cash flow calculation considering the instrument's term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation for interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps are observable in the active markets and are classified as Level 2 in the fair value measurement hierarchy.
Fair Value Measurement
Significant Other Observable Inputs (Level 2)
Other assetsOther liabilities
Notional AmountCurrentNoncurrentCurrentNoncurrent
(In millions)(In $ millions)
As of March 31, 2024
Derivatives Designated as Cash Flow Hedges
Commodity swaps$59 40 — 
Designated as Fair Value Hedges
Cross-currency swaps$1,500 54 22 16 
Derivatives Designated as Net Investment Hedges
Cross-currency swaps5,712 77 — 29 230 
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps$2,137 23 — 12 
Total159 42 58 258 
As of December 31, 2023
Derivatives Designated as Cash Flow Hedges
Commodity swaps$67 36 — 
Designated as Fair Value Hedges
Cross-currency swaps$1,500 40 — 11 61 
Derivatives Designated as Net Investment Hedges
Cross-currency swaps5,712 93 — 61 281 
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps$1,954 — 16 
Total147 36 90 350 
Carrying values and fair values of financial instruments that are not carried at fair value are as follows:
Fair Value Measurement
Carrying
Amount
Significant Other
Observable
Inputs
(Level 2)
Unobservable
Inputs
(Level 3)
Total
(In $ millions)
As of March 31, 2024
Equity investments without readily determinable fair values
170 — — — 
Insurance contracts in nonqualified trusts18 18 — 18 
Long-term debt, including current installments of long-term debt
13,435 13,472 140 13,612 
As of December 31, 2023
Equity investments without readily determinable fair values
170 — — — 
Insurance contracts in nonqualified trusts21 21 — 21 
Long-term debt, including current installments of long-term debt
13,400 13,514 148 13,662 
In general, the equity investments included in the table above are not publicly traded and their fair values are not readily determinable. The Company believes the carrying values approximate fair value. Insurance contracts in nonqualified trusts consist of long-term fixed income securities, which are valued using independent vendor pricing models with observable inputs in the active market and therefore represent a Level 2 fair value measurement. The fair value of long-term debt is based on valuations from third-party banks and market quotations and is classified as Level 2 in the fair value measurement hierarchy. The fair value of obligations under finance leases, which are included in long-term debt in the unaudited consolidated balance sheets, is based on lease payments and discount rates, which are not observable in the market and therefore represents a Level 3 fair value measurement.
As of March 31, 2024 and December 31, 2023, the fair values of cash and cash equivalents, receivables, trade payables, short-term borrowings and the current installments of long-term debt approximate carrying values due to the short-term nature of these instruments. These items have been excluded from the table with the exception of the current installments of long-term debt.
XML 41 R22.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies
3 Months Ended
Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Commitments
Guarantees
The Company has agreed to guarantee or indemnify third parties for environmental and other liabilities pursuant to a variety of agreements, including asset and business divestiture agreements, leases, settlement agreements and various agreements with affiliated companies. Although many of these obligations contain monetary and/or time limitations, others do not provide such limitations.
The Company has accrued for all probable and reasonably estimable losses associated with all known matters or claims. These known obligations include the following:
Demerger Obligations
In connection with the Hoechst demerger, the Company agreed to indemnify Hoechst, and its legal successors, for various liabilities under the demerger agreement, including for environmental liabilities associated with contamination arising either from environmental damage in general ("Category A") or under 19 divestiture agreements entered into by Hoechst prior to the demerger ("Category B") (Note 9).
The Company's obligation to indemnify Hoechst, and its legal successors, is capped under Category B at €250 million. If and to the extent the environmental damage should exceed €750 million in aggregate, the Company's obligation to indemnify Hoechst
and its legal successors applies, but is then limited to 33.33% of the remediation cost without further limitations. Cumulative payments under the divestiture agreements as of March 31, 2024 are $114 million. Though the Company is significantly under its obligation cap under Category B, most of the divestiture agreements have become time barred and/or any notified environmental damage claims have been partially settled.
The Company has also undertaken in the demerger agreement to indemnify Hoechst and its legal successors for (i) 33.33% of any and all Category A liabilities that result from Hoechst being held as the responsible party pursuant to public law or current or future environmental law or by third parties pursuant to private or public law related to contamination and (ii) liabilities that Hoechst is required to discharge, including tax liabilities, which are associated with businesses that were included in the demerger but were not demerged due to legal restrictions on the transfers of such items. These indemnities do not provide for any monetary or time limitations. The Company has not been requested by Hoechst to make any payments in connection with this indemnification. Accordingly, the Company has not made any payments to Hoechst and its legal successors.
Based on the Company's evaluation of currently available information, including the lack of requests for indemnification, the Company cannot estimate the remaining demerger obligations, if any, in excess of amounts accrued.
Divestiture Obligations
The Company and its predecessor companies agreed to indemnify third-party purchasers of former businesses and assets for various pre-closing conditions, as well as for breaches of representations, warranties and covenants. Such liabilities also include environmental liability, product liability, antitrust and other liabilities. These indemnifications and guarantees represent standard contractual terms associated with typical divestiture agreements and, other than environmental liabilities, the Company does not believe that they expose the Company to significant risk (Note 9).
The Company has divested numerous businesses, investments and facilities through agreements containing indemnifications or guarantees to the purchasers. Many of the obligations contain monetary and/or time limitations, which extend through 2037. The aggregate amount of outstanding indemnifications and guarantees provided for under these agreements is $116 million as of March 31, 2024. Other agreements do not provide for any monetary or time limitations.
Based on the Company's evaluation of currently available information, including the number of requests for indemnification or other payment received by the Company, the Company cannot estimate the remaining divestiture obligations, if any, in excess of amounts accrued.
Purchase Obligations
In the normal course of business, the Company enters into various purchase commitments for goods and services. The Company maintains a number of "take-or-pay" contracts for purchases of raw materials, utilities and other services. Certain of the contracts contain a contract termination buy-out provision that allows for the Company to exit the contracts for amounts less than the remaining take-or-pay obligations. Additionally, the Company has other outstanding commitments representing maintenance and service agreements, energy and utility agreements, consulting contracts and software agreements. As of March 31, 2024, the Company had unconditional purchase obligations of $4.2 billion, of which $530 million will be paid in 2024, $592 million in 2025, $483 million in 2026, $429 million in 2027, $289 million in 2028 and the balance thereafter through 2042.
Contingencies
The Company is involved in legal and regulatory proceedings, lawsuits, claims and investigations incidental to the normal conduct of business, relating to such matters as product liability, land disputes, insurance coverage disputes, contracts, employment, antitrust or competition, intellectual property, personal injury and other actions in tort, workers' compensation, chemical exposure, asbestos exposure, taxes, trade compliance, acquisitions and divestitures, claims of current and legacy shareholders, past waste disposal practices and release of chemicals into the environment. The Company is actively defending those matters where the Company is named as a defendant and, based on the current facts, does not believe the outcomes from these matters would be material to the Company's results of operations, cash flows or financial position.
As previously reported, in July 2020, the Company settled a European Commission competition law investigation involving certain of its subsidiaries and three other companies related to certain past ethylene purchases. Shell Chemicals Europe and another group of corporate claimants have filed claims for damages with the District Court of Amsterdam against four companies, including Celanese, arising from those activities, and the first court hearing was held in late September 2023. The Company intends to vigorously defend itself against these claims. While it is possible that additional parties could assert
demands or claims related to this matter, based on information available at this time, the Company does not expect ultimate resolution of this matter to have a material impact on its financial condition or results of operations.
XML 42 R23.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Segment Information
3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Segment Information Segment Information
Engineered
Materials
Acetyl
Chain
Other
Activities
EliminationsConsolidated
(In $ millions)
Three Months Ended March 31, 2024
Net sales1,378 1,261 — (28)(1)2,611 
Other (charges) gains, net (Note 18)
(11)— (3)— (14)
Operating profit (loss)89 254 (133)— 210 
Equity in net earnings (loss) of affiliates
49 — 55 
Depreciation and amortization147 57 17 — 221 
Capital expenditures37 40 28 — 105 (2)
As of March 31, 2024
Goodwill and intangible assets, net
10,407 421 — — 10,828 
Total assets
17,620 5,520 2,893 — 26,033 
Three Months Ended March 31, 2023
Net sales
1,630 

1,250 

— (27)(1)2,853 
Other (charges) gains, net (Note 18)
(21)(1)(1)— (23)
Operating profit (loss)
112 278 (139)— 251 
Equity in net earnings (loss) of affiliates
11 — 15 
Depreciation and amortization
112 54 — 172 
Capital expenditures
45 51 12 — 108 (2)
As of December 31, 2023
Goodwill and intangible assets, net
10,525 427 — — 10,952 
Total assets
17,930 5,538 3,129 — 26,597 
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes a decrease in accrued capital expenditures of $32 million and $56 million for the three months ended March 31, 2024 and 2023, respectively.
XML 43 R24.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Revenue Recognition
3 Months Ended
Mar. 31, 2024
Revenue Recognition and Deferred Revenue [Abstract]  
Revenue Recognition Revenue Recognition
The Company has certain contracts that represent take-or-pay revenue arrangements in which the Company's performance obligations extend over multiple years. As of March 31, 2024, the Company had $1.3 billion of remaining performance obligations related to take-or-pay contracts. The Company expects to recognize approximately $458 million of its remaining performance obligations as Net sales in 2024, $423 million in 2025, $195 million in 2026 and the balance thereafter.
Contract Balances
Contract liabilities primarily relate to advances or deposits received from the Company's customers before revenue is recognized. These amounts are recorded as deferred revenue and are included in Current and Noncurrent Other liabilities in the unaudited consolidated balance sheets.
The Company does not have any material contract assets as of March 31, 2024.
Disaggregated Revenue
In general, the Company's business segmentation is aligned according to the nature and economic characteristics of its products and customer relationships and provides meaningful disaggregation of each business segment's results of operations.
The Company manages its Engineered Materials business segment through its project management pipeline, which is comprised of a broad range of projects that are solutions-based and are tailored to each customer's unique needs. Projects are identified and selected based on success rate and may involve a number of different polymers per project for use in multiple end-use applications. Therefore, the Company is agnostic toward products and end-use markets for the Engineered Materials business segment.
The Company manages its Acetyl Chain business segment by leveraging its ability to sell chemicals externally to end-use markets or downstream to its acetate tow, intermediate chemistry, emulsion polymers, redispersible powders and ethylene vinyl acetate polymers businesses. Decisions to sell externally and geographically or downstream and along the Acetyl Chain are based on market demand, trade flows and maximizing the value of its chemicals. Therefore, the Company's strategic focus is on executing within this integrated chain model and less on driving product-specific revenue.
Further disaggregation of Net sales by business segment and geographic destination is as follows:
Three Months Ended
March 31,
20242023
(In $ millions)
Engineered Materials
North America372 479 
Europe and Africa456 560 
Asia-Pacific516 548 
South America34 43 
Total1,378 1,630 
Acetyl Chain
North America388 365 
Europe and Africa423 460 
Asia-Pacific394 367 
South America28 31 
Total(1)
1,233 1,223 
______________________________
(1)Excludes intersegment sales of $28 million and $27 million for the three months ended March 31, 2024 and 2023, respectively.
XML 44 R25.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Earnings (Loss) Per Share
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share Earnings (Loss) Per Share
Three Months Ended
March 31,
20242023
(In $ millions, except share data)
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations121 94 
Earnings (loss) from discontinued operations— (3)
Net earnings (loss)121 91 
Weighted average shares - basic109,069,060 108,634,068 
Incremental shares attributable to equity awards(1)
444,931 554,198 
Weighted average shares - diluted109,513,991 109,188,266 
______________________________
(1)Excludes stock options to purchase 68,415, and 86,194 shares of Common Stock for the three months ended March 31, 2024 and 2023, respectively; and 0 and 72,574 equity award shares for the three months ended March 31, 2024 and 2023, respectively, as their effect would have been antidilutive.
XML 45 R26.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Pay vs Performance Disclosure - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pay vs Performance Disclosure    
Net earnings (loss) attributable to Celanese Corporation $ 121 $ 91
XML 46 R27.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 47 R28.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Recent Accounting Pronouncements (Policies)
3 Months Ended
Mar. 31, 2024
Recent Accounting Pronouncements [Abstract]  
Estimates and Assumptions
Estimates and Assumptions
The preparation of unaudited interim consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the unaudited interim consolidated financial statements and the reported amounts of net sales, expenses and allocated charges during the reporting period. Significant estimates pertain to impairments of goodwill, intangible assets and other long-lived assets, purchase price allocations, restructuring costs and other (charges) gains, net, income taxes, pension and other postretirement benefits, asset retirement obligations, environmental liabilities and loss contingencies, among others. Actual results could differ from those estimates.
New Accounting Pronouncements, Policy
The following table provides a brief description of recent Accounting Standard Updates ("ASU") issued by the Financial Accounting Standards Board ("FASB"):
StandardDescriptionEffective DateEffect on the Financial Statements or Other Significant Matters
In December 2023, the FASB issued ASU 2023-09, Improvements to Income Tax Disclosures.
The new guidance requires an entity to disclose specific categories in the rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. Additionally, the guidance requires an entity to disclose annual income taxes paid (net of refunds received) disaggregated by federal (national), state and foreign taxes and disaggregate the information by jurisdiction based on a quantitative threshold. The guidance also requires an entity to disclose income (loss) from continuing operations before income tax expense (benefit) disaggregated between domestic and foreign and income tax expense (benefit) from continuing operations disaggregated by federal (national), state and foreign.Effective for annual periods beginning after December 15, 2024. Early adoption is permitted.The Company is currently evaluating the impact of the adoption on its financial statement disclosures.
In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures.
The new guidance requires an entity to disclose, on an annual and interim basis, significant segment expenses that are regularly provided to the chief operating decision maker ("CODM") and included within segment profit or loss, as well as an amount of other segment items by reportable segment and a description of its composition. Additionally, the guidance requires an entity to disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. The update is required to be applied retrospectively to prior periods presented, based on the significant segment expense categories identified and disclosed in the period of adoption.Effective for annual periods beginning after December 15, 2023, and for interim periods beginning after December 15, 2024. Early adoption is permitted.The Company is currently evaluating the impact of the adoption on its financial statement disclosures.
XML 48 R29.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Acquisitions, Dispositions and Plant Closures Plant Closures (Tables)
3 Months Ended
Mar. 31, 2024
Plant Closures [Abstract]  
Schedule of Exit and Shutdown Cost Related to Closure
The exit and shutdown costs related to the closure of the PA66 and HPN polymerization units in Uentrop, Germany were as follows:
Three Months Ended
March 31,
2024
(In $ millions)
Restructuring(1)
Accelerated depreciation expense(2)
37 
Total42 
______________________________
(1)Included in Other (charges) gains, net in the unaudited interim consolidated statements of operations (Note 18).
(2)Included in Cost of sales in the unaudited interim consolidated statements of operations.
The Company plans to cease operations in the fourth quarter of 2024.
Three Months Ended
March 31,
2024
(In $ millions)
Accelerated depreciation expense(1)
Total
______________________________
(1)Included in Cost of sales in the unaudited interim consolidated statements of operations.
XML 49 R30.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Inventories (Tables)
3 Months Ended
Mar. 31, 2024
Inventory Disclosure [Abstract]  
Schedule of Inventories
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Finished goods1,650 1,604 
Work-in-process128 160 
Raw materials and supplies576 593 
Total2,354 2,357 
XML 50 R31.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Goodwill and Intangible Assets, Net (Tables)
3 Months Ended
Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
Engineered
Materials
Acetyl ChainTotal
(In $ millions)
As of December 31, 20236,602 375 6,977 
Exchange rate changes(46)(5)(51)
As of March 31, 2024(1)
6,556 370 6,926 
______________________________
(1)There were no accumulated impairment losses as of March 31, 2024.
Schedule of Finite-Lived Intangible Assets
Finite-lived intangible assets are as follows:
LicensesCustomer-
Related
Intangible
Assets
Developed
Technology
Covenants
Not to
Compete
and Other
Total
(In $ millions)
Gross Asset Value
As of December 31, 202341 2,437 601 55 3,134 
Exchange rate changes(1)(28)— — (29)
As of March 31, 202440 2,409 601 55 3,105 
Accumulated Amortization
As of December 31, 2023(38)(639)(95)(42)(814)
Amortization— (30)(11)— (41)
Exchange rate changes— 12 
As of March 31, 2024(38)(660)(104)(41)(843)
Net book value1,749 497 14 2,262 
Schedule of Indefinite-Lived Intangible Assets
Indefinite-lived intangible assets are as follows:
Trademarks
and Trade Names
(In $ millions)
As of December 31, 20231,655 
Exchange rate changes(15)
As of March 31, 20241,640 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
Estimated amortization expense for the succeeding five fiscal years is as follows:
(In $ millions)
2025161 
2026160 
2027160 
2028160 
2029155 
XML 51 R32.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Current Other Liabilities (Tables)
3 Months Ended
Mar. 31, 2024
Other Liabilities, Current [Abstract]  
Schedule of Current Other Liabilities
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Benefit obligations (Note 8)
25 25 
Customer rebates76 96 
Derivatives (Note 12)
58 90 
Interest (Note 7)
194 246 
Legal (Note 14)
12 34 
Operating leases86 89 
Restructuring (Note 18)
19 18 
Salaries and benefits133 175 
Sales and use tax/foreign withholding tax payable133 128 
Investment in affiliates96 96 
Other179 157 
Total1,011 1,154 
XML 52 R33.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt (Tables)
3 Months Ended
Mar. 31, 2024
Debt Disclosure [Abstract]  
Schedule of Short-term Debt
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates
Current installments of long-term debt2,348 1,025 
Short-term borrowings, including amounts due to affiliates(1)
50 146 
Revolving credit facilities(2)
41 212 
Total2,439 1,383 
______________________________
(1)The weighted average interest rate was 2.2% and 2.9% as of March 31, 2024 and December 31, 2023, respectively.
(2)The weighted average interest rate was 3.2% and 3.4% as of March 31, 2024 and December 31, 2023, respectively.
Schedule of Long-term Debt
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Long-Term Debt
Senior unsecured notes due 2024, interest rate of 3.500%
473 473 
Senior unsecured notes due 2024, interest rate of 5.900%
527 527 
Senior unsecured notes due 2025, interest rate of 1.250%
324 331 
Senior unsecured notes due 2025, interest rate of 6.050%
1,000 1,000 
Senior unsecured notes due 2026, interest rate of 1.400%
400 400 
Senior unsecured notes due 2026, interest rate of 4.777%
1,081 1,105 
Senior unsecured notes due 2027, interest rate of 2.125%
539 551 
Senior unsecured notes due 2027, interest rate of 6.165%
2,000 2,000 
Senior unsecured term loan due 2027(1)
880 880 
Senior unsecured notes due 2028, interest rate of 0.625%
540 552 
Senior unsecured notes due 2028, interest rate of 6.350%
1,000 1,000 
Senior unsecured notes due 2029, interest rate of 5.337%
540 552 
Senior unsecured notes due 2029, interest rate of 6.330%
750 750 
Senior unsecured notes due 2030, interest rate of 6.550%
999 999 
Senior unsecured notes due 2032, interest rate of 6.379%
1,000 1,000 
Senior unsecured notes due 2033, interest rate of 6.700%
1,000 1,000 
Pollution control and industrial revenue bonds due at various dates through 2030(2)
126 127 
Bank loan due 2026, interest rate of 2.8%
111 — 
Bank loans due at various dates through 2030(3)
Obligations under finance leases due at various dates through 2054
140 148 
Subtotal13,435 13,400 
Unamortized deferred financing costs(4)
(69)(74)
Current installments of long-term debt(2,348)(1,025)
Total11,018 12,301 
______________________________
(1)The interest rate was 6.922% and 6.943% as of March 31, 2024 and December 31, 2023, respectively.
(2)Interest rates range from 4.05% to 5.00%.
(3)The weighted average interest rate was 2.7% and 2.6% as of March 31, 2024 and December 31, 2023, respectively.
(4)Related to the Company's long-term debt, excluding obligations under finance leases.
Schedule of Balances Available for Borrowing
The Company's debt balances and amounts available for borrowing under its senior unsecured revolving credit facilities are as follows:
As of
March 31,
2024
(In $ millions)
U.S. Revolving Credit Facility
Borrowings outstanding— 
Available for borrowing1,750 
China Revolving Credit Facility
Borrowings outstanding41 
Available for borrowing201 
Schedule of Senior Unsecured Notes Offering
In August 2023, Celanese U.S. completed a public offering registered under the Securities Act of senior unsecured notes as follows (collectively, the "2023 Offering"):
Maturity DateAggregate Principal
Amount Issued
Discount to ParInterest Rate
(In $ millions)
November 15, 20281,000 99.986%6.350%
November 15, 2030999 99.950%6.550%
November 15, 20331,000 99.992%6.700%
Schedule of Cash Tender Offer
In August 2023, Celanese U.S. completed a cash tender offer for $2.25 billion in aggregate principal amount (the "Tender Offer") as follows:
Maturity DateAggregate Principal Amount TenderedPurchase price per $1,000 principal amountTotal Tender Offer ConsiderationAccrued and Unpaid Interest
(In $ millions)(In $ millions)
June 30, 20241,473 $999.92 1,473 12 
March 15, 2025750 $1,002.85 752 20 
April 30, 202427 $983.95 27 — 
XML 53 R34.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Benefit Obligations (Tables)
3 Months Ended
Mar. 31, 2024
Retirement Benefits [Abstract]  
Schedule of Net Periodic Benefit Costs Recognized
The components of net periodic benefit cost are as follows:
Three Months Ended March 31,
20242023
Pension
Benefits
Post-retirement
Benefits
Pension
Benefits
Post-retirement
Benefits
(In $ millions)
Service cost— — 
Interest cost31 32 — 
Expected return on plan assets
(34)— (33)— 
Total— — 
Schedule of Company Commitments to Fund Benefit Obligations
Benefit obligation funding is as follows:
As of
March 31,
2024
Total
Expected
2024
(In $ millions)
Cash contributions to defined benefit pension plans29 
Benefit payments to nonqualified pension plans19 
Benefit payments to other postretirement benefit plans
Schedule of Defined Benefit Plans Disclosures
Pension and postretirement benefit plan balances recognized in the unaudited consolidated balance sheets consist of the following:
As of March 31, 2024As of December 31, 2023
Pension
Benefits
Post-retirement
Benefits
Pension
Benefits
Post-retirement
Benefits
(In $ millions)
Noncurrent Other assets169 — 166 — 
Current Other liabilities(22)(3)(22)(3)
Benefit obligations(402)(37)(415)(37)
Net amount recognized(255)(40)(271)(40)
XML 54 R35.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Environmental (Tables)
3 Months Ended
Mar. 31, 2024
Environmental Remediation Obligations [Abstract]  
Schedule of Environmental Remediation Reserves
The components of environmental remediation liabilities are as follows:
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Demerger obligations (Note 14)
13 14 
Divestiture obligations (Note 14)
13 13 
Active sites25 25 
U.S. Superfund sites
Other environmental remediation liabilities
Total60 62 
XML 55 R36.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2024
Stockholders' Equity Note [Abstract]  
Schedule of Treasury Stock
Total From
February 2008
Through
March 31, 2024
Shares repurchased69,324,429 
Average purchase price per share$83.71 
Shares repurchased (in $ millions)5,803 
Aggregate Board of Directors repurchase authorizations during the period (in $ millions)
6,866 
Schedule of Components of Other Comprehensive Income (Loss), Net
Three Months Ended March 31,
20242023
Gross
Amount
Income
Tax
(Provision)
Benefit
Net
Amount
Gross
Amount
Income
Tax
(Provision)
Benefit
Net
Amount
(In $ millions)
Foreign currency translation gain (loss)(27)(27)(54)(4)17 13 
Gain (loss) on derivative hedges— — 
Pension and postretirement benefits gain (loss)(1)— (1)(1)— (1)
Total(26)(27)(53)(1)17 16 
Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net
Adjustments to Accumulated other comprehensive income (loss), net, are as follows:
Foreign
Currency
Translation Gain (Loss)
Gain (Loss)
on Derivative
Hedges
Pension and
Postretirement
Benefits Gain (Loss)
Accumulated
Other
Comprehensive
Income
(Loss), Net
(In $ millions)
As of December 31, 2023(701)(28)(15)(744)
Other comprehensive income (loss) before reclassifications(27)23 (1)(5)
Amounts reclassified from accumulated other comprehensive income (loss)
— (21)— (21)
Income tax (provision) benefit(27)— — (27)
As of March 31, 2024(755)(26)(16)(797)
XML 56 R37.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Other (Charges) Gains, Net (Tables)
3 Months Ended
Mar. 31, 2024
Restructuring and Related Activities [Abstract]  
Schedule of Other (Charges) Gains, Net
Three Months Ended
March 31,
20242023
(In $ millions)
Restructuring(1)
(14)(23)
Total(14)(23)
______________________________
(1)Includes employee termination benefits related to Company-wide business optimization projects and the previously announced closure of its polymerization units in Uentrop, Germany (Note 3).
Schedule of Restructuring Reserve by Type of Cost
The changes in the restructuring liabilities by business segment are as follows:
Engineered
Materials
Acetyl
Chain
OtherTotal
(In $ millions)
Employee Termination Benefits
As of December 31, 202313 18 
Additions12 — 15 
Cash payments(8)(1)(4)(13)
Other changes(1)— — (1)
As of March 31, 202416 19 
XML 57 R38.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Income Taxes (Tables)
3 Months Ended
Mar. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Effective Tax Rate
Three Months Ended
March 31,
20242023
(In percentages)
Effective income tax rate21 21 
XML 58 R39.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Derivative Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Changes in Fair Value of Derivatives
Information regarding changes in the fair value of the Company's derivative and non-derivative instruments is as follows:
Gain (Loss) Recognized in Other Comprehensive Income (Loss)Gain (Loss) Recognized in Earnings (Loss)
Three Months Ended March 31, Statement of Operations Classification
2024202320242023
(In $ millions)
Designated as Cash Flow Hedges
Commodity swaps— (1)Cost of sales
Interest rate swaps— — (2)(2)Interest expense
Foreign currency forwards— — (1)Cost of sales
Total(3)(2)
Designated as Fair Value Hedges
Cross-currency swaps(1)
19 — 24 — Foreign exchange gain (loss), net
Designated as Net Investment Hedges
Foreign currency denominated debt67 (56)— — N/A
Cross-currency swaps70 (19)— — N/A
Total137 (75)— — 
Not Designated as Hedges
Foreign currency forwards and swaps— — 16 Foreign exchange gain (loss), net; Other income (expense), net
______________________________
(1)In conjunction with the 2023 Offering (Note 7) in August 2023, the Company entered into a cross-currency swap to effectively convert $500 million of the issued notes into a Japanese yen-denominated borrowing at prevailing yen interest rates, maturing on July 15, 2029. The swap qualifies and has been designated as a fair value hedge of the Company's foreign currency exchange rate exposure on the long-term debt of its Japanese yen-denominated subsidiary.
Additionally, in conjunction with the 2023 Offering (Note 7) in August 2023, the Company entered into cross-currency swaps to effectively convert $1.0 billion of the issued notes into 5-year and 7-year euro-denominated borrowings at prevailing euro interest rates, maturing on November 15, 2028 and November 15, 2030, respectively. The swaps qualify and have been designated as fair value hedges of the Company's foreign currency exchange rate exposure on the long-term debt of its euro-denominated subsidiary.
Offsetting Assets
Information regarding the gross amounts of the Company's derivative instruments and the amounts offset in the unaudited consolidated balance sheets is as follows:
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Derivative Assets
Gross amount recognized201 183 
Gross amount offset in the consolidated balance sheets— — 
Net amount presented in the consolidated balance sheets201 183 
Gross amount not offset in the consolidated balance sheets32 40 
Net amount169 143 
Offsetting Liabilities
As of
March 31,
2024
As of
December 31,
2023
(In $ millions)
Derivative Liabilities
Gross amount recognized316 440 
Gross amount offset in the consolidated balance sheets— — 
Net amount presented in the consolidated balance sheets316 440 
Gross amount not offset in the consolidated balance sheets32 40 
Net amount284 400 
XML 59 R40.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis
The Company's financial assets and liabilities are measured at fair value on a recurring basis as follows:
Derivative financial instruments include interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps and are valued in the market using discounted cash flow techniques. These techniques incorporate Level 1 and Level 2 fair value measurement inputs such as interest rates and foreign currency exchange rates. These market inputs are utilized in the discounted cash flow calculation considering the instrument's term, notional amount, discount rate and credit risk. Significant inputs to the derivative valuation for interest rate swaps, commodity swaps, cross-currency swaps and foreign currency forwards and swaps are observable in the active markets and are classified as Level 2 in the fair value measurement hierarchy.
Fair Value Measurement
Significant Other Observable Inputs (Level 2)
Other assetsOther liabilities
Notional AmountCurrentNoncurrentCurrentNoncurrent
(In millions)(In $ millions)
As of March 31, 2024
Derivatives Designated as Cash Flow Hedges
Commodity swaps$59 40 — 
Designated as Fair Value Hedges
Cross-currency swaps$1,500 54 22 16 
Derivatives Designated as Net Investment Hedges
Cross-currency swaps5,712 77 — 29 230 
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps$2,137 23 — 12 
Total159 42 58 258 
As of December 31, 2023
Derivatives Designated as Cash Flow Hedges
Commodity swaps$67 36 — 
Designated as Fair Value Hedges
Cross-currency swaps$1,500 40 — 11 61 
Derivatives Designated as Net Investment Hedges
Cross-currency swaps5,712 93 — 61 281 
Derivatives Not Designated as Hedges
Foreign currency forwards and swaps$1,954 — 16 
Total147 36 90 350 
Schedule of Carrying Values and Fair Values of Financial Instruments
Carrying values and fair values of financial instruments that are not carried at fair value are as follows:
Fair Value Measurement
Carrying
Amount
Significant Other
Observable
Inputs
(Level 2)
Unobservable
Inputs
(Level 3)
Total
(In $ millions)
As of March 31, 2024
Equity investments without readily determinable fair values
170 — — — 
Insurance contracts in nonqualified trusts18 18 — 18 
Long-term debt, including current installments of long-term debt
13,435 13,472 140 13,612 
As of December 31, 2023
Equity investments without readily determinable fair values
170 — — — 
Insurance contracts in nonqualified trusts21 21 — 21 
Long-term debt, including current installments of long-term debt
13,400 13,514 148 13,662 
XML 60 R41.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Segment Information (Tables)
3 Months Ended
Mar. 31, 2024
Segment Reporting [Abstract]  
Schedule of Business Segments
Engineered
Materials
Acetyl
Chain
Other
Activities
EliminationsConsolidated
(In $ millions)
Three Months Ended March 31, 2024
Net sales1,378 1,261 — (28)(1)2,611 
Other (charges) gains, net (Note 18)
(11)— (3)— (14)
Operating profit (loss)89 254 (133)— 210 
Equity in net earnings (loss) of affiliates
49 — 55 
Depreciation and amortization147 57 17 — 221 
Capital expenditures37 40 28 — 105 (2)
As of March 31, 2024
Goodwill and intangible assets, net
10,407 421 — — 10,828 
Total assets
17,620 5,520 2,893 — 26,033 
Three Months Ended March 31, 2023
Net sales
1,630 

1,250 

— (27)(1)2,853 
Other (charges) gains, net (Note 18)
(21)(1)(1)— (23)
Operating profit (loss)
112 278 (139)— 251 
Equity in net earnings (loss) of affiliates
11 — 15 
Depreciation and amortization
112 54 — 172 
Capital expenditures
45 51 12 — 108 (2)
As of December 31, 2023
Goodwill and intangible assets, net
10,525 427 — — 10,952 
Total assets
17,930 5,538 3,129 — 26,597 
______________________________
(1)Includes intersegment sales primarily related to the Acetyl Chain.
(2)Includes a decrease in accrued capital expenditures of $32 million and $56 million for the three months ended March 31, 2024 and 2023, respectively.
XML 61 R42.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Revenue Recognition (Tables)
3 Months Ended
Mar. 31, 2024
Revenue Recognition and Deferred Revenue [Abstract]  
Disaggregation of Revenue
Further disaggregation of Net sales by business segment and geographic destination is as follows:
Three Months Ended
March 31,
20242023
(In $ millions)
Engineered Materials
North America372 479 
Europe and Africa456 560 
Asia-Pacific516 548 
South America34 43 
Total1,378 1,630 
Acetyl Chain
North America388 365 
Europe and Africa423 460 
Asia-Pacific394 367 
South America28 31 
Total(1)
1,233 1,223 
______________________________
(1)Excludes intersegment sales of $28 million and $27 million for the three months ended March 31, 2024 and 2023, respectively.
XML 62 R43.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Earnings (Loss) Per Share (Tables)
3 Months Ended
Mar. 31, 2024
Earnings Per Share [Abstract]  
Schedule of Earnings (Loss) Per Share
Three Months Ended
March 31,
20242023
(In $ millions, except share data)
Amounts attributable to Celanese Corporation
Earnings (loss) from continuing operations121 94 
Earnings (loss) from discontinued operations— (3)
Net earnings (loss)121 91 
Weighted average shares - basic109,069,060 108,634,068 
Incremental shares attributable to equity awards(1)
444,931 554,198 
Weighted average shares - diluted109,513,991 109,188,266 
______________________________
(1)Excludes stock options to purchase 68,415, and 86,194 shares of Common Stock for the three months ended March 31, 2024 and 2023, respectively; and 0 and 72,574 equity award shares for the three months ended March 31, 2024 and 2023, respectively, as their effect would have been antidilutive.
XML 63 R44.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Description of the Company and Basis of Presentation (Narrative) (Details)
Mar. 31, 2024
Consolidated Ventures  
Variable Interest Entity [Line Items]  
Noncontrolling interest, ownership percentage by parent 100.00%
XML 64 R45.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Acquisitions, Dispositions and Plant Closures Plant Closures - Narrative (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended
Sep. 30, 2023
Mar. 31, 2024
Mar. 31, 2023
Restructuring Cost and Reserve [Line Items]      
Proceeds from sale of businesses and assets, net   $ 0 $ 9
Gain (loss) on disposition of businesses and assets, net   (1) $ 5
Uentrop, Germany | Engineered Materials      
Restructuring Cost and Reserve [Line Items]      
Restructuring and related cost, expected cost   36  
Mechelen, Belgium | Engineered Materials      
Restructuring Cost and Reserve [Line Items]      
Restructuring and related cost, expected cost   $ 130  
Nutrinova Joint Venture      
Restructuring Cost and Reserve [Line Items]      
Gain (loss) on disposition of businesses and assets, net $ 515    
Celanese Corporation | Nutrinova Joint Venture      
Restructuring Cost and Reserve [Line Items]      
Equity method investment, ownership percentage 30.00%    
Mitsui & Co. Ltd. | Nutrinova Joint Venture      
Restructuring Cost and Reserve [Line Items]      
Equity method investment, ownership percentage 70.00%    
Proceeds from sale of businesses and assets, net $ 503    
XML 65 R46.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Acquisitions, Dispositions and Plant Closures Plant Closures - Schedule of Exit and Shutdown Cost Related to Closure (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Restructuring Cost and Reserve [Line Items]    
One Time Termination Benefits $ 14 [1] $ 23
Uentrop, Germany | Engineered Materials    
Restructuring Cost and Reserve [Line Items]    
One Time Termination Benefits [2] 5  
Accelerated depreciation expense [3] 37  
Plant Shutdown Costs 42  
Mechelen, Belgium | Engineered Materials    
Restructuring Cost and Reserve [Line Items]    
Accelerated depreciation expense [4] 8  
Plant Shutdown Costs $ 8  
[1] Includes employee termination benefits related to Company-wide business optimization projects and the previously announced closure of its polymerization units in Uentrop, Germany (Note 3).
[2] Included in Other (charges) gains, net in the unaudited interim consolidated statements of operations (Note 18).
[3] Included in Cost of sales in the unaudited interim consolidated statements of operations.
[4] Included in Cost of sales in the unaudited interim consolidated statements of operations.
XML 66 R47.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Inventories - Schedule of Inventories (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Inventory Disclosure [Abstract]    
Finished goods $ 1,650 $ 1,604
Work-in-process 128 160
Raw materials and supplies 576 593
Total $ 2,354 $ 2,357
XML 67 R48.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details)
$ in Millions
3 Months Ended
Mar. 31, 2024
USD ($)
Goodwill [Line Items]  
As of December 31, 2023 $ 6,977
Exchange rate changes (51)
As of March 31, 2024(1) 6,926 [1]
Goodwill, impaired, accumulated impairment loss 0
Engineered Materials  
Goodwill [Line Items]  
As of December 31, 2023 6,602
Exchange rate changes (46)
As of March 31, 2024(1) 6,556 [1]
Acetyl Chain  
Goodwill [Line Items]  
As of December 31, 2023 375
Exchange rate changes (5)
As of March 31, 2024(1) $ 370 [1]
[1] There were no accumulated impairment losses as of March 31, 2024.
XML 68 R49.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Finite-Lived Intangible Assets [Line Items]    
As of December 31, 2023 $ 3,134  
Exchange rate changes (29)  
As of March 31, 2024 3,105  
As of December 31, 2023 (814)  
Amortization (41) $ (41)
Exchange rate changes 12  
As of March 31, 2024 (843)  
Net book value 2,262  
Finite-Lived Intangible Assets, Cost Incurred to Renew or Extend 0  
Licenses    
Finite-Lived Intangible Assets [Line Items]    
As of December 31, 2023 41  
Exchange rate changes (1)  
As of March 31, 2024 40  
As of December 31, 2023 (38)  
Amortization 0  
Exchange rate changes 0  
As of March 31, 2024 (38)  
Net book value 2  
Customer- Related Intangible Assets    
Finite-Lived Intangible Assets [Line Items]    
As of December 31, 2023 2,437  
Exchange rate changes (28)  
As of March 31, 2024 2,409  
As of December 31, 2023 (639)  
Amortization (30)  
Exchange rate changes 9  
As of March 31, 2024 (660)  
Net book value 1,749  
Developed Technology    
Finite-Lived Intangible Assets [Line Items]    
As of December 31, 2023 601  
Exchange rate changes 0  
As of March 31, 2024 601  
As of December 31, 2023 (95)  
Amortization (11)  
Exchange rate changes 2  
As of March 31, 2024 (104)  
Net book value 497  
Covenants Not to Compete and Other    
Finite-Lived Intangible Assets [Line Items]    
As of December 31, 2023 55  
Exchange rate changes 0  
As of March 31, 2024 55  
As of December 31, 2023 (42)  
Amortization 0  
Exchange rate changes 1  
As of March 31, 2024 (41)  
Net book value $ 14  
XML 69 R50.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Goodwill and Intangible Assets, Net - Schedule of Indefinite-Lived Intangible Assets (Details) - Trademarks and Trade Names
$ in Millions
3 Months Ended
Mar. 31, 2024
USD ($)
Indefinite-lived Intangible Assets [Line Items]  
As of December 31, 2023 $ 1,655
Exchange rate changes (15)
As of March 31, 2024 $ 1,640
XML 70 R51.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)
$ in Millions
Mar. 31, 2024
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
2025 $ 161
2026 160
2027 160
2028 160
2029 $ 155
XML 71 R52.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Current Other Liabilities (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Other Liabilities, Current [Abstract]    
Benefit obligations (Note 8) $ 25 $ 25
Customer rebates 76 96
Derivatives (Note 12) 58 90
Interest (Note 7) 194 246
Legal (Note 14) 12 34
Operating leases 86 89
Restructuring (Note 18) 19 18
Salaries and benefits 133 175
Sales and use tax/foreign withholding tax payable 133 128
Investment in affiliates 96 96
Other Sundry Liabilities, Current 179 157
Total $ 1,011 $ 1,154
XML 72 R53.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt - Schedule of Short-term Debt (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates    
Current installments of long-term debt $ 2,348 $ 1,025
Short-term borrowings, including amounts due to affiliates(1) [1] 50 146
Total $ 2,439 $ 1,383
Loans Payable    
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates    
Weighted average interest rate, short-term borrowings 2.20% 2.90%
Revolving Credit Facility    
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates    
Weighted average interest rate, short-term borrowings 3.20% 3.40%
Revolving Credit Facility    
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates    
Revolving credit facilities(2) [2] $ 41 $ 212
Revolving Credit Facility | Revolving Credit Facility    
Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates    
Revolving credit facilities(2) $ 0  
[1] The weighted average interest rate was 2.2% and 2.9% as of March 31, 2024 and December 31, 2023, respectively.
[2] The weighted average interest rate was 3.2% and 3.4% as of March 31, 2024 and December 31, 2023, respectively.
XML 73 R54.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt - Schedule of Long-term Debt (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Aug. 31, 2023
Debt Instrument [Line Items]      
Obligations under finance leases due at various dates through 2054 $ 140 $ 148  
Long-Term Debt and Lease Obligation, Including Current Maturities 13,435 13,400  
Unamortized debt issuance costs [1] (69) (74)  
Long-Term Debt and Lease Obligation, Current (2,348) (1,025)  
Long-term debt, net of unamortized deferred financing costs 11,018 12,301  
Senior unsecured notes due 2024, interest rate of 3.500%      
Debt Instrument [Line Items]      
Senior unsecured debt $ 473 473  
Debt Instrument, Interest Rate, Stated Percentage 3.50%    
Senior unsecured notes due 2024, interest rate of 5.900%      
Debt Instrument [Line Items]      
Senior unsecured debt $ 527 527  
Debt Instrument, Interest Rate, Stated Percentage 5.90%    
Senior unsecured notes due 2025, interest rate of 1.250%      
Debt Instrument [Line Items]      
Senior unsecured debt $ 324 331  
Debt Instrument, Interest Rate, Stated Percentage 1.25%    
Senior unsecured notes due 2025, interest rate of 6.050%      
Debt Instrument [Line Items]      
Senior unsecured debt $ 1,000 1,000  
Debt Instrument, Interest Rate, Stated Percentage 6.05%    
Senior unsecured notes due 2026, interest rate of 1.400%      
Debt Instrument [Line Items]      
Senior unsecured debt $ 400 400  
Debt Instrument, Interest Rate, Stated Percentage 1.40%    
Senior unsecured notes due 2026, interest rate of 4.777%      
Debt Instrument [Line Items]      
Senior unsecured debt $ 1,081 1,105  
Debt Instrument, Interest Rate, Stated Percentage 4.777%    
Senior unsecured notes due 2027, interest rate of 2.125%      
Debt Instrument [Line Items]      
Senior unsecured debt $ 539 551  
Debt Instrument, Interest Rate, Stated Percentage 2.125%    
Senior unsecured notes due 2027, interest rate of 6.165%      
Debt Instrument [Line Items]      
Senior unsecured debt $ 2,000 2,000  
Debt Instrument, Interest Rate, Stated Percentage 6.165%    
Senior unsecured term loan due 2027(1)      
Debt Instrument [Line Items]      
Senior unsecured debt [2] $ 880 $ 880  
Debt Instrument, Interest Rate, Stated Percentage 6.922% 6.943%  
Senior unsecured notes due 2028, interest rate of 0.625%      
Debt Instrument [Line Items]      
Senior unsecured debt $ 540 $ 552  
Debt Instrument, Interest Rate, Stated Percentage 0.625%    
Senior unsecured notes due 2028, interest rate of 6.350%      
Debt Instrument [Line Items]      
Senior unsecured debt $ 1,000 1,000  
Debt Instrument, Interest Rate, Stated Percentage 6.35%   6.35%
Senior unsecured notes due 2029, interest rate of 5.337%      
Debt Instrument [Line Items]      
Senior unsecured debt $ 540 552  
Debt Instrument, Interest Rate, Stated Percentage 5.337%    
Senior unsecured notes due 2029, interest rate of 6.330%      
Debt Instrument [Line Items]      
Senior unsecured debt $ 750 750  
Debt Instrument, Interest Rate, Stated Percentage 6.33%    
Senior unsecured notes due 2030, interest rate of 6.550%      
Debt Instrument [Line Items]      
Senior unsecured debt $ 999 999  
Debt Instrument, Interest Rate, Stated Percentage 6.55%   6.55%
Senior unsecured notes due 2032, interest rate of 6.379%      
Debt Instrument [Line Items]      
Senior unsecured debt $ 1,000 1,000  
Debt Instrument, Interest Rate, Stated Percentage 6.379%    
Senior unsecured notes due 2033, interest rate of 6.700%      
Debt Instrument [Line Items]      
Senior unsecured debt $ 1,000 1,000  
Debt Instrument, Interest Rate, Stated Percentage 6.70%   6.70%
Pollution control and industrial revenue bonds due at various dates through 2030(2)      
Debt Instrument [Line Items]      
Other long-term debt [3] $ 126 127  
Pollution control and industrial revenue bonds due at various dates through 2030(2) | Minimum      
Debt Instrument [Line Items]      
Debt Instrument, Interest Rate, Stated Percentage 4.05%    
Pollution control and industrial revenue bonds due at various dates through 2030(2) | Maximum      
Debt Instrument [Line Items]      
Debt Instrument, Interest Rate, Stated Percentage 5.00%    
Bank loan due 2026, interest rate of 2.8%      
Debt Instrument [Line Items]      
Debt Instrument, Interest Rate, Stated Percentage 2.80%    
Other long-term debt $ 111 0  
Bank loans due at various dates through 2030(3)      
Debt Instrument [Line Items]      
Other long-term debt [4] $ 5 $ 5  
Long-term debt, weighted average interest rate, at point in time 2.70% 2.60%  
[1] Related to the Company's long-term debt, excluding obligations under finance leases.
[2] The interest rate was 6.922% and 6.943% as of March 31, 2024 and December 31, 2023, respectively.
[3] Interest rates range from 4.05% to 5.00%.
[4] The weighted average interest rate was 2.7% and 2.6% as of March 31, 2024 and December 31, 2023, respectively.
XML 74 R55.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt - Senior Credit Facilities Narrative (Details)
¥ in Millions, $ in Millions
1 Months Ended 3 Months Ended
May 08, 2024
USD ($)
Jan. 31, 2023
CNY (¥)
Mar. 31, 2022
USD ($)
Mar. 31, 2024
CNY (¥)
Dec. 31, 2023
CNY (¥)
Revolving Credit Facility | Subsequent Event          
Debt Instrument [Line Items]          
Proceeds from lines of credit $ 300        
364 Day Delayed-Draw Term Loan | Term Loan Facility          
Debt Instrument [Line Items]          
Debt instrument, term     364 days    
Debt instrument, face amount     $ 500    
5 Year Delayed-Draw Term Loan | Term Loan Facility          
Debt Instrument [Line Items]          
Debt instrument, term     5 years    
Debt instrument, face amount     $ 1,000    
Revolving Credit Facility | Revolving Credit Facility          
Debt Instrument [Line Items]          
Line of Credit Facility, Maximum Borrowing Capacity     $ 1,750    
Revolving Credit Facility | Revolving Credit Facility | Variable Interbank Interest Rate | Minimum          
Debt Instrument [Line Items]          
Debt instrument, basis spread on variable rate       1.00%  
Revolving Credit Facility | Revolving Credit Facility | Variable Interbank Interest Rate | Maximum          
Debt Instrument [Line Items]          
Debt instrument, basis spread on variable rate       2.00%  
China Revolving Credit Facility | Revolving Credit Facility          
Debt Instrument [Line Items]          
Line of Credit Facility, Maximum Borrowing Capacity | ¥   ¥ 1,750      
China Working Capital Term Loan | China Working Capital Term Loan          
Debt Instrument [Line Items]          
Debt instrument, term   12 months      
Debt instrument, face amount | ¥   ¥ 800      
Repayments of Debt | ¥       ¥ 800  
China Working Capital Term Loan | China Working Capital Term Loan | Variable Interbank Interest Rate          
Debt Instrument [Line Items]          
Debt instrument, basis spread on variable rate   0.50%      
Bank loan due 2026, interest rate of 2.8%          
Debt Instrument [Line Items]          
Debt Instrument, Interest Rate, Stated Percentage       2.80%  
Bank loan due 2026, interest rate of 2.8% | 36 month Working Capital Term Loan          
Debt Instrument [Line Items]          
Debt instrument, face amount | ¥         ¥ 800
Debt Instrument, Interest Rate, Stated Percentage         2.80%
Senior unsecured notes due 2024, interest rate of 3.500%          
Debt Instrument [Line Items]          
Debt Instrument, Interest Rate, Stated Percentage       3.50%  
Senior unsecured notes due 2024, interest rate of 3.500% | Subsequent Event          
Debt Instrument [Line Items]          
Debt Instrument, Interest Rate, Stated Percentage 3.50%        
Repayments of Debt $ 300        
XML 75 R56.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt - Schedule of Revolving Credit Facility (Details) - Revolving Credit Facility - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Line of Credit Facility [Line Items]    
Revolving credit facilities(2) [1] $ 41 $ 212
Revolving Credit Facility    
Line of Credit Facility [Line Items]    
Revolving credit facilities(2) 0  
Available for borrowing 1,750  
China Revolving Credit Facility    
Line of Credit Facility [Line Items]    
Revolving credit facilities(2) 41  
Available for borrowing $ 201  
[1] The weighted average interest rate was 3.2% and 3.4% as of March 31, 2024 and December 31, 2023, respectively.
XML 76 R57.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt - Senior Notes Narrative (Details)
3 Months Ended
Mar. 31, 2024
Debt Instrument [Line Items]  
Debt instrument, redemption price, percentage 100.00%
XML 77 R58.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt (Schedule of Senior Unsecured Notes Offering) (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Aug. 31, 2023
Senior unsecured notes due 2028, interest rate of 6.350%    
Debt Instrument [Line Items]    
Debt instrument, face amount   $ 1,000
Debt Instrument, Interest Rate, Stated Percentage 6.35% 6.35%
Debt Instrument, Discount Price, Percentage   99.986%
Senior unsecured notes due 2030, interest rate of 6.550%    
Debt Instrument [Line Items]    
Debt instrument, face amount   $ 999
Debt Instrument, Interest Rate, Stated Percentage 6.55% 6.55%
Debt Instrument, Discount Price, Percentage   99.95%
Senior unsecured notes due 2033, interest rate of 6.700%    
Debt Instrument [Line Items]    
Debt instrument, face amount   $ 1,000
Debt Instrument, Interest Rate, Stated Percentage 6.70% 6.70%
Debt Instrument, Discount Price, Percentage   99.992%
XML 78 R59.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt (Schedule of Cash Tender Offer) (Details)
1 Months Ended
Aug. 31, 2023
USD ($)
Debt Instrument [Line Items]  
Debt Instrument, Repurchased Face Amount $ 2,250,000,000
Senior unsecured notes due 2024, interest rate of 5.900%  
Debt Instrument [Line Items]  
Debt Instrument, Repurchased Face Amount 1,473,000,000
Debt Instrument Tender Purchase Price Per 1000 Principal Amount 999.92
Debt Instrument, Repurchase Amount 1,473,000,000
Interest Expense, Debt 12,000,000
Senior unsecured notes due 2025, interest rate of 6.050%  
Debt Instrument [Line Items]  
Debt Instrument, Repurchased Face Amount 750,000,000
Debt Instrument Tender Purchase Price Per 1000 Principal Amount 1,002.85
Debt Instrument, Repurchase Amount 752,000,000
Interest Expense, Debt 20,000,000
Senior unsecured notes due 2024, interest rate of 3.500%  
Debt Instrument [Line Items]  
Debt Instrument, Repurchased Face Amount 27,000,000
Debt Instrument Tender Purchase Price Per 1000 Principal Amount 983.95
Debt Instrument, Repurchase Amount 27,000,000
Interest Expense, Debt $ 0
XML 79 R60.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt - Accounts Receivable Purchasing Facility Narrative (Details) - Amended restated receivable purchasing facility - Secured Debt - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Line of Credit Facility [Line Items]    
Percentage of fair value of sales receivables 100.00%  
Transfer of financial assets accounted for as sales, amount derecognized $ 290 $ 1,400
Proceeds collected on accounts receivable sold under factoring facilities 318 $ 1,300
Trade Receivables Pledged As Collateral $ 153  
XML 80 R61.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Debt - Factoring and Discounting Agreements Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Europe Factoring Agreements    
Debt Instrument [Line Items]    
Transfer of financial assets accounted for as sales, non-recourse basis, account receivable percentage 100.00%  
Singapore Factoring Agreements    
Debt Instrument [Line Items]    
Transfer of financial assets accounted for as sales, non-recourse basis, account receivable percentage 90.00%  
China, Europe and Singapore Factoring Agreements    
Debt Instrument [Line Items]    
Transfer of financial assets accounted for as sales, amount derecognized $ 164 $ 423
Proceeds collected on accounts receivable sold under factoring facilities 110 407
Master Discounting Agreement    
Debt Instrument [Line Items]    
Transfer of financial assets accounted for as sales, amount derecognized $ 15 $ 45
China Factoring Agreements    
Debt Instrument [Line Items]    
Transfer of financial assets accounted for as sales, non-recourse basis, account receivable percentage 100.00%  
XML 81 R62.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Benefit Obligations - Schedule of Net Periodic Benefit Costs Recognized (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Pension Benefits    
Defined Benefit Plan Disclosure [Line Items]    
Service cost $ 3 $ 4
Interest cost 31 32
Expected return on plan assets (34) (33)
Total 0 3
Post-retirement Benefits    
Defined Benefit Plan Disclosure [Line Items]    
Service cost 0 0
Interest cost 1 0
Expected return on plan assets 0 0
Total $ 1 $ 0
XML 82 R63.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Benefit Obligations - Schedule of Company Commitments to Fund Benefit Obligations (Details)
$ in Millions
3 Months Ended
Mar. 31, 2024
USD ($)
Cash contributions to defined benefit pension plans  
Defined Benefit Plan Disclosure [Line Items]  
Total contributions year-to-date $ 7
Total expected contributions in current fiscal year 29
Benefit payments to nonqualified pension plans  
Defined Benefit Plan Disclosure [Line Items]  
Total contributions year-to-date 5
Total expected contributions in current fiscal year 19
Benefit payments to other postretirement benefit plans  
Defined Benefit Plan Disclosure [Line Items]  
Total contributions year-to-date 1
Total expected contributions in current fiscal year $ 3
XML 83 R64.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Benefit Obligations - Schedule of Defined Benefit Plans Disclosures (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Pension Benefits    
Defined Benefit Plan Disclosure [Line Items]    
Noncurrent Other assets $ 169 $ 166
Current Other liabilities (22) (22)
Benefit obligations (402) (415)
Net amount recognized (255) (271)
Post-retirement Benefits    
Defined Benefit Plan Disclosure [Line Items]    
Noncurrent Other assets 0 0
Current Other liabilities (3) (3)
Benefit obligations (37) (37)
Net amount recognized $ (40) $ (40)
XML 84 R65.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Environmental (Schedule of Environmental Remediation Reserves) (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Environmental Remediation Obligations [Abstract]    
Demerger obligations (Note 14) $ 13 $ 14
Divestiture obligations (Note 14) 13 13
Active sites 25 25
U.S. Superfund sites 7 8
Other environmental remediation liabilities 2 2
Total $ 60 $ 62
XML 85 R66.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Environmental - US Superfund Sites Narrative (Details) - Passaic River, New Jersey
$ in Millions
1 Months Ended 3 Months Ended
Mar. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Sep. 30, 2021
USD ($)
Mar. 31, 2016
USD ($)
Mar. 31, 2024
Site Contingency [Line Items]          
Number of parties included in USEPA order 40       70
Cost of EPA's plan estimate $ 71 $ 150 $ 441 $ 1,400  
Environmental liability percentage         1.00%
XML 86 R67.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders' Equity - Narrative (Details) - USD ($)
$ / shares in Units, $ in Millions
Apr. 17, 2024
Mar. 31, 2024
Dec. 31, 2023
Class of Stock [Line Items]      
Common stock, par value (in dollars per share)   $ 0.0001 $ 0.0001
Subsequent Event      
Class of Stock [Line Items]      
Common stock, dividends, declared (in dollar per share) $ 0.70    
Dividends, common stock, cash $ 76    
XML 87 R68.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders' Equity - Schedule of Treasury Stock (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 194 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Stockholders' Equity Note [Abstract]      
Shares repurchased (in shares) 0 0 69,324,429
Average purchase price (in dollar per share)     $ 83.71
Shares repurchased (in $ millions)     $ 5,803
Aggregate Board of Directors repurchase authorizations during the period (in $ millions)     $ 6,866
XML 88 R69.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders' Equity - Schedule of Components of Other Comprehensive Income (Loss), Net (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Stockholders' Equity Note [Abstract]    
Foreign currency translation gain (loss), gross amount $ (27) $ (4)
Foreign currency translation gain (loss), income tax (provision) benefit (27) 17
Foreign currency translation gain (loss) (54) 13
Gain (loss) on derivative hedges, gross amount 2 4
Gain (loss) on derivative hedges, income tax (provision) benefit 0 0
Gain (loss) on derivative hedges 2 4
Pension and postretirement benefits gain (loss), gross amount (1) (1)
Pension and postretirement benefits gain (loss), income tax (provision) benefit 0 0
Pension and postretirement benefits (1) (1)
Total other comprehensive income (loss), before tax (26) (1)
Total other comprehensive income (loss), tax 27 (17)
Total other comprehensive income (loss), net of tax $ (53) $ 16
XML 89 R70.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Stockholders' Equity - Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Accumulated Other Comprehensive Income (Loss), net [Line Items]    
As of December 31, 2023 $ (744)  
Other comprehensive income (loss) before reclassifications (5)  
Amounts reclassified from accumulated other comprehensive income (loss) (21)  
Income tax (provision) benefit (27) $ 17
As of March 31, 2024 (797)  
Foreign Currency Translation Gain (Loss)    
Accumulated Other Comprehensive Income (Loss), net [Line Items]    
As of December 31, 2023 (701)  
Other comprehensive income (loss) before reclassifications (27)  
Amounts reclassified from accumulated other comprehensive income (loss) 0  
Income tax (provision) benefit (27)  
As of March 31, 2024 (755)  
Gain (Loss) on Derivative Hedges (Note 12)    
Accumulated Other Comprehensive Income (Loss), net [Line Items]    
As of December 31, 2023 (28)  
Other comprehensive income (loss) before reclassifications 23  
Amounts reclassified from accumulated other comprehensive income (loss) (21)  
Income tax (provision) benefit 0  
As of March 31, 2024 (26)  
Pension and Postretirement Benefits Gain (Loss) (Note 8)    
Accumulated Other Comprehensive Income (Loss), net [Line Items]    
As of December 31, 2023 (15)  
Other comprehensive income (loss) before reclassifications (1)  
Amounts reclassified from accumulated other comprehensive income (loss) 0  
Income tax (provision) benefit 0  
As of March 31, 2024 $ (16)  
XML 90 R71.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Other (Charges) Gains, Net - Schedule of Other (Charges) Gains, Net (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Restructuring and Related Activities [Abstract]    
Restructuring(1) $ (14) [1] $ (23)
Total $ (14) $ (23)
[1] Includes employee termination benefits related to Company-wide business optimization projects and the previously announced closure of its polymerization units in Uentrop, Germany (Note 3).
XML 91 R72.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Other (Charges) Gains, Net - Schedule of Restructuring Reserve by Type of Cost (Details) - Employee Severance
$ in Millions
3 Months Ended
Mar. 31, 2024
USD ($)
Restructuring Reserve [Roll Forward]  
Reserve as of the beginning of the period $ 18
Additions 15
Cash payments (13)
Other changes (1)
Reserve as of the end of the period 19
Engineered Materials  
Restructuring Reserve [Roll Forward]  
Reserve as of the beginning of the period 13
Additions 12
Cash payments (8)
Other changes (1)
Reserve as of the end of the period 16
Acetyl Chain [Member]  
Restructuring Reserve [Roll Forward]  
Reserve as of the beginning of the period 2
Additions 0
Cash payments (1)
Other changes 0
Reserve as of the end of the period 1
Other Activities  
Restructuring Reserve [Roll Forward]  
Reserve as of the beginning of the period 3
Additions 3
Cash payments (4)
Other changes 0
Reserve as of the end of the period $ 2
XML 92 R73.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Income Taxes - Schedule of Effective Tax Rate (Details)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Tax Disclosure [Abstract]    
Effective income tax rate 21.00% 21.00%
XML 93 R74.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Derivative Financial Instruments (Schedule of Changes in Fair Value of Derivatives) (Details)
€ in Millions, $ in Millions
1 Months Ended 3 Months Ended
Mar. 31, 2024
USD ($)
Mar. 31, 2024
EUR (€)
Dec. 31, 2023
USD ($)
Dec. 31, 2023
EUR (€)
Aug. 31, 2023
USD ($)
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument              
Derivative [Line Items]              
Gain (Loss) Recognized in Other Comprehensive Income (Loss)           $ 0 $ 0
Gain (Loss) Recognized in Earnings (Loss)           $ 16 $ 2
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]           Foreign exchange gain (loss), net, Other income (expense), net Foreign exchange gain (loss), net, Other income (expense), net
Derivative, notional amount $ 2,137   $ 1,954     $ 2,137  
Cash Flow Hedging              
Derivative [Line Items]              
Gain (Loss) Recognized in Other Comprehensive Income (Loss)           3 $ 2
Gain (Loss) Recognized in Earnings (Loss)           (3) (2)
Cash Flow Hedging | Commodity Contract              
Derivative [Line Items]              
Gain (Loss) Recognized in Other Comprehensive Income (Loss)           3 0
Gain (Loss) Recognized in Earnings (Loss)           $ (1) $ 1
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]           Cost of Goods and Services Sold Cost of Goods and Services Sold
Cash Flow Hedging | Commodity Contract | Designated as Hedging Instrument              
Derivative [Line Items]              
Derivative, notional amount 59   67     $ 59  
Cash Flow Hedging | Foreign Exchange Contract [Member]              
Derivative [Line Items]              
Gain (Loss) Recognized in Other Comprehensive Income (Loss)           0 $ 2
Gain (Loss) Recognized in Earnings (Loss)           $ 0 $ (1)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]           Cost of Goods and Services Sold Cost of Goods and Services Sold
Cash Flow Hedging | Interest Rate Swap [Member]              
Derivative [Line Items]              
Gain (Loss) Recognized in Other Comprehensive Income (Loss)           $ 0 $ 0
Gain (Loss) Recognized in Earnings (Loss)           $ (2) $ (2)
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]           Interest Expense Interest Expense
Fair Value Hedging | Currency Swap              
Derivative [Line Items]              
Gain (Loss) Recognized in Earnings (Loss) [1]           $ 24 $ 0
Gain (Loss) Recognized in Other Comprehensive Income (Loss) [1]           $ 19 $ 0
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]           Foreign exchange gain (loss), net Foreign exchange gain (loss), net
Net Investment Hedging              
Derivative [Line Items]              
Gain (Loss) Recognized in Other Comprehensive Income (Loss)           $ 137 $ (75)
Gain (Loss) Recognized in Earnings (Loss)           0 0
Net Investment Hedging | Currency Swap              
Derivative [Line Items]              
Gain (Loss) Recognized in Earnings (Loss)           0 0
Gain (Loss) Recognized in Other Comprehensive Income (Loss)           70 (19)
Foreign Currency Denominated Debt | Fair Value Hedging              
Derivative [Line Items]              
Notional Amount of Nonderivative Instruments 1,500   $ 1,500        
Foreign Currency Denominated Debt | Net Investment Hedging              
Derivative [Line Items]              
Gain (Loss) Recognized in Other Comprehensive Income (Loss)           67 (56)
Gain (Loss) Recognized in Earnings (Loss)           0 $ 0
Notional Amount of Nonderivative Instruments | €   € 5,712   € 5,712      
Japanese Notes Due 2029 | Fair Value Hedging | Currency Swap              
Derivative [Line Items]              
Derivative, notional amount 500       $ 500 500  
Euro Notes Due 2028 and 2030 | Fair Value Hedging | Currency Swap              
Derivative [Line Items]              
Derivative, notional amount $ 1,000       $ 1,000 $ 1,000  
Euro Notes Due 2028              
Derivative [Line Items]              
Debt instrument, term         5 years    
Euro Notes Due 2030              
Derivative [Line Items]              
Debt instrument, term         7 years    
[1] In conjunction with the 2023 Offering (Note 7) in August 2023, the Company entered into a cross-currency swap to effectively convert $500 million of the issued notes into a Japanese yen-denominated borrowing at prevailing yen interest rates, maturing on July 15, 2029. The swap qualifies and has been designated as a fair value hedge of the Company's foreign currency exchange rate exposure on the long-term debt of its Japanese yen-denominated subsidiary.
Additionally, in conjunction with the 2023 Offering (Note 7) in August 2023, the Company entered into cross-currency swaps to effectively convert $1.0 billion of the issued notes into 5-year and 7-year euro-denominated borrowings at prevailing euro interest rates, maturing on November 15, 2028 and November 15, 2030, respectively. The swaps qualify and have been designated as fair value hedges of the Company's foreign currency exchange rate exposure on the long-term debt of its euro-denominated subsidiary.
XML 94 R75.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Derivative Financial Instruments (Schedule of Offsetting Assets) (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Derivative Assets [Abstract]    
Gross amount recognized $ 201 $ 183
Gross amount offset in the consolidated balance sheets 0 0
Net amount presented in the consolidated balance sheets 201 183
Gross amount not offset in the consolidated balance sheets 32 40
Net amount $ 169 $ 143
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other assets, Other Assets, Noncurrent Other assets, Other Assets, Noncurrent
XML 95 R76.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Derivative Financial Instruments (Schedule of Offsetting Liabilities) (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Derivative Liabilities [Abstract]    
Gross amount recognized $ 316 $ 440
Gross amount offset in the consolidated balance sheets 0 0
Net amount presented in the consolidated balance sheets 316 440
Gross amount not offset in the consolidated balance sheets 32 40
Net amount $ 284 $ 400
Derivative liability, statement of financial position [Extensible Enumeration] Other liabilities, Other liabilities Other liabilities, Other liabilities
XML 96 R77.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)
€ in Millions, $ in Millions
Mar. 31, 2024
USD ($)
Mar. 31, 2024
EUR (€)
Dec. 31, 2023
USD ($)
Dec. 31, 2023
EUR (€)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Derivative Asset $ 169   $ 143  
Derivative Liability $ (284)   $ (400)  
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Other assets   Other assets  
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other Assets, Noncurrent   Other Assets, Noncurrent  
Derivative liability, statement of financial position [Extensible Enumeration] Other liabilities   Other liabilities  
Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other liabilities   Other liabilities  
Other Current Assets | Fair Value, Recurring | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Assets, Fair Value Disclosure $ 159   $ 147  
Other Current Assets | Fair Value, Recurring | Not Designated as Hedging Instrument | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Foreign Currency Contract, Asset, Fair Value Disclosure 23   9  
Other Noncurrent Assets | Fair Value, Recurring | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Assets, Fair Value Disclosure 42   36  
Other Noncurrent Assets | Fair Value, Recurring | Not Designated as Hedging Instrument | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Foreign Currency Contract, Asset, Fair Value Disclosure 0   0  
Other Current Liabilities | Fair Value, Recurring | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Liabilities, Fair Value Disclosure (58)   (90)  
Other Current Liabilities | Fair Value, Recurring | Not Designated as Hedging Instrument | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Foreign Currency Contracts, Liability, Fair Value Disclosure (5)   (16)  
Other Noncurrent Liabilities | Fair Value, Recurring | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Liabilities, Fair Value Disclosure (258)   (350)  
Other Noncurrent Liabilities | Fair Value, Recurring | Not Designated as Hedging Instrument | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Foreign Currency Contracts, Liability, Fair Value Disclosure (12)   (8)  
Fair Value Hedging | Foreign Currency Denominated Debt        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Notional Amount of Nonderivative Instruments 1,500   1,500  
Net Investment Hedging | Foreign Currency Denominated Debt        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Notional Amount of Nonderivative Instruments | €   € 5,712   € 5,712
Commodity Contract | Cash Flow Hedging | Designated as Hedging Instrument        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Derivative, notional amount 59   67  
Commodity Contract | Cash Flow Hedging | Other Current Assets | Fair Value, Recurring | Designated as Hedging Instrument | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Derivative Asset 5   5  
Commodity Contract | Cash Flow Hedging | Other Noncurrent Assets | Fair Value, Recurring | Designated as Hedging Instrument | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Derivative Asset 40   36  
Commodity Contract | Cash Flow Hedging | Other Current Liabilities | Fair Value, Recurring | Designated as Hedging Instrument | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Derivative Liability (2)   (2)  
Commodity Contract | Cash Flow Hedging | Other Noncurrent Liabilities | Fair Value, Recurring | Designated as Hedging Instrument | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Derivative Liability 0   0  
Currency Swap | Fair Value Hedging | Other Current Assets | Fair Value, Recurring | Designated as Hedging Instrument | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Foreign Currency Contract, Asset, Fair Value Disclosure 54   40  
Currency Swap | Fair Value Hedging | Other Noncurrent Assets | Fair Value, Recurring | Designated as Hedging Instrument | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Foreign Currency Contract, Asset, Fair Value Disclosure 2   0  
Currency Swap | Fair Value Hedging | Other Current Liabilities | Fair Value, Recurring | Designated as Hedging Instrument | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Foreign Currency Contracts, Liability, Fair Value Disclosure (22)   (11)  
Currency Swap | Fair Value Hedging | Other Noncurrent Liabilities | Fair Value, Recurring | Designated as Hedging Instrument | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Foreign Currency Contracts, Liability, Fair Value Disclosure (16)   (61)  
Currency Swap | Net Investment Hedging | Other Current Assets | Fair Value, Recurring | Designated as Hedging Instrument | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Foreign Currency Contract, Asset, Fair Value Disclosure 77   93  
Currency Swap | Net Investment Hedging | Other Noncurrent Assets | Fair Value, Recurring | Designated as Hedging Instrument | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Foreign Currency Contract, Asset, Fair Value Disclosure 0   0  
Currency Swap | Net Investment Hedging | Other Current Liabilities | Fair Value, Recurring | Designated as Hedging Instrument | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Foreign Currency Contracts, Liability, Fair Value Disclosure (29)   (61)  
Currency Swap | Net Investment Hedging | Other Noncurrent Liabilities | Fair Value, Recurring | Designated as Hedging Instrument | Fair Value, Inputs, Level 2        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Foreign Currency Contracts, Liability, Fair Value Disclosure (230)   (281)  
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument        
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]        
Derivative, notional amount $ 2,137   $ 1,954  
XML 97 R78.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Fair Value Measurements - Schedule of Carrying Values and Fair Values of Financial Instruments (Details) - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Equity investments without readily determinable fair values, carrying amount $ 170 $ 170
Equity investments without readily determinable fair values, fair value 0 0
Insurance contracts in nonqualified trusts, carrying amount 18 21
Insurance contracts in nonqualified trusts, fair value 18 21
Long-term debt, including current installments of long-term debt, carrying amount 13,435 13,400
Long-term debt, including current installments of long-term debt, fair value 13,612 13,662
Fair Value, Inputs, Level 2    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Equity investments without readily determinable fair values, fair value 0 0
Insurance contracts in nonqualified trusts, fair value 18 21
Long-term debt, including current installments of long-term debt, fair value 13,472 13,514
Unobservable Inputs (Level 3)    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Equity investments without readily determinable fair values, fair value 0 0
Insurance contracts in nonqualified trusts, fair value 0 0
Long-term debt, including current installments of long-term debt, fair value $ 140 $ 148
XML 98 R79.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies - Narrative (Details) - 293 months ended Mar. 31, 2024
€ in Millions, $ in Millions
USD ($)
EUR (€)
USD ($)
Indemnification Agreements Hoechst      
Loss Contingencies [Line Items]      
Number of divestiture agreements   19 19
Indemnification amount | €   € 250  
Indemnification ceiling amount | €   € 750  
Indemnification percentage exceeding ceiling amount   33.33% 33.33%
Loss contingency accrual, carrying value, payments | $ $ 114    
Indemnification percentage, other   33.33% 33.33%
Divestiture Agreements      
Loss Contingencies [Line Items]      
Guarantor obligations, maximum exposure | $     $ 116
XML 99 R80.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Commitments and Contingencies (Purchase Obligations Narrative) (Details)
$ in Millions
Mar. 31, 2024
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
Unrecorded unconditional purchase obligations $ 4,200
Unrecorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year 530
Unrecorded Unconditional Purchase Obligation, to be Paid, Year One 592
Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two 483
Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three 429
Unrecorded Unconditional Purchase Obligation, to be Paid, Year Four $ 289
XML 100 R81.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Segment Information - Schedule of Business Segments (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Segment Reporting Information [Line Items]      
Net sales $ 2,611 $ 2,853  
Other (charges) gains, net (Note 14) (14) (23)  
Operating profit (loss) 210 251  
Equity in net earnings (loss) of affiliates 55 15  
Depreciation and amortization 221 172  
Capital expenditures [1] 105 108  
Goodwill and intangible assets, net 10,828   $ 10,952
Total assets 26,033   26,597
Increase (decrease) in accrued capital expenditures (32) (56)  
Engineered Materials      
Segment Reporting Information [Line Items]      
Net sales 1,378 1,630  
Acetyl Chain      
Segment Reporting Information [Line Items]      
Net sales [2] 1,233 1,223  
Operating Segments | Engineered Materials      
Segment Reporting Information [Line Items]      
Net sales 1,378 1,630  
Other (charges) gains, net (Note 14) (11) (21)  
Operating profit (loss) 89 112  
Equity in net earnings (loss) of affiliates 49 11  
Depreciation and amortization 147 112  
Capital expenditures 37 45  
Goodwill and intangible assets, net 10,407   10,525
Total assets 17,620   17,930
Operating Segments | Acetyl Chain      
Segment Reporting Information [Line Items]      
Net sales 1,261 1,250  
Other (charges) gains, net (Note 14) 0 (1)  
Operating profit (loss) 254 278  
Equity in net earnings (loss) of affiliates 2 1  
Depreciation and amortization 57 54  
Capital expenditures 40 51  
Goodwill and intangible assets, net 421   427
Total assets 5,520   5,538
Corporate, Non-Segment | Other Activities      
Segment Reporting Information [Line Items]      
Net sales 0 0  
Other (charges) gains, net (Note 14) (3) (1)  
Operating profit (loss) (133) (139)  
Equity in net earnings (loss) of affiliates 4 3  
Depreciation and amortization 17 6  
Capital expenditures 28 12  
Goodwill and intangible assets, net 0   0
Total assets 2,893   3,129
Eliminations      
Segment Reporting Information [Line Items]      
Net sales [3] (28) (27)  
Other (charges) gains, net (Note 14) 0 0  
Operating profit (loss) 0 0  
Equity in net earnings (loss) of affiliates 0 0  
Depreciation and amortization 0 0  
Capital expenditures 0 0  
Goodwill and intangible assets, net 0   0
Total assets 0   $ 0
Eliminations | Acetyl Chain      
Segment Reporting Information [Line Items]      
Net sales $ 28 $ 27  
[1] Includes a decrease in accrued capital expenditures of $32 million and $56 million for the three months ended March 31, 2024 and 2023, respectively.
[2] Excludes intersegment sales of $28 million and $27 million for the three months ended March 31, 2024 and 2023, respectively.
[3] Includes intersegment sales primarily related to the Acetyl Chain.
XML 101 R82.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Revenue Recognition - Disaggregation of net sales (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Disaggregation of Revenue [Line Items]    
Net sales $ 2,611 $ 2,853
Engineered Materials    
Disaggregation of Revenue [Line Items]    
Net sales 1,378 1,630
Acetyl Chain    
Disaggregation of Revenue [Line Items]    
Net sales [1] 1,233 1,223
Intersegment Eliminations    
Disaggregation of Revenue [Line Items]    
Net sales [2] (28) (27)
Intersegment Eliminations | Acetyl Chain    
Disaggregation of Revenue [Line Items]    
Net sales 28 27
North America | Engineered Materials    
Disaggregation of Revenue [Line Items]    
Net sales 372 479
North America | Acetyl Chain    
Disaggregation of Revenue [Line Items]    
Net sales 388 365
Europe and Africa | Engineered Materials    
Disaggregation of Revenue [Line Items]    
Net sales 456 560
Europe and Africa | Acetyl Chain    
Disaggregation of Revenue [Line Items]    
Net sales 423 460
Asia-Pacific | Engineered Materials    
Disaggregation of Revenue [Line Items]    
Net sales 516 548
Asia-Pacific | Acetyl Chain    
Disaggregation of Revenue [Line Items]    
Net sales 394 367
South America | Engineered Materials    
Disaggregation of Revenue [Line Items]    
Net sales 34 43
South America | Acetyl Chain    
Disaggregation of Revenue [Line Items]    
Net sales $ 28 $ 31
[1] Excludes intersegment sales of $28 million and $27 million for the three months ended March 31, 2024 and 2023, respectively.
[2] Includes intersegment sales primarily related to the Acetyl Chain.
XML 102 R83.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Revenue Recognition Remaining Performance Obligations (Details)
$ in Millions
Mar. 31, 2024
USD ($)
Revenue, Major Customer [Line Items]  
Revenue, remaining performance obligation, amount $ 1,300
Contract with Customer, Asset, after Allowance for Credit Loss 0
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01  
Revenue, Major Customer [Line Items]  
Revenue, remaining performance obligation, amount $ 458
Revenue, remaining performance obligation, expected timing of satisfaction, period 9 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-01-01  
Revenue, Major Customer [Line Items]  
Revenue, remaining performance obligation, amount $ 423
Revenue, remaining performance obligation, expected timing of satisfaction, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-01-01  
Revenue, Major Customer [Line Items]  
Revenue, remaining performance obligation, amount $ 195
Revenue, remaining performance obligation, expected timing of satisfaction, period 1 year
XML 103 R84.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Amounts attributable to Celanese Corporation    
Earnings (loss) from continuing operations $ 121 $ 94
Earnings (loss) from discontinued operations 0 (3)
Net earnings (loss) $ 121 $ 91
Weighted average shares - basic (in shares) 109,069,060 108,634,068
Incremental shares attributable to equity awards(1) [1] 444,931 554,198
Weighted average shares - diluted 109,513,991 109,188,266
[1] Excludes stock options to purchase 68,415, and 86,194 shares of Common Stock for the three months ended March 31, 2024 and 2023, respectively; and 0 and 72,574 equity award shares for the three months ended March 31, 2024 and 2023, respectively, as their effect would have been antidilutive.
XML 104 R85.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Earnings (Loss) Per Share - Narrative (Details) - shares
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Share-Based Payment Arrangement, Option    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount 68,415 86,194
Restricted Stock Units (RSUs)    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount 0 72,574
EXCEL 105 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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Ð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

#2 0_7>_9//G:*9<4,WBKQC5>VG@=% !6N62?L%[7]%7?QC!U?J83Q M3]CVMAD9EYVQJMF!24'#9?_+GG=Y. 4\3N = =(O>[>D5?Y"[-L,=-J"]I9 M$YM;^% ]FL1QZ3[*TFIZRPEG%W=,2RXW!LY^4\:,X $U+&NF$I+P,]/GD"4AI'&: MG^#+AJ SSY?]5]"OT?YUO3)64XW\?2S>GBX_3N?ZYM*TK,1Y0(UA4#]AL/CX M(9G$5R?$YH/8_!3[8DE]6'4"0:WAW:]U3/1IVJ^U1GSSH7QVW2.#LWL)/U&Y M"4&=8T+ YQ);"\:GJJ(Z&\%UHSII#3!K-5]UUA4+6 748$Q2$N!6Z59IYGOO M5;?PNM=:-5"2;RX[.@>:,;VE@21-8)H?1U3<[$"D]@#S\4.1)ND5G&4C^)T& M&?X ]IP)?/,M2E#V1- -]O$8^-GU-2\AB:=A/''_,:V+<)+EM"[@7I8::1!9 M)O:0'Z/&[QVW+\"V3%?D-AE!GN?A-$M@/,[#9%J<<%YQT;D7SOTXR<(I277K MI"C"=#*!?T[^>6=WSZ7H*F*C>5$^4FKZO)"PMM-E35,+)D68)^,0F*R@F)"D M?*^ ZNI6-0U]IJ5'TZ0'6U-8OD*:OD+05P@U8ED/G>BY7+V$-)Y-BW[ BI&R'M-*J)]&T&"I>(/2.;;V: W>R4JI%Q\L MJFF4>$$HL"3/P-QGAW,4PA,Y&7]ZSFAHZ8''ZP/[U^#=>5DQBW,E?O**ZFGT M,8(*UVPKZ%&UW[#W<^WY2B5L^(6VJ_UP'4&YM:2:'NP4-%QV7_;:G\,1()V< M &0]( NZNT9!Y1TC5N1&M6!\M6/SBV UH)TX+OV?\D3&9;G#47&'MC10>F*Q@QBRW/K$T:%$2"X47#\P8YH_S$B[ND!@7]C*/R>GQK''9 M]YYUO;,3O;\S,X)Q>@59DDW^AG=NM$ MOR7K+(T?@UNK68G32'O79H=1\?Y=>I-\.B-R/(@CH M";Y(XK2'7_>N$A:$C?W]ENCQ?Q ]&41/SI[L@Y*EDF24<)D-\%[Z%:A6HK$U MUZ#1E/Z";!!6>]#,N. M&UVC- F=_).Q*](\WAV+BX^NLW\9W#W9<&E!X-IA MDI&?)=--6Q>0TN&&KQ2Y>0G+VCU0:'R!RZ^5HD/@AV9X\HJ_4$L#!!0 ( M ..!JEAYE6TRQ@0 /$< 9 >&PO=V]R:W-H965TVYSAC.Z8LL6:3HNY&S"8\4Q%+X$80F<4Q M%2_7$/'MU'*MUXI;MMZHO,*>35*ZACM0]^F-P))=JX0LAD0RGA !JZEUY5X& M7A%0M/C!8"MWKDD^E0?.?^:%K^'4>#N]:OZG\7D<3(/5,*<1_^P4&VFUKE%0EC1+%*W?/L75!,:Y7I+'LGB+]E6 M;1V++#.I>%P%XPABEI3_Z7,%8B< =;H#O"K ^]T OPKP]P.&;P0,JX!A0::< M2L$AH(K.)H)OB54B- G)34031>81EYD N5_\2+Y3(6A^Y\A) (JR2'[ VON[@)R\^T#>$9:0 M!8NB7&]B*QQOWJN]K,9V78[->V-L+EGP1&TD^9R$$';$S_7QOB;>1DXU+.\5 MUK6G%;R#])3XSH!XCN=WC4K_0\]_0NP6I M1+94F6#)FLRY5,4MQVH0>$/__8;MR5<%L?ROZ]Z5XL-N\7RYNI0I7<+4PO6H M4+1F[_]PQ\ZG+G FQ0)#8BVHPQKJ4*<^NQ%\"1!*LA(\)I)&0/B*/&02VTD) M9591O%*8;@FH+K+:'OJ2+<7&A5C^$GB:.1/[:1?788N+ND6+P:AF,-(R^(*O M&W*"BP0N!KBTA\VBTI^%MJ>^+$JQT$'A.<:-6%;NP:N7[8CT_R%-_ MO)>GAOIKP;JH85UH82T =]\1) ."^^8UR^(>.:U5[LO)I%A@2*Q%U'6:;:AS MS*RNU UQ-:H6F%)KD]W9X+O'36V]?F^V[L$;UO7WMR2FNFPC\QIDGA;9]TPA M+/Y$R=^'Y@>]P-#R=<+1*O>&85 M,J;4I-O;"/:J_<(T:#*-J@2FU-MG& M8[AZDV%R@^T>;O]'[JB=CW/]>'K3,Z36IM>X$U=O3^:X_"$?P$=2I#S_?('< M?I$^26_4E1A5"TRIM>$V;L<='S7IC7H>HVJ!*;4VV<;VN%H#,/O\F#'U0F)0 M&QX2ECPAZ1B?T0'AVP2$W+"4I""66$77W8]MV4&^'VD^!ISZ^[ENU-284FM# M:VR-J_?\&D\)=]4>-HSV8U:&Z-J@2FU-MW&![D71TUVHV;( MJ%I@2JW]G;FQ0Y[6%!A(]JJ#O60_VTMV_3#Z0C.EUH;6.!U/[W1,?'OU#NW) MR-E?(O7CZ$W-J-FQ=\Z"8A#KXDQ-HKG+$E6>=-2U];G=57%:M5<_=R^#\O2M MD2D/ Q=4K%DB200KE,2'"K<O MA;R#^I1S]C]02P,$% @ XX&J6%H;@<".! !!( !D !X;"]W;W)K M&ULM5AM4^,V$/XK&O>F S,N#-C('WV''%9G-C._QA/Z,SN 9SDUTJ;/D5 M2L)2$)I)011,!]YI<#().E; S?B3P5*O?1/KRIV47VWC/!EX+6L1<(B-A:#X MMX 1<&Z1T(YO):A7Z;2"Z]^/Z)^<\^C,'=4PDOPOEICYP.MY)($IS;FYDLO? MH'3(&1A+KMTO699S6QZ)Z^[Y!WZR%?ESZ,2K\")_Q(R(74IBY)A.10+(I[R,G%3'A(S&CL!'P@JI# M$@4')&R%[1I[)B\7CQK,B:IUBAQ>] S>%6BC\MCDBHE90:RE&KM!+8#<_H[S MR;F!5/]=1UX!WJX'M\'H1&L.??PJZK5_J/-\1V 8/[8J'=A/Z M\#.Z^04C%?D""H\#=='F# 1,F:G=-@58:30.'QN7<$ML%!M^*@^Y[;O+M+'G8$ML'#4<7#T4ZW^5DSW&U82U-5A>7[L:E6AL$CI^XT0ZWW&A4]$8W@M8JU6@U.G(!F"UP$ >X MD_F,Y>DK(EPS]&N/]J[0-HE8R[F"]XQR)?JNN-@1VB87X8J+<.>G_#\@;]OU MM(5/#DAOZWPT [^5BU6.%S2F3B\^Z25,M\F3]TC2 INE;?:LDIN@.;O!-(J< MBYCG"18.D&96*=8%9GD#RE&FQ(C%[83"Y G M.=@>^4,:(!'9/WPT/[$3/Z,F1?;B.54SP$)FAC4Y%E "2WL$;EN M _EK%2KR/G-/ QH!O@9_@!02P,$% @ XX&J6.>4&ULK55=3]LP%/TK5H8FD 9)\U7&TDC0 M:AH/2(B.\3#MP4UN6PO'SFRW@7^_ZR1$I9AN#WM)_''/\3G7]G762/6HUP"& M/%5U EJVH(K[81"D?D69\/*L M';M5>28WAC,!MXKH3551]7P%7#83;^2]#-RQU=K8 3_/:KJ".9C[^E9ASQ]8 M2E:!T$P*HF Y\2Y'%]/4QKJ=-K).%E(^V6"&7\[CF]84D+W&V_L']MO:.7!=4PE?R!E68]\X&SKS#8JQE'[1+WS5+1R^L_ - M56S1XCPZQ MYU^98'B"2K*2LG1N98=/6[RM"]M\E"9!YF]W+;B"@G@(>B4M'J3%!Z4]8 TX M9>*T5K( [=36$22[RX;G>](<,6G@5I8,RI*#RNYH@_?0@&*4:T)%B86PKCG> M%I?(Y(V 9)SNB73$?([<(M-!9'I0Y'=I*'?I2=_L51@E\9X@9]!X3Y&_4WML MW<=[O6)"$PY+A 5G8S2DNEK:=8RLVW*TD :+6]MT9%1*%?\D\%&[7P3X\I"J_"6;>JWGD'BMM,AK96209T7USY[K0.PH^/X1!;]6\%\HT."(0E K!*6C M%;/2K5NF63268D.D68UHYJ.,3:F-WF2%V<9'+7$V0ST=_2E$LLDX)ZQ(R%VA M6;',YAS(5"G0ZH*\QY-T21[Q]"1K%(L%:33.;D&SC*MS\H9D!;E'&6Z,&KL: M>1ET-ZXYW%0<_",< G(O"ITJ\K9((-G7=]&?QBE_Z]2-;P6\9_**!/2"^)[? M(Y\>;\G9FW,+;M $*RAQ@]>"]?EOG"%W&G+UIO M\S7'*":U%*NG)ERHSG .#GSQNH,Y;#@-[1N)E: 0"X840TR8[S3L!7E)\_Z MJ.$X.DU"CGX!2>JU-=8[54K62'MG,O3\[JVD.U6>GB8K:YR]M.R%1\S[K7G_ MI(E9P^U%H=]_F9FO&+6G)FV+/K66ZV@:@_[&R2S%2U$GV5]1[6E;[FGO-#E MK7WC9WFV?8':&\./),%A;P@&_2.'L&T.U%ZJOS\'#OO"Y3'K;86G]A+_PRDP M.&C.PZNH0TTN85,2WOSB_D-^9UT27WKV==ZZ=TB K#SIG1 M]J'BMI2J9PYZA%U2$0X+I.==#?#0R.KE4 VT6)67[[G0>)4O/U-\;8$T"W!^ M(83>#HR!YOT6_0]02P,$% @ XX&J6++*6? K!@ RBT !D !X;"]W M;W)K&ULM9IM4^,V$,>_BB:]Z=S-$&(]Y $*F8%P MUS(#5P9Z[8M.7QA'))ZSK516$JZ?OK(=K,022A#R&[ =[Z[^6EG[2[QG:\:_ MYW-*!7A.DRP_[\R%6)SV>GDTIVF8'[,%S>0G3XRGH9"G?-;+%YR&T](H37HH M" :]-(RSSOBLO';'QV=L*9(XHW<SN2@N],9G MBW!&'ZCXMKCC\JQ7>YG&*\6=,U_G6,2BD/#+V MO3BYGIYW@F)$-*&1*%R$\M^*3FB2%)[D./[=..W4,0O#[>,7[U]*\5+,8YC3 M"4O^BJ=B?MX9=<"4/H7+1-RS]6]T(ZA?^(M8DI=_P7IS;] !T3(7+-T8RQ&D M<5;]#Y\W$[%E(/V8#=#& #4-R"L&>&. 2Z'5R$I95Z$(QV>BH-R M;DIKJ2;.BC0^""X_C:6=&/_*V'0=)PD(LRFXSD28S>+'A(*+/*Y>J9+>9D]@2]Q%@O:O9&S;[ 'Z^H".,D_R3-OCU<@8\?/H$/(,[ K8PB M$Y>?]80<=Q&]%VW&>%F-$;TR1@QN62;F.?B<3>ETU[XG]=:BT8OH2V1U>!OR M8X#A$4 !(H;Q3 XWQY;AX#H'N/2'7_&W9T;_OI'W@VM!T_P?T^15SHG9>;$- MG.:+,*+G'?FB,W[^"(OUM<5C6CZ2/DK M,UQIKAP-2D?%3K4:8XAE*E?;6JS1'+7T:RU]JY;/S]%4=-%)0X@UE*.002UD<$!2Y)*/YK9'YG*@Z< PZ#>$6$,Y"AG60H:^5M=0 MS\D(-E>7-9JCEE&M9637DC(NXO_"HA*:!(QT 00VQC_2'J'M>W:&=5(/Z\3/ MHC_1Q@=18WC62([3"P-5%0,OJW[C9G>I$-S08@_F*F:KQ$.KF**&%R %5F&R MI$894).!T*"9$GL85QE(R4!6&?8R>00F+!?R>K3D7-X@&+BGF<1(QL'G9T&S MJ5$XTH0'3=764;FJ5FP K25W?!-'$IK-CY'=]*VEWY>W7:&J^$/2)@5!3]5^ M,Q=ML -4\ #M]/"&6@5U@-"V>GLT5S6*(* =(0XN"U"'B*ZFI0V&@ HBX"$4 M<4!AT!F":#M+&P@!%4/ /1#QAD5F H\:LJQAG.5H]@#VN%C'Q-!'3JTA+0! M'4A!![)#Q\'/"=*IHRG%'LI5BD(.9$>.0Q\3I(.'OK#LL5RU*.Y =N[8CT]( MIX@F.]ECN&I0%('L%#$I?TFBO"NA*)&KRU!AC<*\ H8O;[MSH #M0H8R"M@ M^/*V.Q<*,) WP$ Z8"""A\WUW09B((48R!-B( -B(&W#:8,QD&(,Y(,+M:J-*[JB"5O(*OL'C>892]CLAU&,WS<7;= %5G2!6Z4+[)4N?'G;G0M%%]@; M76"=+@9!\SN_/9RK' 47V!-<8!TNM!VF#;3 "BVP'[3 .EH8TM(&66!%%M@; M66 #69PT7T[9P[G*46"!WP<6V 64$M)&V!!%%@03V!!=+!H?F.VAW*5HL"" M^ $+8@ +&&BOHML "Z+ @KP7+(@.%N2D^27/'L55A>(*LN='#+:B69C):OJ5 MB>(%SX2E"RH76M&[\KN84VY4YI4R?'G;G8*M#HE6*8-XI0Q?WG;G0E$&\489 M1*>,?G/[MT=S5:,@@WB"#+(?,NRA7*4HR"!^((/HD*%GI0W&((HQB#?&(*:F M"ZVHM<$81#$&>1]CD/WO2.P17+NJ%&'T/1%&7R>,)BS90[E*4831]T,8?0-A M:*]X[;%Y"WBNAM=<6FE,_*9N$<1&R9B:I7M+Y: M-R1?E&VXC>N7\'12M14K-U67LTS>+,YRD- GZ3(X'LHD\:IQN#H1;%'VWCXR M(5A:'LYI.*6\N$%^_L28>#DI M3MV^/_ 5!+ P04 " #C@:I8E29%.)$" M 0!@ &0 'AL+W=OJ0DEOEDJ7S-)6KT)3:62Y!Y4B MC*,H"4O&99"._-FC3D=J;067^*C!K,N2Z5]3%&H[#GK![N")KPKK#L)T5+$5 MSM$^5X^:=F'+DO,2I>%*@L;E.)CTKJ:)B_C29X])]E+G5])83SJ:?E,JW7 A@,H=;:9E< M\85 F!B#UIS# _7%!0F_A0=6HH$3X!+N29P^CQF%EM)QIL*LL3ZMK<<'K/?A7DE;&+@A1_G? M^)#*T-8BWM5B&A\EO&?Z$OJ] #/\QFVW->Y[WOX!WKV*B0,5 M^WY'&+BU6)H?796H!0;= N[B7IF*93@.Z&8:U!L,TK=O>DGTX8C]06M_<(P] MG1CWV6>88;E O2M0O\MF391X(C<.-FDO&0Y'X:9#?MC*#X_*W[QF!54+03.+ M4*\[NZ6F&>Z)7_0.:">M=O(?J5-?9$7;&%W224?>@^@?[7#OEI:H5WX6&&ULG95=3]LP%(;_BI6A"21HTK1) M69=& CHVI#$A*K:+:1=N4 M"2]-W-B-2A-9&D:%F#NRAN% M/;^+DK,"A&92$ 6KF76][5SE,R^PAH!#9FP$ MBJ\M7 #G-A#:^-G&]#JD%>ZV'Z-?NMPQER75<"'Y-Y:;S3:/4G=K@T\DE7:R*(5HX."B>9-']HZ[ C"\!E!V I"Y[L!.9=S M:FB:*%D395=C--MPJ3HUFF/"?I2%43C+4&?2CU+F->.<4)&3*V&H6+,E!W*F M-1A]3+[@OC@A"]P+>87#VPV=L7U,U(*/A,0F#<$SN%G-R M>'#T-(R/E>C*$7;E"%W&E7L5/:L;M-A/$S\;0]J MW*'&^U!Q'ZI114]003\JZE#1/M2D#Q6]'A5WJ'@?ZK0/%;\>->E0DWVH=WVH MR;_?*HK^0OD[I]Y>H'@FUDQHPF&%JF P0:>JN92:CI&ENPB6TN"UXIH;O,=! MV04XOY+2/';LW=+]&=(_4$L#!!0 ( ..!JEB@56%[D , ,, 9 M>&PO=V]R:W-H965T=D 75.)1[5QTDT&WM5' W\+S$ M+2@KG71>OWN0Z5Q4FK,2'B1155%0^7P/7)P6CN^<7SRR?:[-"S>='^@>UJ"_ M'AXDCMPNRI854"HF2B)AMW#>^W=+/S(.M<6?#$[JXIF85#(AOIG!A^W"\0P1 M<-AH$X+BWQ&6P+F)A!S_MD&=;D[C>/E\COY;G3PFDU$%2\'_8EN=+YRI0[:P MHQ77C^+T.[0)Q2;>1G!5_Y)38YMX#ME42HNB=4:"@I7-/WUJ"W'A@(G:'8+6 M(?A1A[!U".M$&[(ZK175-)U+<2+26&,T\U#7IO;&;%AIEG&M)7YEZ*?3924E ME)I\UCE(\I'1C'&F&2CR=@6:,JYNR"_DZWI%WKZY(6\(*\DGQCFN@)J[&@%, M&'?33G;?3!9P3E;U#'"Z_$ M&^3\CIS+\??[3&F)>^P?6Y9-V,@>UAR\.W6@&U@X>+(4R",XZ<\_^8GWJRWG M_RG8JPJ$707"L>CI/92P8YJ(C+,]-><*U_T/H8%,;VR)-]&2.III$,F!#DUEB!XL[L'@4; 62 M':EI0^>J^8&U;/%@ZGC:HQN:S#P[7=+1):-T'TH-N&-TBS:QDB6#:?U9U$,; MV@31EV- DC.Q MBXYXHX1KRJDTND'++QCV"&U&DRM]Q+_0.O][C"U@I8!H^N3B M/0B%OD31U7DN^-94%]^3 WVF&0O=W[8VHWAR MA?=%7?QQ>?DB-.56IF@@9;[G^WTHBY4?]_N0>W%#,]=CO GM&8HMAQVZ>;<3 M3$HV-\YFH,6AOK1E0J/XU8\YWM)!&@/\OA/8 MJ!N0=V]_[T/U!+ P04 M" #C@:I828V1R6D$ #O% &0 'AL+W=O$I7+D+)5:W;FNC):0 M$-GA*TCURIR+A"C]*!:N7 D@L35*F.M[7L]-"$V=\=#./8KQD*\5HRD\"B37 M24+$[AX8WXX<[.PGGNABJ07U>/0K]Y!8H,4T@E92G2,!\Y+S# M=U,\, 9VQV\4MK(T1H;*C/-OYN%C/'(\$Q$PB)2!(/K?!B; F$'2 M*A )LJM74U"$,GFM]WU^GJ*K-]?H#:(I>J",Z;.30U?I2 R>&^5>)YE7 M_XS7!R(Z*, WR/?\L,9\VFP^A:@P#ZKFKN9?B. 7(O@6+SB#ES%^,8SON=#& M-%U(1-(83=9"0*K0QU0JPIA.>"6-1I]XNL@,<@%?EE3$Z)$(M;.&[^9SRBA1 M4*M.%DY8'XXI]3NY(A&,'%W+$L0&G/$O/^&>]VN=5BV!590+"N6")O3Q7A]Z MI \S^M@4BK4^=1)DN#V+:UY.F[$?A/VANRE3.]V$/;];;*J$'!8AAXTAE])[ M5ASVC680L76LQX@D?&UHQ&M BB-2G.05OJYAMZ1^1/ MM^"P5\^]6W#O-@;SPO4IU873/3V-,!@1/KTU*XNTD:H2\^N); *:^P=&@SO=>5]'D]+XK6%5E6OU)[A M_R?W@!S9A'HB(EL4]A%V=0@3)#$1QO7"#-,X*[/44VW5^U%VP=Q=TPG_A MKDXWMW3;DX!8V%LSB2+SU9I]N1>SQ&PO=V]R:W-H M965T5ZLZRS-^><25>O5*BE_O.=9\70Q\D<_/_B2WB_K MYH/)Y?E#?WUX7,IWDVV*(MTQ?,J+7)4\KN+T:_^.S;UF@IMB?^D_*G: M>8V:H=P6Q;?FS8?%QL0S/J\;B$3\>>17/,L:)-&/_W6@HVV;3<7=US_1 M_]4.7@SF-JGX59']-UW4RXM1/$(+?I>LL_I+\?1OW@V(-GCS(JO:_]%35]8; MH?FZJHM55UGT8)7FF[_)]XZ(G0H^V5,!=Q6P7B'84X%T%"E%6A7 MH1WZ9#/VEKA94B>7YV7QA,JFM$!K7K3LM[4%7VG>3)3KNA3?IJ)>?3GCMS5Z MBZ[%!%RL,XZ*._2QR._?UKQ)VE6O1'%OE[/T.M?WJ!?4)JC3VF6 MB=^Z.I_4HB,-W&3>-7JU:13O:?134HX1\<\0]G!@J3YS5Y_Q^;8ZL51G[NJ_ MKN_W59\(]K84XBV%N,4C+@H_Y%5=KL4*JM'-1U$ ?:CYJOK#QLT&+;"C-8'A M7?60S/G%2*S\BI>/?'3Y][_YH?=/&U.08 P(3&&1;%DD+O3+WVZS]#YI@D>% MUOF"E^@NS9-\SE'&12"HT&+-45*CQZ1,B[5XF]3BPWI9%NO[I?@IJ6TB76W: M#-LVFYCY>.D'WOGD<9="6YE8+<.D7I=IG7+K MTT27<'30)"-6JLI3R-0.;L_D!R MZ)8 M*QLGSI;Z'N,@P1@0F,+P=,OP%#13F$*R" G&@, 4%GU/YJQ>OYG:K&-K&NH9 MQ_8@(MK*[ I15R'F[M'0$>]DZ;YSQ-K,:8[WW5K\(M;B&;JNQ9\%^LS+N?A: M*#PK&YT4\'=&ZHT]XZCO[DO?J0*%IC(GDW/?F;4.B&IT/-T3U=Q-]5V0H&@, M"DVE66;O/@$-;3Y01MU1"8G&H-!4*F6Z[[OS_9='M\"(;A1'^F(VZQ49T(SC0%W-L M1#="=%'E[M'0$+,=(]+%,]''/1/_9\!:* MB&\/;^ZF>N^[0J(Q*#259JDNL ^[@PTI$&:@: P*3:5RQPOH*3?VA;<.1]EV M]O2MU5E7BCI+,7>?AHY9YO[8O74/$N"Z-O0 %WIZ@'-WIO=T.4:NCV6NCWOF M^DJ "ZWY6[!'G;J;ZKTJ(=$8%)I*LQ08F,(&.$B-, -%8U!H*I52<>">BF-O M@ O-O3DON7LT=,0R^<=NNP FO$7V_$U/:-U]Z3U7CI'K8YGKXT,< M!5MT"\91%-FC&ZBE (K&H-!4FJ7 P+"V @;U%4#1&!2:>@Z"%!P$R%D@IK/@ M>[&OGUI@6@N^KV%C-;X%8CGKG("F^U!H*G' MN N1)<+AL=#LU@CG;JKOL@1%8U!H*LT[YP;!N@L$U%T 16-0:"J54G$0('>! M6-P%HF^F$XN[0/7]-W>/AHY8)O_D!.Y"UX8>W["Y >?N3>_9B8I0 @)W 8NC;T"!>*Y:QS IKQ0Z&IY];*C#_HF?&W)P9F M19)OH]QK_XWU%%I00P$4C4&AJ:1*21' &@H!J*$ BL:@T%0JI<((8 R%]\_@ MW& [\Z8-$<=Z$'Q)(>9N?RA/4B($)S ANC:,&#C%6*=D7\F >/*?G@F[QS"4 MHYT+"0YQ&V)+-N>-PSUJU=U4[R4+ZC9 H:DT2\$1P+H- :C; (K&H-!4*J7^ M"(#C1R0L-M>KN3>_9D^J! M?@.U^0V&6J46O\%4J^X^#1VS% ?T!'X#M5_+$!H7,[@[TW>ZO*!9E169Y]-# MG(2I]3H%0NQ>J;NIO@L.%(U!H:DT2YE 89T$"NHD@*(Q*#252JDF*)"30"U. M@I&;49N3H.=F[AX-'?'.M<8G'. FV^"9R M,V+/S=Q-]5Z4H$X"%)I*LY0/%-9)H*!. B@:@T)3J91J@@(Y"=1T$B)JQ#?3 M2# *,7>/AHY8)O;T!#X"M5^I$!+]NEMW9WI/EF,D\J%,Y,,#KE0@GC6\T3W2 MT]U4WS4)BL:@T%2:I78(88V%$-18 $5C4&@JE5)PA$!7*H3F[O]TJI\($IH7 M*AB%F+M'0TD^6YYM569%I?'B *4"P/3&+IO;( M!6H*@*(Q*#259JD=0EA3( 0U!4#1&!2:2N7.;8R 3('0W.^W;)J%YC4(EDTS M=Y^&CEGF]>$);('0;@N$8CGKG( F\E!H*GB]+ M4%L "DVE6:J'$-86"$%M 5 T!H6FWI],JHD(R!:(7F0+1"^R!=Q]&CIFF=I' M)[ %HCW[\_K6FKLO?6?+\ZVJG,@B[$D'1&!2:^@M(S1#!^@41J%\ MBL:@T%0JI="(W$+CMWK)2Y0I-U^TGF5E#E1I@*(Q*#3UMY!*(PIA5S^H,0&*QJ#0 M5"IW[KEZ @$3V:^B#HR;1+@[TYNZ8^B72.J7R*U?CA01DN][(P*HR %%8U!H MZF\A14X$*W(B4)$#BL:@T-2[#4N1$[M%#DA$Z-IH;L^JN.E:/'!WI2]Q4&@J M<5(IQ6ZE]#[)ORE7J-CNI(#'L?W.S*".""@:@T)3>95J*X9]D$,,*IM T1@4 MFDJEE$WQ":R6V.YY8/W6ZNZ^]&;N&"HIEBHI!E%)5[%%[_CZ_2=B4^_HNS[N M[@P=KE0[L5OM;&/92_(68MV]<+?0>QF"ZA ;F)K 3'QFKV4AAGBW"W&T/I6CG^1%NG:(_5^.I?4J7"//) M(R]%C%>3E+-FL3\4XK/F85)UNK(? V+[,4#?T-U7+M0I.H9\B!OYH#X10F;! M4W<6?./_@;[PK#T(?__YE)_BF<]ZK35_Y_7F(57;3[?/OWO?/B9._SR>OIN)']SRS=1[ M-]L\,F\BF]@\<$^,XCX5/U7&[T1SWKC9URHWS[#;O*F+A_8A;;=%71>K]N62 M)^)W;0J([^^*HO[YIFE@^R3!R[\ 4$L#!!0 ( ..!JECG_VHS5@@ %1; M 9 >&PO=V]R:W-H965TM M1,G<$B@%I"6VM5V5"L&V5;7:'R9Q8,1<4L\$BK0/OYX+<9P.)D-/]P_DYL^> M.1Y[^'!\>)>KF^):RI)\2Y.L.!I>JU24^JFZ M&A8+)<6L+I0FP\#SQL-4Q-G@^+!^[4P='^;+,HDS>:9(L4Q3H>Y/9)+?'0W\ MP<,+Y_'5=5F],#P^7(@K>2'+CXLSI9\-5Y19G,JLB/.,*#D_&OSN'_!HKRI0 M?^)3+.^*M<>D.I3+/+^IGKR;'0V\JD4RD=.R0@C]ZU9.9))4)-V.KRUTL*JS M*KC^^('.ZX/7!W,I"CG)D\_QK+P^&NP/R$S.Q3(IS_.[/V1[0*.*-\V3HOY) M[MK/>@,R719EGK:%=0O2.&M^BV_MB5@K$/B/% C: L%F@>"1 F%;(-RV0-06 MB+8M,&H+C+8M,&X+C.MSWYRL^DQ348KC0Y7?$55]6M.J!W5<=6E]@N.LZED7 MI=+OQKI<>4SE94E>DPN9Q;DB$R5G<4FXF,9)7,:R(!^$4J(*G[RDLA1Q4KPB MO_WBCT=O29R1TSA)=/\H=LB+]:>'PU(WK:I@.&V;,6F:$3S2#)^2LHSQSEP\=Y8?ZE*S.2_!P7DX")_!4W!-O?X<$7A"1CQ>4O'SQJNNPW)0_ M1;9+0K_&A&3RX0MYV9R\+A9]JD5JQ0H<36+;8Z*GFL3=+"JG6QV>E4"XZIEA M#8\>@9_+VSRYC;.KC5YY3_XE%\O+0GY=RJPD[%;_[&CZB9->#=@'Q4),Y=% MC\B%5+=R<%PUWGO;%3,21I$PAH1Q$,S*.UKE'=7TT#42OE3(M_NO*-D/DB810)8T@8!\&L?$>K?$?.Z_E,Y5,I9P69JSPEU;L%R>=D M6E_<70$WN'&-JVZ0;H]#SSLY39VYA:.(T+U M;$AE(N[E[#55XH[\)55*WN?PP0G>EZ:RD[^6*A%$DC"%A' 2S8M]; MQ;X''8[WD/DB810)8T@8!\&L?/=7^>X[+^LZWWB5[PXI]67<%:P3TS=8)(RZ M#[ :MV;BONN/$89L!@?!K!3?K%)\TR_%N:Z)B#1?=M\4.VE]PT3"Z)OO9OO1 MYFS/D!5R$,R*S??,G]V>,[@1^2*%^M%)U5U)WSRA- JE,2B-HVAV^&O.Q8?. MK2T.%3.21J$T!J5Q%,V..3 Q!Y@IULWIG2^21I\XQA&YU^-8YR0+;0='T>PL MC8SRW3:J[T3KQO6.%.J?6MKZ7.M[WTVVT#HYBF;'9]R2[U0;3IGXZ'N=N4*U M$Y1&H30&I7$4S<[?N"=_A)UQD?IF J51*(U!:1Q%LV,VJLIWNZHZU7R^>2'O MD%/Q+4Z7*3G)E8;6U[K0[7CL(H?**BB-MC1K\-X;?3=X0ST4BF:G:DR4[Q0A MSQN\]7N?A(K%9:*O\TS?>5V*[*9Y)(N2G(M2ZH^PABQP&W$?N8HW\S^7;W MW:B^O0!*HU :@](XBF9W%F/0 JQ!"Z JC4!J#TCB*9L=L#%K0TZ#U'N7= M%?0.'JK6H#36TC9'^6!CE$=5:B=J/%K@]FB3ZS@3SO&\EXYQU]8[7JAF@](8 ME,91-+L7&!T78-=Z!5#K!J51*(U!:1Q%LV,VUBUP+_EZAH[1 T"SA+2S&T"M M7$OS0Z=*H=!*&93&430[7Z/; K=N:P;SS[FZ:2.,2Y%8_\9^XA.=(4/E&Y1& MH30&I7$4S>X+1M(%V/5B 52O06D42F-0&D?1[)B-7@M R\;>F]?YN#%1Z06FLI;E[%D?5::=G9%;HM"@_?ANU MA07M[ 90*0:E42B-06D<1;.[BY%B80"]TPJA"@Q*HU :@](XBF;'O/;UQYXK MSGJ[3W<%O8-O:+YO^T5OM#%-0VME4!I'T>Q(C?8*W:O03JIA.:D&[-E25E^: M'>_HA-M1NDJQFKV#W?U?.].$.C HC4)I#$KC*)J=N7%@(7;E60AU7% :A=(8 ME,91-#MFH\)"MPK;B'G'OOO:(1>E_C4C9U)-]=OBJGO AJHO*(U"::RE;4XF MP?[FG?G/D%JAD5JA>^79U@.VO@,/QXV#Z&<[W0WH'3E4@T%I#$KC*)K=,8P& M"[&KS$*H#8/2*)3&H#2.HMDQ&S\6_B0_YN;VSANZN Q*8U :#Y\P@?;.(L:/ M16X_!IF=W77TS11*HU :@])X2W/,]7:JQIM%;F_6;EJUS HY72J=7Y:7LGB8 MJJ..J3K<'7E>YU]7[JIZAPMU85 :@](XBF9W >/"(JP+BZ N#$JC4!J#TCB* M9L=L7%BTA0O[X?$;JL.@- JEL:A;U84;JHZC:K537=OPRZW#GCM^;[D!G+OV MWGE#A1F4QJ TCJ+9O<((LP@KS"*H,(/2*)3&H#2.HMDQ&V$6_0_"+.K62)L# MW<3=EMZI0E48E,91-#M5(\RBI[ZJN;D0H3.V!N+>VL]=4^_,H"X+2N,H6I/9 M<&TSX%2JJWK;YH),*V?1['^[>G6U-?3O]8;(&Z]/_ /:;/!L,,U^TZ="7<59 M01(YUTAO=T\/):K9PKEY4N:+>LOAR[PL\[1^>"W%3*KJ _K]>:YG^O9)5<%J M(^WC_P!02P,$% @ XX&J6*;$9A!N P $PX !D !X;"]W;W)K&ULM5?;;MLX%/P50NTN$J"UKK:3K&V@L1&TP!8(DK;[ M4.P#+1U;1"G1)6F[^?L]I!3&H&)"#BDVE!0_-O!'#@W M3!C']YK4!W($W M^_-5. K^:I/<$UG#@-@9$'>QSYZ6/*TL6%46,%!GT7E+M-?=?%_#5K\JT,B" MS&=K-TO"B;\[=.'YD"B,W)B&N,2)2WY2W-'ZMH782?6K2]H364/UT*D>_I8] M/>S3@)[(&@:,G &C?O?TO.(;'NR]X&AW=L[X0CUCIV??=#C_0=(E?S9FK<KFV2?ZS]NAJ'D:M/3'VV+3=?YJB>BZABC4K%>&PPNF" MP1BWI*Q>(%5%BXW-R9="8X9OBSF^VD": =B_$D(_5LP$[ATX^P]02P,$% M @ XX&J6.DE7K4K @ KP0 !D !X;"]W;W)K&UL?93;CM,P$(9?Q0H2 FEI#BT%E232=@NB$KNJM@(N$!=N,FVLC>U@3YKE M[1D[:2A2Z4WBP_R?_TEFG';:/-D* -FSK)7-@@JQ682A+2J0W$YT XIV]MI( MCC0UA] V!GCI1;(.DRB:AY(+%>2I7]N8/-4MUD+!QC#;2LG-[R74NLN".#@M M/(I#A6XAS-.&'V +^+79&)J%(Z44$I056C$#^RRXC1?+F8OW =\$=/9LS%PF M.ZV?W&1=9D'D#$$-!3H"I]<1[J"N'8AL_!J8P7BD$YZ/3_1//G?*9<H6OKGZSK8V?S@!6M12T',3F00O5O_CQ\ MAS,!<2X+DD&0>-_]0=[EBB//4Z,[9EPTT=S I^K59$XH]U.V:&A7D [S%>R0 MO6%;4$(;]J 1+'O@QG#WL=BK%2 7M7V=ADB'.4E8#.!E#T[^ YZR>ZVPLNRC M*J'\5Q^2R=%I2G=GC:[3'.]L[ -+R +J#DLF",$^MS+]J@.Y937L21I-WE$MF[X]^@GJQI?D3B,5N!]6 M=*. <0&TO]=4B,/$'3#>4?D?4$L#!!0 ( ..!JEC'H,9JC , #L1 9 M >&PO=V]R:W-H965T0Z2.Y2E@&:X%DGJ94_/T>$GZ8.\1YO''+MCME;KB+ MV9YN80/J;K\6NN=6*A%+(9.,9TA /'?>D>L;$A@#.^)/!@=YTD8&Y9[SKZ:S MBN8.-AY! J$R$E1?'N &DL0H:3^^E:).-:,; *PV\GS7P2P/?@A:>6:PE570Q$_R A!FMU4S#QL9::QJ6F67<**&?,FVG M%DNX5^ABHW='E"> >(PVD#$NT%TF(%%]X9+SY1,4 ^N4(>]H8- MYC?MYN_R;67NU\U='8\J*%X5%,_J#<_HE2'(JQ!D-@11#F:&R96&52! *B2H MLD$+!OX(_]($WCJ3>4FOY9Z&,'?T6RA!/("S>/.*!/AM4QAZ$JL%Q:^"XEMU MOVVGK#*I1*Y?8X4^_Z8'H)6"5'YI O?[!.])K 8^K,"'K;O!@K,*_ K%>B9$ M4YYGJ@F\5:TK>"$66#&3DA\6!&,\K'.IDW4193$'+B&1[@P!]5OA4 SX^K,0050]"-8H$"->#7$ZG4Z"9L9QQ3C^]VG(QXUI:'0F#;7.U!6X)[%:4"954":] MIJ%)G^ ]B=7 IQ7XM-AF]JDZ M\[]$C42.11+IMTHBO99)?:G5X8^%$NFW4FJ7ZPS?I58BQV*)_ _5$CE3!HV? M)JEGQ]4ICN42>=%ZJ5V]\TJ=JYBFWA-.]^1D:SXKZ(/B5F\PE$"L+?%@K.,E MBI-ZT5%\;P^[]USIH[-M[H!&(,P _3SF.E&5'7-^KKZ7+/X!4$L#!!0 ( M ..!JE@><0(DJP, "P0 9 >&PO=V]R:W-H965T>:WQ\>CO?49DPLG4:JX]#P9)9!3Z?(" MF'ZRX2*G2@_%UI.% !I707GF$=\/O9RFS%G.JWLKL9SS4F4I@Y5 LLQS*OZ] MAHSO%@YV]C?NTVVBS UO.2_H%M:@/ABQ*G.3"9]?(E/+ ^7Q? M[]$_5,7K8AZHA!N>?4ECE2RREH)_335<6IY"P\*G:WURX[+#!#?H!LJ$_07L!@$^G.S 7&.SFY! MT323YW-/Z9PFTHL:_.L:G[R"C]$GSE0BT7L-&#^/]S37EC#9$[XF5L"KNXY3JVH?_(]0+=0U&**-&[,T8? M=%9TE?.2J2'>-7)8(1O)/BX)"?SZ,_<>!U@%+:O RFH-+.4"E4Q"5 K-A'$% M$L4EF'"5<(,-Q\-SU7](@ M5A(]3\ _H>1@0,FAZP?#2K:G.E(>F'2ED).*N8$[,=W.A+#5-WY*SPUT?T-, M["<[[@P''^0XIU!TD[$O:1U+W&GP"MG.A[#=B(Y3=0/Z?/GL@NHN<$K_FQ/=:Q,.G_!T].JVNI7Q]+M7 8?;3/_K^J7 M;D,FM@U!.J\A=J]Y U$W&9_Y]'3DSE[1-.DLB=@MZ3A--Z '+%YG+,3J! =( MN@'J_\G]8W:OU\#E(+95FRI19.JJ>[GV;ML*7]4-8#>][J,_4;%-F409;'2H M[TYT\:)N3>N!XD75#CYPI9O+ZC+1[3P(,T$_WW!]+#0#DZ#]!\'R/U!+ P04 M " #C@:I8GAX[:4$# #Z" &0 'AL+W=O)ES.&=&G-'BI/1GLT>T\*42TBR#O;6'RS T^1XK M9B[4 27ME$I7S-)4[T)ST,@*#ZI$F$31+*P8ET&V\&L;G2U4;067N-%@ZJIB M^NLU"G5:!G%P7KCEN[UU"V&V.+ =WJ']<-AHFH4=2\$KE(8K"1K+97 57Z[F MSMX;_,GQ9'IC<$JV2GUVD[?%,HB<0R@PMXZ!T>N(*Q3"$9$;?[><07>D _;' M9_8W7CMIV3*#*R4^\L+NE\'K HL62WLK3K]CJV>J>/+E3#^":?6-@H@KXU5 M50LF#RHNFS?[TL:A!R">84#2 I*'@-D3@+0%I%YHXYF7M6:690NM3J"=-;&Y M@8^-1Y,:+ET6[ZRF74XXFZUQ:^$57.6YJJ4U<(LY\B/;"H1-K?,],USNX W+ MN>#V*[QC6C,7>'B^1LNX,"\&Y\]>P#/@$FZX$)1ALP@M"71NAGDKYKH1DSPA)H4;)>W>P&_.G0'\:AP? M)R,$(46V"V]R#N]U,LIXP_0%I/%+2*)D,N30.'R->0=/1]Q)NVRGGB]]@N\/ MFH,J846QY_8^K9_\QEN+E?EK*.P-ZV28U16:2W-@.2X#JB0&]1&#[.>?XEGT MZY#D'T3V30 F70 F8^S9!G6.TE)]O _]4T[?=-1?>\UDZ9$[=5QR63.F0!F#-+=9LTEIVM'U9\6 M&\4O@55NF8H?:5<[R?\9O#O7SK5&J-$ 35=7>UJC56Z5W7X<#Z;HZ<]A]/X]0-1L\>B MTJ=$S3M1\^\EJL!>M36P$5CL2-N5 >I)@NJH9F+(Y?EC=Z;I Y='#_^OWV#8 M:R\5ZIWONBX=%/^FTW2K76._\OTLO#=O_@JH'NZX-""P)&AT,:?(ZZ;3-A.K M#KY9;96EUN>'>_HY0>T,:+]4RIXG[H#N=R?[%U!+ P04 " #C@:I8PUDD MEP($ (% &0 'AL+W=O 1CR+<^$'@1,7\HU"'RSD"IG M!IMJ&>JU I8ZISP+XRCJASGC(IB,7-^#FHSDQF1I/G3/U["YGI^3UJS?D%>&"S'B6X>SH46@P.#M$F!2!W.X#B4\$ MTB$S*G0"Q)'<;Z*]UPC\K)O0"%)$+LN""B82SC#"M 6N1):Y"(26XE6,GT2P#?4&$%&\5 MX#NEP>YO'/L*6]QU$^!;-L^ K$$EF$SQ!L)W04;NN):0W] M.Q/3+Q/3;TW,(ZY^MI;JY<70BG?NFO $=D!]4%(?>"V&@4_BGL .B ]+XL.? MM!B&SXLANKPZ*H?6X+\S-5=E:JY:4W.WPGQHOVZ+H?OU4Z'?/2J$ M!J.NE3_;)EIQ12MNI?6@9 *0:H)RUWX ( 7W">#XZ'HM:YFE9(,*4)%%N?;Q MB6?<<&C6I?NQ>W5>-#KF]=RH&PU.\*HD'6W7=#.F#4;:J+<;0_6JZGRA'9*O M=!WU*^RH5V7G"^V0?*7MZ \0=R\MU-[S0NT=K^?G-MW>B>5Z$E?G^CFS&U)(+33)8H&MT.<":5/MKIWW# MR+6[N9E+8V3N'E? L/RM ;Y?2&F>&G: \O)O\C]02P,$% @ XX&J6$!. MGGAF P ^0P !D !X;"]W;W)K&ULM5==;]LV M%/TKA%H,+=!$GW'2S#90VRT:8.F,>-T>ACTPTK5-E")5DHZS_OI>4K+\)1,K MZKW8(G7/T3E7Y.55?RW5%[T$,.2YY$(/@J4QU6T8ZGP))=67L@*!=^92E=3@ M4"U"72F@A0.5/$RBJ!>6E(E@V'=S4S7LRY7A3,!4$;TJ2ZK^'0&7ZT$0!YN) M![98&CL1#OL57< ,S.=JJG 4MBP%*T%H)@51,!\$[^+;<9Q9@(OXD\%:[UP3 M:^51RB]V<%<,@L@J @ZYL104_YY@#)Q;)M3QM2$-VF=:X.[UAOV#,X]F'JF& ML>1_L<(L!\%-0 J8TQ4W#W+]$1I#5Y8OEUR[7[)N8J. Y"MM9-F 44')1/U/ MGYM$[ "0IQN0-(#D$)"= *0-('5&:V7.UH0:.NPKN2;*1B.;O7"Y<6ATPX1] MC3.C\"Y#G!F.0,"<&?+[(V<+:C.KR069X6HI5AR(G)-/N):FH)@L6$XVX6.I MC28/D,N%8-^@(*\F8"CC^C6B/\\FY-7+U^0E88+<,\XM:S\T*-<^-,P;::-: M6G)"6DKNI3!+3=Z+ HI]?(@V6Z_)QNLH\1+>4W5)TO@-2:(DZ] S_N_PU",G M;5.?.K[L!-^TV0Q-3CLSY&6P6_Q65S2'08![6(-Z@F#XRXNX%_W:9>],9'MF ML]9LYMC3$V8G:%'@.MDLH"FG@DR8SKG4*P7D[]_P-KDS4.I_NA*1G3,19R+; M2\15FX@K[UN?(1_+@>2X@[J,UNB>0]L:_#3$M?:TJ_XX(FLC]B3U6DD]KZ0[ M80"-FI.::OC5KJ;X0%1'2-*MZKI5=>U5]?ZYPE*/2T:!62E!<*=4=M%0K:%[ MLUP?:;A(LP.=73%IM]";5NB-5^@?TE#>I>?FZ%G1@9KCB!-:WK9:WOIK"K[! M"TP84X!GK?'6%B_3CVZI,Y'MF8ZC[2$6_:_5I:$_4R[.Q;:?C)T3/?ZI"M/ M?>O2&[(O*]G*2GZNRC3XW8<>5IF.D%.ZMJ=P[#^&?[S.-(3>!/I"]H5N3]#8 M>RZ=KC,-KN=+W''(H9YPIXDL02U<;ZWQ;:V$J7NL=K;MW]^YKO5@?F3[>M>< M;FGJCP+LH!8,&TP.&PO=V]R M:W-H965T_LX#(:.)XE @ZAL2HH_LWA'#BW MFI#COE+JU#:MX.;W2OM%X3PZ,Z4:SB7_P2*3#)P3AT00TYR;:[GX#)5#':LO ME%P7OV11[?4<$N;:R+021H*4B?*?/E2!V! (@AT"0240%-REH8)R3 T=]I5< M$&5WHS;[4;A:2",<$S8K-T;A*D,Y,QR!@)@9\G7*V8S:0&ER2&XP^5'.@X?>PJH1.$)&.F0RYUKH#\ M_(++Y-) JG]M8V^_ 7NG9N\TAO^;-)0_B?\2J#HT\C"B!K;QEAJ[A49[<J]=E M[UG^.]O3[WOK"][['Y596=E$\W>4IK_Q^/C_7)S2)*!()K518)@"N["^1'<5 M:;.A%V;:#]:.!&]:IY7Z5\9?/V!^\POVDE*M5#XJB!WUL'Z%_,:'XM5JM?WL M>F\]07,W6J84U*QH##5:S(4INZ=ZMFX^S\J6:[V][%RQK9@QY.,0HZAW=(PA M464S6 Z,S(H&;"H-MG/%9X(--"B[ ==C*V,=HP_B36 1,\)3<786DNYN;%M$:TAP>**;2!5/4O& M$RQ5DZ]LL>& XQR44-MSG,!.,$FM<)2_F_%PQ#))20HSCD26))C_O@7*=F/+ MM?8O'LAJ+?4+.QQM\ KF(!\W,ZY:=L42DP1205B*."S'U@?W9N+Z&I!'?".P M$[5GI%-9,/:D&W?QV'*T(J 024V!U=\6)D"I9E(Z?I6D5C6F!M:?]^P?\^15 M,@LL8,+H=Q++]=BZME ,2YQ1^"7 >RW +P&Y=G%^@,D13=$THUX\B62JH>T(Y*6;>%+.^$ MK'O,KY#OOD.>X_5:X!,S? I1!?>;<%L95+GD52YY.5_O!-^L7+>E!ZT)&1GT M;KP1&QS!V%+;30#?@A6^?>,&SONV]#HB:R3K5\GZ.;M_TKR7$UZ;;_3CL^I& M=Q(2\;/-"+]+(SHB:QC1JXSH&6?]"TNCC'-(U?:0:^ ("P'MDU\0!3F1KIS; MT V&(WM;3Z4M)JAB&@K[E<*^4>&D(8\2O""42 *M&@NJ?FW\2\\[TFB.:6@, M*HV!4>-^&;%#A6E3%[P<E@E M/?RO56C8I1$=D36,<)W#$>UT58=*IOKZ1UC>?9ZVM1R1,TR^6Q1G-0H=&N MW1WUQ5W=O%9$7? H+!7*N1JH%'EQ%RX:DFWRZ^2"274YS1_7ZOL!N Y0_4O& MY+ZA;ZC5%TGX%U!+ P04 " #C@:I8G^K'M\L" !E" &0 'AL+W=O MM5H(VTM"![& MII;! ^+!;4X;:TX<;*<=WYYC)XN2-HN&Q$OBR_F?\SLGOF1V%/)1Q0":/"4\ M57,GUCJ[<970/:] /V;W$GEMYB5@" MJ6(B)1)V<^?:OUI,C;TU^,[@J&IM8C+9"/%H.E^BN>,9(."PU<8#Q==HJF:N1DH3 MR]V61#<%4? "T2V5?3+PWY' "X8M\D6W? G;2CYHREVL356@H"I08/T-7E6@ M>A7N-ISM;5.1G]<;I26NR5]M"1<1ANT1S#Z]4AG=PMS!C6@KZX1OW_AC[T-; M^O_)6:,8@ZH8@R[O6-P$Y!XD$;7<>U^%AB*$/[QLR[]P.K9.S;%R"'W\-(=Z M5BTFP\JDP3JL6(?=K'@\*,UT+N$?<0N_HR[<3I,&[JC"'77B7MOSC"BFH773 MC,XB!J,3J$Z3!M2X@AIW0CWTUWVRSC.0NSR-7H8;GT6>G+"=6TS;T285VJ03 M[4['N ZAL3ME;7=R1C>,,\W:B2?GM3HA[K)H$$\KXFDG\3>!C&TLT[.U/_9. M8%I,3FG&PO=V]R:W-H965TW%L!>T=+:)4J1&4G;S[7>4%-5Q%,$=_,86J?O_>+P[D^?Q M0>DO9H=HX6LNI)EX.VN+:]\WZ0YS9JY4@9+>;)3.F:6AWOJFT,BR2I0+/PJ" MD9\S+KUD7,TM=3)6I15>*!;W?63?C)N&!;7*%] M+)::1GY+R7B.TG E0>-FXMV$UXN1LZ\,_N1X,$?/X':R5NJ+&WS.)E[@'$*! MJ74$1E][G*(0#D1N_-LPO79))SQ^?J8OJKW37M;,X%2)OWAF=Q/O%P\RW+!2 MV =U^ V;_0P=+U7"5)]P:&P##]+26)4W8O(@Y[+^9E^;.!P)HN@-0=0(HG,% M@T8P.%<0-X+X7,&P$0Q/!!2+;L&H$53)].M@59&>,E MI@!SZ0IK936]Y:2SR5SNN5:22L4R 3_#XPI698%Z4\H,5MRB@7NF-7/YA_,7T%@_ C1$$TH #- MX/V[#QU^3?LQ,TQ;3-2#F?5C5E@0)J@P80]F?O:FPE$/9G%^;.*>6 _:N0;U' M+_GQAW 4_-J5P$O"9I>$S2\)6UP(]B+!<9O@N(^>W)?Y&C6H#11,6T['"Y>I M*.F7ZDZ-Q]5\>0-*9ZB[DEVCAQ7:W9C[) [&_OXXA;VK?V\*+PF;7Q*V>!V) M3]\B\2(QPS8QP][$3)6Q+BV4@)\,%())0&,YW=W8E8H:-CIV(#Q)Q6N3<'B2 MKMEKFS@^X^ MJ5K"D_G;\'I>M[C?,'7#3??>EDL# C>$#*X^4?WINHFM!U855=.U5I9:N.IQ M1WT_:F= [S=*V>>!6Z#])Y'\!U!+ P04 " #C@:I8Z5MP&^L" 9"P M&0 'AL+W=O68@(!# MJ(T#Q<<&YL"Y,<(P'BM/J][2")OM%_>OQ=GQ+$NJ8"[X+Q;I>&9]LD@$*YIS M?2>VWZ ZS]CXA8*KXI=LJ[6.1<)<:9%48HP@86GYI$\5AX9@,-HC<"N!^U;! ML!(,WRH858)10:8\2L$AH)KZGA1;(LUJ=#.- F:AQN.SU%S[0DN<9:C3_D*+ M\"$6/ *I/I"KQYSI9_*1_*!24G,CY#@ 31E7)SAZOPC(\=$).2(V43&5H A+ MR7W*M#K%06S?,,[Q.I5G:PS.;&&'52"792#NGD N,GE&!M-3XCKN:(=\WBV_ MH2@?#O;*@VYY &$M'[;E-A*ML;HU5K?P&^[QFW.J%!$K4O EO[_C/+G6D*@_ MN]"49J/=9B;SSU5&0YA9F-H*Y 8L__V[P<3YL@M4GV9!3V8MB,,:XK#+W9^+ M),%/@S((3TE&)=E0GN,KB2]:)#BG4I$,9/DJGNSBVNE_*-?2['-A9KZF&]\Y M&ULK59103J:^7!\Z?5!@#9H(1"5A-_?KNQ*$(RFA3<=^,)+8[]/NIV6UR[V0]ZH MT.1+R2NU<@JMZPO756D!)56GHH8*WVR%+*G&JY87VBRX\;*F.6Q W]8W$F=N MSY*Q$BK%1$4D;%?.Y>PB61A[:_ O@[T:C(F)Y$Z(>S/Y.ULYGG$(.*3:,%!\ M[. *.#=$Z,;GCM/IMS3 X?B1_4\;.\9R1Q5<"?Z!9;I8.6<.R6!+&Z[?B_U? MT,4S-WRIX,K^DWUGZSDD;90690=&#TI6M4_ZI=-A $"><8#? ?SG@/ %0- ! M@N> Q0N L .$5IDV%*M#0C6-EU+LB336R&8&5DR+QO!998Y]HR6^98C3\4:+ M]+X0/ .I?B-O/S=,/Y#?R0;3*VLX$+$E_V ZJ48^$&M+CA/0E'%U@F:WFX0< M'YV0(^(255 )BK"*W%9,JS>XB.-KQCF>KUJZ&KTU>[IIY]FZ]8_^U7<3*F M8\LWMWRF.N]B;^GNAN)\UR+YUB(Z#_PP],][PR?1S/MHYI/17.Y 8M4GC\&0 M6K(4;$29X)Q*4H-L@QN-;9+]M3ER2+*D)5L,%#L+3A?>^> W+EW42Q?]3"(< M8?5N2^&H8).<&X1HM>H\5T>N6YA)QBJ5D+*C-SRR1, M8BL@Y% Y0AM=",G^HZ9'4"1K)*MRH@LPZ M*>L.[O829&Y[)$52T52ZO;GZU;X-N[3=Q[/U]>SBJNVF_J=I>SN\6'*&\G+8 M(J5WNL!O1+;]4CO1HK8=Q)W0V(_888$M)DAC@.^W F^-;F(VZ)O6^"M02P,$ M% @ XX&J6 D%TDW- P 0PX !D !X;"]W;W)K&ULK5=M;]LV$/XKA%9L"=!$;WY),EM XK1;@:8+ZG7[,.P#+9\M(A*I MDK2=_/L>*5FV)5E-D'R11.KN^#S'X]UQM!'R024 FCQF*5=C)]$ZOW)=%2>0 M474N-W SRK@3C>S$K7* M,BJ?;B 5F['C.]N)KVR9:#/A1J.<+F$*^EM^+W'D5E;F+ .NF.!$PF+L7/M7 M$[]O%*S$/PPV:N^;&"HS(1[,X--\['@&$:00:V."XFL-$TA38PEQ?"^-.M6: M1G'_>VO]HR6/9&94P42D_[*Y3L;.A4/FL*"K5'\5FS^A)&0!QB)5]DDVI:SG MD'BEM,A*9420,5Z\Z6/IB#T%M-.N$)0*05VA=T0A+!5"2[1 9FG=4DVCD10; M(HTT6C,?UC=6&]DP;K9QJB7^9:BGHZD6\4,BTCE(]1OY\'W%]!,Y(U,,E_DJ M!2(69"*R7'#@6IG17SH!:>*?.!SF!_J MNTB[XAYLN=\$G0;OJ#PGH?^>!%[0:\$S>;YZV $GK+8BM/;"EVS%%Z&!_'<] M4UIBQ/_?YK7":J_=JDD#5RJG,8P=W#$%<@U.].LO_L#[O8WR&QD[<$"OPEQ)X_$20,U=]B2F)G*1%A"TEO@G-Q(KK-I<4ZPSL.B:1 MK:.S8#ARU_M,6V1ZE<@!_GZ%O_]&^%EQ8#1])">Y%&MFLN(IF0&'!6ME5*S< M[V34E/&'[8P&%:/!FS!J0SQH(N[W:HB;,G[8CGA8(1YV(OYC!XH@1CQ+;$U- MI2"8T):@?AX[PP:FH(:Z*7$D<"XJT!>O!/WR@+EH@/1J-+HD#FA<5C0N7T6C M#>;E3[W=E#CB;=_;U3RO$^A]V890/B>YP-0*FDG YD1O/:I>EF_*]0Z"W:_Q MZ)8Y9+)7O?VW9?+R0"H1=$52I\@ALV#'+'@MLU:TP3-VHE/F$.^N>/N=I3'Z M6VB:$F&[H_B@.RI=OMV!&6#S;7>@%7_8DN@'=0(M0L<([(JOWUU]GTW@&/)> M\RC7*U2+S-FQ&N7ORJ[?77>?C9QC8XHM[#$"_69'T _K#)I"_J!&P-UKQS.0 M2WM+40@-LT?1G5:SU4WHVO;_M?D;V/T U!+ P04 " #C M@:I8VH0 90(% ! '0 &0 'AL+W=O^^JNUU!=:T_&&KN .Y+?-@JNS5N;%\T.(A,\BQ&$Y<:[PY9R, MM$%\QU\^[,7!,=)0[AE[T"N(,'>3!DFX#^97M/T$*J*?]N2P0\2?:I_>V M'>1NA61A:JPR"/TH^::/:2$.#)2?<@.2&I"\0?<%@TYJT(F!)IG%L*ZII-,Q M9WO$]=W*FSZ(:Q-;*S1^I-MX)[GZU5=V^D.N@:,Y"]426NO>[@#=1"X+ M 9U]9D*\.NF617 OT,?+ .[9OJ1IDA2#/A9@1J\-;RB]0![]'I$VZ)?G, M3S?O6-+I9'WIQ/XZ+_A[994C5>5_/BL?Z$9"*/XM*V@2L%L>4(^+2[&A+DP< M%48 WX$S_?DGW&__6E:-FIP=U::;U:9K\SZ]$GI97H,+X;TJ3'G5$\R)HW[L M2$^TW?3#H*O:NSO$8HU6$4LOP]*S8DEZZQ[UUD][&^C>HGM0PQK4R'0#*H2_ M]%TJ7WIFDEB]0[B]'%AK.A7!]C.P?7OC0K;54\1@4:M[R5FHIKE9[NQ')2E# MWB\B)S@'W9I<1>B##/K "CU]7B5]1&<;SG:^YD'=W B6OBQ#-"A!-,@A&A26 M-S:W'.4YS/(47B$YEO. M(7*?T)^<1B*(GQWTN](WZ>PL V?U_-I)69.SHR+@MJ'W]EOS2!JQIO+4Y>VX M/@?R!]?%):FGXS7?S@\9>[RJ>(C!0]Z03])@]B%DSZ@J8B.4L%5K-$DJ:>1# M^.T\^":$$#9*"-NET.MI)77X@Y8V(8FPT438+HI.)2%K"L9H M'FP7/0=<@Q3U7 /W=U3_=T6?P%N!0&=?F 2$2?D2K$FTI*5H0@)AHX'PX,W) MR"J[7EV?FKP=U\=H+WR*^#J-C$H$&!GF5WX3 @P;!8;M$JQF+AH5$.O2' -N M0FP1([:(5:PT245I9/L?''MZ5>$;+47L6NKU9$2*DBI/L/:853$9/47L>NI4 M*B)E2JF?Q]*$4B)&*1&[4EJD;U]IY*$%$Y*#]#GH%WMHEO1('/XS2HEI6+X> M:WV;5)>WX\(8%46Z;\U+I"8%E=:G"3U&C!XCI^BQDWB)E$@RG%=D]G!5X1A% M1NR*K%Y>(B6OG@J#N0G=18SN(O:73TWR4O$U56&"-R&JB!%5Q"ZJ*K!245L5 M,#6AK(A15L2NK$YFI5'Q_32;>(=KWLF)0OC MPS50#[B^0?V^9(K8TA,=(-LTG?X/4$L#!!0 ( ..!JEB;YS\B* , #$( M 9 >&PO=V]R:W-H965TK-2.F>6MGH=FD(C2STH%V'4 M[0["G'$93,?>=J.G8U5:P27>:#!EGC.]NT2AMI.@%SP8;ODZL\X03L<%6^,= MVOOB1M,N;%A2GJ,T7$G0N)H$L]YH,73^WN$3QZW96X.K9*G4=[=YETZ"KDL( M!2;6,3!Z;'".0C@B2N-'S1DT(1UP?_W _L;73K4LF<&Y$I]Y:K-)\#* %%>L M%/96;=]B7<^%XTN4,/X7MK5O-X"D-%;E-9@RR+FLGNQGW8<] /&T Z(:$#T% MQ < <0V(GP+Z!P#]&M#WG:E*\7U8,,NF8ZVVH)TWL;F%;Z9'4_E M;H8;./&-ZC>8$KNBFF%-X3Q?N#.[HDJ6E0% K..+86:!E7)#Q#.[O M%M!Y?@+/@4NXYD+0X9IQ:"E5%S!,ZK0NJ[2B VG%<*VDS0R\EBFFC_$AE=C4 M&3W4>1D=);QF^ASBWBE$W:C?DL_BW^'QD73BINVQYXL/\-VBL;I,;*FY7 .3 M*=RB8!93F+D/@5N.!K[,EN1%7\;7M@96 ?KM 9Q:C$S!$IP$) <&]0:#Z8MG MO4'W55OU_XGL42_Z32_ZQ]@?]Z+3.VDKMF(8> :G9)OI68^.<;/G,S\>Y4NO MK8N+%F)WP)N6>BZ:>BZ.1OJH+!-M15S\O8A%B\^A? ;!$\.P27#XMU; .YF( M,J5+AGDAU X1+&K2%^;5>(D25]P:$O;J5EH%68083L[;;EVX)X+$M_;#Q$!"46UU>(VUF5H+ %:76/1_2J>MJ0%4; MJPHOV4ME:0#X948S';5SH/&ULM5A=C]HX M%/TK5K:JIE)GDICO*2 QS'1W'VA'PW;WH>J#22XDJA-G;0/EWZ^=A)A9$E-0 M>8$X\;WG7-OGQ/%PR_AW$0%(]".AJ1@YD939O>N*((*$B#N60:J>+!E/B%1- MOG)%QH&$>5!"7>QY73J,A_F]9SX>LK6D<0K/'(EUDA"^>P#*MB/'=_8W M7N)5)/4-=SS,R KF(+]DSURUW"I+&">0BIBEB,-RY$S\^P<\T %YC[]CV(J# M:Z1+63#V73?^#$>.IQD!A4#J%$3];6 *E.I,BL>_95*GPM2!A]?[[!_SXE4Q M"R)@RN@_<2BCD=-W4 A+LJ;RA6W_@+*@CLX7,"KR7[0M^WH."M9"LJ0,5@R2 M."W^R8]R( X",&X(P&4 SGD70#G+1R+)>,C9%G'=6V73%WFI>;0B%Z=Z5N:2 MJZ>QBI/CSS("CFZF$>$K$._0[VHBQ7OT2:V'6S17:R!<4T!LB5Y 2+X.Y)K' MZ4JW@&\ +7;HKUV6=Y@R(='-(T@24Y7H%CTE&64[ #2'#7"2!H#>H#A%LYA2 M-2%BZ$I5@*;A!B79AX(L;B#;0C.6RDB@IS2$\'6\JPJOJL?[ZA^P->&,\#O4 M\M\C[.$V^C)_1#=OWEGRMJI1;>5Y6PUYZP?KZPNC%*G%M"4\_%97?I&U79]5 M"_1>9"2 D:,4F.=TQF]_\[O>!POG=L6Y;,S".N)%ZFZ>6AO!9NSWA^ZFADZGHM.QTIF$82R;EDD1VCF$Z]3#=2NXKA5N M2D2$,K)3AB-K(;M'D+=^JQZS5V'VK)B%]H*(I$IZ=9B]&LQZR'X%V3]SDB$- M3T]O_WB\!_5$!A61@97(4ZK6%@"'$,V(5,"$U@Z!-571E,O@R_I6Z&CS+-Q[J MVTWTI*3+^)_1M&^LTK=[Y86J]FMLM-O Q?BH;S?220!R1Y':4*A7_=<9) O@ M]1JQYKE4(\9[_=YUI&WU]$MI&__VSS7P%G89_S,2P\92L=U23PH;']MF4ZG&-;'=-2_4-:[QTP8JQDZQW4Z+ M^B?Z&TI-=\,07&/[BHWWXO95%(VMEGXI;6/>^%SS/D/1^-C"&][5V#@X/N'@ M-D7CXWUP$Z"Q8FS?!Y]6=,U&N-V :IP4VYWTM**/W;))T<8ML=TM+U7TX.C[ MZO_&[1Z< 22@/N;U28= 5NGLC@.J.Y6IRF3X@S!="^.8M17L5J E%8JE#O MKJ>&@!>G&T5#LBP_45@P*5F27T9 0N"Z@WJ^9$SN&QJ@.F,:_P=02P,$% M @ XX&J6%H8W/M0 @ K04 !D !X;"]W;W)K&ULK51-;]LP#/TK@@<,&[#%CIUF0^<8R$>']5 @2/9Q&'90;#H6*DN>)"?9 MOQ\E.6Y:I.D.N\2BQ/?(QY!,]U+=ZPK D$/-A9X$E3'-=1CJO(*:ZH%L0.!+ M*55-#9IJ&^I& 2T),=BMR60/Y2@^@R7NRQBXI6@Y$EN2F+,$5V;Z2%35 WBS 4,;U MVS0T&-Q2A'D7:.8#Q<\$2LB=%*;2Y$844#S&AYATGWE\S'P67R2\HVI DN$[ M$D?QZ$P^\W^')Q?22?I")HXO>;&09,%TSJ5N%9"?TXTV"GOUU[F*><;1>48[ MO]>ZH3E, AQ0#6H'0?;ZU7 .R6V:718-XF(:[4SDO>?D\PY/.KT%MW4+0))>M,+Z5^MM^YTS=J#VY MG^$N\JOC@<8O,FR4+1.:<"B1,AI\P$E6?CEXP\C&S==&&IQ6=ZQPGX*R#OA> M2FF.A@W0;^CL+U!+ P04 " #C@:I8[(SA?J4- !BH &0 'AL+W=O MQ;^*QKNSMYU):@/&3K))9MH8 M2>QLNSO-[=Z'3A^(+=O %G#1W]L-?@8EE&2R;]#2S+VT,TD]"')#T/R N M'Y+TSVPN1$Z^+J(XN^K,\WQYT>UFX[E8!-F;9"EBN6>:I(L@ES_363=;IB*8 ME)D64=?N]0;=11#&G>O+;&A>WVY#&;B5N2?EK^G\E=W0YF$"Q%G81*35$RO.F^M"W_@%AG*%'^$ MXB';^IL4AW*7)'\6/_S)5:=7U$A$8IP7B$#^=R]N1!05)%F/ORIH9U-FD7'[ M[R'LQ=D(F;)/I/.,GG5YVS#IF(:;"*\H_) Q?5 945'"=15OY+'JJT MO0X9K[(\652990T68;S^/_A:-<16!LO9D\&N,M@[&6Q[3P:GRN @? MF\&M,KC'9AA4&0;'9AA6&88[&0;[6NFLRG!V;(;S*L-Y*8?U^2M/_BC(@^O+ M-'D@:9%:THH_2@65N>4Y#^-"[+=Y*O>&,E]^/1)I>!\4@B,TC(-X' 81\>,L M3U=2TGE&7MW*ZVNRB@1)IN1F'L0SD9$P)C0(4_)'$*W*'0J3O2:O1B(/PDC^ M]=,/9\Z@_W.1_GT815+=V0GY71U'4I3NN:LS6-;;WU-@B[Y,XGV?$ MBR=BTI"?F_,[AOQ=V7J;)K2?FO#&-@+?!^D;XE@GQ.[9??+I=D1>_?BZH5ZC M-ACOTT?RJFJ^)IAGAHW$> -S#'6B;3"'ZL3,L+>KV5%UXICF]H_'[*F-I@9G M_ARMOP?(&&Q/OZ[B\6,B-5%LJ[^GD\WNQN!/I%_(W^9#D\I+)9+H@ M%Q,29(2+R2R,9UN77L,AW1B++OK%BVP9C,551W9\F4CO1>?ZIQ^L0>_G)CDB M81X21I$PAH1Q),P'P329]CDL>Q!,X-@C.BV@D'"/"2,(F$,">.#FARLP8YBZDGL M9L4,-XH9&A6C>KH3LJ6>$W*;R\%7,=(J)C#5S2;9>K%>F=3E_IRY6D7P-GF C@[^@*(DT*VHG7N]O42*;)$AH3Q8QK,!Y6H">!\(X!SHP!N@FQ.:"0S5;/,IM-N M1+2]:R%A'A)&D3"&A'$DS ?!-+E9/153[*$FEQ4)I#LHS8/2*)3&H#0.I?DH MFJZ^K8BV]9*S3'-IK16*I'E0&H72&)3&*YJ[U2(J8-E*RW9WV^Z M:6:W5@Z2YD%I%$IC4!JO:-O*.:U)IR'-/NTH(\ R.P&U81?YN[CW+)))F#]N M;(%&X4#C_%":!Z51*(U!:1Q*\U$T78PJW&_!XOT6-. /I7E0&H72&)3&H30? M1=/5I^+^UHL&_LVEM58H-/0/I5$HC4%IO*(9AV3U)'OB_Y8R *SOZ "8V:V5 M _4 H#0*I3$HC5OU(/^IM2N=!J]@CW24$V#]PZP $)N)3$, MS&6WUBW4+8#2*)3&H#0.I?DHFJY7Y4%8Y[ )"-2+@-(\*(U":0Q*XU":CZ+I M3^@J1\(VQIS;>J 5;7O\_#3NHWR@%H"4)H'I5$HC4%I'$KS431=G,IHL&U4]VA#;04H MS8/2*)3&H#0.I?DHFJX^95789JL"')\SE]9:H5#_ DJC4!J#TGA%:PZ^5;)S MCK5,;>4TV,98\K?%Y\SLULJ!>@]0&H72&)3&*YKIP>Z&)*=[XG.VL@ELLTWP MXO$Y01%W+RJ:PS39%TVS#CW,AVR,G'Z6< MR>U#L#1/,Z!F!93F06D42F-0&H?2?!1-5Z5R0.PA;)H!]2Z@- ]*HU :@](X ME.:C:+KZE&=AFST+]#0#ZE) :1Z41J$T!J5QN_[^0VVP:$JB:TGY";;YI89O MFV9 '08HS8/2*)3&H#1>T;0YA+TK'6,:?84&Y08XQ[L!+S+/,->GK=Z@- ]* MHU :@]+X 55L1N?>^@6\I@[TFQ"Z6I5OX9A]BZV5=K:L_E6:BGC\6,XB&B4' M]2B@- ]*HU :@](XE.:C:+H0E4?AP#P*!^I10&D>E$:A- :E<2C-1]%T]6VM MJ_1&X2@C MPWFND?&J[ Z7MDR#4$('2/"B-0FD,2N-.W>VP=I]N:4BS3X+*$''^88:( MN3ZMY08U1* T"J4Q*(T?4,7!%44:>V\H4]>S,D412E?=RAE1JU[ < MA1G46HA0[P-*HU :@](XE.:C:+KXE/?AP+P/!^I]0&D>E$:A- :E<2C-1]%T M]2GOPWE1[\-<6FN%0KT/*(U":0Q*XT[#TE6UI9\:$IT.W3U#0^5_.-_1_S"S M6ZL'ZG] :11*8U :KVBF!_2,2?2%?Y7[T3<'J9L'8Y$?T7?6/"7%IK+4&=!BB-0FD,2N/] M^AL3PYJ8ZFE.MV+!NIRVOL9@COX_A=\V0["1B)-%N'YM?R3NBA?YZ\\!-"H) M:AA :1Z41J$T!J5Q*,U'T71Q*A>B[\+&:%#_ $KSH#0*I3$HC4-I/HJFJT]Y M!OT#GL'3Z_IOR]?U"\/K0Q)/E":WOE;6*,E![89MN;V=V_K(7(G64FM8O*A6 M)H66R: T#J7Y*)HN(17Y[Q^W!+^I=SW>FC(7UOH>!S4'H#0*I3$HC4-I/HJF M"U29 _TS6 \+#?Q#:1Z41J$T!J5Q*,U'T73U*2NA_UPKX7ES6:BY *5Y4!J% MTAB4QOMUYV!W02&_(R[K*7W#-_L(W!=7,[+;B@=(\*(U":0Q*XVY] M-:K:E]WJ"S[M":JYR@QPS6\ZM!GJRR%;]2G:1AE!O8**9O6W#M8=6COO*GG0 M0NEQA3)HH1Q*\U$T74XJNN^:H_N_!,L@EMSB<[LB(Z.5*#[V>]X82CO&_C07 MUUI4T( _E$:A- :E<2C-1]%TB2H;P750 W\7:A% :1Z41J$T!J5Q*,U'T73U M*=?!-;L.+5?%K&C:JIBU0)JYR-;"@CH&4!JK: -3<_!CVLQ'U4N7P=97FWUEBO\Z,_3PS]OO,V \T8[_0#'4"4#1=I\H)< >P MSA+Z^@"4YD%I%$IC4!J'TGP435>?,A'<4QG.:Q;0+UZ;PF-_D-I%$IC M1[4'/RJ5CZJ9K@05K7?-C_(W])>-"H!&ZJ$T#TJC4!J#TCB4YJ-HNO)4I-Z% M?43!A4;AH30/2J-0&H/2.)3FHVB:^@8JL#\XM&S274["30CVA.0B731IS\QI MJSTHS8/2*)3&#K2_2QY%D#8]Y,*A]?!1-%UGR@88F&V 6O_J]!I5!HWQ0VD> ME$:A- :E<2C-1]%TY2G'8 !;X6@ -0.@- ]*HU :@](XE.:C:+KZE!DP,+]3 M<'S_"K4"H#0/2J-0&CO0_D-#_PH-^Z-HNLZ*L+^^146 !^8(\&?K"_%C,D[B M_Z[B<1';( ]A/B?YO)S>.N2WZ53>&N,9>55VS&1(7A4(",DZ3+#L=/\6,LV+E<[E#2.JXN-M&CT79]R+-R8]N MKT<68105E4BF)37,LI6$Q>60H$)NS-U'$9].MI[GO$M2>?Q%78.LYU^K( JGH5@O M%#\/,G(G)&JB?58Q(-,B2GY?1LGG8C(33W6O6N1?&9E63Z%NFF&SUDI1&_EK MF62K5!1U*3)&23P[+>X LJB[\EF(,,_V'W:VNLO"21BDCV_(V\DD7 >HHL>3 MXCQ]IQ/;<%JSO>?5>M,C=X?.JWM:7()E2P_7?PHY&&P^O]G."2Y2&L_PA^2^ M7&S_Z2RO78Z=K4[OA$C \ND E!*R2@J/E1#D(*%!";LZR+Z3$&KMLB6 IKM$ M-YL+D8^"/+B^7(AT)FY$%&7R]*SBO BX;6V5QS\M/NAX\<[N=&O;;ZR+D=6P MW;,N:--V;EWX3=O?#OH77-ZTFO:X!^D,]E%DDA,9;5[ M;X;RQI:&L_GF1YXLKSIR%'F7Y'FR*/^&PO=V]R:W-H965T M D-;OX"=W)V?Y[GS73I+J9[U%,"0EXP+W?6FQLS. M?5\G4\BH/I4S$/AF+%5[5Q-ZX,'-ID:^\"/.S,Z@2&8Q]E X-\T8V3-@L#HW"MPS]3-P'Q1;42DFNF: B8923&Z&-FF.NC";' M0RR<=,Z!R#&Y'X\U&,/$A%QH7.D/Y+@/AC*.JX_D<=@GQT+D8H$%;@]RIR>;1Z=31[*\_UC";0]?#::5 +\.+W[VK-X%,5 MU3<*MD8\*HE'^Z+'GY74FM!,SH7!&YO(B6"_(*WBG =JND"V<2SB,*AU_,4J ME6V;6CLJ;=80UDN$]<,12E>\'?(=@"NDN>L$C_#7UC"]NV_-LV.^5OE@R:A\LOY'^F MH+D%, HW.&R;U'V2;9YM8*JPJ>_0M5V":N\%M=EQ3LC0 MH(BV(=LN_*=1#Z1F;AH^7;T8.UI'V*>O!+9N1>WSROZT_^Q[S)PBU#6Z$Y+O M+HK=G13)7"FH%*OW]G%S\?R5Z6:_+' \3)C0A,,83PI.6U@/*I_6^<;(F1MX M(VEP?+KE%#]P0%D#?#^6TKQN[ PM/YGBWU!+ P04 " #C@:I8QVK;XP@# M !("0 &0 'AL+W=OV#FUQ:"\?N;+>%_?J=G1"U).VJC2^)[=P] M?I[S^2Z#E52/>@9@R%/.A1YZ,V/F)[ZODQGD5!_+.0C\DDF54X-3-?7U7 %- MG5/._3 (NGY.F?#B@5N[4?% +@QG FX4T8L\I^KY#+A<#;V6][)PRZ8S8Q?\ M>#"G4[@#:>MDU+?VSN [@Y5>&Q.K9"+EHYU< MID,OL(2 0V(L L77$D; N05"&K]*3*_:TCJNCU_0+YQVU#*A&D:2_V"IF0V] MOD=2R.B"FUNY^@*EGH[%2R37[DE6I6W@D62AC@ MV)+:4)(+)JA(&.7D4FBC%GA61I/#.TR<=,&!R(Q<9YD&8YB8DJ^,3AAGAH'^ M0 ['8"CC./I([N_&Y/#@ SD@3) KQCF>EA[X!LG:+?VD)'96$ NW$+NBZIA$ MK2,2!F&[P7VTVWT,2>4>;;K[&*(J3F$5I]#A17^/TYIR\G ZP5!A+OYL4EA MMILA[?T\T7.:P-##"ZA!+<&+W[]K=8-/37K?"&Q#?52ICW:AQY^5U)K07"Z$ MP;N;R*E@OR%MTEP =1V0+2'+.&IU!_YR74K=IMT.*IL-ANV*87M_AM*EJ(=D=I24[%Z:]0B>/Y:G[/_&-@C MIDQHPB'#?8+C'N:#*OIV,3%R[EK?1!ILI&XXPU\=4-8 OV=2FI>)[:;5SU/\ M!U!+ P04 " #C@:I8% MA:78+ IBP &0 'AL+W=OJE'WOJCV M!;$G,2H&+^"DE>Z'OV!C#P-DS+B/-[QI8R?\SG >.!X>YN"+ISCYEBXXS\CW M91BEEX-%EJW>#(?I;,&7?OHZ7O$H_\U]G"S]+'^9/ S35<+]^6:C93@T1R-W MN/2#:'!UL7GO4W)U$:^S,(CXIX2DZ^723WZ\XV'\=#DP!KLW/@68#L]S K&]@/K.!56Y@=8U@EQO872,XY0:; M71]N]WV3..IG_M5%$C^1I/CKG%;\L,G^9NL\7T%4'"BW69+_-LBWRZZN_2 A M?_GAFI,;[J?KA.='09:2IBG/W_2C.?D0^'=!&&0!3W=; MS(F?D0JHT)]\YK-UD@31 WGGIT%*7E&>^4&8_DY^^V5LN?8?)(C(31"&^>&2 MGI%?JR\OAEF^:\4 A[-R-]YM=\-\9C=N_.0UL8PS8HY,FWRYI>35K[^W8*8Z M&/;E,WE5CK8-1M4PRF=[F*48$]/!*,8TS*7?ZV_N]3Y\TNVO2=L?^C[;$V8W].#?'=BUSRE"ZF6N) M:(]&M=2!(DJI<_:I<[2.MS-RF_G9YG.D^.RX#B(_F@5^2#[%:;"9'7QEW[-B MKG&7?[JP:+WDB5^\WUHPU+'_DRUX0OQ-X6JK$,JM=97XJ:$PT% DB=R]1*ZF M1'GI+@IWKA%6+O4XMCG:?LY4Q] FG9*D*QUL6 PT+$E&;R^CUU7&<%>DSDA: ME>]^+]_J&/G4\;=Y"L7Q=6_H;P2U:UQ'^., M4)X&#U'^J37/)[OD3SY_*'[W/DJS9+WY(-,NA>HQ:I\U4%< 2F,HFJRV, 8, MJU_E$&DA3*$T"J4Q%$T65I@7AMJ]N(X3GI^4Y8D\^T&F<90E_BP[VUWO=2^4 MVTA.I6J95KU.0@V.EHB3>I4\A;]A"(/#Z')I+Z;M\,F@.K[VB0)U/: TAJ+) M2@H?Q'#[50&1+L842J-0&D/19&&%,V*HK0#]":'7J#JV6:]S4"^C):+EU@O= M*=P*0]@51I=K2+4H&B+:3F-B>(IC =+& ^6VG@XLNR= M9JZH'JON202E42B-H6BRZL(0L8Q>54<+ZHY :11*8RB:+*QP1RSU A'T7+$, M)\_>G"2AHU*QX;:JJBD;U?V\EI73SWE4;P,M@62\KOV MQ@[HD@LHC4)I#$63)1.&B&7WJ^)!;0\HC4)I#$63A16VAZ5>[)'/1((X\D/R M=AFOM^NR<[GF8B6WF)"T-BJ6^&JY,9QZP\Y4/0AM ;K$9*B8/ M/,MS]\C3;#.9^]E"!UU9 :51*(VA:+)LPL>PO'X5.JBC :51*(VA:+*PPM&P MU(L]= I=?I:63<>MDD&]BI)FV)5JYGCU22*%!F4'@\I)%NZ"I787IO%R&<_S M.?)^XIRG3>8&%JV/WJ([&AO@64 M1J$TAJ+)P@K?PE8OY! ->FH=T3ZMH"X%E,90-/F0$'Z&W:]&$QOJ>D!I%$IC M*)HL;.4I&>IE(%V>+5(BI")9KY%0^^%P0(8***=-> JVVE/0+)$Z"[!/4"6A MZS"@- JE,11-/BJ$(6+WJQG%AEHF4!J%TAB*)@LK+!.[\W,ZGJ^2+?TG=9-0 M'48[Q1WZ3U 1Y<0)2\)66Q)'3B6[W6(^0:6$^AY0&H72&(HF'Q?"1;'[U:9B M0XT5*(U":0Q%DY\<)HP51[U:I.MCUYQF2\AY_:ZQ.I1NFCM$9*B(>&H MS8OC9Y4O53#5.Z1[7D%I%$IC*)I\: A/QNE74XL#=5:@- JE,11-%E8X*T[G MAWNJ"V:SIZ0^NU1'TL[RP8 ,%5!.G? N'+5WL;^]?/ODKZ3:U2>/4KT3VF<2 MU&B!TAB*)A\.E:>6]JN]Q8':*E :A=(8BB8+*VP5Y\CV%OW69Z?99^+4'_:K M'HVV$LV(=5N H2+*^17NAJ-V-S3JZ,L:F>K]T#[CH&8,E,90-/F($+:-TZ_> M& ?JNT!I%$IC*)HLK/!='/7J%60I;3:O-"[@H3Y)2\!&(3V%^>$*\\-5FQ]' M3$A?ZL)=O2>Z9QR41J$TAJ+)QX3P=-Q^-=*X4$<&2J-0&D/19&&%(^/^NXTT M;DM7BUFOJ.HQ:>O1UKMCU&HJ*J2<9N&/N&I_Y+C)Z8N55>BZ%2B-0FD,19,/ M"^']N':_RBK4Q8'2*)3&4#196.'BN.J5-?"RVNRD:3Q98JH>D[8>+2'=1ED] MR=?'5+X_1NVIU,OJL[T\+^Z?JG=$^\S#?@L-=)$+BB8?$L(&A .\Z"\C54N;Y]6+*=1^:8DXJ7_/'"JBG%]AJK@'6H+T M:NG+>JCJ?=$^ZZ .#Y3&4#3YF[V$&>3UJ\7(@SHZ4!J%TAB*)@LK'!U/O4H' M6$Z]9C-0_::^>C#:0AP,R% !Y>P*6\4[T'QTW,3TI2[XU7NC?=9![1THC:%H M\G$A?""O7QU('M3)@=(HE,90-%E8X>1XZE4\Z O^,ISLH]9[.M5CTM:C)63C M@A\54DZS\%6\ QU+1T]27ZRT0M?70&D42F,HFGQH""_(ZU?;D@=U=* T"J4Q M%$T6MO+MPNJ%/?#2VFPX.C>MQHP5^X7!;3''C>)Z"H?%$PZ+U\UA8=]G"S]Z MX&+]_M<;OKSCR=\=GXC9FG7HXA@HC4)I#$63510^CM>OIB0/:L5 :11*8RB: M_)W=PHH9=VU*ZO10D))6_9Y7T[#J-J7 V- [N(LBY>;'Q?#'/^4YQ\V\2X^C]02P,$% @ XX&J6)J:ZNT1! [Q( M !D !X;"]W;W)K&ULQ5AM;Z,X$/XK%K MQ^.'P:.M5#_TFE*#?B96M ER;CY)K=_TQ)0S\:+)=?Y+]J6MH&'XDP;F93.D$'"1/%/?I9$ M[#C@[A&'L'0(7^L0E0Y1#K3(+(=U30R9C)3<(F6M(9J]R+G)O0$-$W899T;! M4P9^9G)#F$+?"<\HNJ=$9XK"&AF-/J,95,PBXQ3))9H2I9Z96!66&A&Q0+6G MMB8W3! 1,\+1K=!&9468LVMJ"./Z' (^SJ[1V:=S] DQ@>X9Y[",>N0;0&%S M\>,RXZLBX_!(QO=$7: (=U 8A-T6]ZG;_9K&E7O4=/>!NXK L"(PS.-%OR2P M@ZX(!PXHFN4;\*N260JD=7:XF1EB^_X7[P1QLW)PK68"JJF(I[C<5DTT/0J-#TG&MB\FKD.(I(YPM&5T@V-W:O&Y->@?YX>$>A$.3$+=CZ%<8^B?#X%Z M_J_3/S0YEOZ@2G_@3/].BM5G6S!0-W/3@=1CGBTLSW&FE-4.!@I+."^*#;27 M[WF\8F$&A\BB;M3; ]=J%1PIL6&%;_C.^-R+-FQ)NH_#/6BM5OVP'=J7"MH7 M)[3=E\&M2#-;87=T0SD*VS)U!GNKM)\H6 ,W#NHV(OC8UV Y_XG(.E6T)EL[ M31?^J'=&.;/KI>$T:2*JNR#L;!U.J+GE1$[1;;$YIKJX;D^PNS]Y;UTJI]]3 MT\&^,+6:]7#W"+RZ3<'N/N51R+FMY+R@"G%"9X4X1>>M^3KCO7G'G2A:$WW= MUN#>!^N3LZ]Z,ULGBM9DJVZ@L+N#>D]].FR8#O3)9=)$5/=4V-U4G5"?#INB M P NDR: NFG"']LUE=,W/HVZ!\#:C(9[T/R=TPA[% 0?["O(#7&Z!*_@8@"\ MJ.)TI1@8F>8'%'-IC$SRRS54&576 )XOI30O WOF49UQ3?X'4$L#!!0 ( M ..!JE@>E3*6N@, .\0 9 >&PO=V]R:W-H965TN^+:2\<. G6L,ULD[32 M/ORU@3+H""L3>1$PG//W.3]L<\SBP,4WF0 H]$!3)I=6HE1V:=LR2H!B><8S M8/K.E@N*E6Z*G2TS 3@NG&AJ>XXSLRDFS%HMBFLW8K7@N4H)@QN!9$XI%H_O M(.6'I>5:3Q=NR2Y1YH*]6F1X!W>@[K,;H5MVK1(3"DP2SI" [=*ZINN6'#U E-#5Z$4]E\8\.E:UCH2B7 MBM/*64= "2N/^*$"T7!P_2,.7N7@O=3!KQS\ESH$E4-0D"E3*3B$6.'50O # M$L9:JYF3 F;AK=,GS#SW.R7T7:+]U&K-*25*/T@E$68Q6G.F"-L!BPA(]!?Z MC(7 YM&@TQ 4)JE\HZ]Z@UZ\N_%GP%A&& M/I$TU<]73M!)L[FPE0[>A&!'5:#ORD"](X'>WX7H].1-A^.ZW_']_2TZK2+J M<@__H%];4ZY1>S5JKU *CBA=:U*4D2V)<#'DKW8"H"3_@4.42-5%I5?3K J7 M,L,1+"T][26(/5BKUZ_6Z3.:U+G M@TAE("(]G1]U=1>)'*<3%.ERXM& V.,TAPG*\&/Y!OR!3KJHE/W,FE/?#=I) MK'MC&;H6CR36PC:OL/F]W8M *[SLQIU>A&$ MC9?05>]+J%]H:.*CJH5CJ;4A-DIZ=^SBJ%(Z3!'E[KIL*)X5^\T-5WKW6IPF@&,0QD#?WW*N MGAIF"UM_XUC]#U!+ P04 " #C@:I8%*(+6*H" #3!P &0 'AL+W=O MLY$!=*BZP)-@09Y?6?/#?KL!?@^Z\$^$V 7W'7$U64^![_A"6CW,X/3E[*>,::ZT_O_7G5[J#__(WIRIF0A42X?O52FEI M#LF/+OAZDF'W)/;B7*JASF!%K!"6!":]. ![5N1H 2QAANS 2;H&Q+915XSC/;(1X-7P$4R#@POF!W^3NGMOM$UWYL';4/.8,ER;*.]\8HS*.H74%2WR MZME>"6V20%5,3=9%:0>8_K40>E>QF:#-X]%O4$L#!!0 ( ..!JEAHT-/ M^P@ "9% 9 >&PO=V]R:W-H965TU!EVA:FBR?133/LPX^ZQ+1(FK85 MZJ&-+9]S>/Y'%/D3=;EYRO*_BS6E#'Q+XK2X':P9VUP/AT6XIDE07&4;FO)? MEEF>!(Q_S5?#8I/38%$Y)?$0.HXW3((H'4QOJFV?\NE-MF5QE-)/.2BV21+D MSW?S3!!WLVBP=]S^_1/^Q$L_%? D*.LOB/Z,%6]\.Q@.PH,M@&[//V=//M!%$ MRGAA%A?5_^"IL74&(-P6+$L:9YY!$J7UW^!;4X@]!Q<=<("- Y0=R $'U#@@ MV0$?<,"- S[5@30.E?1AK;TJW#Q@P?0FSYY 7EKS:.6'JOJ5-Z]7E)8=Y8'E M_->(^['I UWQW<[ A[3N=.7.NP0/O#\NMC$%V1+<;0ON4Q2@,2W Q9RR((J+ MM]SR]X.IE0T,PR:-69T&/) & O=9RM8%\-,% M7;3]AUS23A=\T36#QH#W07X%D/L.0 =B33[ST]V1QMTWN\]I>,B]I0;M]A*J MXJ$C>^DSW60YB])5:W\]_L+-P0=&D^(O7>GKV%@?NQR)KHM-$-+; 1]J"II_ MI8/I]]^YGO.#KFXV@_F6@K5JBG1J;(C4'WQC0AWECG9R1T:Y_C_;B#V7@W"Y=VF0IUQZT8@NA_%@ MN8SB*&#Z_CY2Y!$B54 U<243WYABQP*,=P48&PLPISQH&-4C8I N0)"40^6_ MU0:=Y+&Z1Z%\A*LV[@A*HHUI=10]V8F>&$7/@DW$@AC0;QP<%Q';YMK=>V>. M\NAJIXV)*MZ1.X7.9BP5R-AXQP*YCN ;QRCNIRQ;/'$NJ?I$E+(@745?.-D$ M14%9/1AJ<<71*8.2MKFY\7.GPR::UVIT0D2/:]=@C_%<8PU^R\I.4BO6BG75 M8\%S$)+%&ELY6ZRN43(9'1 +A5AH%/LA#?D94T'!Q8+6G]Z6PV(0AOF6+D!X MVB$S:UII37 (RA71&!%/ZO_F?+L> (=72-%37W>X5-*13$>L%6 M,=%J--]6M'8)!2FZN$?\=BTA8%-8F]%\6]':A15\ZIH!U8S!;SM F;L^M1O-M16L75C ^ M-#.^<2J%*FMKIE*=E3J5FO/HJE/@/33C?=8W#G%)7R8*_H7FI]I6+6TWT?8E8*8-J(_<. MWYQEURH(6(9F6#Y[A0MJT!B/9.$:(W7_]X'/4. S-./SB:UW(Y+5E"S0NM@1RF 58C5-DH@T:_B0$>$R8QY:LH&YI MUH/RLKVYE;/%ZAJ=[,V0;;$"-F$'V#QVSFB.>38+685,6]':%TL%9*(^(1-9 MA4RKT7Q;T=J%%9")7@&92(./T),12VM%9,@TY]%5IX!,U ]D(I4?Y1%)8W(I M@X8YNZ[J]VXVL$:82*5'2.1+Q3HC^>3#-^?45;- 3-0K8B(5'^5K!1H39;_W M 9A( ":R#)A(9480H9&ENY&RENC;1^(!4 9;H MR/T!6 MX!*KI*<,[5;1TMA@6[L 2_PZL,2:6T['$V5 LPJ6FC:1"R<'I JPQ&:P].,H MB=+JT-5+M3X@N9Q$]^<7%?Q@CF)->8D*DTJ>H^: M^.9\NNH5M$EZI4VBHJ12@Z,FOCG'KC78>_+),FT2E205U4=-?'-6754+V"1V M8).H(*F(/6KBFY/I*E:@)ND%-#)J$H&:Y'6H253L4T1:Y"2 &9Y'3(/.&"N#G:V6ADE3EM16L_"BF8T^N3.3VKS&DUFF\K6KNP@CF] M5ZQ7-K[M!X3EYTHU-C([FG/HJK%DQ_86 52>&:@>W;]X!PKC[8(6( OSUD= M>\RJ1(\W"(*D?DU -6Z_(=[N.^^1@',J_Y=3"I+ZA0"T?"$ N _R<+U[GK_R M+!^M?P=XV VM7C81/U\!_UN3%)\.:%XTO;[:057C<-QN'(XL-KZKB*;Q31XE M01[%S]PGYN"U "RKFML?U*YTNVNX]VZ'A')Z+U^J48 PVZ:LW$-[6W1K.U8A/ M-7G]4H[Z"\LVU5LGOF2,94GU<4V#![7!0 ^B8 !D !X;"]W;W)K&ULM5I=;]LV%/TKA!<,+=!&)BE_)',,)':&!5B&($&WAZ /C$S;0B71 M(^FD ?;C1WU$-&6*KE/JH8U%W7MT[^7QU3')R0OCW\2:4@F^ITDF+GIK*3?G M02"B-4V).&4;FJD[2\93(M4E7P5BPRE9%$YI$J!^?QBD),YZTTDQ=L>G$[:5 M29S1.P[$-DT)?[VB"7NYZ,'>V\!]O%K+?""83C9D11^H_+*YX^HJJ%$6<4HS M$;,,<+J\Z%W"\WF(*BU\\CH@F-9 Y!U)]G M.J-)DB.I./ZM0'OU,W/'W<]OZ+\7R:MDGHB@,Y;\$R_D^J(W[H$%79)M(N_9 MRQ^T2FB0XT4L$<7_X*6R[?= M!62I96SBB"-L_(O^5X58LF*% -L"3)%04$2*L"'.94D3L1' M9??E80X^G'P$)R#.P&V<),I:3 *I LOA@Z@*8E8&@5J"P."697(MP'6VH O3 M/U )U5FAMZQFR EX2_@IP/ 30'T46N*9_[@[=H2#ZR+C @^WX.V7\ZWLCW\J M4W C:2J^VNI6XH9VW+PGG(L-B>A%3WWI!>7/M#?]]1NP<,T;U?,4#2&JH!LZHKK.5&J&< M+L MD93')+$&Z$0Y=AH\@1D)#^N$AQTQ<>BS!)[ C!*,ZA*,WL_$TG6P0S*( M1^,&$RU&0]RW,W%<1S5V1G494?F:@-E:O:IM@3F]CRV_)S CT;,ZT;..&'CF MLP2>P(P2P+Y^Z?;?S<&K [Z/T%J=RLM@)<*X05VK%6KIHG!'1$!G3#>9:IZ" MKI0@E. ZB950*:;7K@6<6,=.I"\T,W.D,T<=T;D"]E4&3VAF&;3 @4[Q<(#0 M;M]'9*\/WJ/J9]1LQ5:C40N=M5:!;K'22F?P'SC4J-W01T^K)S2S$%H>P4%7 M[/8JF7RAF670H@DZ!8E;,E2^NQ3N&/7IJ/*&91="R"8Z[8JA72>4+S2R#%E70*5@.,/1LCWUXA)H4W3<*1V=V MCB(M=- !H=/@Z*'NZ88[=E)\H9G):U6$8$?<1%XEDB\TLPQ:(B&G]G!SL_(U MN#ENMD^;T7#0PDVM69!;=UQO.=M00+(%N%P>V4/=T$=/4!S'(S=/!?GL<#)L\W3<:#%L6!I!6'\BM/FP\/=A'O2[7^$(S M"Z"%#AIUQ4^O4L<7FED&+760>XG(S<_Q/C]1\]>_S:B5GUI[(+?VN!0Q^7Q' MHG@91\>T4*_K.;[0S/5]K7-POZL5?J^*QQ>:60:M>+!['_N4Q: M608M=/!/;$WA_6TGO$?1?9NP97$?:]V!W;JCR="#W=/KPHHO-#-Y+6YP5]M5 MV*N^\85F;MYK?1.^?\-J5OF:6_/-W?M]&PSMS QSN6&.Z!=]Z'[1/\*OX/I[ ME&P75(!X=QF_/+RBYN\$C4%:'E4I?E.=H%%]O603U%-QD[0_?\#@E/$Y>E4^B>OL"2%8\;O<; M=6J;KV#G@(_Z'JZ*@U("1&R;R?(,1CU:'\:Z*HX@-<9G\'P.+>.7(3R?A?8[ M2-TIL +]Z/)4F*J)>ED)D-"E"J-_.E*-AY<'K(\YOAG/Y]GM+82\ M55-$#7=)G*J^,]4ZZ[JN"J>8,+4K,DQI)Q(R89JF8H7$M0L29B\/\)8+/J.[SPL#/EDJLV".^AE;((CU)?9 MA:296UH9\P13Q44*$J.^<^AWC_R.4; 2/SDNU,H83"@W0MR:R>FX[W@&$<88 M:F."T6..QQC'QA+A^%,8=4J?1G%U_&#]JPV>@KEA"H]%_(N/];3O[#LPQHC- M8CT4BV]8!-0V]D(1*_L/BT+6H&8_5#FP!3^&J,!.%48Z*NJ]#F5EO55@U#NBIC(?8=HH!".4=G\/&#W_$^UV!NEIB; M==:7F&69_VPE_Z+,?P-8(F:IK@H@=]&Q+@PCYP._Z7D]=UX!K%4":]4".Q:I MED0?*DT]+7/9@$.E4!.82%-F#V,BN 4:F81+'',-9T)5%D7NK[V"<@W$=@FQ M_;+[#?ARE]$7 V4BA=S: >:_$O+?Y0M][4NBM]GYU$>V7N/;?"A<^%)$N MBT@]*B)2Y&)PP$DQ+:IJDGS01G.P7_F1)L(L883M=!>65^^MVQJWD98 M49A]8]@KO=C?/#$*'X^8$32KF>$O^ZE?V_K>B1O/@/#A'IFL2_6RU_HO;+8; M(T=G/3GJL;VVS);MW&]MAAVUQX37PEZV>/^%/?Z?V-%^>D Z:*]AQ[()^[7] M\KW840]B/3O&PO=V]R:W-H965TT#4L M0'_9/$M[]N[EO#:S&GPQVZN"=&"I+(5[,XE,V<3R# M"#BDVKB@^+>%&7!N/"&.;XU3ISW3&!Z^[[U_M.21S)(JF G^E64ZGS@CAV2P MHA77G\7N-V@(#8R_5'!EGV37Z'H.22NE1=$8(X*"E?4_?6T"<6#@AQ<,@L8@ M.#487# (&X/PU""Z8! U!I&-3$W%QF%.-9V.I=@1:;31FWFQP;362)^5)N\+ M+7&7H9V>/E)9LG*M2.]WH=1[\@R2+'(J@=R0!5ZRK.) Q(I&.>86C5V-0(UQ[EI VI6@PHN@ K)DRAUKLACF4%V;.\B MP99EL&$'7@F?^X>7@%3M@&/;3^P@O^[@M1E5H1JK5D MRTK3)099"X+7GY:@@,R$W A)S9?1%;W:>]3MW52*.[6A*4P<+ 4*Y!:#V\?MK5I)49 4<\_*"N4$RUL=A;!?\><,=7 ANP[J&OO@P-$W@GF\"NZKKGX7DX?KA_SE_]U%?W1&*HJB)#S-W;G:8!#YR07B M24L\^9G\98Q7^K2*U["3KJP-_#!)3I%W:OJC41#'W>!],UX<2PY:HO^]()/' MUY17&>80.W#Z@I^T_9Y-$C>53'.<-$@\ZD?^H$]HF9%1W/>3:)]W[)3 M2 %R;2?'?H^OQ M%>FO&::/PPIA>+=#O$FRG@CKA18;.R,MA<:)R[[F.$6#- JXOQ)"[Q?F@'8N MG_X#4$L#!!0 ( ..!JEANBJUJ @, "$* 9 >&PO=V]R:W-H965T MU\THXTXXL&L3&0Y$H5/& M82*)*K*,RI<1I&(U=%K.>F'*%HDV"VXXR.D"9J ?\HG$F5NCQ"P#KIC@1,)\ MZ%RU+L=]8V\-OC%8J8TQ,9$\"O%D)K?QT/$,(4@AT@:!XM\2QI"F!@AI_*HP MG?I(X[@Y7J-_LK%C+(]4P5BDWUFLDZ'3=T@,BI6GZ&*IV/P(I$J^TM6 ME:WGD*A06F25,S+(&"__Z7.EPX8#XNQV\"L'?]NAO<T=?,9_[AX7*J<1#!TL5 5R"4[X_EVKZWW<%?61 MP!H:M&L-VA8]V*/!%=V]'@FL$7FOCKSW7Q1"[YB" M'0FL(5B_%JS_KPNA_R;%O:TB>&O1\SN][2)P-U[;#.3"-B$*N>&YY>M5K]9] MSI5]WK?61]C_E.W**TS9/.';M&!5N_*P$SEW/*MIYA.A%"]?5&"8=/DYZOS@NW]V6+PFG6LI0 M3S%:ST+3>1HF=#!R9"=OLU%ZMV6?D=\_D26L@;UKV/7MLG]^_$)T&V1#V*NJ M<-A/,M$48^":@,Y,4NK<$3YP1X2SB63 2DC*^,J$VQ"89CR3CM*[0%OQ(5+< M&]@W/=@@E4[*1";+W":#^3VI;M\!UCTPR#BO#;9=$QCV)*=\J;R^ # MR*G:XU6N'@4EFJ M&S$CLTR0TL.:436T[)1R?@-/CZ_)EO8RV5C3LE!$W=2&JJ:1,1W0WU0SVINR MG6?I.CF[R]2'A1Z.*/M0*?1:TH0MR_XRJ0U@ZCZN3O*44$E MX9NF=>T?\BP_VW'0?2G+Y5-EU[#58W4D.'23G<,W&42'[[$Z4!VZR:/8-[UC M,'D,-=E]L2?[4TSZ!VG2JXYK&V?"K1-A'77@Y#UPO\ 9GS=)G!FK)S@@!6%?.&[6 ^/M@N"8(HLB. MV1T$ 8; ;L01S %XP) @*-^#.^\C;_V>\IK_X [_ E!+ P04 " #C@:I8 MEXJ[', 3 @ "P %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S M9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X M 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA-/E_G;@2=&A(E@6FD7) MTZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0 M ( ..!JE@MKL)[8P8 X / >&PO=V]R:V)O;VLN>&ULQ9O?4]LX M$(#_%4U>CLZ4"W'\(^V4SM $>LQPP!#:UQMA*XFFMI23[%#ZU]_*(=,U.#OW MLN0)8CO.EY6E;U=2/CU:]^/!VA_B9U4:?SI8U?7ZXW#H\Y6JI/_3KI6!,POK M*EG#2[<<^K53LO KI>JJ'$8G)^FPDMH,/G_:W>O6#?$+6ZN\UM; P7#@NU:/ M_O?Y\%)LM-3H8;4]\5Z[6^:O#\P!Y+Q]\>Z26#W<20$X'Z0G<<*&=K]LKVOM+8-PHN'C[ MJJGMA2YKY6:R5E^=;=;:+,-MX%L,T==HX[#[NPWB1_=_PF@7"YVKFGR@!H_$JO_4 86:G3P=1NE O?!S[@LMA^MQJ@4*3<1PTGW&71XO&A?#.R M*72M"G%I(#2Z$E.XPI:ZD.$@@HP(R.B D/]$"'),0([?"K(3P2^RE"97.)(Q M 1D?$+(3R82 3 [9W&,$F1*0Z2$A8P29$9 9+^1,^=SI=3@N[$+4*P64U5J: M)R%-IW=/",@)+^2=RN$"<9;GMC$UC,D"!&/@_UR%=R+(#P3D!U[(L_S?!CZS M/?Y>S+1?V^=7+R,Y.J%&\Q->S$NS@0O J0^:?8\Q*<6,F!TS;9P+C^$-=!(GKK1LDY<7<:3T,F+VRTP]X+XPHBPR M8M;(%V740D.P'DJ]W)[&:)0[1LSR.#<;#<-'N$J6&(IRQ8A9%O/:YC]6MBR4 M\W^(J\[11?A@Q"^+2Y+92 MXE[^[/9&2@H+<:$-)$]:EC"Z^=HU+Z0543Z(F'UP(;43WV79 M*/&WDKYQK5)Q%"/*#1&S&R 9J73=(K5Z@!0J) *PMEIZH@L/IC-,%?+< 6T M[O;M'-U+^'#_#D]P M4#89,]N$3.6[\S"45<;<5MF7RF\#BC$IKXR9O1(2^MXF)B>QF(W2D]GW,E)J M&7.K!:?XO7245\;,7NG+]7LA*:^,F;VR/^EO43$FI98QLUIPYM\;0THH8V:A MD"5 =S2DA#)F%LJ>$F 73CPO3;DE9G9+3Y;=U^(Q)9:862P]Z78O(V65F-DJ M>_/N5_*+*<_$[+-9Q,QTI_/$Y'()LVKHI!$O1<24#$BIJP3LU MHK;I=O'YRKKZN%:N$C.,25DH>8,U ME1>85]8LGRGQ+%!"62AAMM .4QEMG9@Z54"%=B'SURM4";ELSVRAGFA"QF3+ M39@3FN(-+PEEH8390MUH7ML:.L^U=&Z;RA]A3,I""?O:?9@>Z/2@+?$WXU7> M8$S*0@E[%?02;-6;M% 5YIW M,,GM8P?8$@"T.Q%A3,I"*;.%]F#N&A]C4A9*F2U$8G9[.F6AE-E"-";NZ1EE MH8S90L3L<(#%F)2%,F8+D9B=1L\H"V7,%NI,8G?3X_/% G>AC+)0QEX+4=/9 MG6>3LE#&7@M1F)U]MY2%,O9:B,+$LQX99:&,V4+[%@>>'U.,26YC9K80B=GM MZ92%,F8+D=N9Q#'&I"R4,5N(QL0%\(2RT.0 *T+]1<:$LM#D (M"QZ%FD\NE M4TN,25EHPFRA/LP[%7[FU>[8P9B4A2;,%MJ_?-4V/<:D+#0YU.ZV;0J/,2D+ M35H+#=N+_>=/!92!1A77\!$>CN>RS&^="'_"G491G(0]KXNF+*=P[,9<65GL M?L"V^_'=Y_\ 4$L#!!0 ( ..!JE@@%;X0A ( "8R : >&PO7W)E M;',O=V]R:V)O;VLN>&UL+G)E;'/-VDUNHT 0AN&K6!P@[:[JJNZ,XJQFD^TH M%T!.^T>QC06,)KG]6,["_M L9A/QK5"#*-X-CQ#P]*L>VG'?G8;=_CPL/HZ' MT[!J=N-X_A'"L-[58SL\=.=ZNAS9=/VQ'2_+?AO.[?J]W=8@RZ6'_GY&\_QT M/W/Q^GFN_S.QVVSVZ_JS6_\^UM/XC\'A3]>_#[M:QV;QVO;;.JZ:\'&X[1[" M=1,?+I.;QH2@Q_F#XA)E7!(D3; FT#HBUY' ZXA@1P*Q(Y(="@OJ+01Z"^HM!'H+ZBT$>BOJK01Z*^JM!'HKZJT$>NOD90F! MWHIZ*X'>BGHK@=Z*>BN!WHIZ*X'>BGHK@=Z*>BN!W@GU3@1Z)]0[$>B=4.]$ MH'="O1.!WFGRLIM [X1Z)P*]$^J="/1.J']G4!O1[V=0&]'O9U ;T>]G4!OG_QL0J"WH]Y.H+>CWDZ@ MMZ/>3J!W1KTS@=X9]F?4.Q/HG5'O3*!W1KTS@=X9]F?4.Q/HG2<_ M"Q+HG5'O3*!W1KTS@=X%]2X$>A?4NQ#H75#O0J!W0;T+@=X%]2X$>A?4NWRG MWL/X>:C#K>=KC=?_3JK'R[GU=OGK\FOGY(:ZXASN*X;GOU!+ P04 " #C M@:I8B6[,?BL" "[, $P %M#;VYT96YT7U1Y<&5S72YX;6S-VTUNVS 0 MAN&K&-H&EBQ2I-0BSJ;MMLVB%V E.A:L/Y!,ZMR^E)P$:)$:"5R@[\:"37*^ M$0=X=K[^_CA9OSKVW>"WR3Z$Z6.6^7IO>^/3<;)#7-F-KCY1G)S_=GNS'T75E^.\6??CL,V<;;SR>K3:>._R^G?Q5W)!DKR;,*W\/>#KW[<$ZUS9V=6M<^&KZ MN"L[=ID/CYWUZ?D2K_0X[G9M;9NQON_CD=1/SIK&[ZT-?9>>BEZ=3P[QANWI M,[\X?RES+C#NO'7CY./$G'U_W/-(YM/K*1:R+K3G7_$E,9:^^/WL/.W&-F_, MCM?[FC@/2A('UH2!\EI(\*TL<'2!_Y MAM((1=2<0FI.,36GH)I35,TIK.845W,*K#E%5D&155!D%119!45609%54&05 M%%D%159!D5509)44625%5DF155)DE119)45629%54F25%%DE1=:"(FM!D;6@ MR%I09"THLA8460N*K 5%UH(B:T&155%D5119%45619%54615%%D5159%D551 M9%44635%5DV155-DU119-45639%54V35%%DU159-D;6DR%I29"TILI8464N* MK"5%UI(B:TF1M:3(6E)DK2BR5A19*XJL%476BB)K]3]E_3&.AW\&UL4$L! A0#% @ XX&J6!+.T'"T!P 0C@ M !@ ("!#@@ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ XX&J6.OR5AOM!P ;B$ !@ ("! M#1L 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ MXX&J6&6W^R1Z!P PR$ !@ ("!,3$ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ XX&J6-<+.)?? @ 3 8 !D M ("!E%0 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ XX&J6&AQD)S?#P .BH !D ("!MVP 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ XX&J6&-] ME(W?# 72( !D ("!+H< 'AL+W=OMS,FQ8& "+$0 &0 M @(%$E >&PO=V]R:W-H965T&UL4$L! A0#% @ XX&J6/BK^Z%<"P '1\ !D M ("!AZ$ 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ XX&J6-$N&PO=V]R:W-H965T&UL4$L! A0#% M @ XX&J6*%_7I6X!@ ]Q$ !D ("!S, 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ XX&J6/7>I^_G P !PH !D M ("!3=P 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ XX&J6#&[@^)_ P ^ < !D ("!E.< M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ MXX&J6+6AY.=T!0 N@\ !D ("!I_, 'AL+W=O&UL4$L! A0#% @ XX&J6%E\T8IG P MH@< !D ("! P$! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ XX&J6%H;@<".! !!( !D M ("!&0P! 'AL+W=O$ $ >&PO=V]R:W-H M965T&UL4$L! M A0#% @ XX&J6++*6? K!@ RBT !D ("!B1&PO=V]R:W-H965T&UL4$L! A0#% @ XX&J M6*!587N0 P PP !D ("!5",! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ XX&J6.?_:C-6" 5%L M !D ("!ZS&PO=V]R:W-H965T&UL4$L! A0#% @ XX&J6,>@QFJ, P .Q$ !D M ("!?T8! 'AL+W=O&PO=V]R:W-H965T M'CMI00, /H( 9 M " @21. 0!X;"]W;W)K&UL4$L! A0# M% @ XX&J6,-9))<"! "!0 !D ("!G%$! 'AL+W=O M>&8# #Y M# &0 @('550$ >&PO=V]R:W-H965T&UL4$L! A0#% @ XX&J6$:- M^0,U P G0P !D ("!XEP! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ XX&J6.E;&PO M=V]R:W-H965T&UL4$L! A0#% @ XX&J6-J$ &4"!0 0!T !D ("! M&PO=V]R:W-H965T&UL4$L! A0#% M @ XX&J6%H8W/M0 @ K04 !D ("!3'X! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ XX&J6,=JV^,( M P 2 D !D ("![Y$! 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ XX&J6!Z5,I:Z P [Q !D M ("!(Z4! 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ XX&J6)(AK>[7!0 ^B8 !D ("!)[4! M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ MXX&J6&Z*K6H" P (0H !D ("!Y,(! 'AL+W=O&UL+G)E;'-02P$"% ,4 M " #C@:I8B6[,?BL" "[, $P @ 'CTP$ 6T-O;G1E C;G1?5'EP97-=+GAM;%!+!08 70!= ((9 _U@$ ! end XML 106 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 107 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 109 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 327 374 1 true 108 0 false 6 false false R1.htm 0000001 - Document - Cover Sheet http://www.celanese.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Statement - Unaudited Interim Consolidated Statement of Operations Sheet http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations Unaudited Interim Consolidated Statement of Operations Statements 2 false false R3.htm 0000003 - Statement - Unaudited Interim Consolidated Statements of Comprehensive Income (Loss) Sheet http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss Unaudited Interim Consolidated Statements of Comprehensive Income (Loss) Statements 3 false false R4.htm 0000004 - Statement - Unaudited Consolidated Balance Sheets Sheet http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets Unaudited Consolidated Balance Sheets Statements 4 false false R5.htm 0000005 - Statement - Unaudited Consolidated Balance Sheets (Parenthetical) Sheet http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical Unaudited Consolidated Balance Sheets (Parenthetical) Statements 5 false false R6.htm 0000006 - Statement - Unaudited Interim Consolidated Statement Equity Sheet http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity Unaudited Interim Consolidated Statement Equity Statements 6 false false R7.htm 0000007 - Statement - Unaudited Interim Consolidated Statements of Cash Flows Sheet http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows Unaudited Interim Consolidated Statements of Cash Flows Statements 7 false false R8.htm 0000008 - Disclosure - Description of the Company and Basis of Presentation Sheet http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentation Description of the Company and Basis of Presentation Notes 8 false false R9.htm 0000009 - Disclosure - Recent Accounting Pronouncements Sheet http://www.celanese.com/role/RecentAccountingPronouncements Recent Accounting Pronouncements Notes 9 false false R10.htm 0000010 - Disclosure - Acquisitions, Dispositions and Plant Closures Sheet http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosures Acquisitions, Dispositions and Plant Closures Notes 10 false false R11.htm 0000011 - Disclosure - Inventories Sheet http://www.celanese.com/role/Inventories Inventories Notes 11 false false R12.htm 0000012 - Disclosure - Goodwill and Intangible Assets, net Sheet http://www.celanese.com/role/GoodwillandIntangibleAssetsnet Goodwill and Intangible Assets, net Notes 12 false false R13.htm 0000013 - Disclosure - Current Other Liabilities Sheet http://www.celanese.com/role/CurrentOtherLiabilities Current Other Liabilities Notes 13 false false R14.htm 0000014 - Disclosure - Debt Sheet http://www.celanese.com/role/Debt Debt Notes 14 false false R15.htm 0000015 - Disclosure - Benefit Obligations Sheet http://www.celanese.com/role/BenefitObligations Benefit Obligations Notes 15 false false R16.htm 0000016 - Disclosure - Environmental Sheet http://www.celanese.com/role/Environmental Environmental Notes 16 false false R17.htm 0000017 - Disclosure - Stockholders' Equity Sheet http://www.celanese.com/role/StockholdersEquity Stockholders' Equity Notes 17 false false R18.htm 0000018 - Disclosure - Other (Charges) Gains, Net Sheet http://www.celanese.com/role/OtherChargesGainsNet Other (Charges) Gains, Net Notes 18 false false R19.htm 0000019 - Disclosure - Income Taxes Sheet http://www.celanese.com/role/IncomeTaxes Income Taxes Notes 19 false false R20.htm 0000020 - Disclosure - Derivative Financial Instruments Sheet http://www.celanese.com/role/DerivativeFinancialInstruments Derivative Financial Instruments Notes 20 false false R21.htm 0000021 - Disclosure - Fair Value Measurements Sheet http://www.celanese.com/role/FairValueMeasurements Fair Value Measurements Notes 21 false false R22.htm 0000022 - Disclosure - Commitments and Contingencies Sheet http://www.celanese.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 22 false false R23.htm 0000023 - Disclosure - Segment Information Sheet http://www.celanese.com/role/SegmentInformation Segment Information Notes 23 false false R24.htm 0000024 - Disclosure - Revenue Recognition Sheet http://www.celanese.com/role/RevenueRecognition Revenue Recognition Notes 24 false false R25.htm 0000025 - Disclosure - Earnings (Loss) Per Share Sheet http://www.celanese.com/role/EarningsLossPerShare Earnings (Loss) Per Share Notes 25 false false R26.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 26 false false R27.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 27 false false R28.htm 9954471 - Disclosure - Recent Accounting Pronouncements (Policies) Sheet http://www.celanese.com/role/RecentAccountingPronouncementsPolicies Recent Accounting Pronouncements (Policies) Policies http://www.celanese.com/role/RecentAccountingPronouncements 28 false false R29.htm 9954472 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures (Tables) Sheet http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresTables Acquisitions, Dispositions and Plant Closures Plant Closures (Tables) Tables 29 false false R30.htm 9954473 - Disclosure - Inventories (Tables) Sheet http://www.celanese.com/role/InventoriesTables Inventories (Tables) Tables http://www.celanese.com/role/Inventories 30 false false R31.htm 9954474 - Disclosure - Goodwill and Intangible Assets, Net (Tables) Sheet http://www.celanese.com/role/GoodwillandIntangibleAssetsNetTables Goodwill and Intangible Assets, Net (Tables) Tables http://www.celanese.com/role/GoodwillandIntangibleAssetsnet 31 false false R32.htm 9954475 - Disclosure - Current Other Liabilities (Tables) Sheet http://www.celanese.com/role/CurrentOtherLiabilitiesTables Current Other Liabilities (Tables) Tables http://www.celanese.com/role/CurrentOtherLiabilities 32 false false R33.htm 9954476 - Disclosure - Debt (Tables) Sheet http://www.celanese.com/role/DebtTables Debt (Tables) Tables http://www.celanese.com/role/Debt 33 false false R34.htm 9954477 - Disclosure - Benefit Obligations (Tables) Sheet http://www.celanese.com/role/BenefitObligationsTables Benefit Obligations (Tables) Tables http://www.celanese.com/role/BenefitObligations 34 false false R35.htm 9954478 - Disclosure - Environmental (Tables) Sheet http://www.celanese.com/role/EnvironmentalTables Environmental (Tables) Tables http://www.celanese.com/role/Environmental 35 false false R36.htm 9954479 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.celanese.com/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.celanese.com/role/StockholdersEquity 36 false false R37.htm 9954480 - Disclosure - Other (Charges) Gains, Net (Tables) Sheet http://www.celanese.com/role/OtherChargesGainsNetTables Other (Charges) Gains, Net (Tables) Tables http://www.celanese.com/role/OtherChargesGainsNet 37 false false R38.htm 9954481 - Disclosure - Income Taxes (Tables) Sheet http://www.celanese.com/role/IncomeTaxesTables Income Taxes (Tables) Tables http://www.celanese.com/role/IncomeTaxes 38 false false R39.htm 9954482 - Disclosure - Derivative Financial Instruments (Tables) Sheet http://www.celanese.com/role/DerivativeFinancialInstrumentsTables Derivative Financial Instruments (Tables) Tables http://www.celanese.com/role/DerivativeFinancialInstruments 39 false false R40.htm 9954483 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.celanese.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.celanese.com/role/FairValueMeasurements 40 false false R41.htm 9954484 - Disclosure - Segment Information (Tables) Sheet http://www.celanese.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.celanese.com/role/SegmentInformation 41 false false R42.htm 9954485 - Disclosure - Revenue Recognition (Tables) Sheet http://www.celanese.com/role/RevenueRecognitionTables Revenue Recognition (Tables) Tables http://www.celanese.com/role/RevenueRecognition 42 false false R43.htm 9954486 - Disclosure - Earnings (Loss) Per Share (Tables) Sheet http://www.celanese.com/role/EarningsLossPerShareTables Earnings (Loss) Per Share (Tables) Tables http://www.celanese.com/role/EarningsLossPerShare 43 false false R44.htm 9954487 - Disclosure - Description of the Company and Basis of Presentation (Narrative) (Details) Sheet http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails Description of the Company and Basis of Presentation (Narrative) (Details) Details http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentation 44 false false R45.htm 9954488 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures - Narrative (Details) Sheet http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails Acquisitions, Dispositions and Plant Closures Plant Closures - Narrative (Details) Details http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresTables 45 false false R46.htm 9954489 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures - Schedule of Exit and Shutdown Cost Related to Closure (Details) Sheet http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresScheduleofExitandShutdownCostRelatedtoClosureDetails Acquisitions, Dispositions and Plant Closures Plant Closures - Schedule of Exit and Shutdown Cost Related to Closure (Details) Details 46 false false R47.htm 9954490 - Disclosure - Inventories - Schedule of Inventories (Details) Sheet http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails Inventories - Schedule of Inventories (Details) Details 47 false false R48.htm 9954491 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details) Sheet http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details) Details 48 false false R49.htm 9954492 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details) Sheet http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details) Details 49 false false R50.htm 9954493 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Indefinite-Lived Intangible Assets (Details) Sheet http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails Goodwill and Intangible Assets, Net - Schedule of Indefinite-Lived Intangible Assets (Details) Details 50 false false R51.htm 9954494 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) Sheet http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) Details 51 false false R52.htm 9954495 - Disclosure - Current Other Liabilities (Details) Sheet http://www.celanese.com/role/CurrentOtherLiabilitiesDetails Current Other Liabilities (Details) Details http://www.celanese.com/role/CurrentOtherLiabilitiesTables 52 false false R53.htm 9954496 - Disclosure - Debt - Schedule of Short-term Debt (Details) Sheet http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails Debt - Schedule of Short-term Debt (Details) Details 53 false false R54.htm 9954497 - Disclosure - Debt - Schedule of Long-term Debt (Details) Sheet http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails Debt - Schedule of Long-term Debt (Details) Details 54 false false R55.htm 9954498 - Disclosure - Debt - Senior Credit Facilities Narrative (Details) Sheet http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails Debt - Senior Credit Facilities Narrative (Details) Details 55 false false R56.htm 9954499 - Disclosure - Debt - Schedule of Revolving Credit Facility (Details) Sheet http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails Debt - Schedule of Revolving Credit Facility (Details) Details 56 false false R57.htm 9954500 - Disclosure - Debt - Senior Notes Narrative (Details) Notes http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails Debt - Senior Notes Narrative (Details) Details 57 false false R58.htm 9954501 - Disclosure - Debt (Schedule of Senior Unsecured Notes Offering) (Details) Notes http://www.celanese.com/role/DebtScheduleofSeniorUnsecuredNotesOfferingDetails Debt (Schedule of Senior Unsecured Notes Offering) (Details) Details http://www.celanese.com/role/DebtTables 58 false false R59.htm 9954502 - Disclosure - Debt (Schedule of Cash Tender Offer) (Details) Sheet http://www.celanese.com/role/DebtScheduleofCashTenderOfferDetails Debt (Schedule of Cash Tender Offer) (Details) Details http://www.celanese.com/role/DebtTables 59 false false R60.htm 9954503 - Disclosure - Debt - Accounts Receivable Purchasing Facility Narrative (Details) Sheet http://www.celanese.com/role/DebtAccountsReceivablePurchasingFacilityNarrativeDetails Debt - Accounts Receivable Purchasing Facility Narrative (Details) Details 60 false false R61.htm 9954504 - Disclosure - Debt - Factoring and Discounting Agreements Narrative (Details) Sheet http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails Debt - Factoring and Discounting Agreements Narrative (Details) Details 61 false false R62.htm 9954505 - Disclosure - Benefit Obligations - Schedule of Net Periodic Benefit Costs Recognized (Details) Sheet http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails Benefit Obligations - Schedule of Net Periodic Benefit Costs Recognized (Details) Details 62 false false R63.htm 9954506 - Disclosure - Benefit Obligations - Schedule of Company Commitments to Fund Benefit Obligations (Details) Sheet http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails Benefit Obligations - Schedule of Company Commitments to Fund Benefit Obligations (Details) Details 63 false false R64.htm 9954507 - Disclosure - Benefit Obligations - Schedule of Defined Benefit Plans Disclosures (Details) Sheet http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails Benefit Obligations - Schedule of Defined Benefit Plans Disclosures (Details) Details 64 false false R65.htm 9954508 - Disclosure - Environmental (Schedule of Environmental Remediation Reserves) (Details) Sheet http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails Environmental (Schedule of Environmental Remediation Reserves) (Details) Details http://www.celanese.com/role/EnvironmentalTables 65 false false R66.htm 9954509 - Disclosure - Environmental - US Superfund Sites Narrative (Details) Sheet http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails Environmental - US Superfund Sites Narrative (Details) Details 66 false false R67.htm 9954510 - Disclosure - Stockholders' Equity - Narrative (Details) Sheet http://www.celanese.com/role/StockholdersEquityNarrativeDetails Stockholders' Equity - Narrative (Details) Details 67 false false R68.htm 9954511 - Disclosure - Stockholders' Equity - Schedule of Treasury Stock (Details) Sheet http://www.celanese.com/role/StockholdersEquityScheduleofTreasuryStockDetails Stockholders' Equity - Schedule of Treasury Stock (Details) Details 68 false false R69.htm 9954512 - Disclosure - Stockholders' Equity - Schedule of Components of Other Comprehensive Income (Loss), Net (Details) Sheet http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails Stockholders' Equity - Schedule of Components of Other Comprehensive Income (Loss), Net (Details) Details 69 false false R70.htm 9954513 - Disclosure - Stockholders' Equity - Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net (Details) Sheet http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails Stockholders' Equity - Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net (Details) Details 70 false false R71.htm 9954514 - Disclosure - Other (Charges) Gains, Net - Schedule of Other (Charges) Gains, Net (Details) Sheet http://www.celanese.com/role/OtherChargesGainsNetScheduleofOtherChargesGainsNetDetails Other (Charges) Gains, Net - Schedule of Other (Charges) Gains, Net (Details) Details http://www.celanese.com/role/OtherChargesGainsNetTables 71 false false R72.htm 9954515 - Disclosure - Other (Charges) Gains, Net - Schedule of Restructuring Reserve by Type of Cost (Details) Sheet http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails Other (Charges) Gains, Net - Schedule of Restructuring Reserve by Type of Cost (Details) Details http://www.celanese.com/role/OtherChargesGainsNetTables 72 false false R73.htm 9954516 - Disclosure - Income Taxes - Schedule of Effective Tax Rate (Details) Sheet http://www.celanese.com/role/IncomeTaxesScheduleofEffectiveTaxRateDetails Income Taxes - Schedule of Effective Tax Rate (Details) Details 73 false false R74.htm 9954517 - Disclosure - Derivative Financial Instruments (Schedule of Changes in Fair Value of Derivatives) (Details) Sheet http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails Derivative Financial Instruments (Schedule of Changes in Fair Value of Derivatives) (Details) Details http://www.celanese.com/role/DerivativeFinancialInstrumentsTables 74 false false R75.htm 9954518 - Disclosure - Derivative Financial Instruments (Schedule of Offsetting Assets) (Details) Sheet http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails Derivative Financial Instruments (Schedule of Offsetting Assets) (Details) Details http://www.celanese.com/role/DerivativeFinancialInstrumentsTables 75 false false R76.htm 9954519 - Disclosure - Derivative Financial Instruments (Schedule of Offsetting Liabilities) (Details) Sheet http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails Derivative Financial Instruments (Schedule of Offsetting Liabilities) (Details) Details http://www.celanese.com/role/DerivativeFinancialInstrumentsTables 76 false false R77.htm 9954520 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 77 false false R78.htm 9954521 - Disclosure - Fair Value Measurements - Schedule of Carrying Values and Fair Values of Financial Instruments (Details) Sheet http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails Fair Value Measurements - Schedule of Carrying Values and Fair Values of Financial Instruments (Details) Details 78 false false R79.htm 9954522 - Disclosure - Commitments and Contingencies - Narrative (Details) Sheet http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails Commitments and Contingencies - Narrative (Details) Details 79 false false R80.htm 9954523 - Disclosure - Commitments and Contingencies (Purchase Obligations Narrative) (Details) Sheet http://www.celanese.com/role/CommitmentsandContingenciesPurchaseObligationsNarrativeDetails Commitments and Contingencies (Purchase Obligations Narrative) (Details) Details http://www.celanese.com/role/CommitmentsandContingencies 80 false false R81.htm 9954524 - Disclosure - Segment Information - Schedule of Business Segments (Details) Sheet http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails Segment Information - Schedule of Business Segments (Details) Details 81 false false R82.htm 9954525 - Disclosure - Revenue Recognition - Disaggregation of net sales (Details) Sheet http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails Revenue Recognition - Disaggregation of net sales (Details) Details 82 false false R83.htm 9954526 - Disclosure - Revenue Recognition Remaining Performance Obligations (Details) Sheet http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails Revenue Recognition Remaining Performance Obligations (Details) Details 83 false false R84.htm 9954527 - Disclosure - Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details) Sheet http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details) Details http://www.celanese.com/role/EarningsLossPerShareTables 84 false false R85.htm 9954528 - Disclosure - Earnings (Loss) Per Share - Narrative (Details) Sheet http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails Earnings (Loss) Per Share - Narrative (Details) Details http://www.celanese.com/role/EarningsLossPerShareTables 85 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 3 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 - ce-20240331.htm 4 ce-20240331.htm ce-20240331.xsd ce-20240331_cal.xml ce-20240331_def.xml ce-20240331_lab.xml ce-20240331_pre.xml ce-20240331_g1.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 http://xbrl.sec.gov/ecd/2023 true true JSON 112 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ce-20240331.htm": { "nsprefix": "ce", "nsuri": "http://www.celanese.com/20240331", "dts": { "inline": { "local": [ "ce-20240331.htm" ] }, "schema": { "local": [ "ce-20240331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd" ] }, "calculationLink": { "local": [ "ce-20240331_cal.xml" ] }, "definitionLink": { "local": [ "ce-20240331_def.xml" ] }, "labelLink": { "local": [ "ce-20240331_lab.xml" ] }, "presentationLink": { "local": [ "ce-20240331_pre.xml" ] } }, "keyStandard": 341, "keyCustom": 33, "axisStandard": 28, "axisCustom": 0, "memberStandard": 52, "memberCustom": 47, "hidden": { "total": 30, "http://fasb.org/us-gaap/2023": 25, "http://xbrl.sec.gov/dei/2023": 5 }, "contextCount": 327, "entityCount": 1, "segmentCount": 108, "elementCount": 706, "unitCount": 6, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 980, "http://xbrl.sec.gov/dei/2023": 44, "http://xbrl.sec.gov/ecd/2023": 4 }, "report": { "R1": { "role": "http://www.celanese.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations", "longName": "0000002 - Statement - Unaudited Interim Consolidated Statement of Operations", "shortName": "Unaudited Interim Consolidated Statement of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CostOfGoodsAndServicesSold", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "unique": true } }, "R3": { "role": "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss", "longName": "0000003 - Statement - Unaudited Interim Consolidated Statements of Comprehensive Income (Loss)", "shortName": "Unaudited Interim Consolidated Statements of Comprehensive Income (Loss)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "unique": true } }, "R4": { "role": "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets", "longName": "0000004 - Statement - Unaudited Consolidated Balance Sheets", "shortName": "Unaudited Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-10", "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-10", "name": "us-gaap:AccountsReceivableNetCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "unique": true } }, "R5": { "role": "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical", "longName": "0000005 - Statement - Unaudited Consolidated Balance Sheets (Parenthetical)", "shortName": "Unaudited Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-10", "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-10", "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R6": { "role": "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "longName": "0000006 - Statement - Unaudited Interim Consolidated Statement Equity", "shortName": "Unaudited Interim Consolidated Statement Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-13", "name": "us-gaap:SharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-13", "name": "us-gaap:SharesIssued", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows", "longName": "0000007 - Statement - Unaudited Interim Consolidated Statements of Cash Flows", "shortName": "Unaudited Interim Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProfitLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DepreciationAmortizationAndAccretionNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "unique": true } }, "R8": { "role": "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentation", "longName": "0000008 - Disclosure - Description of the Company and Basis of Presentation", "shortName": "Description of the Company and Basis of Presentation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R9": { "role": "http://www.celanese.com/role/RecentAccountingPronouncements", "longName": "0000009 - Disclosure - Recent Accounting Pronouncements", "shortName": "Recent Accounting Pronouncements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosures", "longName": "0000010 - Disclosure - Acquisitions, Dispositions and Plant Closures", "shortName": "Acquisitions, Dispositions and Plant Closures", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "ce:AcquisitionsDispositionsandPlantClosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ce:AcquisitionsDispositionsandPlantClosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.celanese.com/role/Inventories", "longName": "0000011 - Disclosure - Inventories", "shortName": "Inventories", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.celanese.com/role/GoodwillandIntangibleAssetsnet", "longName": "0000012 - Disclosure - Goodwill and Intangible Assets, net", "shortName": "Goodwill and Intangible Assets, net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.celanese.com/role/CurrentOtherLiabilities", "longName": "0000013 - Disclosure - Current Other Liabilities", "shortName": "Current Other Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.celanese.com/role/Debt", "longName": "0000014 - Disclosure - Debt", "shortName": "Debt", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.celanese.com/role/BenefitObligations", "longName": "0000015 - Disclosure - Benefit Obligations", "shortName": "Benefit Obligations", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.celanese.com/role/Environmental", "longName": "0000016 - Disclosure - Environmental", "shortName": "Environmental", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EnvironmentalLossContingencyDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EnvironmentalLossContingencyDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.celanese.com/role/StockholdersEquity", "longName": "0000017 - Disclosure - Stockholders' Equity", "shortName": "Stockholders' Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.celanese.com/role/OtherChargesGainsNet", "longName": "0000018 - Disclosure - Other (Charges) Gains, Net", "shortName": "Other (Charges) Gains, Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "ce:OtherChargesGainsNetTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ce:OtherChargesGainsNetTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.celanese.com/role/IncomeTaxes", "longName": "0000019 - Disclosure - Income Taxes", "shortName": "Income Taxes", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.celanese.com/role/DerivativeFinancialInstruments", "longName": "0000020 - Disclosure - Derivative Financial Instruments", "shortName": "Derivative Financial Instruments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R21": { "role": "http://www.celanese.com/role/FairValueMeasurements", "longName": "0000021 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.celanese.com/role/CommitmentsandContingencies", "longName": "0000022 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.celanese.com/role/SegmentInformation", "longName": "0000023 - Disclosure - Segment Information", "shortName": "Segment Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.celanese.com/role/RevenueRecognition", "longName": "0000024 - Disclosure - Revenue Recognition", "shortName": "Revenue Recognition", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.celanese.com/role/EarningsLossPerShare", "longName": "0000025 - Disclosure - Earnings (Loss) Per Share", "shortName": "Earnings (Loss) Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R26": { "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure", "longName": "995410 - Disclosure - Pay vs Performance Disclosure", "shortName": "Pay vs Performance Disclosure", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true }, "uniqueAnchor": null }, "R27": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.celanese.com/role/RecentAccountingPronouncementsPolicies", "longName": "9954471 - Disclosure - Recent Accounting Pronouncements (Policies)", "shortName": "Recent Accounting Pronouncements (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:UseOfEstimates", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:UseOfEstimates", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresTables", "longName": "9954472 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures (Tables)", "shortName": "Acquisitions, Dispositions and Plant Closures Plant Closures (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.celanese.com/role/InventoriesTables", "longName": "9954473 - Disclosure - Inventories (Tables)", "shortName": "Inventories (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R31": { "role": "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetTables", "longName": "9954474 - Disclosure - Goodwill and Intangible Assets, Net (Tables)", "shortName": "Goodwill and Intangible Assets, Net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.celanese.com/role/CurrentOtherLiabilitiesTables", "longName": "9954475 - Disclosure - Current Other Liabilities (Tables)", "shortName": "Current Other Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R33": { "role": "http://www.celanese.com/role/DebtTables", "longName": "9954476 - Disclosure - Debt (Tables)", "shortName": "Debt (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "33", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfShortTermDebtTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R34": { "role": "http://www.celanese.com/role/BenefitObligationsTables", "longName": "9954477 - Disclosure - Benefit Obligations (Tables)", "shortName": "Benefit Obligations (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "34", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.celanese.com/role/EnvironmentalTables", "longName": "9954478 - Disclosure - Environmental (Tables)", "shortName": "Environmental (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "35", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EnvironmentalExitCostsByCostTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EnvironmentalExitCostsByCostTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R36": { "role": "http://www.celanese.com/role/StockholdersEquityTables", "longName": "9954479 - Disclosure - Stockholders' Equity (Tables)", "shortName": "Stockholders' Equity (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "36", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfTreasuryStockByClassTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R37": { "role": "http://www.celanese.com/role/OtherChargesGainsNetTables", "longName": "9954480 - Disclosure - Other (Charges) Gains, Net (Tables)", "shortName": "Other (Charges) Gains, Net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "37", "firstAnchor": { "contextRef": "c-1", "name": "ce:ScheduleOfOtherChargesGainsNetTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "ce:ScheduleOfOtherChargesGainsNetTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.celanese.com/role/IncomeTaxesTables", "longName": "9954481 - Disclosure - Income Taxes (Tables)", "shortName": "Income Taxes (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "38", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables", "longName": "9954482 - Disclosure - Derivative Financial Instruments (Tables)", "shortName": "Derivative Financial Instruments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "39", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R40": { "role": "http://www.celanese.com/role/FairValueMeasurementsTables", "longName": "9954483 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "40", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.celanese.com/role/SegmentInformationTables", "longName": "9954484 - Disclosure - Segment Information (Tables)", "shortName": "Segment Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "41", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.celanese.com/role/RevenueRecognitionTables", "longName": "9954485 - Disclosure - Revenue Recognition (Tables)", "shortName": "Revenue Recognition (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "42", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.celanese.com/role/EarningsLossPerShareTables", "longName": "9954486 - Disclosure - Earnings (Loss) Per Share (Tables)", "shortName": "Earnings (Loss) Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "43", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails", "longName": "9954487 - Disclosure - Description of the Company and Basis of Presentation (Narrative) (Details)", "shortName": "Description of the Company and Basis of Presentation (Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-50", "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-50", "name": "us-gaap:MinorityInterestOwnershipPercentageByParent", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R45": { "role": "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "longName": "9954488 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures - Narrative (Details)", "shortName": "Acquisitions, Dispositions and Plant Closures Plant Closures - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ProceedsFromSaleOfProductiveAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-56", "name": "us-gaap:RestructuringAndRelatedCostExpectedCost1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "unique": true } }, "R46": { "role": "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresScheduleofExitandShutdownCostRelatedtoClosureDetails", "longName": "9954489 - Disclosure - Acquisitions, Dispositions and Plant Closures Plant Closures - Schedule of Exit and Shutdown Cost Related to Closure (Details)", "shortName": "Acquisitions, Dispositions and Plant Closures Plant Closures - Schedule of Exit and Shutdown Cost Related to Closure (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-1", "name": "ce:OneTimeTerminationBenefits", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ce:ScheduleOfOtherChargesGainsNetTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-55", "name": "ce:OneTimeTerminationBenefits", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "unique": true } }, "R47": { "role": "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails", "longName": "9954490 - Disclosure - Inventories - Schedule of Inventories (Details)", "shortName": "Inventories - Schedule of Inventories (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-10", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-10", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R48": { "role": "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails", "longName": "9954491 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details)", "shortName": "Goodwill and Intangible Assets, Net - Schedule of Goodwill (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-11", "name": "us-gaap:Goodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "unique": true } }, "R49": { "role": "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails", "longName": "9954492 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details)", "shortName": "Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-11", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-11", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails", "longName": "9954493 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Indefinite-Lived Intangible Assets (Details)", "shortName": "Goodwill and Intangible Assets, Net - Schedule of Indefinite-Lived Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-77", "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-77", "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails", "longName": "9954494 - Disclosure - Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)", "shortName": "Goodwill and Intangible Assets, Net - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-10", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-10", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R52": { "role": "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails", "longName": "9954495 - Disclosure - Current Other Liabilities (Details)", "shortName": "Current Other Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "c-10", "name": "us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-10", "name": "us-gaap:PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R53": { "role": "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "longName": "9954496 - Disclosure - Debt - Schedule of Short-term Debt (Details)", "shortName": "Debt - Schedule of Short-term Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "c-10", "name": "us-gaap:LongTermDebtAndCapitalLeaseObligationsCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-10", "name": "us-gaap:OtherShortTermBorrowings", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfShortTermDebtTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "unique": true } }, "R54": { "role": "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "longName": "9954497 - Disclosure - Debt - Schedule of Long-term Debt (Details)", "shortName": "Debt - Schedule of Long-term Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "c-10", "name": "us-gaap:FinanceLeaseLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-10", "name": "us-gaap:FinanceLeaseLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R55": { "role": "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "longName": "9954498 - Disclosure - Debt - Senior Credit Facilities Narrative (Details)", "shortName": "Debt - Senior Credit Facilities Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "c-141", "name": "us-gaap:ProceedsFromLinesOfCredit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-141", "name": "us-gaap:ProceedsFromLinesOfCredit", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R56": { "role": "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "longName": "9954499 - Disclosure - Debt - Schedule of Revolving Credit Facility (Details)", "shortName": "Debt - Schedule of Revolving Credit Facility (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "c-80", "name": "us-gaap:LinesOfCreditCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfShortTermDebtTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-139", "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "unique": true } }, "R57": { "role": "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails", "longName": "9954500 - Disclosure - Debt - Senior Notes Narrative (Details)", "shortName": "Debt - Senior Notes Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtInstrumentRedemptionPricePercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtInstrumentRedemptionPricePercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R58": { "role": "http://www.celanese.com/role/DebtScheduleofSeniorUnsecuredNotesOfferingDetails", "longName": "9954501 - Disclosure - Debt (Schedule of Senior Unsecured Notes Offering) (Details)", "shortName": "Debt (Schedule of Senior Unsecured Notes Offering) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "c-144", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ce:ScheduleOfSeniorUnsecuredNotesOfferingTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-144", "name": "us-gaap:DebtInstrumentFaceAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ce:ScheduleOfSeniorUnsecuredNotesOfferingTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R59": { "role": "http://www.celanese.com/role/DebtScheduleofCashTenderOfferDetails", "longName": "9954502 - Disclosure - Debt (Schedule of Cash Tender Offer) (Details)", "shortName": "Debt (Schedule of Cash Tender Offer) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "c-147", "name": "us-gaap:DebtInstrumentRepurchasedFaceAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ce:ScheduleOfCashTenderOfferTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-147", "name": "us-gaap:DebtInstrumentRepurchasedFaceAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ce:ScheduleOfCashTenderOfferTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R60": { "role": "http://www.celanese.com/role/DebtAccountsReceivablePurchasingFacilityNarrativeDetails", "longName": "9954503 - Disclosure - Debt - Accounts Receivable Purchasing Facility Narrative (Details)", "shortName": "Debt - Accounts Receivable Purchasing Facility Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "c-154", "name": "ce:PercentageOfFairValueOfSalesReceivables", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-154", "name": "ce:PercentageOfFairValueOfSalesReceivables", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R61": { "role": "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails", "longName": "9954504 - Disclosure - Debt - Factoring and Discounting Agreements Narrative (Details)", "shortName": "Debt - Factoring and Discounting Agreements Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "c-158", "name": "ce:TransferOfFinancialAssetsTreatedAsSalesNonRecourseOrLimitedRecourseBasisAccountsReceivablePercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-158", "name": "ce:TransferOfFinancialAssetsTreatedAsSalesNonRecourseOrLimitedRecourseBasisAccountsReceivablePercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R62": { "role": "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails", "longName": "9954505 - Disclosure - Benefit Obligations - Schedule of Net Periodic Benefit Costs Recognized (Details)", "shortName": "Benefit Obligations - Schedule of Net Periodic Benefit Costs Recognized (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "c-167", "name": "us-gaap:DefinedBenefitPlanServiceCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-167", "name": "us-gaap:DefinedBenefitPlanServiceCost", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R63": { "role": "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "longName": "9954506 - Disclosure - Benefit Obligations - Schedule of Company Commitments to Fund Benefit Obligations (Details)", "shortName": "Benefit Obligations - Schedule of Company Commitments to Fund Benefit Obligations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "c-167", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ce:ScheduleOfCompanyCommitmentsToFundBenefitObligationsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-167", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ce:ScheduleOfCompanyCommitmentsToFundBenefitObligationsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R64": { "role": "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "longName": "9954507 - Disclosure - Benefit Obligations - Schedule of Defined Benefit Plans Disclosures (Details)", "shortName": "Benefit Obligations - Schedule of Defined Benefit Plans Disclosures (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "c-171", "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-171", "name": "us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R65": { "role": "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails", "longName": "9954508 - Disclosure - Environmental (Schedule of Environmental Remediation Reserves) (Details)", "shortName": "Environmental (Schedule of Environmental Remediation Reserves) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "65", "firstAnchor": { "contextRef": "c-10", "name": "ce:DemergerObligations", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:EnvironmentalExitCostsByCostTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-10", "name": "ce:DemergerObligations", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:EnvironmentalExitCostsByCostTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R66": { "role": "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails", "longName": "9954509 - Disclosure - Environmental - US Superfund Sites Narrative (Details)", "shortName": "Environmental - US Superfund Sites Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "66", "firstAnchor": { "contextRef": "c-181", "name": "ce:NumberOfPartiesIncludedInUsepaOrder", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-181", "name": "ce:NumberOfPartiesIncludedInUsepaOrder", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R67": { "role": "http://www.celanese.com/role/StockholdersEquityNarrativeDetails", "longName": "9954510 - Disclosure - Stockholders' Equity - Narrative (Details)", "shortName": "Stockholders' Equity - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "67", "firstAnchor": { "contextRef": "c-10", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-183", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "unique": true } }, "R68": { "role": "http://www.celanese.com/role/StockholdersEquityScheduleofTreasuryStockDetails", "longName": "9954511 - Disclosure - Stockholders' Equity - Schedule of Treasury Stock (Details)", "shortName": "Stockholders' Equity - Schedule of Treasury Stock (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "68", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:TreasuryStockSharesAcquired", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:TreasuryStockSharesAcquired", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R69": { "role": "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails", "longName": "9954512 - Disclosure - Stockholders' Equity - Schedule of Components of Other Comprehensive Income (Loss), Net (Details)", "shortName": "Stockholders' Equity - Schedule of Components of Other Comprehensive Income (Loss), Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "69", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R70": { "role": "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails", "longName": "9954513 - Disclosure - Stockholders' Equity - Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net (Details)", "shortName": "Stockholders' Equity - Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "70", "firstAnchor": { "contextRef": "c-11", "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "unique": true } }, "R71": { "role": "http://www.celanese.com/role/OtherChargesGainsNetScheduleofOtherChargesGainsNetDetails", "longName": "9954514 - Disclosure - Other (Charges) Gains, Net - Schedule of Other (Charges) Gains, Net (Details)", "shortName": "Other (Charges) Gains, Net - Schedule of Other (Charges) Gains, Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "71", "firstAnchor": { "contextRef": "c-1", "name": "ce:OneTimeTerminationBenefits", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ce:ScheduleOfOtherChargesGainsNetTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true }, "uniqueAnchor": null }, "R72": { "role": "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails", "longName": "9954515 - Disclosure - Other (Charges) Gains, Net - Schedule of Restructuring Reserve by Type of Cost (Details)", "shortName": "Other (Charges) Gains, Net - Schedule of Restructuring Reserve by Type of Cost (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "72", "firstAnchor": { "contextRef": "c-319", "name": "us-gaap:RestructuringReserve", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-319", "name": "us-gaap:RestructuringReserve", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R73": { "role": "http://www.celanese.com/role/IncomeTaxesScheduleofEffectiveTaxRateDetails", "longName": "9954516 - Disclosure - Income Taxes - Schedule of Effective Tax Rate (Details)", "shortName": "Income Taxes - Schedule of Effective Tax Rate (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "73", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R74": { "role": "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "longName": "9954517 - Disclosure - Derivative Financial Instruments (Schedule of Changes in Fair Value of Derivatives) (Details)", "shortName": "Derivative Financial Instruments (Schedule of Changes in Fair Value of Derivatives) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "74", "firstAnchor": { "contextRef": "c-210", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-210", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R75": { "role": "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails", "longName": "9954518 - Disclosure - Derivative Financial Instruments (Schedule of Offsetting Assets) (Details)", "shortName": "Derivative Financial Instruments (Schedule of Offsetting Assets) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "75", "firstAnchor": { "contextRef": "c-10", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-10", "name": "us-gaap:DerivativeFairValueOfDerivativeAsset", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R76": { "role": "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails", "longName": "9954519 - Disclosure - Derivative Financial Instruments (Schedule of Offsetting Liabilities) (Details)", "shortName": "Derivative Financial Instruments (Schedule of Offsetting Liabilities) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "76", "firstAnchor": { "contextRef": "c-10", "name": "us-gaap:DerivativeFairValueOfDerivativeLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-10", "name": "us-gaap:DerivativeFairValueOfDerivativeLiability", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R77": { "role": "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "longName": "9954520 - Disclosure - Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "shortName": "Fair Value Measurements - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "77", "firstAnchor": { "contextRef": "c-10", "name": "us-gaap:DerivativeAssets", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:OffsettingAssetsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-238", "name": "us-gaap:AssetsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "unique": true } }, "R78": { "role": "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails", "longName": "9954521 - Disclosure - Fair Value Measurements - Schedule of Carrying Values and Fair Values of Financial Instruments (Details)", "shortName": "Fair Value Measurements - Schedule of Carrying Values and Fair Values of Financial Instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "78", "firstAnchor": { "contextRef": "c-10", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-10", "name": "us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R79": { "role": "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails", "longName": "9954522 - Disclosure - Commitments and Contingencies - Narrative (Details)", "shortName": "Commitments and Contingencies - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "79", "firstAnchor": { "contextRef": "c-270", "name": "ce:NumberOfDivestitureAgreements", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-270", "name": "ce:IndemnificationFloorAmount", "unitRef": "eur", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "unique": true } }, "R80": { "role": "http://www.celanese.com/role/CommitmentsandContingenciesPurchaseObligationsNarrativeDetails", "longName": "9954523 - Disclosure - Commitments and Contingencies (Purchase Obligations Narrative) (Details)", "shortName": "Commitments and Contingencies (Purchase Obligations Narrative) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "80", "firstAnchor": { "contextRef": "c-10", "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-10", "name": "us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R81": { "role": "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails", "longName": "9954524 - Disclosure - Segment Information - Schedule of Business Segments (Details)", "shortName": "Segment Information - Schedule of Business Segments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "81", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "unique": true } }, "R82": { "role": "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "longName": "9954525 - Disclosure - Revenue Recognition - Disaggregation of net sales (Details)", "shortName": "Revenue Recognition - Disaggregation of net sales (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "82", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-292", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "unique": true } }, "R83": { "role": "http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails", "longName": "9954526 - Disclosure - Revenue Recognition Remaining Performance Obligations (Details)", "shortName": "Revenue Recognition Remaining Performance Obligations (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "83", "firstAnchor": { "contextRef": "c-10", "name": "us-gaap:RevenueRemainingPerformanceObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-10", "name": "us-gaap:RevenueRemainingPerformanceObligation", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-8", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } }, "R84": { "role": "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "longName": "9954527 - Disclosure - Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details)", "shortName": "Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "84", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:IncomeLossFromContinuingOperations", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "unique": true } }, "R85": { "role": "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails", "longName": "9954528 - Disclosure - Earnings (Loss) Per Share - Narrative (Details)", "shortName": "Earnings (Loss) Per Share - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "85", "firstAnchor": { "contextRef": "c-312", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "link:footnote", "div", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-312", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "link:footnote", "div", "ix:continuation", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ce-20240331.htm", "first": true, "unique": true } } }, "tag": { "ce_A364DayDelayedDrawTermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "A364DayDelayedDrawTermLoanMember", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "364 Day Delayed-Draw Term Loan", "label": "364 Day Delayed-Draw Term Loan [Member]", "documentation": "364 Day Delayed-Draw Term Loan" } } }, "auth_ref": [] }, "ce_A5YearDelayedDrawTermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "A5YearDelayedDrawTermLoanMember", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "5 Year Delayed-Draw Term Loan", "label": "5 Year Delayed-Draw Term Loan [Member]", "documentation": "5 Year Delayed-Draw Term Loan" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilities" ], "lang": { "en-us": { "role": { "terseLabel": "Current Other Liabilities", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Trade payables\u00a0- third party and affiliates", "label": "Accounts Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r36", "r928" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Trade receivables\u00a0- third party and affiliates", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r365", "r366" ] }, "ce_AccountsReceivablePurchasingFacilityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "AccountsReceivablePurchasingFacilityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Accounts Receivable Securitization Facility [Abstract]", "label": "Accounts Receivable Purchasing Facility [Abstract]", "documentation": "Accounts Receivable Purchasing Facility [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccrualForEnvironmentalLossContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccrualForEnvironmentalLossContingencies", "crdr": "credit", "calculation": { "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Accrual for Environmental Loss Contingencies", "documentation": "Total costs accrued as of the balance sheet date for environmental loss contingencies." } } }, "auth_ref": [ "r413", "r898", "r1023", "r1025", "r1074", "r1079" ] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes payable", "label": "Accrued Income Taxes, Current", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r155", "r217" ] }, "us-gaap_AccruedMarketingCostsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedMarketingCostsCurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer rebates", "label": "Accrued Marketing Costs, Current", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for the marketing, trade and selling of the entity's goods and services. Marketing costs would include expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services; costs of public relations and corporate promotions; and obligations incurred and payable for sales discounts, rebates, price protection programs, etc. offered to customers and under government programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [] }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pension and Postretirement Benefits Gain (Loss) (Note 8)", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent." } } }, "auth_ref": [ "r6", "r18", "r50", "r1039", "r1040", "r1041" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated depreciation, depletion and amortization, property, plant, and equipment", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r72", "r250", "r725" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss), net [Line Items]", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r276", "r277", "r674", "r676", "r677", "r678", "r679", "r681" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive income (loss), net", "periodStartLabel": "As of December 31, 2023", "periodEndLabel": "As of March 31, 2024", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r49", "r50", "r170", "r259", "r721", "r755", "r758" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r276", "r277", "r674", "r676", "r677", "r678", "r679", "r681" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Income (Loss), Net", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r3", "r18", "r50", "r640", "r643", "r690", "r751", "r752", "r1039", "r1040", "r1041", "r1054", "r1055", "r1056" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency Translation Gain (Loss)", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r5", "r18", "r50", "r277", "r278", "r676", "r677", "r678", "r679", "r681", "r1039" ] }, "ce_AcetylChainMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "AcetylChainMember", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails", "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Acetyl Chain", "terseLabel": "Acetyl Chain [Member]", "label": "Acetyl Chain [Member]", "documentation": "Acetyl Chain [Member]" } } }, "auth_ref": [] }, "ce_AcquisitionsDispositionsandPlantClosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "AcquisitionsDispositionsandPlantClosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Acquisitions, Dispositions and Plant Closures [Abstract]", "label": "Acquisitions, Dispositions and Plant Closures [Abstract]", "documentation": "Acquisitions, Dispositions and Plant Closures [Abstract]." } } }, "auth_ref": [] }, "ce_AcquisitionsDispositionsandPlantClosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "AcquisitionsDispositionsandPlantClosuresTextBlock", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosures" ], "lang": { "en-us": { "role": { "terseLabel": "Acquisitions, Dispositions and Plant Closures", "label": "Acquisitions, Dispositions and Plant Closures [Text Block]", "documentation": "Acquisitions, Dispositions and Plant Closures [Text Block]." } } }, "auth_ref": [] }, "ce_ActiveSites": { "xbrltype": "monetaryItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "ActiveSites", "crdr": "credit", "calculation": { "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails": { "parentTag": "us-gaap_AccrualForEnvironmentalLossContingencies", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Active sites", "label": "Active sites", "documentation": "Active sites." } } }, "auth_ref": [] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r980" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Additional paid-in capital", "label": "Additional Paid in Capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r159", "r928", "r1116" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Additional Paid-In Capital", "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r594", "r595", "r596", "r770", "r1054", "r1055", "r1056", "r1095", "r1118" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r986" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r986" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r986" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r986" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation, net of tax", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r98", "r99", "r566" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net earnings (loss) to net cash provided by (used in) operating activities", "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r951", "r962", "r972", "r997" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r954", "r965", "r975", "r1000" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r986" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r993" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r958", "r966", "r976", "r993", "r1001", "r1005", "r1013" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r1011" ] }, "ce_AmendedRestatedReceivablePurchasingFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "AmendedRestatedReceivablePurchasingFacilityMember", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivablePurchasingFacilityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amended restated receivable purchasing facility", "label": "Amended Restated Receivable Purchasing Facility [Member]", "documentation": "An accounts receivable purchasing facility which allows a wholly owned, bankruptcy-remote subsidiary to sell an undivided interest in a pool of trade receivables (received through contribution from certain subsidiaries that retain the responsibility of servicing the receivables) to financial institutions participating in the facility." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Amortization of intangible assets", "negatedTerseLabel": "Amortization", "label": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r14", "r65", "r70" ] }, "us-gaap_AmountOfIneffectivenessOnNetInvestmentHedges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmountOfIneffectivenessOnNetInvestmentHedges", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (Loss) Recognized in Earnings (Loss)", "label": "Amount of Ineffectiveness on Net Investment Hedges", "documentation": "Gain (loss) on hedging derivative instrument or the foreign currency transaction gain (loss) on the nonderivative hedging instrument designated as a hedge of a net investment in foreign operations related to hedge ineffectiveness, which is included in earnings in the period." } } }, "auth_ref": [ "r213" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r324" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities [Axis]", "label": "Antidilutive Securities [Axis]", "documentation": "Information by type of antidilutive security." } } }, "auth_ref": [ "r56" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesNameDomain", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive Securities, Name [Domain]", "label": "Antidilutive Securities, Name [Domain]", "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "auth_ref": [ "r56" ] }, "us-gaap_AociDerivativeQualifyingAsHedgeExcludedComponentParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AociDerivativeQualifyingAsHedgeExcludedComponentParentMember", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (Loss) on Derivative Hedges (Note 12)", "label": "AOCI, Derivative Qualifying as Hedge, Excluded Component, Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) from increase (decrease) in value of excluded component of derivative hedge, attributable to parent." } } }, "auth_ref": [ "r235", "r270", "r277", "r278", "r1039" ] }, "srt_AsiaPacificMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AsiaPacificMember", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Asia-Pacific", "label": "Asia Pacific [Member]" } } }, "auth_ref": [ "r1120", "r1121", "r1122", "r1123" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "terseLabel": "Total assets", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r215", "r254", "r290", "r335", "r350", "r356", "r372", "r418", "r419", "r421", "r422", "r423", "r425", "r427", "r429", "r430", "r624", "r628", "r664", "r715", "r814", "r928", "r942", "r1084", "r1085", "r1099" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsAbstract", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "ASSETS", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r248", "r262", "r290", "r372", "r418", "r419", "r421", "r422", "r423", "r425", "r427", "r429", "r430", "r624", "r628", "r664", "r928", "r1084", "r1085", "r1099" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current Assets", "label": "Assets, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Assets, Fair Value Disclosure", "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r135" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r1008" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r1009" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r1004" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r1004" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r1004" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r1004" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r1004" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r1004" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r1007" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r1006" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r1005" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r1005" ] }, "us-gaap_BalanceSheetLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationAxis", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Axis]", "label": "Balance Sheet Location [Axis]", "documentation": "Information by location on balance sheet (statement of financial position)." } } }, "auth_ref": [] }, "us-gaap_BalanceSheetLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BalanceSheetLocationDomain", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Domain]", "label": "Balance Sheet Location [Domain]", "documentation": "Location in the balance sheet (statement of financial position)." } } }, "auth_ref": [ "r122", "r127" ] }, "ce_BankLoanDue2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "BankLoanDue2026Member", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bank loan due 2026, interest rate of 2.8%", "label": "Bank Loan due 2026 [Member]", "documentation": "Senior unsecured working capital loan for CNY800 million, payable 36 months and bearing interest at 2.8%." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "auth_ref": [] }, "ce_CNCWorkingCapitalLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "CNCWorkingCapitalLoanMember", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "36 month Working Capital Term Loan", "label": "CNC Working Capital Loan [Member]", "documentation": "CNC Working Capital Term Loan for CNY800 million; payable 36 months and bearing interest of 2.8%." } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "periodStartLabel": "Cash and cash equivalents as of beginning of period", "periodEndLabel": "Cash and cash equivalents as of end of period", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r55", "r187", "r287" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net increase (decrease) in cash and cash equivalents", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r2", "r187" ] }, "us-gaap_CashFlowHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashFlowHedgingMember", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash Flow Hedging", "label": "Cash Flow Hedging [Member]", "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk." } } }, "auth_ref": [ "r119" ] }, "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Operating cash provided by (used in) discontinued operations", "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations", "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r152", "r187" ] }, "us-gaap_CashSurrenderValueFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashSurrenderValueFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Insurance contracts in nonqualified trusts, fair value", "label": "Cash Surrender Value, Fair Value Disclosure", "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI)." } } }, "auth_ref": [] }, "us-gaap_CashSurrenderValueOfLifeInsurance": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashSurrenderValueOfLifeInsurance", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Insurance contracts in nonqualified trusts, carrying amount", "label": "Cash Surrender Value of Life Insurance", "documentation": "Carrying amount as of the balance sheet date of amounts which could be received based on the terms of the insurance contract upon surrendering life policies owned by the entity." } } }, "auth_ref": [ "r1034" ] }, "ce_CelaneseCorporationMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "CelaneseCorporationMember", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Celanese Corporation", "label": "Celanese Corporation [Member]", "documentation": "Celanese Corporation" } } }, "auth_ref": [] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r984" ] }, "ce_ChinaEuropeAndSingaporeFactoringAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "ChinaEuropeAndSingaporeFactoringAgreementsMember", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "China, Europe and Singapore Factoring Agreements", "label": "China, Europe and Singapore Factoring Agreements [Member]", "documentation": "China, Europe and Singapore Factoring Agreements" } } }, "auth_ref": [] }, "ce_ChinaFactoringAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "ChinaFactoringAgreementsMember", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "China Factoring Agreements", "label": "China Factoring Agreements [Member]", "documentation": "China Factoring Agreements" } } }, "auth_ref": [] }, "ce_ChinaRevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "ChinaRevolvingCreditFacilityMember", "presentation": [ "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "China Revolving Credit Facility", "label": "China Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "ce_ChinaWorkingCapitalTermLoanMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "ChinaWorkingCapitalTermLoanMember", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "China Working Capital Term Loan", "label": "China Working Capital Term Loan [Member]", "documentation": "CSIT senior unsecured working capital loan contract for CNY 800 million payable 12 months from withdrawal date and bearing interest at 0.5% less than certain interbank rates." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r242", "r256", "r257", "r258", "r290", "r315", "r319", "r321", "r323", "r329", "r330", "r372", "r418", "r421", "r422", "r423", "r429", "r430", "r461", "r462", "r465", "r468", "r475", "r664", "r762", "r763", "r764", "r765", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r801", "r823", "r842", "r865", "r866", "r867", "r868", "r869", "r1019", "r1049", "r1057" ] }, "us-gaap_ClassOfStockLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockLineItems", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Line Items]", "label": "Class of Stock [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r256", "r257", "r258", "r329", "r461", "r462", "r463", "r465", "r468", "r473", "r475", "r762", "r763", "r764", "r765", "r905", "r1019", "r1049" ] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r985" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r985" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r45", "r142", "r718", "r800" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies Disclosure [Abstract]", "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r197", "r407", "r409", "r873", "r1078" ] }, "us-gaap_CommodityContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommodityContractMember", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Commodity Contract", "label": "Commodity Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to commodity prices." } } }, "auth_ref": [ "r913", "r927" ] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, dividends, declared (in dollar per share)", "label": "Common Stock, Dividends, Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r202" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r930", "r931", "r932", "r934", "r935", "r936", "r939", "r1054", "r1055", "r1095", "r1114", "r1118" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, par value (in dollars per share)", "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r158" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r158", "r801" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r158" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r19", "r158", "r801", "r820", "r1118", "r1119" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, $0.0001\u00a0par value, 400,000,000\u00a0shares authorized (2024: 170,780,600 issued and 109,210,286 outstanding; 2023: 170,476,740 issued and 108,906,426 outstanding)", "label": "Common Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r158", "r720", "r928" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r990" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r989" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r991" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r988" ] }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CompensationAndRetirementDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Retirement Benefits [Abstract]", "label": "Retirement Benefits [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income (loss) attributable to Celanese Corporation", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r51", "r273", "r275", "r283", "r711", "r736" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedLabel": "Comprehensive (income) loss attributable to noncontrolling interests", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r11", "r106", "r114", "r273", "r275", "r282", "r710", "r735" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Total comprehensive income (loss), net of tax", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r114", "r209", "r273", "r275", "r281", "r709", "r734" ] }, "ce_ConsolidatedVenturesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "ConsolidatedVenturesMember", "presentation": [ "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidated Ventures", "label": "Consolidated Ventures [Member]", "documentation": "Consolidated Ventures" } } }, "auth_ref": [] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]" } } }, "auth_ref": [ "r292", "r337", "r348", "r349", "r350", "r351", "r352", "r354", "r358", "r418", "r419", "r420", "r421", "r423", "r424", "r426", "r428", "r429", "r1084", "r1085" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]" } } }, "auth_ref": [ "r292", "r337", "r348", "r349", "r350", "r351", "r352", "r354", "r358", "r418", "r419", "r420", "r421", "r423", "r424", "r426", "r428", "r429", "r1084", "r1085" ] }, "us-gaap_ContractWithCustomerAssetNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerAssetNet", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract with Customer, Asset, after Allowance for Credit Loss", "label": "Contract with Customer, Asset, after Allowance for Credit Loss", "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time." } } }, "auth_ref": [ "r477", "r478", "r489" ] }, "us-gaap_CorporateAndOtherMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateAndOtherMember", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Activities", "label": "Corporate and Other [Member]", "documentation": "Component of an entity that provides financial and operational oversight and administrative support for other segments and other segments not separately reported due to size or nature of business activities. Excludes intersegment elimination and reconciling items." } } }, "auth_ref": [ "r1059" ] }, "us-gaap_CorporateNonSegmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CorporateNonSegmentMember", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Corporate, Non-Segment", "label": "Corporate, Non-Segment [Member]", "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment." } } }, "auth_ref": [ "r26", "r349", "r350", "r351", "r352", "r358", "r1060" ] }, "us-gaap_CostOfGoodsAndServicesSold": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfGoodsAndServicesSold", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Cost of sales", "label": "Cost of Goods and Services Sold", "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities." } } }, "auth_ref": [ "r178", "r701" ] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityAxis", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivablePurchasingFacilityNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CreditFacilityDomain", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivablePurchasingFacilityNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [] }, "us-gaap_CurrencySwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CurrencySwapMember", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Currency Swap", "label": "Currency Swap [Member]", "documentation": "Swap involving the exchange of principal and interest in one currency for another currency." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerRelationshipsMember", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer- Related Intangible Assets", "label": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r101" ] }, "us-gaap_DebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtCurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 }, "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Short-term borrowings and current installments of long-term debt -\u00a0third party and affiliates", "totalLabel": "Total", "label": "Debt, Current", "documentation": "Amount of debt and lease obligation, classified as current." } } }, "auth_ref": [ "r255" ] }, "us-gaap_DebtCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtCurrentAbstract", "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-Term Borrowings and Current Installments of Long-Term Debt - Third Party and Affiliates", "label": "Debt, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.celanese.com/role/Debt" ], "lang": { "en-us": { "role": { "terseLabel": "Debt", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r198", "r288", "r431", "r437", "r438", "r439", "r440", "r441", "r442", "r447", "r454", "r455", "r457" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivablePurchasingFacilityNarrativeDetails", "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofCashTenderOfferDetails", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtScheduleofSeniorUnsecuredNotesOfferingDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r33", "r154", "r155", "r216", "r219", "r292", "r432", "r433", "r434", "r435", "r436", "r438", "r443", "r444", "r445", "r446", "r448", "r449", "r450", "r451", "r452", "r453", "r684", "r900", "r901", "r902", "r903", "r904", "r1050" ] }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, basis spread on variable rate", "label": "Debt Instrument, Basis Spread on Variable Rate", "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument." } } }, "auth_ref": [] }, "ce_DebtInstrumentDiscountPricePercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "DebtInstrumentDiscountPricePercentage", "presentation": [ "http://www.celanese.com/role/DebtScheduleofSeniorUnsecuredNotesOfferingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Discount Price, Percentage", "label": "Debt Instrument, Discount Price, Percentage", "documentation": "Debt Instrument, Discount Price, Percentage" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentFaceAmount", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/DebtScheduleofSeniorUnsecuredNotesOfferingDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, face amount", "label": "Debt Instrument, Face Amount", "documentation": "Face (par) amount of debt instrument at time of issuance." } } }, "auth_ref": [ "r139", "r141", "r432", "r684", "r901", "r902" ] }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentInterestRateStatedPercentage", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtScheduleofSeniorUnsecuredNotesOfferingDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage", "label": "Debt Instrument, Interest Rate, Stated Percentage", "documentation": "Contractual interest rate for funds borrowed, under the debt agreement." } } }, "auth_ref": [ "r42", "r433" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofCashTenderOfferDetails", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtScheduleofSeniorUnsecuredNotesOfferingDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r292", "r432", "r433", "r434", "r435", "r436", "r438", "r443", "r444", "r445", "r446", "r448", "r449", "r450", "r451", "r452", "r453", "r456", "r684", "r900", "r901", "r902", "r903", "r904", "r1050" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivablePurchasingFacilityNarrativeDetails", "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofCashTenderOfferDetails", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtScheduleofSeniorUnsecuredNotesOfferingDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r43", "r292", "r432", "r433", "r434", "r435", "r436", "r438", "r443", "r444", "r445", "r446", "r448", "r449", "r450", "r451", "r452", "r453", "r684", "r900", "r901", "r902", "r903", "r904", "r1050" ] }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentRedemptionPricePercentage", "presentation": [ "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, redemption price, percentage", "label": "Debt Instrument, Redemption Price, Percentage", "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer." } } }, "auth_ref": [ "r25" ] }, "us-gaap_DebtInstrumentRepurchaseAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentRepurchaseAmount", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/DebtScheduleofCashTenderOfferDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Repurchase Amount", "label": "Debt Instrument, Repurchase Amount", "documentation": "Fair value amount of debt instrument that was repurchased." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentRepurchasedFaceAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentRepurchasedFaceAmount", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/DebtScheduleofCashTenderOfferDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Repurchased Face Amount", "label": "Debt Instrument, Repurchased Face Amount", "documentation": "Face (par) amount of the original debt instrument that was repurchased." } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTable", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofCashTenderOfferDetails", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtScheduleofSeniorUnsecuredNotesOfferingDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/DebtSeniorNotesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r43", "r83", "r86", "r138", "r139", "r141", "r143", "r200", "r201", "r292", "r432", "r433", "r434", "r435", "r436", "r438", "r443", "r444", "r445", "r446", "r448", "r449", "r450", "r451", "r452", "r453", "r456", "r684", "r900", "r901", "r902", "r903", "r904", "r1050" ] }, "ce_DebtInstrumentTenderPurchasePricePer1000PrincipalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "DebtInstrumentTenderPurchasePricePer1000PrincipalAmount", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/DebtScheduleofCashTenderOfferDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument Tender Purchase Price Per 1000 Principal Amount", "label": "Debt Instrument Tender Purchase Price Per 1000 Principal Amount", "documentation": "Debt Instrument Tender Purchase Price Per 1000 Principal Amount" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DebtInstrumentTerm", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt instrument, term", "label": "Debt Instrument, Term", "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [] }, "us-gaap_DeferredFinanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredFinanceCostsNet", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Unamortized debt issuance costs", "label": "Debt Issuance Costs, Net", "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs." } } }, "auth_ref": [ "r140", "r1087" ] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r600", "r601" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes, net", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r14", "r206", "r236", "r614", "r615", "r1052" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r600", "r601", "r716" ] }, "us-gaap_DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent", "crdr": "debit", "calculation": { "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails": { "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Noncurrent Other assets", "label": "Assets for Plan Benefits, Defined Benefit Plan", "documentation": "Amount of asset, recognized in statement of financial position, for overfunded defined benefit pension and other postretirement plans." } } }, "auth_ref": [ "r214", "r492", "r493", "r515", "r813", "r915", "r1109" ] }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanContributionsByEmployer", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total contributions year-to-date", "label": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets." } } }, "auth_ref": [ "r509", "r519", "r557", "r913", "r914", "r915", "r916" ] }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanDisclosureLineItems", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Defined Benefit Plan Disclosure [Line Items]", "label": "Defined Benefit Plan Disclosure [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total expected contributions in current fiscal year", "label": "Defined Benefit Plan, Expected Future Employer Contributions, Current Fiscal Year", "documentation": "Amount of contributions received and expected to be received by defined benefit plan from employer in current fiscal year." } } }, "auth_ref": [ "r916", "r1090" ] }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "crdr": "credit", "calculation": { "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Expected return on plan assets", "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets", "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan." } } }, "auth_ref": [ "r494", "r531", "r552", "r915", "r916" ] }, "us-gaap_DefinedBenefitPlanFundedStatusOfPlan": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanFundedStatusOfPlan", "crdr": "debit", "calculation": { "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net amount recognized", "label": "Defined Benefit Plan, Funded (Unfunded) Status of Plan", "documentation": "Amount of funded (unfunded) status of defined benefit plan, measured as difference between fair value of plan assets and benefit obligation. Includes, but is not limited to, overfunded (underfunded) status." } } }, "auth_ref": [ "r492", "r515", "r915" ] }, "us-gaap_DefinedBenefitPlanInterestCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanInterestCost", "crdr": "debit", "calculation": { "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest cost", "label": "Defined Benefit Plan, Interest Cost", "documentation": "Amount of cost recognized for passage of time related to defined benefit plan." } } }, "auth_ref": [ "r494", "r498", "r530", "r551", "r915", "r916" ] }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "crdr": "debit", "calculation": { "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan." } } }, "auth_ref": [ "r528", "r549", "r915", "r916" ] }, "us-gaap_DefinedBenefitPlanServiceCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanServiceCost", "crdr": "debit", "calculation": { "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails": { "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Service cost", "label": "Defined Benefit Plan, Service Cost", "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan." } } }, "auth_ref": [ "r496", "r529", "r550", "r915", "r916" ] }, "ce_DemergerObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "DemergerObligations", "crdr": "credit", "calculation": { "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails": { "parentTag": "us-gaap_AccrualForEnvironmentalLossContingencies", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Demerger obligations (Note\u00a014)", "label": "Demerger obligations", "documentation": "Demerger obligations." } } }, "auth_ref": [] }, "us-gaap_DepreciationAmortizationAndAccretionNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationAmortizationAndAccretionNet", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation, amortization and accretion", "label": "Depreciation, Amortization and Accretion, Net", "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r14" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r14", "r340" ] }, "us-gaap_DerivativeAssetCollateralObligationToReturnCashOffset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetCollateralObligationToReturnCashOffset", "crdr": "credit", "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails": { "parentTag": "us-gaap_DerivativeAssets", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross amount not offset in the consolidated balance sheets", "label": "Derivative Asset, Subject to Master Netting Arrangement, Collateral, Obligation to Return Cash, Offset Against Derivative Asset", "documentation": "Amount of obligation to return cash collateral under master netting arrangements offset against derivative assets." } } }, "auth_ref": [ "r15", "r22" ] }, "us-gaap_DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetCurrentStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative asset classified as current." } } }, "auth_ref": [ "r630" ] }, "us-gaap_DerivativeAssetFairValueGrossLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetFairValueGrossLiability", "crdr": "credit", "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross amount offset in the consolidated balance sheets", "label": "Derivative Asset, Subject to Master Netting Arrangement, Liability Offset", "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r22", "r31", "r125", "r859", "r860" ] }, "us-gaap_DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetNoncurrentStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative asset classified as noncurrent." } } }, "auth_ref": [ "r630" ] }, "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative asset." } } }, "auth_ref": [ "r630" ] }, "us-gaap_DerivativeAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssets", "crdr": "debit", "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net amount", "terseLabel": "Derivative Asset", "label": "Derivative Asset", "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r264", "r266", "r663", "r782", "r783", "r784", "r785", "r786", "r788", "r789", "r790", "r791", "r792", "r807", "r808", "r854", "r857", "r858", "r859", "r861", "r862", "r891", "r932", "r1115" ] }, "us-gaap_DerivativeAssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeAssetsAbstract", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Assets [Abstract]", "label": "Derivative Asset [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails", "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r790", "r792", "r806", "r807", "r808", "r809", "r810", "r811", "r812", "r815", "r816", "r817", "r818", "r829", "r830", "r831", "r832", "r835", "r836", "r837", "r838", "r854", "r855", "r858", "r861", "r930", "r932" ] }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeAsset", "crdr": "debit", "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross amount recognized", "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset", "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement." } } }, "auth_ref": [ "r28", "r125", "r168", "r263", "r891" ] }, "us-gaap_DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral", "crdr": "debit", "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails": { "parentTag": "us-gaap_DerivativeAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net amount presented in the consolidated balance sheets", "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset of Collateral", "documentation": "Fair value, after offset of derivative liability, of financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, before offset against an obligation to return collateral under a master netting arrangement. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement." } } }, "auth_ref": [ "r24", "r29", "r32", "r132" ] }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeLiability", "crdr": "credit", "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross amount recognized", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset", "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement." } } }, "auth_ref": [ "r28", "r125", "r168", "r263", "r891" ] }, "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral", "crdr": "credit", "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeLiabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net amount presented in the consolidated balance sheets", "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset of Collateral", "documentation": "Fair value, after offset of derivative asset, of financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, elected not to be and before offset against a right to receive collateral under a master netting arrangement. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement." } } }, "auth_ref": [ "r24", "r29", "r32", "r132" ] }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeGainLossOnDerivativeNet", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (Loss) Recognized in Earnings (Loss)", "label": "Derivative, Gain (Loss) on Derivative, Net", "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement." } } }, "auth_ref": [ "r1094" ] }, "us-gaap_DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "label": "Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement of income or comprehensive income that includes gain (loss) from derivative." } } }, "auth_ref": [ "r1094" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails", "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r123", "r126", "r128", "r129", "r790", "r792", "r806", "r807", "r808", "r809", "r810", "r811", "r812", "r815", "r816", "r817", "r818", "r829", "r830", "r831", "r832", "r835", "r836", "r837", "r838", "r854", "r855", "r858", "r861", "r891", "r930", "r932" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]", "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstruments" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Financial Instruments", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r212", "r637", "r646" ] }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Axis]", "label": "Hedging Relationship [Axis]", "documentation": "Information by type of hedging relationship." } } }, "auth_ref": [ "r20", "r123", "r128" ] }, "us-gaap_DerivativeLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilities", "crdr": "credit", "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net amount", "negatedTerseLabel": "Derivative Liability", "label": "Derivative Liability", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r264", "r266", "r663", "r782", "r783", "r784", "r785", "r788", "r789", "r790", "r791", "r792", "r815", "r817", "r818", "r855", "r856", "r857", "r858", "r859", "r861", "r862", "r891", "r1115" ] }, "us-gaap_DerivativeLiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilitiesAbstract", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Liabilities [Abstract]", "label": "Derivative Liability [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DerivativeLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivatives (Note 12)", "label": "Derivative Liability, Current", "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset." } } }, "auth_ref": [ "r264" ] }, "us-gaap_DerivativeLiabilityCollateralRightToReclaimCashOffset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityCollateralRightToReclaimCashOffset", "crdr": "debit", "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeLiabilities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross amount not offset in the consolidated balance sheets", "label": "Derivative Liability, Subject to Master Netting Arrangement, Collateral, Right to Reclaim Cash Offset", "documentation": "Amount of right to receive cash collateral under master netting arrangements offset against derivative liabilities." } } }, "auth_ref": [ "r15", "r22" ] }, "us-gaap_DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityCurrentStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liability, statement of financial position [Extensible Enumeration]", "label": "Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative liability classified as current." } } }, "auth_ref": [ "r630" ] }, "us-gaap_DerivativeLiabilityFairValueGrossAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityFairValueGrossAsset", "crdr": "debit", "calculation": { "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails": { "parentTag": "us-gaap_DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross amount offset in the consolidated balance sheets", "label": "Derivative Liability, Subject to Master Netting Arrangement, Asset Offset", "documentation": "Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r22", "r31", "r125", "r859", "r860", "r890" ] }, "us-gaap_DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityNoncurrentStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "label": "Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative liability classified as noncurrent." } } }, "auth_ref": [ "r630" ] }, "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofOffsettingLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative liability, statement of financial position [Extensible Enumeration]", "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]", "documentation": "Indicates line item in statement of financial position that includes derivative liability." } } }, "auth_ref": [ "r630" ] }, "us-gaap_DerivativeLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeLineItems", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Line Items]", "label": "Derivative [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r646" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative, notional amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r1092", "r1093" ] }, "us-gaap_DerivativeTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DerivativeTable", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative [Table]", "label": "Derivative [Table]", "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item." } } }, "auth_ref": [ "r20", "r115", "r116", "r117", "r121", "r124", "r128", "r130", "r131", "r134", "r646" ] }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DesignatedAsHedgingInstrumentMember", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Designated as Hedging Instrument", "label": "Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r20" ] }, "us-gaap_DevelopedTechnologyRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DevelopedTechnologyRightsMember", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Developed Technology", "label": "Developed Technology Rights [Member]", "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property." } } }, "auth_ref": [ "r207" ] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Line Items]", "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r488", "r906", "r907", "r908", "r909", "r910", "r911", "r912" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Table]", "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r488", "r906", "r907", "r908", "r909", "r910", "r911", "r912" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionTables" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue", "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r1088" ] }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings (loss) from operation of discontinued operations", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, before Income Tax", "documentation": "Amount before tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until its disposal." } } }, "auth_ref": [ "r146", "r147", "r151" ] }, "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax (provision) benefit from discontinued operations", "label": "Discontinued Operation, Tax Effect of Discontinued Operation", "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r147", "r148", "r149", "r150", "r151", "r153", "r602", "r613", "r618" ] }, "ce_DivestitureAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "DivestitureAgreementsMember", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Divestiture Agreements", "label": "Divestiture Agreements [Member]", "documentation": "Divestiture Agreements [Member]." } } }, "auth_ref": [] }, "ce_DivestitureObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "DivestitureObligations", "crdr": "credit", "calculation": { "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails": { "parentTag": "us-gaap_AccrualForEnvironmentalLossContingencies", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Divestiture obligations (Note\u00a014)", "label": "Divestiture obligations", "documentation": "Divestiture obligations." } } }, "auth_ref": [] }, "us-gaap_DividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCommonStock", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "negatedLabel": "Common stock dividends", "label": "Dividends, Common Stock", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK)." } } }, "auth_ref": [ "r10", "r202" ] }, "us-gaap_DividendsCommonStockCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsCommonStockCash", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends, common stock, cash", "label": "Dividends, Common Stock, Cash", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash." } } }, "auth_ref": [ "r202" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r946" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r979" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_EMEAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EMEAMember", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Europe and Africa", "label": "EMEA [Member]", "documentation": "Regions of Europe, Middle East and Africa." } } }, "auth_ref": [ "r1120", "r1121", "r1122", "r1123" ] }, "ce_EURSeniorUnsecuredNotesDue2025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "EURSeniorUnsecuredNotesDue2025Member", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "1.250% Senior Notes due 2025", "verboseLabel": "Senior unsecured notes due 2025, interest rate of 1.250%", "label": "EUR Senior Unsecured Notes Due 2025 [Member]", "documentation": "Senior Unsecured Notes Due 2025 [Member]" } } }, "auth_ref": [] }, "ce_EURSeniorUnsecuredNotesDue2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "EURSeniorUnsecuredNotesDue2026Member", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "4.777% Senior Notes due 2026", "verboseLabel": "Senior unsecured notes due 2026, interest rate of 4.777%", "label": "EUR Senior Unsecured Notes Due 2026 [Member]", "documentation": "EUR 1 Billion 4.777% Senior Unsecured Notes Due 2026" } } }, "auth_ref": [] }, "ce_EURSeniorUnsecuredNotesDue2027Member": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "EURSeniorUnsecuredNotesDue2027Member", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2.125% Senior Notes due 2027", "verboseLabel": "Senior unsecured notes due 2027, interest rate of 2.125%", "label": "EUR Senior Unsecured Notes Due 2027 [Member]", "documentation": "EUR Senior Unsecured Notes Due 2027 [Member]" } } }, "auth_ref": [] }, "ce_EURSeniorUnsecuredNotesDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "EURSeniorUnsecuredNotesDue2028Member", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "0.625% Senior Notes due 2028", "verboseLabel": "Senior unsecured notes due 2028, interest rate of 0.625%", "label": "EUR Senior Unsecured Notes Due 2028 [Member]", "documentation": "EUR Senior Unsecured Notes Due 2028" } } }, "auth_ref": [] }, "ce_EURSeniorUnsecuredNotesDue2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "EURSeniorUnsecuredNotesDue2029Member", "presentation": [ "http://www.celanese.com/role/Cover", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "5.337% Senior Notes due 2029", "verboseLabel": "Senior unsecured notes due 2029, interest rate of 5.337%", "label": "EUR Senior Unsecured Notes Due 2029 [Member]", "documentation": "EUR 500 Million 5.337% Senior Unsecured Notes Due 2029 [Member]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareAbstract", "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share [Abstract]", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Net earnings (loss)\u00a0- basic (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r284", "r302", "r303", "r304", "r305", "r306", "r313", "r315", "r321", "r322", "r323", "r327", "r650", "r651", "r712", "r737", "r892" ] }, "us-gaap_EarningsPerShareBasicAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasicAbstract", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings (loss) per common share\u00a0- basic", "label": "Earnings Per Share, Basic [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDiluted", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Net earnings (loss)\u00a0- diluted (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r284", "r302", "r303", "r304", "r305", "r306", "r315", "r321", "r322", "r323", "r327", "r650", "r651", "r712", "r737", "r892" ] }, "us-gaap_EarningsPerShareDilutedAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareDilutedAbstract", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings (loss) per common share\u00a0- diluted", "label": "Earnings Per Share, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings (Loss) Per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r312", "r324", "r325", "r326" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange rate effects on cash and cash equivalents", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations", "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r673" ] }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EffectiveIncomeTaxRateContinuingOperations", "presentation": [ "http://www.celanese.com/role/IncomeTaxesScheduleofEffectiveTaxRateDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effective income tax rate", "label": "Effective Income Tax Rate Reconciliation, Percent", "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r603" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Salaries and benefits", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r40" ] }, "us-gaap_EmployeeSeveranceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeSeveranceMember", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Severance", "label": "Employee Severance [Member]", "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan." } } }, "auth_ref": [] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Share-Based Payment Arrangement, Option", "label": "Employee Stock Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "ce_EngineeredMaterialsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "EngineeredMaterialsMember", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresScheduleofExitandShutdownCostRelatedtoClosureDetails", "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails", "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails", "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Engineered Materials", "label": "Engineered Materials [Member]", "documentation": "Engineered Materials" } } }, "auth_ref": [] }, "dei_EntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitiesTable", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entities [Table]", "label": "Entities [Table]", "documentation": "Container to assemble all relevant information about each entity associated with the document instance" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r944" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r944" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r944" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInformationLineItems", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Information [Line Items]", "label": "Entity Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r1018" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r944" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r944" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Small Reporting Company", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r944" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r944" ] }, "us-gaap_EntityWideRevenueMajorCustomerLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EntityWideRevenueMajorCustomerLineItems", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, Major Customer [Line Items]", "label": "Revenue, Major Customer [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "ce_Environmental": { "xbrltype": "monetaryItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "Environmental", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of EPA's plan estimate", "label": "environmental", "documentation": "Loss exposure for environmental contingencies at an individual site for which no accrual has been recorded based upon EPA determination." } } }, "auth_ref": [] }, "us-gaap_EnvironmentalExitCostsByCostTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EnvironmentalExitCostsByCostTextBlock", "presentation": [ "http://www.celanese.com/role/EnvironmentalTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Environmental Remediation Reserves", "label": "Environmental Exit Costs by Cost [Table Text Block]", "documentation": "Tabular disclosure of material liabilities for remediation, site restoration, postclosure, monitoring commitments, or other exit costs that may occur on the sale, disposal or abandonment of a property as a result of unanticipated contamination of the assets." } } }, "auth_ref": [ "r1083" ] }, "ce_EnvironmentalLiabilityPercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "EnvironmentalLiabilityPercentage", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Environmental liability percentage", "label": "Environmental Liability Percentage", "documentation": "Estimated ultimate allocable share of cleanup costs." } } }, "auth_ref": [] }, "us-gaap_EnvironmentalLossContingencyDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EnvironmentalLossContingencyDisclosureTextBlock", "presentation": [ "http://www.celanese.com/role/Environmental" ], "lang": { "en-us": { "role": { "terseLabel": "Environmental", "label": "Environmental Loss Contingency Disclosure [Text Block]", "documentation": "The entire disclosure for environmental loss contingencies, such as presence of hazardous waste, relevant information from reports issued by regulators, and estimated costs to achieve compliance with regulatory requirements. This element may be used for all of an entity's disclosures about environmental loss contingencies." } } }, "auth_ref": [ "r397", "r897", "r898", "r899", "r1020", "r1021", "r1022", "r1024", "r1025", "r1026", "r1027", "r1028", "r1029", "r1030" ] }, "us-gaap_EnvironmentalRemediationObligationsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EnvironmentalRemediationObligationsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Environmental Remediation Obligations [Abstract]", "label": "Environmental Remediation Obligations [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EnvironmentalRemediationSiteAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EnvironmentalRemediationSiteAxis", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Environmental Remediation Site [Axis]", "label": "Environmental Remediation Site [Axis]", "documentation": "Information by location or named area designated for environmental remediation." } } }, "auth_ref": [ "r897", "r898", "r1023", "r1024", "r1025", "r1082", "r1083" ] }, "us-gaap_EnvironmentalRemediationSiteDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EnvironmentalRemediationSiteDomain", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Environmental Remediation Site [Domain]", "label": "Environmental Remediation Site [Domain]", "documentation": "Location or named area designated for environmental remediation." } } }, "auth_ref": [ "r897", "r898", "r1023", "r1024", "r1025", "r1082", "r1083" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r19", "r243", "r276", "r277", "r278", "r293", "r294", "r295", "r299", "r307", "r309", "r328", "r373", "r376", "r476", "r594", "r595", "r596", "r607", "r608", "r639", "r640", "r641", "r642", "r643", "r645", "r649", "r674", "r676", "r677", "r678", "r679", "r681", "r690", "r751", "r752", "r753", "r770", "r842" ] }, "srt_EquityMethodInvesteeNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "EquityMethodInvesteeNameDomain", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment, Name [Domain]", "label": "Investment, Name [Domain]" } } }, "auth_ref": [ "r369", "r370", "r371" ] }, "ce_EquityMethodInvestmentLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "EquityMethodInvestmentLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment in affiliates", "label": "Equity Method Investment Liability, Current", "documentation": "Equity Method Investment Liability, Current" } } }, "auth_ref": [] }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityMethodInvestmentOwnershipPercentage", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity method investment, ownership percentage", "label": "Equity Method Investment, Ownership Percentage", "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting." } } }, "auth_ref": [ "r369" ] }, "us-gaap_EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesFvNiAndWithoutReadilyDeterminableFairValue", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity investments without readily determinable fair values, fair value", "label": "Equity Securities, FV-NI and without Readily Determinable Fair Value", "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI) and investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r662" ] }, "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity investments without readily determinable fair values, carrying amount", "label": "Equity Securities without Readily Determinable Fair Value, Amount", "documentation": "Amount of investment in equity security without readily determinable fair value." } } }, "auth_ref": [ "r367" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r987" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r951", "r962", "r972", "r997" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r948", "r959", "r969", "r994" ] }, "ce_EuroDenominatedBorrowingDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "EuroDenominatedBorrowingDue2028Member", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Euro Notes Due 2028", "label": "Euro Denominated Borrowing Due 2028 [Member]", "documentation": "Euro Denominated Borrowing Due 2028" } } }, "auth_ref": [] }, "ce_EuroDenominatedBorrowingDue2030Member": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "EuroDenominatedBorrowingDue2030Member", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Euro Notes Due 2030", "label": "Euro denominated borrowing Due 2030 [Member]", "documentation": "Euro denominated borrowing Due 2030" } } }, "auth_ref": [] }, "ce_EuroDenominatedBorrowingsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "EuroDenominatedBorrowingsMember", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Euro Notes Due 2028 and 2030", "label": "Euro Denominated Borrowings [Member]", "documentation": "The amount of 2023 Offerings converted to euro denominated borrowings. Maturing on November 15, 2028 and November 15, 2030." } } }, "auth_ref": [] }, "ce_EuropeFactoringAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "EuropeFactoringAgreementsMember", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Europe Factoring Agreements", "label": "Europe Factoring Agreements [Member]", "documentation": "Europe Factoring Agreements" } } }, "auth_ref": [] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r993" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r656", "r657", "r660" ] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]", "label": "Fair Value, Recurring and Nonrecurring [Table]", "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis." } } }, "auth_ref": [ "r656", "r657", "r660" ] }, "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_FairValueByBalanceSheetGroupingTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByBalanceSheetGroupingTable", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]", "label": "Fair Value, by Balance Sheet Grouping [Table]", "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r135", "r136", "r137" ] }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByBalanceSheetGroupingTextBlock", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Carrying Values and Fair Values of Financial Instruments", "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r135", "r136" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r445", "r519", "r520", "r521", "r522", "r523", "r524", "r657", "r693", "r694", "r695", "r901", "r902", "r913", "r914", "r915" ] }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByMeasurementFrequencyAxis", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Axis]", "label": "Measurement Frequency [Axis]", "documentation": "Information by measurement frequency." } } }, "auth_ref": [ "r656", "r657", "r658", "r659", "r661" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Fair Value Disclosures [Abstract]", "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.celanese.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r655" ] }, "us-gaap_FairValueHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueHedgingMember", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hedging", "label": "Fair Value Hedging [Member]", "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk." } } }, "auth_ref": [ "r118" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Inputs, Level 2", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r445", "r519", "r524", "r657", "r694", "r901", "r902", "r913", "r914", "r915" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unobservable Inputs (Level 3)", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r445", "r519", "r520", "r521", "r522", "r523", "r524", "r657", "r695", "r901", "r902", "r913", "r914", "r915" ] }, "us-gaap_FairValueMeasurementFrequencyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementFrequencyDomain", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Measurement Frequency [Domain]", "label": "Measurement Frequency [Domain]", "documentation": "Measurement frequency." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r445", "r519", "r520", "r521", "r522", "r523", "r524", "r693", "r694", "r695", "r901", "r902", "r913", "r914", "r915" ] }, "us-gaap_FairValueMeasurementsRecurringMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsRecurringMember", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Recurring", "label": "Fair Value, Recurring [Member]", "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value." } } }, "auth_ref": [ "r655", "r661" ] }, "us-gaap_FinanceLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinanceLeaseLiability", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Obligations under finance leases due at various dates through 2054", "label": "Finance Lease, Liability", "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease." } } }, "auth_ref": [ "r688", "r689" ] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedPeriodStartLabel": "As of December 31, 2023", "negatedPeriodEndLabel": "As of March 31, 2024", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r252", "r393" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2025", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r195" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2029", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r195" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2028", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r195" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2027", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r195" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" ], "lang": { "en-us": { "role": { "terseLabel": "2026", "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r195" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r390", "r392", "r393", "r395", "r702", "r706" ] }, "us-gaap_FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Cost Incurred to Renew or Extend", "label": "Finite-Lived Intangible Assets, Cost Incurred to Renew or Extend", "documentation": "The amount of capitalized costs incurred in the period to renew or extend the term of a recognized finite-lived (amortizing and amortizable) intangible asset." } } }, "auth_ref": [ "r71" ] }, "us-gaap_FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Exchange rate changes", "label": "Finite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "As of December 31, 2023", "periodEndLabel": "As of March 31, 2024", "label": "Finite-Lived Intangible Assets, Gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r194", "r706" ] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets [Line Items]", "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r702" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r66", "r69" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Net book value", "label": "Finite-Lived Intangible Assets, Net", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r194", "r702" ] }, "us-gaap_FiniteLivedIntangibleAssetsTranslationAndPurchaseAccountingAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsTranslationAndPurchaseAccountingAdjustments", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Exchange rate changes", "label": "Finite-Lived Intangible Assets, Translation and Purchase Accounting Adjustments", "documentation": "Amount of increase (decrease) to assets, excluding financial assets and goodwill, lacking physical substance with a finite life for foreign currency translation adjustments and purchase accounting adjustments." } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyContractAssetFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyContractAssetFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency Contract, Asset, Fair Value Disclosure", "label": "Foreign Currency Contract, Asset, Fair Value Disclosure", "documentation": "Fair value portion of asset contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward contracts, and swaps." } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Foreign Currency Contracts, Liability, Fair Value Disclosure", "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure", "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into." } } }, "auth_ref": [] }, "ce_ForeignCurrencyDenominatedDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "ForeignCurrencyDenominatedDebtMember", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Currency Denominated Debt", "label": "Foreign Currency Denominated Debt [Member]", "documentation": "Foreign Currency Denominated Debt [Member]" } } }, "auth_ref": [] }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign exchange gain (loss), net", "label": "Gain (Loss), Foreign Currency Transaction, before Tax", "documentation": "Amount, before tax, of realized and unrealized gain (loss) from foreign currency transaction." } } }, "auth_ref": [ "r668", "r669", "r670", "r672", "r839" ] }, "us-gaap_ForeignExchangeContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ForeignExchangeContractMember", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign Exchange Contract [Member]", "label": "Foreign Exchange Contract [Member]", "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates." } } }, "auth_ref": [ "r891", "r913", "r926" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r955", "r966", "r976", "r1001" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r955", "r966", "r976", "r1001" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r955", "r966", "r976", "r1001" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r955", "r966", "r976", "r1001" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r955", "r966", "r976", "r1001" ] }, "us-gaap_GainLossOnDispositionOfAssets1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnDispositionOfAssets1", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (loss) on disposition of businesses and assets, net", "label": "Gain (Loss) on Disposition of Assets", "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee." } } }, "auth_ref": [ "r1047" ] }, "ce_GainLossOnNonDerivativeUsedInNetInvestmentHedge": { "xbrltype": "monetaryItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "GainLossOnNonDerivativeUsedInNetInvestmentHedge", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (Loss) Recognized in Other Comprehensive Income (Loss)", "label": "Gain (Loss) On Non-Derivative Used In Net Investment Hedge", "documentation": "Adjustment in other comprehensive income reflecting gains or losses on foreign currency transactions that are designated as, and are effective as, hedges of net investment in foreign entity, gross of tax effect." } } }, "auth_ref": [] }, "ce_GainLossOnNonDerivativesandDerivativesUsedInNetInvestmentHedge": { "xbrltype": "monetaryItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "GainLossOnNonDerivativesandDerivativesUsedInNetInvestmentHedge", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (Loss) Recognized in Other Comprehensive Income (Loss)", "label": "Gain (Loss) On Non-Derivatives and Derivatives Used In Net Investment Hedge", "documentation": "Adjustment in other comprehensive income reflecting gains (losses) on foreign currency transactions that are designated as, and are effective as, hedges of net investment in foreign entity, gross of tax effect." } } }, "auth_ref": [] }, "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GainLossOnSaleOfPropertyPlantEquipment", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (Loss) on Disposition of Property Plant Equipment", "label": "Gain (Loss) on Disposition of Property Plant Equipment", "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property." } } }, "auth_ref": [ "r14" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "periodStartLabel": "As of December 31, 2023", "periodEndLabel": "As of March\u00a031, 2024(1)", "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r251", "r378", "r707", "r896", "r928", "r1063", "r1070" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]", "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsnet" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and Intangible Assets, Net", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r193" ] }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Goodwill, impaired, accumulated impairment loss", "label": "Goodwill, Impaired, Accumulated Impairment Loss", "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r380", "r387", "r896" ] }, "us-gaap_GoodwillLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillLineItems", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill [Line Items]", "label": "Goodwill [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r896" ] }, "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange rate changes", "label": "Goodwill, Translation and Purchase Accounting Adjustments", "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r1", "r1062" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r176", "r290", "r335", "r349", "r355", "r358", "r372", "r418", "r419", "r421", "r422", "r423", "r425", "r427", "r429", "r430", "r664", "r893", "r1084" ] }, "us-gaap_GuaranteeObligationsMaximumExposure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GuaranteeObligationsMaximumExposure", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Guarantor obligations, maximum exposure", "label": "Guarantor Obligations, Maximum Exposure, Undiscounted", "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions." } } }, "auth_ref": [ "r417" ] }, "us-gaap_HedgingDesignationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationAxis", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Axis]", "label": "Hedging Designation [Axis]", "documentation": "Information by designation of purpose of derivative instrument." } } }, "auth_ref": [ "r20", "r636" ] }, "us-gaap_HedgingDesignationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingDesignationDomain", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Designation [Domain]", "label": "Hedging Designation [Domain]", "documentation": "Designation of purpose of derivative instrument." } } }, "auth_ref": [ "r20" ] }, "us-gaap_HedgingRelationshipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "HedgingRelationshipDomain", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Hedging Relationship [Domain]", "label": "Hedging Relationship [Domain]", "documentation": "Nature or intent of a hedge." } } }, "auth_ref": [ "r20" ] }, "us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeAmountsAttributableToReportingEntityDisclosuresAbstract", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Amounts attributable to Celanese Corporation", "label": "Income Amounts Attributable to Parent, Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeLossFromContinuingOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperations", "crdr": "credit", "calculation": { "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings (loss) from continuing operations", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent." } } }, "auth_ref": [ "r105", "r177", "r189", "r302", "r303", "r304", "r305", "r320", "r323" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Earnings (loss) from continuing operations before tax", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r0", "r172", "r224", "r335", "r349", "r355", "r358", "r713", "r728", "r893" ] }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Earnings (loss) from continuing operations", "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r209", "r290", "r298", "r335", "r349", "r355", "r358", "r372", "r418", "r419", "r421", "r422", "r423", "r425", "r427", "r429", "r430", "r651", "r664", "r728", "r893", "r1084" ] }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Continuing operations - basic (in dollars per share)", "label": "Income (Loss) from Continuing Operations, Per Basic Share", "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r171", "r222", "r225", "r284", "r298", "r302", "r303", "r304", "r305", "r315", "r321", "r322", "r651", "r712", "r1112" ] }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Continuing operations - diluted (in dollars per share)", "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r171", "r284", "r298", "r302", "r303", "r304", "r305", "r315", "r321", "r322", "r323", "r651", "r712", "r1112" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_ProfitLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Earnings (loss) from discontinued operations", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r146", "r147", "r148", "r149", "r150", "r153", "r247", "r620", "r729" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "crdr": "credit", "calculation": { "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings (loss) from discontinued operations", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent", "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal." } } }, "auth_ref": [ "r146", "r147", "r148", "r149", "r150", "r151", "r153", "r209" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued operations - basic (in dollars per share)", "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share", "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation." } } }, "auth_ref": [ "r174", "r284", "r319", "r321", "r322", "r1108", "r1112" ] }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Discontinued operations - diluted (in dollars per share)", "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share", "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation." } } }, "auth_ref": [ "r211", "r319", "r321", "r322" ] }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestments", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Equity in net earnings (loss) of affiliates", "label": "Income (Loss) from Equity Method Investments", "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)." } } }, "auth_ref": [ "r14", "r173", "r223", "r342", "r368", "r727" ] }, "us-gaap_IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Undistributed earnings in unconsolidated affiliates", "label": "Income (Loss) from Equity Method Investments, Net of Dividends or Distributions", "documentation": "This element represents the undistributed income (or loss) of equity method investments, net of dividends or other distributions received from unconsolidated subsidiaries, certain corporate joint ventures, and certain noncontrolled corporations; such investments are accounted for under the equity method of accounting. This element excludes distributions that constitute a return of investment, which are classified as investing activities." } } }, "auth_ref": [ "r14" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Tax Disclosure [Abstract]", "label": "Income Tax Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxDisclosureTextBlock", "presentation": [ "http://www.celanese.com/role/IncomeTaxes" ], "lang": { "en-us": { "role": { "terseLabel": "Income Taxes", "label": "Income Tax Disclosure [Text Block]", "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information." } } }, "auth_ref": [ "r291", "r599", "r604", "r605", "r606", "r612", "r616", "r621", "r622", "r767" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Income tax (provision) benefit", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r228", "r239", "r308", "r309", "r343", "r602", "r613", "r738" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Trade payables\u00a0- third party and affiliates", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r13" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 13.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventories", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r13" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Changes in operating assets and liabilities", "label": "Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingAssets", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 15.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other assets", "label": "Increase (Decrease) in Other Operating Assets", "documentation": "Amount of increase (decrease) in operating assets classified as other." } } }, "auth_ref": [ "r13" ] }, "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOtherOperatingLiabilities", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Increase (Decrease) in Other Operating Liabilities", "documentation": "Amount of increase (decrease) in operating liabilities classified as other." } } }, "auth_ref": [ "r13" ] }, "us-gaap_IncreaseDecreaseInReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInReceivables", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Trade receivables\u00a0- third party and affiliates, net", "label": "Increase (Decrease) in Receivables", "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r13" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "ce_IncreaseDecreaseOfAccruedCapitalExpenditures": { "xbrltype": "monetaryItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "IncreaseDecreaseOfAccruedCapitalExpenditures", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (decrease) in accrued capital expenditures", "label": "Increase (Decrease) of Accrued Capital Expenditures", "documentation": "Increase (Decrease) of Accrued Capital Expenditures." } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Incremental shares attributable to equity awards(1)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r316", "r317", "r318", "r323", "r567" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails", "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived Intangible Assets [Axis]", "label": "Indefinite-Lived Intangible Assets [Axis]", "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r391", "r394" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived Intangible Assets [Line Items]", "label": "Indefinite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "As of December 31, 2023", "periodEndLabel": "As of March 31, 2024", "label": "Indefinite-Lived Intangible Assets (Excluding Goodwill)", "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r196" ] }, "us-gaap_IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange rate changes", "label": "Indefinite-Lived Intangible Assets, Foreign Currency Translation Gain (Loss)", "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value." } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails", "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "label": "Indefinite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company." } } }, "auth_ref": [ "r67", "r196" ] }, "ce_IndemnificationAgreementsHoechstMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "IndemnificationAgreementsHoechstMember", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indemnification Agreements Hoechst", "label": "Indemnification Agreements Hoechst [Member]", "documentation": "Indemnification Agreements Hoechst [Member]." } } }, "auth_ref": [] }, "ce_IndemnificationCeilingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "IndemnificationCeilingAmount", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indemnification ceiling amount", "label": "Indemnification ceiling amount", "documentation": "Ceiling amount above which the Company will indemnify Hoechst for." } } }, "auth_ref": [] }, "ce_IndemnificationFloorAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "IndemnificationFloorAmount", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indemnification amount", "label": "Indemnification floor amount", "documentation": "The amount that the Company will indemnify Hoechst for in full." } } }, "auth_ref": [] }, "ce_IndemnificationPercentageExceedingCeilingAmount": { "xbrltype": "percentItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "IndemnificationPercentageExceedingCeilingAmount", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indemnification percentage exceeding ceiling amount", "label": "Indemnification percentage exceeding ceiling amount", "documentation": "The percentage of the amount above the ceiling that the Company will indemnify Hoechst for." } } }, "auth_ref": [] }, "ce_IndemnificationPercentageOther": { "xbrltype": "percentItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "IndemnificationPercentageOther", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indemnification percentage, other", "label": "Indemnification percentage, other", "documentation": "Percentage of other liabilities the Company has agreed to indemnify Hoechst for as part of the Demerger Agreement." } } }, "auth_ref": [] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r958", "r966", "r976", "r993", "r1001", "r1005", "r1013" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r1011" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r947", "r1017" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r947", "r1017" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r947", "r1017" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, net", "label": "Intangible Assets, Net (Excluding Goodwill)", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r64", "r68" ] }, "us-gaap_IntangibleAssetsNetIncludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetIncludingGoodwill", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill and intangible assets, net", "label": "Intangible Assets, Net (Including Goodwill)", "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance." } } }, "auth_ref": [] }, "us-gaap_InterestExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpense", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Interest expense", "label": "Interest Expense", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense." } } }, "auth_ref": [ "r140", "r227", "r279", "r339", "r683", "r826", "r940", "r1117" ] }, "us-gaap_InterestExpenseDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestExpenseDebt", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/DebtScheduleofCashTenderOfferDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Expense, Debt", "label": "Interest Expense, Debt", "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt." } } }, "auth_ref": [ "r182", "r451", "r459", "r903", "r904" ] }, "us-gaap_InterestPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestPayableCurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest (Note 7)", "label": "Interest Payable, Current", "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r40" ] }, "us-gaap_InterestRateSwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InterestRateSwapMember", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate Swap [Member]", "label": "Interest Rate Swap [Member]", "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period." } } }, "auth_ref": [ "r885", "r937", "r938" ] }, "us-gaap_IntersegmentEliminationMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntersegmentEliminationMember", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Eliminations", "terseLabel": "Intersegment Eliminations", "label": "Intersegment Eliminations [Member]", "documentation": "Eliminating entries used in operating segment consolidation." } } }, "auth_ref": [ "r337", "r348", "r349", "r350", "r351", "r352", "r354", "r358" ] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Inventory Disclosure [Abstract]", "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://www.celanese.com/role/Inventories" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "label": "Inventory Disclosure [Text Block]", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r377" ] }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoodsNetOfReserves", "crdr": "debit", "calculation": { "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Finished goods", "label": "Inventory, Finished Goods, Net of Reserves", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale." } } }, "auth_ref": [ "r192", "r888" ] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 }, "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Inventories", "totalLabel": "Total", "label": "Inventory, Net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r260", "r887", "r928" ] }, "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves", "crdr": "debit", "calculation": { "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Raw materials and supplies", "label": "Inventory, Raw Materials and Supplies, Net of Reserves", "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments." } } }, "auth_ref": [ "r192", "r1038" ] }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWorkInProcessNetOfReserves", "crdr": "debit", "calculation": { "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/InventoriesScheduleofInventoriesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Work-in-process", "label": "Inventory, Work in Process, Net of Reserves", "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing." } } }, "auth_ref": [ "r192", "r889" ] }, "us-gaap_InvestmentIncomeDividend": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeDividend", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Dividend income - equity investments", "label": "Investment Income, Dividend", "documentation": "Amount of dividend income on nonoperating securities." } } }, "auth_ref": [ "r180" ] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Interest income", "label": "Investment Income, Interest", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r181", "r338" ] }, "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Investments in affiliates", "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures", "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate." } } }, "auth_ref": [ "r1035" ] }, "ce_JapaneseYenDenominatedBorrowingMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "JapaneseYenDenominatedBorrowingMember", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Japanese Notes Due 2029", "label": "Japanese yen-denominated borrowing [Member]", "documentation": "The amount of the 2023 Offering converted into a Japanese yen-denominated borrowing in August 2023. Matures July 15, 2029." } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r163", "r221", "r724", "r928", "r1051", "r1061", "r1096" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "LIABILITIES AND EQUITY", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r41", "r249", "r290", "r372", "r418", "r419", "r421", "r422", "r423", "r425", "r427", "r429", "r430", "r625", "r628", "r629", "r664", "r928", "r1084", "r1099", "r1100" ] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Current Liabilities", "label": "Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Liabilities, Fair Value Disclosure", "label": "Liabilities, Fair Value Disclosure", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r135" ] }, "us-gaap_LiabilityForUncertainTaxPositionsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilityForUncertainTaxPositionsNoncurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Uncertain tax positions", "label": "Liability for Uncertainty in Income Taxes, Noncurrent", "documentation": "Amount recognized for uncertainty in income taxes classified as noncurrent." } } }, "auth_ref": [ "r44" ] }, "us-gaap_LicensingAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LicensingAgreementsMember", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Licenses", "label": "Licensing Agreements [Member]", "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory)." } } }, "auth_ref": [ "r102", "r598", "r1091" ] }, "us-gaap_LineOfCreditFacilityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityLineItems", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivablePurchasingFacilityNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility [Line Items]", "label": "Line of Credit Facility [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r1050" ] }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility, Maximum Borrowing Capacity", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility." } } }, "auth_ref": [ "r38" ] }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Available for borrowing", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)." } } }, "auth_ref": [ "r38" ] }, "us-gaap_LineOfCreditFacilityTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LineOfCreditFacilityTable", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivablePurchasingFacilityNarrativeDetails", "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Line of Credit Facility [Table]", "label": "Line of Credit Facility [Table]", "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line." } } }, "auth_ref": [ "r38", "r1050" ] }, "us-gaap_LinesOfCreditCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LinesOfCreditCurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails": { "parentTag": "us-gaap_DebtCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving credit facilities(2)", "label": "Line of Credit, Current", "documentation": "The carrying value as of the balance sheet date of the current portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement." } } }, "auth_ref": [ "r154", "r216" ] }, "us-gaap_LoansPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LoansPayableMember", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Bank loans due at various dates through 2030(3)", "label": "Loans Payable [Member]", "documentation": "Borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebt", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt, including current installments of long-term debt, carrying amount", "label": "Long-Term Debt", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation." } } }, "auth_ref": [ "r33", "r219", "r444", "r458", "r901", "r902", "r1111" ] }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtAndCapitalLeaseObligations", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt, net of unamortized deferred financing costs", "label": "Long-Term Debt and Lease Obligation", "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent." } } }, "auth_ref": [ "r33", "r717" ] }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails": { "parentTag": "us-gaap_DebtCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Current installments of long-term debt", "negatedTerseLabel": "Long-Term Debt and Lease Obligation, Current", "label": "Long-Term Debt and Lease Obligation, Current", "documentation": "Amount of long-term debt and lease obligation, classified as current." } } }, "auth_ref": [ "r40" ] }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-Term Debt and Lease Obligation, Including Current Maturities", "label": "Long-Term Debt and Lease Obligation, Including Current Maturities", "documentation": "Amount of long-term debt and lease obligation, including portion classified as current." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongTermDebtFairValue", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Long-term debt, including current installments of long-term debt, fair value", "label": "Long-Term Debt, Fair Value", "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission." } } }, "auth_ref": [] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r43" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r43", "r79" ] }, "us-gaap_LongtermDebtWeightedAverageInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LongtermDebtWeightedAverageInterestRate", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt, weighted average interest rate, at point in time", "label": "Long-Term Debt, Weighted Average Interest Rate, at Point in Time", "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time." } } }, "auth_ref": [] }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesByNatureOfContingencyAxis", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies by Nature of Contingency [Axis]", "label": "Loss Contingency Nature [Axis]", "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur." } } }, "auth_ref": [ "r410", "r411", "r412", "r416", "r1080", "r1081" ] }, "us-gaap_LossContingenciesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesLineItems", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Line Items]", "label": "Loss Contingencies [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r410", "r411", "r412", "r416", "r1080", "r1081" ] }, "us-gaap_LossContingenciesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingenciesTable", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingencies [Table]", "label": "Loss Contingencies [Table]", "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations." } } }, "auth_ref": [ "r410", "r411", "r412", "r416", "r1080", "r1081" ] }, "us-gaap_LossContingencyAccrualCarryingValueCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyAccrualCarryingValueCurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Legal (Note 14)", "label": "Loss Contingency, Accrual, Current", "documentation": "Amount of loss contingency liability expected to be resolved within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r410" ] }, "us-gaap_LossContingencyAccrualPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyAccrualPayments", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss contingency accrual, carrying value, payments", "label": "Loss Contingency Accrual, Payments", "documentation": "Amount of cash outflow reducing loss contingency liability." } } }, "auth_ref": [ "r1079" ] }, "us-gaap_LossContingencyNatureDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LossContingencyNatureDomain", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loss Contingency, Nature [Domain]", "label": "Loss Contingency, Nature [Domain]", "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability." } } }, "auth_ref": [ "r410", "r411", "r412", "r416", "r1080", "r1081" ] }, "ce_MasterDiscountingAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "MasterDiscountingAgreementMember", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Master Discounting Agreement", "label": "Master Discounting Agreement [Member]", "documentation": "Master Discounting Agreement" } } }, "auth_ref": [] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]" } } }, "auth_ref": [ "r411", "r412", "r414", "r415", "r564", "r700", "r750", "r791", "r792", "r847", "r849", "r851", "r852", "r863", "r883", "r884", "r895", "r905", "r923", "r929", "r1086", "r1101", "r1102", "r1103", "r1104", "r1105", "r1106" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r985" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r985" ] }, "ce_MechelenBelgiumMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "MechelenBelgiumMember", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresScheduleofExitandShutdownCostRelatedtoClosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mechelen, Belgium", "label": "Mechelen, Belgium [Member]", "documentation": "Mechelen, Belgium" } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]" } } }, "auth_ref": [ "r411", "r412", "r414", "r415", "r564", "r700", "r750", "r791", "r792", "r847", "r849", "r851", "r852", "r863", "r883", "r884", "r895", "r905", "r923", "r929", "r1086", "r1101", "r1102", "r1103", "r1104", "r1105", "r1106" ] }, "us-gaap_MinorityInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterest", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interests", "periodStartLabel": "Balance as of the beginning of the period, noncontrolling interest", "periodEndLabel": "Balance as of the end of the period, noncontrolling interest", "label": "Equity, Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r48", "r220", "r290", "r372", "r418", "r421", "r422", "r423", "r429", "r430", "r664", "r723", "r803" ] }, "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Distributions/dividends to noncontrolling interests", "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders", "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders." } } }, "auth_ref": [ "r202" ] }, "us-gaap_MinorityInterestOwnershipPercentageByParent": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MinorityInterestOwnershipPercentageByParent", "presentation": [ "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling interest, ownership percentage by parent", "label": "Subsidiary, Ownership Percentage, Parent", "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage." } } }, "auth_ref": [] }, "ce_MitsuiCoLtdMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "MitsuiCoLtdMember", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Mitsui & Co. Ltd.", "label": "Mitsui & Co. Ltd. [Member]", "documentation": "Mitsui & Co. Ltd." } } }, "auth_ref": [] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r1004" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r1012" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r986" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) financing activities", "label": "Net Cash Provided by (Used in) Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r286" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Financing Activities", "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) investing activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r286" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Investing Activities", "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by (used in) operating activities", "label": "Net Cash Provided by (Used in) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r187", "r188", "r189" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Activities", "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Net earnings (loss) attributable to Celanese Corporation", "totalLabel": "Net earnings (loss)", "verboseLabel": "Net earnings (loss) attributable to Celanese Corporation", "label": "Net Income (Loss)", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r175", "r189", "r226", "r247", "r271", "r274", "r278", "r290", "r298", "r302", "r303", "r304", "r305", "r308", "r309", "r320", "r335", "r349", "r355", "r358", "r372", "r418", "r419", "r421", "r422", "r423", "r425", "r427", "r429", "r430", "r651", "r664", "r732", "r822", "r840", "r841", "r893", "r940", "r1084" ] }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Net (earnings) loss attributable to noncontrolling interests", "terseLabel": "Net earnings (loss) attributable to noncontrolling interests", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r113", "r210", "r271", "r274", "r308", "r309", "r731", "r1041" ] }, "us-gaap_NetInvestmentHedgingMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetInvestmentHedgingMember", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net Investment Hedging", "label": "Net Investment Hedging [Member]", "documentation": "Hedges of a net investment in a foreign operation." } } }, "auth_ref": [ "r120" ] }, "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "presentation": [ "http://www.celanese.com/role/RecentAccountingPronouncements" ], "lang": { "en-us": { "role": { "terseLabel": "Recent Accounting Pronouncements", "label": "Accounting Standards Update and Change in Accounting Principle [Text Block]", "documentation": "The entire disclosure for change in accounting principle. Includes, but is not limited to, nature, reason, and method of adopting amendment to accounting standards or other change in accounting principle." } } }, "auth_ref": [ "r237", "r238", "r240", "r245", "r296", "r297", "r300", "r301", "r310", "r311", "r374", "r375", "r609", "r610", "r611", "r644", "r648", "r652", "r653", "r654", "r665", "r666", "r667", "r685", "r686", "r691", "r703", "r704", "r705", "r754", "r755", "r756", "r757", "r758" ] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://www.celanese.com/role/RecentAccountingPronouncementsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "New Accounting Pronouncements, Policy", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r985" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r955", "r966", "r976", "r993", "r1001" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r983" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r982" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r993" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r1012" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r1012" ] }, "us-gaap_NoncontrollingInterestMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncontrollingInterestMember", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Noncontrolling Interests", "label": "Noncontrolling Interest [Member]", "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest." } } }, "auth_ref": [ "r103", "r476", "r1054", "r1055", "r1056", "r1118" ] }, "us-gaap_NondesignatedMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NondesignatedMember", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Not Designated as Hedging Instrument", "label": "Not Designated as Hedging Instrument [Member]", "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)." } } }, "auth_ref": [ "r20" ] }, "ce_Nonoperatingpensionandotherpostretirementemployeebenefitexpenseincome": { "xbrltype": "monetaryItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "Nonoperatingpensionandotherpostretirementemployeebenefitexpenseincome", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Non-operating pension and other postretirement employee benefit (expense) income", "label": "Non-operating pension and other postretirement employee benefit (expense) income", "documentation": "Non-operating pension and other postretirement employee benefit (expense) income" } } }, "auth_ref": [] }, "us-gaap_NontradeReceivablesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NontradeReceivablesCurrent", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Non-trade receivables, net", "label": "Nontrade Receivables, Current", "documentation": "The sum of amounts currently receivable other than from customers. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1037" ] }, "srt_NorthAmericaMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NorthAmericaMember", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "North America", "label": "North America [Member]" } } }, "auth_ref": [ "r1120", "r1121", "r1122", "r1123" ] }, "us-gaap_NotionalAmountOfNonderivativeInstruments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NotionalAmountOfNonderivativeInstruments", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notional Amount of Nonderivative Instruments", "label": "Notional Amount of Nonderivative Instruments", "documentation": "Nominal or face amount used to calculate payments on a nonderivative instrument." } } }, "auth_ref": [] }, "ce_NumberOfDivestitureAgreements": { "xbrltype": "integerItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "NumberOfDivestitureAgreements", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of divestiture agreements", "label": "Number of divestiture agreements", "documentation": "Number of divestiture agreements." } } }, "auth_ref": [] }, "ce_NumberOfPartiesIncludedInUsepaOrder": { "xbrltype": "integerItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "NumberOfPartiesIncludedInUsepaOrder", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of parties included in USEPA order", "label": "Number of Parties included in USEPA order", "documentation": "Number of Parties included in USEPA order." } } }, "auth_ref": [] }, "ce_NutrinovaJointVentureMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "NutrinovaJointVentureMember", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Nutrinova Joint Venture", "label": "Nutrinova Joint Venture [Member]", "documentation": "Food Ingredients joint venture under the name Nutrinova" } } }, "auth_ref": [] }, "us-gaap_OffsettingAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingAssetsTableTextBlock", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Offsetting Assets", "label": "Offsetting Assets [Table Text Block]", "documentation": "Tabular disclosure of derivative and other financial assets that are subject to offsetting, including master netting arrangements." } } }, "auth_ref": [ "r167", "r265" ] }, "us-gaap_OffsettingLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OffsettingLiabilitiesTableTextBlock", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Offsetting Liabilities", "label": "Offsetting Liabilities [Table Text Block]", "documentation": "Tabular disclosure of derivative and other financial liabilities that are subject to offsetting, including master netting arrangements." } } }, "auth_ref": [ "r167", "r265" ] }, "ce_OneTimeTerminationBenefits": { "xbrltype": "monetaryItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "OneTimeTerminationBenefits", "crdr": "debit", "calculation": { "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresScheduleofExitandShutdownCostRelatedtoClosureDetails": { "parentTag": "ce_PlantShutdownCosts", "weight": 1.0, "order": 1.0 }, "http://www.celanese.com/role/OtherChargesGainsNetScheduleofOtherChargesGainsNetDetails": { "parentTag": "us-gaap_OtherNonrecurringIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresScheduleofExitandShutdownCostRelatedtoClosureDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofOtherChargesGainsNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "One Time Termination Benefits", "negatedTerseLabel": "Restructuring(1)", "label": "One Time Termination Benefits", "documentation": "The charge against earnings in the period for known and estimated costs of one time termination benefits provided to current employees that are involuntarily terminated under a benefit arrangement associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan." } } }, "auth_ref": [] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Operating profit (loss)", "terseLabel": "Operating profit (loss)", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r335", "r349", "r355", "r358", "r893" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating leases", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r688" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r688" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r687" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r348", "r349", "r350", "r351", "r352", "r358" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentation" ], "lang": { "en-us": { "role": { "terseLabel": "Description of the Company and Basis of Presentation", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r145", "r208", "r759", "r760" ] }, "us-gaap_OtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets, Current", "documentation": "Amount of current assets classified as other." } } }, "auth_ref": [ "r261", "r928" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Other assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r253" ] }, "ce_OtherChargesGainsNetTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "OtherChargesGainsNetTextBlock", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNet" ], "lang": { "en-us": { "role": { "terseLabel": "Other (Charges) Gains, Net", "label": "Other (Charges) Gains, Net [Text Block]", "documentation": "Other (Charges) Gains, Net [Text Block]." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income (loss) before reclassifications", "label": "Other Comprehensive Income (Loss), before Reclassifications, before Tax", "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r50", "r277", "r674", "r677", "r681", "r733", "r1039" ] }, "us-gaap_OtherComprehensiveIncomeLossBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossBeforeTax", "crdr": "credit", "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total other comprehensive income (loss), before tax", "label": "Other Comprehensive Income (Loss), before Tax", "documentation": "Amount before tax, after reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r280", "r674", "r675", "r681", "r708", "r733", "r1039", "r1040" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (Loss) Recognized in Other Comprehensive Income (Loss)", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness." } } }, "auth_ref": [ "r267", "r269", "r631", "r632", "r638" ] }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTax", "crdr": "credit", "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (loss) on derivative hedges", "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments and Tax", "documentation": "Amount, after tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method." } } }, "auth_ref": [ "r268", "r633" ] }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsBeforeTax", "crdr": "credit", "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (loss) on derivative hedges, gross amount", "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, before Tax", "documentation": "Amount, before tax and after adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method." } } }, "auth_ref": [ "r268", "r633" ] }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsTax", "crdr": "debit", "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (loss) on derivative hedges, income tax (provision) benefit", "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments, Tax", "documentation": "Amount, after adjustments, of tax expense (benefit) for gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method." } } }, "auth_ref": [ "r268", "r633" ] }, "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (Loss) Recognized in Other Comprehensive Income (Loss)", "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax", "documentation": "Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method." } } }, "auth_ref": [ "r268", "r269", "r633", "r635", "r638" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax", "crdr": "credit", "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation gain (loss), gross amount", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax", "documentation": "Amount before tax, after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r4", "r170" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "crdr": "credit", "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation gain (loss)", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r4" ] }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "crdr": "debit", "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Foreign currency translation gain (loss), income tax (provision) benefit", "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax", "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature." } } }, "auth_ref": [ "r4", "r8", "r671", "r680" ] }, "us-gaap_OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain (Loss) Recognized in Other Comprehensive Income (Loss)", "label": "Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax", "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative designated and qualifying as net investment hedge." } } }, "auth_ref": [ "r634" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 }, "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Total other comprehensive income (loss), net of tax", "verboseLabel": "Other comprehensive income (loss), net of tax", "totalLabel": "Total other comprehensive income (loss), net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r19", "r30", "r272", "r275", "r280", "r674", "r675", "r681", "r708", "r733", "r1039", "r1040" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income (loss), net of tax", "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax", "crdr": "debit", "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Pension and postretirement benefits gain (loss), gross amount", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax", "documentation": "Amount, before tax, after reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan." } } }, "auth_ref": [ "r7", "r170", "r915", "r1089" ] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "crdr": "debit", "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Pension and postretirement benefits", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan." } } }, "auth_ref": [ "r7", "r170" ] }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax", "crdr": "credit", "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossTax", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pension and postretirement benefits gain (loss), income tax (provision) benefit", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax", "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan." } } }, "auth_ref": [ "r7", "r8", "r209" ] }, "us-gaap_OtherComprehensiveIncomeLossTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossTax", "crdr": "debit", "calculation": { "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/StockholdersEquityScheduleofComponentsofOtherComprehensiveIncomeLossNetDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total other comprehensive income (loss), tax", "negatedTerseLabel": "Income tax (provision) benefit", "label": "Other Comprehensive Income (Loss), Tax", "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss)." } } }, "auth_ref": [ "r8", "r276", "r280", "r602", "r617", "r619", "r674", "r678", "r681", "r708", "r733" ] }, "us-gaap_OtherCurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentAssetsMember", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other Current Assets", "label": "Other Current Assets [Member]", "documentation": "Primary financial statement caption encompassing other current assets." } } }, "auth_ref": [ "r122", "r133" ] }, "us-gaap_OtherCurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentLiabilitiesMember", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Current Liabilities", "label": "Other Current Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other current liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherCurrentLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherCurrentLiabilitiesTableTextBlock", "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Current Other Liabilities", "label": "Other Current Liabilities [Table Text Block]", "documentation": "Tabular disclosure of other current liabilities." } } }, "auth_ref": [] }, "ce_OtherEnvironmentalRemediationReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "OtherEnvironmentalRemediationReserves", "crdr": "credit", "calculation": { "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails": { "parentTag": "us-gaap_AccrualForEnvironmentalLossContingencies", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other environmental remediation liabilities", "label": "Other environmental remediation reserves", "documentation": "Other environmental remediation reserves." } } }, "auth_ref": [] }, "us-gaap_OtherIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherIntangibleAssetsMember", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Covenants Not to Compete and Other", "label": "Other Intangible Assets [Member]", "documentation": "Intangible assets classified as other." } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 }, "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails", "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "totalLabel": "Total", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r40", "r928" ] }, "us-gaap_OtherLiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesCurrentAbstract", "lang": { "en-us": { "role": { "terseLabel": "Other Liabilities, Current [Abstract]", "label": "Other Liabilities, Current [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r44" ] }, "us-gaap_OtherLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherLongTermDebt", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other long-term debt", "label": "Other Long-Term Debt", "documentation": "Amount of long-term debt classified as other." } } }, "auth_ref": [ "r33", "r219", "r1111" ] }, "us-gaap_OtherNoncurrentAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncurrentAssetsMember", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails", "http://www.celanese.com/role/FairValueMeasurementsScheduleofCarryingValuesandFairValuesofFinancialInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Noncurrent Assets", "label": "Other Noncurrent Assets [Member]", "documentation": "Primary financial statement caption encompassing other noncurrent assets." } } }, "auth_ref": [] }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNoncurrentLiabilitiesMember", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsScheduleofAssetsandLiabilitiesMeasuredatFairValueonaRecurringBasisDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Noncurrent Liabilities", "label": "Other Noncurrent Liabilities [Member]", "documentation": "Primary financial statement caption encompassing other noncurrent liabilities." } } }, "auth_ref": [] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Other income (expense), net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r183" ] }, "us-gaap_OtherNonrecurringIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonrecurringIncomeExpense", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 6.0 }, "http://www.celanese.com/role/OtherChargesGainsNetScheduleofOtherChargesGainsNetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofOtherChargesGainsNetDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other (charges) gains, net", "negatedTotalLabel": "Total", "negatedLabel": "Other (charges) gains, net (Note 14)", "label": "Other Nonrecurring (Income) Expense", "documentation": "Amount of other expense (income) that is infrequent in occurrence or unusual in nature." } } }, "auth_ref": [ "r184" ] }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherOperatingActivitiesCashFlowStatement", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Other, net", "label": "Other Operating Activities, Cash Flow Statement", "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities)." } } }, "auth_ref": [] }, "us-gaap_OtherPensionPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherPensionPlansDefinedBenefitMember", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Benefit payments to nonqualified pension plans", "label": "Other Pension Plan [Member]", "documentation": "Plan designed to provide retirement benefits, classified as other. Includes, but is not limited to, defined benefit and defined contribution plans." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r985" ] }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Post-retirement Benefits", "verboseLabel": "Benefit payments to other postretirement benefit plans", "label": "Other Postretirement Benefits Plan [Member]", "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits." } } }, "auth_ref": [ "r492", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r519", "r520", "r521", "r522", "r523", "r524", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r542", "r545", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r561", "r562", "r563", "r915", "r916", "r917", "r918", "r919" ] }, "us-gaap_OtherShortTermBorrowings": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherShortTermBorrowings", "crdr": "credit", "calculation": { "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails": { "parentTag": "us-gaap_DebtCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term borrowings, including amounts due to affiliates(1)", "label": "Other Short-Term Borrowings", "documentation": "Amount of borrowings classified as other, maturing within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r35", "r799" ] }, "us-gaap_OtherSundryLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherSundryLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other Sundry Liabilities, Current", "label": "Other Sundry Liabilities, Current", "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date." } } }, "auth_ref": [ "r40", "r78" ] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r953", "r964", "r974", "r999" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r956", "r967", "r977", "r1002" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r956", "r967", "r977", "r1002" ] }, "srt_OwnershipAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipAxis", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership [Axis]", "label": "Ownership [Axis]" } } }, "auth_ref": [] }, "srt_OwnershipDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "OwnershipDomain", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Ownership [Domain]", "label": "Ownership [Domain]" } } }, "auth_ref": [] }, "ce_PassaicRiverNewJerseyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "PassaicRiverNewJerseyMember", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Passaic River, New Jersey", "label": "Passaic River, New Jersey [Member]", "documentation": "Passaic River, New Jersey [Member]." } } }, "auth_ref": [] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r981" ] }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForProceedsFromOtherInvestingActivities", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other, net", "label": "Payments for (Proceeds from) Other Investing Activities", "documentation": "Amount of cash (inflow) outflow from investing activities classified as other." } } }, "auth_ref": [ "r1031", "r1042" ] }, "us-gaap_PaymentsForRestructuring": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForRestructuring", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cash payments", "label": "Payments for Restructuring", "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r399", "r1046" ] }, "us-gaap_PaymentsOfDividendsCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsOfDividendsCommonStock", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Common stock dividends", "label": "Payments of Ordinary Dividends, Common Stock", "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity." } } }, "auth_ref": [ "r53" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Capital expenditures on property, plant and equipment", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r186" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r984" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r984" ] }, "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Benefit obligations (Note 8)", "label": "Liability, Pension and Other Postretirement and Postemployment Benefits, Current", "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as current." } } }, "auth_ref": [ "r91", "r92", "r155", "r203" ] }, "us-gaap_PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Benefit obligations", "label": "Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent", "documentation": "Amount of liability, recognized in statement of financial position, for pension, other postretirement and postemployment benefits, classified as noncurrent." } } }, "auth_ref": [ "r91", "r92", "r156", "r203" ] }, "us-gaap_PensionAndOtherPostretirementBenefitContributions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementBenefitContributions", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Pension and postretirement contributions", "label": "Payment for Pension and Other Postretirement Benefits", "documentation": "Amount of cash outflow for pension and other postretirement benefits. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree." } } }, "auth_ref": [ "r12" ] }, "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock", "presentation": [ "http://www.celanese.com/role/BenefitObligations" ], "lang": { "en-us": { "role": { "terseLabel": "Benefit Obligations", "label": "Retirement Benefits [Text Block]", "documentation": "The entire disclosure for retirement benefits." } } }, "auth_ref": [ "r491", "r516", "r518", "r524", "r541", "r543", "r544", "r545", "r546", "r547", "r559", "r560", "r561", "r915" ] }, "us-gaap_PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Pension and postretirement net periodic benefit cost", "label": "Pension and Other Postretirement Benefits Expense (Reversal of Expense), Noncash", "documentation": "Amount of noncash expense (reversal of expense) for pension and other postretirement benefits." } } }, "auth_ref": [ "r14" ] }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities", "crdr": "credit", "calculation": { "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails": { "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Current Other liabilities", "label": "Liability, Defined Benefit Plan, Current", "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans, classified as current." } } }, "auth_ref": [ "r155", "r492", "r493", "r515", "r915" ] }, "us-gaap_PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesCurrentAndNoncurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails": { "parentTag": "us-gaap_DefinedBenefitPlanFundedStatusOfPlan", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Benefit obligations", "label": "Liability, Defined Benefit Plan", "documentation": "Amount of liability, recognized in statement of financial position, for defined benefit pension and other postretirement plans." } } }, "auth_ref": [ "r218", "r493", "r515", "r1110" ] }, "us-gaap_PensionPlansDefinedBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PensionPlansDefinedBenefitMember", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Benefits", "verboseLabel": "Cash contributions to defined benefit pension plans", "label": "Pension Plan [Member]", "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits." } } }, "auth_ref": [ "r492", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r542", "r545", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r561", "r562", "r565", "r915", "r916", "r920", "r921", "r922" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r983" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r993" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r986" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r982" ] }, "ce_PercentageOfFairValueOfSalesReceivables": { "xbrltype": "percentItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "PercentageOfFairValueOfSalesReceivables", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivablePurchasingFacilityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Percentage of fair value of sales receivables", "label": "Percentage of Fair Value of Sales Receivables", "documentation": "Percentage of fair value of sales receivables." } } }, "auth_ref": [] }, "ce_PlantClosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "PlantClosuresAbstract", "lang": { "en-us": { "role": { "terseLabel": "Plant Closures [Abstract]", "label": "Plant Closures [Abstract]", "documentation": "Plant Closures [Abstract]" } } }, "auth_ref": [] }, "ce_PlantShutdownCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "PlantShutdownCosts", "crdr": "debit", "calculation": { "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresScheduleofExitandShutdownCostRelatedtoClosureDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresScheduleofExitandShutdownCostRelatedtoClosureDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Plant Shutdown Costs", "label": "Plant Shutdown Costs", "documentation": "Amount of plant shutdown and exist costs." } } }, "auth_ref": [] }, "ce_PollutionControlAndIndustrialRevenueBondsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "PollutionControlAndIndustrialRevenueBondsMember", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Pollution control and industrial revenue bonds due at various dates through 2030(2)", "label": "Pollution Control and Industrial Revenue Bonds [Member]", "documentation": "Pollution Control and Industrial Revenue Bonds [Member]." } } }, "auth_ref": [] }, "us-gaap_PostemploymentBenefitsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PostemploymentBenefitsAbstract", "lang": { "en-us": { "role": { "label": "Postemployment Benefits [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, par value (in dollars per share)", "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r157", "r461" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares authorized (in shares)", "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r157", "r801" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares issued (in shares)", "label": "Preferred Stock, Shares Issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r157", "r461" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, shares outstanding (in shares)", "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r157", "r801", "r820", "r1118", "r1119" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Preferred stock, $0.01\u00a0par value, 100,000,000\u00a0shares authorized (2024 and 2023: 0 issued and outstanding)", "label": "Preferred Stock, Value, Issued", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r157", "r719", "r928" ] }, "ce_ProceedsCollectedOnAccountsReceivableSoldUnderFactoringFacilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "ProceedsCollectedOnAccountsReceivableSoldUnderFactoringFacilities", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivablePurchasingFacilityNarrativeDetails", "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds collected on accounts receivable sold under factoring facilities", "label": "Proceeds Collected on Accounts Receivable Sold under Factoring Facilities", "documentation": "Proceeds Collected on Accounts Receivable Sold under Factoring Facilities" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfLongTermDebt", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from long-term debt", "label": "Proceeds from Issuance of Long-Term Debt", "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r52", "r762" ] }, "us-gaap_ProceedsFromLinesOfCredit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromLinesOfCredit", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from lines of credit", "label": "Proceeds from Lines of Credit", "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements." } } }, "auth_ref": [ "r52", "r1050" ] }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Other, net", "label": "Proceeds from (Payments for) Other Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities classified as other." } } }, "auth_ref": [ "r1032", "r1043" ] }, "us-gaap_ProceedsFromPaymentsToMinorityShareholders": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromPaymentsToMinorityShareholders", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Distributions/dividends to noncontrolling interests", "label": "Proceeds from (Payments to) Noncontrolling Interests", "documentation": "Amount of cash inflow (outflow) from (to) a noncontrolling interest. Excludes dividends paid to the noncontrolling interest." } } }, "auth_ref": [] }, "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Net change in short-term borrowings with maturities of 3 months or less", "label": "Proceeds from (Repayments of) Short-Term Debt, Maturing in Three Months or Less", "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months." } } }, "auth_ref": [ "r1044", "r1045", "r1048" ] }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromSaleOfProductiveAssets", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from sale of businesses and assets, net", "label": "Proceeds from Sale of Productive Assets", "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r185" ] }, "us-gaap_ProceedsFromShortTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromShortTermDebt", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from short-term borrowings", "label": "Proceeds from Short-Term Debt", "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r52" ] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Stock option exercises", "label": "Proceeds from Stock Options Exercised", "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r9", "r21" ] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProfitLoss", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 }, "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 1.0 }, "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "totalLabel": "Net earnings (loss)", "terseLabel": "Net earnings (loss)", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r247", "r271", "r274", "r285", "r290", "r298", "r308", "r309", "r335", "r349", "r355", "r358", "r372", "r418", "r419", "r421", "r422", "r423", "r425", "r427", "r429", "r430", "r623", "r626", "r627", "r651", "r664", "r713", "r730", "r769", "r822", "r840", "r841", "r893", "r924", "r925", "r941", "r1041", "r1084" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Property, plant and equipment (net of accumulated depreciation\u00a0- 2024: $4,243; 2023: $4,080)", "label": "Property, Plant and Equipment, Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r16", "r714", "r726", "r928" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r981" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r981" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Axis]", "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r411", "r412", "r414", "r415", "r516", "r564", "r590", "r591", "r592", "r696", "r700", "r750", "r791", "r792", "r847", "r849", "r851", "r852", "r863", "r883", "r884", "r895", "r905", "r923", "r929", "r932", "r1073", "r1086", "r1102", "r1103", "r1104", "r1105", "r1106" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Statistical Measurement [Domain]", "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r411", "r412", "r414", "r415", "r516", "r564", "r590", "r591", "r592", "r696", "r700", "r750", "r791", "r792", "r847", "r849", "r851", "r852", "r863", "r883", "r884", "r895", "r905", "r923", "r929", "r932", "r1073", "r1086", "r1102", "r1103", "r1104", "r1105", "r1106" ] }, "ce_RecentAccountingPronouncementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "RecentAccountingPronouncementsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Recent Accounting Pronouncements [Abstract]", "label": "Recent Accounting Pronouncements [Abstract]", "documentation": "Recent Accounting Pronouncements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amounts reclassified from accumulated other comprehensive income (loss)", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax", "documentation": "Amount before tax of reclassification adjustments of other comprehensive income (loss)." } } }, "auth_ref": [ "r50", "r277", "r674", "r679", "r681", "r733", "r1039" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r948", "r959", "r969", "r994" ] }, "us-gaap_RepaymentsOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfDebt", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Repayments of Debt", "label": "Repayments of Debt", "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation." } } }, "auth_ref": [ "r1045" ] }, "us-gaap_RepaymentsOfLongTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfLongTermDebt", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Repayments of long-term debt", "negatedLabel": "Repayments of long-term debt", "label": "Repayments of Long-Term Debt", "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r54", "r765" ] }, "us-gaap_RepaymentsOfShortTermDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RepaymentsOfShortTermDebt", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Repayments of short-term borrowings", "label": "Repayments of Short-Term Debt", "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r54" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Research and development expenses", "label": "Research and Development Expense", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r144", "r597", "r1107" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r949", "r960", "r970", "r995" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r950", "r961", "r971", "r996" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r957", "r968", "r978", "r1003" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock Units (RSUs)", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedActivitiesAbstract", "lang": { "en-us": { "role": { "terseLabel": "Restructuring and Related Activities [Abstract]", "label": "Restructuring and Related Activities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RestructuringAndRelatedCostExpectedCost1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringAndRelatedCostExpectedCost1", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring and related cost, expected cost", "label": "Restructuring and Related Cost, Expected Cost", "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost." } } }, "auth_ref": [ "r398", "r401", "r404", "r406" ] }, "us-gaap_RestructuringCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCharges", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Additions", "label": "Restructuring Charges", "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation." } } }, "auth_ref": [ "r14", "r402", "r404", "r1075" ] }, "us-gaap_RestructuringCostAndReserveAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveAxis", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Type [Axis]", "label": "Restructuring Type [Axis]", "documentation": "Information by type of restructuring cost." } } }, "auth_ref": [ "r398", "r399", "r404", "r405" ] }, "us-gaap_RestructuringCostAndReserveLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringCostAndReserveLineItems", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresScheduleofExitandShutdownCostRelatedtoClosureDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Cost and Reserve [Line Items]", "label": "Restructuring Cost and Reserve [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r398", "r399", "r400", "r401", "r404", "r405", "r406" ] }, "us-gaap_RestructuringReserve": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserve", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Reserve as of the beginning of the period", "periodEndLabel": "Reserve as of the end of the period", "label": "Restructuring Reserve", "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan." } } }, "auth_ref": [ "r399", "r403" ] }, "us-gaap_RestructuringReserveAcceleratedDepreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveAcceleratedDepreciation", "crdr": "debit", "calculation": { "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresScheduleofExitandShutdownCostRelatedtoClosureDetails": { "parentTag": "ce_PlantShutdownCosts", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresScheduleofExitandShutdownCostRelatedtoClosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accelerated depreciation expense", "label": "Restructuring and Related Cost, Accelerated Depreciation", "documentation": "Amount of accelerated depreciation charged against earnings associated with exit from or disposal of business activities or restructuring plan." } } }, "auth_ref": [] }, "us-gaap_RestructuringReserveAccrualAdjustment1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveAccrualAdjustment1", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other changes", "label": "Restructuring Reserve, Accrual Adjustment", "documentation": "Amount of expense (reversal of expense) which increases (decreases) the restructuring reserve from an adjustment to a previously accrued restructuring liability." } } }, "auth_ref": [ "r399", "r405" ] }, "us-gaap_RestructuringReserveCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveCurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring (Note 18)", "label": "Restructuring Reserve, Current", "documentation": "Carrying amount as of the balance sheet date of known and estimated obligations associated with exit from or disposal of business activities or restructurings pursuant to a duly authorized plan, which are expected to be paid in the next twelve months or in the normal operating cycle if longer. Costs of such activities include those for one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, relocating employees, and costs associated with an ongoing benefit arrangement, but excludes costs associated with the retirement of a long-lived asset." } } }, "auth_ref": [ "r1036", "r1076", "r1077" ] }, "us-gaap_RestructuringReserveRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestructuringReserveRollForward", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restructuring Reserve [Roll Forward]", "label": "Restructuring Reserve [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r160", "r202", "r722", "r754", "r758", "r766", "r802", "r928" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r243", "r293", "r294", "r295", "r299", "r307", "r309", "r373", "r376", "r594", "r595", "r596", "r607", "r608", "r639", "r641", "r642", "r645", "r649", "r751", "r753", "r770", "r1118" ] }, "us-gaap_RetirementPlanTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeAxis", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Axis]", "label": "Retirement Plan Type [Axis]", "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r492", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r542", "r545", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r561", "r562", "r563", "r565", "r915", "r916", "r917", "r918", "r919", "r920", "r921", "r922" ] }, "us-gaap_RetirementPlanTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetirementPlanTypeDomain", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Retirement Plan Type [Domain]", "label": "Retirement Plan Type [Domain]", "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement." } } }, "auth_ref": [ "r492", "r495", "r496", "r497", "r498", "r499", "r500", "r501", "r502", "r503", "r504", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r542", "r545", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r561", "r562", "r563", "r565", "r915", "r916", "r917", "r918", "r919", "r920", "r921", "r922" ] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Net sales", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r336", "r337", "r348", "r353", "r354", "r360", "r362", "r364", "r487", "r488", "r701" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://www.celanese.com/role/RevenueRecognition" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition", "label": "Revenue from Contract with Customer [Text Block]", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r241", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r490" ] }, "us-gaap_RevenueRecognitionAndDeferredRevenueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRecognitionAndDeferredRevenueAbstract", "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition and Deferred Revenue [Abstract]", "label": "Revenue Recognition and Deferred Revenue [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueRemainingPerformanceObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligation", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, remaining performance obligation, amount", "label": "Revenue, Remaining Performance Obligation, Amount", "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue." } } }, "auth_ref": [ "r233" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r234" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format." } } }, "auth_ref": [ "r234" ] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.celanese.com/role/DebtScheduleofRevolvingCreditFacilityDetails", "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolving Credit Facility", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r1012" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r1012" ] }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesAndExciseTaxPayableCurrent", "crdr": "credit", "calculation": { "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails": { "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/CurrentOtherLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Sales and use tax/foreign withholding tax payable", "label": "Sales and Excise Tax Payable, Current", "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r36" ] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.celanese.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Adjustments to Accumulated Other Comprehensive Income (Loss), Net", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r50", "r1097", "r1098" ] }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities." } } }, "auth_ref": [ "r56" ] }, "ce_ScheduleOfCashTenderOfferTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "ScheduleOfCashTenderOfferTableTextBlock", "presentation": [ "http://www.celanese.com/role/DebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Cash Tender Offer", "label": "Schedule of Cash Tender Offer [Table Text Block]", "documentation": "Schedule of Cash Tender Offer" } } }, "auth_ref": [] }, "ce_ScheduleOfCompanyCommitmentsToFundBenefitObligationsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "ScheduleOfCompanyCommitmentsToFundBenefitObligationsTableTextBlock", "presentation": [ "http://www.celanese.com/role/BenefitObligationsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Company Commitments to Fund Benefit Obligations", "label": "Schedule of Company Commitments to Fund Benefit Obligations [Table Text Block]", "documentation": "Schedule of Company Commitments to Fund Benefit Obligations [Table Text Block]." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.celanese.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Components of Other Comprehensive Income (Loss), Net", "label": "Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of components of comprehensive income (loss). Includes, but is not limited to, foreign currency translation adjustments, foreign currency transactions designated as economic hedges of a net investment in foreign entity, gain (loss) and prior service cost (credit) for pension plans and other postretirement benefit plans." } } }, "auth_ref": [ "r169" ] }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDebtInstrumentsTextBlock", "presentation": [ "http://www.celanese.com/role/DebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt", "label": "Schedule of Long-Term Debt Instruments [Table Text Block]", "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer." } } }, "auth_ref": [ "r43", "r83", "r86", "r138", "r139", "r141", "r143", "r200", "r201", "r901", "r903", "r1053" ] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "presentation": [ "http://www.celanese.com/role/BenefitObligationsScheduleofCompanyCommitmentstoFundBenefitObligationsDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofDefinedBenefitPlansDisclosuresDetails", "http://www.celanese.com/role/BenefitObligationsScheduleofNetPeriodicBenefitCostsRecognizedDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]", "label": "Schedule of Defined Benefit Plans Disclosures [Table]", "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r17", "r93", "r94", "r95", "r96" ] }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTextBlock", "presentation": [ "http://www.celanese.com/role/BenefitObligationsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Defined Benefit Plans Disclosures", "label": "Schedule of Defined Benefit Plans Disclosures [Table Text Block]", "documentation": "Tabular disclosure of one or more of the entity's defined benefit pension plans or one or more other defined benefit postretirement plans, separately for pension plans and other postretirement benefit plans including the entity's schedule of fair value of plan assets for defined benefit or other postretirement plans." } } }, "auth_ref": [ "r17", "r93", "r94", "r95", "r96" ] }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "presentation": [ "http://www.celanese.com/role/DerivativeFinancialInstrumentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Changes in Fair Value of Derivatives", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments." } } }, "auth_ref": [ "r123", "r128", "r636" ] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Earnings (Loss) Per Share", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r1058" ] }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "presentation": [ "http://www.celanese.com/role/IncomeTaxesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Effective Tax Rate", "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations." } } }, "auth_ref": [ "r205" ] }, "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionRemainingPerformanceObligationsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]", "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]", "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers." } } }, "auth_ref": [ "r190" ] }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Investment, Name [Axis]", "label": "Investment, Name [Axis]" } } }, "auth_ref": [ "r369", "r370", "r371" ] }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "presentation": [ "http://www.celanese.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)." } } }, "auth_ref": [ "r656", "r657" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]", "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r66", "r69", "r702" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r66", "r69" ] }, "us-gaap_ScheduleOfGoodwillTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTable", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill [Table]", "label": "Schedule of Goodwill [Table]", "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons." } } }, "auth_ref": [ "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r388", "r389", "r896" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Goodwill", "label": "Schedule of Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r896", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1068", "r1069", "r1070", "r1071", "r1072" ] }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]", "label": "Schedule of Indefinite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity." } } }, "auth_ref": [ "r23", "r196" ] }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Indefinite-Lived Intangible Assets", "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment." } } }, "auth_ref": [ "r23", "r196" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://www.celanese.com/role/InventoriesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Inventories", "label": "Schedule of Inventory, Current [Table Text Block]", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r34", "r164", "r165", "r166" ] }, "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock", "presentation": [ "http://www.celanese.com/role/DebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Balances Available for Borrowing", "label": "Schedule of Line of Credit Facilities [Table Text Block]", "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line." } } }, "auth_ref": [ "r38" ] }, "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNetBenefitCostsTableTextBlock", "presentation": [ "http://www.celanese.com/role/BenefitObligationsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Net Periodic Benefit Costs Recognized", "label": "Schedule of Net Benefit Costs [Table Text Block]", "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments." } } }, "auth_ref": [ "r204" ] }, "ce_ScheduleOfOtherChargesGainsNetTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "ScheduleOfOtherChargesGainsNetTableTextBlock", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Other (Charges) Gains, Net", "label": "Schedule of Other (Charges) Gains, Net [Table Text Block]", "documentation": "Schedule of Other (Charges) Gains, Net [Table Text Block]." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresScheduleofExitandShutdownCostRelatedtoClosureDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring and Related Costs [Table]", "label": "Schedule of Restructuring and Related Costs [Table]", "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring." } } }, "auth_ref": [ "r398", "r399", "r400", "r401", "r404", "r405", "r406" ] }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Exit and Shutdown Cost Related to Closure", "label": "Restructuring and Related Costs [Table Text Block]", "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets." } } }, "auth_ref": [ "r73", "r75", "r76" ] }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restructuring Reserve by Type of Cost", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period." } } }, "auth_ref": [ "r74", "r77" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r60", "r61", "r62", "r63" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.celanese.com/role/SegmentInformationTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Business Segments", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss." } } }, "auth_ref": [ "r60", "r61", "r62", "r63" ] }, "ce_ScheduleOfSeniorUnsecuredNotesOfferingTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "ScheduleOfSeniorUnsecuredNotesOfferingTableTextBlock", "presentation": [ "http://www.celanese.com/role/DebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Senior Unsecured Notes Offering", "label": "Schedule of Senior Unsecured Notes Offering [Table Text Block]", "documentation": "Schedule of new senior unsecured notes offering in the period by the Company." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShortTermDebtTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShortTermDebtTable", "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Short-term Debt [Table]", "label": "Schedule of Short-Term Debt [Table]", "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation." } } }, "auth_ref": [ "r39" ] }, "us-gaap_ScheduleOfShortTermDebtTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShortTermDebtTextBlock", "presentation": [ "http://www.celanese.com/role/DebtTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Short-term Debt", "label": "Schedule of Short-Term Debt [Table Text Block]", "documentation": "Tabular disclosure of short-term debt arrangements (having initial terms of repayment within one year or the normal operating cycle, if longer) including: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation." } } }, "auth_ref": [ "r39" ] }, "us-gaap_ScheduleOfStockByClassTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfStockByClassTable", "presentation": [ "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Stock by Class [Table]", "label": "Schedule of Stock by Class [Table]", "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity." } } }, "auth_ref": [ "r80", "r81", "r82", "r83", "r84", "r85", "r86", "r200", "r201", "r202", "r256", "r257", "r258", "r329", "r461", "r462", "r463", "r465", "r468", "r473", "r475", "r762", "r763", "r764", "r765", "r905", "r1019", "r1049" ] }, "us-gaap_ScheduleOfTreasuryStockByClassTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfTreasuryStockByClassTextBlock", "presentation": [ "http://www.celanese.com/role/StockholdersEquityTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Treasury Stock", "label": "Class of Treasury Stock [Table Text Block]", "documentation": "Tabular disclosure of treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock." } } }, "auth_ref": [ "r87", "r88", "r89", "r90" ] }, "us-gaap_ScheduleOfVariableInterestEntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfVariableInterestEntitiesTable", "presentation": [ "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Variable Interest Entities [Table]", "label": "Schedule of Variable Interest Entities [Table]", "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide." } } }, "auth_ref": [ "r107", "r108", "r109", "r110", "r111", "r624", "r625", "r628", "r629", "r697", "r698", "r699" ] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r69" ] }, "us-gaap_SecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SecuredDebtMember", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivablePurchasingFacilityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Secured Debt", "label": "Secured Debt [Member]", "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r943" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r945" ] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentDomain", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresScheduleofExitandShutdownCostRelatedtoClosureDetails", "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails", "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails", "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r332", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r358", "r364", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r401", "r406", "r739", "r740", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r896", "r1033", "r1113" ] }, "us-gaap_SegmentExpenditureAdditionToLongLivedAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentExpenditureAdditionToLongLivedAssets", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capital expenditures", "label": "Segment, Expenditure, Addition to Long-Lived Assets", "documentation": "Amount of expenditure for addition to long-lived assets included in determination of segment assets by chief operating decision maker (CODM) or otherwise regularly provided to CODM. Excludes expenditure for addition to financial instrument, long-term customer relationship of financial institution, mortgage and other servicing rights, deferred policy acquisition cost, and deferred tax assets." } } }, "auth_ref": [ "r346", "r894" ] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresScheduleofExitandShutdownCostRelatedtoClosureDetails", "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Domain]", "label": "Geographical [Domain]" } } }, "auth_ref": [ "r362", "r363", "r784", "r787", "r789", "r848", "r850", "r853", "r864", "r874", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r882", "r886", "r907", "r932", "r1088", "r1113" ] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.celanese.com/role/SegmentInformation" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Information", "label": "Segment Reporting Disclosure [Text Block]", "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments." } } }, "auth_ref": [ "r331", "r332", "r333", "r334", "r335", "r347", "r352", "r356", "r357", "r358", "r359", "r360", "r361", "r364" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting Information [Line Items]", "label": "Segment Reporting Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Selling, general and administrative expenses", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r179" ] }, "us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeniorLongtermNotesCurrentAndNoncurrentAbstract", "lang": { "en-us": { "role": { "terseLabel": "Senior Notes [Abstract]", "label": "Senior Notes [Abstract]" } } }, "auth_ref": [] }, "ce_SeniorUnsecuredNotesDue2024Member": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "SeniorUnsecuredNotesDue2024Member", "presentation": [ "http://www.celanese.com/role/DebtScheduleofCashTenderOfferDetails", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior unsecured notes due 2024, interest rate of 3.500%", "label": "Senior Unsecured Notes Due 2024 [Member]", "documentation": "USD Senior Unsecured Notes Due May 8, 2024" } } }, "auth_ref": [] }, "ce_SeniorUnsecuredTermLoanDue2027Member": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "SeniorUnsecuredTermLoanDue2027Member", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior unsecured term loan due 2027(1)", "label": "Senior Unsecured Term Loan Due 2027 [Member]", "documentation": "Senior Unsecured Term Loan Due 2027" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r13" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Award Types", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r568", "r569", "r570", "r571", "r572", "r573", "r574", "r575", "r576", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r588", "r589", "r590", "r591", "r592", "r593" ] }, "us-gaap_SharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesIssued", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance as of the beginning of the period (in shares)", "periodEndLabel": "Balance as of the end of the period (in shares)", "label": "Shares, Issued", "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury." } } }, "auth_ref": [ "r19" ] }, "us-gaap_ShortTermDebtLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtLineItems", "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term Debt [Line Items]", "label": "Short-Term Debt [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtMember", "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Loans Payable", "label": "Short-Term Debt [Member]", "documentation": "Debt arrangement having an initial term within one year or the normal operating cycle, if longer." } } }, "auth_ref": [] }, "us-gaap_ShortTermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeAxis", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term Debt, Type [Axis]", "label": "Short-Term Debt, Type [Axis]", "documentation": "Information by type of short-term debt arrangement." } } }, "auth_ref": [ "r39" ] }, "us-gaap_ShortTermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtTypeDomain", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Short-term Debt, Type [Domain]", "label": "Short-Term Debt, Type [Domain]", "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing." } } }, "auth_ref": [ "r36" ] }, "us-gaap_ShortTermDebtWeightedAverageInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermDebtWeightedAverageInterestRate", "presentation": [ "http://www.celanese.com/role/DebtScheduleofShorttermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average interest rate, short-term borrowings", "label": "Short-Term Debt, Weighted Average Interest Rate, at Point in Time", "documentation": "Weighted average interest rate of short-term debt outstanding calculated at point in time." } } }, "auth_ref": [ "r37" ] }, "ce_SingaporeFactoringAgreementsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "SingaporeFactoringAgreementsMember", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Singapore Factoring Agreements", "label": "Singapore Factoring Agreements [Member]", "documentation": "Singapore Factoring Agreements" } } }, "auth_ref": [] }, "us-gaap_SiteContingencyLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SiteContingencyLineItems", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Site Contingency [Line Items]", "label": "Site Contingency [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r414", "r897", "r898", "r1023", "r1024", "r1025", "r1073", "r1083" ] }, "us-gaap_SiteContingencyTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SiteContingencyTable", "presentation": [ "http://www.celanese.com/role/EnvironmentalUSSuperfundSitesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Site Contingency [Table]", "label": "Site Contingency [Table]", "documentation": "Information and financial data about the reasonably possible loss or the recognized and additional reasonably possible loss from an environmental remediation obligation." } } }, "auth_ref": [ "r414", "r897", "r898", "r1023", "r1024", "r1025", "r1073", "r1083" ] }, "srt_SouthAmericaMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SouthAmericaMember", "presentation": [ "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "South America", "label": "South America [Member]" } } }, "auth_ref": [ "r1120", "r1121", "r1122", "r1123" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresScheduleofExitandShutdownCostRelatedtoClosureDetails", "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofGoodwillDetails", "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails", "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails", "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails", "http://www.celanese.com/role/SegmentInformationScheduleofBusinessSegmentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r246", "r332", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343", "r344", "r345", "r346", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r355", "r356", "r358", "r364", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r396", "r401", "r406", "r739", "r740", "r741", "r742", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r896", "r1033", "r1113" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r242", "r256", "r257", "r258", "r290", "r315", "r319", "r321", "r323", "r329", "r330", "r372", "r418", "r421", "r422", "r423", "r429", "r430", "r461", "r462", "r465", "r468", "r475", "r664", "r762", "r763", "r764", "r765", "r770", "r771", "r772", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r801", "r823", "r842", "r865", "r866", "r867", "r868", "r869", "r1019", "r1049", "r1057" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofAdjustmentstoAccumulatedOtherComprehensiveIncomeLossNetDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r19", "r47", "r243", "r276", "r277", "r278", "r293", "r294", "r295", "r299", "r307", "r309", "r328", "r373", "r376", "r476", "r594", "r595", "r596", "r607", "r608", "r639", "r640", "r641", "r642", "r643", "r645", "r649", "r674", "r676", "r677", "r678", "r679", "r681", "r690", "r751", "r752", "r753", "r770", "r842" ] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresScheduleofExitandShutdownCostRelatedtoClosureDetails", "http://www.celanese.com/role/RevenueRecognitionDisaggregationofnetsalesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Geographical [Axis]", "label": "Geographical [Axis]" } } }, "auth_ref": [ "r362", "r363", "r784", "r787", "r789", "r848", "r850", "r853", "r864", "r872", "r874", "r875", "r876", "r877", "r878", "r879", "r880", "r881", "r882", "r886", "r907", "r932", "r1088", "r1113" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Line Items]", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r293", "r294", "r295", "r328", "r701", "r761", "r781", "r793", "r794", "r795", "r796", "r797", "r798", "r801", "r804", "r805", "r806", "r807", "r808", "r809", "r810", "r811", "r812", "r815", "r816", "r817", "r818", "r819", "r821", "r824", "r825", "r827", "r828", "r829", "r830", "r831", "r832", "r833", "r834", "r835", "r836", "r837", "r838", "r842", "r933" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Cash Flows [Abstract]", "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Financial Position [Abstract]", "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Comprehensive Income [Abstract]", "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "terseLabel": "Statement of Stockholders' Equity [Abstract]", "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementsofComprehensiveIncomeLoss" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r293", "r294", "r295", "r328", "r701", "r761", "r781", "r793", "r794", "r795", "r796", "r797", "r798", "r801", "r804", "r805", "r806", "r807", "r808", "r809", "r810", "r811", "r812", "r815", "r816", "r817", "r818", "r819", "r821", "r824", "r825", "r827", "r828", "r829", "r830", "r831", "r832", "r833", "r834", "r835", "r836", "r837", "r838", "r842", "r933" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r952", "r963", "r973", "r998" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Stock awards (in shares)", "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures", "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited." } } }, "auth_ref": [ "r19", "r157", "r158", "r202" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of treasury stock under stock plans (in shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r19", "r157", "r158", "r202" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Stock option exercises, shares", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r19", "r157", "r158", "r202", "r576" ] }, "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Stock awards", "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures", "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited." } } }, "auth_ref": [ "r19", "r202" ] }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Issuance of treasury stock under stock plans", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r97", "r157", "r158", "r202" ] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Stock option exercises", "label": "Stock Issued During Period, Value, Stock Options Exercised", "documentation": "Value of stock issued as a result of the exercise of stock options." } } }, "auth_ref": [ "r19", "r47", "r202" ] }, "ce_StockRepurchaseProgramAuthorizedAmountInPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "StockRepurchaseProgramAuthorizedAmountInPeriod", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Board of Directors repurchase authorizations during the period (in $ millions)", "label": "StockRepurchaseProgramAuthorizedAmountInPeriod", "documentation": "Amount of stock repurchase plan authorized in the period." } } }, "auth_ref": [] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total Celanese Corporation shareholders' equity", "periodStartLabel": "Balance as of the beginning of the period", "periodEndLabel": "Balance as of the end of the period", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r158", "r161", "r162", "r191", "r803", "r820", "r843", "r844", "r928", "r942", "r1051", "r1061", "r1096", "r1118" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "totalLabel": "Total equity", "periodEndLabel": "Balance as of the end of the period", "label": "Equity, Including Portion Attributable to Noncontrolling Interest", "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity." } } }, "auth_ref": [ "r103", "r104", "r112", "r243", "r244", "r277", "r293", "r294", "r295", "r299", "r307", "r373", "r376", "r476", "r594", "r595", "r596", "r607", "r608", "r639", "r640", "r641", "r642", "r643", "r645", "r649", "r674", "r676", "r681", "r690", "r752", "r753", "r768", "r803", "r820", "r843", "r844", "r870", "r941", "r1051", "r1061", "r1096", "r1118" ] }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Shareholders' Equity", "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteAbstract", "lang": { "en-us": { "role": { "terseLabel": "Stockholders' Equity Note [Abstract]", "label": "Stockholders' Equity Note [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://www.celanese.com/role/StockholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Stockholders' Equity", "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r199", "r289", "r460", "r462", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r474", "r476", "r647", "r845", "r846", "r871" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r682", "r692" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Axis]", "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r682", "r692" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails", "http://www.celanese.com/role/StockholdersEquityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Domain]", "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r682", "r692" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r992" ] }, "ce_TermLoanFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "TermLoanFacilityMember", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan Facility", "label": "Term Loan Facility [Member]", "documentation": "Term Loan Facility" } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r984" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r991" ] }, "ce_TradeReceivablesPledgedAsCollateral": { "xbrltype": "monetaryItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "TradeReceivablesPledgedAsCollateral", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivablePurchasingFacilityNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trade Receivables Pledged As Collateral", "label": "Trade Receivables Pledged As Collateral", "documentation": "The amount of trade receivables pledged as collateral." } } }, "auth_ref": [] }, "us-gaap_TrademarksAndTradeNamesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TrademarksAndTradeNamesMember", "presentation": [ "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofFiniteLivedIntangibleAssetsDetails", "http://www.celanese.com/role/GoodwillandIntangibleAssetsNetScheduleofIndefiniteLivedIntangibleAssetsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Trademarks and Trade Names", "label": "Trademarks and Trade Names [Member]", "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof." } } }, "auth_ref": [ "r100" ] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r1011" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r1013" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.celanese.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/DebtAccountsReceivablePurchasingFacilityNarrativeDetails", "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transfer of financial assets accounted for as sales, amount derecognized", "label": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized", "documentation": "Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition." } } }, "auth_ref": [ "r27" ] }, "ce_TransferOfFinancialAssetsTreatedAsSalesNonRecourseOrLimitedRecourseBasisAccountsReceivablePercentage": { "xbrltype": "percentItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "TransferOfFinancialAssetsTreatedAsSalesNonRecourseOrLimitedRecourseBasisAccountsReceivablePercentage", "presentation": [ "http://www.celanese.com/role/DebtFactoringandDiscountingAgreementsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transfer of financial assets accounted for as sales, non-recourse basis, account receivable percentage", "label": "Transfer Of Financial Assets Treated As Sales, Non-recourse or Limited recourse Basis, Accounts Receivable Percentage", "documentation": "The percentage of accounts receivable, treated as Sales, transferred on a non-recourse or limited recourse basis, as part of a factoring or discounting agreement." } } }, "auth_ref": [] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r1014" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r1015" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r1013" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r1013" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r1016" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r1014" ] }, "us-gaap_TreasuryStockAcquiredAverageCostPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockAcquiredAverageCostPerShare", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Average purchase price (in dollar per share)", "label": "Shares Acquired, Average Cost Per Share", "documentation": "Total cost of shares repurchased divided by the total number of shares repurchased." } } }, "auth_ref": [ "r87" ] }, "us-gaap_TreasuryStockCommonMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonMember", "presentation": [ "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury Stock, Common", "label": "Treasury Stock, Common [Member]", "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r87" ] }, "us-gaap_TreasuryStockCommonShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockCommonShares", "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Treasury Stock, Common, Shares", "label": "Treasury Stock, Common, Shares", "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury." } } }, "auth_ref": [ "r87" ] }, "us-gaap_TreasuryStockSharesAcquired": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockSharesAcquired", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofTreasuryStockDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Shares repurchased (in shares)", "label": "Treasury Stock, Shares, Acquired", "documentation": "Number of shares that have been repurchased during the period and are being held in treasury." } } }, "auth_ref": [ "r19", "r158", "r202" ] }, "us-gaap_TreasuryStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValue", "crdr": "debit", "calculation": { "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.celanese.com/role/UnauditedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "negatedLabel": "Treasury stock, at cost (2024: 61,570,314 shares; 2023: 61,570,314 shares)", "label": "Treasury Stock, Value", "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury." } } }, "auth_ref": [ "r46", "r87", "r90" ] }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TreasuryStockValueAcquiredCostMethod", "crdr": "debit", "presentation": [ "http://www.celanese.com/role/StockholdersEquityScheduleofTreasuryStockDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares repurchased (in $ millions)", "label": "Treasury Stock, Value, Acquired, Cost Method", "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method." } } }, "auth_ref": [ "r19", "r87", "r202" ] }, "us-gaap_TypeOfRestructuringDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TypeOfRestructuringDomain", "presentation": [ "http://www.celanese.com/role/OtherChargesGainsNetScheduleofRestructuringReservebyTypeofCostDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Type of Restructuring [Domain]", "label": "Type of Restructuring [Domain]", "documentation": "Identification of the types of restructuring costs." } } }, "auth_ref": [ "r398", "r399", "r404", "r405" ] }, "ce_USDSeniorUnsecuredNotesDue2024Member": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "USDSeniorUnsecuredNotesDue2024Member", "presentation": [ "http://www.celanese.com/role/DebtScheduleofCashTenderOfferDetails", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior unsecured notes due 2024, interest rate of 5.900%", "label": "USD Senior Unsecured Notes Due 2024 [Member]", "documentation": "USD 2 Billion 5.900% Senior Unsecured Notes Due 2024" } } }, "auth_ref": [] }, "ce_USDSeniorUnsecuredNotesDue2025Member": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "USDSeniorUnsecuredNotesDue2025Member", "presentation": [ "http://www.celanese.com/role/DebtScheduleofCashTenderOfferDetails", "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior unsecured notes due 2025, interest rate of 6.050%", "label": "USD Senior Unsecured Notes Due 2025 [Member]", "documentation": "USD 1.75 Billion 6.050% Senior Unsecured Notes Due 2025" } } }, "auth_ref": [] }, "ce_USDSeniorUnsecuredNotesDue2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "USDSeniorUnsecuredNotesDue2026Member", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior unsecured notes due 2026, interest rate of 1.400%", "label": "USD Senior Unsecured Notes Due 2026 [Member]", "documentation": "USD Senior Unsecured Notes Due 2026 [Member]" } } }, "auth_ref": [] }, "ce_USDSeniorUnsecuredNotesDue2027Member": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "USDSeniorUnsecuredNotesDue2027Member", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior unsecured notes due 2027, interest rate of 6.165%", "label": "USD Senior Unsecured Notes Due 2027 [Member]", "documentation": "USD 2 Billion 6.165% Senior Unsecured Notes Due 2027" } } }, "auth_ref": [] }, "ce_USDSeniorUnsecuredNotesDue2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "USDSeniorUnsecuredNotesDue2028Member", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtScheduleofSeniorUnsecuredNotesOfferingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior unsecured notes due 2028, interest rate of 6.350%", "label": "USD Senior Unsecured Notes Due 2028 [Member]", "documentation": "USD 1 Billion 6.350% Senior Unsecured Notes Due 2028" } } }, "auth_ref": [] }, "ce_USDSeniorUnsecuredNotesDue2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "USDSeniorUnsecuredNotesDue2029Member", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior unsecured notes due 2029, interest rate of 6.330%", "label": "USD Senior Unsecured Notes Due 2029 [Member]", "documentation": "USD 750 Million 6.330% Senior Unsecured Notes Due 2029" } } }, "auth_ref": [] }, "ce_USDSeniorUnsecuredNotesDue2030Member": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "USDSeniorUnsecuredNotesDue2030Member", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtScheduleofSeniorUnsecuredNotesOfferingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior unsecured notes due 2030, interest rate of 6.550%", "label": "USD Senior Unsecured Notes Due 2030 [Member]", "documentation": "USD 1 Billion 6.550% Senior Unsecured Notes Due 2030" } } }, "auth_ref": [] }, "ce_USDSeniorUnsecuredNotesDue2032Member": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "USDSeniorUnsecuredNotesDue2032Member", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DerivativeFinancialInstrumentsScheduleofChangesinFairValueofDerivativesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior unsecured notes due 2032, interest rate of 6.379%", "label": "USD Senior Unsecured Notes Due 2032 [Member]", "documentation": "USD 1 Billion 6.379% Senior Unsecured Notes Due 2032" } } }, "auth_ref": [] }, "ce_USDSeniorUnsecuredNotesDue2033Member": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "USDSeniorUnsecuredNotesDue2033Member", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails", "http://www.celanese.com/role/DebtScheduleofSeniorUnsecuredNotesOfferingDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior unsecured notes due 2033, interest rate of 6.700%", "label": "USD Senior Unsecured Notes Due 2033 [Member]", "documentation": "USD 1 Billion 6.700% Senior Unsecured Notes Due 2033" } } }, "auth_ref": [] }, "ce_UentropGermanyMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "UentropGermanyMember", "presentation": [ "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresNarrativeDetails", "http://www.celanese.com/role/AcquisitionsDispositionsandPlantClosuresPlantClosuresScheduleofExitandShutdownCostRelatedtoClosureDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Uentrop, Germany", "label": "Uentrop, Germany [Member]", "documentation": "Polyamide 66 and High-Performance Nylon polymerization units at the Company's facility in Uentrop, Germany." } } }, "auth_ref": [] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2023", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r1010" ] }, "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesPurchaseObligationsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year One", "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year One", "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r408" ] }, "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnFourthAnniversary", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesPurchaseObligationsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Four", "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Four", "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r408" ] }, "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnSecondAnniversary", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesPurchaseObligationsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two", "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Two", "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r408" ] }, "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecordedUnconditionalPurchaseObligationBalanceOnThirdAnniversary", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesPurchaseObligationsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three", "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Year Three", "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r408" ] }, "us-gaap_UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesPurchaseObligationsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecorded unconditional purchase obligations", "label": "Unrecorded Unconditional Purchase Obligation", "documentation": "Amount of the unrecorded obligation to transfer funds in the future for fixed or minimum amounts or quantities of goods or services at fixed or minimum prices (for example, as in take-or-pay contracts or throughput contracts)." } } }, "auth_ref": [ "r408" ] }, "us-gaap_UnrecordedUnconditionalPurchaseObligationDueInRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnrecordedUnconditionalPurchaseObligationDueInRemainderOfFiscalYear", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/CommitmentsandContingenciesPurchaseObligationsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unrecorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year", "label": "Unrecorded Unconditional Purchase Obligation, to be Paid, Remainder of Fiscal Year", "documentation": "Amount of fixed and determinable portion of unrecorded unconditional purchase obligation to be paid in remainder of current fiscal year." } } }, "auth_ref": [] }, "us-gaap_UnsecuredDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UnsecuredDebt", "crdr": "credit", "presentation": [ "http://www.celanese.com/role/DebtScheduleofLongtermDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Senior unsecured debt", "label": "Unsecured Debt", "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer)." } } }, "auth_ref": [ "r33", "r219", "r1111" ] }, "ce_UsSuperfundSites": { "xbrltype": "monetaryItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "UsSuperfundSites", "crdr": "credit", "calculation": { "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails": { "parentTag": "us-gaap_AccrualForEnvironmentalLossContingencies", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.celanese.com/role/EnvironmentalScheduleofEnvironmentalRemediationReservesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. Superfund sites", "label": "US Superfund sites", "documentation": "US Superfund sites." } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://www.celanese.com/role/RecentAccountingPronouncementsPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Estimates and Assumptions", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r57", "r58", "r59", "r229", "r230", "r231", "r232" ] }, "ce_VariableInterbankInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://www.celanese.com/20240331", "localname": "VariableInterbankInterestRateMember", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Interbank Interest Rate", "label": "Variable Interbank Interest Rate [Member]", "documentation": "Certain interbank rates at current Company credit ratings" } } }, "auth_ref": [] }, "us-gaap_VariableInterestEntityLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableInterestEntityLineItems", "presentation": [ "http://www.celanese.com/role/DescriptionoftheCompanyandBasisofPresentationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Interest Entity [Line Items]", "label": "Variable Interest Entity [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r624", "r625", "r628", "r629", "r697", "r698", "r699" ] }, "us-gaap_VariableRateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateAxis", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Axis]", "label": "Variable Rate [Axis]", "documentation": "Information by type of variable rate." } } }, "auth_ref": [] }, "us-gaap_VariableRateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VariableRateDomain", "presentation": [ "http://www.celanese.com/role/DebtSeniorCreditFacilitiesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Variable Rate [Domain]", "label": "Variable Rate [Domain]", "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average shares\u00a0- diluted (in shares)", "totalLabel": "Weighted average shares\u00a0- diluted", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r314", "r323" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.celanese.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails", "http://www.celanese.com/role/UnauditedInterimConsolidatedStatementofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average shares\u00a0- basic (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r313", "r323" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "SubTopic": "20", "Topic": "940", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "16", "SubTopic": "10", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479405/805-10-25-16" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a),(b),(c)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i),(j),(k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(i-k)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-12" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(g)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480463/815-10-45-5" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "20", "Topic": "715", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b),(d)", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-3" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "e", "SubTopic": "470", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "SubTopic": "10", "Topic": "280", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-4" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "860", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(c)(2)", "SubTopic": "20", "Topic": "860", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-8" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "9", "SubTopic": "20", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-9" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.22)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29,30)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "420", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481573/470-10-45-10" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "480", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(CFRR 211.02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-2" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-3" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "30", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-3" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-4" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "715", "SubTopic": "20", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "31", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-31" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-18" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-9" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4I", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a),(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "4D", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "10", "Section": "55", "Paragraph": "182", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "25", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3" }, "r141": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "835", "SubTopic": "30", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8" }, "r142": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r143": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3" }, "r144": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r145": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//205/tableOfContent" }, "r146": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3" }, "r147": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3A" }, "r148": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-3B" }, "r149": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-4" }, "r150": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r151": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r152": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B" }, "r153": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C" }, "r154": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r155": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r156": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r157": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r158": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r159": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r160": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r161": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r162": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r163": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r164": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r165": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r166": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r167": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r168": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-7" }, "r169": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "45", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1" }, "r170": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r171": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-1" }, "r172": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r173": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r174": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r175": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r176": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r177": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.13)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r178": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r179": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r180": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r181": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r182": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r183": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r184": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483613/220-20-50-1" }, "r185": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r186": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r187": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r188": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r189": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r190": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r191": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r192": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r193": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r194": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r195": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r196": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r197": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r198": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//470/tableOfContent" }, "r199": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r200": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6" }, "r201": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7" }, "r202": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r203": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3" }, "r204": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "715", "SubTopic": "20", "Subparagraph": "(h)", "Name": "Accounting Standards Codification", "Paragraph": "1", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r205": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Paragraph": "12", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r206": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r207": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r208": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r209": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r210": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r211": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 5.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479836/810-10-S99-5" }, "r212": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//815/tableOfContent" }, "r213": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r214": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r215": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r216": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r217": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r218": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r219": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r220": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r221": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r222": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r223": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(13)(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r224": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r225": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r226": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r227": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(1)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "30", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-2" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(1)", "SubTopic": "20", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(d)(2)", "SubTopic": "20", "Topic": "310", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "250", "Publisher": "FASB", "URI": "https://asc.fasb.org//250/tableOfContent" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-4" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(dd)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(210.5-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 11.M.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-6" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//260/tableOfContent" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-22" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-23" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-28A" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//280/tableOfContent" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-21" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-25" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "26", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-26" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "34", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-34" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "321", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479536/321-10-50-3" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//410-30/tableOfContent" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.P.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-1" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-3" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1E", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1F", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-3" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//715/tableOfContent" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-2" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480535/715-20-45-3A" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(10)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(8)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(j)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(k)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(o)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(p)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(q)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(r)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-2" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(6)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-8" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480126/715-20-S99-2" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "60", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480266/715-60-50-3" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480606/715-80-35-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-9" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r567": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480454/718-10-45-1" }, "r568": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r569": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r570": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r571": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r572": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r573": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r574": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r575": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r576": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r577": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r578": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r579": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r580": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r581": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r582": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r583": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r584": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r585": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r586": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r587": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r588": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r589": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r590": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r591": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r592": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r593": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r594": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r595": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r596": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r597": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r598": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1" }, "r599": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//740/tableOfContent" }, "r600": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-4" }, "r601": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6" }, "r602": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10" }, "r603": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12" }, "r604": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14" }, "r605": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17" }, "r606": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21" }, "r607": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r608": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r609": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r610": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r611": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r612": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r613": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r614": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1" }, "r616": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 11.C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2" }, "r617": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-11" }, "r618": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r619": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2" }, "r620": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482551/740-270-45-3" }, "r621": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "270", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1" }, "r622": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2" }, "r623": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19" }, "r624": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r625": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r626": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r627": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r628": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r629": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r630": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r631": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r632": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r633": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4C", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C" }, "r634": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4CCC" }, "r635": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4CCC", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4CCC" }, "r636": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E" }, "r637": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5C", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C" }, "r638": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480627/815-20-45-3" }, "r639": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r640": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r641": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r642": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r643": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r644": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r645": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r646": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5" }, "r647": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r648": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r649": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r650": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r651": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r652": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r653": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r654": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2" }, "r655": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r656": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r657": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r658": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r659": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r660": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r661": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A" }, "r662": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-1A" }, "r663": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10" }, "r664": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r665": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r666": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r667": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6" }, "r668": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481839/830-10-45-17" }, "r669": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482014/830-20-35-1" }, "r670": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1" }, "r671": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-5" }, "r672": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1" }, "r673": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "230", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r674": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r675": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r676": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r677": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r678": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r679": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r680": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "21", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-21" }, "r681": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r682": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r683": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1" }, "r684": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "835", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1" }, "r685": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r686": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5" }, "r687": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r688": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r689": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6" }, "r690": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r691": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r692": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r693": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r694": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r695": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r696": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r697": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r698": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r699": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A" }, "r700": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r701": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r702": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r703": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r704": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r705": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2" }, "r706": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r707": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r708": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r709": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r710": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r711": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r712": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r713": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r714": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r715": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r716": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r717": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r718": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r719": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r720": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r721": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r722": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r723": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r724": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r725": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r726": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r727": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r728": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r729": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r730": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r731": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r732": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r733": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r734": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r735": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r736": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r737": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r738": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r739": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r740": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r741": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r742": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r743": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r744": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r745": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r746": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r747": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r748": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column J))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r749": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-16(Column K))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-1" }, "r750": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r751": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r752": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r753": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r754": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r755": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r756": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r757": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r758": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r759": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-1" }, "r760": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-2" }, "r761": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r762": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r763": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r764": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r765": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r766": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r767": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13" }, "r768": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r769": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3" }, "r770": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r771": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r772": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r773": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r774": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r775": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r776": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r777": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r778": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r779": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r780": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r781": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r782": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r783": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r784": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r785": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r786": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12" }, "r787": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r788": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r789": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r790": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r791": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r792": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r793": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r794": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r795": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r796": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r797": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r798": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r799": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r800": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r801": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r802": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r803": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r804": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r805": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r806": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r807": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r808": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r809": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r810": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r811": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r812": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r813": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(7)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r814": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r815": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r816": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r817": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r818": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r819": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r820": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r821": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r822": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r823": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r824": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r825": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r826": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r827": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r828": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r829": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r830": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r831": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r832": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r833": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r834": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r835": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r836": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r837": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r838": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r839": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r840": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r841": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r842": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r843": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r844": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r845": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r846": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r847": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r848": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r849": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r850": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r851": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r852": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r853": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r854": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r855": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r856": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SX 210.12-13(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5" }, "r857": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5A", "Subparagraph": "(SX 210.12-13A(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A" }, "r858": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r859": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5B", "Subparagraph": "(SX 210.12-13B(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B" }, "r860": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r861": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r862": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r863": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r864": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r865": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r866": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r867": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r868": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r869": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r870": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3" }, "r871": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r872": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r873": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r874": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r875": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r876": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r877": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r878": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r879": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r880": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r881": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r882": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r883": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r884": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r885": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(1)", "SubTopic": "10", "Topic": "815", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r886": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r887": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r888": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r889": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r890": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-20" }, "r891": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22" }, "r892": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r893": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r894": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "48", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-48" }, "r895": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r896": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r897": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481899/410-30-55-11" }, "r898": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "16", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481899/410-30-55-16" }, "r899": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481899/410-30-55-17" }, "r900": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r901": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r902": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r903": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69E", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E" }, "r904": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F" }, "r905": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r906": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r907": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r908": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r909": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r910": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r911": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r912": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r913": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r914": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r915": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r916": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18" }, "r917": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r918": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r919": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r920": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r921": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r922": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r923": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r924": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4J", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J" }, "r925": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "4K", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K" }, "r926": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r927": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4D", "Subparagraph": "(a)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D" }, "r928": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r929": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r930": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r931": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r932": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r933": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r934": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r935": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r936": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r937": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r938": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5C", "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C" }, "r939": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r940": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r941": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r942": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r943": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r944": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r945": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r946": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r947": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "16", "Subsection": "J", "Paragraph": "a" }, "r948": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1" }, "r949": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i" }, "r950": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r951": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r952": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r953": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r954": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r955": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii" }, "r956": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "1", "Subparagraph": "iii" }, "r957": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Section": "6", "Subsection": "F", "Paragraph": "2" }, "r958": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Subsection": "F", "Paragraph": "1", "Subparagraph": "ii", "Section": "6" }, "r959": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a" }, "r960": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1" }, "r961": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r962": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r963": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r964": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r965": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r966": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "2" }, "r967": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "a", "Subparagraph": "3" }, "r968": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Section": "19", "Paragraph": "b" }, "r969": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a" }, "r970": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1" }, "r971": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "i" }, "r972": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "ii" }, "r973": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iii" }, "r974": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "iv" }, "r975": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "1", "Sentence": "v" }, "r976": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "2" }, "r977": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "a", "Subparagraph": "3" }, "r978": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-CSR", "Section": "18", "Paragraph": "b" }, "r979": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r980": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v" }, "r981": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "1" }, "r982": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "ii" }, "r983": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iii" }, "r984": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "iv" }, "r985": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "2", "Subparagraph": "vi" }, "r986": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "3" }, "r987": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "4" }, "r988": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "i" }, "r989": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "ii" }, "r990": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iii" }, "r991": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "5", "Subparagraph": "iv" }, "r992": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6" }, "r993": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "v", "Paragraph": "6", "Subparagraph": "i" }, "r994": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1" }, "r995": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i" }, "r996": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "A" }, "r997": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "B" }, "r998": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "C" }, "r999": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "D" }, "r1000": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "i", "Sentence": "E" }, "r1001": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "ii" }, "r1002": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "1", "Subparagraph": "iii" }, "r1003": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "w", "Paragraph": "2" }, "r1004": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "1" }, "r1005": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2" }, "r1006": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "A" }, "r1007": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "C" }, "r1008": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "D" }, "r1009": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "E" }, "r1010": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "402", "Subsection": "x", "Paragraph": "2", "Subparagraph": "ii", "Sentence": "F" }, "r1011": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a" }, "r1012": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "1" }, "r1013": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "A" }, "r1014": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "B" }, "r1015": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "C" }, "r1016": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "a", "Paragraph": "2", "Subparagraph": "D" }, "r1017": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-K", "Number": "229", "Section": "408", "Subsection": "b", "Paragraph": "1" }, "r1018": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r1019": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r1020": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r1021": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r1022": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r1023": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r1024": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r1025": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r1026": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(d)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r1027": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(d)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r1028": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-11" }, "r1029": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-14" }, "r1030": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-17" }, "r1031": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "12", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r1032": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r1033": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r1034": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1035": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1036": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1037": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1038": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r1039": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r1040": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r1041": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r1042": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r1043": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r1044": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r1045": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15" }, "r1046": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17" }, "r1047": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r1048": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-9" }, "r1049": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1050": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1051": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1052": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r1053": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-04(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r1054": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r1055": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r1056": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r1057": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r1058": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r1059": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-15" }, "r1060": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r1061": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r1062": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1063": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1064": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1065": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1066": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1067": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1068": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1069": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1070": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r1071": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r1072": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r1073": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r1074": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-7" }, "r1075": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482047/420-10-45-3" }, "r1076": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r1077": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2" }, "r1078": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r1079": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-1" }, "r1080": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r1081": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r1082": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r1083": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r1084": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1085": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r1086": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r1087": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r1088": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r1089": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r1090": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r1091": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "730", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483041/730-20-50-1" }, "r1092": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A" }, "r1093": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B" }, "r1094": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A" }, "r1095": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r1096": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r1097": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r1098": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r1099": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1100": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r1101": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1102": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1103": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r1104": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1105": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1106": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r1107": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r1108": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r1109": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1110": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1111": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r1112": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r1113": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r1114": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r1115": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r1116": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r1117": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r1118": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1119": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r1120": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r1121": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r1122": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r1123": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 113 0001306830-24-000098-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001306830-24-000098-xbrl.zip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

7[P'L%^6(ZQ6*=0 M(<[\W_=O.?0ECRX8*?O_MR:A!8M>H16:M4I);Q0K94WED*?[NI#19%$-/GI M3&M";*7S2@W6R49Y&((6@/<3QU3^;4T4S*WLYT&*HQ,^) <*HKSE4;("#1U, M<$U[CXF/^Z[ W;E@)QY'KO,NG,=&6>6R7@1&KH7S"@>TW1=YBW#E-U\)J$TG M.&?%89.^@J@%>R^!UE# &20[@+>:VLD;/O$36G1]4CPV-=P]J$RFGC_%D"QP M%;B"V5-5^S#XB!*'*PR;>BF7KJO5C$J;(!+3LBD# M@U'5U>V/BCQC4;R\+>'%MGK(OA6$=84=8HR4MDU\7T 7]]#)>X3IE-[;>.#: M'WP1O?L#IQ[:H5FRB#&_\VJ,B/,,'SC*WT86?/(TUUQQ,:/XRUM;S;"V;(8C M=?ZF:@,F,7,S7 ES]D RUL7O2ID03WDA]I0J_\E2U2JN 2O^Z$A)# %H&4E= M*'1S0K),K:30"MIF$AEFM-]GS2A\NYHPPUY[?? B<+Q_=[V?(2;G@ITD$73F M9-83"76]T%2OM4KIO\!);E.5M9"XGD67L=5:^KM5J\;*\/3E^.>2+E65L!,9DN=J29$HGS+H4YNUD MKB02YG*AJ5VK6B5>F&N7B]+*;F&N1,(LJ912EJM2EK>3N9I(EB%6*5U7-\ER M_7)16MTMR_5(EB654LIR0\KR=C+7DLBR#K%*Y5K7-SC9CQMH^LI&PX1(_4!JE\ DF>?.O]UVI#\M%VE//@P>'NSY0V ,2 M3/TY1"$._#OUWT,Q>E4$R"/O<&'HFF^#W&L(6>([I$&T+.5R0I'RYR2+\14Q M= +*!8C$V H"D"1J@VAXKH.VP7Y3L-?FF\(.K"0&*_:Y)0$)-Z&\TQ:+9RR7 M,SQ-X^ZO8#3[^AI< M \I&9M*AY;"=CZR,L+!I9 6E$/OAYA$4F)DO;!A! 7>VH!**G!=M4-1F;LNR MKW+-->L/V>?GM8&"SZ[W%N,DLXL8;8WHHB5_N5)HWL5S)UZ3'22]?P-6H4+W M4XJM5BEG_>I:HEK?>,2<&(/-7HQ3#D/DYM2J:+ U%R4MQ?+9TK0(8Z!B@Q4(^[SQ(OQ& 63>*:OX,9.R]Q4_:Y_(!]C_33N M]"F?^-@_5O!'U+9G$%(^ #"8SQ[N#4_@07^,6 ,1[X&J%0>PI_C6-XHOEQ%F MA6_48)H\W%J##':G 9-6)K98J.S/V.XM[\I9K7..JIM#>L^+GJ^PV0#<_)U$ MFEX/.RVQI$R$DV\LD0)/FD*]2!]_U]KX'=0F6 M[SC>.[8O)[YKI3]Q0ZSG3MB[->L6K_GL$G[? #^^-.N18'74_J6-A]-@:S_2P_I5 M9&1N]]U'G:?IWW,LR4T_-N%Y;#WU0]7;#?\I*M^Z]ZW[=K=UIT"T_?#T/6J5 MN.82;"Y'/,!+/JB"=A=^CNX@GA E>XYE#Y3HA68WH&-%O=X+!))OI^?;MWE* M?G[B=9QSGPL38Y2WAS,\?MAVKMS5-[ R&[N=>)C1\XZ(H M.H 74H8U48D0U9"*/8?9Z2$"SX%%^D+/0-&%'KXJ].A9;DCH&92%'CVKO-5* M0L]!V^0U20>8@['LQTOI $N0; =)H] <1/L!]_*"L2S)HR/J^+@'"GO!CZGR MX<[U_8_GXA8WSL M;K#B5H%'+[I/WQ#>IV^([=,WA/;I&\+[] VA??K&&?CT M#>G3GY.[5I8^O03)-I!@.TICS:=?\>6_$ILX!E5Z(TK!GP]KT875<#CA[T*/ MGGA"#U]@]Q:'+[![B\,7U[W%T5^%BDID'Q>G(:Z/RR0 ?=Q;:E#53$SZ[C'&2(<3YN955F MUR5(MH$$^]#3/4O&V\0?*=]L]]>B9%Q8A8?S%SMNPAF$A3U"3T' MC/M.'/+,-.EOOG)K^<;4][$C+WJ.+8?8;[[%$CP+U0L:V0Q;@^,U3]2?VN_; M!DB=?#;XT%6IE85D7K4::65=:N73CV5/QOT%#T>P M8#F*E9^,">_8U:VG;] M*79G)P-W&F#WS)\T4)XL_Z=4O6<#@G+*?3!2@D_%O$:D>LM2]9Y^+'LR#AM@ M>\ ;IG8?/=>@)FI:J5?/AL/E'476LWG-7E[9'L>P#@XILL"LLX^[H,[%#5X$=6"Y]A?/A;3EE MM:04S%,QKS[3J"VI4D\_ECTYAYDLY1LQ M>3VO1\V"JUJ:#,JY?E$J^PC/OA MA(>W4@_+]HE-ES<*]Z@Q]:S HN(66[-)8KI.\!G\\-D)?%$@(>W>^4B@M'N" M,J]1DHOHPC+NE@X)JTWZ,<'#RJECN=Y[>R?UZSEP6NI749FGRY5R81GW'>Z! M>&)((8Q8JDF2>O5L."SUJJC,FQ5_5J1>/?U8]F3<0S"BGM)UAJXW9H^2&O5L M>"LUJIC,TTJS34Y5J5%//Y8]&==Y'5D#2^X5/2.6EO?:2UX501XOHN)1*U4* MS1Z0E@0R6#P?B<12J<8VB?P4D(%-9Y\O<20:2UF[KE5@O!/79YM+;SQJL^U. MGW]99C!B8UUE9F]+B%C+P77L:;+YE3+QGRRD&[N1&?0>@757-0+I<6*#A M&+5W5%OZB:.WS-\+"?S+4F%VT\A;B,PS+0X\2GX6R1 F>$/L7^3-QYK@9;H M4=[Q(2$)CR\_&D?RLWTLR>6G5FCV43S"8R_#+P/KV[9 ^T MZ(4888RX&XG6UGXG&0G$FJ%A H&>=E@*KUXKLRGF-!#VQ!LK #U@)!A:? ^2 M YE0W<($)F(G45+Q$V]W[EKWG5Y':3\\/3X\L5T)2NO^5NG]^-KKWG9;3]U. M;YT2?$_JQWWKQVVWW[E5NO?]SE/W.\SNOO=PU[UMX8>]/OSSO7/?[RD/WY2' MQTXX[633W#1/9@D75LP#?8&]4FTR\>G-[)?/IN5/;/)V8SELU.RFSZORB7KZ MG<_#WA=^':GP1N.Z7M%1BT=.*U_7RFKL5Z7K^,\W/4HM M78,@[/6HS9]7="V[095W/2K&!YVQQ7%!PY_DJAV9HIT->&,WBS52-? -H;W1 M_\Y4L!L)(A4PI]B_5?GNLM,7.MB(DUE+UL]2T=6KN5'9$FYPQ)X$]T>*)%*P M"FN:I??U9LT'.3$NXE+H%"%('5]42L_M!U ME/]4X+DV=F^Z4NBK07%&(^*%[4*!#:?A,N*3'39ADIKN;]Q7I%,?OF$8-U_)HZ5O"$0>W4-PLP>0=' MSSXPBFI!@3#8&A/;_[U0K!84AXPI7EE\)F1R\T1?J#.EWSQWS%HLP!/_9@6C M]M2'Z5&O\VK84R1/R_"$BZ!0BCU&MPXTW'1=%FLC2\!>@.1*,OM M8K0U+);QH(JKJJI^^;0Z[&882K[GW9X 91PK)>77'I;EW>MBU9&$5^/D\*HB MO""6XAI>XIMC$>Q!V_4#3-8=;A-B)BV(T'[(T"@@'1^&?[BNZ;<]%\N@ M?L^US7V%LX;"6:K4UH3S8V*YC,=A;FH_B1'H#HB2-,T7A$DH&;? M8NEJX3(3STK^#\_U?67BN4,K2./W)XX3!1'?#/4_(_$CHW",1#8*S4JEG)&[ MM4^TSKNK?\F(VF$/MB*J4BHTJWI6\>$)$"6@#1#0N^]1&SY\OE*>J4,]8K,4 M&#''EF/Y@14;)#?>^-DC+/*!%0:POHB#]1 MG[**'73 3?I";7>"!9?2^\YB/3:D+3A2MPO*;O:B*H6FOIZ+X<2)DCYW/DI[ M7Y#@#E>90+]H3SO]?QL'N5 M!X3H.H8[WA+SU@I--8VVEBXVCRC9H:WW1DD]/%Z;3Y0(J*X%=+&_N1[\Z6#) MYP@B,LKTM?+!=GW_X^%:6USO*4.E'9&V#;)('>.M[\&PPJ?^ 32^ PI_I4.X MAI6BK;Z$J8L/,_!71>E//%A0G'EVWF.2A0C=9_&7[_DNK)= M&9@9M<.8&F4W1DIU"*C54D;^%Q<5BQFY])>,K%U9FT3(*@.R*EG%@[)R\4S= M_NA0'_#]P9=7*/$ MJ!^PED Q(ES!BX0\%3!7B0KX!(Z!6W^+T,V2\5^_L;\LQ@4?TSP\5.7W\'+FHEP$4]39'D97OTIQ\@KU==0KG2W(+)>"6M_9IE'L+L MQ(RP,0H+EZ=3-[V2@0B'&-EIRQ)C1"LTZUQ#1$#U+&" <6N]6"9US$@]*T6% MSE8DYHG."PLZNUN+I]2Q#$".HK.W8*3,/48$5-H"^M3ACJU( M8\]7!&3Q?R8[MMS5ZH[-:8$*>-DRW2\*4M*EC#84#N^-F6IHUR>O MU.^\!AX!BEH.\=[P_#,?- &^U'-9WZLMP3=N]HWI?"Q,5T/9)_/4-4EY(Q37 MGS79=U,&(CN2^RP$ ;.D?)AX[HN%]0\?9\5*%Q:+9+M8'0EQY$I^#2D:(ZB- M0E-/TQ% !B \PB.1+4@ CWH)=R'P"@\!E?2E1!PRS#A1F %7A.<>/6+W1==I M!8%G#:;L--F^F]1_J^,2L"8[\4MP9AIA9 1.K=!LI.YY(6.+\XXM8FW5W$#A MUCB@2F2[J)G6=,E=K[M,U^T2M><:855EQ%YR.\7&9H\CXM.':? (\W#-=YF* MU8.?AM8K-8O_IIX;HSKT NB)NJ9JG\7=62OW;)]RS297'*_A%9?LTX=?TLCQ M.$!>K[J$NK7MFAK'?[V'<*YD9=UD(QR&Z M=H2?>:.K*@:Z!+0?6Y+$HB9%96QYNK1HK*#[]Q1TP'[!8DT&BY<#QUR"Q?V MN0; NHS^>%B94QNT8MVP#5*!6: MC=0;<>5"UWDO=*'R_S#3_A\5U/X*65I850)7<5:65O$P5+:V*H_3.]P2 -D7 MWMUA"]D--1/_3K# X=QQLT/A9X$;+:Y1'">X$5#IGYGKOZ;]V]0F#O6ITG:] MB1N&G3(^R"4^6)'N&,G5!=\7(4.$XX<(NS!5ABA!8$@):# $C!):8YA L!X9 M[&4;$M!D"4 Z0,1TI_BB#0CB6X3C)2@S5UD2\US4@=S4167U#;/PL(S_V*VC9Z>&382PO#CFU\KE690SYG$#7R!I%6 M:):NZUFUFY4NX%FDEF]E%OD(2G][0N^=Y.Y('B])=.9=<&3V^*39XZ2F(8,D M\DYK449K49*)8YDXWI X3I8GD!F_#(S)+&4SNYM);IS05C*-$V1:^;Q MCW" M2 RR*HLC!-X?*Z#M..,\LVG9TX":,M,L,\TRTRPSS3+3G'.F^3;4MQL#OQKS M(4M9=,*HS+S&K]N[2$939YK/) 9X\V[PJN\GSS0V9;Q8-:QSE MFW=8#+4D,\XRXYPDX[PK8R#3@3GDG"/IC1-<-=.(06:=SPMF^V6=M\ LK%^1 M??1.'VYP;3C^QOZ ^(+ J,@S#;/-?OKERKWSHZ(+=4BXK6:C>__MO43/Z-\* MR7\_'0^H]S!DTNT_3 ,_( Z2*%I?6HX^G.FX:+I!,7I^G!+ QDNEQE6IBO^E M-CF'I+QY#U(N'9^-D^*SC/BL7U7U,N"S+C ^!316 IY?M,-891#IG+_ 'VB0 MEM,1RW*_M\A70I-44?6K1F;;[P0+=,X?90>:ET7II?X,?LZC'QGBTG#/W>P=2@V*TW0F3SR\##AT4T/?0QF0&[L0O7 M&N*Z1ZD2C*A"#,,=P^O?<)'=<0-X0>"R;Z8.F9H66AW60-QB;<)8 $SPPZ'E M$,>PB T#AP_&,!?_>B,5HG>7M7#U:>+Z%@+RQJ,V":P7^OF790:CF!1\K-(AC#!&V+_(F\^8GR9+D"4 M=WQ(2,+-!*,T-X*%? -=%_6IO '%1#V\"H9#N!F+,O)0]?]I-^MJA6:?->)T MAPHNEZ/$?/E$FG&PV,"+DZ"Y%HOF=N>N==_I=93VP]/CPU.KWWVX5UKWMTKO MQ]=>][;;>NIV>HFT(D>3^G'?^G';[7=NE>Y]O_/4_0ZSN^\]W'5O6_AAKP__ M?._<]WO*PS?1YM9^^/[XU/ESY[[7_6L'Y@=_=Y0/=P^]WL=4QBML+CM7URP& MA3G99.+3F]DOGV>VUW+8R-A-GZ/'1SH>%=(['X*]+_PZTE6-QG6]HJ.ZBF*^ MZ,61)KN&F7Y:_[Q6OJZ5U=BO2M?QGV]ZE%JZ!DG?ZU&;/Z_H6G:#*N]Z%+]. MV.;X?6O(T5B[+":F"(%ZG*#BO>^U)HG,TO;!9%#E.UPW\I4.6!*3N9#?B6>, M%%V]4G*K14U#[*7X<(]%$;XYH97P!*_=5=1))IR,:)&N6W_,61%5/X=JZH2J M1P3&U1,Q[D/74?Y3@>?:6).S6E!S"6G6C/O>G5.V*]NS$U6UEN7AB3(+RA,N M4AR!J*KU#,] /.NTY9F79SP$HW CX,2C(^KXU@M5+%9(&BGF*\4!;>T.E8"\ MGG(?W)'NYQYUIQ\@KU==V)Z];ZX'?SJ*,?4\ZAAO2N#!TVR6-E6>B>55 M[C#2#:7U3$NVEY7D4K%]R(=VQ(8^M,Q_3OT EV\V'TVOXJI# M9=U=2UYS+STU\3RUHZ%+*T$T(+T^N0=P"<=_+"R% C VX2DO;*58&5'SFXI[E/CTEH;_MG"A>2'>/LI]O'2K<><7 MRYV X@,MA?W(!6A:H9DZI20W!YY3,/*(N ,4$\=4)JX?>#2P/%:KI RH0X=6 M<&GM1-+%(98[A M):#1V&)$N=]1WG<#8BMN)OGG_?9AK:X>G[WT9Y'DVB;3E4*SDD&;B&0,$B 8 M.2ND'1J4"VPFL6>\$B/D,P&' MO^PIDN81CTD%QW+E]-1[U\$7>:X-XWON8MT6]8,XI5 K-&NRL;9$Y1[VYPBH MK+-=@>+"4D!SE;+F9FD/1O2((EY_H^M+ILYR3(AK;XJ-;3NTX53L0 M>GHI;AV1>^@):+M2ENYOM%WU:XU;V[42BZW9KC:UB4-]JK1=;Q+M 4YAMU8] MJ6A+4$S/GDOVF@\W;7&Z0RTTT_=9RIQMX@1N$J/9VL XC&H8I65U\"J/(.7$ M%,J.+[+CRW$ZOI3?^0@'=7S!LB;9\45V?#E] Y'S[OBRTNGE:POFVNXHO3]W M.OUDDQ*Z/XI^K=5JV;0B4:_UU/LEAH4FS$4Z^W;%WVV;Z<)+P_Q?V7L#D]W/46*"W?IUL*R-/- MFK_,R.D/G16=7!>V^Z)-_!';>F'@+_1?4^N%V&$,=%%[+O9*>Y=VY!2!E/A? M9T'-)^H'GF4$U,0O6HZY^L'2E(214/HAQ@ZG#81C"S/5";$"]Z8 MX_%9D#3A7SX<^E8%X : M;B+C^QP5Z?[FHTCW TH=&V3Q91T;&<,5OLQM8QEYW,EU^G@!)T@UK)T T $@M=3M$#N,$01K[&-': M?0I]N&LCV?O:G'.4A5WI[%4QV-,EU"&6OFJ44R\%[X?,I.0-]3UL+523WCW9CGM-E2:O?3(C1<]=1* M>2.4%_\]]<[^N>M_^EW]CYX[@=&_72D3FZ"?[YBL\G#"FCY_B'JL$<.8CJ"+_;-#HWHS7&-D__9I_/YH%- M; /XKC.;P]YHKA6:Y=@U_,\X37W?:>XN/SC--.LXS5)]76C?G6XM5X;VANY& M)AV2[\>3A*[*Z9ODR94B'I&T^U#0S)!4*2&2*G5>UAPO(31[ .Z!WG:>%1N/ MYE 828KNL#B%/^020]HEAAEU[Y"X3_B6A^$/G[+<1IP$J(6FWI#526>)E5VK M#?MB!0_'T&XKFO^LFQ;>I,'*\ 9"?>V^34L%6AH M69W\(WU'KE"S0R4>C)HZ0\VY>8HA $JB;6WO.@%QGBULRQ*PST.1@D<&3)JX:)5Y25M+W/&[!1_:(JI88HFKGV&)$G"/P9.%U_H77 M>TL&;ENI7I7TK!H]<%&4)TNNCU%RO3?6-(:U2B,K7YBC\CHAFY#>=5M?NW?= M?K?38]V\.W_YT>W_/4U3TB6.Q!P\<>J6I9M'=]G=3.\L,K!L*]C61>$">G3* MEJ9[D>O"-E/W1JX7%$&%CQ70(Y[["^;@ASU.(S&R'!_<7#OSJHYM*,IZ5H?DRFP#5\#961)P.'!8#8#. MS9[_"VO]%'8IG9 WV:+T6"U*'T-B'RHO;/M?NA4U M]0:]XZRFR8Y')ZD1LQ/$L](U2E0HMI0:.%1D:RBR)967#IG2OSYZ)5D&(*HC MB-3T72:/XVL+J/?%#@:Z2QLM9C&!=/C3./S>=*E.?EO_XRHV@)7[*G&RO"=B][N,?&-9B;%9+-*[.S456UHTTLN+[)1T1K#;H8TS M@)W&.JEDUJ24H_H, 5?G[U:6#UFA,JXJ3H'KK(L.:V 4;30>6@YQ#.S.8+B^ MK+'+3;,#2_K $5PU:CEFFTPLL*UL'_[# *;*&AOM71=5PTW)F"+)O0FEK,$3 M"(N[U'T^6,1%3>U*+V75I8DC&R#@GN?L.DE<2#IRWTX22T[3 6T :I4PMRT; M\9PEF/9M)_$>3.MXJ1::C08OE4:7X$3_< P8#;$<5)W*Q/4M9A9E;CAU=N/M MF^O-J0O@?YS1=FO'@%JMT-0:,EU\ELA)F* X$#GU0E,O"5+X<1;.YU?JT*$5 M*.XBG)"NY^&M=*GCAUV0V9HX@#[P:&!Y%.O%X5/\@(XGMON&'T2TQVZI_K); ML55"&H5FNY"O)"]6NW.?9+M MV,==TNG;[4JOE4>\[-5N-R%>-/!5SZW:@6]=*0M_ET MGK*X=SM0R@"4!B]5X)?@/[;=\=B*3M/#O7!MN /&3ATCHXW^H=CLK7M>?>O& ML>S?"X$WI>\QM31H7-5<'O("2I60A:?;LW_(S-4L9EZ=S_P2K'IO1#PZOYO"AX9$[RE:4\B>LN%(_=+$9U@>_]M_<2GZ#4]?,LC\1Z\7H"GP_V5V%.Z>&SD*9062JZV7;-N'%$I MMQ'5"\W2=4Q-S 9O9D(\Y06?>:5LG(B/[_)34I4-V&]-@Y'K845@L@*&I8DU MMI!ZPPCWHW+:$39*A2; ]JH4_I>4 ^'8%3)_K_(!3W9D?E!X]N$Q&/,P#?P M7@F:(&YJZO[$/V047=^?(N'7!Z =A_N;!Z ?9P [^ "120)@[?Y L=A$&05U3M<^<9.1D!O>H:V/I MT%/E#3W'COP$<6LQ?G:=?'W:\!W[NH^-O!S: X<3>K.EH_BS>TPAM:MX@#.[ M!\-3#D\KX0)Z9I[L_@[LWIR8N6U[3A.\6K56NJK52U?5F&DN.TFY3V'%\=MS M'AH&'HTK32U=:?7UM=]E#^]S3C%%5BS10Y:4:]6K6CE;ENP]A30LP-QIH).=NRU[_1PW MS5T]F>O?]RCQI][;S/DG =L'G9>G-'L= WB$]>A)>QHT/%).O:J ;=;5]<)= M)1Q?7MY%=M.H)YG&9:;!/F1IDE/A3>[F1'T$FG:=J(-" M'/#50I.?/N\RE#EJC[OD*,&B[P8OVZ\NK 'H$\7-I-14*/$AOM!9NZ(/MNO['R_QC.V48;\/$X#? M8AKNSLC.]EZTEXD>MJ&Y XK?T^!AV">O<8)3*31K,0=P)H_@I!?+)8365'!^ M$*H"A&+:#!P=0EFZN()T<6Y3FSC4ITK;]2:NQYIRA.G5^2X)NGV7A.P FLHW M9MFSB-;A?I2]79<:B,]5J99[@\7WW!+ 3Y;-/O.#79W!+OT&S+U8)4)YXRFP M@3MEX2+/M6WL[V'AT>#TT,;-XKHX66KF[Y;C>B 8W8B6<3* #9*JJ5N(20^8 M1WCLT* )X*%A@6;US':HB^3=YNBZGCW\]_9;(=:SITB21SQ-P'5:0>!9@VF M1V?UW54#M1":_9P.346GHZ+S[W1(1Y/FRYS/> QV2&L,8N@&FLR1"E2C"B"C%P#9,X;YB1<=P M7A"X[)NI0\ #"=@Q+#!,:XRP8]1G"Z#1X5M@IWSJDV;-2-4MDH5X9T0"I#0ZW6:[I.J]62\0^M4IC=-/(6&Q*>:7'@ M4?*S2(8PP1MB_R)O/F)\F2Y E'=\2$C"S02C-#>"A7P#-12M^-R XJ >7@7# M(=R,11EYJ(;_M)MU-7#L4-?@>7;8Z PEYLLGTHR#Q09>G 3-M5@TMSMWK?M. MKZ.T'YX>'YY:_>[#O=*ZOU5Z/[[VNK?=UE.WTTND%3F:U(_[UH_;;K]SJW3O M^YVG[G>8W7WOX:Y[V\(/>WWXYWOGOM]3'KXIG;_\Z/;_GDKQ,]NS4'7,T,%< M;3+QZU_X]4+.<0,\RGH43$5OCKZ^ MAJ\^K7]>;ESK>CWVJ]*U&OOYID>II>M:6=OK49L_K^CQ+Y&#RG50U:V/VA&J M;P\!U,([68C0O7.)=UVXCN/-O_>UUK1*&,Z#B:#*=[ANY"L=L!RF\IUXQDC1 MU2MEG]Y]6ZG7>$^\1(OC?%,.=S(FZ0699,*71#0],U3M260A"!3N]\P55VO/ MB-5D>Y6Q\$W3UA@"^\WUKH>B[=S))J%X%"AFZY7L3D6=BD#U1 3ZT'64_U3@ MN3:>;G:ET%>#XG00BXI) O)Q'^*=OA4$KU=)PDG"2<()<=4EE%]&K2+9 A / M#?;E_8?='WDA7LC:A1\R,&FMKJT__L(V17\E-G$,JA ?$^VXDC6@SY:#>S!G M'TS@R:XI-TMO;:2D[6BDE*8W(ZYB;>MI*/='"X:AN+($+=WNCJT-\S3N^E-+ M\&2M@/0\%5 M5$#EFG[5T+.J@)08XDH!Z7DJH#IO"NC"FC$P[BGNA,& OE+/ ML'QY .H.E5K>I5*1J*%&O9UZ6'[./.50T[(O'QC!_4Y$\/T5;P.+SAME7HY4 ME_O1,E6YY00J=QU?K#%C GAMURA);6>NO2L[Z*P9@"]6EJQ)@9P.P M..55.:'RTGC#EEQ*.&UC>K'\*9L/YFC]_U$_<"SC" ZT*V%!&?]JKZY MWI!:P?2 %O8Z;D1K5*X:JFQ1*3SH,G;']\?;=@-7YBU?(J'&E7>>BWZK%)JZ MJEW52W*)27C09>RQ9ZW?N%N0RC(?S'TKG?5%?XK'4:=>[E\MN3C_YI ;-'LU MQZ4XO;;]R,E4>\I/VR RV[X'YX^^.!5?S7$13\]N$4_"3ES8;5!ZM3R57B.L M/ZC5JU'JHS/10 MS!DCO)T-=?K:&%ZONK":'=2;S%U&UW@6>_JLD(2266>PZ2IM,K(#8^=3D<%Q4(H>6S=!D M'=3BG;L!YGHNG>UF^)+M&WQF\=9NF%YIZXQRK?$Y]OP2HEF3;WTZ E@&@ MM=2=_S@\]UX ,\$X5!Q@=E2KA>9Z0\6C(UZ6GYWV M] FAK/]:Z];4ME\ZWT=QOI-LR-ZO2]ZZ/L.6 )QXYCRA3Z(W-7J3[*S-J<=C M)?-N SQ%G6==D"* _WW)^^6UM5UGAR2$&H6F7L^J$2(7K1C.)+2\:&BO;60Z M -K5$D"[6A$!VI=P$-\3#0A\:"H=XN'*6*+S?WEU.'/JFL#)[(Y,G0M;!LAW MM9@3ZW7F!DI/LD4I57E45<6$_E5#:W!2Q\\3 "6 4P,XR2:5= #6 ,#JE59+ M70XA$_4R47]$,;JG@4(C'U7Y8+N^_U$A0>!9@VE T)$)7*5-P893GRIMUYNX M'EO(XM:?E0E0?<>IK,#RKF.X8WH'W([393H:8YFDQ>T[+($MS,FAJQE;G"3E*/V!OR)[)DEJ8 M[:OEOA?WF"NQ9Q* 7#3T#]AULB?TZV&>L)XZT2T;\V>T(=@PIN.I30)J*@]@ MO3P%Z[4].J*.;[U0)0Q'E0\8D'Z\@K<&W$8\PC? /_7]L@&_W/@KGH7;+^A* MNJTK6=51 V*O\OJ:E]#MV4]]OT1I44^Z$RL12FO8;$KEX!"!"TL8A^Z4L>). M69$[98?NE-P++(0X)CWR@W%\Q7]>K.:PDW?[Y#5.0%40T/5D@$PP2]BFB>9W MU%4?"E8L]>'EL'&9=#Z?T./<,F][F9CR6HUI*H]/A[BDD6;)4F:6);XSQ?=: M"6HJ?..!1*4T'5 $2A^S]VH5_N.=OAL0.[9:4F%=;R.N_J90QE>1(YYDF5*! MA'FOD\=RWP]1PXJ;JU(M=:7;WNR289/$_E8[MJ.D+ /L5[%5L@"#S7MG&MIPMX\*@?R#VMW,Y.[FD5=R&4$RMW[G9L1_'I=\MQ/;!>,V47 M9ZAJA68Y,S,EG3 )SR5X[BC"3 +/.L)S?=53_$2U "8BR;9*9]6MLKAWJ\ZS M,&$OL=Q1(+JR?:VUQ.^^N^I$;Y-;;%+%R0XWGM GT9L:O3OZ>F:!WGJIT!2D MX_[I>PWP>E6F32.K\=::_6TY)G6"FR*N//,D5;>6'Z(?&X%^FN]US=QJ2V?Z M.(MO.\SV>V_ZEAH>)3[]YKGC%2AL4H1_#A.> M ND=#JGMKCY$ 6F0'_Q,@#_YK62_,+_)@->4R\9\L)'8=WP#(H4B_"4//+ MP,.'1?,^]#&90;&Q"XD:.]F.4A8]$@,WMA+G#;/ CAM0EAW&;Z8. 3!A/Q&6 M'+;&B$\F_:S)R-!R(":UP"/P _B G2)YO9$*T;O+6IA%G[@^.R;RQJ,V":P7 M^OF790:CF90LW1@!H[2XA0Q@$--@\RU'I_ANX6 &E ?U\"H8#N%F+,K(0WW] MI]VLJX$+S8HFW*'21E7OX'(+:<;!8@,O3H+F6BR:VYV[UGVGUU':#T^/#T^M M?O?A7FG=WRJ]'U][W=MNZZG;Z272BAQ-ZL=]Z\=MM]^Y5;KW_];>&'O3[\\[USW^\I#]^4=JOW9^7;WA:[1FZ.OK^&K3^N? MU\K7M5HM]JO2M1K[^:9'J:7K2J.RUZ,V?U[1XU]RT*#J6Q^U(]S?Z@DWUBZ+ M<5=#1!S'7WWO)*R)0QCQ@VZCRG>X;N0K'5!Y)O-UOA//&"FZ>J6L>'MI"+04 MBNRQE8]OZFDEK9PD3Y)DPLF(MAZF18\Y*Z+JF:&N(13JZHD(]*'K*/^IP'-M M7!C]N ^MSF*7S\.$HH\&T4P+XM(7B!DHOZ6HA]Q_8;M48DJ0-[+S/$LJ]DK@ M;L\9/7KNT HV'$I19_V,>3GY29;:9(F+'3V$MN.B7F@VLCIMF*<-&$+6=+;, M?T[]@*7;,%/G46"T84$$Z<3LUR;W MNO01NSU&BG/B^@&RR6,+<;C"L&_AB3V.Z\3N(P^42""3^R'8?0!KKV##Q8G/VI<';KXVR0EGG:%7#GA M2>-GV^U%>;9;M#$KNYEM5;DPSW:O_4 9J.#V,JWCY -/!3ZS'MT2.5DHVYW( M*6-Z]/3($3VAP?T SRM*N*5#ZGDLV\>.K C(*_79B147%@NDLT0;VAS/J!LV MG.B3U\A!BW1*G!JIL$K 4Y_A(GW]HZ97]D9)E9^P\*+<^ ]_$%P6P>43!9B. MIB,J/,:RS<'4ASM\']['TM7P6Y!"F8KKG.6A2Y'RN 3YX/1 &AZ&CQXN3@5O MCS9Q MSA,$%O+4Y8:AD(B_3K>;3#.Q3KX9"II[/",E^]/^/9AJ7B@.#2,VXZ M 0M(#E[KNPR_8D="I(?',7Q%@K:7Z!D']P9HR*R:!$C7DR>([-"022&BEW A M+W7QEW0Y]^?V#\><]3("S3@OX;&0[RM;[LAP:-D6_"J3R(?KS$5K2.PB%6Z< M_4Z#D0O1V0N-*JO8N7FWLWYY#]Y*LZDXX5$+32W-R:S2^Q1!M6X(7/*!E :0 MJG 2U5R4G\J6""XQ0YJAEF4TG&_%6.S$:!-_],UV?_5F>\;CD*_SLX0M?=5\ MP_EM!S ?"I]RNLZ.TH5-L^EJ2ZDY>+F(!LN9P@=1W;DLB,@D=8IR\1@1_>O; M#Q^7&F+$YW:) P]S!L3)4*70E.ZL &C*,%.0.8:R6,+BT'\58,]D>T2<9\I2 M"$O[>]AB%5NWLBTRL.R+V^MS7C:W[Q&3XOXO:KU@-Q _%*VB$HPLSU0FQ O> MPE7*>=KH$E=I0?XX%5@K-"OK,;RTHV*C9(E;'AJ:3\A;PKA<.J!YJ-B680"] O\QY$.4EO],P@<[AF30"9 M,C9).3UD+M ;39*U/D^WXD@*<]6ON%N0.TX.*E@NFB:2ETXIC^C)RBO=@9XJ M:-$&!RO,6;JE6H7_E<'[#+L!ICD&KW3^Y_?LR)P")Q*NN,?)#^YX*V6U072? MYM>\^[;GAKA*NHS<8ZYU>5A]$FTJ?5*F>"V5I8[HK.]K3)U='@[*?+&=F;TW98!Y/3H MRN[AEF-NV4"LJ[B0J:\W2Y6Y([$QLZN15!K,:+C%LKJ^FL-;\DC #DU;PD$! M-#^ "!AK^LK0<\>*3\(SXF2SD5P.P&"4QHUZ\Y81YA3])SI;2%L^$'5HO5*S M^&_JN7'RK!8@XJIKJO:9DU4VF0P[8L%\$BRM8P8793E!R_F9 ;$#@(O=>)J' M5__-]98%E-%V'C%O37!H>FPG#.G9BXV;A)Y]"MS@TG":UL(<+@V?P9J&-4^3 MI5S3B,ATT1GFI(O+&S+,"04)UY8K:>IR]F65 +[V1<,NY<)&0MA5XX^RX0MV MEW"&ZS?+(8Z1P=SW%IOZE57WEE/9ZHI/(U7T8]I 5?>#$+1T$WQGQ MG>>NP\Y]#X]]?_#N:-RIH+I6RZ*EI,Q[B6QN\X!5O=#42^NX$KHR3 5_6X) M(DY%7UA2*J]5AV79B!, 7%@NK]?7R/YGXL-DGP6%'3#12Z G]=3G;G*8/%>UWA;O+]H MC]-VG>=0AYK 1^EJ9N%J=GU_2AR#/@SO@+K;M"BN>*J\G#ITI3'.TIWE$=\[.&/[L)'M=!,LVM EO[E ML\QI6B^S9T>/*.+U-U6F]$]Y8IKB3A@^Z2OU#,M?6@F%,4L7.64V%BG\P CL M=R("FW%BF\41D](_YA L^^1DX\&2W#VN2_?XM#LLW?'8Q;>B6C5G9S%)QSAU ML?72R58AC9FHQ(E ]P?#OP?Z1^?HK8Z,4S*)8 )!V&4]$(!"2LGU7V:JTTE M R7=1<"JF7_8_%YN/OEN-Z5O#&3G<=N;9)O;AB MFC*NCIU^0X)T6$]>G;4_=#013E'C/D_!_0#/S<5/N8?R0ORU--;GF^LQ(L^+ M]+=NJBCK*?NE2H>?1P"EL4%[ BCMKDJ^0H%SV54YG&_1D9TB3[VK,J$@5?! M\0S.WN%B5Z5L%WGR794)85!X)J (DI4; ^@LR+8\= MIM@OV%GP!7CH7-S!/[FH[ ZC\\-P1OTG(/Z#@^*$_W46Q'ZBF&4S FKB%RW' M7/U@ZP$PYXB<9EV9J=;VJ6$28,[OU*<#39V?EDTM%H6/B@3,> MOOH=H@R*Q9<1>)I?!AX^;+D*\X#'9(;!QBX(:FR[$Z5*,*(*,0QW#*]_PZ## M<0/*:DWQFZE#(-H,V!HT#-,:(S 9 PA^&"U*$QL&#A^P:H/KC52(WEW6PAAM MXOH6PN;&HS;!'OZ??UEF,)J)Q]*-$31*BUO( 8Q#3;?A0QJZKJI=JP43=*9:-<&=(!J0P-M5JOZ3JM5DO&/W#;=W33R%O4+S_3 MXL"CY&>1#&&"-\3^1=Y\Q/@R78 H[_B0D(2;"49I;@0+^0:ZR,6#\H#QH#ZH MAU?!< @W8U%&'BKJ/^UF7:W0[*.N0=^PC3J>I9!),PX62[PX/GQKL?!M=^Y: M]YU>1VD_/#T^/+7ZW8=[I75_J_1^?.UU;[NMIVZGMU$!\#*+^X=^IZ?T'Y3^ MGSO*C_O6C]MNOW.K=._[G:?N=YC;?>_AKGO;P@^_=>];]^UNZT[I]>&#[YW[ M?LP$$\IMK;#;.)R()NJU$GDD]],Q/,)83]>O^AP/WC-QK'\S46C/C0+\ ;[& MHT=]8##[\V'X;68E>G,C<6OYANWZ4X_VX15?;;8K9>9?5$+WQW*FU&P%T63 SER6:XSNQ@^^B M%[.+%P."EY^&9>R)-WA*H64D8.)FDB1U34YD%MO@ CC )ABN-XGT*^.B!0&U M/QWXEFD1#]L4?X AV92=^6._7;$I%J(Y%CXJP'&B/-ON %P28T3'Z/*QY_@3 MB@@,WK#E,8P1'&DE4#GL_'16U<<2CP;< [/&)-_P@>68T[1 MOZ?^ZG3@!G<^\O!<,YC-= @>.SONDBA@_NGRH&3 MO"FV]0)>XLI+?O.5@><2 HB#]U/X((BR(T4@V0I9 M<.DU7-M0R!3\/1=Y?+7$1G#T\2.@$3JAH 18U!'^A?(< B8B!+MA1/WP!J0B M/&/I6HH@\ES',N!KZE#O^0WWJ7K@15V!7VL'(0BOE FQ6%8'4STN.ZW7QP\G MT?LF$-80(._SU%EZ$FM6RZQ3OF5Z> E\^\;O_T8]^J1+H.R"-H@+], MB0>2 _+Q1!&*6'/U#:0X#$_54O$ORH?"^XL*'T-EPMKW%&;ZJ*" 8\<$W57B M=!2(LG(+G_]">356/@>F0RBUIL!"R5E]B_+CNG>]_*I@1;CFMX.^6]S24_[L MVB9KY7YWUUX9B&V-6.R< _YXZ[%"?B0=ZVIJ +E.>46^"#7K#[^DDF+T"T.FP M&3*'CS&IQ?PM H*'6%?^:+4>P5SCO-"&A5ER'X> K(0[0U6.]F"1HIA&;;:6 MI..* 9F90(2Y^PNGN>(ON&!W(INZ["'.F[LHT7Y:?",:7^K,E#=$:5?,,+)X M;;;55D&;R Y,@*FN/]?RV9] )$#U*8SGCU/ M[,:_AQO8)EN_CU#X4>IUVX2.39_\PB0:!FMH (PI#(&9$ MWG].G7 E@(URU05(H"38%$*RA\;B#6*$R$C< I?' ^JMVPF=.;M(,_"1Z, # MS?$6?:DO6Y/YF&#N^"[@3/!.%\,P6PZ$SO8[MTL!C^M_>-<+#Z$D@EP 2*?V MH387S"AZ5S.ILAC.318)O- 9O69O "4+"*"OH(H96Z,7HH'Q0O;Q3K69-O7 M#T4= C8:@[REL[2O5JTN2@A:3I@ZL[O$B-0G>08JATB>+0<@?8CB3!&XC'2@ MM#%86PH3\4CX<$4 /L>-V.[\KW^Z\!;E!9Z(:N<*G *PZF]+[[F:AZMX_O>R ME26>AS(?KF:L1-/(?O+BADZZR9(M T2(Z].E^:!3LYC./$4P2SS@O>BU+$@T M \2*1<#'+"1]-K/5\8Q)%.'/Q^*CU5B>P.+]",SY& ;3(-Z!&5#;HB_,O<$S MW'"N^!:F9HFS<(/-;GH1O!X $?<\T?6Y!'<;'0C MGNG7MT= H;,H4RUJBY0OG@08W3K+TU@T-&.1LXQ7A3'6,[XV_@:%A*_ " E>\_PJ",,-.AMFZ!>@Z&/F.!RHX?HK#_L03>2C\@QC\EE?DZM9,!:05R0!$F 6 MXH1W@8(-/(I>&\-'&/0'+,^/^>ZEK]R!;3W/AD*=%\MS'?P">+'"4^0Q1'X+ M]AL,&\ 3#.GPI>"9M& 6+*0+O0>#V5+3 MAYX1D/H=F8D_J=PEM;"GNW_"5K M-][IFWH6M1O8:4_6;EQ2[08?Z_O:ONO[\-[6/.O["'H*?C5"8]%RS#9+B_A= M9_F:66(X9DV_'K.F7U]?TW^B*.'*XJ'*ZIMWKM]G,K]',)7&V_]C[TV;U%:R M=>&_HN!TOUV.H#!(C-X=%5$NV_NXP]-U>7?'^=0A4%*H+22VABK3O_Y=:V5J M0@(D$" @^][C78"&')Y<\\#_S9G+*"/DK0L<&)XL<&"KX#0%<9@ZIRD4^QA6 MG4%?[=@UV51H7E$L@9O9F4?@R8;N&LH?"X,X^4WC_O$/-#_>/;QNOWI00.?FX(S9#,:(8'* O//8F_..WL#R;:=,ZT$V_ MB8<)WH2$="4^E,@%_SFFL:TVI[,BRT&\6?S<@I]>YWP_:FG]0>Y/[5:GY/<] M+?\EZ^Y8-RA-;6F#4FV>EVM9H-2!ZV.NOGE6Q)?:E&Q9#4<.,,B1/<# M?B@+='XOV*#]C":?")VZROGS'&(TH;T#8G[%2X!NBS3?>DSX[%R%2NFE=-G/ MNH]F[=2:":JPHCYIG''E9]84R7(HN-A;+I.O.EJE<1@-EP!/YJ )?7\*]_81 MM$'6"J4T$-GHE]OVJ*F$$#ZV77+-X. _>G)94\\ MW&.I3)F!H4YPB\X'\:K)K:>ARQV6V1;/QF^2#Z#!)A?P#4]P^3>E['N M<0_\^MG_2,Z77'Y;)IT*(.'F0*&B4E1([&8<,QQ]8G5"&Z]R(PR9F>5@_@OZ M^@RXP0-@IY9 !&ZM?]:&H>RVZJT"PHH\^K%\1T%W_$B$<7=QR1$R/\8\H]-K M(G?HMI3W/.#<$,W13#+<\R ;N0%%:6\B2A##L.#8PIHRS!#@L2=$*."2211; M$RTXKCE&I61]-\GPJE:>$'KH*INGEW&^H)A01,89U%W&X3$)9-EZ9$^TO17) M.D5JO!P*&V<@ZS2)_]HA9>1LC#M/QQAIWJ0B7Z'*YXF]B=RA490-CRE$6AG5 M\18Q*9,9FE6=*- , RK(D8C.9%>Y:3Q\??>Y\2H9^FR0.QHDKO!]\$Q@HJB& M(E]/)Q+9PF5+842DI(9W<2$+^*D;HRO\C?RXJ\9>T^?945'0T>["%X70F;[% M67;XQ"AT$*;,AX#]-A>6;D>N_##FF"X)^!HGW--SIN.1N 'A!B[.7Q\*0O+@ M5@_7.[HFD=-%HAKL X63T1N=R*N-CE4G<"=ASD9 9FZDW6+*AHC@HWAQAN&D MONN@R,R3T_#7!?!7-QO>WHQ%/IS4!F2E)&\#UQ>#MD,1DY8X"KKGKZ'8 L$U M=N/,UT8I]A*-M&84=!O2BU-*5=>V=Z>2JM(50[*A$ZM^2AE*D=JV426A%)H, MI9"A%,U MF2#VN%;[O_%(^^R_7P+?-6WG65?^04D1_^2AXS6/[@6U_A%S2N.\I5BY#SD^ MRO$H#6.J&8K!3R"4FZ1*I](_>%#O9^#T@:G\?_I\\1L\H=54/OE&"_0N_@-H M7D3)Z 5X?I5HW=))%Q1,CNU92>1'BS%2,DI,P?@C&M>)?=/["I+T% MSS.6LV0\F99$EM491XD.+S/30N4% MWT#"9^EH_U1)7373!H&2#S\S?X;EJ3&5 R>5$_&?%^G?[P#]S OTCQ)+A#*3 MVL!6N'F4\4.:%^F"MJ5% M=*)1W"-,XNOT&T^' @GTG@!9MBY@'\2Q7GM=\4N@$!851O""\7\H+MY1?!?H M@YA+(G\U?=RPI$L<.$9Z%@7M;X"+,(>(+-DY;:3(9^+G+ZPL0Q'JL34BCJ3F MK"Y,T4LG6#/E?5P)YG-4348H[BWEGF+'0]T^.]C=O(>_PWL^.9[WU4ZP M_:]3OGV=TOO7A?WKK"M=+?9/>=&]U'K@&$(O$_R<2,)+I@'&.1)$Z6P6;5RA M[.A".:VDC=<@FZLD\UX5T"Y7/CF5Y3UO4"OKUVU1N_<_&.:)+9K*[PP-A'6O MF@4BTM>)[VP0D'2;AS4;P@?M\[.32#!",OC-L98P/H,I_3[(0]_N^WUAA_Y? MK&#U+6$P_;*T* 7^?[]]@4M$'2Q1!8YH&24DD8"B3WCM&3CHJ^N*=!4M,'.8 M;)B&BP\0Z3@3EXRW\*, MR-%&4\J\.$O?EJ,QS6#_11\TB-MR+7 M/<^>T&_<[=T(:T.7H/V;F1SIK._9N_ID9_T>%M]"589AD,S"Q0K*A!X1FW*& MQU_=Y_A?1Y>S=<<_U"!3' ^8(7G!%+>)8"21Q0&C3MM[\XQ!VV/=Q"J4'L1 M10[P6$(>)QEJ_5O<_7!\W3I8Z[KU;9VNE<*"@$7.@$=AI")37!X-'3;NNGNW MB*]PCVI!>POU\*K>"KFJW.8;(?^]\7]%3(3]T_A\"HAC:A7:&& Y*A=,,+=O MR8')O_KN4."D[R_>O'[]\O+2^C5VK9;C/KU6VVWMM0L_OPZO/8F9>65KVJTN MI7I_3'@FOJXM,!;Z+78L':W<;!'$I]/Z!":>9BS% Q/A]\;=%T1AA^(1SW8. MPV0XY2G\+J]B-U7B<%\AD5,W$3GULH@C:QOQLR&^OCYNQ[C9 MQ(+:)F")2WL2N,GD^&.Z)C$S:+%PG5]4#]):EHQ&ZI*:=@E=2T:9959CCS S;"T6A7&9WLXQ9FL/3"\WIZ:'QRC5CM+2;1(< M*+8LJ?5%8>2!Z\^P;@QV-U)/3)*248IR2BE^JR>C%*2 M44K2PR9#*V1D5>T=?X-#AE8,N-7WVN*M:D^U:C_ 4O$UEQVX("8N Q=*T:^B M@0N#3@44JL(MJ@5EDW$+Y^?2VQBWH$F7WLXNO;4^EWK8+P_KU(MLF;J?8\O< MTWDW/(WS;J V[CHY!3].X+TK5E2LUVO4P'R>[Y?HENWA]3&L2!/7D,VF]@ZT MK"%ZH&53>\.'F07*2.V2D!P-]H$7\2.?5,YPNT7;;]$D+L&8/5!;@ZJZ+'5: M_4[M6C^AA;V2+DN79!6_)^:Y:@G'CP4MON6,LP+'M;7/EEZTJ-PJK%NX;%IE MGH21-&X?U#1["EWX@VF;'K CZCSL[9/Y<.&&@$Y[LS09L?)P17_'!?W"?"H[ M@F;-TM7%!B"7=9K]WCI1LAX6SMW:7$A =3K'!U2? -7NU@10QTXK/@4D_N6X M/V]!9EY@\4%O-PI['5FXA2DL+NE'^QM?T)4#D<7\ #"O5F6"/18)+5+37B*F M, DMAY@A(*:_-].M"#'7((1^UU^4>11(2$;$@!J,2(&T G()JQM%:=[;QJ-8 MVJW'8-2XZPW6)2%(V?.LL5.4<.Z(G6$;L#-:5Q?Y3,5,&0L0F7@*VW\N\>P4 MI;MP2,HJ:,-.XTYM:KV]%;3*-_(,A%V)VBHH_BZH53EJJZIQ=%K4[MSKJJ"S M=5A?9VNOK+,535(OIF6!:/#1]G7[R815X[7X-[E?ASGNUV&.^S5\/*D$\0N4 M>U%3'["Z4W1FW:%_O4X<5/XV(5J=[!<*NFEC]-?&+Q/>9CIIBT# M&7;06P]SD#N]*PMJJ&=6VDD2TBAN)ADRHV3"9:39,!51.]K2G$N(DJ45R%[C MKM_LMZLJ\%BGA =IN*X2@?TMQK<8@5F0];$,<[VKLTM8',:ZM3-A&B!A&@WV MMFP=E3#5/CGSO*^2RWL.F;NU%CW?_YK,=/N)*9CDKO"_KRTT[*84W\\0> \F M '^MH_0_L >M15;?>]OX)AH+WT===>_CWKMY=!_+C6=#'S*:U&G"Q0XKB%YO MZ%DY1*K'1>0HK[-030 I0;0CB(Y+U488E=.I*XA.;8)*N+;2&>+J*7*O$Q:J M=$]<)9D)5^F@ZE\K249X;&)(VF%TX%$'=>!>KZI(T#K&))V%:4^B?Q/ZNSL; M!D$T&69:,NL6Q4]_S+1OV8,9OQLQ8P>KECP=%@\/4<'B>O7EVI8(SN,;.LPTI$=1F2'D628\ID$)*^+S:X@ M/!FK'_CL$U" 3(CYFFI9HUZYL.53G'0^JUL+IX7U!,/5TVEBBN[BGT#:+1^[PR3[G&YQ4RJ/:VVRBWF"8 M(?J69X'N-^ZZV0 D68KO M"RI5/Z=K24=((.L.9(5ZNJYHA$4ZW0M*5KW"ZT M9]BXZ[>N]D08F6&J)E6[)@Q:P*!MRXTYH=K:JB;K4( MOSY]GIB\2F[5V5TEM^ILKJK($'DN!I+J4E+/M^1 N03 +<50-H@1'QP77FOS MIF^392*KZW?=M#_E2J3==J=QMT_REBQ<44<4#;8$@E:.(JS5FNV&(6%4.QB5 M0M'N*DT1%!4-,>ZVM08H-4.UH_Y6ZXHI$F<[XBR3]'XBG'4ESLX-9_LEQA^8 M*_: *X[JRA4/Z;KMC&JNER1RX)75]/<]>EM<94;B8$N*>'D[>;>-+MVJ>F75 M(C6VVFX4UXFS+#DX&3)D5YQLXB-S,\[VZNNS)$C6T96JZIMJBM=ILM:8%F%JXZZJ$%B)K5IAJVBCR,-A2VO<92W_$EL7@*VBC6P/AZUN M7F:[Q-;Y8^OT9*L'T*HWW3JDY^EZLOO*1 R>T6$K9RO>/;VON!]7[>\9N%9V MI\[ )GC=J-L]V:\$Z@:-NWZ_ O>6A-VEP.X84;HJ.LO:^P2M2-A=&.R.$>"K MCJKQF4C470CJ]LC[*XXZK=VX&W:ULX3=(9U#6KNEUMT[](7YRMAQ?BK/&]O) M%$^OE2W=*]:P8(?RSERG.K-J'?NX'SH+7,*T8I6,8%HN25Q304AN#KH55U^1 M.)8XWEW'6T-N-1"L1U7UC)% E4#=6RM< U1TB575,$+B5.)T;SUR%\$ JVHV MU?XE"[BYBN=K7X=AP7\-\_DNG/R78 X;/ GW2WS,.DS3._(XF3$CL!C&VAIL MNL%/BJ_\ 4]Z:SF3G_$>P'8PV)D%/--W P9X@4&%HY_K[I-I\P7#XW9T!*N( MX'AFMQ9.33&CN2DZ34[17?P3\&=9SHOW)D0.K7.$&[[[,&I+7WCL3?C';^$> MF3:]FV[Z34Q=@ GU^Y6=)V3PGW\+6\>W6VU^YH1I0;QY<\?YX:"E;N\X7^A1 MG7:K-^K+YO4[]7AV=8/!KO_THI;8])7R!0Y4Q=C"&-__FE@!KL_OCF.\ #I+BS$#M&_T]R_&>"V9+/5]=5&[?ZTI MB,P$*>NSS=1&61.&N(62[-1:0,,0@MK6VSEH\*%:?[_9@>(/\U74]?KI.1[! M4B=P2S+6P5GXB%CX_HT**MQFR?KEJ^6K]WCU9BM;[:Q<[P(7CK[BSQC\G\N8 M,H=;9I["@/89G 5Q8@1\B/^!S*A)-SPXUVV[Q^K4BLDP[O)/= MU)ENZA45^('+DF%1[W\MF.VQ-<;4;J?^QM3WG@_[C96_]<2\8)UI8KAUA"@O M0%:&S$B9PM+ /[AYRI+IKJ>87IZQE>_"Q@E+>VSF41=E:=W?$'@-)CZ@VSUI MSSM(,&N65'^!!_]X8=8S^TS\-(\+88!2?^\,TXK,=]=@HH(3T+\RB]3I3L#_ M <_^\9(K?FD(_*JZ\QT=^.=)^@>2]!\3^*A*Y4&_6PGT)KASR86!55G9B()KN'[%&#O8BO&-@\/FN 2H M-P!KYN)5,!R]-F-10&@#TO _V[=NT+@C6RQZ:1^0JMB^]_?7^ET>+$YHBLW8 MP0B]_992SF@MJAIYW_0E3AH^N@$S/IGZV+3@)#/OWC:^^C/F)KYZ9WH3R_$" ME_&X!#_';#W@)!G(##/N??'=;<:8+1Z@T"N4Q#NRA&MGNSP]6[PH\89U!O=A MQN"^0C+C.<*[+L$Z/0 RH^7_5-HZW6GU.Z-2CUK_?:_"0:F;7WY1)O-BP/:!AR77K1D/&VX;%H9Q\/&]1M=6;1V[:N@'UNK M)#YW"CWK+;/9U/059PP#(H;G*3?A7AU9OFS72+[@3@J@03?.L"Z/&G5H7X\*1BR]=.K*VQ$D=&%F]=HV0=0VNBH? @Y>#M.@" M1_"O+GFB2J(K;!2@M/QD6(X9XP8W01V4]$&_)KZ)(U+V6&*FV3H<@P.&>) MX4J4GRT20WA A&=_ P? Z+U1597_I(9<*Y!L$1:*@Z3?N%.[4CD^\EY_8D^Z M)5E4DZSPKO_-<%0XIO/RD6TSWI/-N#8$9+ M^0E7,K00+3> ?=2X&]9%[I/*P3&)9&FL]+&=4UW:P5^-CO =]#I/SK:POM0Y@0_,?=X@Y/4[:!6KB9 GE8-C\KV20,%2+W5Q MM5Z#-O"H6[IKPO.PGOZ81SY*E6!WNOB>PD@9^\ZH96OK>ZT?J\2^BG%RSJB90O]W $M6&5$E3+F M,:.+GD$)P-0:Q;05?3H%#B?3-G8BDA/VYOV?@>DO/S-_YACQRA8Q* YJ%)$O MIX1E<9?%U"AL*C*05LF+Q,HV;UQ) MK& L;Z>W=^/Q>@F-9]/EZ8?CZ]8^TJ)L*KTO75Z. W0!]1L=_:NXU[Y MGIZ!_"H!O"^QKP# Z)MJ=GI5!?>?%L!KRINFRYGF-64J5K,3&69=ZSH.RM9U M?,?&?ERG,5OF<*!E"S0.M&R!1GQ.A;48X][RCS/']7\P=XYOR!E?MV@91C[J MG+FHLCCCRO>R../I2^7)XHS'6#19G#%>O-ITT.)B7#M'>NXKO,"4^*>U;!Z\4?; VW/0BLE0?"38S_Q&Y"Y*;?* MCYGI&LHWW?67=./]=H?"O@:54]Q?I9(_X*7/ZZSCA]MOKFR_A=OOX_8;)#U) ME]'.V5WV4R@BWMO&@[XP8:$I&OUK7)UT5]VHU[A3FUIW;[>J="_5$5I;$\ . M":T^V8WV+[!XIJZHA-8E'G&+U[_I]!)$/<'N3Q4B18R="/4X8NQ-(.>B]3NV ML\7>"(H1,,5WMULK10L< 9YY_<=.1"035>.M" MNT4L"^91@$'CKE>7JDK23W=\/UTQE R!3^Q?5*->+KJ]N42?F,2)D/"=/3O6 M,Q+_BF^B1J27-V1%^5992V'>?A-AT$GNY]G3X0&C9XVT>-NVY5?D*I M2M0*(=M4B6((&6+)]?W+C1Q')3C#0H:;;(ZCFEN2=H\6$;/>Z)A=[Y6]]*.[ MO:KNV-]1QP>J<*/>K5QY676CYK6/_O?%_:4D\?^A]>$_:8C9<-9?A-U5/KX 2HE9A>0+\31W' MM[&B!J'3ONTAG/E7WQVOWYY>6G]&KM6RW&?7JOMMO;:A9]?A]>> MI#GPRM:T6UT-]^+'C"G\+F8H.JR#_@33"\L3NSI,]D7WE+7D ([PF+D9J5-- M4@0M$TB3#)_YEWC[/7]Y6-3S.[PZ(@BW:DP1-&!=K:PD^E?R398=IW:X<79Q MG%D&"^,D/QM%1G BIG6:_ \,CZ!IA!$ V=^UI@)O7; )0MA:MJ*#F8#G%1Y3 M==,Q[XTRH[IKW#C;./X\R&F![QF!8+ Q4HE%WN,?=\?9=[ MV;"^#F,Y3,/Z]3&T:FX,K=;8.< 7*0D&1KD!!<9D0WR'@TR(KPS7E>&Z,EQ7 MANO*<-T:A.O6Q&*>/_]TB.TU1=&>H6OF$@,%'IEM.BZH71Z;!"ZHE*B/\% Q MI/G-%=42*5U)C:V?U-AZ>1;A6+Q*ZFB//I9E^\9?J;%C"OM5K9T.4 M_BHC!K;Y@_N;;?5_A)# + M_H1^U#XDH<<*RRTU)^E 2O3;#O-H2YC8UL.,GCI5=E"]2&QLBD%'NB#.-*-](V?K5\#9NH?C;+TV5JQM=:538A?RU-U+3.VU.XV[O)67 M*LP%8*.W)S;4.F&C+BK,U9'^ _JC>VT-(-8:#+(&4:G4;#W>Y?S1I2337KM+ MDNEP;P.&5&KJ")UR[NJ2T.E1\>GVWE6P+LS)<5:,8U !XSB@?[O7[F..6">G MU)K4&;:>_OW\V[TV%KG:/P%>Z@QUQ,9^_NU>>PC8Z$FWQW63?GC-(6G_"#TA MG7ZUM/\Z)+^5G:E8].M@K:,:V;.EUE M=LKYQ$MBIU,O[$BUH1COH#JZE@,C M"?G'&19,W*M*[G5(AIUV.2=Z]H"KC;OAL"[F9*DV5 N.=4_M(_7OR;SKG0[XGCYC=="X&XVJZK4D9?]Z@6-/G[$ZK!,XI.R_ _57 MJZ#^A_09JQ1KJ@URNM%(V7_K 2_G,RYG^=7:];+\2M6@6NR49TVK5]T=J5A4BYU#>IRU;KVP4Q>] MHW\R-O'-L:R 4($X0I_@S6Z&E&%JDSS%]09?["=JJPQ0_]U9\Q%_O+A/T0\PX_UC90^S41&Z7* M42U MOBB"P&DCP#9N[[WA>D5I^,-;W7[9RH[K8**2!TUY=/,-%7=4VL88&6+ MH=09RA]@=8NON= !QF#4CBQ[=)D V>)OS@%(4CF8FK^8*"+\(0NAO_61*23,G^U\-CB@RX$CTY] MX"$E_J]C&"%U.?<4:JNN3$U;MR=,L1B0SJV5@O;6J.W-A^8#7_!/N-Z? M3'UL6J:_S#LX*LC:,K+_,C&R1=0NC!%TU72SZO!9B]1\NTV\: O3%AJ.@X)#O;1GE@!+M-#X+K,]C_K M?N""JL"\LFZK+KJMM&97JTI2*;:S9R#B7B]$MY#HHT.TQR%:65C.X2!:&S'[ ME/W4_@"X.##>_S(#<#1E+H;H<&$;!@CKXOG>&5I5NOM85<0^7Q1-N:F2[[T3 M0!'RWP."Y O+5:LQ\2(;=_NJK,QW>D95D<9PQ:#:PJE*@&K0N!MD.[;6"%15 MJAB#1#AG394,(34HINV!<&&AQ]1#GZP%PL_$A)RW@M856)=K KK'A9GYQ2C4>'546B/KU7:[?4NA/D'SN; M?-*LD4_BC093-YQ@;#$E'/M:WGFFHLSQB779X]3#7"DX3YVJ[*C5[?'YR-T2 MT(=C$Z4!C0E<('>TJPK4.BV@B<>\]G5X86AU2%A\YKK[9-KAJZO&Q' ;)%2$ MQ+\W_B]M,,D?>A_>DTXV&ZYFFN$W54^O@*U(K:)O *!PZC@^9JAQD-JW T0U M_^J[@Y.9^?[BS>O7+R\OK5]CUVHY[M-KM=W67KOP\^OPVN,?>EJ U-:T6UT- M]^+'C*V$R[[H7OG:?(>LS]&C++N1FJT!]E?* RD]6.V0@Z524J.NEC=8TGL_ MZ^YDQFF8UFGR/]2VVJ6YO&,3AH/._JXU%1C'@DT0N]:R%9W(!"ZO\'RJF\[G M\/S/Y\?DV?3@7_N)*5/7F9>/:4_EZG MOSP)X5S(4B_4G-JT._&_=$1DI>.DS)9L\IQD?8) MGO@&-6ASDEJW0:[6)@IH/+C,,'WE@S[!*#N3>47TM<-.9*.R^=%.T@(XXFI3 M>8#=MIG'XK^4/UJ/+:(-$S@$N@G##,:>:9BZ"U-4&%$CS ,'@.B)-G43OAKZ MD\L82@C*#9 ?H'& !P(3!@0W"5*-E5'P-Z(U0_F$3Q+K>A\^J9$7[;#6,'VL MU7S55!:!ZP4Z3!6F]S(S)S/ .\+?4Q:N\VSBQ&&%0'J.CTWU/'(,,]N)@9Y8> MEVY-#^R>WE?::#4"T7)M M%1H76^OV:9S:IZ.LLIJSRK=X20H>0)EF1SF>?2WW>*[@59F![*R, M&;.5:6!92Q#2%KII'"0@K" E;-6<[]U;GH,GI7+F5TN^9,-C3HD&EST[UC-% M*A:7"&C9OT=W9B0 W!*XU'EBF#BFO)C^C&XL*4DDW[;Z&W(".-:>Z?DDTTYA M@\L14BWMA!QD=#Q8JZ]3_EXA-"X_Z[_,>3!_Z[BN\X+1OOH"?L&4C9+$%>/0 M6X-U4>@A=?562[]E=FLJ!J;2KC$B>NM#EAX7+A,-[[: M_P0"@'XD5,([>5IXOT?<+VF3&F>G,K MJ.XK$Q%5)I3"$!'P.^Y=W?D Z#_WP5/@^4D;1T+'C6A3N (36 [08WT/\;T# MN<&=7\"ON$0LCN#&HQ1R%WX>>0%&/'!.@-?^&9ATK'0X)#:02<==@DH!C'Y) MCXW/2,D!K>P0(@"!9]H!:>^I/1-+UU5YL&/67/)B&OXL=&TG;A3.WG9\BS[V M'"OPU]^R@H^DBW="//=$B.FL)JTF_IVY<>K $[L=P_'[>:M/8;!O=.L%5"KT M0"?G"!-<6=."R[%^\HP=SCI$>P TR'$)&V\(=-P(]G>]-F-19BZ2S/\Q^\!^ M!]/1<-+N3KJ]*1OKO>FDTQ\.-(WU^^W)OP>-NQ](&/'X/2"UM3&-0K_+V^&5 M@W6J<5,,OS+CWPV^[.^[?0<'[U58^L+$;Z.Z24XA.OZE$AM_T3VK: M\%N**.9+4U@/*K0/"M*')0-Q/8&H(6_A%L+H<77G'C_63E717:8\P6+"-!BL MU'BY4;,P'!B5#TID2K6(9%L@\RY<;Y,4BI?X\%A8.U#UX!]$;]HLRY_K>0P' M H\?!QZ,W?,4!UB/,,IRL>PQ?-]2^9V/UG$C!3?W1YJ9!1(QZ3S;U I)C2)J M-!@-1A-CJDX'XWYWU)GH3.MT!CW-F(['VG"H_KLSNE5O._#_M*[6QAZZ[W_- MS#' 2E5;G219.@74N>W?])3_!T@ A@;0^\X6CKLJ/]3NC(*$]P_=3I UHF;1 M$;QYG.GVTTPW7RGD5+-I_X L_7!U(E0/3JNI?/(-Y:;Q\/CQ1P-4'%V865 U MQ. T\HU$)W?97+4)H*<.KB$Y#75(6V&_A$JYJF$E%&,ZGP\SH).;M.!7N#'! M E>$COK<,V$ MJNV@D&H;V!-G#J(V[4]Q-5=_UDV+Y *Q:"].: KVA X,',HU7!#MF@JI0Q&I M%^1\0EH84LX5#=E[M7EGDQIQLK[*&&V0D6L<]2[!>ZE2&KUU:CFD=''=C)/P M;?A1X$3GLREB(C4_VZ$5+^^ PUE=/8<9"+PX[D\" ^5%4XK>"W"B:P0I0_% MECX9A J, M#U(;"[>9*SOK8F;J3B1! $I']*Q*0%]T^S^P3J]@V=@<(UPBF:>%0L^7!Q R M=J*DL3"S$RG=4D2\*LHU4/,I5XI0Q63'R2QG+P9#O[K3/SQ@X>.!MJ;P<4B/ MOSQD3D_ZX#0;.9Z7K<(&+DXI:B&<,_SZK#VAL?+$K!J>'>0ZTP2]Z'?+&2/^ MLWZ@?*JW=9TRY,[@SI&R-(:3-6%^8;\P!(^HM+]Q]B\ WL@VA;*_$'&138$H MJK#IU)R8.$RD?MC!@;")]%7W9F&X%ZT8_$W&9@KTHF6'F\- 0/C)<(!TF' ^ M= 4IMG@,OH1NI[O@&7RD,&P@YLX++&-NU.<*2=W(Z%=/QB-(Z49@@>J1HX"8 MS/L!][ZUG,G/^#2 S,;@D"S@*7"@6!T-=S]2]AU:30 J6LNXA8>'>W@)U27E M0Q.8Q>THK >A!0IM/0A@QX+=\MZ$VT+I4[%MG]*U8"4L?>&Q-^$?OQFFM[#T MY1O3IOG03;^)Y10.@9RX2K*D\)]C8WBKS0WB(CE8O%G\W(*?7F>_'_9:6EO+ M_:G=ZN1^O^Y1';75'0VV/2HG43)< H O*Y#AO#%],GM93H8C=XT<)\5QM(+< M3& D[=D]!1S_?>R^OB/JI@!AXQ^1L*W-?C[T&I9),CS5 J_F"^8O\ T(>']1 MA)SB99+V]U_1RDML'9: YJ_2YLB! HNV6\YSA8M^WL5GWL;A'$[@HP,#9W%E MQ6;*A0YMB<%$\<8+Y9OI4U43AH59F2YV;U\BJOJK(^R1D+'E9"R[K;R2;GB1Y8F#1IWW7KW^-I1P3RS$[ [-Y=(+\>TLV< M*S>6K9]T1*RGRR'5(?EV6Q#C9WVI#'GD8CHRT7#A'>52-+I;RFI]BKU_O]'N(4L2#3NP MWJV\O-2_-FDR3@K9-7 L[Y8$_P5WY_2#+^I0 3"FI,(U<&M2BBV/>EU@--<$ M #9E+@F5+GO"D%B\.'8//N+MW)%R/Z& N\Y(TYI*(N5-1.&F+FR\4F[0B1)Z MUX1O,KFX481NXCM^G,085P.YN),H'9,,:,OQY(\QCB1U?^ACS0T';JV\9ZZ3 M-Y"QN>(Y$RPYF;P6 M!P7.Q4]V^S)S+'CPPF5S,Y@C4G MS*G)HM 4?;$ [)$DQTNFP+:%3YE,W$!$ M P:VB&?A- K0B_&>"";NU4VLHI%UN#"L\I'T@2M=FW>F M-Z%5 )GWF^Y>Z2I$E6N_%SLE95U%6_LS%5S,72.V+CU*'6/ECXDXPB[G1WSO_.LKL!$J]LF^ Z10OO&R:WRP&[! K9.P2S M&W)FMR-IE%M9P596S>Q&R.QZIV)VYZ_X:9I4_ [([/K'4?Q&;:GX72X![1^ M%XXZG!>.)=_9(G G,]UCQN[M,$9=K,N2TXH]7=;. M3);M6PTH$R&%?-MY0 /V,\D6<;B4P(;.L*5UNS5SU]=U4)W1L'Z#JN5*:;VM MCY+1%E?G2\^)ME!$I 6GN%<;:_%-L#\1D[T YO,7TI$R'.I*%^B'PXNT!Z*Z3*010:R[/*>D=R':[3#_B.P MF:*U>6:=M,$>T 9;JFSK'FISPAR+?;::W8%V.>;8O5%4NP/XEWUVH?#JG]T! MV61?YK)B*%B'5F9X93M2/E:<]>WX3/3)6=_*,3B?[:&09'9_,KLCA1U<'(65 M8$J :4O9LE#G>O]KP6R/\5H369 ,D[T2:HF0:PRWXU5W1=QY3\;:'>X8];84 M$BHD^F:/U:AQ5T%-O_J$W>T-D]H=L>*R;=X4+_8$5"3;%A%5(L&WWQ:Q.6IK MN,Z/>H9G1I+9_0PNXMN4BTU!(M6\J[%9)M^VT52_C5&B'7:-6] M7[BF)MS*"09W9^,KJ>@OV8EJ[%6J\U\ M92%J2<=]:U-EYQ(5D6],ZNP^#43QU53<&(9#W9AP!4:U\V*>HA(TUK]SJ.%E MLJ MU@D=^\RPF8=E;.V)%=#W5)!4W!A67A9U2K5^]];0EW%33MYG,.P)K-TN ML2&YC[]:]"M0*B_0>:TE/?XA;"H8]X)-M9*%1SVRA9_N3JN>7^7C^\F$-V#\ MSB;,?*:X>2$!X$)G&GW4LRCR1UO!.)EDCD6RN'JZ";#-BQC3GHJ:LF%58T0* M$B9,HH$_PA4AD/ @T1@./%WA7MSY/7%Q%%&::/^=:&3)RQJ'ZQZ_)7P)KKMH M9;G$R%-L<"G0*S">*# >EC8VJ;&8TE0:VOW:#A3_!ZL9S MQ\>,("S,JUOXNH4#H_3B\L@WC<=O[S'K(G%BGGAKV:EIZS;=9P*;-_T Z:T' M=X2S=:/BSL761 'R"M=YO*4L'CLQNZ)+XP636=Q*%@9.-9P]AJUCQ=B36PB/ M!)4[ADEG&/>I[;64/Z+"G,6&#PAS ;% U:A/Y-I-C0@F#A +6?LN(WAAB63= M"MN@NM&\X2>DCEAK&VL=!YS?8NI,SM/';*(#V>7K%JUL/+*HURVQ:-C\5JGS,Z]A''7/SWB-^ASFD._KR \.?D<2B,M/AG;835I;EQ!P+[K.0 M:-.VBX'BX5SW[J;@"[RUNZA_BB7 <=F,N6F;('52^68JP(V1R>.H#:P-9\"Q M)PR#)(WFYCGB'L"(+3APU-\W;#L"<_?@^=YT*7B"P[<\26$B=I9="EHP/&9\ MLUTQ:Q!8$ 0B+ZQL@F"OFUL('%2Z./?OZ_2#;KK_U*T "_/BVQ.(SDD,[+<' M6VJ P]%CRC,^,/P&)LR>D7FNWSW8E,#R.0 43#28.$^V&39:WK0C"6DCIGB! MK8,,@&L'2T*AK[3BHJFPXLT8\],8-=BM>.E_X<)RN72]+55(?@@ PUJ']/'> M\YCOW8>'^8/CWGNT^EP5>L?BP92,9NFWL1_+:$O'=SH8)6>93C\?GF*6HWB6 M(X!AJ[LEEQ"PDW>(P_K*II>@AZ&T6:)Q.:TBB8K\NG?PBEC62UZJ-1.%_[$J M,S%/3J?*XVU-!3@\V$($?P@?_=4.A;?X7#\"F2-.!H(;T"DX=7$#\;)HZV"7 MEK0-\M%VO#G&6.MT$&OKHL.V8 UY2C[@C, -U10/YH9)1:9C>"AET$UK M>1"\J1H"!8L)I]9@"9+_S6+&$S/N:76!:+JX(B4A@5TB>NN6*X0$*8,+_C9L MR!%)/QZ="_[J4*2(Q4?\'>:_[D2>GVX5X9,.25AT 3]'4N2Y=9N9QE.*IH!\ M_7W@.@O><>41?M47#D" FANMT1M0J$))O;3@,UPG^*QE4C^XP"WXTQ?'AC/A M@-+/OKJ?S#F*$N$7;[&%3);@;"RGT.]HZZ0F7(W2\QO5;GYHV5\C%(9ZUCK! M+\$5J6D//(!D,1P,;]BSHDY8GD,XT_.0AD#C#4EYVZQ\;.T,K7Z[=DO?VR"0 M;UA[OM@6'X&2L^!>K(30:2RGET9:J5=*+?4B=:^L6II4"<17XV#)W#1X$#>@ MO\V1OR FBJN>B>=7K6WNK6B*X;)G822-#3K5:3G]+:$FQ]5R.M@-NK]._M]= M[NQO<6$=>9;87U;=)DIMT7+P(.>RY//1>/IK?$4GT7@P$:!3O7[=KY-6!]IU MM[W.\;H%=RF-9RWXUFD_-9=U/]HKF-_F2("CA%V=\B5[X1_8=$GCU69!)A)W MX&6&>,!:0:I)G(&Y?Z-N>FSADSG,V)?- V7SP&3SP%X=B^ZMRO=$ MF83BD$MJRO7Y9H 6%"()6\QH'(K9%&IO@;26DESZP-P>=C8<[*I@K 6 MF2L$84)1VH6M?Q+"-*(F#Y7"6; MX6/(5B3DH(7K/)L>6FZXTB8HSP0C&Y+.V <>^W2?,-W,L*DU-F6V2;!,&*!B MBDK<"*1-+QC_!W!$$57&?V#@P@N'=3S-1#C+GP%L[71)=Q.*IX!D%>%J/.'VFR2_FKEO(!*&_@$N&E.JM++G)S[26QDD)?=B:3 M $Z]46O8+U<]=]VCAJU. MIUSUW,/7X95C*CZF?@7EBN55)0LWYZ>N= J58FW7I])DP0JVY 7YS+T@[V,O MB +BAE(@^?;X.U&@V.?9[4+13.>F\Z4[)S3^+C1-"ND(][4.A M_*#P+U9'&Q]S0:L,HO)MK/R47FVYH!*V9PC;TY/[NEY5K?A;:ZCM7V7]&BKM M/#+W&?MZH%%E[U=QZ%'B20=@72EO+-I6E.OW&W+FY80N6LH3+86CNS(IHS. ^: M3WX,>@:68+3]-[>C4T3-T5'#*J$3GLCN!ZZ-"7"P9+:B4_3^2HSH=5AV M;PXL!(=+_IU6_*N-W_%DB3RBHP+GRII=,@U=I<7EU+ YL#2\"37%69AV'@88 MB:N=R5%IT;D<.4+'4];S),E1[6!S8!FZ&G)T)CZHTTNN=;UJBT1]^@'*JR[C M*@DT>94$FKSJ5/G%^9_$PG8B2SS,AIB=>VH*MS<,_#Z20Q797A=A^$L5@?5 M!21(E%XW2DM;<8NC=%A!ZH!$J43I+E;C_>6!T67+ Z?7%NIZ58$&GX5*($U8 MHOJ1J+H%_YF;5$?-^^%\ (P(<"9*,ZTIC-1MU[\P4EAH*JZ(1@U$J?2F=\EE MD 9J:U!1*9U.I]7OC$H]ZO#U?7!0ZM:7[V\A*)AA7I/,W6))XO=4(8Q2PQ/5 M:O!CP4HJ%:7=5Q!:=O#ZU07K *'915E+0VHRRBC>K>X#3<$P/_SN<":_;16 MM@A3%Y[97\]@TU.H"P^Z-R-!RS7'<>\Q@\O]4N,4D]HFQD]-:N>OB6#E/KH[<^!'[@LA U M*3 ]4*EF_X.)2/H_IN=B2L66N;4&U34FL(8*WT)?BOKB#O:TX07!L3G-_@3Y M6G*+MG0UVXL@:XV[=3T,ZI%()%/2=H6-=BJ"W&W<=?8FR$?-3KL&,3F/(/-^ M!8M4>?E88I:2!'U=*RG6$S6!-K\C#$^9^W0NV76AX8@&W4>T< M-ND>1LSS36SU0@9K[/M"K7DVV5A6+#(NFUK4, @>&_ZP2'52\'*_:H/Y>M7#=L/?0!BZNC'4+^_A0][&P M@;3HL138>F!0%W%82;*54N=,<8?BS1CC/:H\T_/#_8H:/5VEF!PY:7UOC@N/@A M/)?QRN=9G(:-NTZ_WLY9:<<\FAUS*X *A^!WJPO!E^"J);AZAZ=.O392I[X$ MT$4"J'\ZZM2KKDAK1>"ZAHBCAY0 :)GZV+1,WV37%EQ4KE;?-C%P8ROZ')^* MV(5/\?+G'1",VP4^&'-433%M$PL. 2?&VVO]-*?8F#((X&W+I9^<9.?NU]2*W4N^L) MK8IEP!V@-0"ZFTTSD\@Z=V15+!'N@*PA$*U.-F%&0NOS #^VFZ=QXI(S'CT=3_P MOD[QFYQ#U&^#^M[;ASY7OH]GH/U+T)84:"L&;0>,R M"RY^9G'^U%_3*6]BONWX%GT,4PO\];>L)(%E8VA/E#?7&:Q4-4O\B\-'P)C] MCM8>3$?#2;L[Z?:F;*SWII-.?SC0- :2YN3?0R""XJ:9&\<>/[';L]*6'.Y=<&%B5E8THN(;K5XRQ@ZT8WS@XFXY+@'J#Q\W%JV X>FW& MHLQ<)"7_LWWK!HT[*J:*&3R81XT%$?[^6K_+@\4)LSXSP=Z$WE%+*9<$^]Y^ M-EW'1EN%;GUR/.^!B,,3LR?+. ^^ Z?GTZ,33T_2XU6 MDG>3E"E^$SXUYUUJ'=-N$[G16+W6"\;_H=QF1V')E5 L_<6CW%R7/046=TLI M+XYK&7#8F>+/=%\QYT!.F6*9<],75S@\,]> G9G!? FD"\<"2JMCW0[3AA?A M!;KITM-?=* S3KUN6HB_@ MJPF1@@)[AY^9_03+1P_7L57UDX/KL'"="?,H(S!8&+I/A8UYXK3O@HB((X<= M1NLB6YR1AY3)?ITS[]!@3WD[%6X#D1(6U8&#/NFOB_M'; M0IXP#N QF!;,=+U/[ M +!R;!86 UBX#.@Q7 A?3^@*W)X]LO93!.7]+UZAW7N[Q/_DD*E>_3/U<8-Q M:6#5< =@X=);B2?&,/D12H0NPE8Q61W[S)/(-[]$F7(LC:Y7M&FF5F\=27*OLM/N8 MBNHSGN31Z295RE/L^*L5??8Z0N%*&1W7M ^:L#?A<4DT8,DS*L*6=^I=54V& MA>R(C35!DL6Q@B6ZV@ M0Y<4\.J(B_4$KP@NM,;=L":XN ;)CA>Q*>0CEH+?+K20%C@59_ ]7M[O# ;W MG'\0L$)$3;B_E B/1"!W!DNO/F"I-+%/;:F]FE-0:@4M<_F.3%G#"*[[R<0- M=.N#XVX(/LTOFS+H-^[ZV3#]W60-F5\B$;N9O%>!V $@=F\Z7PO$UK15%3WQ MC0G[84X*1,@GN'.)B,E3Q(6^"R@XVJ2X;B/P?!D>?8XOX!'%?(58&#@\P5!3G8+/<3#.B\TM+1A] M^L(P4II^XY'"S&C"6>(N\*;BN(L9AD*[2IZI1KF)VX19SLNKEO+15A"E.)0F M/G:ANU%GJ?"I<;@RW.:_,&:G)H7S_E^'36:>K]S_KMPTQ(?&*WAB(A9ZX;@T M8_%TEWD+[&1%JM.2HN-7HKX3H;<4':TK=D"A=O"$\(6):&D*D5=@.VQOREP7 MWBAB\\.!GLKI?(E).W5R.M/A!2P_B%!Y#C!/^&( A+[R,C,GLQ08YG E7NV% MF2Z4)6 _.]8SX\D9+\SEF1EA*@SB:8S' E,AJ3,;X TS0\)4&<6!TQ:FELS@ MF& V#S/2*074<<]@/!_$"V!8R< (N@W'R9[QO,%4X!$>YB' ?6,*(^>)$+KG MV/!Q*=H!P@^;'U3&0<^)8X4>R"#R]"O.+^5V!/W- CRGI%+E.^=DK$E7P27\9.$Y_10]5_30[(R&;6*T M(.]BFG13'&>+Z E?$4IWNL&T$$;>+SCD0)8CE@8W-R($-5X1'0'"A73@*7[S MQ&*Z'2S$^082$"82$5%L*?=P/)VHBV1,+&T4+7F^DD@>:L+3)U: HFSZB!=( M/&KR\S]&F8&GIN$RV374$$YJ?'M^S=86XZ&^+S"R\*]PEWB))?R MS1BNC\=_I95RDNM*N4.)9#"8RU.8-1?N5)BVAMA$4DR+1NEIC'B-V+"0J9$X MRO@YB)JW C\+7$IFF^ Z86XAL1EGSN*=3HX7&$M@"VBT,/W68W\&L#36,GU@ M)KJ-8](G$WB^CY T8%3N'*@%[3Y0;VI*FSA)65PB,E9AF5BD&E#SC83PWN-< MF7@QB,0>38#I@"\AP86"S. M<^4!Q!9;'UD7R&WP& -C\EI@DFG O;Q+L,F?:%&Q: M9%_.S$4(N36/"S6IL!44);.2*@7J3-C7"7/#XQHZ>;Z MDPU:A<'"7X7,! +,A LG1,4$"[2)\.F1ELA"304_/D4AN(QW[=@[CKPOR>ZLBIHNM27.GFVZAD,W7C(AAB"[3Y@U! MB/L]ZZ9% G'-ZS9-6D]IBG- M&&2P6\$CTGS[D_."B-(!J' $OX-@ 9P-( ZR"5 <8'F?OGU_)$X;O82VBF[K M#&YA!9#=N,Q'G44T"T\]#1Z1]PX8#-D"Q-%8B0Z6]5&VU$<9KJ^/(DN=U&$L MAREULKXZ1RWK<,!C=/>G\A880TQ46MPZE+1+(!58ZRK@5"Q;C&J0=!=\_/(A MX0[^0K=\G7[CDOM'(GG,^&C_X;&%_A7-\Y&7H!U["8:-NT'6KR6X;JPMH-@> MZ@0DDGS6EWQ.:KL]4.X-.%$@U+A$C11Z&_(GDJ.!+865-11087B]#!?Y%#SG M>RA.?$Q*R*\_@.@76D3Y,MXTOG]\_>$1=!'!H->16%0OR!M!DI>!4MR4%XJP M0&JU0MDLEM5P)V)Q+Q3,A7BSRCSB"^?FDYL0'1(/3!J'B9=$)#\?'#5GSR!D M4T9\N-^=?C/:2]/ST-Z'HBG:PM &0*58>!-RT^.6-1*$PQ5,&MT$]^2L==C2 M,!N:14K\1GO:+QJ*=\21A$Q/!#VLN-I)IX=/4"9!YY/1DW0WI_0 M+Z#;/TE'QO_B]L&Z,QMV@S$T/TST170+B*H@AEM<-87+<%U"V:Q#+"SX-JP'%(#^XBJC[1BX M:?PA+MUE\[%Z$6X,[30.C&R^8U*%C&#B\VHU9)9)OH7(GF&0MNL%[E2?@! ( ML^":!Q$XF.JSV'-!#6AK>9T4Q-0RM$T@7J(3D$76)AR51,ZH2N3$WN5ANW'7 M[69K;7)XB)H&=2=L27;LO* W$ [Z:[3FD5H.GV&70^U,8.+9G "GXSIL#AWA M]OX95<<)J R5PM#+@9:HL @4^4I-N(Y>N"Q@/\AH&$*>@(/YC\!F$6$>-I6O MDPGQ/#35SM@<_>DP1W8\]D4C;T.1H!F_'"A+9;P)^E MN]PF[J(?9QH:(H5IM .R!W^UAB.*E<0I&5]1G8>9$4L'\I)@R"L^V"W*YK9% M?6XI:@>.YP-<$\!8/SB_E'N*3-";0#TGK::"1=VMIO+%@4O?=(:W#_^\[734 M@:;JZ9D)S$XJ@CD28#K(<27_,8D-M-43""$EJ^E_ OI'1J, MA<,C90_'#]$8+3Y&U**IGEQLHD** WOY #JLC6:[]$C>>Q[[A4M@^_#(>!&X MRP)M/O0@$_ PMT,)+X0C;C\!R&'8N*:-M1PB*0MMW4D9 M\&>=VZ/Y\O]ATTIC\5EXB>603*-'\CBP0UA I&EYB L9QXB6^X-*S3<^>.2Y315H9M03W(@(=0CI'[*L'7UYSM ML2-4C%7)#M^6YN3;Q$N8(/LE$$-(4F(?%-"V96BA+<>*A^OCOO=CQ1T0XGKK M8A,%*VZN(.(939M TI1/<(Z\D$AQZJ2JMP--[9>D3(T5;-W3*% VXVPV]2/5 M$B2PB"B U.E=Q+XO,JJF^$+H3EURM'@).)B\E8EQ(%RDX@K^1LX/K 5I1)#P M'=#NN*)7$VBH!:"1!#>WG=-DPDF9G(!&<0MI8O\W+S]DH9D,6( -R@9*Y.(" M"Y?Z"(N$+WT1C"VJSCB?A_Z3"<&/-*IGW:H[;5[5GU6M&7M]RY%>LK^2V"A, M'*!)+,.2IWK*" -*)O=+"C=LDB<+N:&)=4O)LD$D.TA'I?T9 '_D(EM@F+1W MX8K'TM\J.\GYEA,"I#<>LNOL6N"(IB;ISXH-4G$V;3;R?-MIS\:%1>U52TM:K>43^9/SJ^8[H).XH: #07? M]!VA'L>=2)&,NU:\701P/,B_IPL]AGNA"LK#7&;BQ9'S1&,DNTC2$^?L:H3D MI+Y/PD3 !S-U',2,9 "FB9RBP,%3K$Z$?W*M,E6YG MNLLB!3\5\O&2HT&MDSR:&%3T;/+1Q1L"[[70'$7BZ!K)$YRG]MQB&58Q9)$35 2LEX19[[FH[1^LRAN M:<6Z&H:CSQFBQK$ 0?I/=-4 S$7#&_/BGAO36_F+)K*#_8++5LA#7L)PWZ? MD2]Q@8KND*6D?NE7 ,> E*EO-D-'$F M@'B^\/&\\G8!S!#F5F1[1K^?WK#_U^@ MT\3#T0)G#N,68Y\&(O\Y+I1M.R]Q\%I+^=<,HP=60S#Q>(!$P.#$DQ3D^.:$ MZ 8<>F$HMH'FTIKI6/O<$[9#3&+@H7]A!7IB MGH$[*$T\-=GAJ*HA@'=1@[ MDHQ%B2),,(AU8BZX\( $[#8.6B._F2<"!I/OY\N.8G]VU=-[&/&>%#5=%4=- M3Y!A3DQ60ZE%A);($HE5#33HFV' 7:Z:TI(Q&.5B,$:5]*CIR1XU5Q"X4;L> M-9UVV28UC[XS^3ES+(P9??\G",M+3/79U)YFV,^VC!GVL^UI'E$R%$_^F\*? MO5.7&O[PG%>>*CJFI&#UP!,5:*5K+DFES7]O'5WXED&"F?B.&W7$(&4<9D\& M .[# AFCF31J47XDB"Y1C*:"[B8,9U?^#'07Z!^VI4$3&D7RHSH"B\1#K),Z M13R_NF19-OZ)+XV? MF#6E 6AKASKU'XTR/(IHDDYGA,ZN0);Z#N;]P$%.QY.[5B\91'VQ48S0!2K M[W'K\8OI";.NZ+@<[\=*SB0:(O65+?%"XZB0H'@.!1D48F__[Y8S1H,%2+F@ M:]\G&M[81IAB2VY#&%.PQ>P*BG$66LH-P4QE>0RH\(XV+N M@N*1H^&)++6 Z@Z'<0YSW6!A$%6\.%E$Y0"<.COA8PRVX)@,XZRYZ\;'*'PO MC)%?;Q=.-F1JYDELS51&<;BJ9MCOB+\-%!$:591'LW'L%*H-BT\JRC/(M350 M0@N;*\0>&YOHPQ:KWMIC/M22YUS=<,[?A<@*G_5.#"OOH _QH.?%%L8G7$CL MR6..WY&ZJG0&332F=9OB; K#:4G+I;:YP$(TH\0L'V!92ULR1XV[07]+. S/ M_I>AS2(TX'I<1DY FV>(P,C"UG.$"$QA$?>+=%_,[ 5R98-&1"ZO M!)$&BA[RL-!L 0\*/4 1^?1$G PW'=-A\\(RVM MK6WKYY53J"<<-ZPW.]E5A:;845O=T:!(G[$5$XNF\7WH M)AVFBK7GHG)CR@<@.]21ZP,;NP'Z)=5V>TC?_.!U7%:ZGF4:GN5O4T>MR3;M M==4U%.Y\Y P@0?D+]+,[_=:4+ 5Y-87$.#_/RKK=-1Z]D/&FV"W'Q/V$%#&C MF+P;2_>C3N.N/VIJ()YWU5%%U20/7T3LPJN2WXM2!PEQ#OU(D<)U+J=^[ZK8 MM=N9O^Q3C[HPS&M&IS8:';H;C0XI4A42*0%O;+B\P<(X4AMW0ZVU-JY(5@8_ MAH"AW)CKNYO6F/3(VM/KSFC6>)8ZI&3X#T\J'M'/S)\Y!06+V) VTAIWO>:P M79?NE2?H4+BB0MWB]:3PT3.XN^#-[>@4YC N93P]N>P)(SQR3&$)6]**57])+R^?I6*MUJWHS.+3L#0-.^1T1JH>3 1%8D2Q74XPW<" M'^L[!--INE-DJ4"A?G94P+?M,S_KE3:^YLGQA2[ "F.)^17-#%9(U=H:JK Q3\Q^M&>8#G&&ZQF_PI3&OQ*G$JIE_!WX!LH;"W'N32X0.>2-FRIZF;/ M2V$_5:O;5DL]:?WW/2W_'7),^W"GU>OT5E>OD'N@WDN7<;"N,2X4F?!5K9I6&:Y*KO)9 M+-#O+L@YY,OG6O5!(5:M8-2R)8K**F#I Y7LO0;J$.UHGNMUVI8:*UN/JYWS&Y9K'HY7N15,KH1 M ?W!<1D6S.%96),E;WTGTN:QAI!R@[W#UH<@7*:K_Z:4"V_5@8 I:,0+9 UOTYS<0;R5N.NERVG+G%V MWCC+U% _-7,P]!4A^CY5?+"Y@,.H/B[$W,^QRX^VD$5])3.ON9^9=M,SO?_'RP@]AR"!< MA$%HC$HCPW_OL=)9?':\C3R_"TI,3>)<=SPSI>FSQ-KAL$8HVQ+VF$!?KP%8 M&ZH=]3>)08G!BC"(0D0^L>M+8G>90-M#&#T48QWD*=,2:Q)K1V&L0\E8)0:/ MQUA']2%VU^"<_H:;*MH9+ASJ&B\*7RIC'@SD21_UP454L0MP*NBJ;ZF-$$%9 MWRR82#'S>Z>=U^M"FM]KAZ^ZP:N<:-#I5"8:2,1)BK;!,M]1)4&[/'CM(7I6 MS3 UB:^SP%?=X%62878EPSPWQ-68HFUBF+G=[HY.T"IR8G.DJ"VU5W-MF@H: M[^.U3J?$: OL?AE@18?_V9@0<_$'JXI0RHT" /ISLE6:BA^8"O?O#&RB$J:5 M*TQK<#G8,S)MG .8E2B=)C!QAO9/*C_81BB=(+1>FQ M09H/3[5=182[!*D$Z3YVB UL7NT 0*LJ97LJ@!8H@2O;;&^IT*JVU[?9EAVS MZS"6PW3,WK'BZ?UD$LP#"]OO;N:*>150!ZJ:J8"ZOM7TJ9I*;SPNB;@G[*R8 M6(ZH2G2R[JPIZLY:O.ZLS?RF0OUSHP;.;TK4USV+@K#=7FNHCH[9;;#0L#J= M5K^S=5@%OZ^J&J@<5)E!J=W#%4X]2(63%QA+E+CA M67Z?-H8/5EX7KX+^)@>7M@K6Q+X3.FH20GW!)M:O)>0)(?K ];K?G33,1QU M'^W;,-S_C!B.)(Y5$<=!7]#&H22--1:X$[8#DK/)GL+%[Z0-@;Y)U/O-ZV%3 M787Z"GK4=60AVXM++;OWJ/4BFS#JRH9M-S(M$@X&*!F+VAGV"KHJ"]IG-WF& MM,;=H%V#@%,9SUPQAOK'PQ#6#QI*"%T4:5,87Z*2Z;6+KGF5,8.77R/KF M>;Z%0TI2]F%E 9O?5S=Q4QRG6E%0_)G%NITAGLK!:8^HM5U0A T<]J[V*J%4 M2](T:I^(-%438B[A5"\XG09,&K9K.#V8CFVK3+B9Q"-N\?HWG5Y"C$V(K:=*U*R^T@WW!;)ZSP75)\_9=RLXBZ28?%8Z4M]F2VV'W3D;6> MM+*>!U*.9F4MR?G[LG+\14-IF\A9(90&$DKG!J73%L[2]FW/72_C*=_R4A/M324G5@./+_+\C8X78Z.-&G>#7@5A6M5M MZ1F8$21^-^-7/1I^N^T]:X5*^$KXKL)7.QY\\ZLX2?A*^.X,WZ+1-A6@5P7A M8;2/8%\+^*ZI0I:N.K9:EPP#(W 9MF=S@C17J#C089&528NC:DB=3DLI5TF* M P/P\,[T)I;C!6Y.F:BNQE$)R\>,>U]\AP]+%X\2]FIX&M9^6*W\EHS%R*\R M)1Z:\RJUL7.%K/?3*9OXT1F P7V',_*=P0,FIF72^]>4Q^IV,^6QSK\>U$!M M#2Z^,M'6EQ]$5=[WJGU2AD?G6>7HQ\QE3/D,U\T\Y;UMB-SKV,YQ,!M'-?G9 MYY!276PG"AJ4"DUXS[(!%[6HQTG*K@?I.8>-*UY@8,%<')C^Q*ZPPD D-H4A MM1B%X(+D=&5M:M?J:G: I13']&3W# S@B1S0= ]Y#U69:2O6O MAV=0MWM^(SR)/QY307C2A^_ -2 LV+H%YV7LPP]3T]9!E[>?%!]+HW)P>]6/ M3DN/SIPO=!R9,\7O7:9[\,.S;@F3AH[EI&%<3($/?[0>6_A&K.A*0X#K#=-7 M)KKK+N'[%]TU/,4(&,YO,M-MD#EPF?&6B>[QMX3W>TX @HD1S@C;R\.8 CYM M&)KN*P;(7;:#BW/K3":!B\\JN16M$H6P3P']CW94_R@<=&?0I%D"=50> E@T M7)I_.&-/N9_XR@W^U/CQ\(_[QBN".;-A_V %\"KZ'&'E'[H=Z.Z2/S=>E,Z0 M@XIV\P?N>. NE1G<:GI>0+L/YR/P<.G-">/O1W1:]-?"=18.@L1E3VBH=>!F M@-!/%# 5+U@L+"IF2$#&6H MS]RTS7DPYX^;*IW>7_&I.E6SAS>.'>>GPG37ACT2E"S_WH4.)]WT!#TA^R.2 MC< /8'A+> *5Q<=) G]&@LZQX-+-EJF/3ES> 1#@]U\>FSA#<"1RA_8"^\2/DQX?)$[@ M<;AB/1,L!%]@>XR_'N #Y-YS^)L,&$-("'BH]@2?QG?(([X#W[I/2R0X\!O? M%;XT< ""*;R4#F>3\S/8=5^P%"0G ;.\IC);&J[SQ.S7P$'&\!.RB04-$B]R MX04O! ;^IJ;R,C,GG)&':P6@88); 1TP\1%/P(5PNB 6V38C@O4?9+YU/_5) M"-!.AAX$G S0-=,7O)[# EEGS+OQ)E@MY2DPC9!=)];I;[!C<$9@B<+>,IRL MTWM<+ R:E@: AH!@"9OMY^%%G'#>KT+P9"%4X9_1&$R/DVY8!*+C8X9/2K"H MNF_).[[X$1_#)0M@9@!E$-^6N$SQN4H+-F+9FBFT+ESVC"?*6HI%)[*\1MK2 M@9N./5\'$" _A/.#EZ"K^LP&F;&$@2W%Q?HCY(8N7* V(Y)1)F8YK/T40XQ+OR5LA$ M4@SJ&1#!NL,H1\A3.QP97]TGW3;_RR>'1/4]G'IG;DY@I6Z=4!TFX+V#V5K. M D^=)O#S%C?D MO>N$E;*5;ZXSA3U\G)E3@L9-X^W[;X_P!D$^6R!\*$](B'6K*9[,'VP8+L@+ MR++8KX#4+C@@@K[@%''+>$*7X*E40UH'BO9$:>\P?RYX<.H.K"NP8 AT!TR* MC*K -V&\-XW/7][#D. 5*/UX-)-Q "(E#* 5#@IGJ9MS@6+T!7,LPC@4N-\# M:0-.KIT'0!@?R* 6BC]PBQT*-# +TXW%&IOY(5%$<4F'08OC\1_@>)YA"ATF MFA+\M.1\.=K1]' !RW.L5,7)[S2P0JH3'F 4SGT.?KZU.JZX1UA@*-68? "F M#> WC0 Y-18?<'%I#8=+$R@4TI*E1*](K* =YHO23*TE?RL.@S]S2?ITO&$V M+JN8&B<>%GM>TM.#!2T?K#Y>DI;A8$(&\!=WCMO'+\)?\4*3-@EA&.^%3KN1 MMVDV32IG>S@1]-&1CT,R2319XEMLX$4A,)$&$QBS.TB# K1A&D(X>CQXBHMG M;(7LR*9PVYK"=613N"MM"K\4#4(94CH!-%_'X NQF"< M?]@XNYO&^S^ 1P4V\+4YE_6>':$PZH:S\",J\K;4%-5W_^O*+".6TE2M*P%PX-MYB/^8^75ANERJMI?1!-+) 2P]Y-P++2!I_D-58VMM^[C5I3(8)CT3!'#CZ@@EE#I#*9_ M;^#D2,G!#?P]5%+Y-!$-0J]3/'V*5DEWS.TL0CQJ"DL:7IF2'DD( 33XPCSF MPF; &"-)%W\*31<@IGGP?H]*046/L(3"#]*[OLR #/8T(8W!SJV#U"#"*1\( M4@(JI@![S+UU^*RPWE0('<1P9%'(X"*Y%K T*#!9222U2),PA)3LL;6+EY1F M$[KH+PYZ%+1P@14/53IX162^2A&QY![XPH)'/2M@2J#&&G#!(Q")__)/3>5W MD"[AA4WE <15'7Z$&_6%(^Q+#[JM&_"MZ?/E_Q/$9G.ZC'PJR:DD]XKDUV@, M^F)AF;%^0P80RQGC'!*'"5;;M#;L7,V/6&';E!$KJ5P#C."46B$ZF\3((NN< M\A"A(HF5R!@Z9XQ#TF5_!J)CDA?MU[IQ: MLS.N#IT1WH KT208S PF&GN+B/4K>H"FIQ &W%>@MCL: M^H.D7+\R!9^ MKA4GA!>P; :KCL27N*[R'\=$UDYC=!G:\!+\1D]W_24S.0@#<(4YX5S&$(!/ MFU"$[6',_!=]H&,O$"9$!V? #04DV1)SH96QHKM=7JJ;CF5 'H8H?E[80ME" M)R GIPBG:ZQ[)C==X+U3)W!!1@1*[OJ\1]G- CYC'?%[P.K=V!YPDW MBH@6>!?X$SHP,"8^MV7&KLJ HSR1&SMY;',?QSEO:C]L8ZUM%LU5&*,BYKEP M4,S5T=(1]R["<'_V:_X$#:PLA4\V/^T8ZFF-JCOWFI0 =Q]&&) M/[-?YL0AF67=\2??4G:Y$"4*2M M2 HVF4QQ!1JZ/UDI,H?+D=5SE/#"(@U3CVD^EGOC/#(H.*(H:LT9M+G^-E& M&3 R0Z;'PMWF&W2P-60P7"M<;%.W5R:/E 3)#7T9>0]3VS%*;4H--9T:/"6Q+^5_G!34*/DI0S.BU*$#%8 3] M"#=M3-A"QL(,#H?(SP>HYQY6\K; 6'33XR0_@5&#>1/7'"-]&#MX6BFR D[@ M,[\4T6#;C,\]&YF6<(P1>L34!.P2Z YL+YA@A :Z">"Y!IL*;01'$;EW5WE> M8!DX12$\"VL4,GQ^V_K=2?MWX=TS/JV BR,8E^71 H6/;M)2T85)D2(:0G0H MQ%:N)4V1R#HE!T1J(#?>J\B%*NWP)>WPZGH[?/$,4FJ6+*WW%V^]KU]ZL%HV M/3AN.?_1]GPW(&)S;QO8WQT(YSVJRL0O-J8/#W)R>@?9].%$?_L//*072%WB MO;NE% ]R4XH'^Z04YZX*MG;&!/N/]F-(EK].HWE\8RY59+,G>0LT+)=G?!J% M@U>4,QT[(0\F0I5)B=1-ET).C'AWD3W!NM\FOC+CA416K:.D2][S-R5D MO+/(OU8'K=%(JR35>=CJCWHU2[^68SK?,0$T!^W!QD=5FB=Z&7W#D? KO NX M@F4EGFR*VH0O>9^]5"$61=3(X-<72 V6*YI2!%$V@@4 M\KECH&_:>]$7ZWO:7V;OB'*UD[N[-X] JH5$BVA6:!W/;]5[;QMK2M*.&G>R MC_AE0JMW5&@5[H?3:\M^..<&O)(%X3-$;4U)[=C/%V+LJQU_]X7Y>?#IR"[U M9X&92HG53DA1\Y!R_B3FRN!_1.H*Y8!2KOKMD?H$%(W,I4K^FXE-/]J2^;. -:@J\ MZEJB2N#54V[/D+PJY?9!XTX]?8=SB9F*,9.A5E5B9GAQF+E<^7*;9#[:>DF_ MG9!210K2[O+[Z0M>7\-5E?HUZ@_R#Z*V(,^+G5#V'145E$Z.#3QB6$^)MM^1 MENC+!M[HM-ZUOIHGOTAH70*TMM"T N)N<3JE23IU;F JJ45E"%6%6E2_>W$> ML\L5,+>I2+WME_1/XP+IC&J^M#\<7[?V<7FLC;H\1P)5ACZI[4R3[",+4H,* MPI1*[>*I[402CIO@V#DQ''/MDA*.EP/'4N);#GFL4GS+#=$L;027.+L G&7H M7H4X&[0K<;:4V M\KBF(EXQ7HWOIO-J2UKI91K"RPFXZNZ* M?2S?OO_%JVCCA8X-3.2C:!_]3O3[X^K^?5P"=*VF/\!LDY'TNEPDV+33@JVP M_V^@2O_?92-Q"]G;29W70)WO2KQ<)%ZV4*XJ@P\&W4LF/E?K2!YL=R0/^G&\ M(_O%*]$J3U0ZT,+B@$WL9[K=N;R?O:RNFIF\_[SOS]6L^[M1@W.W80%#4#[: MSXS+I_O8L0YE<93W7Y#%MY_//&MR8 K&_<,P'6KS D?(8&-?IE)O$%?7%#F: ML#>Q?/K%28BH?WC,^&@#78K)$E&E//ETT+CK#V1&ZID IZ3#.U,69,7A70V$ MAHV[7O^R\@PO$SV5D)U02[Z?8Z?AK]./=M24U&:$HPQHO#(*\TCFR5\VKK;4 M*CH0KH;5U4VK(:XN-R_ZR^O[_6+NS]L.M%$Y?N5$G35U9=8[.F!H M1N)3";_'L >JEU:5[^P\$O^N#7PE30/;ZM /Q2W% P^%Q>%U8E%FY,NAR:&=-CZS)DIE?LSR%\=7TG'+,N%> MWG_Z=XU:K+"[:5Q<96D/7H@2> MVCEN7+D$O&PA5#OAY4*;75QNR,R6 M_/_1]G:[HVZ!$@&_*<3W%)-XG7(C.GL5K1]07SWE&JZB37CMZV.+A87+$D7B MYKK[9-JA:;EJ& ^WH5A%%/][X__2-=?RA]Z']Z3*W76&BQ4-$;^I>GH%RLVI M592; XH\=1S?=GS&:;5]B_0?68)I!\RX]\5WMQV4*?F5WQVRJ/O^XLWKUR\O M+ZU?8]=J.>[3:[7=UEZ[\//K\-KCDR]:E]2.M5M=#;?HHXT3^T]@3_LO8[H:=M[OINQYQM[;^-^NBBD C06$J-'M]F__LO,*CT @00( M** V[L8TE$I5E5GY?H2>P0QS/3G)@!\2AYZS0&S"2V;\M)N 5;JB%QP=S,8< MX4Y<5NK<:'9O>00AG"E/Z.KN*OF5+AUUX,)Z=P_=QGH*T08!$;#!P;5[8P*7 M'01 F PD+D$,J_]B $$><&/!W?ML^861Y_O>"UYK%AJ@6C\SV\&_8!P^FS:] M#VH&[" B"@#O^J_(68BW-[NU!&&&=>,;K(!0X<\(R.K8YL+N-F6!,>(PJ;7D MA6#&&&L /U,-X"EJ[_$N)-+]-<"S6S;H)<(2K@M[G7I!Y'-<%3[H>$#78.$S M*BV!T]EAL/D @F@4V);-_$4]87<9HA\S/_A*TGRZ["DO +J_$VL\"[V_>WB$ M90B4=!8UO.J:T&M"7XK0YY#YH"(Z7U!CX#!R.DS):7]7.E^0I%[9P@9W#\UZ M:3H_*J+S^:S$??7 MN=R =KKQ]W:C9L"D\_AVI#PQD$QQ(5GB,\_CB:L<,3@22UP[JSQ6**IMKW"_ MA]7#WZ36'D&O+4GEOG)N:/95&?MJ-MJ2?S7;YV9@B/T&2^09N,2"8"!I]/F$ M^2AP$=YG;M+:%;(2&@X3Q/0GJ)9P1K9^ RZ*%<&T[IC>;>7 DDD'7EDE; M_&4N+T=:M$90UIWFQAP(B!TN"0K &@$/0X<;(%L2P4>N%:1"I8FLD?MS MYL/JPJGO19,I"/X!0 D>FK,%%4Z$3<%QLHG/@1)%?Q?:2:N(!"DI?! M!0F23DN8J=>-3"^V%4YC0W'F06&Q?MM('V&CP'.B="1-; M[94#R_QWFD25SMF$WX]\SK[?LS$L]BUS7M@B0.-H=H^PP94S+7DOJ?L. MRLG=PS4*)#2AAELIG89NK"-_W._W[5B)EYTM_S36/_G@*\^N<9/ MAC2Q!Z]W.:NKR!S8'L0P:+2*A[2Q9GK"Y@2OWQ*Z<.XP]B.'P5];(,S?,P(. MR#ZF-W'A:4O'6&^T+YR@K=%K=.]$BJ@JW0?DIM"@/C%9B/;L<-% M^=2 0:-WS56E-4*5I[I5(53EM31.3I.WI1.J7GH+>SE)>CSW>8"ZJ'4LDKR> M*+]=4;[&ZU6!'"P"+SY[H3 F/V+\?! ^H9$RY'Y>=-V@,:A23M[%TJ&Z$'W3 MR%B!A+T/,@ZKE,"/BHRW+)Z[GA;1SR"BIU?GRP@V2OZU;][O/(Q\%W-^Q3W+ MN5;PGH?VP0EU6BA7$85V$\KW1Z'FW4/GX#8>6@P_1 RO0+*6+KR5*E2X@9N6 M=G:CPT'>_<#>([WUYB,'22X50.MRY&R-FA70]US4; -J=BH6JL^$FCDYQ*O! MUWL&7<4&*IMOBKS"!(U=(J]TX) .'%(_!D8'#NG (1TX5"'/WRMPJ-DM'M); M"AS*\"L=/:2CAVXV%.0PKTG&+;DN-_?O'MJZ;-EUHLUA_HVM:#.X>^@<;BK3 M440ZBDB%BU*:OB9W8CGP0P;;E0[Z:%97V58[+%1$J-*4MR*$:E57L5:[+W04 MD>K7JR)Y>(_@C5:S2GGY"CTGU^ MQY=B)(CI,'NV-12DU=;11->*0KL+Y_NA4$='$YU;'-?11,K089OGQ6VTNG6TJZ^<=L:B96L1&H2^S79]>[W>M>#!Q&#QW@Y,AVK,!NMA@ZW^:H,,_.Y^ MK8P;SF;0=,:OG.%D,W%^JW0H>Y8[K?>K.>56Y/ OXV3E(FCTT;4RI%Z^W?KB M@B@?^5@!^&<6V)O"(EN#M;#(_*IXFL%\;LSDR6%QY6RU5==@&,TASM(8X6'N68SN' >1"3I*3R%;GL]V32>R M^(8BJZNE6 ^JNHJ?\*3I8!,_ IS3=]!K(BRB:EAP&:G&*HB,H(,:8SAC(^3F MU+7_C'A ]:<#GOF&NDGYP3D$D3E% MN"[7T<[?VU*)ZF116$V*&G@J M8@58D/@4J( 5O4> T\_$XZZ6H*;X$4_G@!M!.;>YCA.QJ M$?#+C_SNM.O]0;N2(.MAO=/J5333H-'=!.'-A>[4EM#]NO-D(^ M=Q@VF2@1-*Y*T'.YB/%\D:ZR./&*CW:C@GU9AY[E5J);Y)>42WP2[.L5<0"C MM5,<>A6PZ!6']E_6:1<$K;>&A4/:C>(AS>(AH$,(:+-M%37+1LA7V0>S&-(: M51""A3UB!^U.\9#B1(IV+T85IS"'8AU?;C!;+&[K9#QN=QSM@O(7L?$G4C]V MV/#&1+8&/2FWX9\.VN+U MQ'.UFH-]&S2OQ72U^W:PX-+@;4'F7;5&KHJ0;=U> W" M]E"AJ'I5Q6Z-:JU610' G<;=@XIY0!K$K59K+Q"73JKO-"\LJ;Y*PG.+HRI- MDNKE:!;TM^U:W W?W@_7XY[.;$O(V@\R81W:@* -"*4-".KG93_E!&1J0\+- M&!):[>U2P[+YX,OXL^>F$<"?THCP94'"C6;WED?))3ASGC2!Q=-KW<-SR;0P M>12TZ&Q'BX\B6OM)D@W,_,%YE[O I3DR>0C0OGOH'ISIJJ%_%.AWCP[]CIIZ MI#9;J(6(O;T0,5BO([<=&S'M7D5TU"C0PES*4Z! #YNY*(("N3I(;S_-^W)] M]EBWY),+WX>4EG4Q>K?6FZ_?\7Z32O.__]N@W>L<1 TO577FD;_.F0I\\$=3 MG=%A7^LWMBW"WSZ.T._O'_N0JJH:\5: M!30MB >H2*OJ8KB CBU3$P4*X@6J0H$FH$!;%3/_K4;#@RRZHEU?C#JMU7&M MCA?0O8_%M8.N7SO7+NV8L16XM#?'QN^FAW=;P-EJS;;6Q-1$@Z.[L+MM%&TT M])6$?M4N[-)Z>+>C]7"MAY=%T],XN+M=G02D*@:K#!3H\3W8GF!R3O&KD*/#3[808R?,KB<9#$!,'%X7&&D&V(4B!EV]G!.FA/^\" M,.1VJGB]YR:?C;@?%_)JZT)>)[!YPH*UH6\M /S^AR8NI#7K3HK.Z6K M=A06\NHU[QYZVAFI)IA+^Z0WEGKJM;0-7U7H%KB:RT 7.ZRKDG^FJMBM4:W5 M*?!KERWDU5,T 5N#N-4I\ D?6LBKUU4M0$$7\KJ$0EZE%8I,HT0YQ3V.?]M, M:B%EBGXI7MY+M"_6Q@5M7-!%OK2109V][291%,08'2M3N=?31;Y41HN"\)C# M(Z1[?47+4VOHMSI5YZF75T &JBD@VN"A+)IV]TNHWS4^MC<$5M54$!TU"K2Z MITE6[S?N'GJJH(#V]E]R"3"ME9]?*U<&Z;5*KDN(;2@AUBWP_A]+,>\W=0DQ M1= B5^ IB!8X7#'OM^X>ACIU64WH5YVX7EHQ[[>U8JX5\[)HNE^&_JX,"M:N:ZA)A6QZ]7'=_3B*1HYRB)' M@9MN)^1H59'_>5+(&K1!GSTXX%N3.&40I,#)MSN"=(#. M==7'$!(PWX1LY/ D"Q"6C,=CNQ&C-<>;^!S- !3F4N*C//).2R2'S;W QF?> M^MPAN^&[%]L*IS%(,@^*);QMI(^P$>PK"C<_,F/^Q';%*:R@G\D!G/[I,:V% M:VQU5](H,_^=^FF*Z(3?CWS.OM^S,2SV+7->V") (&3W"!M<.=.2Q[%Y\YP? M;?,"!G!S/)]PY6V$@5LX"I;#E%F+,?7QHO^;W6NV&_WQ<& V.F:G.^8CUAV; MS=Z@WV[S7J]A_E\?U!"\#%AS#A5(C#K[VQOVD ?AE7L27_U6_[Z5D!]Y9U;H M37--=8V)RL^+GYG#7)-_G7(>_AV(P1RN]S=X]&?',[^G] 4(%@>J,X=)0C_B M&U&C=X+4X_QK\<1\?P&+-YYQ8\+!-,8$9/DWG/#8=F&O-G,,.PWR,\(I"PWF M<\/U0L.$66STPX:9A^E7%AACSW&\E^#M,G2VWA$B=2D1(KH*)^*P><#?QA_> MQ3*<[=*^Z*%WG1KV9^_VFJ9K->J^YVU2;O^^V\U^B%W7,1;4Z6Z7.D7K7/\2LLP![#8MS0^!).N4_G^64$LST3,Z*_/[GS M"$0-_/CJ%_[,':/UNHPMM,PQ:5!(4/S#]0J/O:V/O>IC7S?L'T).6\W=P'#F M(QJ4.J)7GUSC)P/F=4"3"%[O:%@<:-4,-&5D6AD%NJ!V5PE[ M[Y5;=9L%(2/B[+]R,_+)LOM/X_COCJ: MW_S*\:C5*\C_6$6DC\^?[4?7*H%/.T3+#?J51'FK#<=CUITE;"%SU>*1;6XN")?QK_88YX_ M>+ P%-P! T9A#00^TXEPM3(9/*0@'.8XP@SIC0UGZ0EM;SSPMB!"]:N==H'M\;2:KF"J%,H'&9Q9X/*70*)N@*)^E6U<-=(I!82%4B+ M&Y!H'4_0F7%X/7N-) HBR2Y,:G]"TR="TSN\\*9:]CU%C'JZ4?JM/J]5&QU% M<6J&45!UH@55ID[BWQXJYWK46%8MEA64LSH%E@T;#8UE MUXQEN_+$XR!94S4DTU$4.HJBZJNT1Q3%L-&Z>VBI4D=;.S!/*D7NZ<$<-MH: M9ZX69PIDPHJC*(:-CHZBN&:$VIUGE:1!785HD#8UZB@*%2_7 5$4PT9/., / M[]2NU7(%4:=0.*S"N3EL".=FMWEP-P.-1$HB48&T6#**8MA 9T;GX*!(C20* M(LDN3&I_0C,4410]I:(HUHM%;B@-6;H^X5&KT'URC0EWN<^,T_*T,VCD6.;SL((?89#L9@=C+7]I9)V\>@\IW/=^ 9S M/WDS.(2%,>*.S;'=&+[07*V4-Y_[W@_ BC#KJJX;Y0V..""P@W!9_B2E%;?K MS;@1)-;IFO$RM9!E1@,M!:7O.2>0VGN%?SS?F &7\:>99W!%>=B-3 M4\>F MYKS-XK^U;]W/F ^A'S/TNJA'*A?T9>:$< MC-_"/*;#@D"<)PN6ER>WEK]*8VH#IOGF=)&W7@]0:")?1+4I9?U#;C@PQ3(< MLCBYND^Q@LAEH'=@BSJ$-5:^H7YU(U$^T@BP?B1,F3T5>HTQ9PN!][A9"_11 M=,8;/CR]M +$XR7(TENWPS)8!F9[$S!WJ-=X#IJ1*48C-]*L2?@W6AW:?!QF MM?Y[N[:"(#29R8(I/4@?D C!;WAB-3@]D]MTR/ 'D1<$D?P[F'I^*( _\GS? M>X'+%\3'7U+E7*(GJ[3& M"$'LV6>9?+0H 53@4_!#Q;GI,P&[\*^2PPI@PN M^(ASU^ _),;*"Q?342(11'E_F'Q.G%5,6W+U*\BR7IT8T090-)3,]-:Z=@A1H#*$^368RB_ MP^F7"\IFIB>$6WK!&N-? E)^95SYEIQWM_:L;'Q4@&3V?WYZ13.^M>&>V&:) MM?\]8B HA'PUODTY4IN5B:; :]G$YRC%>,8DWH(!8@=*(C/7'B\$)S>0DP,6 MHD!M: M_F14'V:Z*);#R& MY3'!P?$$8*%UX]'!&(')%#BMNT@)<%9VP O$@!_//)>'S%_@6][ 080 &-@U M(*T86!,' 6OWA SK>\\V<)<@ A:?&:RV(Q-2,&0BKKQZNX)IIMX0-H>[U[CI10KW6BA<2.4 MQ=?VE7)=/GS_&$I3)WWZF1[Z,WZ=T_3$AT.LU:X9-K+*PWL)T U\PJ, H MJ6\ K%$")=2?D5)[RZ>>V?#/L.%7!3=.-W0HW] !&TY]]D#Q&6;;.)SCQK^^ M(#[[UR##\W:F-VA! 9T3[4AT;U/DQC8.P%7:O91T4W.;6WPD7^)%=F MF[38CX[G^7MUJ1XV,6QL8\\>69NW;GP:"_W;DUHM]@@1'_/(&BC5D6.1\@OG M<=R]/W&@R>YDS]VW[Q[Z1;M'*LTF0.8 ,_@2;RK&&*.,(B]17K<5 E3LZ;9" MU\*%#F\K),PD><:3]GF-)_G(NXDYH"W2(9_#*"*3/9 05RBC0K ]3,;K;":. MOW$?KS-[7^B]#(+4VK=X1'V; M.;_)!>_,6+#JQ,9@B82M?A-FCZRZ ^@1I,TS0*,71X5XE>$U(&JLR1DU8^8) M[]>6UDQ'Q?^/;0G((K<+U0N(%R>;LP%61LX&268@ZL5)B#K L2 M^81IQ0D\<9@A^\[=V.NSKA[F<_B-MQXUR%?V:^FV/OX5ISXKN3>ZM_5&DY(- MFT#+4*J#+JF[U)W,YT'DA$*;C3<_XJCG3KE#3D-!&X(Y^F&1\ O?8]8.*5S* MAL->R.PDG2'P<1P1IJYHW&+8:-4"NC2C;S^CCP?]M.GD)#,)XKJBFL-&7]DQ M5-;V&.\+;J&/#BM?S($>PRD@+\]:"$+V(WM(63_BJGD@MJC&KWGA*^[.)81# M+D$CT( IO[5BIY5 ,SCET+=-89WSI O?ATLQ)HO>6-@[R5V5^*X$WM!>5XRC M8WGS$^-JCF%UV96/]P9G( J )P7K04=L>BU@J3.X3C1O0O;M/ .0'22W2N)T MW0#RZ_EXRLYBV1H4OWB&+L.EN>&%15=2=.+9)Z^JN#1 ;]DS MLQWIJ!;L"88L82A,XS#S.SXF@23(TLIY+Q\Q\!T\86%)#GG,\9GMXIP)EF;L MP_!.(B/X;M+Z L)!1C)&8KLN??K:7GP4>W%&(+@@Y4F8LKG7J1 MN' M,9D8CMJH.15Q#TEH2'P[7D#& G9ER[>8WC-W&845?!5NJ8QA&861V-V2;W^& M:P:$VXK,,/L5SD]Q4/G>P!4N$-]\L:#$[1AD0I2"$'YBOI7$78$X;&"$PKKU M.US,,79NHRSO6M(MA]S/W6Q67Z9#EL=C)D-Q8X)UPH@%T)BY%_"ET0#WC-QL M^';P7=N4M4WYW#0+Y15Q+>"RN!@X@D0E)3NUI:A,T2[83$52G_3#S%V2?O X M4G'I*@,9RMQD::M-R5X=U.G$O;ZGG,6AYD M"?4?TR6:O0*[\G8;1UTTSLQN?1^Q7?&[<@R15ZC414(OGI9@2E*%D$&)0HW) M+&49D02I+,8,9SBZ!U:G>X]'\34Q5TFR'U, M%@WQ*B%6LA>,V8%M R&K&5&8R(R)P)>^]PFM678:=II,&]-ZEGQGR'A]NA2C M:'&/EERB,0&YM:@S/?608F2X%L&'LQ$8J%.,[%TL\89!XY MH13]Y>YH+F\?;Z/ M^"?W=\)*"R-C/MJXD?_ES-^9Y0_O'KKM(E?R"_P+^@RP')OL?@(SS@KC+^Y' MVP_"1]<%WN4'($?LNO56 [8^W 3JC!<==ML]^VZ_>B /V2Z6Q!F4V^X@R4F)$Y H/8A" M$C+*4:>E@&!7$/6_E.6@R%J+E6OR'#Q[SK/,&2-SOPB(GJ#+&1U9(,A(SS<& MKK.7(+*)M0LW)ID420'/QCK;EC!-214ZD15=,KHM"8LB. <%&D_X7.*H:A;D M6>D/@<9$(V%L!P2,6SWCT@H]U*.8F:\95B^#W._>/YW&/U7,:\;2/7*G/(9 M&?BXU(?1_#F"0_."S% ]P9ALX9!AO ?\0Y>0%M%+=A2CD8X$$)?SB;7+44WU>BU99% MJKQX)%OD^F7R.B?77T@S$;-K76, SQ[3) M4:I%MWR2OO3CY$I^/8\74 MH4T;\Q)!J']&S0M@ Q(^("JW2)'^K\A9) )V8UG EK$( )8/$=X$6#CE-@6! M"%I)K@VYBY=(@*0I)/6G6A0Z'H)H%-B6C9DT<3ZBC[DZ=)E23T36^2PG(,3E MX12.SDUM2S_G-IH(B(_/B"ZB$80BJR5:EPR MFL"DNX6N'U_':^X:K]G7\9K7XN&I)EY3R1R^BI3QC$IX/SRP(:4\>ZN*>-?^00%OM])= !.M"U/O-59 M#S=N==;SQ.6]_-"_IBSB^[J>C==6-I; M 91%28.$=X$Z[F.-'8?- _XV_O .Y7&'+=[:+L&,'GHG)Y,,#RGZ2IT=HEOB MYY38UQN"X,M"C/+-\N;+>+9LJI*Q6? M ,"9[S2JU&H;]?:@<[K]Z355N*9F?3AL*;:F%MRR[4\4%$,MV>=I2VE4(;F> MIA[:H%0[L0\ND"N.2:Q_&_EO'GZ-O6TE^HGM??OW/UI)BR5UQ>)F5!+)B(_I MHH[^T>3P/CKVIRGH="6._!:/B6)"Z)0>$[U;'U7^9<8P&'J8DRHO\*X:6!\ M<#$"D.(HXH:>G2,4*)S0>GK=X5%;5O]]G8?]._\ MF;L1_^A[LR?ID,.65D]1 !OD_H^L1\[^YRQ0GNMW3^X;/*N M\*RNIG*5TN]A^]JW?<=M7X+.^2\!ADS76KVJ6H&QZU M!E7W/-)8>Z%8^VHWM.VMHBWFKL&G2O!W'4^'&-2VAJ)KZLG586=)$1XFJ1IM M>N6PIKE913SD$EWB#=HIJUFL>75PY>QN\,_1$.P\"BG2[5Z+0 M1_#:H,BBFN&"BGVN1.*&0F$FV]=2/LRDB5>',HF;@S.F$A/(7Z\$3=Q&9[H= M994" PE=F\\>ANI'OD\Q"AC&^N$'!A#G]8AJ8U79=;I97AHY:G>HXUHR=*>I M2NP113A76H-KMU3K)Z\QJ6+R56 AV)U\M>\>UI._%*%>&D_VI3AK&OFQ*$YU M?;(U)JE(<0ITT]WI#9827:\D>G$$IT"/K%+NTJ/4&74+7O@O(@K?G6#6Y=@. MC5?8?.<@T]X%4LEJM;2Q=_>P,5E[5Q/<)>J3FXQV&MMVTR?+ M85L?>V4J$5*BA3%/.PHKQT. MJXXHT.BC$OH4*8>E2$L'?8_-3:6F+@U!SN!?7 D9%G6RAZMEQH?G2%<6F0M_ M1EB*#MO<\]#@S'>I [;0*JAP9-Q&-;A)!U:EFD9ZU3!>0!S]KSR<>M:GM#)O MWBW$,F 'ZQ[:EW7U^%>@>^R-?]BY3VGTTRASI*C6O5&F#21+H\Q5HDR!6E(2 M94HK*AWMQKIJA"I05/:F0-V[AV[W2C#F%EP;[[&DMFFGS=/8#"O1_$N6O-$. MCGW5CNS!PF>'XX='UWK,G&_>!<)8Z4:9 [2B',N6U#NT>N6I\*M Z]B1 7?27M*K*U#HWQIS: M7W(.G'EB<^Q!1;54L? I%HK?2]FX#66]4-F0E4(_I,<9MUGZYOWBN9-?L.W9 M(S4_S;L_S;N']L$,7'LZKAX+"U2. [$0&]$<[/16Q'2D,6- S&GGEC_0 MF',-F%.@@.R$.:7UD*[V?EPU6A7H(0>2(TSH:5RX$T3YRBJMY4#;0WTUA25, M]W#VJ%>',]/"=)?2F^HJKQ<0[/=WS[.H+:CH116V MT7Y0!=JO8W8?&\(>;$T]'UIK5#P]*@ZKIL#;U;/JZG)J-+TA-!T4]*.N&DVK M\V9J-+V5RI>5HVBQ+-MKD"P[J,R&>OYBEZJ$=%Z ?OK-0T^LT$8/4$1O(X"A M4-?,,S67N(%8,K%?Z[743OK4@9\J8&"!VK!4,CS14@39&ZM+-;M5>=6U5CC((84Z2\[$EEND!E>K5&3K&=RT2: M0YUDN_LJB[ULZODJBWH&MO=R7&K%\(#>@WMKA3=KSFD-SM_*I$?M!WOMJD3[ M4UMWSMM[<(54+-W<&?,GMAOW"FX!]I2]RP_4XEE?K ,N5NO\%TNT-.Q>ZL72 ME^%J+L.QF]QN5^M.UR91U9M088/$2T36W2JQ#M;R2([:';&'W1'7P[2JZXZH M'E(J'[VK^R+N1>@+K+@GD'GZU!=QT*W*%J/,I5(AE%GW1=1]$4\"0B\.1 M3?M(70_[.F'ZXC!I)XI3H'GN3F_0J7\%;59UU\.;'*7#!79NDJA#RO=5-$LU M#>JCE[]Y<,,('3]^]>A6I&*60S?LE=@_.&%(D8B\ZT>10]7+@WHE]JE7XGHO M)=TK43D\J5:]/*A78E\7 [YJ]"E2*4N1E@'Z([NZ]N_5JA6Z5^()58U]V_X, M,'^UJI(QEZA[W*X5L5+=8V_\R_5RJ81^&F6.%-JZ-\JT[QX.#F+2**,DRE33 MD;6THC+0SJ^K1JC"XF9[4B"L$WSA98)U_N1F%"O76E&[1?;45?9L%C30?A)M MG:I"5]D7_[#!XL%-NA6Q5VF4V4E7V1=E!G-3 M@::R)_T98GW0OMHBD_:Q'*L=HW:F[*F@'-9%:-B\>^BH;1W0+A45L+! 33D0 M"[$LJ/:L7"?F'+6I[! 3B@Z6&33F*(DY53:"+:V\#+6;Y:K1JD!Y.9 <45/& M"V\2JWQ9%]V4<>^FC.^YR6?%VE3DMO2G=MVAG;"]J4[]F+<4B]&(_>8O34\HS&P"-@8.5-<+M>6Q\W2=%S5V7CQV-@NS8BH756&1HNGBL%N5C509#-6QH<7H MJ9LN5JE+[M57"-8ANBX.*^N,<8E*H0ZLJ43!VQ<%1=O%MBZD<9U8F,Z+S8'1YL@50$:T@3 M>1,R4.5B>7N]@Y'4H*H&^Z (ZBV$^O]M_=^RJI"_]-YJYZ7F8%7OP6\J]Q#7 MNR4V^&[N!>2S?^MSAX7V,W^':[YOT].K<&Z6$B?\-2] M;[80L\5WOWNXFVD8SM^^>?/R\E+_,?*=NN=/WK2 ;;[QX>$4ZY\6AR6+KQ-&6V M6T]P(W-"-X@IK:V8TKXB3&%(\GT.6\?J.,PT_0A0P\R)Y<;X@I]VXB<%Y=], MCEG/].[W<@U?QH]B!3*8/!.GLP?CZ8& N\DP!@?MQ"FU.^UJ+<#HU+O"U+]- MB5SQKF!.NMLAM;^=>=3^EJ?M;\7H=K,F/K0:K0Z=!(:,U(! !'-NXFUQ%ELI M GZ'IV.[$:5]/,3+^AS- %E-03-PY24ZFS0'=P7L] C\=.T.K477$$-M]NK& MWY:VMH[K.W51^@:/_NQXYO<,8 <"U> PN?48QE_BU!S08 Z3AX!$=P]R:N-W M;GH3UQ:)X"OGOL3B5Z"4>2-.GO?.5FY7QI,!(5^J^08(_>3-X,T+8\H"PP3R M#3R+-H#G&P"ZLQ"P=PX(C(PO9-_YO>??SQDR/7%HS/>9.^%43@$IWLO4-J=T M5^34?P56R7VZE*[)#6\$O(&.#2[0CQ#ND.$!WS!FD1/:=BH@WG9X=!B3-D>*5BN0YP6@%I<.&FP+&9ME;(C;7(W:+1&'$' (P M]C[@; QR>[V,@G9&9ACS,^-GL?1 F?7F\XUDO8[-@& !P\Q1AY#$,.N9]F. M]&1Q4AWP.IH<@\*-,;#R%49A2FX>&",.&,,3+F,'*;VRB*2!?,UF7H1:\D_1=B^[,1B+ MBXQ<%H&(B;(\D QTXQ+9C;$MF'(.Q%9QR&59@>7!O ?PRS5*D">6D8D+:&NA M6;21N?OMNP<0BM?N/K#Y9X3EPD!.Y=N@3L5<3OIL$?A;A 9UH)-/!][; 9M, M?#XAS)*$59DUYV/4)]>8<)?[S*FMW.51%,#H(#"DV42*R@ D- [@337QRB)? MEH83EZ$&1S<2;K/KS5 KF#($,"PN"&TSB'DZ""Q6A((,#HZIAJ \R-&G]ES\ M!..>;53+9YPA=QI'CF&EQRRE!,Y 9%U=[U^1Y 0@E=)+/5'W&.9>P:)UE2T# M(WE4G5:]C_:1=>/)BVV%T]BTG'E0]FMOI(^P$1"=*-S\R H^K&=7G E#6H.5 M \O\=^JG(2$3?C\"AOW]GGCV6^:\L$6 YN'L'F&#*V=:\C@V;_Y8'4I;"G5+ MW;Z6\MU2^\!"T$R/-P+)/2I]V:ZI6=AN49*5UX9A,L#'@$C-!Q<6Q[E/IA[! M=]:)&QJ&O&@RC8G3'Z!ER5GHY[D])U-H3>K'0 9->!=0-9@6RV4;(]]C(+&@ M+HU?R#FD"H[""UU_)$#W:%>U$J$&5'8X(*$!$B&+R2$0,&#G?X+\ \NW0!'\ M+9Z39"$T)=MC6\X4< =^(H&&E@3''YDF[M!'80Z'S!@6_'[V'.3"!@CQF!<% M2[7L,72"2 *A! CI73-O1<+D85@&$[A6%UN M/-LN;"M^08)0\0XYH,E[D$$#TMOCS62V@)--N#?QV7R*^X.OEK= U\;Q4.I8 M\=70M4C07QP "+QPZA8@I,\L;HP=[R60E^&'/;/_9J\YW&FJS=]W*UQ4J_#E1PX#U:-.,:H@[GUK M3--P;=A%Y+)_(Z_EK\)K^0&]EG\;^6\>R$Y"F>TELMK/#[A;&'4(3DG:B-N6BV*U-RHB1T=HGM_?0/KS MZZJJ"0.%91YK0J'>GL,3X&-KO_C5&D@588MU"T@C(U55&T(;8%.9@K:H5121PJ*%I3 M$0ZU&M@(4^V*_.>G\GJ45A@W7NNO7G2@'?56!/V"BDI5D;3FW4-;]_:]3A0J MEWY\, JU[AXZF[)LU4"A\Q-Y/>I\JF*K*[*A5.:+5%WW$#6Q=,#,%5*Z7KDT M_-T(W8Y)^2UL'EAK]ZO2#G8)@%)=_;QEW&PWRM6^."YR=A Y>X=7C3X?E1>['P^.?X!G5$8L]I@] R"-L&E+2\"/.*=@V"5GIUYP>X'E6IC'O^!>I1 MUS%*(YH>I1%-C[J>41K1]"B-:'K4]8S2B*9':433HZYG5$4N/$7<=OG)NMD2 M67LEZ9;QL*CS_/F12H\Z\B6\Y."RPY-T;R,RJ-TXAL,\Q^V(2;H#W2CT.G'H M-(G>+>RKU-O4[$ -'#H_F=>CSB*;7@9;K"9)]S922=J-]FG(6G];;QHU4DET M.M*^.'2:1._6 '#H\"1=G8ZD1]VJQGAPDNZM"/NG*3O0&H*P/]3I2->)0Z=) M]&XW4&%4N_W[^:F\'J45QB,FZ=Z*H'^:N@/MIN@4IK"[19P MQ:;2*'1^(J]'G455+,T+,ZV"Y!3W./YMJT,)OBJD[E:Z@%Z]6V(%.9TS,9/H MOEW/:7J$+;Q$C\57S;06O>A,N(?>N]P7(B=YZ993/WO'\)#MF/G9IK3D5KNJ M^@S5 ?P"-'*-W5LEEV.4%]D5O2FQN76X(T5A]#X_G]>C]I"+WE ;PH(NA]4+ M+:M-:?)[//[?UO^5:=#8PY;=62&L.8BIF^UB^]RW]_A-U=LK(1*UJA")@)J, M/2]TO9 +8N/>8^_.^+O?/=S-- SG;]^\>7EYJ?\8^4[=\R=O6HU&^XT//[^) MQYZEC><*;!KU3AN!(8@N%VU3_;ASI^CIZ8V-GW9B $T%*ENTNUM,([+I$D4^ M[+@U!2K*M'NPM4UV['AK<3_GD+H8SCSJ8LBQBZ%!'0S%Z':S)CY@RS@Z#FQS MACV'L1!^HALL-<45?V<;F LJ@2LO[I/>Q&HDYV\IO1;0382Q MV:\;NW4 _L!\%R =_,;]KU/FYW7][30$@L%I<>LQC+_$N9:; <=S&:]^\8+@ MM0%S&C3I.@"R%'JG]7XUI]R*'/YEO+KRGUE@FX^N]=YVHA!Q-K^'<6=MV1O; MV=,>=8O?Y>]UB]]3&J%TRUI5#CNCL%] _\[NY//LJU]7-M4H'-(HQJ"QQKH(?&]XVD+S &?')-4/I1 M8XOM >)POR1GFZ?>=UJ@;;;4=LGKJ([]$*; ,[(GPK3O'@Z/C;WR$(XJH]]L9]Y^&7\C?UXS AZW[S?.0AW,'3R 1X( M%\LVX+']@UOW_^*^EWO=.W=PMP>M9NN=TK',.AX^HP =Q"0"6#]\.B+VY6 9 MINBOX==K-5#K MG)MK#O5KVE.C\!/#+X,D_132F.PE/@I-.+G7LS>U7J!TJ$ M9>EV$L?6+(JQJ@]*Q 4CE3(L(?Y9MS6X]K8&UU7'+I\$_9/^ '61P:K8A N; M?2#(PKTQPL@ ;2 41%@R/9\+Q(-D0D&]1Z[0X@F=KY MB!?(-@Y/CCH/#H/ Z7.,(V6.9!MKWD[^9V2'"X.],-\*;C15ZOJI4Q$+S"#* MDS>;>:Z@2\LVJS@2D5N_L04.?O1]YD[HN6!GDM5MW#UT.IW:\/#<5VU$51/K MBGCB.;"N>??0[79JS:':M4\OD$E>N'VU0,^R1.1U!297G;-8K9XF8^+7).G= M:4-+:&K=9KLVK-H2IU3>XK'MOQK%J]42JT/QMD#QYF!0:_5Z5XSBBC!0G6J: MDVJZ$9%.H6L>+0>U6TD.ZO'.II+DU"#TS.^&-Z?0!K0?S"/?G,(1&3M2PG:S M54 +']W0)JD+X/.5FY$/(..!7(DEPO-F^@-:IWF M>EW[&J5G[KS/MIK[[-X]#'J@!ZV'+<:F(F]L"+7,^$I0KRZA]=U^)]DYS4GF M'%;O[F'=B0-1'&N%$=+L"M"G JVS= G89OC1(<<\33$RE,A5Y.?5[-S1 M/L)&(-& @+;QD974VO54H;,4(KA[: U7C*>9_^Z0-8YU7>53T\3[/@?Y]7[D M<_;]GHUABV^9\\(6 4I&V9.!8UF!1,E#W'QDG!^//1+DX![)O*"WP*>Y+\2# MOS%EUF+ K01R\V_%L(-K3\GD@M@#*KIA\+X5B! 5P#(?J\K "B8AJM(IJVN *!*SK.N * K )R& M]%P"X/:I '#>=/^S!<3\S@,0>\P0M&IWHJ-=+L7+LE/RUH;L#E0!7([+^L9] M4#M)^OZ9NWQLA[GQ^#W0:IOKYA!%$K!T6$I5N7W[H@=V?M#Y>?ORW_,O4-51 M^N#TP>F#NXA1^N#TP>F#NXA1^N!T'/#N/8,J#_/=; F\>L6KH.H"N;$^>ZZ/ M,0]HGA'9\A]^S+D;\%P-K'6@@EXAP"X]-O>&\;*@;L,>>-D^T#*@)%XJPHET M0.VU]6[I77[O%B )(CR6S^:.M^#<"%,CHC&25D2#3HU;5&38F\'B%_X* XFIG]K_$8W/?^X.;6*#8M2C6;N[S9]N+ F,?@#J^-Z\9?X>%P8N-5P7>#QU$53Z("LM_?@:4 ME$&/V?BITZ/HWU&MSM:IJ@EN4B1BHURHS0<7+C7G?A)! M!NNS04LI$7YSA@I>12%0%W7TCR:']]&Q/TV97:;_0T618A=U3*0;Z[,I:4<\ MA(2UFCHD[:@A:<<5-C<0^%A;S(2<&'',R06TG*F4?5QX^YS3/7]C;7(>*1'U M/3JNQ Z++Q.Y<1,>BSP?S2P6S5$XEGMT*OA5$7N7C6_EV:/V&;H=VW0C4 MJH9@]9L5"&\:191$D79%*((QG>NEU\Z#(S=F:7MBP=28BR+;M]9S>J>(T4() M3E8J#SYZ_A+BYV)\^^YA75O9.5A4)656F]+;16^-DONC9$6!YH-V=8&_ M&B5O&R4KBD4?H)]L>.$XJ?4=!49I("@P2@-!@5$:" J,TD!08)0&@@*C-! 4 M&*6!H,"HG,J::STLUWKKZEZZ2Y7CVHU*>NEV6KJ7[H66@;SH7KJ?0CZ3O;KK M28O*(RV$9GQKAW!KS1)+^Y6Y@/_H6_YK8+RW S,* K0#85W41Y'QJPRX^>+X'7;-S_/^/5W>J@N]#6@-O<# M*D@KOX.S\^?R%M0,9KR'[U^PJ*6Y]#TS._\QU?C/ST'36V!\*0"X]1E"S%&J=6>L>"J1HR54^&6XH-CSZ>9%YSY!LX."G\.T*) M;P+#;)AL[L#K)]P%&NI@$6K3Y'.Q %K1/UQ:SE=\'\'QD61'!N>!=]+X^^/C M;W>O+^]R?'*?>1!Z0$V(#K((L1O+>$]92!L'7 528=T[GO<=3RMSXB@R,]N- M#\G&0L%F.?6\&Z_"( M$(S#9Q\RX+L4XYKAU^ M)W8$--K#CR.^\.35P//R/0>GG25L'S<(O.2C/.9?Y#%_3=YX!U, [1*3"YB, M.."2B\-@*F Z1LZ55 5MPH^FS>LS,+S;\Q1)#8@([^^_WLSLQU2)4*O!J\&VAE372#>0*11 MWD *'AAW]/YGDJWXCSD0%_R$+,&UZ+L@M/%^X^?T1N-?LK\ ?03NC?_.&$EJ MIOB+: =]C:"M2;'MQ78<^3D T.TK)AY3A^)BELRJ^]* RP983$-DDN MZ\;'R,?+4"N%Y@D*1W.\2%AO+U)?XE/7 I_" \484A8\<:U1&HBUB?.;)F1(49N8F7B2D@"(O$TPXS7 M%D-S@:P#TF[ 4X%Q#H<$UYK6!YA3-_Z) IB%9_T=L<3P1HX]R2A'*$([#(0R MA* 5A7!O$;81##/A;=&\(^X]"IE%FJ?F\#T65<]E/\E?T&^"X$'H^ MB7_NC=3:TWRL&WFG>XZCVR*JD3[(#(L'IF\3L<+!,;$CTA"+O$0B%EX4ZZZH M%@')]"45%1(Q9CC80'29X+= .R1?2?4F25[JQB>@D;*N64W*^[&F+-\)=W[F MH:B)]PFO74;JQDEWE+SEN-H21\']FU-D];-EL@R4."5L, J4 &"$)+.3D+"9 MK)3N3G*.EE0E<093DUJ]=^=#VY6SZ6 OK+N'#.&5"K,1*T.UI&E,#=LUV12Z M14S#YY,(A";/1QN3E(>3-C2DBPMC&'*-2?R;P.H70!"2E/D[#=1C 17!X'!W M@K81Y/%\#I^ #(%09$529(/3BX+0SW0&,A>@A MJQD<15L2,X'( !QL>"C^UG-M4TB02,PH?A$IH'P7X(0&^M& #C(\"$QD^/7\ MU=Y0TFHNP =DH$)R(%+B+ RG\5GTOA9 ^(]GSLX5TWJ M OYW'HHWDJ , B$1H)F2L,>[AVE/%6BS8"("#F1K%CDQ78M1!+0&4C40'(=181B8!N)KA>!-0 M39$RF%X@S1<"11H'OA0@5%71M5;&$#(J73(0+$250%CN&0D(#Q�"K2L3GRPN M,.^OGIR4[&5&TCHJY4JOR#WW*_W^J_&S_/KN-:Z F7]&-CH%2"9]'_T&[P'2 M!(LK,SSB,R*& R9!?1.#VG%E@$@.')5@>%F;(_)(>F8"'$!+@Z7HWNU@_8$B&;-):(UJKX:ZQI M\H032SSD'MRZ^70KB'5XU-U#N[DY/$H'.JFPEE,'.FE*MRNE$XX$J2I,'&^4 M6!6$V,Z!<4H)WD0O0KA$JN AVP>) \%E"VBPL,;A3& MKY.&99CH#1%582?CZ$\)X*V$#BA^$",$[BLE%C@'%]T2:+T"!=EQ-",\,GH( M*P'I T'@ 3-$484<&2FC="A>8,)3(:A ^$H?I6 3'H3D2W!EO%:*5(!VTC@! MM"$1-LE9&")Z3&S3&",/%NBFL>%42N4,O8XHP:"O-S0B-&G()O%T;06)\,AZ M+-S7.! #5TP&=(+H2MSGKH=F!E/P"WQ$>A\\P &T/F!P M&&*4UG!.H>$(ZPSJ,3Q,PV40,6P,!,C07CF&8O?H>VI7'YN',(A1:Z4GO*Q) MP(O% ]LG:2EEFBQENGB= 0P8M4/RUI*!([Z\0H\-N?#O 5]U U&>(,CR;&^$ M- $_951@-L=+S!PR6P %#W -0CQ *5 R:%9U=XO9-[2E". M2:\&Q1&=M'B/["1>*VL[7Y9J+3OPHWE\/TD$3OY>XK%H*4P#%BUAF@50T_6G MVYD^2IJ<=*ZL>8QJXEI3.*\0QE-K/[Q$^H9,[$V?61W>ZL6(^X&(;T<_8_)J M?+$'*L(,GT_]SI&+TGQ-AB894\X.)D/Z1G93F4N0>C.S9T=1=2!U.M*P MFU*U%=/NA'OI7E*GN5B:9?L4UH$@DY_QC: FN@CH&QLOS"?WGN>.'8R^ M>Q7'5^(\OV/X*KO_QW;L2#Y\37]*L\\3 %!FO#R M'EXX$[%[L?<. ,J ,*.E/3E) 1%-#$[%L 7W-"8@\?HNRKS(IV/FF3)BB;\9 M9"6W&R5 D=9K3D%,1_^_)/C2H1-I4)XD^ 9 !K=1G#J#%XSA3EE1*DSY%'@Z M\7D<:!FR'U(A1@<.!YKK"(HD':1>)$*&7SS?L8P"^LB2JKC+L9AQ4':0L).Y MSS-QF13NRLG2'_NE8%G\!QR@FXZB_)],()@TZ/EHW+5$+)BTVN'3XM=5SI85 M#5TKW?"S>,A"1=*;"YTO-\TG99Q_ ,L),'09UZ>Q^Q38+4)&$'L11Q"1'(SD MP%A#H%3 3)?B.81+#'X(XQ2D\5A@"M*[K 1*K"O6_;E@0Q0U/X6%X*N(.^:^ M3P/^:(!/;VV:BSHF8_R,6T*/#!.37-8KB@(M^7E2FTU*&[C[;/N>9'&U6 D MWL7&/%S$)&)5O8Q#5=,4&=,AHB8)72JZ!$ #@9?&2X8Q*-MH1#DIH@AQ,PE\ MF'/IZ$[P@-(59-A"F.0R9%T 9)68I/R'HW!ORERGV/Z $^(+5JB4PU[@QPPJ MQ5J(B)489P2M3+S%LO0ES)12'UB)B=6!L&=B0<+D;"Z M,A[G[H3$E\1??4. MO],P.5J<*HBW7A3(FY,D)HBL82R&@#JOE=0LR'RU*1E*G:2@C5FFF?SC./UC MS^3CI6RZKR)SQ'.%>\7S>?H>X67U_)5DOMAR ^NOQ?DDD:!+:.SP*!0.S@B0 M&.EE'.R7YGQ:'L%%I&A)6X3(6Q'9=IF,%:*R,KM%Q&\LA&DD3>03WAV@WIZ/ M=H]:3AK*]O025"@ I18;4E1$(LYH6RH=6CG2:+F:(1-5X5.L_E@UN5W\%*>' MUA+'HT<2Z1_T.V71/I>FX)&"+3+L)&YLS:Q#MA',.?L. M ,=DH#@BT?8I$5'I)*>Q2&(R'R74YH 7#\XAC^$)5/F?-2-1V%'-#V@#/^B MY;O>,RKSB7R4S!6GI=20Z,0'$><81T@[B3X:+YA.;2?17;CL5?6*HNFX-#*I$%!$ \@ =,V37)V$QR32W) M=H#C8Q-XY]AVPKCL28R[?WB+-78C+UOBZD,I2Z3V$K&D-(\0=EAF6B,^1<5:UV T&[\EF%-3(QH:4&<6RU$$LR9(,"7GF9/ QXBX' M2H@OA<-<60XA\FVG7AQ6BQ24U( M%&(D^#BU)\] 8MP&8<-@_X MV_C#N[@\L>W2 NBA=W(R*>@@)U]I>T+\2OR<,OEZ0S!Z66%:OEG^7(>?WJQ_ MWV_6N[W\GQKU9N[W&Z>J=UO=G6;:_'VW?=5K*IY)R=+9)ZR%OK5EU'!M6$YO M)R'7GZ:YT["HL$]#%!Y%Y^6O,&X:&!^H/%C:*7-CE\R29[+SL,M&@4S7L4T= MI1"6%X4?6YNE[KCA<[?R=7$%SWQO;X5Z<)V?O%W)_NMW.CJ1M"YR/0=K*B'S7"9I> M>U>10(/F5%RGWR_/=(X*E?,S"JWC[(8[7[GC4!187/*;_/'6S'9M\HYC<,:K MNZ]_3YK8R!I*MZ83O6KUNHI(=EK@SH)EH,&B'EA:#94TU/-S$@55(:6YTA?* MF7AE3BDJ_;4Q839:\5U^:PK1JV9'$=%."]Q9KM/64%$.*D.5]-/S\PFM">UH M=L/:.:\<+P!^0V'+01Q)G:T+*X-Z&7P*#^!(ERO:O6IJ>5LYH'15$K(45!\ZJS@Y2F M]2"M!V5PYX/HR((5:'AH<.9C/>X@T8S&6"G&=C"9\]9\0%TM9BL*F::&C**0 MZ6A/D#K<: NG)W"NLJ6E\G7#]?3E\T9G>^Y]6G4"@Q+BWB*BG-S<"T*?A[8O MP,W2@\W MJ:SN3 ZU4G0BR PT8-0$S*X6<:VM:FTU@S[O[6=L_FA)?F/<&SSV"V)/G9FH MBGQ3&FQ[U]QDK2UIR-PX9+#Q4+/U3B7PG)]_**C["&SJ79H/\,-*=(IHXP:/ MV6Z$7L%,8^L1]4["#J&WICMU^RJ)@EI&SX"FI91/28,F(U+T5(+,^?F,@OK3 M111S*L^A;DR;:K:TT*XH:(:[TCX-F5,%;>UJ;M6:U%DTJ8OD2G @DC%A(]/# M^-+E"G[[62RT7'ZJ>!5=>4,]H"CEG3T_)U%55VH.%6=+G]<3SK16I&5O-4 S M5"HD3T,FPWZ4:E9P?IZAJE;4&ER:?RF'(1DL#'U[%(FVH*%G/'&'N3S@QI/G MSV7CZ1O3F;0?0UG0##5D%(5,6ZG"-N?G- IJ38HH2_GMW$2-W+V;MY41%_7S MZJ"T@D*=(M=C0P KG_OQ%A,[59[C#8;]7-8[_3=RQ&?/WV8M-SY@_L1,%J=*U].K=$HMY M%[==>.MSAQK0O0N]^=O[-CV]>L8LX#C!T&.Y/**L342R*5MZO! M#.KG2,^_-MRH[OGSL[X3LM'S+U"/TDIY!9T%U1'#+_WY\Z/X-:H1S6Z]WU5' ME?B=!Z$?F6'DPPIO4B3733N5A(INVJD@5+2/1I0&Z$V.T@"]LE$:H%B//M[A_+T[E;1LT M,,N+,"$*-Q?_BFY;5,X"S[$M\!*L6!7 M:Y62B'!^GETY_W]#V;@Q0\NP:!'-%)]MU5@S*$*:%B+-_VW]WS(OSE\ZUN5= M=OD,5H4-_*;J[96(UVI5$:]UXIM,:UXZS4:]T\;C>\_',-#"..TT(&[N>]0N M5&1_6U07WS)&BS1TN[X1AO*5G9;PT*V?U(MMA5-)7+(/2E+12!]A(R ,4;CY MD2RJKQ!2C#?G_NEI)J%_N[TB;F;^._5367K"[T<^9]_OV1@6^Y8Y+VP1X W/ M[A$VN'*F)8]C\^8Y/QZ:$0PL;LJR &^!-7!?X/_?F#)K,:8^'__'W;_9O6:[ MT1\/!V:C8W:Z8SYBW;'9[ WZ[3;O]1KF__5!MZ"Z!][8>((7BBX0["$/PEMA M(:HG),A.#!#.P6'S@+^-/[R+:;WMTF[HH7=R,GE#]B#NT]-_ELQ'T\M_C8VDO'=@A2#5?/;UUL5NCP5@7$_,-[%;DLLNR0 M6Z^/<$Z7=12?7.,G ^9UL/3H3L=Q85GK^?O_F3G,-;GQ=<%H"E9$A5JQR62'B7.1SQ]7= G'].O7\\!Z$EID!I^-[+U29CZAMY/M M90W;#4+F.-2@$&52QW,GX@&+CT*!\O=&.+5]RY@S/UR(XC#CL>W8++RY//Q6 MK=/>TZJMJ?3QJ73[7"STNH3M_./]98DTD&<<*09H8Z)4%+?@AS$'NF(98]L% MP1SMP:87["G+76Z4=K-9:S1UJV=5H=.JM1MGJO!5:7WZ5KW559QFB- :I!>' M" I;'<);?<(7ZCAOMFN=G?M05GY8%R"EW")F] 9[-CTX+V:4CSPX0NA!L3V1 MG*\?F1EZ?F \CL?<)'?VSU$ HX+ ^,HGJ"21&_OK4@6R2RV:P%H0Y3O/#\9X46^,8J/ M*1#'!&.I?MO8/)FH!##]W!81:/;.^S_(GR]G4Z]UZO,K3IL[NK3/8&O5R^JRM"T\AOL:P_[ M,LO_'\^)9EQ[TG,/YS??-O79Y)_-$]EXS45UQU-E9.I5'37IN95%([2:.FQC MUX.ZK+/XY&:$\ZL.W-C04=<%095SGP1E ([-G%LS$K]JMG2!%?6@HH&B(%": M%PV4*N6G:P5P]^00UJGM"HRZA2"<1Y/#"XVG*;/WZZ1TP1$92K6:U;$R68K; MV#E!6T/EV%#Y]W\;M)JM=Y=_:4XE\EPNJ,]$&:ML4'TY 2CDJW,W&T*O5*K6 MNJR"0#F]IJ.!H@T,MVY@&)S'OJ!XO-.3YY)'B6)Z?N=!Y(0*Q#5=3*C..>*Z MTHBM.)#+,GYJ=61;7)D*7#,\WQC\I49Q6AC!%=*N9V+7/-VU> JV+C[0:9F9 MT\)G S:C4#+;LS!D#,^H9LQ]&\X#MF=8$<:+E8[P6JXET^Z=HC)/R:-%[:O5 M2T3RTR]AI* D$ 8+Q=GO\LCKU; HYO/W,7R^^\S30"V:U'%G* F0OT\?R::@,O8O\]1Z-NN]\R,/SS;#0V8 M+HQ\;KP* *$*CDK7BBE?*Z;3AKOMA5S>2./>>#3_C.P@!LY[X-FRN)'(X/O- M80".)\<+ !Q+967.<7<0,1%=F&D*70N#9Q.//_R*2#I#=$L9CDP2 G0,0OA" MQ(TBQ1I'/A7CM-T$'5_+K,4 N"O\8G'X8'Z'E[S3A.>XA >("29RY5,5I$59 M^W9,@R17,!CP'" 6(U&GP8K)C\5GE$8*_Q]$\SE,R=UGV_=<0;]8 .3*1C@BCTK,D-C9O^HT$<FO5 M&C.J1*>YKDDT>UJ5N(I;(#AZJD*6T":T?'5LFA3,X1;A9=Q&E8#H_-1IKUS- M].: I,0DY\2A<](-0$]S&9FV1!:^X);B-N*+EA2ZFO&1V?X+6QB_\G#*7,\Q M?OGE28A-MHN#/#]FUU0I9(U PFHM[\4-0O@::P2 D"AXH1'G@$S M>;Y17VBHG[X1$DS$%1$BGC9Z:!1<5?=\]F+,$E8F-(%MS Y)89X.(GY);7C+ M\\[L'UJ=5 #:J]KD5N-YGDG?L@-1"02)"EGI+5 G\$NAS0DZ8V@X'A>.(#). M4)1% *1B"^K2?W S7.$E[9UXB6;\IV#\:U:V/)JJNJ7X V!>2'9MK/;(F>]2 M!5G9W0=P+ZT$FS$(_=1I+".DMAU?/EHS-RTB!>>?X )YZ1"_?UTXS#>^SE'; M=@!I/MK.#&@.\@T^LI!;X MDX<95Q\R4 %7U6GM%S@-+@K//5/!-@^6'[(?!IX+;KK5_,M>E/2%!60F !D. MA;X7.YQNHJAU ^O&;5Y%_/JX?'CRM.E$N 9:&@P6,RQY',A@XF1,)!9IAJ3IJ)P)_4" !O P Y-+;8;QEAX;) M?'\!W[\PWPJ2X),I"T>,C)@O$6^+G T!TDT@5;49$HJ!+A$Q/X92%('5; MANOAN=Q[)IQN3-;B@U[ S:D;7[6%L$H+X;"9M1 VF\:]\4F Z!O[?6C\OL%M=I;^@5=5F>\D@7YMJ7Y5% 0T?=>UO+EKJF@X1.) MM/J@"@_J+]2TL_1QG9] ')_8;&U.MELA5J7K7I9#D))M<$MM^,#JM5=UJ.T* MB--NP\Y_WTY8>DL7J+WU K5I8^&:P7^8?![>=LW:Q*%W8V5DFK5V7S4]=1;)WJ6!<18'L2R+,ER5S7OKSYR> JHZZ M>9FYL,WFM4K-6FA60VB\]>?/3P-5':5[G.E1*B#:A=G*\UF!2*=^)>O%OC8F MS,;0")>'MZ:5-7=@_0HVI[I2J+0T5-2#2G/7X P-F1-!IM.O]\X &W75F/-+ M$:J.TF*T'J4"HEU%&.U:\7%13.;&K&>#H0[:5!,RS69+@T9-T+QJM74XK8)0 M:>AP6G5D"%5'W82),)%M1"6-&S,,]NI=K5%K<\L&W-A5XM6XH7) C ZH4891 M'F@$R!236BKA.%RM=SD\1VG$QHYE:%=:K-R&-:&CK0F*0J;9U)!1$S)MG=.N M*F0ZW9T5"6U5N,U1VC6G1ZF :)6;KRY *G^?;:U'C4IF'FQ&-+H[0 Z_7"-' ML]/7X3Z*@F9GMYX&S:GDO7-8C35DRD"F66]KJZU2D-EY!5H#;"Y MP\K6?GBR74A G6EX.C)M1W7C2^$<%G_FCC5]XAU$HH^C,HS=M#$>>&Y3 ,G M:KKD!?3U4H?;&I"L$/Z$=\>MI+"]O.A))_I@R=928R=5B=-&4]2VCMI; ;0] MG]?P;7)%-1DO$M#\_,<<'P4:#K07J*I)M-#GP=S#YO7+#:=RNOO6C7_"EL.0 MST#P@M$@BOE$:>5:-CV'3;6\"+@+\ C?@[.6+=@(8G%_+H6[Z6Q"NRV=(*@_ MVE.FTV31Z/;Y][]UMVG742 U$O-T]\W+[[XIF@*+GH:UW+[-+\"[88@4EX#/ MN-X,A#'XU[*EM(> 3+I_Q?3R%2@J;0O#^S4$I^,GQ @#'U3>C>RV4#1#H/50V0 D+ M/?,[O$1WC#\R48DY/ )F)B4?5-MB 6V=SA-WX*%-RB7\\IV'B0X+(I+]HR9[ M7,8<"*6?K\OT:L)<RW; 3HD P!_MKTHP);>KNM%+O9% M-H6,DS >8>"3CF2@9#;U>S?^ ? !O;1F_)VCZ7.A1=2CBJ@D<5[J-MH7O7I0 M#BYZ_:397/0.0!&[Z/5?]NEO4(@O>D_.1:_^IDP1I4T.9Y(3R4M*?@QO/ Y M"AXMM+)Q9&4CSU^"1"G5LI='S.P?6BTY 5P"=.-)E^)/<4Y'HGWD&F^ 6T=@@?FN(D8(>,N(P/4ML^+A_M814Q0/'\$]"3_0[5YU\7 M#O.-KTF\S$?;F06YX3ET9YK+=V;=V)NB#_#^T(_,4/B\R4L./Z)QT8IY0:7T%&RL.3[/5F&*TEC,9Q,!H0X1D/IPO'"#&:D_F+ M>R"N\*<($!,^2QH#5X5I;P[5ZF\.UEZENJ1[D MM9$BKK68)(1^-#D2@ZN]YC#WIT:]F?O] MIJGZ]5X__XE-,VW^OMO.?X=>T_'6-"B:2*K>DY MP[5A.?DW@N^?)B=EN,)-\MOS;HU&+)&N4E2+Q_=>UM*7!*F5Q!-3=\B(9L1[ MO:CS>Z(X67U0A0?UE[^-_#?EC^O\!.+XQ*;9V9?8M%=QA,2:RT80- 65J6I6 M9L/E#FWCQ;JJ0VU70)QV&W;^^W;"L@S;$-?N('/?/LW.A[S.<;_4.#!K:DYYQ#6U)4(SMV:_M:?/S\9 M5'5411+9Y9+GWWQ[BX1VG?447S4;I^W1?4F4^;($STM__OP44-51-R\X/\ER M$3_:%E"#YE3&LU;GM,8S#94R4!G4>]JFJ8H,H>JH6XBL M364;D8!Z8^:S5J.N?<\Z4G$#T65DI&435420;O:$"LR>$"5UK'-R41T8S-IL.R>1NU/9MRB[MWFE,^PL\&B9O!9 MY 14X%VT5\-Z2%BUF[O<>+9=>">#5U/+[V2 S_$8X:.-Q7CGWHL%GX48)<>& MWHLQB@+82A!P>,(.J%/XLR@S#M=G8>N&.@_]Z5+T\;%_41C<1,\6JL.,"DBS -#F>6C+J#G<9 #"(\5_P+GIAA'] Y[&$3I)3OB?%MFK:KA\L00Y7.3K8G M6#HC&_<]!I!2$\+1(M[RP@#P.''[09\Z)1!+NX MP9M7K%_@WQD82+.2*=LP"4G 39W>3UMO&>L:Z_1Y5GX7U_ M1LR' 2K@ ,U8OB/#UAJZU.'D*=/AI&AT^_S[W[K;%$MTUY=KZOHB&VW(9AIK MG5DL/B-^5J*%-T#O,;"9[G&FT6M;)_AE])$(QP"[@(N!>,"(9TI106)?(E(L M@+H\V[[GHO"J ,?0K<)O%[,EX5QJ$]=I;VP3M]+?"%1(%X2HR'<961&D<)1I M:HWWY \/] P#M9 (Q;Z/S/9?V,+X%41WYGJ.\!: MH^* )I;WXH(DRMD,OO3M9]&9+KZ/FG9K#-_>GY)(,: FD7/"V2R2(UTSF3\" MG0.(FO?#MH0.&ML#+J@]VR4"3)*D1%37#=&V ;'=KZ0A6J^A&Z+IAF@J-$3[ M0@:]1[22PM7DP0[,7#=%4Z/9EUY3N37IIFA'".]9$0YT4S3=%$TW1=--T4Y" M;'13M.645]T433=%4V^4;HJFFZ)M/HMJFZ*=']OUJ.L8=5LU0@ZO?W:Y4;NO MFNUV^9I!.ICZ=& 9:K H!Y9S1+AKP)0 3*=^CKP0G7QP>:.T#*U'J8!HMU@D MY;/GWGNIV,W=($X%%AD>4F?U4=H$'85R+ MD_(IA.8(DP<>UJ#BELCC%V^B5:7+P =$XE$0IV^:;"Y+*021CVLS*+O,A>&4 M9[[YE)@3>,OE(JBH@(NATSB[RT.9E&:;B:9+">VODHW@GS7:@XDK!QTY\ET# M=><@X*%8,,X#>X@8U0F8,%@I?8]>+1Z\3C()+7B!BTGV\E6Q&H[Y5<%F95S\ M['JX(<,LZ,_W\^R^99XG(H;,LKRJE2>2@S;@_X;ZL#_-G9(O4 M(W1U_P$T9#D'L[6<@ZE3SDX 'V (6"GG67 #(,&"QQ&OU#FE&E_64A1C^09K M "U=WL[&!&I9*>#3MZ1 58)B.1RZ;/)>^TX!Q,Q/Y_K%!DIG8=5UI'M/;([\ MW_A=BHB[9'>=2]86P%L8L1O_,'$Y%N"Q9K#Z0S^.+/3\<>X!!^,JTL%6F>KW@):;,9RQ@%F(I)=LA ;EN/-+^-@D6 M->.%&U,&%/*G9KW?%3^,!)9GUH$B2[*6]:7\H_ZU7F(] F-^:C6:2[>IU'N M'**V\S0%50*0+7[!DWC!Q_@%KU+!&UC :U!3QK < N,J^$]G7$@I3CEB^=_ MIR5*!'8YM[*2.6A; " 4]1W#&SGV)*[&]@D6#!0D)#J I\<=:S,>$/EHUE=/ M=BM0ZL8_.>&AJ"SG8$DYEZJL+6L"N!VL^(;5L*B.P@PDCV>)E&/8O]2QL *: MU$I&H2C,\(+^/L?FSRB&LC"#_X2L*&*R$M&8ZWH1G650:+BNMC) P'$,9'70-GD:5J0&%%3(^+"*94C!!,:LQ67.+M@PMG MR+E/JDA<6T$JG(250CN6M9C@+?%-@#?]__:^OJMM).GWJ^AP9W?('N-8?@$[ MV2?G$" S["2!!;)S]Z_GR%+;5K ECUX WT]_ZZ5;:LFRL8F#9=#.GAG KN%Y0:1D#K,.#".4S<(B'_JAJH? XO[);67.6$6R-QIWX:P*JZW; XSS?C0 MD3Y?'AX=[;V@G?X?Q#RY%0)%#C-1]G8U!ZO;W?K_\"H_(EJJJIV3L MN:B=HCG]]@WH%_C3FO$;-@_U9B]-O2'%F%Z77XN)4D2$>5W8.JQ48:4**U6X M 55X+:8P65"&B7'&&A$U&:S*@A\HJ#I$UX),^$R[,\YH? '1C5WC[]9D^MXX M\>LUXW/DU$']\0>@ =EY09IZ&*O]&D>!Z_EW%ND9ZDO7KY;/Y2C=D*1; MYA::>!;W(Q=,[D#@&RAM8[0:?]-3/K2P#%WJBB84"0WDP1*(B1SBJ&" Q1- M#\ RIN!PC*R0NQR3IONET\CWL@OC_G>IM,%A\T*+3PS+^1Y+IUKSIVPX]"*] MY>/2-5%W/$^!S$U$-/(=S8^I);V*T;''ETJMK]):N,VN%PMRU?KSYU'5!VM9 M'ZSNXCY854>K,LSEY72T6LJ(RZW&3SZ&C0/2PGHB/1!#*Z !T#C-'P;6A+,Q%$A@ M3@Q\&S<(76[$1N'R#BU(D"-6CD8,:C.Q9IER)8+-4&.H,,(C/H@C0AO\!W17 M,$I?T^>0O#.,7-MP=$U'W?(]H> R0_@,B2.M. #B;R@N-)7= \C,:5!,4W< M2 8^ FOJ.EER(^6T_(3*76A) ""P(UC@N4ZF[-KJ3W**J$ZM.#=4DU1),WFT M.@3[0<4E\U#\:9:90R+T.7-LB-"21N!+L2; TWPN6'&+G-(FF MJO7"3%HFS?#H\] K!O7)UI(<#,W/;,HZ)1 V5:JG"2NB2Y=*'25&C5+A)KBQ)H-98^= 'I&"L MF9[^H])%( \>_V2.W+DP#"( M>V-X/@H4%SG6C)%_CPQ08_VLME7?HLJBZE@VG??)/6O\9?$EF;1G? *!OT5;)8WUYY:R?!G$ M*7ES#K/+KF..N!6MB/IFC?1)BA05I M0(0D4<5L(*W,#(,2N=*)))%CI3.A!T-:C6I\H@$D,&!K^/>YV&/=#L*@L M#-8GW\!2J!I;9)Y/%@ >/731_@$8C WTQ%9B1>@&."*H47#W*60TGI%,SQ2: M'I89TCC(#J3<$^LK&2&9C3IN^,]J"_&8!:LJ+4K#1R:@ *15Y>!5$6=C6RDJ!FVTAS"9J?BOPJ+B1 M\%GH#34P8>'5=S %"G/) !@LUV('%LU[M(.Q$N" .W:R.$Q]?TS:.0CPG6Q9 ML5&'.AILBR&J*=#1G*$G>"_*!P4S%>K(+Y*(2D22(UW&01A;[-5(D%9VN8;Q M6+$^5JW!X7# RI?.<5@(V)&,H2K/,/1Q\@R-Q=YQE,JT9=OQ).;Z NZ?%U)% M(Q"DAF8"Y?CY++-(=Y#K06O!EY#TIBDO4G16X*BK5\F4SK3=EG1#6L.<$LH'S= O%6Y+,EOTSA*Q\FQD!.K0-,T#HC'* @SP55P MI"S/%35UE8QD)5S,&G" DA7(!B2,S3"_Y&IP>:$1H;0*3]9])0/D@G([H-@XT\LV MS 0(E+(B>R-W ASC* &3_8WK=V3][O$P$#(PDJO@S3IUQ6_I\+\ MG627Y/[J%PZU6B'TSJ0-EP_AI3<6*?;!87F*_!0,F=FTM!ZX<#B0_,$ XQG2 MVQNGM;>AT*>_,":"<0C,3UM .6^H1QQ)(?+2<+ M;U:D-VI_:36;V? =*,)U;UUD[MB>@I.R;Y8!K_DIX57^ MA0O$, ?=+NG/9+T6&9895Z]N?$N4](WU8)S$,O7P+[\?XDUY.CQDDA6KV\!6 M T.83$8.O%(D8"ZXB>,YJ.2=U&!71ZF5?$M1ODY>4&V-D9,*41#1A8. MBD:@%E%7!Y\1P;PQ\ %KQSPPV[AX1R0-T[!;G:02UC>,M7?4_.+FZFAC.@OV);&>=L."6=.]>"DVS3G%<'?3IE$V@YNL00\^ MIINGV0@_K!8Y M_(=W@-S!K-*4/UU3?DIZ_.VNIBSL4YCQ_!KSJK+9Z?UD55DX+13!PP5OKIR^ M4IE[U'S2FLG"7YCAR ^B RI9I()8W,I6(]_L0B\\-"R99L)G9:^J9,34B2ML M%[2D.Q#7=E Z^D_IEZI$_PW.[K,/*TF2/?G47-5!K>+YY3R/UR4$E^J,??A" MEN5-L_E8W"/?"XI*$[Z>S''K01.V8>!9AXK( M^.I;=EPN$$P/CWS!P-X;JNM):JBX$ %+OK!**(G"6U0Z9(_DG4 JTCYP,$:9 M3#(D'=$Z;,-L9O+^F1OBP#9GMSQ5-"3^PFH---4ZN4-67M^#00Y@D'3:H6QR ML_(T.K*<=J59F J.HY^91>> $G'Z)+CI]?STN+ZT+P1>?!M3V1 &]DJ@YY:R MX3'?>EN%%[&H:LYP684?B?_F^@.F_(?[FK_B2-<6U^-C[65S-3' /+)5NXS7 M6T7-%5?NX@A.%LW2 C&)9(VZ?"*,^U1-!D(UL619-MO[1V7G!5!)Q_$0O/-< M%Q:UJTF58;YP;.V-\M$3 B(EE[-4%D6^02\U3M+47&;%K4\F6#9)R90IRAE9 MW9H]LN:$RKXQ6@=#7I1YJ#NJJ!;3#H=Z7<1JVU'J1G6]'TQ52X4DX M #E<57>V; _;C:KNK*H[*X$RN5DH\50G- 0M M(L.):H+IGD;M/P16I_(N@^ M>^::2W*,@U[&3K&RSAT>B6!8]OWA7ZK\ZH2KQG\-Y;@IK$=RZ5VKWF6K[#JY MY&/\QK/U [3,2J[%X7C]E^6E2IP5=$+7_6NLV!]9+F:XZ%J2K,FZ"2Q2PJJE MF;&_=W)]?H-FNV6HNW9::PK]#E3.A,-\LVQ$PJ7(V$*1;:*YMM"I84=$7]#E M6?,BZ-;W%"G"%YE\QQW,L@UED3&$/*9]99')F5C#(?;GP8;27_\[;YO%7MK> M8 T[+;V3+E][[RL'(I1&'%ZG =B$-6,ON7=IA(@N=R.Z1X?<%O.Q O?+*>- MZH"-3H,6+@ GP=*:G&'W#WDR#]P'>;%S 'X,;0O>#9) .X_M %Z@*)9>DJV2 M2X=R1(I$!+@]S\ES+) OXF&GV>>F$!2%![;J%CN;*X=;R57F0IOT7C)[F,A* MZ(;"%U$,687!1K/]G^YUH][Y&W@-(5VG][0+Z_ (L9^VX[0&+C3_!_BR\OCC#A>M-@EUA96XNRL$DD$-E9U50 MY-E:Y+PFEU>CWP"QQ 11.#/M*$^^GN"%ZJ?PA/D)YWN!?DHBNM1% M%R%5S!N^+!3P ;S9!Z[&6WN6WF437T)?5PW#>*; 7I;,A5FRU5;">JCKRB[M M%Q@R"9"GX+Q.DRG);0,88\1P$&"-4[HY MV0Z78XO%7<8X6(*13SE%"E!Y66+C/K7J'7 3:_2H/[^XJLJCI!D.;)ZX UF- MPA BW0P5$:41IF@^VY@ YC8J8/6#%T"'8:I>KY&K.2%^;).+L(#A4FY63S4 _ BA-(U%X=1FQN,?6-!3OU _O%;BIZQ$U MZ$OOY6 R?(7QF1P>-TD%?YR&;NH-#M](#%[Y9OEQ'3YZ.__W9JO>,CN%'S7J MYII_[[2*7[+H&]6D-C"I]N&CD_IQ\.8<:OQ\5/1Y .-[CZ&9D0!\H;P)..^G M<&*M@!VO%M? I2TFV4[1X#B)AER"YK+=J37^9S]X^^&8,Y?G81@+YY72YM0- MJ8$&&D:75O!*J7"N[+JKU:1D38TA#SPZ#Z>10>%% Q?U?DUB/O+8X^_9\FYT M5]J-?;!\?C&D$Q"^V1Q/EF\W*DEQ#2QXUGJXEWU+^8:?30YR-%GQ7 MDKIQ8JW#+\UZ,U<1YNHU8U,5)55W.[B:X8;'H0007B!)DD4O+A%D=NNM=KMD MZ8VR3LKL=S4X9,C/%&O?5YJ8NL\"(4SA\?B';=.Z$ M>J4$NO&YWB\]E_$*1>@ZLLA_XYD3>?:6,[FTHKC9=A#+RO!O'M72JNQ?E?A[ MO8F_W:'/#Y.E]R+)LA;;O,:HV+]B3QBM!A>F5A&Q-2-B[:/6[D?$7N;F]# N MUJQVIYR[4XE.F3>G5&+S&O/Y?%M/ECQUJF3^6L0[ZJR;IBIA,O]E;@W&:9KU M;J?:GW+NSU%G7=5?;^\A/9]ZA,-F6U,YJCW&W5 M>^N>R-7N5'+SRG<&+[>;S?=EVIY=+%C"QA^9MMD*#MC(7"S7FC7LNV\23$0" M@-0SG9C VW?A"84*D#:OQ 8:U*W$CR-"!><>+=A+0SC8!TWOQXA?55],FD)P M0[6"SK346D+V&6IQ1UNM5Z[>^G=IP^%,QQH8ZEI,HVP3G&;9>WG<8/\QK5.O MYZ>(EPR8'A)>!>.C ,#6[;K?1FW MP7*JZY5EV]SJT*7.^18(TKK@>,+6C4A@@;GFKZ)=^37V+6F\GG4PG/K8#E':< M[+>FM]ZMT5_N1_YX/#OP[SWAU(P];"D9Q-/(QKYM$S@=P1R?"CI;X"53M$S2 M?K'&_M[UY9D$6E!O&G)?O/1,#%7G6..("E^$,/R(]0 MAGF +AS\%[/>GD-=+Z*$Z@CEAKGFA^NB>>%;R?3EYY: R==P)Z=I'RDB!G>6 M(EQ[LUNXGGEX^:+UP/GJ%"]*ZPZH8841F#Q]:2&S$&Y/IY6=%#DDT[%PAMS7 MDWIJ79[A#0BZL0!\S= 7^$&ZA?@YC%N!^/3T/L1&V/K3!T!R[:'V'1KI((\*_$(9TB!LG],0EP%7$) M=DX/!R+(]FI<2KKE!PIKK55YO@1\MN8YZZN&-L343I&EB(DTD*BZ)LW%W@Q*)\7& AOYD^6. MXT P!,)D.IXE':I#H5-2GB:^;<<@<7*%L$,RN$@$UN@+"L&/QXY")<7KL: \ MQO)>C:*EAD>*2^*A4G)I@GUG4([0,7J,J3=D M^6Z)&-=@<%2QY"J6O%(LF0S501R0[+L>_#8A4I6 R=<\7Q/\'X5U#NL\3Q>T M_?6LY/GH*;_B-MX0C[0_\:!!3F9 M/,0,V*;4F#906)T+\:3 V BF4D QA@1/PEF6[*;\/JVC".PI.W6>.2'LP#1_ M"_QXBE.O5&*E$G]<)9($,%<33Q;S(W(ZIH<,BKMF$=&DX97G<2E;"X<;HTQ7 M.>*UF/BH=]2SG4%S<-0_;/=,VQ(MTSSJM)Q!O]_J=IO_:_8.F@1VP=CO=FLFUOG90K'NJ'Q;^ $X%O0;%<" 59*<"X_ZCWFV?L1!4[G MGG8V1/ESAD(C5-B" R'Z&YR/C(A7,[[[KH04"@5BRL"?YLY-BJ2PD"7O8V&]CQ)*1 3^:%5$Y$X3:,] =)!(9<0:[Z<$#A1<%Z[-OW7&V$ M3TQ$,,2O!9HNI$0!.$RUPIM1&[761CRX[NY!3$82^]QZ_!N^4+[4%)[& MTGU!L+W??>R= J9=::%.K0*RV;5?>PH MEJ%XZ;K;ENZ5G%V&0:V(0QT12!+SA1O1@KF&*/URNJY?PTPA46JL+0APZ$$+ M9H+(#0>\.HIV)%RK4 H1$1W8C/@8T9)Y(&G'Z>]6*RH4SF1B;I"7'0(^Y( C M;(\(0_PJXCD''(X@DFC?(6(BQW$DE,";!P$!_D'"C3P7 M:PH.ODTQR+%UO]/Z4-D26(CFCTG(V70A]%3D(U1UL1TM!$V%7=$P4:,1&+S# MD?P@FQ"^'[FP'2!LQ6-A6"1C&;%<,[?,+0!GRT$W*7,LB.YD GR+O8"*#"#I M5_"B:T8_CD#UA]G"NT4S2#OFA#!3&>"36&4(AU5D5?T:Y@B=E3E=M1:+8E;& MY5!SFN!)\HQ.G(IMCGBK\SE\8R@\04!=*@Z?V>RZ<6;AABX37HKJQ0&E%8;) MYF5>@GEG#&:"/ *;C<402(Q O5AEX#DUN9#D;,R>39HH5B5IRTK2FE5)VHZX M#2\;\)N2SOX@D:8F)M&(,T^O )'>I6FN? (O PK4BG4FA,9@8QVR43 M2WYG3G_]:EA]"?5,>4>'K64UA#!CP6Y#-JG&!#\K/!A_MHCZTT&P24 M=1WA.0A('=UC.3S?2$A\E2E/F))R49C9Y[KQYP@!0/$;2PX:Q\?PY>JV,+*3 M'@Q%SF,#0O=.B*YZK0):Q'<PHC\P '*ZI*POX)M:MT'PP<+T# MYP 6#8_+RQ4<%M(Z]WE.BJ?I>W,&0VWIZ3]_OX/7=^)/@$F,:[*JTEVA*A?] MHT"H:L+2Y^;0? OC"4R&"F_TFH@DM*;V)!.X1=L$?(D03V[$*A[[]QP* &[O MNY[RZPTZ+.GK C61IT9\1QYS1CXTES"4XDA>"ED\KK3RR$]&ERDBF%5A!1[% MULD,XVV_$YPT#E7,<3'C@_VJOY1];(J(3[BFPF&(7O)Y_$EMF0S1UP8#8&-B M:@I@B"G*,8:^DVLEJY?F%1E(S]OBN->K=SNM=3L<=\UZ:U.-;0_K[:/E0ZW8 MLO9%M>:DLK4O7+9VABDB@AS,@K-G[A)NAD@+6_HU7E)7OQ?%4"N2(TG$K$6* M%]&/X:N(*%X9RJA^X* ]A>?-PMX,+_,F&+2K*4G/CF8HA M[(.#'KY)4J&1Z\64?TK2.J_,(MPW&ZVYCN>5-;@9:U!DN>Z567[ 6NW56:M< M5M^NL99A19Q?X*MA_GPP]_7IM368;Y-Z;=4N6CL;^SULU1O-]3#;EL5^#WL; M0UIK;BX@O?SE+RI^N"+N$26AY-4?=+77D M?0WN]075[_!E_$A6*K\R_[I9,UMFF5K]5R ,^N8TVU7BZQD37QM0!2\Q^]6J M-=96$C\]__7,ML.+V] GHJY5"E-.3.>[VW.B-E![FO5FIUN%9T=[MV=,?\FNB5] M:]%AM^R.E["AW>838R4E(7; EGE96]JL]7JMTFWI:PBO+-%%Z8W;5Y;A>:(WOF.V3+4QE4VR*+&K M:8-7%PTQ&Q6B;TDWQZSUVENJNWF=T9!-Z8.7Z#X?UMJ]=4-S53RDQ!O:KO76 MOJ=?Q4,V<;$FC;E6(9&GAD0Z54CDI6WIX;K1V2HD\E/2PANR?G:0"4VSUFD\ M,>FS8Z;,+NY.J]98VUDM5TQDQ_RA#2J%K*Z6]^[RZOI%V==FN]8]?*+[O@DR M[8X)\RJXX;#6.OJQBMIGYX:U+IJ7!B#N>H0-4T\8+*3D37,O/.-X&KACY@OS MB!MN4D]I;MV,^ @(4"K!@:@/LNH73##PC?I1 Y%8C)"6[3/R9::),'>@E: L MOQP=9M!_&7IK:?9 MX\=WH'5Q(''Y^M@4.P-50>BUU&R/.I\3E142C2-".W#[C-F%'^-M:^.3'TPD MO1H'?RB4&A@'_N6'(FW@:UA]_TXH"-P*\VMCS?N['1VXSFP8!P9I!BF"7'95C35,%EQ!8=A2#.%^DT @E/RX5 MABWB/)!@LZ[R"; M.3C]P>"@;XT)Z"L<"1%EL"K*;A*7 ] ML*A$9G= 4KZ(!]?V"4]#8@S.[0WN1E=9Y">69SG6_-X=:GO7;-+KC^-A'$;2 M[0%A)!?.$T,_+)ZD!,R;']5Q"4&*M!%1Y1IT*/U9 M)PSM.U+618\HLV1X!^*]\!^)X^9HW\O0OI9PNGP>]U:N91I(G!C0LK"4(6*T M<*;GB?UHQB*!SF+8GG1R(RH..98-QA+I8;,CP[81T6OIIH&0C@ASL^ M:)"7/$_PVKT0P:H5$Z/,(2O9"E,,45:%E+0PMA$V=! C%A"<70/!4$CX)>5> M,(X6'(9CAY%9"6;(':=.!UWV&T'YI[S"A!M@W'+%%!#5UC M?%E\D-_ G)Y,(9$;A<2Z2!J0 RE^,AC[][F)[(=O9'1$.!4\_8:=@9Z9\?)- M\/+/F25ND"5>BG>_$*>^-.91L3GW4=FS9]Z=&_BD7THSY86>#6JQP!7@M4@L ML@,/"3YFBV$\8PRW"0F]PB<''6!3'WH)38YGX@&LZ)9P;?\4B=U$^.,8^@,C M:^*#K2=/-W4T#_@\0T ^&%4PW/90^%,?,V\VCCP8@)(EK/2"6VK8+\E\ LMH*1.PLC=Y*YT[+MA2SVI9ZB&]'"Z!.&N\1F M!-F2&/*$HL?(Q0I[,'2'GCN /Z"EDU)L*BFF,*C9K9'?>-35:M60A M$4+D;\?'E\H "74T405-*=1V\>R!VR=3A?F-YB@QNH2UQ-"#2/$%8:I\@YN^ MJJ7K:RKA@)*#6)HDH\/TRG?^"XASCZ_ !2K$QB?MC51'15--4(QJR@612QZ/ M?9N&!$T0#*DL,G EG"H/1#M&UA78\QP>86VEC#?''2!LJ(33QHQ+0E;-G);F M*1K.LL8!/=][BXF$MB%XR*&/_C)"W]ZBSB; >S)N,PC9O#GW]'*>"G* 4JD$ MV8@S0HK+F99'KRP\"%6,B=->RP4'EYM:8DU,MQ 2*(&P%JBFFF(KQER7%O:) MSE&?$HZZUN5*1@F6A+WP3)&1 PZC*159-&]DN53F,$1P^G=K,GU_7.[ VM(S M ;O8PC;I9 ?K"WZVF8JEF7XQZU5.TD:=I'9#=Y)0-!_GCQ?B-^G:@L+U_T[J M**[H))%1A!2>.!!#*Z#81,!$TG5&AD@%2L!U_F?O\?TP#P_W2B![Q:KC'$@G MXV+UQX3PF9,#L'<(WDQ9:U+;\(>Q^OTT,7!"K*D :_X+>1C&E1O>EES?R9D& M,-,DVJG"XAA7) .%BE ^*E:"E=.L7EVRR;@[Z$MBJ\) MM0H4$(UTTX^.Z\;3Z;ST4$:M#MZE7ZGVS:EVLY'1[28J]U.8S1UO5FI!G7O@ MM<#!B294FIN5>B0>DBJIN?$SCN%:D5D8E'=8C M:?LGDI%)F-:>T'M7)!G&"1-RESTD="*+V-':1V, BW2D^!D7L!D:::Y4C+4T M2RJ6P],T++R4K51Q'E4_>7Y2SR^=%5>10^ZS@8-H]E\:3U]2R>@93L+#C&XXC:DBVO7 *J,[!73<@WK6/E05\YA4GDS'_HS- M;0IH!K&L(TEJ5]"PQ"-XC 4#F$6&MX,I@2_%NA.J9':][W' !=%\C<^RU;IA M_FA=W/O!+5TIHW&]4%JL]DA,N&#G84J&)!JQ?:"<'VI_HM)%^$^ 9:,X "P< MU@;/VG_%;JB5ZP!G(=DCM#V3_CBE\V%%[QE<4Y4TW6(H%Z[Z'?S&A M_) 6BLNP9?X3-@2,%BX-D+,.^3X'F^])\5:VQ-P-B1AW:..D-9V<;U=;>D^F MEQOAPQ[X!G1'U)*/6SCB:9S@B+O>B'/D8=S_3G8UE01S64,8IC4%L2?+7"63 ML*-#A;%$$^;L#"MGPWM8YL ,C''((+;&^4PPC *D"ET\5!#Y',T[NKPR_\G$ MFE&,'JPUV!LJYL!ZB3$/Q<\D"6XF'<7NYV99U8=N^A9H4P^/]XP#O1(1KX9O M.12.+%=M]P;3(8>9=$@;-ASOP;M1JCI.5.V3[;ZP F$KEP5)RM>%SO/I8>LY MVAWW')5LG4KZO87'; 8Z(?(WX?3:(4? >>%/DRHYNLO$)3'$_"+>Z"3+= MD&AJ@Y0TGDWR&IJL<>&I9OQ V#Q0W_,6\=/#&]V="&\Q!B;ITN-*MN5&ZM\2L$XKY$F,$JM M!):63:\HS-WV+@ASLVRR_,T#(QTOZ6)2[!KO6N#N<.JO:2,\F^_<:X"2Q*35Z.K=*WUM.JVE2_K.76:@TC[(ZT00U6]>2S MFH?8\("J'/_I/KSS?.]K/(%)V13=![/F"LT7^\# M!:)K\3?^^3;SR@_YWY$@3UO]33#QHI5G=/0#BU_O3=V]#\ 4U#AJA>6C2\3U MO/"R Y,*#>@N(XH"$FYQRT&P^-(+8T:[T44OXXKS0,AQU\NN M1E>%BGL?VH>;*%0$J7^.0D58I'T A,-2D71VW>C]UN? MX$\O:?RQ77LFJ^:P;%;-&?/'SXF<'M8[3YI6@8[$'3QHT7AYS 8K%"P"^^:; M.27\X9^$X9"J5 *,@)6-K6DHWJD?WF.!V-B:O7,]F@Q]27&/U,,%[R9VYX]3 M;5)OL$:1D#GRS?+C.GST=O[OO7JS6_Q)HVZN^?=.:[V1%LVI>U0_ZBT?2D(# MY4XZLTV2E@-4"?Q[_CD%1UD"%<:G5:E@3*2H_+,?O/T 9D9?! O1@%IS2RR$ MB5GRV#J4?=JK=@&?[91J8:89;PMI74R=PR7$68@4@PMXZB9MXE6/H&NMN5OP MTFV!&-;-S8O#NCQ*"O^9[;)&V>VRY1.4=MDHBJ;AN[=O[^_OZS#/^M"_>WL, M?C?67K\5SM *WCI69+T%X^VPVVJ\A?G*'\&L:33:9N.M>&B9K;_,P_HHFF O M(RR#-X[Y5B1EVJX$QE.IC%>K,II''5(9W5L4P$:[:;+BR"D'4B"J4:2\B_TTQ8+N M)+@3'M9;G6A_YZ2>AN!E-$W6"NOKHA-Y)R6GB;I8#5:HB.0+FY4:VIX:ZE=J MZ'6JH2ZJH48C54/=GGE4 BV48$<8#(MH=I]!$\V_M-)&V]!&=J6-7JVW21HCVTC:[W=NM:B,V3J2/U'L^:ZC%+ZSTS_/KGV:E?%ZC\FDV\>#.Z0+ M7OD^7%5$V/NP6(VMI@5X&4O.TT&@Y*?)MN9X(\+\-"XW86OK7;]?&[_Z8+E8:GS^?:)^-V>HA+1?BA8T'W1W(?X9P^6MZMM-,#8,B:\;5^7*=6CL?. MQ/7<, JX3_7QD+OT3)(6,E:47!G-4R1#$"J*E*;YRNG4:9/5Z:$UU1B>:61+-=B>9+$LWVYD63[EHOZ'E?B>V6 MQ+93B>U+$MO.$K'%R4AY92&]H KMZ@0MB2@>ED04JXC!C\OAX8_+875=EC/H]UO=;O-_S=Y!\\"$ M?UKM5L/$V]YR]I5<;RL2V.R]%0_-)FQ*X]9L@GYHL7+X[(8$.O";BK\9URHH MA\W.5HMP(8.J"->QY\4)+I*><7T\PM6J(EQ;*N$QZ^8_MJ]AJB*>IY_ZH($; M+11VD+2_\@6 JFIO >2;#FQF*F@.R:H%@J M:7U^:6U6TKKCTMI<45KG01@K:=TM:6U69^NN2VOS)YRMO<9A):UEE-;J;-UU M:?T)9VLEK6645BP./?]Z70*!W<;JSZGME/%_/UY]-LZ],"*8QU/?CBF >R!A M&>3?'?5WQX<98"MX:SH55J!Z61/.-0,4&J=69(%PC!&3RK;B4! D);TGLH82 MRWO2%XXCPSG)&.F$U/OJF;VI).$G2L+UR>^5)!@WUH/O^9,9V&*1\ C>[1IQ M.JU$-"J6?#:6/#G^7+%D$4N>6&-;-8+]['JWV)"P8M#G9]#3LT\5@Q8QZ"GV M+W8K_MPR?WX^_ECQ9Q%_?K;Z8ERQYA99\_+JK&+-(M:\9%SSZG#?+H>V7R=S MWH C;OMW=%EJ*(Q!X$_XYA%#5?TZ#_&8NQ;O!_-X&AP$6P2J88RLD.&K&9 A MDK@'J9@4,/U;:I?]8;O0!ZOT?R\/'L+18CR$"MF@;-'J+2,;Y)E8JK #U%?O MS*YB:Q=FY$7O#O O6V+K?[ BF?_W)RH7P[N>&&-^R&#_&0"PZC798ZL.Z%"]U,KC PW#&/A M\)5H!"V5GPWB* X$?RIM 9@\U6K"?VO&V(=W(T*2X8A^5#?T%^,PF"C LLVT M:M.:3L= 1]1( 9L/MC]U&2Q791R"F/$M"03)E0!= 2Z:'I-PGOAC]OVJAE2@ M+1WQ#6UZYW 8B"$VHYL&KF>[4VN,M\YC+U)OI6_KKX:_XQI\,$!P8WA^86R/ MYA]%B^=^Y-JCN?D3E9$$;-RP/K(X?2(>$/H7_H#?=L=C[8]@2/U-3[1@=L7(VL\P$L/.!!Q MCWR &I# Z>/S>"F*^6(=JY&UP]&=78"8ZC3KO5YK(\A0K;K9ZI5LI';]J'VT MF3F!Y=9MKH)[]:10E+D2_E6Y(G G9Y^/OYY=GQDG%U>7%U?'-^<77U>(?9J= M[04_MQ)*W>S;2\\6'V?O%@9F#_=R"E&J.',A)-8N1&39V7\;OC4^7UR=&_^J M&U?_/;OZ _Y?) XEX.FY;5@.2[8+>_ 9SF>B_$P$M_#_TE-^EXA[,K+<0%EE M'WV\2 Z_G$J4[;!6$7NCQ"Z^:("!'\P\NAB&J\[9DDQR%SCJU(K$XC-Y-]?T MQ9H9INR8N$;NL=CY72] 7OEVI1AI9WR[%ZU;7K.U?_+[MY,_C(]UXX__7IU? M_UYZ*^C%&/LGH]B^)<+/ C<P:9\N1XUE/.;;+E]G=IRF(A"2<4( & 'W97[\ 2(JD M0!* ),?<0^4E,HGN1N-KW+H;X*]_>YY%X!$QCBDYZ>V^'_0 (@$-,9F<]![N MS_N?>G_[_--/O_Y/O__/+[>7X(P&\0P1 88,08%"\(3%%(@I O^@[#M^A. F M@F),V:S?_ZS)AG3^PO!D*L#>8.\@*Y:]9<>[>VCT*3S7R?$'M#H?!J/! =H_ M_ CW]C339W[,@RF:02!5(_SXF9_TID+,CW=VGIZ>WC_MOZ=LLK,W&.SN_//; MY9TNVDO+1IA\+Y5^'K$H*[^_HUZ/($=9\0"5"@]G;0!8Q&EAZ],V=TCIC B!>G%LU@ MRM#XI*=[4#):_CEGZ+VL1U; 8%_N NJUY"_'7))H>YFKD[%05G#2XQ*%""4- MU%[M0S3VU5Z28(+_'^@>P9&O[I($1?_E:@Z'^[H)\OGOM 4_VZLUQVB4O,47A- M/NO?RYTY)4Z+-! N-8HS7;G_5)*E#[/&:VC2!P+C$,L-PP41B.'9D!).(QRJ M/<2=5$HO+>GX6IJ'KBEW;7Y_QE:H]B0^"U+Y>R$"I#) 44BA*!V#7,X6W#(& MG(Z'="85G2+"\2.ZD-O,&;JD?+-0-XBQ K^_(O!<(5^2"A*QX)T2_',73:'8 M4E]@I'8#=U.$A#_:]9RL@![4 EH",N4*$K9;M IM? .95&^*!)85WAQT9;96 M'#^L@B-X5Y+2R5[8-%)^_2O&XF6C@V_*THKGQU5GV$3 %DESSH-\>A[1I\U/ MI@O&5E0/UYH^I1R@!74(W3/$ X;GBAL=RX%*K2$@>8%$CI8F\D M#F*8-)HS5L[\;*CM#I91*[+^!129Z[ZFV8.,?X<@O""/:EO/L#M*11(K$+O+ M0!2H.]3,OU$:/N%(-J5:)D RP:,(G7(N5]<$"=>6MW"Q@K&W#$;&4/>!G"5( M>/X")-<.@32,F=KF7,N)F%UB.,(1%A[]HH[<"LO^,BPI)Z!9@0*O#H%QAD;. M_4*7M3;S@;G^&G7)O+\@(MF)ZU&$)WZNX0I*:VM_6&[ME DH<.E0XW\ECU@N M$]4*T=W]4R:R-OG'Y28OT7>HL>\$#;Y/:10BQOV<,Q64UF8_7&[V(I/_[9ZG M1<]:PZG*8N*_04SXE?L*IY+6BH"QLTXFSG8, MP8(C*+#L$$+G$+,_8!2C;PBJUO$"IIK8BH>Q\55\@&8$BIPZ!,.0SF98:*WE M?G-(M?<,2\-8KXBXVLQE=\FOT6GHK!(;GOB)&U45$2G$C M/S"J2*TX&/[[$ILB-F9GKB!C>FX^0P+BR&.ML(X0*\*&=V"5 M\UK@W4+PS^!=*KM+EK!2Z&95B]B,,*ME&/Z*M2)&?;"HP=9"7$%3UPV&<83H M^.LS%K+HW306(7TB0\K%K30,@4)!T](_PHI6JI#5T@QOS)J6EM52#5.JGIHH MJRE0505I78&@&6$GK;(05\RA+3STM"E7=C:+.#(<0<4 :!G@4FBT@Q VQS-S M&+)RGI"NRMX*L>%@-4^@4DE03%6H*TFITTP9I<($_KL7"Q N^3 M4M1!D%223]X%[Z;2=@52]\"/A+?WR\K)"E9U#E*Y&VK.?<4ZS5#J/&J7E$PV M EH5(RMF%6Y) S/%> N9N$,$4S9D*,3B' ;IN+.ZN]F9HQ7$BKO $A U?Y ( M +F$CKL(R]WF%CW2Z!&320F'E[6ZHH6G%5##45?1*Q=9,@.65C0)L@M!*<:9J&[&Z(S:6X^<=7L-QX\?4BK/A@"N#V0#9W'\S20E9;< +P&A5K*4 M(/TUH>0L06:8/PKR#5:AR&:\_!./)ZZ,]#ZFR"AD\%ID>AMR94 O,T M_+^89WNQTR"(9['.]OYQYK1F#:RF9=XN:3>M0IW4UK!0JZV=U=M9U74&.@%Z/;2DQCOIIT4[MDH;/+'8Q2HM;Q\?BN'6^\S M-1X\K:@;KL72M1Y+1ZHM4&(Z"6KS91V%)>04$MEQ,%G<%Z&\?1FMK\=H MPU*MAE&1<&>[3*2T;DVJ 3 I7G"AO8Z+NG33K>0*Y/5XS)'0@<=5#EFL*\9J M(!7)?#X&DLM-4]NWUN &T^I)[AN19;6+BIS %>VB(+V;QE%YT5!A4ZG[#21A MH:'2DB$4^?A/X*U*^5*K,WU;@Z?9O'(M; 9E?N.E[L:DI>UMS 8]0 <<<%@($YZ8QAQU ,$SM!)SXF6J$MW MY-N3GF"Q)'T>L0@?S_5A%57YDQXF7$ BLEG_22@EB@60\(S2-Y,J-R;0;9RX5\HWCW=FJT_AHS>H8(G6&B$EJ^4,;H MD[*@;V@V0JRH<5+K1&$KF5W9,&8:#D>]0L'ZZA<_#JF:GZR:G09(O$3#J2S; MK$M%P=>K_:YK]<\I0WA"DNMQ@I="8ZL3<0V$ M>P?->CD0MJ#WWC :(!3J+08*5(H\,2_AN*-1^*#N/UG2*H@5Q,SI6UM WGS\>CROM8R3X3[ZKZ2 MHJMK]>,P+JQX"R[+6@WKBK=SD/[Z<%L_.'VR;-F=:%LPL/T!&595N)!+ S:" MY+O^(5%2B=3-.CJ1MD#%.O=)LD8C\-Z1"6Y8=>779M^];VJQLMV T&Z6=NIV3X%!.T#3"H1K\TDV'Q0O61-&" M@>5&KK,U3Y5 Q6ATJF[F#V.I"5; Z CM%TI"BY;>;%J@^@4)U*%^=(:2_Z_' M59OS7Y,VKDU20X>?T-B2L/<'YWE8[^DM^37-H$K M>3M[=#Y]--WQZCT7^3!KQ<245[WV6_ ^^KLP:7E)H"Y3;R%I@@(V;8ZN+Q(WX[<<2E]N6;;W/C\?; M=LIO2$YJ$2)?4#3!\VK_)*$90/C0-F"SI<[PJ_'B_-F M:W.;H5(6A5U77GT\+E&_L:X=K]-/#%BE9\N4MMOWY M>%KO.+ 2MB!VV3B26(9:-]H60'C/(.%CY3=?G(-.3N:K:R^%2B;6\^"5PE8;^-YDF',>XJ^&_Z#LNUH= M)DY/^W:ND>3M-?H"R7=5HZ2G?FS6I:;PVVO1./Q8E'*C;<'0I1TY=]-8A/2) MZ(]MU"_Q*XJVTR-_3= ]GB'EXU#N ,DYO?^_(:S60-).)9?L*W/H."V.W&A; M8)Z_P[E.*_@7(E7>G68M'8G??J1I7*M:'%]NM&^O8VFUZK:F;6O/4R=Q\FMN MLI,,-PP'+NLU1^H6++A.9RH;)%17G\)DM5CK;;1XG_T9M6#L:>Q9ECQD-]H6 M*-FX4+',(FZT+5"RD.-D?+CJON;#5?[I4RNS;D<@]RI6>%V/*\^=U1\5::;: M]"B6/B$"31!;+S:]OT9L>K\]\VH&P UD*G__@@11'*K3D0\$U"\LJ5H+7 M2/M*X2-7#+.UJ=M,4U>Z!8-0XY1@V4ZZT;9 R?+B)LDFS2X3RY8XNX/!0/XF M 9[#R!*?7YE?.X/W^F;QYD-GI3(MS?E2W]VX1?,%#G3"X.PT%E/*U#+"&Q;%OK"5HPXNIX53FXXS:?.!"V M0+TD!<$[BF&UL[7U;:[?X5V]G73JOO%<>P3&ET< MLS$S4D@:^[PAZI(E8@T"V@:HDD_ M_@? ?_WX_N=GKQ;I[!3GJVSL"J+ M[A3@;_V?O5Q\_M9-/YVLG@DFU,7'+M[M_L(%1I>M )Y* *5S .^5!!>9DR5; MGP/_7Y_^HE$P:X.!R(T%E>E?GD<'-D6F4%H3A.B_=#:=_^LO]4<,2WQ&PYLO M^U__^L/):O7Y+\^?__[[[W_^&KO9GQ?=I^>",?G\XM,_G'_\ZZW/_R[[3W/O M_?/^W!I@.E^NPCS5!RRG?UGV+_Z\2&'52_U! M7,_N_$3]#2X^!O4EX (D__/79?[A;W]Z]FPMCFXQP_=8GM7__^W]3]<>F7 6 MYKC$/Z?%Z?/Z@>>_S<-9GI)R?YJOL)N>OES,EXO9-%=]?UC1STJ 17G[&;M^ M!$L:5O^8U;?/^-.VDP_+7'U(%)Q23:VC_\_&/>'XUFA1FZ6S6 MO_XS_7[^H I]V('AUQ7.,ZX%>P%FMDC7/C2K:EUT%W\Y"Q%G_:N3LR5\"N'S MY'7HYC2]EN^P^W 2.GPUG9T1@(E!:[(7"IA4F29"$1"T21"*1YNU2ES(ZU*M M@UW2:'M.E+",/3'.GT,$$?(YSE;+BU>J"F0O_@>@K(6]_PA_HA7D%']>+)=O MND65\FHZ/Z/G7 F6'GC^K/ZY$\V,*E$P0.=H=KO"P27&P,:DM-,Z)!X;C_W1 M(*]+98.$+[KT;-%E[&@!_>'9[U@7N_.U=(TX=.D6.Z_/X_-//%^>G9[VWPE$ MT].+OR\$L#V'5HMC:FW-'1IG6W*]FB[3&BGF*Z"_XNIM^1B^W@3,N$.GO(1( M*Q$HAA*\9@HR5M$PCBGCH#1[%-Q=""?^,(0;3I,#46_;#*%/S,ZJ\_1NT?6: M6JVZ:3Q;A3C#CXM?%_,Z1!(\/>%3;X1PN9JX+(/(08 *GJ:1$9E0=*L\LQ*PTV"!* MDKP8S&D0 =V"\D@; (/.R1'0OOZZZ0'J2_O(.(CJ$;#B@<+Y B+R%(R4(>#Q7?E&,V,?2:^_YWP]G!3K56$8@7,D M&G(23 A>T;\B$S$*$4-H+IUK$+XS$W8<(MZ>\?NK;:!9^OK_GDU7WW[!U$26C^,<_0 L._+ICP5S5IK MN"'Y+@"L0;Z:?IEFG.<)9RP&KBRXZ"CRXH;&&S4#+J4+,5D7+6O.M^U8=J&8 M_+>G6 ,]#L:JRR'&$J3+AH,(09VC*1ZA6*8KLZP8Y&N5A+I8ZQ@KHPWD*9D'D]4F+9D,.?'80Z6A:"D(;'I%-IS*W[$>W" M,/UOSK"&.FW'L^M8JM (B!7:&0TZ.03E,@>G:!D5QOFB"RN+3!V893Y M=V?4@=H[F$8))YN$KD0F:81Y7E2N?UXL5QVNIEU_"HFGGV>+;XAQO8&&:]I/ M>^034Z1@*2=(-CI0T0:(R20PPAHTAHN -US^F^>OK:#LPCO[;\J[)U%WL[7N MYH'/CV$Y31-7:(XHF2'SP$D.7(&3)0!S'$7!P'EH'6QN!7*4$^K^2>OCILA] M"LHEP,1J"&8=.%HW($O'F$(>2FZ_;?,HB&,^G7X\=_8ZF]Y37T]U,KT!5QHL M$KD#+WDB,X0>HL@:K/3HE6.(0CWMN?3CB/94I]*MB3:4#IM1[EVW('/1NS*) MC! K29$+;&G4*68(B0(Q)CB6)$MFP3?FT-731WJR3K;2ZB)I\AOM*4IPNF8G M"(I+T0C.)+)BOL.3]:==W??DW..7],%5_B0K_R0GBBM4C&"K15+)2P@YD)7* MHBC$$"BR?<+%?DSK^R!4:ZB>IR&0"%IDBCN@<,MJ*K0$GS5"B%J)8K*RS9WP M_0GT>%EL_?8= +PZZ^I:<1*6^/9L1<9YNL@W(KZ)+ YYE95(GHRT%(5"*6TA M!2S>"^V5;YT ..!PQF05!F/PS=FG>7\,W:;VG=(?AZD[A /->NZ(C,,-CO5TF*"J/#F0H.27D MVJC6OM*C08YJB6Q'EF&5U8Q3?^\(WIK8$V.U+KD MY=ER15.R>_WU?&_EQ7*)]-_YLF")F&2C()L%EQI?!4\V3D>Q$] M,B_Y^W([&BJC&4%>G-9'Y37C_3[X,6_%HNRLO%Z><. M3VHB\Q?!QZM&-BN@VY4&FS+LRZ.(_=*AD(=R;-Q&KCDIAXH M:HC.< @AEH*>2L$GBDZ:R%=B5H(:QN[5:- M\SSP*5EVSXGB8_33UJ&Z8XI?9@+$S%!+(<"D4B]@&(3(4W_CS%I&X!)KO:NS M"ZXQ;82/B5/-==J,;?=(:<*S"B*G#)R>3MY 30,)2M$/9TT./.C2NJ+0/7 & M'.E.^@\R)$Q< ;>1TV(@-?E&14*6.;G$0A2N]6)](.11[@]JVN3!"]JUH)*260OA-&M@ZA!O:K16HZAJ#JXUH\3K6U& M+#^&62TP_>$$:U"]?T!V]WJJ1E=?IZ&.)U-5U-$92PA*-P#DQB]")QK5AKNMQ&T6138Y"&')9ZC%D3*OM])- M A8XJN0+.<6M#<@=4,:T>A[(@JW1_X'";W>W!^/J H"-3BCO!(2:0:UB30/- M)4"Q)5EC(OK2_.[9U>/'M 0VUOB^0FYWZ);2XFR^6KX+W^J:?3DF$;5$IL#[ M2 LS:@'>1 ]&)B^,*:;$UJ>QVY&,*?.GL>X;B+XE#;JS>IYT65_H H[)KLB4 M(R23:VV(S""BR6!9\5)%(=/-@DTMF+ =S)@R?]J3H8$"AG!OZI6 VTZ7]5%K MKC)DFVL)3I8AR&S ")36R9A*;%V8\"%, [AT)/(BF#/ A*A[?EJ!(V,,B<1N M(BL!F]^Y_FX;H*LY^Q7K^.L^FG M]67;B>/!*\XE)#2![#6+9*^]ARQ*-E;8J'-S?W\G9"/UEP8@3'M%-72?"Q*' MKU;T#4G\BJN)$(G5N]$4L'(*@@O:VCS!0:PW4Z4RQHO6-T\>@#125ZL];5JJ MIKG%_?9FT?TV3]BMPK1>NW]WG@3\<#2P"/H/83/,UTK%=54T"#ZCB380 MM['UE"#L9K7,JZFJG!3CK0]%,*I%U^P29N^#L0A'W M1Z!(*Y4,>!R\7^N^E T3EIP]%[$6H5$0L'9"XL)8+K0RO#6=ALB[V,X\_T=@ MWA,HNMVN_?HRCA&%.^,T>%UJT>A4P!67:V:B-2I%YG5KDFV[ ;4O_HN]/L%5 M2DDH2%ZDNGT>:1A8LYP3O56O*KK61\S7 (QIGW4/S=XZ4=A;N .TS%K^-']1 M"DWBL,+EA[.XG.9IZ.J$7BX7J7^5IO;_7DSGJW_0Q\^ZNNX'R[GG$J3E-)%L MPEHG(T!05J%)SF39^HCA(,!CVG9MP)_C*:]E27D*25;?:AQ;@]RZGO?U5^JN MGE&U0ZV4X% Q4-+7(O?> KE;+-#Q(G00S;=0[P4TIDW3!G1H)_SA#F36 MPZS\]+1&Z7J;63+.:JY^GQ]/L0;#5!2C=TQK!^IN-&/:HFS A$9B;[L[=([A M:A^"%W*+"C)PGO<%\&HK/:<>O@7;W$FG#X.)Z M30I:42YK35XBBTI*:SV#R)P%I5D 'Q4'&R.RS*TWJGT7G8=QC6E?KTFHT%@5 M0][J<$12);P"]+7&6K#D?.C@P!)+LT[TIFM-B?:Y:N^Z<[/:?_4_PNP,RLC5^3S#!?M ]]D=+9:14U9HJTIVFZFJ0BO&8F@ LV@4*"%$)M[HG" M$'F=BJ9U+/LPJC'M:C3F1V.5M+S3FP!8*,49 M3MXY1>O-CQ$?!W%,NR.M%YD!E=7XO/GB2%$5:X-!"N-0&2 $')QD%B1FSUT, M1K'6=8[N.:_=[W1R3A_Y5OF<@4Y:$MH)SF%.IA!9]XUEX9%UMWE3P(\)@"L79<.IX.FU=6N%K\ MR I>7A77B?%@7>V/:@D14BP@;(9D7%;DTDE,0]57V(9G3-%9.](TT\ X*I@3 MJ=_,%K\/6;/\\A%'K5*^?6"-"NA5E=,#WG6++U/ZMA^__;:LB"X35%ZDU?1+ MGUL\*2:5X),&;:T&54J]C. IQ)*Y> JJ-'>M#U!V1]>PFCBS%H71%AQ:HGXL MACQQ;D X&K+B*2;[;]-=> ANW%,H_#&B;WA2GNH^-K["]?__-+]1>F;"4.@L M>!V=EK3*1DNCHRC-!8#X(:4TAT)**T5=2 _.E=^ZL&0M!!X2H!9,\&/TH]BY0379 M,!'X$Z",%%9S@"S2Z!DK=[)D4/V)N506.!E>.=J M ]"H&ML]F17<5T--MR5W&/:KZ3+UUZ'/,)^_75?.X$OBR0:0R8C:X(T<05_O MT1LB@Y%8G&K>9.00P&-*?3X2YXZGX';ILB>APQ]I?N1Z_DSFO ?L'5 MR2)O7!;M4Q1>3:M0YGGYMGM5FYE?>GS6)&FST""D+U44&CP7"!RERE9BD*9U MRN+AJ!]9#.&/8C&/J>NCAI/+\SZW[_$+=LLP>UO.7ZB7E$BVDQ*CE/6: E>^ M>I'&0(R109)"6D=N 0]'+72V(^Z=]E;9'VM]/+J^VV8C;!''Q7G(Y1G)1/A0 M3%8>DK8@)DJ[,=CF"EU)"L5Z)K(KS90"7[FY .]'G:#=2GFR# M8U\5#5=PX=SHGAOEB>3DUO'6G=@>@+03/YG64O$D;)$I1$'IL*!"M24 $\":FE5LHT[SN\&[*=B*3_ M\$O0P4IKEP>^701OIO,P3]=%H(CHDBD'H7;<4H5'"-H$T#&[Z'EV.C7/"]\9 MW<'1<>CK/2\WHO:-VZT3%1W6:\N0T JR$[9/5*E'P:)VXE!8=.NCBOL1C:HS M]4 DNA71MM-1PVN'GR]1?3A9=*N+MAN3K+A Z05P1EZ%BF0I^MYT5I*M$!(3 M;]['XDXPCTP9^D.PI8UF6I;@2XBYWS2\(/+'Q46+UWXS^_S2W(0GU"ZP "63 M*ZI0,W#)1- EFR2]=TPU3^/8&=UWD"G4?-T91G6#4.M.UO\25F==7YCW(W$& M?UG,5R?+M]W/N%Q.C':%O-4$RDB:$%[6&VC. Y:4$ZV=D8G6W;P.Q3RFVQQ/ M0,/!U3P(.7]:+L]J6_BW9;-!U80[G\C1I?F2#452OM9:HB\"X:(UD4G'5?-# MA0=1?0>I1$,2K(&J!O&QKJ,IVEF*PX&>BK70A*RU[P48E1C:)+/*K;?_[\+R M/>0.#>EA[:V701VL-XNN#[6WC=SZ$$Q2-%1=NT\%1N&VXA*$CM+XJ&1J7D7[ MD1"_@]2@8[A:K90X"-.N1Q;&*V,3F=0B:DM:6;NVU$L)Z*U#HTH4NG7RV9U@ MOH.4H"'9L[]BAN%)W:)X^[G/_WC]%;LT)0E,N->(-4\I!Z,)5E002KWZA$(6 M';A4K/4=Z@=!C:G!R5/PYF!%C>-^_COLIC4EZ>;6\WGUT==?TTF8?\+W886O M2\&TFB157/"UD;"N=4ABB+5GBP494:(L4K+0.@H\[@@'VBO?=ER 3ICLDJ_W M%VMON[I]A[K?NOW3\]#U=^,GNLAU@S#JV&_G1]6OR0D M&8W- EA.!92."$YZ5;>U9 D>T9;6/!Y@&&/:4O^."/_4A!IZX5ZGDU^?N3Q% MEWU,((.O5;4%4KS+.&"R2B2NZ-76%2IV1S>F/?GOB,<#J?\IZ!FL$US5((R MD-]32QG&["%BL258GCBVCF?WI>?^*2)O%MUFP-CO36U5EI,*$1.DOB"V]PF\ MTQ*0.T,L,62"FP?WCX/X/221'$JSNY)(AM#B,#M'%UG/^:RB.N\D,HDLZ!*# M 1,] V6#K$63R5P5%;U(0K0O2OPPJC&Y[L?B4UM5M:/09:+"BT26K<,[&Q%. M??E7+R<_VJ/)W/&@MJ@,^D2 /K"J8<-(#VGSNNO'7A> MR]IJ7F@Z2$63(.=2 M*[\7[=;?W>?==&^K*W<_PX/<5Z,#2=]]JYN HYD=:B M*AX)IZ_-:]!#X,*!E8%>0);ES_?UCV'4]7$L72U4[439,$Z%PC@QO MG_]$OV!'%CC1!*O[L[7EQ%6AG$G-3_ &,T5IAKRZ;'U=0"TXGBSS$;FTK2M: M/@+>&-RH=E096C^#FK6-RV)7:^S&BWL;I5V_N(5)V6L0C4M96LTQM3YBO+N9Q %C>3.=3YN#L,9@>8;C22-UM.?) M^_#[+Z'6 @^S)85W'\X^?Y[1NGP=(F:C,^-(%M?XFH#+P N1*-1SH=Y-=,6T MSG9]%, Q'6.UYTYS%0WJMEPT%Z9(<$L/XBLGH*Z<*_QY^@5O?6YOSZ;ALULX M/T.)HI%_=,]C*W=+M-5*<\>[[] M[UVM!"\+D\G1;-4L2E LD\7.28/B& 1GND3>.C1["-.8O*>&?+FYUC5533,C M>0^JC=Z FZ5O)[[>U&=UW2WU_F_2&0+'4G^09>?96-$Z#?OQ*$=U)_=I6-5" M?X.:T?.>./WAX$8]^+U-XP/?U\+44N;6Z_D=T!I4I'NP]D\=]^VC#-C%)K& @IIB$HJ![%>_TV%\^@S MO9U;W]>^%]"8S%4+;FRM,M=$&P<;J823[15 +X!]NX#EA3/)48")]?*)\ER# M8YHB!1:,LUY:;O+]B\?.SQI3$-]2_\,(NUV-Z###&AJ^_EKOC'P,7\][TUR M8A@I_B,4CF=&0X[5JCD&I6@4(6KKFGLE#T :4\0^Q$+14B/MJIM>-IBI286W MJ&NS)6_:\WJ"3PX6T16B-P42,\4606N:;YW7';I8%SS,:B!%A-8)2.&J(L$5*R1J;:2SVW3M>Y#\^8"B4,P8]F MNFAWDX("C<4WQ/.\CBWCE2[Y*)"<'IT5*.4%1(()KMCD,HM)ZM;-QAX$]<@* M"=\=3]IJI6&QT6[Z)=1LQ"V(F%7:*&E !E&/\V4$7R(%]R%&AED%JUH?0MV' M9TP%#X:@2#-=#)HSBZ;_32/\+L[!*?%-(8D=KH4E+S$)=; M!.4+9[F_G5E$ <49N5*&W"M3M"0C*E'RYO<6&N(?58.0(]$RHUA.Z MRAKHRPRMSLL,[7TNM,-WMC@;>BST1N=#]?LOU!A"2EXC!\N=JZ4',CAIZQZM M-SX:AS&WCDPW'G^X';RJ)U<>?0A6I.(AF.C) M;:.Q!F,L1%IA$S-)DRB:F\)' !S3.=&^'+EM (?24#MG:DJS\FUYV6&>7HZ9 M*62"10/>U=JLP22(,B.MN.3SQVA=;MY)0^J%-Q M[OQL+%%7=OI77*T+4DS39:_X92UGD1:?YM/_KC=G]G0[FCRUA6/2?OC-7)=" MJT?>\$VWPYDH1G:#$3U]243/'"7YR>2>>E<"<5.6T+RBUJ[8&K2KNO&<#]A] MF2;L!YYLB<&Y!-D@#3SY6NJLJ-IW+14C6;%L^(%O !J74S, >[;TJ6JDGI8- MSFY JKVS:J&=][@ZZ^9OY_6U\^H(UJ;(-!,@9=1 ?I> $$.!$E :'XRPKOT9 MQ.[X1I6F^42$:J2] ?EUL5G:#][QY")CG)A>.5_K+[C,ZB55;8KVWBDQ_)*T MB6AUINS^K6U;? 9 MA7#UE8GQG&(V(8#K4EM0V +1((5OPH;D7.WA-/SLOHVK_9JV7F%KG2KZY:*T M0FW,?1X1&:5,[6D&2J<,2B@21)2"I)$%]T5EQUK7 GPTR'%[8P>RZ^%5KZ4* MCW,&LV7RW]Z,IS_=&(2O1P11"4#.:^=EFR PD:$($5*)HI#HCGD,\_@AC-S' M:TS3I]3_DY'X'/G&6";HK$A.&A):S?X-SI(74B)X##%;7MO0MUX_#T<]JG)H MHZ/J@5H>U-=\/?\R[1;SBCS,-NIU;;[\G@:6UR5P+NZ4[^UH'OB\%EYFRR$W M=@6^?A[XKM@,M* MKTC:W2?L-AS_B0F>2RXILE/UL@S22)VBB#Z&Z)GR0K!@[Z?:]B\>D^\WB-HW M[B4=*M<6%]%>3?LJE"N*TC9A6!ZEM$F#05FK7V0%/B:*O95D3F0G_,U;F-O4 MN_6[QW1:.+B&#Y=N"R7W%4;Q \EB.2E29X.1@_>Z=AEA]>"*QI15,L8P)LK- MANQ;-+OQA6/:IAI:G?O*L84.?UM^./N,72%?:0T@,&=1*@8Y-:9+64,KO[WL!XT#^@9SY_W"U]>9KSSCEXO3SXMY M+?V\*/VPZ@L=GM0PZ$MM0+$XQ2JW7W'_7,/&SV\1)PPIDI8U+NYX](]8%EV] M7CR16F2N8H(BD1BLZO4=E2PQV 9&O"->M]X*VPE8D\2E.QYR;XR^&9R_R/_G M;'U?_TI@+G"E1"T/+&IY1DU3/@J>P-&_C(B)O.1C"NR0L8RJF49[NF[-J7IJ M2K3-S+MC-&2X2&?S]=Y2^O:Q(^ AK=8#['\[U_.6P3#/O,='6J8#M7PV(U0[S$F(3D:"4J*?K.' M0<@Y09(A18S*NYO;9V,U/]^1GS4DD8_(AZ/P>^=XJ*+WW&N27P(6;:EW4C2$ M0A:]UMCUBE$ A*,,B1_O-#U="#PD>0=3]E&HVM>SK\C("BB%,@%*KBD,#Q*< M- @6C2M:)F-;I M @,-Y;O9Q]J+J@-O8^W%AY'N8EV.15AIBZ%H+=I,BU2D'QZ]!^&38$DD9N13 M1P2[C>1[\:T&9_:1R##VX*$.MAIAGY.L77G1!IJKQGKPAFG@]$^')3/I6AU> T/RXU!CTU7@_S)'2?YIY_\9@96 MFY7C3D3#=,851D9?A"-GIM1,QEJS-&<'.1>T6B5CA;F?4Z/OC#N PG=KE?L8 MV0YAE)6K[LTP.J](F9J6QM(X3]@(ZLNN,@S!N*+T-0+$#)@>A]K$67HQ MCDA82T]'\A]<8"1'8FZ^$VYEJN@\/)<.(YI\">*2@IU082,4%P2@-& MIDG+DI&O_T0R&J'=1].0H<;98VVO+M_]::] M']6D<%.;@3:*RG[%U55.QX2;D),S!FIR""@7,W@M&(3B'7D16175VJ!< W!X M7[W++"R:E>L*"&K%:==-XMJIM JN3_7G1U3V3 MU_0'9*NE\4Y(IJ%XI-4SHX)@50')?6+6,F-,ZT3N9N#'E+ Y%.>.I=MFU/QG M+VW,+[X0V$_XZ]EIQ(ZWFZ@0YS\*!=+TO M(U,11Y+'=H!C6NB'Y-K-:3F<%EM:A?7M@S![N3@]7GY<-1CL@/'I.21 M];UC\'3^>OT1Z;%_^]/_ U!+ P04 " #C@:I8>B_^5BIU "T/04 $P M &-E+3(P,C0P,S,Q7V1E9BYX;6SLO5F7&T>2)OK>OT*WYO5:R?>E3E?/H4BJ M1C.2R"&IZNG[@N.+.8FN), &D)0XO_Z: PGFABT0'LA,L*I/4YD@&/ZY?1;N MMKGYO_[W/SY>?/<99_/Q=/+7/_$_LS]]AY,TS>/)^[_^Z;=W/X+[TW__MW_Y MEW_]?P#^SP]O?O[NQ31=?L3)XKOG,PP+S-_]/EY\^&[Q ;_[]^GL'^//X;O7 M%V%1IK./ /^V_&?/IY^^S,;O/RR^$TRH]=?6?SO["Q<87;8">"H!E,X!O%<2 M7&1.EFQ]#OS_??\7C8)9&PQ$;BRH3#]Y'AW8%)E":4T08OG0B_'D'W^I?\0P MQ^]H>I/Y\M>__NG#8O'I+]]___OOO__YCSB[^/-T]OY[P9C\?OWM/UU]_8][ MW_]=+K_-O???+__VZU?GXTU?I,?R[__/+S^_31_P8X#Q9+X(DW0] V?%U__ MX4TT^OO57])7Y^._S)?__N=I"HLE07NG\-W6;]3?8/TUJ!\!%R#YG_^8YS_] MV[]\]]U*$>/F$Q9=/ M^-<_S<_U:=]WQO3!P(R2Y<1@3[%257QAA@W M/;T_YJ_/@HPE7%XL&B*^_^RF>*S[]? BL5%]?H9ACC./1R\EB MO/CRTZ1N"N$*%/ZTP(_S42DLI( 2C.<&E/ %7$$'G!OE56+6:'&?DOF:XCFF M/[^??OZ>1B%>A*P_5-'(%2D[QU[)J\>,QCA_%^(%CI@H*;L@00K:@E0N')S/ M!K@V:##R'%SJ/XGU<+=Q7S/];+:>P96R=UJSRVSZL3ECBVD+D:T((8__JGQ>P2KS^<3A:DMB\OL!HJ] KA^_K#L81?SN%] M")]&;Q=D[]0'/;\(\_FK\G8Q3?]X]L=X/F)HLG3%@[(B@5).0>!2 B8C,1?T M(9H="E#"/"[YN1III05XL9BO/[E6A[U@&JK'CNUS@[HY-_$ M\V*YV!^$:'1G$V_$_GTT#6G?:H%@<^V M '=1:&G1HX]/E/U;]MP#DM]%Q$.0/OWX<3I9 OIE:=^-=$854$7(J= *1_R MUT*#S-&D8%T*LK3F_"Z(EI1O,HKO\]V7F;M$]Q+K?9[9L3PG'+W\[++5#2++A"[T/GKF"9TO)NN0$)5M-RY?TX)4UP% $C"GFXG(_HLV9$WV, M).\3+88BVE[!$S&+$H(%FQC!\Y[@Q1PAQJ@,-\R))/H1;<^9]H.131 M;KVST,J2DM*@@V7DM$8'D80!OB03EEA8(V:8H$AF%0O4*KMT<[72L#A1E.UIT#>WIFSC^]V68+7!V M\>4-?IK.%J,07%:"12A1<#+QN8 @L4 ,4B=9HF-EE[=\.)MW!CX;8OL(M*$I M?1/2:YR-I_GE)+\("QPI49CSDE0-M2>3SQC:(.H*0K/D1IB(=D.2Y0B&;PU[ M-OP>+\R&]O.ME606)O.E+-<:E[R29,Z!5=748U*#"\A!A"Q]EK(POBOXT6%! MOC/RV7#<2Z0-K>?K:?XXOL!?+Y?[?A%(SAH-SH*LBJ8+>*>07/58,EGXDFO9 M("-W/>*3I[67"!O:R-=8WN#[\7Q!6K;X-7S$$0\ZJR@S6,;)3'3"D0E0,G#- M2](BY6Q;4'I[U#.AM84DEQ'XY]/+R6+VY?DTX\@Q86S2 M&8J($E3F6.F/YZ\"[\\5.FO61C(6&S ^(:ASX3MOD*] MS[1KQO1S^O'5[-WT]\E(*>VYSQRTR @*::;>*@))P5$PM?#81/%F-H+@B\['X"-)8'\D?3$ZU,-;/<1[89H2:^0V"U@KZ?S1;CX_\:?5M9$CCJH6O*N%,%RUM*^H@-P<@P3 M)E1!-B@@W#CV>?%]O%@WL-TK.%;7F6XEP Y^]8EUO:[*+9LA%?#=>7.!(+S,DI$W1LEJ' MXAW0(B'!ZJ2M#"XSTV^GO3OBD^>SEP@W\-DKV/5N%NHQM;=?/L;IQP6VUCKU\H_T(4S>XS+0 MIK.V3!0)V;((JGBD=;]HD#6#J6C.)O1_#&G#'?%9\D:F+V;1W_R7#<3[0;. M&X2J?IHL=@X9D-PP947.&HMO<^!K MT^AGPGD#T6[@O$'0JN; 9L_)Y7X_G7T9>2F3X4P 38?<+VMKE6\TP HSJN10 M<.@9\+P\8+<0&R#2-7;C^'BXH?+.4UO/A_E8E2.44%DGC:4Y,B&C]4Q M\UI+X8T3-C<@]M:@9T+L\8+<4-[1(!SU\B/.WM.V\;?9]/?%A^?3CY_"Y,N( MIZR=# &RK&7;/&3P05;5DUFJ(()T+=*(&P<_$Z+["W8#X;TB4E<*^ $O+M9P MF#&F'K8@U2.M4S$%\-8$T%%':X/&W.3T]H\6X@=5>,:HK*_#Z+-7; M#V&&\U>7B]IPI'IX(\U-=E$42$AFH#)D!D8LY*P+HQB+EHQ#WL+,WH'A3%AO M)N8-6M"@BNLY68&SH%U$J01.:,*( M03%D/F<5^B46MHS\Y$EN(M(-/#YA4 WD-PK)'8;TZK>>X5*KSP-M!X%=SZU^_O2(-@_N/89EV_3<)E'B\P M+^-QXX_/IY/Y]&*<:U?$K[TQYM-2W809?JA=-3YC+2O]B#]/Y_/;: ]I\]5W MP 8-PIK.N6=KL7M]2*YU+HL0];*EI!+U0$5&(+<[@Y;(C0]DI[O!&C)]1=&L MW]2JK9*7T8@B'41R,T'ER,!IG3-!YKQ.?6EE+=Q?CH M.H^]_*_+E1OZ:3JI+]JRVXX-3GJFR--D85F+KL&ALO74IU9*\FC#KBJ&7HJQ M"="I.Y"U('J;SO06^ #]B.Y@NCH+?@BH@;J1;03TP W)^A,W'4KJ)U.)I$50 MA99):Z(%IS:1DOJHTU M(F,[RT(S*L)%4#7=X%(.P$5"ES'&U-SXN1[]]'TQ&IL+1PJR8?^$-9)7BP\X MVV)(_XJ+5^5=^&/EZ=+G,PQS?(&K_SZ+]'X_6050$U?EH?9:S$*$33)R]\N MEA& 9_D_+^>+*M7UG$=><[*^R!"3S-,:Z6IC X89H@XIE!B<#O:$ZGC\3$ZO MHJ?6J0XJ?2*%.+&:OR!A?@ZUQNKE'^GB,F/^NN/?DW!9X.QZ=O,Z;9IDDR3G9V2BCM;;WGM _E?[!U*-A;Y=#)O=Z96,3T.6W MZJFJ&2[&L^4>^0-.B/K%ZPMZL3>\TK:0L6L9^=FJFM=), @ED#%L"S+D4>BR MJZBWM=;WF,H_]?T!5*)A>YLN4AUA8%(F3W*S6"NSC(!8!()FKI3D0[2^M=-T M"*YOPA;N)/P!EL(-\-;0Z#=:W,>3]Z]K>3W)?;&8C>/EHD88WTU_G4YJQ)?$ M2X]^OTR)X'PQ4D+FX..RJ7$]=TI"\6C:-=:GQ%)Z\VCTDI0,L M83NFFN_L=-7/:Q"Y -5.%P] M_%35#)OF,ESE@M$Z.*<#R%@C(K&V+\6E4+N029(HYDR=H:1Y" M:_!69N#..^$8+7*VM:'\-"H7.A#=J7*AB\!/EJ8^!-2W7KG0B;B#\M7'2/UD M*A$L.EF[TWH(NR37*]FG8T, M7014R8&J]WI'1BLA1V54).?;-M\6'L'U:@W(V7O#6A?)#E#1\*[&JB]G7Y:0 M5NBN@$41JA9'8(X1,')\(48;P"<,M4=C(D.I,>5;P9P#]6TD/<#;_BSGI3## MQ>LP)K_K>?@T7H2+*W"<^4 K6(2:,2!PGMQ=QA.@B<*C)7=7[SJQ>(P:[ 1T M#JK03N(#A-[?X(+FA_EEF$W&D_?S]06!BC21>05>%K8.MVH!R7KN4#$MS:X& M!,?HP68DYZ #60\0$C[64J7'R\O:JAE6X[H"F@U>%A(]78;&4"AM> SX0[* M>L435U[O:C=RU*)P*+AST(]AF!@@)KTY4GZ%+01=+\GAX*RNQ9HJ0$@^@,O9 MI1A45J7U*8A=>,Y!,9K)N^%-&&ML=PL@?EK9N1^F%_3\^4H6;PCXC]/9[V&6 M1Y87,GL\^4E&T6HG;:1]3DK($D4J3M**U_J:[HX0'T4>HT^X&/_TW ]*UMV8Y+&2 M'L#_N#_+48DA%-J\@#:Q&FXM$5QR";2D-X$QY8)IG+BYQ,^ D66(N8FTD5J_2+F1?I]I6 M*B@9.7,R[6R^UU#-MH/\)K6L$6<#.$8[7XLW9+//QFE9TD!?>U;%LZPO(5$5 M'"\NZ3LCIJ,407H0)9,U'RP'FHD![W3A+@2CY(F4[G#0WZ02#L3I ![:KK?H M(/R>1^6R9!#IA:*7BI'KZ@.]5 :CBE*78EHG ?MB_B95)CU4/_\ M@22X/,B#D_GRS-J((6=:(H).@1-D+\ YGR#91$M[#@73KBM?VAM]&V%^DWK7 MC+>&5S4>9$)L1ER$)+?'2C"*UV;05D-$K\$J840HC$5L':'JCO*;5+16K#6\ M*/(ZN??U6.&[Z99,WQ)YO(O\#9+HYN,%OL79YW'"U53?8)J^7U&ZG/7(V\QH M629_*=?\H-<%HI0!DA#>TWGK\*/2B(;79GY-2N#B^@39*&6C ME*M'NG2\K%M>GKE&\V+\>9QQ MDN(>GN5,MR3?\,MY! Y-SDP[EJ?;-J$X[SUH+?D6]ZNN09U MT,E2DW(.TF@PNC8?]9F!QWJ2@T^ M!S3H@O&\?5/(W4FM[O/Z93R9SM877M5#D4YI(Y*64(Q.M.8XTDI5?*U'B2X[ M'T5IG:J[B^&\7]U>$F]Y,>1&$^2P@[-!9"E;KYP+Z:04WY;)O!_UC)<22U"*+V M):?M+=:&5@(<)P_)<%N$\\9G/O0"=2SV\];)!V&XY29YX*!Q$-N6C),F5:ER7LWA-;V"]'->GP:)-,9%+*7%.QRTN,$(])BM:^8!ODY_WJ/0"[VV_!;-H+X07.TVR\+ :8%G)ZGJ\NA N3_$.8C^?3 M\IJ0XV2Q#*_]&F:S9<.X%[4>_^*(^Q_Z#=>@7T+#^3;JH/#W,!M7K5EKR>H> MDI^_UK,F),_'N@#H576#LH985VM6VZ09I1-O[MCM@=1[K4P?,%]>X*NR<: Q MSE>'R%&$Q"WYL%S6.DOKR*22UD$VCDF1!)>B=>#^0&BGZL;04C?NK6D#L/#0 M/1OFL\7HU>\36J4_C#\MSQH7F9+6&, NP[XJ.PCUGDOZS#L59!3RH),W].0; M^D._7>O.O4$?K ?#$(Q.6TBV817T+2!7)T0.@=*E_<*A9#]$LX6>1&RBLX<4 M!R:6_!.>M%? 4@B@&.,0(_WJI/?6I9*+.ZA^ZC$0NJ5EPG!\=A%>0QX3CFXV MH?H[+>>U M$I^V%M< !XSN>LE?)_R:=J5J);_''[Z\#O4:TI$TV2N?$]DBMIZL]!%BT81< M68[)&JV:]S_H ._T_NF0MMM0O&Q5H:8^Y[.TJM*HL:H7X_FGZ=7/Y(35_LN+ MYV0IUG?@UB_]?<\VPS;P00>8?R-?=%D">YD6R\JQY]/YXMDDTV"D0S4O)X$9= RC1;2M'=)#<+7S2F^-MAQI>;*\CGME03LKC"XH M0&GYO:F-6MKFH7Z0[LT1P"Y7Q=U4Y$['!MCI'BP,1F M89ROF2NKLP!EZCU +EMPWF^I$'JPJ]J*SR[":^RJ7EEGSZ>S3]/9 M,NI_Y7J)4.-@%D$J0YA*B153 LT+S"_'SZ<_+_*Z*Y15+M:*/%,,ISUC=4U+)(NCF*PQ<Y;7/AC/V9XZ&7<-^V14W-MPK0-V!R!K:(WM1G-ZX^QTK$X' MI:3Q0K4'H16T7\?L$\O>&(3D/.W5==ID"#N0O# E4F3"[C<<=PQP M6DND)073YO)K:$LNE7S=3NYO.'T_"Y\^C%.X6&JPB\D(SAV(>N"#J++@HZ#) MFFQLL,9+==!%]/OLCVT SMJX:"+UAIV/EJ!6(;Z;D*Y4_A!0#8V&K4 >P%YH M0]1T*"FW=EBV@C-<,1%J,M9$4SLF&7#*ENI%)69BB=H>=!W0XZ)^U^Y_0N:[ M"+?MKOX;UIK=3W_#V<ZP,D/>/%^?/EQW>[9!<"H 1%;/2 ME7N)NDVQH$V/?N+L]1?7()U-KU:9'R[GXPG.YU?37ET;XS4+P=D 0<=$"&V& M&%(FRS.FD)T)W+9O\+8#T+F:9.W9&*)?X K+U4MP")B![M^Z!>2![]WJ3]1= M%>@MY2%6B5N@0DGD:99$^TPF4)K6OZADK9#C4N9ZSVQN?DI\>,H/O5]K8,:[ M"+>M*?9R\IXFAC/,OX1ZL6FX6)=$LA29C2R"=9+3'A4]1"P*' _,J%"8UWKO MEK[U\0_0POYXB4\;BVN "M+-P<(-]8HC+8*T47.@!82!$E&!YSY ]B9JKXS, MOO7V?C"XTVO%X+55PQ S@ :]GDT38I[78\YO0S5[Z)-,HAE_QF?S.2[F(U0B M*/H_J.>7Z[E*#H%S!F* 52U<6P=NP)/&OP6&0V.:L86C>HW(WH#)6D(06#W-:VU65Z M^< M_C3#VH>?EI=_C!?TU;^+A*&@/=2JBOQQ/>7*" M*8.Z^ 2Z=F93Q7'P01HH12A7C-;F;F;X_$Y.(*NGCBW(6%MP9<;!94;+?TJT M#5@32VE]$^)3/3G115MZG9SH0,EC.#FQ/1?%2BFT[Y!%D5FHC1 -[4"6@),U5-(TK=GOHMP3Y"D)P..O */4#):4*%80F(4 M6,5R85%G=D#-_V-.TG>2]YXD?1=AG2))CT$H*8.MS1(8.8XF0BA9@#"YQ!)2 M27C @8W'G*0_DKW^XCIYDMYDK7@('@H/NIX(R^!9"/2KB\H[[NT #0R?>I+^ M").L/1M#W%!Z*[5U")AO-4G?B:B=*=MCI#QXDCXIVE60WIQ@=.V4KP)XTFLH M3%M/>Q$+JOD59(\\2=^.\2["/5F2/C@?1'$@4Q&@&#<0>9+ O+$B,F=I:7NZ M2?I.$C\H2=]!7&TMLE<3?$<:_8X,Q/%D>:+W!YR00!?S4?3)>\L3".XS@8JD MH5I$<*2ZV6GIF,I[.=S^_$>:Q3@FZM9.C@/DSV_-^FJZSU(BNW)6[9 7^&F& M:;RZ"LY%;9.W&NHUEJ"T1/ F$G*M>>:2*9T';>VS&]X9:L>;AN".E+@6"M"D$U%;FLG=QN/_<,Z*XO]RV6N1-\Y=_FT[S M[^,+^CC_-%D$VJ/()UEEZW_%Q76";?V]H[.1QP[4(+?89(Z-,H7K,:ZURQ7+ M.5H!)<1ZX-'1B^U)V;QQUG*EBI2MRY?N@6B7 UP_>N7;1L^]9X5!*B;7^Y)% M3=4SP(2FQ!Q\+LVOA-T,Y52YO7[\;D_D'2_7AT[:'>80"72J9&9 1$UK+ 8% MOEZ.D"6+"GG./K>^!.211XYZ,-XI2M1%\H.'"@X!\ZU&B3H1M3-F<(R4!Z<^ MHTU"5P/+()*!BQ&\U.0H*15T29%);+X"//(H43O&NPCW5%$BC[09DG<,(:,& MY1@9PT%E(%L[92\,S][M=2(>;92HD\0/B1)U$5?;*-&SA(LO%\\_T+2NL%AF MF?":0S:2@5+&0G :H3B6'#?".;;_%,Z]QSY1ROJ)9X@R^"O+8:2CXB4PTI%8 MZE$P03@4.9ZFGO-ET7O;O%'Q>NS3<]G6\CY*A@/$[[Y:@;,PF5\L0T'/)OGU MY2Q]"/,:+)I>3A8UM9C_\W)UB&<^(D12>IL@9:E Y7HH/"I)OR87>3 BV-:' M(H^ >2X:,A0S0RX,T9;"(SD2>7G27T8)+BE'"U\QVAI#WL9!'4QZ+PS'S^&G MCY_"F+9)$O3EQ\ME4GWU495T/8$R0L%S\4)#$(+>7)HPN4R2 TW>\LA43"D- M-,F]X,Y%^=NR<)HC&X>& W^L8^'/X\]X[WN#1T$/&/N$@=&NDF@4*]TQ[(W@ M?!8BVE / HE<;UXFL[CD!$85U$J6[$OK@\.'X&H74=TQVM6%;EXF(7T!P4UM MP\T3D'-@ V+VD;#=!KN.HI]Z$X5=VVN*]M#L4T)>2S1V1V3^N'++^$_I[/G M%V%^5;S"@B9_B)/<9"3W)C'PD78/JY%S7R^Z2@>U0&WSRMV%]_"1V[8*,CT- M40.8FSN@7@.]T4WT$+@#!7\[0GV8\/!@U!^N8LUX>P3JYKG*(F8.0CEZ"U,0 MX%RPH)DN7F*(Y).=HYKM"4D_5BWK0M< VO7S.%4!DC__?H;+O7<=F!7)D-LD M!%@,]99&0\!\O0+#:N6(-!2,-]:CK6!.[U<.2N-T" X&B-(]OYPOIA]QMJSN MK\?6/XP_K:'19B\9&9R0EK&61+ZV3\9!5(PE9,H4V3H,L0/.>2M(*QX&6#]> MX&>\F'["_ [3A\GT8OK^RYOQ^P]?-3C4$KY("Z@JGJ8MF0=7C 21)-=8+UK2 MK;VX/9#.6U5:\C' X9E7BP\XNR>$%30G9$G!:HB:8^VRY&O_' %%,B,-9RZK MUA5C.^"^:H= 'LB%/P+NP[CQ@ZI!-Y5KQN$ !M,Q MT",:GYV+$%..M=TIH8Z1@PQ)1C+\?.&&@1&1P+%"X$0L8#CF[!EZX5OKU4Y I[>Y!J=T M.A0? [C[.ZR$O\UJTELP1\8?S\!RK23C.4-DM;#,2LM+8[RF_KW6I!U0#QEIM87I6[H$>>Z6"#"Y!84;4!<@9Z1FW,5$HBXT0EW?K\ MRFY$9Z@T#2D8X%:B7<&C#D7"TO&@,$HR::VLUW#53MJ9%F=FR6A&C_;NX8HA M5Z1'7=']D*O44)3>5TS] -MBEE$;6E5!&EDOEL-ZLR]F<$4X299!R.F@&V]/ MN"TVEB;^L%ZTK!_1?' M#J@@M:''3Y-4[?_\;OH&)_C[J]G+9>'SR+F@G34(-M%+KC)+0"\0O?T^F*Q% M4IRW/H!S'-)O2Z%:479?T=P#'E/8$YD;_*C"@>.?\+C",1)I=&2A0Y3]6MVM ML,+5,SA.I5)/]C+R:QPIOM9))J%1R]9[[3$XVQUIV#/Z5<<+%@.3W((LJ.J5 MM+7A%5>@2_!":9>=;QU#[8;P5$<;!M>I[4<=FA/U6(X[=,V&&6-I.L8 *[S> M@L?K>3;F2*8Q*HW)&-=:&9]<[41[9>E9/]&%M$>2P#X$\C_K)P94@P:9[&,X M?"3J%X5P,==Z?F$$J&3( .;* N?6%.\+LZJUX_)HU*YQ_<2IM:X+=2>OG\C1 M>:]1@%6Q5M1BA)#0T29 'KW/(9.E\L_ZB5Z4=JJ?Z,+' (GQW5VO"DM91Y% M.&W)%7R0. ?.M=@CL1-3.?G'' M2'GX>R30YUE!%<< KFRQB@A@RJM"]@?>X? =HQW$>ZI.@1:Y[B7 M7@*/HM &F#,$EVHK?10A!BTMNT/X4^H0V$GBAW0(["*N 7;U/;O4RS_2Q64> M3]Y_[4+%4'KN7 'GZ[UTGG:LZ$T&(XW2VFLN7.N*B:X8'YVAV#[:-RAMIU>S M PKS,%OE:@F1]4@RBLE"E,P"RREYQ3PMFR?V5C4\3&Q)X^XG+_3=), M>5UB(!GY",JX>JM?%A 8F>O(G(RN=>WA<0M@T\3F"XPWDG5O/TQG"]K'/M:/ MCTY6'O#,!@G(KL@;)167 [V[&NCZ76,R1U^KW71(OAYH5_36D1,?)*FZ8:9P MV=P,@!9%DE)F5NS9@PS3@?3RG M2OHUX'Q[6J^GF!]+$N\YV<#CQ8\AC2_&BR^KJ&N,#(OB8(PDVX0'#TY[1XZU MR31!#+)YGNX^BH!XF0M27JYW4 M]Q#TJ93 :AV%U/3"U.[*RFBRJ10&8A@*)-K7-_ MG0 ^S!K1B]*[39H'XV. Y6+9WO/K>_+#=#:;_DXKVWQDDK$B%0ED)]4*24VX M&!1 M2 MV;PB92_N1@4IM]W*:\\"O5WN)D/)W]-IECNB3?]M?I NY5&&W\7C(,(\HG=")C.E DFP86R9LO[U]L1]>,EEF6Y5:10]*,')[I510 M%"FUB3PD5'N)/F2DI\]U<_); M!$76*^U@"+X$!E9$Z^E_ M)MP];]SU[3X;NIO+LV'L=Q\\#1MQWW<2:W[I MYVF8W(8GDY/<\D+PG*"IUXOH2ZU(E#(RFYWB0NZE^Y"1GC[=S>6YM1UV^\7< MK>$5(4/0#!A&42W)"-$(2=Y#3"D*6XC5?HNY.Q>ZF\OS/MU^J,5\#<\YX5P) MM?V=K;D$DR#4NE6I@[>1I((Y]UO,SX;NYO+<$&;I$U;;J8Y^;4IZ%QRS"HP, M%E2T$;RLEF7.3I)"FGO7;79]O?VY\-UA>R,T!"4++3' MD%*Z+,B@K-?,1FN<%[[?^WTV?#>7YP:^APJL2;;61TS>BD [C=2$C]7>N %I M)=).>JV#T&:_+W;(2.?-]U'RW,#W4)$U*=9A_1C(*\R!G$/'"9\MX!7I8R9+ M,ON@%6T^_?@6WP3?Q\AS ]]]0FL[\)K;V>7EQ<5I$^GTX6)*AG]>Z=?$D"&(>+-_@9)Y?X MPW22USTHC73&659O6^;USF]7+Y4EJ1A#3H7+1<:TWW3K..C3UX(AI;Q!(?I$ MWWX(DW]VC<^^NF3VU]B M&RCL?;5=131_';[48KUU.M;(7.IAWI1CJL46@L!Y 58+C+:@#ZKU?8?W43QQ MOAN)=P/C1P?5YK/%Z$V8O,?5T7_A<@K1 3>Z!G+I#Z<3S4QB3E9D9D0^A&1Z MZ@V"Z;=KKT$#+;OY[[BTM["/\N?3TD MU[#2Z"Z<;)!Y46@7,'47R$*!,YH!%YR'F!&=/^AH^D,3N*4HM#U_7036F+=? M2%(?+S]^K4QD!G.]:<.[>H9)DDV>F(?"G4(LLLA\T 'A/V,OL4]; MR*QA-><22/CC!A#/BH\B,2A>UQ;F:,A^IHF)E,FCCK$6*K4@[^:@3Y"\HV4V M0,']5_^X;NPC[I-R3&3 &&NG;\? 95NK15W*2B0;U$%63 =3]1: A[92?VYR M'NMXF0[>R^_F>='E%2CY-=E^]!?A?>UD9X-,A8&A*8(RRH!+*D+PB=$*(XSP MK6^(.AS=>:C&0&P,U<+C9M.1$5."S'F9:*7BM,U@)D/'\21,$BZ[R?P\#G'9>6KDN<\\"0M%^0HJD&$IK0:="XNR MN,1SZY.Y&X&0M;6RT: E76]@:A\RTWC/Z8CX/=3HI

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